
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
          "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html>

<head>
    <meta http-equiv="Content-Type"
          content="text/html; charset=utf-8" />
    <title></title>
    <style type="text/css">
        table.diff {font-family: Menlo, Consolas, Monaco, Liberation Mono, Lucida Console, monospace; border:medium}
        .diff_header {background-color:#e0e0e0}
        td.diff_header {text-align:right}
        .diff_next {background-color:#c0c0c0}
        .diff_add {background-color:#aaffaa}
        .diff_chg {background-color:#ffff77}
        .diff_sub {background-color:#ffaaaa}
    </style>
</head>

<body>
    
    <table class="diff" id="difflib_chg_to62__top"
           cellspacing="0" cellpadding="0" rules="groups" >
        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>
        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>
        <thead><tr><th class="diff_next"><br /></th><th colspan="2" class="diff_header">Original</th><th class="diff_next"><br /></th><th colspan="2" class="diff_header">Corrigido</th></tr></thead>
        <tbody>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__0">f</a></td><td class="diff_header" id="from62_1">1</td><td nowrap="nowrap">APRESENTAÇÃO&nbsp;DA&nbsp;2ª&nbsp;EDIÇÃO</td><td class="diff_next"><a href="#difflib_chg_to62__0">f</a></td><td class="diff_header" id="to62_1">1</td><td nowrap="nowrap">APRESENTAÇÃO&nbsp;DA&nbsp;2ª&nbsp;EDIÇÃO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2">2</td><td nowrap="nowrap">A&nbsp;Portaria&nbsp;SVS/MS&nbsp;n°&nbsp;25,&nbsp;de&nbsp;1º&nbsp;de&nbsp;dezembro&nbsp;de&nbsp;2015,&nbsp;que&nbsp;aprova&nbsp;este&nbsp;Manual</td><td class="diff_next"></td><td class="diff_header" id="to62_2">2</td><td nowrap="nowrap">A&nbsp;Portaria&nbsp;SVS/MS&nbsp;n°&nbsp;25,&nbsp;de&nbsp;1º&nbsp;de&nbsp;dezembro&nbsp;de&nbsp;2015,&nbsp;que&nbsp;aprova&nbsp;este&nbsp;Manual</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_3">3</td><td nowrap="nowrap">Técnico&nbsp;para&nbsp;o&nbsp;Diagnóstico&nbsp;das&nbsp;Hepatites&nbsp;Virais,&nbsp;estabelece&nbsp;que&nbsp;o&nbsp;manual&nbsp;seja&nbsp;revisto</td><td class="diff_next"></td><td class="diff_header" id="to62_3">3</td><td nowrap="nowrap">Técnico&nbsp;para&nbsp;o&nbsp;Diagnóstico&nbsp;das&nbsp;Hepatites&nbsp;Virais,&nbsp;estabelece&nbsp;que&nbsp;o&nbsp;manual&nbsp;seja&nbsp;revisto</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_4">4</td><td nowrap="nowrap">profissionais&nbsp;de&nbsp;notório&nbsp;saber.</td><td class="diff_next"></td><td class="diff_header" id="to62_4">4</td><td nowrap="nowrap">profissionais&nbsp;de&nbsp;notório&nbsp;saber.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_5">5</td><td nowrap="nowrap">ações&nbsp;de&nbsp;atenção&nbsp;à&nbsp;hepatite&nbsp;B&nbsp;no&nbsp;Brasil,&nbsp;as&nbsp;atualizações&nbsp;desta&nbsp;edi&nbsp;ção&nbsp;tornam&nbsp;mais&nbsp;ágil</td><td class="diff_next"></td><td class="diff_header" id="to62_5">5</td><td nowrap="nowrap">ações&nbsp;de&nbsp;atenção&nbsp;à&nbsp;hepatite&nbsp;B&nbsp;no&nbsp;Brasil,&nbsp;as&nbsp;atualizações&nbsp;desta&nbsp;edi&nbsp;ção&nbsp;tornam&nbsp;mais&nbsp;ágil</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_6">6</td><td nowrap="nowrap">o&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;fazendo&nbsp;melhor&nbsp;uso&nbsp;das&nbsp;tec&nbsp;nologias&nbsp;disponibilizadas</td><td class="diff_next"></td><td class="diff_header" id="to62_6">6</td><td nowrap="nowrap">o&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;fazendo&nbsp;melhor&nbsp;uso&nbsp;das&nbsp;tec&nbsp;nologias&nbsp;disponibilizadas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_7">7</td><td nowrap="nowrap">pelo&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;com&nbsp;destaque&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;do&nbsp;acesso&nbsp;ao&nbsp;diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_7">7</td><td nowrap="nowrap">pelo&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;com&nbsp;destaque&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;do&nbsp;acesso&nbsp;ao&nbsp;diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_8">8</td><td nowrap="nowrap">utilizando&nbsp;testes&nbsp;rápidos.</td><td class="diff_next"></td><td class="diff_header" id="to62_8">8</td><td nowrap="nowrap">utilizando&nbsp;testes&nbsp;rápidos.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__0"></td><td class="diff_header" id="from62_9">9</td><td nowrap="nowrap">›&nbsp;Os&nbsp;testes&nbsp;rápidos&nbsp;agora&nbsp;podem&nbsp;ser&nbsp;utilizados&nbsp;como&nbsp;testes&nbsp;para&nbsp;investigação</td><td class="diff_next"></td><td class="diff_header" id="to62_9">9</td><td nowrap="nowrap">›&nbsp;Os&nbsp;testes&nbsp;rápidos&nbsp;agora&nbsp;podem&nbsp;ser&nbsp;utilizados&nbsp;como&nbsp;testes&nbsp;para&nbsp;investigação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_10">10</td><td nowrap="nowrap">inicial&nbsp;nos&nbsp;fluxogramas&nbsp;de&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C;</td><td class="diff_next"></td><td class="diff_header" id="to62_10">10</td><td nowrap="nowrap">inicial&nbsp;nos&nbsp;fluxogramas&nbsp;de&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_11">11</td><td nowrap="nowrap">›&nbsp;A&nbsp;complementação&nbsp;diagnóstica&nbsp;após&nbsp;um&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;detecção</td><td class="diff_next"></td><td class="diff_header" id="to62_11">11</td><td nowrap="nowrap">›&nbsp;A&nbsp;complementação&nbsp;diagnóstica&nbsp;após&nbsp;um&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;detecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_12">12</td><td nowrap="nowrap">do&nbsp;HBsAg&nbsp;ou&nbsp;para&nbsp;anti-HCV&nbsp;pode&nbsp;ser&nbsp;feita&nbsp;utilizando&nbsp;um&nbsp;teste&nbsp;molecular.</td><td class="diff_next"></td><td class="diff_header" id="to62_12">12</td><td nowrap="nowrap">do&nbsp;HBsAg&nbsp;ou&nbsp;para&nbsp;anti-HCV&nbsp;pode&nbsp;ser&nbsp;feita&nbsp;utilizando&nbsp;um&nbsp;teste&nbsp;molecular.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_13">13</td><td nowrap="nowrap">APRESENTAÇÃO&nbsp;DA&nbsp;1ª&nbsp;EDIÇÃO</td><td class="diff_next"></td><td class="diff_header" id="to62_13">13</td><td nowrap="nowrap">APRESENTAÇÃO&nbsp;DA&nbsp;1ª&nbsp;EDIÇÃO</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__1">n</a></td><td class="diff_header" id="from62_14">14</td><td nowrap="nowrap">no&nbsp;Brasil&nbsp;e&nbsp;no&nbsp;mundo&nbsp;<span class="diff_chg">–</span>&nbsp;distribuindo-se&nbsp;de&nbsp;maneira&nbsp;universal,&nbsp;atingindo&nbsp;vários&nbsp;segmen-</td><td class="diff_next"><a href="#difflib_chg_to62__1">n</a></td><td class="diff_header" id="to62_14">14</td><td nowrap="nowrap">no&nbsp;Brasil&nbsp;e&nbsp;no&nbsp;mundo&nbsp;<span class="diff_chg">-</span>&nbsp;distribuindo-se&nbsp;de&nbsp;maneira&nbsp;universal,&nbsp;atingindo&nbsp;vários&nbsp;segmen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_15">15</td><td nowrap="nowrap">de&nbsp;saúde&nbsp;como&nbsp;o&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS).</td><td class="diff_next"></td><td class="diff_header" id="to62_15">15</td><td nowrap="nowrap">de&nbsp;saúde&nbsp;como&nbsp;o&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_16">16</td><td nowrap="nowrap">e&nbsp;impacta&nbsp;diretamente&nbsp;a&nbsp;qualidade&nbsp;de&nbsp;vida&nbsp;do&nbsp;indivíduo,&nbsp;sendo&nbsp;ainda&nbsp;um&nbsp;poderoso</td><td class="diff_next"></td><td class="diff_header" id="to62_16">16</td><td nowrap="nowrap">e&nbsp;impacta&nbsp;diretamente&nbsp;a&nbsp;qualidade&nbsp;de&nbsp;vida&nbsp;do&nbsp;indivíduo,&nbsp;sendo&nbsp;ainda&nbsp;um&nbsp;poderoso</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_17">17</td><td nowrap="nowrap">instrumento&nbsp;de&nbsp;prevenção&nbsp;de&nbsp;complicações&nbsp;mais&nbsp;frequentes,&nbsp;como&nbsp;cirrose&nbsp;avançada&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_17">17</td><td nowrap="nowrap">instrumento&nbsp;de&nbsp;prevenção&nbsp;de&nbsp;complicações&nbsp;mais&nbsp;frequentes,&nbsp;como&nbsp;cirrose&nbsp;avançada&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_18">18</td><td nowrap="nowrap">câncer&nbsp;hepático.</td><td class="diff_next"></td><td class="diff_header" id="to62_18">18</td><td nowrap="nowrap">câncer&nbsp;hepático.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_19">19</td><td nowrap="nowrap">Sendo&nbsp;assim,&nbsp;o&nbsp;Departamento&nbsp;de&nbsp;Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções</td><td class="diff_next"></td><td class="diff_header" id="to62_19">19</td><td nowrap="nowrap">Sendo&nbsp;assim,&nbsp;o&nbsp;Departamento&nbsp;de&nbsp;Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_20">20</td><td nowrap="nowrap">Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids&nbsp;e&nbsp;das&nbsp;Hepatites&nbsp;Virais&nbsp;do&nbsp;Ministério&nbsp;da&nbsp;Saúde</td><td class="diff_next"></td><td class="diff_header" id="to62_20">20</td><td nowrap="nowrap">Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids&nbsp;e&nbsp;das&nbsp;Hepatites&nbsp;Virais&nbsp;do&nbsp;Ministério&nbsp;da&nbsp;Saúde</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_21">21</td><td nowrap="nowrap">elaborou&nbsp;este&nbsp;manual&nbsp;técnico,&nbsp;com&nbsp;o&nbsp;intuito&nbsp;de&nbsp;ampliar&nbsp;as&nbsp;possibilidades&nbsp;de&nbsp;diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_21">21</td><td nowrap="nowrap">elaborou&nbsp;este&nbsp;manual&nbsp;técnico,&nbsp;com&nbsp;o&nbsp;intuito&nbsp;de&nbsp;ampliar&nbsp;as&nbsp;possibilidades&nbsp;de&nbsp;diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_22">22</td><td nowrap="nowrap">e,&nbsp;em&nbsp;especial,&nbsp;orientar&nbsp;os&nbsp;profissionais&nbsp;de&nbsp;saúde&nbsp;nos&nbsp;passos&nbsp;necessários&nbsp;à&nbsp;realização&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_22">22</td><td nowrap="nowrap">e,&nbsp;em&nbsp;especial,&nbsp;orientar&nbsp;os&nbsp;profissionais&nbsp;de&nbsp;saúde&nbsp;nos&nbsp;passos&nbsp;necessários&nbsp;à&nbsp;realização&nbsp;do</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__1"></td><td class="diff_header" id="from62_23">23</td><td nowrap="nowrap">diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_23">23</td><td nowrap="nowrap">diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_24">24</td><td nowrap="nowrap">A&nbsp;avaliação&nbsp;clínica&nbsp;é&nbsp;de&nbsp;extrema&nbsp;importância&nbsp;para&nbsp;guiar&nbsp;o&nbsp;médico&nbsp;quanto&nbsp;ao&nbsp;exa-</td><td class="diff_next"></td><td class="diff_header" id="to62_24">24</td><td nowrap="nowrap">A&nbsp;avaliação&nbsp;clínica&nbsp;é&nbsp;de&nbsp;extrema&nbsp;importância&nbsp;para&nbsp;guiar&nbsp;o&nbsp;médico&nbsp;quanto&nbsp;ao&nbsp;exa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_25">25</td><td nowrap="nowrap">me&nbsp;a&nbsp;ser&nbsp;solicitado,&nbsp;de&nbsp;modo&nbsp;que&nbsp;o&nbsp;diagnóstico&nbsp;seja&nbsp;correto,&nbsp;de&nbsp;acordo&nbsp;com&nbsp;o&nbsp;tipo&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_25">25</td><td nowrap="nowrap">me&nbsp;a&nbsp;ser&nbsp;solicitado,&nbsp;de&nbsp;modo&nbsp;que&nbsp;o&nbsp;diagnóstico&nbsp;seja&nbsp;correto,&nbsp;de&nbsp;acordo&nbsp;com&nbsp;o&nbsp;tipo&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_26">26</td><td nowrap="nowrap">hepatite:&nbsp;se&nbsp;A,&nbsp;B,&nbsp;C,&nbsp;D&nbsp;ou&nbsp;E.&nbsp;Hoje,&nbsp;entretanto,&nbsp;sabemos&nbsp;que&nbsp;isso&nbsp;não&nbsp;ocorre&nbsp;em&nbsp;muitas</td><td class="diff_next"></td><td class="diff_header" id="to62_26">26</td><td nowrap="nowrap">hepatite:&nbsp;se&nbsp;A,&nbsp;B,&nbsp;C,&nbsp;D&nbsp;ou&nbsp;E.&nbsp;Hoje,&nbsp;entretanto,&nbsp;sabemos&nbsp;que&nbsp;isso&nbsp;não&nbsp;ocorre&nbsp;em&nbsp;muitas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_27">27</td><td nowrap="nowrap">solicitações&nbsp;médicas,&nbsp;levando&nbsp;à&nbsp;realização&nbsp;de&nbsp;exames&nbsp;sem&nbsp;a&nbsp;indicação&nbsp;apropriada&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_27">27</td><td nowrap="nowrap">solicitações&nbsp;médicas,&nbsp;levando&nbsp;à&nbsp;realização&nbsp;de&nbsp;exames&nbsp;sem&nbsp;a&nbsp;indicação&nbsp;apropriada&nbsp;ou</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__2">n</a></td><td class="diff_header" id="from62_28">28</td><td nowrap="nowrap">relação&nbsp;com&nbsp;a&nbsp;história&nbsp;clínica&nbsp;dos&nbsp;pacientes&nbsp;<span class="diff_chg">–</span>&nbsp;o&nbsp;que&nbsp;gera&nbsp;desperdício&nbsp;de&nbsp;recursos&nbsp;pú-</td><td class="diff_next"><a href="#difflib_chg_to62__2">n</a></td><td class="diff_header" id="to62_28">28</td><td nowrap="nowrap">relação&nbsp;com&nbsp;a&nbsp;história&nbsp;clínica&nbsp;dos&nbsp;pacientes&nbsp;<span class="diff_chg">-</span>&nbsp;o&nbsp;que&nbsp;gera&nbsp;desperdício&nbsp;de&nbsp;recursos&nbsp;pú-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_29">29</td><td nowrap="nowrap">blicos&nbsp;e&nbsp;privados.&nbsp;Este&nbsp;manual&nbsp;visa,&nbsp;portanto,&nbsp;a&nbsp;orientar&nbsp;os&nbsp;profissionais&nbsp;que&nbsp;realizam</td><td class="diff_next"></td><td class="diff_header" id="to62_29">29</td><td nowrap="nowrap">blicos&nbsp;e&nbsp;privados.&nbsp;Este&nbsp;manual&nbsp;visa,&nbsp;portanto,&nbsp;a&nbsp;orientar&nbsp;os&nbsp;profissionais&nbsp;que&nbsp;realizam</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_30">30</td><td nowrap="nowrap">testes&nbsp;diagnósticos&nbsp;das&nbsp;hepatites&nbsp;virais,&nbsp;sejam&nbsp;laboratoriais&nbsp;ou&nbsp;testes&nbsp;rápidos,&nbsp;quanto&nbsp;à</td><td class="diff_next"></td><td class="diff_header" id="to62_30">30</td><td nowrap="nowrap">testes&nbsp;diagnósticos&nbsp;das&nbsp;hepatites&nbsp;virais,&nbsp;sejam&nbsp;laboratoriais&nbsp;ou&nbsp;testes&nbsp;rápidos,&nbsp;quanto&nbsp;à</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_31">31</td><td nowrap="nowrap">escolha&nbsp;do&nbsp;marcador&nbsp;a&nbsp;ser&nbsp;utilizado&nbsp;ao&nbsp;receber&nbsp;solicitações&nbsp;genéricas,&nbsp;como&nbsp;“sorologia</td><td class="diff_next"></td><td class="diff_header" id="to62_31">31</td><td nowrap="nowrap">escolha&nbsp;do&nbsp;marcador&nbsp;a&nbsp;ser&nbsp;utilizado&nbsp;ao&nbsp;receber&nbsp;solicitações&nbsp;genéricas,&nbsp;como&nbsp;“sorologia</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_32">32</td><td nowrap="nowrap">para&nbsp;hepatite”&nbsp;ou&nbsp;afins.</td><td class="diff_next"></td><td class="diff_header" id="to62_32">32</td><td nowrap="nowrap">para&nbsp;hepatite”&nbsp;ou&nbsp;afins.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_33">33</td><td nowrap="nowrap">A&nbsp;publicação&nbsp;restringe-se&nbsp;à&nbsp;indicação&nbsp;de&nbsp;algoritmos&nbsp;(fluxogramas)&nbsp;a&nbsp;ser&nbsp;seguidos</td><td class="diff_next"></td><td class="diff_header" id="to62_33">33</td><td nowrap="nowrap">A&nbsp;publicação&nbsp;restringe-se&nbsp;à&nbsp;indicação&nbsp;de&nbsp;algoritmos&nbsp;(fluxogramas)&nbsp;a&nbsp;ser&nbsp;seguidos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_34">34</td><td nowrap="nowrap">para&nbsp;o&nbsp;diagnóstico&nbsp;seguro&nbsp;e&nbsp;eficiente&nbsp;das&nbsp;infecções&nbsp;causadas&nbsp;pelos&nbsp;vírus&nbsp;das&nbsp;hepatites;</td><td class="diff_next"></td><td class="diff_header" id="to62_34">34</td><td nowrap="nowrap">para&nbsp;o&nbsp;diagnóstico&nbsp;seguro&nbsp;e&nbsp;eficiente&nbsp;das&nbsp;infecções&nbsp;causadas&nbsp;pelos&nbsp;vírus&nbsp;das&nbsp;hepatites;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_35">35</td><td nowrap="nowrap">assim,&nbsp;não&nbsp;se&nbsp;abordam&nbsp;os&nbsp;aspectos&nbsp;clínicos&nbsp;dessas&nbsp;infecções.&nbsp;São&nbsp;apresentados&nbsp;oito&nbsp;al-</td><td class="diff_next"></td><td class="diff_header" id="to62_35">35</td><td nowrap="nowrap">assim,&nbsp;não&nbsp;se&nbsp;abordam&nbsp;os&nbsp;aspectos&nbsp;clínicos&nbsp;dessas&nbsp;infecções.&nbsp;São&nbsp;apresentados&nbsp;oito&nbsp;al-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_36">36</td><td nowrap="nowrap">situações&nbsp;e&nbsp;localidades&nbsp;em&nbsp;que&nbsp;a&nbsp;infraestrutura&nbsp;laboratorial&nbsp;está&nbsp;ou&nbsp;não&nbsp;presente,&nbsp;permi-</td><td class="diff_next"></td><td class="diff_header" id="to62_36">36</td><td nowrap="nowrap">situações&nbsp;e&nbsp;localidades&nbsp;em&nbsp;que&nbsp;a&nbsp;infraestrutura&nbsp;laboratorial&nbsp;está&nbsp;ou&nbsp;não&nbsp;presente,&nbsp;permi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_37">37</td><td nowrap="nowrap">tindo&nbsp;o&nbsp;atendimento&nbsp;ideal&nbsp;a&nbsp;todos&nbsp;os&nbsp;cidadãos&nbsp;que&nbsp;buscam&nbsp;esse&nbsp;serviço.</td><td class="diff_next"></td><td class="diff_header" id="to62_37">37</td><td nowrap="nowrap">tindo&nbsp;o&nbsp;atendimento&nbsp;ideal&nbsp;a&nbsp;todos&nbsp;os&nbsp;cidadãos&nbsp;que&nbsp;buscam&nbsp;esse&nbsp;serviço.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_38">38</td><td nowrap="nowrap">Por&nbsp;fim,&nbsp;os&nbsp;algoritmos&nbsp;aqui&nbsp;propostos&nbsp;destinam-se&nbsp;exclusivamente&nbsp;ao&nbsp;diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_38">38</td><td nowrap="nowrap">Por&nbsp;fim,&nbsp;os&nbsp;algoritmos&nbsp;aqui&nbsp;propostos&nbsp;destinam-se&nbsp;exclusivamente&nbsp;ao&nbsp;diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_39">39</td><td nowrap="nowrap">das&nbsp;infecções,&nbsp;não&nbsp;sendo&nbsp;recomendados&nbsp;para&nbsp;estudos&nbsp;epidemiológicos&nbsp;ou&nbsp;para&nbsp;o&nbsp;mo-</td><td class="diff_next"></td><td class="diff_header" id="to62_39">39</td><td nowrap="nowrap">das&nbsp;infecções,&nbsp;não&nbsp;sendo&nbsp;recomendados&nbsp;para&nbsp;estudos&nbsp;epidemiológicos&nbsp;ou&nbsp;para&nbsp;o&nbsp;mo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_40">40</td><td nowrap="nowrap">nitoramento&nbsp;de&nbsp;pacientes&nbsp;já&nbsp;com&nbsp;diagnóstico&nbsp;estabelecido&nbsp;de&nbsp;qualquer&nbsp;uma&nbsp;das&nbsp;hepa-</td><td class="diff_next"></td><td class="diff_header" id="to62_40">40</td><td nowrap="nowrap">nitoramento&nbsp;de&nbsp;pacientes&nbsp;já&nbsp;com&nbsp;diagnóstico&nbsp;estabelecido&nbsp;de&nbsp;qualquer&nbsp;uma&nbsp;das&nbsp;hepa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_41">41</td><td nowrap="nowrap">tites&nbsp;virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_41">41</td><td nowrap="nowrap">tites&nbsp;virais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_42">42</td><td nowrap="nowrap">Desejamos&nbsp;sucesso&nbsp;a&nbsp;todos&nbsp;e&nbsp;colocamo-nos&nbsp;à&nbsp;disposição&nbsp;para&nbsp;esclarecer&nbsp;quaisquer</td><td class="diff_next"></td><td class="diff_header" id="to62_42">42</td><td nowrap="nowrap">Desejamos&nbsp;sucesso&nbsp;a&nbsp;todos&nbsp;e&nbsp;colocamo-nos&nbsp;à&nbsp;disposição&nbsp;para&nbsp;esclarecer&nbsp;quaisquer</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_43">43</td><td nowrap="nowrap">dúvidas&nbsp;por&nbsp;meio&nbsp;do&nbsp;endereço&nbsp;eletrônico&nbsp;clab@aids.gov.br.</td><td class="diff_next"></td><td class="diff_header" id="to62_43">43</td><td nowrap="nowrap">dúvidas&nbsp;por&nbsp;meio&nbsp;do&nbsp;endereço&nbsp;eletrônico&nbsp;clab@aids.gov.br.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_44">44</td><td nowrap="nowrap">1.&nbsp;INTRODUÇÃO&nbsp;ÀS&nbsp;HEPATITES&nbsp;VIRAIS</td><td class="diff_next"></td><td class="diff_header" id="to62_44">44</td><td nowrap="nowrap">1.&nbsp;INTRODUÇÃO&nbsp;ÀS&nbsp;HEPATITES&nbsp;VIRAIS</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_45">45</td><td nowrap="nowrap">As&nbsp;hepatites&nbsp;virais&nbsp;agudas&nbsp;e&nbsp;crônicas&nbsp;são&nbsp;doenças&nbsp;provocadas&nbsp;por&nbsp;diferentes&nbsp;agen-</td><td class="diff_next"></td><td class="diff_header" id="to62_45">45</td><td nowrap="nowrap">As&nbsp;hepatites&nbsp;virais&nbsp;agudas&nbsp;e&nbsp;crônicas&nbsp;são&nbsp;doenças&nbsp;provocadas&nbsp;por&nbsp;diferentes&nbsp;agen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_46">46</td><td nowrap="nowrap">tes&nbsp;etiológicos,&nbsp;com&nbsp;tropismoG&nbsp;primário&nbsp;pelo&nbsp;tecido&nbsp;hepático,&nbsp;apresentando&nbsp;caracte-</td><td class="diff_next"></td><td class="diff_header" id="to62_46">46</td><td nowrap="nowrap">tes&nbsp;etiológicos,&nbsp;com&nbsp;tropismoG&nbsp;primário&nbsp;pelo&nbsp;tecido&nbsp;hepático,&nbsp;apresentando&nbsp;caracte-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_47">47</td><td nowrap="nowrap">rísticas&nbsp;epidemiológicas,&nbsp;clínicas&nbsp;e&nbsp;laboratoriais&nbsp;semelhantes,&nbsp;porém&nbsp;com&nbsp;importantes</td><td class="diff_next"></td><td class="diff_header" id="to62_47">47</td><td nowrap="nowrap">rísticas&nbsp;epidemiológicas,&nbsp;clínicas&nbsp;e&nbsp;laboratoriais&nbsp;semelhantes,&nbsp;porém&nbsp;com&nbsp;importantes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_48">48</td><td nowrap="nowrap">particularidades.</td><td class="diff_next"></td><td class="diff_header" id="to62_48">48</td><td nowrap="nowrap">particularidades.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_49">49</td><td nowrap="nowrap">As&nbsp;hepatites&nbsp;virais&nbsp;são&nbsp;causadas&nbsp;por&nbsp;cinco&nbsp;vírus:&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV,&nbsp;do&nbsp;inglês</td><td class="diff_next"></td><td class="diff_header" id="to62_49">49</td><td nowrap="nowrap">As&nbsp;hepatites&nbsp;virais&nbsp;são&nbsp;causadas&nbsp;por&nbsp;cinco&nbsp;vírus:&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV,&nbsp;do&nbsp;inglês</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_50">50</td><td nowrap="nowrap">hepatitis&nbsp;A&nbsp;virus),&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;B&nbsp;virus),&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite</td><td class="diff_next"></td><td class="diff_header" id="to62_50">50</td><td nowrap="nowrap">hepatitis&nbsp;A&nbsp;virus),&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;B&nbsp;virus),&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_51">51</td><td nowrap="nowrap">C&nbsp;(HCV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;C&nbsp;virus),&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;D&nbsp;virus)</td><td class="diff_next"></td><td class="diff_header" id="to62_51">51</td><td nowrap="nowrap">C&nbsp;(HCV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;C&nbsp;virus),&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;D&nbsp;virus)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_52">52</td><td nowrap="nowrap">e&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;E&nbsp;virus)&nbsp;(LEMON,&nbsp;1997).&nbsp;Essas&nbsp;infecções</td><td class="diff_next"></td><td class="diff_header" id="to62_52">52</td><td nowrap="nowrap">e&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV,&nbsp;do&nbsp;inglês&nbsp;hepatitis&nbsp;E&nbsp;virus)&nbsp;(LEMON,&nbsp;1997).&nbsp;Essas&nbsp;infecções</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_53">53</td><td nowrap="nowrap">têm&nbsp;um&nbsp;amplo&nbsp;espectro&nbsp;clínico,&nbsp;que&nbsp;varia&nbsp;desde&nbsp;formas&nbsp;assintomáticas,&nbsp;anictéricasG&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_53">53</td><td nowrap="nowrap">têm&nbsp;um&nbsp;amplo&nbsp;espectro&nbsp;clínico,&nbsp;que&nbsp;varia&nbsp;desde&nbsp;formas&nbsp;assintomáticas,&nbsp;anictéricasG&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_54">54</td><td nowrap="nowrap">ictéricasG&nbsp;típicas,&nbsp;até&nbsp;a&nbsp;insuficiência&nbsp;hepática&nbsp;aguda&nbsp;grave&nbsp;(fulminante).&nbsp;A&nbsp;maioria&nbsp;das</td><td class="diff_next"></td><td class="diff_header" id="to62_54">54</td><td nowrap="nowrap">ictéricasG&nbsp;típicas,&nbsp;até&nbsp;a&nbsp;insuficiência&nbsp;hepática&nbsp;aguda&nbsp;grave&nbsp;(fulminante).&nbsp;A&nbsp;maioria&nbsp;das</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_55">55</td><td nowrap="nowrap">hepatites&nbsp;virais&nbsp;agudas&nbsp;é&nbsp;assintomática,&nbsp;independentemente&nbsp;do&nbsp;tipo&nbsp;de&nbsp;vírus.&nbsp;Quando</td><td class="diff_next"></td><td class="diff_header" id="to62_55">55</td><td nowrap="nowrap">hepatites&nbsp;virais&nbsp;agudas&nbsp;é&nbsp;assintomática,&nbsp;independentemente&nbsp;do&nbsp;tipo&nbsp;de&nbsp;vírus.&nbsp;Quando</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_56">56</td><td nowrap="nowrap">apresentam&nbsp;sintomatologia,&nbsp;são&nbsp;caracterizadas&nbsp;por&nbsp;fadiga,&nbsp;mal-estar,&nbsp;náuseas,&nbsp;dor&nbsp;ab-</td><td class="diff_next"></td><td class="diff_header" id="to62_56">56</td><td nowrap="nowrap">apresentam&nbsp;sintomatologia,&nbsp;são&nbsp;caracterizadas&nbsp;por&nbsp;fadiga,&nbsp;mal-estar,&nbsp;náuseas,&nbsp;dor&nbsp;ab-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_57">57</td><td nowrap="nowrap">dominal,&nbsp;anorexiaG&nbsp;e&nbsp;icteríciaG.&nbsp;A&nbsp;hepatite&nbsp;crônica,&nbsp;em&nbsp;geral,&nbsp;cursa&nbsp;de&nbsp;forma&nbsp;assintomá-</td><td class="diff_next"></td><td class="diff_header" id="to62_57">57</td><td nowrap="nowrap">dominal,&nbsp;anorexiaG&nbsp;e&nbsp;icteríciaG.&nbsp;A&nbsp;hepatite&nbsp;crônica,&nbsp;em&nbsp;geral,&nbsp;cursa&nbsp;de&nbsp;forma&nbsp;assintomá-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_58">58</td><td nowrap="nowrap">tica.&nbsp;As&nbsp;manifestações&nbsp;clínicas&nbsp;aparecem&nbsp;quando&nbsp;a&nbsp;doença&nbsp;está&nbsp;em&nbsp;estágio&nbsp;avançado,</td><td class="diff_next"></td><td class="diff_header" id="to62_58">58</td><td nowrap="nowrap">tica.&nbsp;As&nbsp;manifestações&nbsp;clínicas&nbsp;aparecem&nbsp;quando&nbsp;a&nbsp;doença&nbsp;está&nbsp;em&nbsp;estágio&nbsp;avançado,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_59">59</td><td nowrap="nowrap">com&nbsp;relato&nbsp;de&nbsp;fadiga,&nbsp;ou,&nbsp;ainda,&nbsp;cirroseG.&nbsp;O&nbsp;diagnóstico&nbsp;inclui&nbsp;a&nbsp;realização&nbsp;de&nbsp;exames&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_59">59</td><td nowrap="nowrap">com&nbsp;relato&nbsp;de&nbsp;fadiga,&nbsp;ou,&nbsp;ainda,&nbsp;cirroseG.&nbsp;O&nbsp;diagnóstico&nbsp;inclui&nbsp;a&nbsp;realização&nbsp;de&nbsp;exames&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_60">60</td><td nowrap="nowrap">ambiente&nbsp;laboratorial&nbsp;e&nbsp;testes&nbsp;rápidos,&nbsp;a&nbsp;fim&nbsp;de&nbsp;caracterizar&nbsp;o&nbsp;agente&nbsp;infeccioso&nbsp;e&nbsp;sua</td><td class="diff_next"></td><td class="diff_header" id="to62_60">60</td><td nowrap="nowrap">ambiente&nbsp;laboratorial&nbsp;e&nbsp;testes&nbsp;rápidos,&nbsp;a&nbsp;fim&nbsp;de&nbsp;caracterizar&nbsp;o&nbsp;agente&nbsp;infeccioso&nbsp;e&nbsp;sua</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_61">61</td><td nowrap="nowrap">gravidade&nbsp;(BRASIL,&nbsp;2009).</td><td class="diff_next"></td><td class="diff_header" id="to62_61">61</td><td nowrap="nowrap">gravidade&nbsp;(BRASIL,&nbsp;2009).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_62">62</td><td nowrap="nowrap">A&nbsp;distribuição&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;é&nbsp;universal,&nbsp;sendo&nbsp;que&nbsp;a&nbsp;magnitude&nbsp;dos&nbsp;diferen-</td><td class="diff_next"></td><td class="diff_header" id="to62_62">62</td><td nowrap="nowrap">A&nbsp;distribuição&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;é&nbsp;universal,&nbsp;sendo&nbsp;que&nbsp;a&nbsp;magnitude&nbsp;dos&nbsp;diferen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_63">63</td><td nowrap="nowrap">tes&nbsp;tipos&nbsp;varia&nbsp;de&nbsp;região&nbsp;para&nbsp;região.&nbsp;No&nbsp;Brasil,&nbsp;também&nbsp;há&nbsp;grande&nbsp;variação&nbsp;regional&nbsp;na</td><td class="diff_next"></td><td class="diff_header" id="to62_63">63</td><td nowrap="nowrap">tes&nbsp;tipos&nbsp;varia&nbsp;de&nbsp;região&nbsp;para&nbsp;região.&nbsp;No&nbsp;Brasil,&nbsp;também&nbsp;há&nbsp;grande&nbsp;variação&nbsp;regional&nbsp;na</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_64">64</td><td nowrap="nowrap">prevalência&nbsp;de&nbsp;cada&nbsp;tipo&nbsp;de&nbsp;hepatite&nbsp;(PEREIRA;&nbsp;XIMENES;&nbsp;MOREIRA,&nbsp;2010).</td><td class="diff_next"></td><td class="diff_header" id="to62_64">64</td><td nowrap="nowrap">prevalência&nbsp;de&nbsp;cada&nbsp;tipo&nbsp;de&nbsp;hepatite&nbsp;(PEREIRA;&nbsp;XIMENES;&nbsp;MOREIRA,&nbsp;2010).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_65">65</td><td nowrap="nowrap">2.&nbsp;NOTIFICAÇÃO</td><td class="diff_next"></td><td class="diff_header" id="to62_65">65</td><td nowrap="nowrap">2.&nbsp;NOTIFICAÇÃO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_66">66</td><td nowrap="nowrap">As&nbsp;hepatites&nbsp;virais&nbsp;são&nbsp;doenças&nbsp;de&nbsp;notificação&nbsp;obrigatória,&nbsp;conforme&nbsp;Portaria&nbsp;vigen-</td><td class="diff_next"></td><td class="diff_header" id="to62_66">66</td><td nowrap="nowrap">As&nbsp;hepatites&nbsp;virais&nbsp;são&nbsp;doenças&nbsp;de&nbsp;notificação&nbsp;obrigatória,&nbsp;conforme&nbsp;Portaria&nbsp;vigen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_67">67</td><td nowrap="nowrap">te.&nbsp;Para&nbsp;a&nbsp;vigilância&nbsp;epidemiológica,&nbsp;devem-se&nbsp;seguir&nbsp;as&nbsp;orientações&nbsp;de&nbsp;definição&nbsp;de&nbsp;ca-</td><td class="diff_next"></td><td class="diff_header" id="to62_67">67</td><td nowrap="nowrap">te.&nbsp;Para&nbsp;a&nbsp;vigilância&nbsp;epidemiológica,&nbsp;devem-se&nbsp;seguir&nbsp;as&nbsp;orientações&nbsp;de&nbsp;definição&nbsp;de&nbsp;ca-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_68">68</td><td nowrap="nowrap">sos&nbsp;do&nbsp;“Guia&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde”&nbsp;e&nbsp;suas&nbsp;atualizações&nbsp;(BRASIL,&nbsp;2017a).</td><td class="diff_next"></td><td class="diff_header" id="to62_68">68</td><td nowrap="nowrap">sos&nbsp;do&nbsp;“Guia&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde”&nbsp;e&nbsp;suas&nbsp;atualizações&nbsp;(BRASIL,&nbsp;2017a).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_69">69</td><td nowrap="nowrap">3.&nbsp;SISTEMAS&nbsp;DE&nbsp;INFORMAÇÃO</td><td class="diff_next"></td><td class="diff_header" id="to62_69">69</td><td nowrap="nowrap">3.&nbsp;SISTEMAS&nbsp;DE&nbsp;INFORMAÇÃO</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__2"></td><td class="diff_header" id="from62_70">70</td><td nowrap="nowrap">As&nbsp;ferramentas&nbsp;informatizadas&nbsp;de&nbsp;informação&nbsp;são&nbsp;utilizadas&nbsp;com&nbsp;o&nbsp;objetivo&nbsp;de&nbsp;aces-</td><td class="diff_next"></td><td class="diff_header" id="to62_70">70</td><td nowrap="nowrap">As&nbsp;ferramentas&nbsp;informatizadas&nbsp;de&nbsp;informação&nbsp;são&nbsp;utilizadas&nbsp;com&nbsp;o&nbsp;objetivo&nbsp;de&nbsp;aces-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_71">71</td><td nowrap="nowrap">sar&nbsp;e&nbsp;analisar&nbsp;de&nbsp;maneira&nbsp;ágil&nbsp;dados&nbsp;em&nbsp;saúde&nbsp;pública,&nbsp;subsidiando&nbsp;a&nbsp;tomada&nbsp;de&nbsp;deci-</td><td class="diff_next"></td><td class="diff_header" id="to62_71">71</td><td nowrap="nowrap">sar&nbsp;e&nbsp;analisar&nbsp;de&nbsp;maneira&nbsp;ágil&nbsp;dados&nbsp;em&nbsp;saúde&nbsp;pública,&nbsp;subsidiando&nbsp;a&nbsp;tomada&nbsp;de&nbsp;deci-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_72">72</td><td nowrap="nowrap">sões&nbsp;nos&nbsp;diversos&nbsp;níveis&nbsp;da&nbsp;administração&nbsp;pública.&nbsp;Também&nbsp;são&nbsp;úteis&nbsp;para&nbsp;o&nbsp;ambiente</td><td class="diff_next"></td><td class="diff_header" id="to62_72">72</td><td nowrap="nowrap">sões&nbsp;nos&nbsp;diversos&nbsp;níveis&nbsp;da&nbsp;administração&nbsp;pública.&nbsp;Também&nbsp;são&nbsp;úteis&nbsp;para&nbsp;o&nbsp;ambiente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_73">73</td><td nowrap="nowrap">laboratorial,&nbsp;facilitando&nbsp;o&nbsp;gerenciamento&nbsp;de&nbsp;amostras&nbsp;e&nbsp;exames&nbsp;no&nbsp;laboratório&nbsp;e&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_73">73</td><td nowrap="nowrap">laboratorial,&nbsp;facilitando&nbsp;o&nbsp;gerenciamento&nbsp;de&nbsp;amostras&nbsp;e&nbsp;exames&nbsp;no&nbsp;laboratório&nbsp;e&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_74">74</td><td nowrap="nowrap">seus&nbsp;pontos&nbsp;de&nbsp;coleta.</td><td class="diff_next"></td><td class="diff_header" id="to62_74">74</td><td nowrap="nowrap">seus&nbsp;pontos&nbsp;de&nbsp;coleta.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__3">n</a></td><td class="diff_header" id="from62_75">75</td><td nowrap="nowrap">Desde&nbsp;2014,&nbsp;o&nbsp;DIAHV&nbsp;recomenda&nbsp;o&nbsp;Gerenciador&nbsp;de&nbsp;Ambiente&nbsp;Laboratorial&nbsp;<span class="diff_chg">–</span>&nbsp;GAL</td><td class="diff_next"><a href="#difflib_chg_to62__3">n</a></td><td class="diff_header" id="to62_75">75</td><td nowrap="nowrap">Desde&nbsp;2014,&nbsp;o&nbsp;DIAHV&nbsp;recomenda&nbsp;o&nbsp;Gerenciador&nbsp;de&nbsp;Ambiente&nbsp;Laboratorial&nbsp;<span class="diff_chg">-</span>&nbsp;GAL</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_76">76</td><td nowrap="nowrap"><span class="diff_sub">(http://gal.datasus.gov.br/GALL/index.php)&nbsp;como&nbsp;sistema&nbsp;preferencial&nbsp;para&nbsp;o&nbsp;gerencia-</span></td><td class="diff_next"></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_77">77</td><td nowrap="nowrap">mento&nbsp;dos&nbsp;testes&nbsp;laboratoriais&nbsp;para&nbsp;as&nbsp;hepatites&nbsp;virais&nbsp;(Ofício&nbsp;Circular&nbsp;nº&nbsp;98/2014).</td><td class="diff_next"></td><td class="diff_header" id="to62_76">76</td><td nowrap="nowrap">mento&nbsp;dos&nbsp;testes&nbsp;laboratoriais&nbsp;para&nbsp;as&nbsp;hepatites&nbsp;virais&nbsp;(Ofício&nbsp;Circular&nbsp;nº&nbsp;98/2014).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_78">78</td><td nowrap="nowrap">4.&nbsp;DIAGNÓSTICO&nbsp;CLÍNICO</td><td class="diff_next"></td><td class="diff_header" id="to62_77">77</td><td nowrap="nowrap">4.&nbsp;DIAGNÓSTICO&nbsp;CLÍNICO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_79">79</td><td nowrap="nowrap">Os&nbsp;quadros&nbsp;clínicos&nbsp;agudos&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;são&nbsp;muito&nbsp;diversificados,&nbsp;variando</td><td class="diff_next"></td><td class="diff_header" id="to62_78">78</td><td nowrap="nowrap">Os&nbsp;quadros&nbsp;clínicos&nbsp;agudos&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;são&nbsp;muito&nbsp;diversificados,&nbsp;variando</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_80">80</td><td nowrap="nowrap">desde&nbsp;formas&nbsp;assintomáticas&nbsp;até&nbsp;formas&nbsp;de&nbsp;insuficiência&nbsp;hepática&nbsp;aguda&nbsp;grave.&nbsp;A&nbsp;maio-</td><td class="diff_next"></td><td class="diff_header" id="to62_79">79</td><td nowrap="nowrap">desde&nbsp;formas&nbsp;assintomáticas&nbsp;até&nbsp;formas&nbsp;de&nbsp;insuficiência&nbsp;hepática&nbsp;aguda&nbsp;grave.&nbsp;A&nbsp;maio-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_81">81</td><td nowrap="nowrap">ria&nbsp;dos&nbsp;casos&nbsp;subclínicos&nbsp;cursam&nbsp;com&nbsp;predominância&nbsp;de&nbsp;fadiga,&nbsp;anorexia,&nbsp;náuseas&nbsp;e&nbsp;mal-</td><td class="diff_next"></td><td class="diff_header" id="to62_80">80</td><td nowrap="nowrap">ria&nbsp;dos&nbsp;casos&nbsp;subclínicos&nbsp;cursam&nbsp;com&nbsp;predominância&nbsp;de&nbsp;fadiga,&nbsp;anorexia,&nbsp;náuseas&nbsp;e&nbsp;mal-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_82">82</td><td nowrap="nowrap">-estar&nbsp;geral.&nbsp;Nos&nbsp;pacientes&nbsp;sintomáticos,&nbsp;o&nbsp;período&nbsp;de&nbsp;doença&nbsp;aguda&nbsp;pode&nbsp;se&nbsp;caracteri-</td><td class="diff_next"></td><td class="diff_header" id="to62_81">81</td><td nowrap="nowrap">-estar&nbsp;geral.&nbsp;Nos&nbsp;pacientes&nbsp;sintomáticos,&nbsp;o&nbsp;período&nbsp;de&nbsp;doença&nbsp;aguda&nbsp;pode&nbsp;se&nbsp;caracteri-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_83">83</td><td nowrap="nowrap">zar&nbsp;pela&nbsp;presença&nbsp;de&nbsp;urina&nbsp;escura&nbsp;(colúria),&nbsp;fezes&nbsp;esbranquiçadas&nbsp;e&nbsp;icterícia.</td><td class="diff_next"></td><td class="diff_header" id="to62_82">82</td><td nowrap="nowrap">zar&nbsp;pela&nbsp;presença&nbsp;de&nbsp;urina&nbsp;escura&nbsp;(colúria),&nbsp;fezes&nbsp;esbranquiçadas&nbsp;e&nbsp;icterícia.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_84">84</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;crônica&nbsp;é&nbsp;assintomática&nbsp;na&nbsp;maioria&nbsp;dos&nbsp;casos.&nbsp;De&nbsp;modo&nbsp;geral,&nbsp;as&nbsp;mani-</td><td class="diff_next"></td><td class="diff_header" id="to62_83">83</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;crônica&nbsp;é&nbsp;assintomática&nbsp;na&nbsp;maioria&nbsp;dos&nbsp;casos.&nbsp;De&nbsp;modo&nbsp;geral,&nbsp;as&nbsp;mani-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_85">85</td><td nowrap="nowrap">festações&nbsp;clínicas&nbsp;aparecem&nbsp;apenas&nbsp;em&nbsp;fases&nbsp;adiantadas&nbsp;de&nbsp;acometimento&nbsp;hepático,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_84">84</td><td nowrap="nowrap">festações&nbsp;clínicas&nbsp;aparecem&nbsp;apenas&nbsp;em&nbsp;fases&nbsp;adiantadas&nbsp;de&nbsp;acometimento&nbsp;hepático,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_86">86</td><td nowrap="nowrap">podem&nbsp;incluir&nbsp;fibrose,&nbsp;cirrose&nbsp;hepática,&nbsp;carcinoma&nbsp;hepatocelular&nbsp;e&nbsp;comprometimento</td><td class="diff_next"></td><td class="diff_header" id="to62_85">85</td><td nowrap="nowrap">podem&nbsp;incluir&nbsp;fibrose,&nbsp;cirrose&nbsp;hepática,&nbsp;carcinoma&nbsp;hepatocelular&nbsp;e&nbsp;comprometimento</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_87">87</td><td nowrap="nowrap">de&nbsp;outros&nbsp;órgãos.&nbsp;Muitas&nbsp;vezes,&nbsp;o&nbsp;diagnóstico&nbsp;é&nbsp;feito&nbsp;ao&nbsp;acaso,&nbsp;a&nbsp;partir&nbsp;de&nbsp;alterações</td><td class="diff_next"></td><td class="diff_header" id="to62_86">86</td><td nowrap="nowrap">de&nbsp;outros&nbsp;órgãos.&nbsp;Muitas&nbsp;vezes,&nbsp;o&nbsp;diagnóstico&nbsp;é&nbsp;feito&nbsp;ao&nbsp;acaso,&nbsp;a&nbsp;partir&nbsp;de&nbsp;alterações</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__3"></td><td class="diff_header" id="from62_88">88</td><td nowrap="nowrap">esporádicas&nbsp;de&nbsp;exames&nbsp;de&nbsp;avaliação&nbsp;de&nbsp;rotina&nbsp;ou&nbsp;da&nbsp;triagem&nbsp;em&nbsp;bancos&nbsp;de&nbsp;sangue.&nbsp;O</td><td class="diff_next"></td><td class="diff_header" id="to62_87">87</td><td nowrap="nowrap">esporádicas&nbsp;de&nbsp;exames&nbsp;de&nbsp;avaliação&nbsp;de&nbsp;rotina&nbsp;ou&nbsp;da&nbsp;triagem&nbsp;em&nbsp;bancos&nbsp;de&nbsp;sangue.&nbsp;O</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_89">89</td><td nowrap="nowrap">diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais,&nbsp;principalmente&nbsp;os&nbsp;tipos&nbsp;B&nbsp;e&nbsp;C,&nbsp;ocorre&nbsp;na&nbsp;maioria&nbsp;das</td><td class="diff_next"></td><td class="diff_header" id="to62_88">88</td><td nowrap="nowrap">diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais,&nbsp;principalmente&nbsp;os&nbsp;tipos&nbsp;B&nbsp;e&nbsp;C,&nbsp;ocorre&nbsp;na&nbsp;maioria&nbsp;das</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_90">90</td><td nowrap="nowrap">vezes&nbsp;durante&nbsp;a&nbsp;fase&nbsp;crônica&nbsp;dessas&nbsp;doenças.&nbsp;É&nbsp;importante&nbsp;que&nbsp;o&nbsp;clínico&nbsp;esteja&nbsp;atento&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_89">89</td><td nowrap="nowrap">vezes&nbsp;durante&nbsp;a&nbsp;fase&nbsp;crônica&nbsp;dessas&nbsp;doenças.&nbsp;É&nbsp;importante&nbsp;que&nbsp;o&nbsp;clínico&nbsp;esteja&nbsp;atento&nbsp;a</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__4"></td><td class="diff_header" id="from62_91">91</td><td nowrap="nowrap">esse&nbsp;fato&nbsp;para&nbsp;então&nbsp;definir&nbsp;o&nbsp;melhor&nbsp;seguimento&nbsp;do&nbsp;paciente,&nbsp;conforme&nbsp;os&nbsp;protocolos</td><td class="diff_next"></td><td class="diff_header" id="to62_90">90</td><td nowrap="nowrap">esse&nbsp;fato&nbsp;para&nbsp;então&nbsp;definir&nbsp;o&nbsp;melhor&nbsp;seguimento&nbsp;do&nbsp;paciente,&nbsp;conforme&nbsp;os&nbsp;protocolos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_92">92</td><td nowrap="nowrap">clínicos&nbsp;e&nbsp;diretrizes&nbsp;terapêuticas&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C.&nbsp;Os&nbsp;referidos&nbsp;protocolos&nbsp;clínicos</td><td class="diff_next"></td><td class="diff_header" id="to62_91">91</td><td nowrap="nowrap">clínicos&nbsp;e&nbsp;diretrizes&nbsp;terapêuticas&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C.&nbsp;Os&nbsp;referidos&nbsp;protocolos&nbsp;clínicos</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__4">n</a></td><td class="diff_header" id="from62_93">93</td><td nowrap="nowrap"><span class="diff_sub">podem&nbsp;ser&nbsp;acessados&nbsp;em&nbsp;http://www.aids.gov.br/pcdt.</span></td><td class="diff_next"><a href="#difflib_chg_to62__4">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_94">94</td><td nowrap="nowrap">As&nbsp;aminotransferasesG&nbsp;<span class="diff_chg">–</span>&nbsp;alanina&nbsp;aminotransferase&nbsp;ou&nbsp;transaminase&nbsp;glutâmico-</td><td class="diff_next"></td><td class="diff_header" id="to62_92">92</td><td nowrap="nowrap">As&nbsp;aminotransferasesG&nbsp;<span class="diff_chg">-</span>&nbsp;alanina&nbsp;aminotransferase&nbsp;ou&nbsp;transaminase&nbsp;glutâmico-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_95">95</td><td nowrap="nowrap">-pirúvica&nbsp;(ALT&nbsp;ou&nbsp;TGP)&nbsp;e&nbsp;aspartato&nbsp;aminotransferase&nbsp;ou&nbsp;transaminase&nbsp;glutâmico-oxa-</td><td class="diff_next"></td><td class="diff_header" id="to62_93">93</td><td nowrap="nowrap">-pirúvica&nbsp;(ALT&nbsp;ou&nbsp;TGP)&nbsp;e&nbsp;aspartato&nbsp;aminotransferase&nbsp;ou&nbsp;transaminase&nbsp;glutâmico-oxa-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__5">n</a></td><td class="diff_header" id="from62_96">96</td><td nowrap="nowrap">lacética&nbsp;(AST&nbsp;ou&nbsp;TGO)&nbsp;<span class="diff_chg">–</span>&nbsp;são&nbsp;marcadores&nbsp;sensíveis&nbsp;para&nbsp;detecção&nbsp;de&nbsp;lesão&nbsp;do&nbsp;parênqui-</td><td class="diff_next"><a href="#difflib_chg_to62__5">n</a></td><td class="diff_header" id="to62_94">94</td><td nowrap="nowrap">lacética&nbsp;(AST&nbsp;ou&nbsp;TGO)&nbsp;<span class="diff_chg">-</span>&nbsp;são&nbsp;marcadores&nbsp;sensíveis&nbsp;para&nbsp;detecção&nbsp;de&nbsp;lesão&nbsp;do&nbsp;parênqui-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_97">97</td><td nowrap="nowrap">maG&nbsp;hepático,&nbsp;porém&nbsp;não&nbsp;são&nbsp;específicas&nbsp;para&nbsp;nenhum&nbsp;tipo&nbsp;de&nbsp;hepatite.&nbsp;Níveis&nbsp;mais</td><td class="diff_next"></td><td class="diff_header" id="to62_95">95</td><td nowrap="nowrap">maG&nbsp;hepático,&nbsp;porém&nbsp;não&nbsp;são&nbsp;específicas&nbsp;para&nbsp;nenhum&nbsp;tipo&nbsp;de&nbsp;hepatite.&nbsp;Níveis&nbsp;mais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_98">98</td><td nowrap="nowrap">elevados&nbsp;de&nbsp;ALT/TGP,&nbsp;quando&nbsp;presentes,&nbsp;não&nbsp;guardam&nbsp;correlação&nbsp;direta&nbsp;com&nbsp;a&nbsp;gravida-</td><td class="diff_next"></td><td class="diff_header" id="to62_96">96</td><td nowrap="nowrap">elevados&nbsp;de&nbsp;ALT/TGP,&nbsp;quando&nbsp;presentes,&nbsp;não&nbsp;guardam&nbsp;correlação&nbsp;direta&nbsp;com&nbsp;a&nbsp;gravida-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_99">99</td><td nowrap="nowrap">de&nbsp;da&nbsp;doença.&nbsp;As&nbsp;aminotransferases,&nbsp;na&nbsp;fase&nbsp;mais&nbsp;aguda&nbsp;da&nbsp;hepatite,&nbsp;podem&nbsp;elevar-se</td><td class="diff_next"></td><td class="diff_header" id="to62_97">97</td><td nowrap="nowrap">de&nbsp;da&nbsp;doença.&nbsp;As&nbsp;aminotransferases,&nbsp;na&nbsp;fase&nbsp;mais&nbsp;aguda&nbsp;da&nbsp;hepatite,&nbsp;podem&nbsp;elevar-se</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_100">100</td><td nowrap="nowrap">dez&nbsp;vezes&nbsp;acima&nbsp;do&nbsp;limite&nbsp;superior&nbsp;da&nbsp;normalidade.&nbsp;Também&nbsp;são&nbsp;encontradas&nbsp;outras</td><td class="diff_next"></td><td class="diff_header" id="to62_98">98</td><td nowrap="nowrap">dez&nbsp;vezes&nbsp;acima&nbsp;do&nbsp;limite&nbsp;superior&nbsp;da&nbsp;normalidade.&nbsp;Também&nbsp;são&nbsp;encontradas&nbsp;outras</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_101">101</td><td nowrap="nowrap">alterações&nbsp;inespecíficas,&nbsp;como&nbsp;elevação&nbsp;de&nbsp;bilirrubinasG,&nbsp;fosfatase&nbsp;alcalinaG&nbsp;e&nbsp;discre-</td><td class="diff_next"></td><td class="diff_header" id="to62_99">99</td><td nowrap="nowrap">alterações&nbsp;inespecíficas,&nbsp;como&nbsp;elevação&nbsp;de&nbsp;bilirrubinasG,&nbsp;fosfatase&nbsp;alcalinaG&nbsp;e&nbsp;discre-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_102">102</td><td nowrap="nowrap">ta&nbsp;linfocitoseG.&nbsp;Embora&nbsp;não&nbsp;sejam&nbsp;marcadores&nbsp;específicos&nbsp;para&nbsp;os&nbsp;casos&nbsp;de&nbsp;hepatites</td><td class="diff_next"></td><td class="diff_header" id="to62_100">100</td><td nowrap="nowrap">ta&nbsp;linfocitoseG.&nbsp;Embora&nbsp;não&nbsp;sejam&nbsp;marcadores&nbsp;específicos&nbsp;para&nbsp;os&nbsp;casos&nbsp;de&nbsp;hepatites</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_103">103</td><td nowrap="nowrap">virais,&nbsp;as&nbsp;alterações&nbsp;nos&nbsp;testes&nbsp;de&nbsp;função&nbsp;hepática&nbsp;indicam&nbsp;a&nbsp;necessidade&nbsp;de&nbsp;investigar</td><td class="diff_next"></td><td class="diff_header" id="to62_101">101</td><td nowrap="nowrap">virais,&nbsp;as&nbsp;alterações&nbsp;nos&nbsp;testes&nbsp;de&nbsp;função&nbsp;hepática&nbsp;indicam&nbsp;a&nbsp;necessidade&nbsp;de&nbsp;investigar</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_104">104</td><td nowrap="nowrap">a&nbsp;origem&nbsp;dessas&nbsp;alterações,&nbsp;que,&nbsp;entre&nbsp;outras&nbsp;possibilidades,&nbsp;podem&nbsp;ser&nbsp;causadas&nbsp;pelos</td><td class="diff_next"></td><td class="diff_header" id="to62_102">102</td><td nowrap="nowrap">a&nbsp;origem&nbsp;dessas&nbsp;alterações,&nbsp;que,&nbsp;entre&nbsp;outras&nbsp;possibilidades,&nbsp;podem&nbsp;ser&nbsp;causadas&nbsp;pelos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_105">105</td><td nowrap="nowrap">vírus&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B,&nbsp;C,&nbsp;D&nbsp;ou&nbsp;E.</td><td class="diff_next"></td><td class="diff_header" id="to62_103">103</td><td nowrap="nowrap">vírus&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B,&nbsp;C,&nbsp;D&nbsp;ou&nbsp;E.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_106">106</td><td nowrap="nowrap">Vale&nbsp;ressaltar&nbsp;que,&nbsp;nas&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;a&nbsp;definição&nbsp;de&nbsp;suas&nbsp;formas&nbsp;crônicas&nbsp;se&nbsp;dá&nbsp;pela</td><td class="diff_next"></td><td class="diff_header" id="to62_104">104</td><td nowrap="nowrap">Vale&nbsp;ressaltar&nbsp;que,&nbsp;nas&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;a&nbsp;definição&nbsp;de&nbsp;suas&nbsp;formas&nbsp;crônicas&nbsp;se&nbsp;dá&nbsp;pela</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_107">107</td><td nowrap="nowrap">presença&nbsp;de&nbsp;replicação&nbsp;viral&nbsp;persistente&nbsp;por&nbsp;mais&nbsp;de&nbsp;seis&nbsp;meses.</td><td class="diff_next"></td><td class="diff_header" id="to62_105">105</td><td nowrap="nowrap">presença&nbsp;de&nbsp;replicação&nbsp;viral&nbsp;persistente&nbsp;por&nbsp;mais&nbsp;de&nbsp;seis&nbsp;meses.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_108">108</td><td nowrap="nowrap">Não&nbsp;existem&nbsp;manifestações&nbsp;clínicas&nbsp;ou&nbsp;padrões&nbsp;de&nbsp;evolução&nbsp;dos&nbsp;diferentes&nbsp;agentes.</td><td class="diff_next"></td><td class="diff_header" id="to62_106">106</td><td nowrap="nowrap">Não&nbsp;existem&nbsp;manifestações&nbsp;clínicas&nbsp;ou&nbsp;padrões&nbsp;de&nbsp;evolução&nbsp;dos&nbsp;diferentes&nbsp;agentes.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_109">109</td><td nowrap="nowrap">O&nbsp;diagnóstico&nbsp;etiológicoG&nbsp;só&nbsp;é&nbsp;possível&nbsp;por&nbsp;meio&nbsp;de&nbsp;exames&nbsp;sorológicos&nbsp;e/ou&nbsp;de&nbsp;biolo-</td><td class="diff_next"></td><td class="diff_header" id="to62_107">107</td><td nowrap="nowrap">O&nbsp;diagnóstico&nbsp;etiológicoG&nbsp;só&nbsp;é&nbsp;possível&nbsp;por&nbsp;meio&nbsp;de&nbsp;exames&nbsp;sorológicos&nbsp;e/ou&nbsp;de&nbsp;biolo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_110">110</td><td nowrap="nowrap">gia&nbsp;molecular.</td><td class="diff_next"></td><td class="diff_header" id="to62_108">108</td><td nowrap="nowrap">gia&nbsp;molecular.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_111">111</td><td nowrap="nowrap">5.&nbsp;METODOLOGIAS&nbsp;DE&nbsp;DIAGNÓSTICO&nbsp;DAS&nbsp;HEPATITES&nbsp;VIRAIS</td><td class="diff_next"></td><td class="diff_header" id="to62_109">109</td><td nowrap="nowrap">5.&nbsp;METODOLOGIAS&nbsp;DE&nbsp;DIAGNÓSTICO&nbsp;DAS&nbsp;HEPATITES&nbsp;VIRAIS</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_112">112</td><td nowrap="nowrap">no&nbsp;sangue,&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;fluido&nbsp;oralG&nbsp;da&nbsp;pessoa&nbsp;infectada,&nbsp;por&nbsp;meio&nbsp;de&nbsp;imunoen-</td><td class="diff_next"></td><td class="diff_header" id="to62_110">110</td><td nowrap="nowrap">no&nbsp;sangue,&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;fluido&nbsp;oralG&nbsp;da&nbsp;pessoa&nbsp;infectada,&nbsp;por&nbsp;meio&nbsp;de&nbsp;imunoen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_113">113</td><td nowrap="nowrap">saiosG,&nbsp;e/ou&nbsp;na&nbsp;detecção&nbsp;do&nbsp;ácido&nbsp;nucleicoG&nbsp;viral,&nbsp;empregando&nbsp;técnicas&nbsp;de&nbsp;biologia</td><td class="diff_next"></td><td class="diff_header" id="to62_111">111</td><td nowrap="nowrap">saiosG,&nbsp;e/ou&nbsp;na&nbsp;detecção&nbsp;do&nbsp;ácido&nbsp;nucleicoG&nbsp;viral,&nbsp;empregando&nbsp;técnicas&nbsp;de&nbsp;biologia</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_114">114</td><td nowrap="nowrap">molecular.&nbsp;O&nbsp;constante&nbsp;avanço&nbsp;tecnológico&nbsp;na&nbsp;área&nbsp;de&nbsp;diagnóstico&nbsp;permitiu&nbsp;o&nbsp;desenvol-</td><td class="diff_next"></td><td class="diff_header" id="to62_112">112</td><td nowrap="nowrap">molecular.&nbsp;O&nbsp;constante&nbsp;avanço&nbsp;tecnológico&nbsp;na&nbsp;área&nbsp;de&nbsp;diagnóstico&nbsp;permitiu&nbsp;o&nbsp;desenvol-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_115">115</td><td nowrap="nowrap">vimento&nbsp;de&nbsp;técnicas&nbsp;avançadas&nbsp;de&nbsp;imunoensaios,&nbsp;incluindo&nbsp;o&nbsp;de&nbsp;fluxo&nbsp;lateral,&nbsp;que&nbsp;são</td><td class="diff_next"></td><td class="diff_header" id="to62_113">113</td><td nowrap="nowrap">vimento&nbsp;de&nbsp;técnicas&nbsp;avançadas&nbsp;de&nbsp;imunoensaios,&nbsp;incluindo&nbsp;o&nbsp;de&nbsp;fluxo&nbsp;lateral,&nbsp;que&nbsp;são</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_116">116</td><td nowrap="nowrap">atualmente&nbsp;empregadas&nbsp;na&nbsp;fabricação&nbsp;de&nbsp;testes&nbsp;rápidos&nbsp;(TR).</td><td class="diff_next"></td><td class="diff_header" id="to62_114">114</td><td nowrap="nowrap">atualmente&nbsp;empregadas&nbsp;na&nbsp;fabricação&nbsp;de&nbsp;testes&nbsp;rápidos&nbsp;(TR).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_117">117</td><td nowrap="nowrap">A&nbsp;seguir,&nbsp;são&nbsp;descritas&nbsp;as&nbsp;principais&nbsp;metodologias&nbsp;utilizadas&nbsp;no&nbsp;diagnóstico&nbsp;das&nbsp;he-</td><td class="diff_next"></td><td class="diff_header" id="to62_115">115</td><td nowrap="nowrap">A&nbsp;seguir,&nbsp;são&nbsp;descritas&nbsp;as&nbsp;principais&nbsp;metodologias&nbsp;utilizadas&nbsp;no&nbsp;diagnóstico&nbsp;das&nbsp;he-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_118">118</td><td nowrap="nowrap">patites&nbsp;virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_116">116</td><td nowrap="nowrap">patites&nbsp;virais.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__5"></td><td class="diff_header" id="from62_119">119</td><td nowrap="nowrap">5.1&nbsp;Imunoensaios</td><td class="diff_next"></td><td class="diff_header" id="to62_117">117</td><td nowrap="nowrap">5.1&nbsp;Imunoensaios</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_120">120</td><td nowrap="nowrap">As&nbsp;técnicas&nbsp;de&nbsp;imunoensaioG&nbsp;são&nbsp;baseadas&nbsp;na&nbsp;detecção&nbsp;do&nbsp;antígenoG&nbsp;viral&nbsp;e/ou</td><td class="diff_next"></td><td class="diff_header" id="to62_118">118</td><td nowrap="nowrap">As&nbsp;técnicas&nbsp;de&nbsp;imunoensaioG&nbsp;são&nbsp;baseadas&nbsp;na&nbsp;detecção&nbsp;do&nbsp;antígenoG&nbsp;viral&nbsp;e/ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_121">121</td><td nowrap="nowrap">anticorposG&nbsp;específicos,&nbsp;como&nbsp;as&nbsp;imunoglobulinas&nbsp;da&nbsp;classe&nbsp;M&nbsp;(IgM),&nbsp;que&nbsp;são&nbsp;as&nbsp;primei-</td><td class="diff_next"></td><td class="diff_header" id="to62_119">119</td><td nowrap="nowrap">anticorposG&nbsp;específicos,&nbsp;como&nbsp;as&nbsp;imunoglobulinas&nbsp;da&nbsp;classe&nbsp;M&nbsp;(IgM),&nbsp;que&nbsp;são&nbsp;as&nbsp;primei-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_122">122</td><td nowrap="nowrap">ras&nbsp;a&nbsp;aparecer&nbsp;e&nbsp;caracterizam,&nbsp;portanto,&nbsp;uma&nbsp;infecção&nbsp;aguda,&nbsp;e&nbsp;as&nbsp;imunoglobulinas&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_120">120</td><td nowrap="nowrap">ras&nbsp;a&nbsp;aparecer&nbsp;e&nbsp;caracterizam,&nbsp;portanto,&nbsp;uma&nbsp;infecção&nbsp;aguda,&nbsp;e&nbsp;as&nbsp;imunoglobulinas&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_123">123</td><td nowrap="nowrap">classe&nbsp;G&nbsp;(IgG),&nbsp;que&nbsp;surgem&nbsp;após&nbsp;as&nbsp;IgM&nbsp;e&nbsp;podem&nbsp;permanecer&nbsp;indefinidamente,&nbsp;servindo</td><td class="diff_next"></td><td class="diff_header" id="to62_121">121</td><td nowrap="nowrap">classe&nbsp;G&nbsp;(IgG),&nbsp;que&nbsp;surgem&nbsp;após&nbsp;as&nbsp;IgM&nbsp;e&nbsp;podem&nbsp;permanecer&nbsp;indefinidamente,&nbsp;servindo</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__6">n</a></td><td class="diff_header" id="from62_124">124</td><td nowrap="nowrap">como&nbsp;marcador&nbsp;de&nbsp;infecção&nbsp;passada&nbsp;<span class="diff_chg">–</span>&nbsp;que&nbsp;caracteriza&nbsp;o&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;vírus&nbsp;<span class="diff_chg">–</span>&nbsp;ou</td><td class="diff_next"><a href="#difflib_chg_to62__6">n</a></td><td class="diff_header" id="to62_122">122</td><td nowrap="nowrap">como&nbsp;marcador&nbsp;de&nbsp;infecção&nbsp;passada&nbsp;<span class="diff_chg">-</span>&nbsp;que&nbsp;caracteriza&nbsp;o&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;vírus&nbsp;<span class="diff_chg">-</span>&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_125">125</td><td nowrap="nowrap">de&nbsp;resposta&nbsp;vacinal.</td><td class="diff_next"></td><td class="diff_header" id="to62_123">123</td><td nowrap="nowrap">de&nbsp;resposta&nbsp;vacinal.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_126">126</td><td nowrap="nowrap">A&nbsp;seguir,&nbsp;são&nbsp;descritos&nbsp;os&nbsp;principais&nbsp;imunoensaios&nbsp;utilizados&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;das</td><td class="diff_next"></td><td class="diff_header" id="to62_124">124</td><td nowrap="nowrap">A&nbsp;seguir,&nbsp;são&nbsp;descritos&nbsp;os&nbsp;principais&nbsp;imunoensaios&nbsp;utilizados&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;das</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_127">127</td><td nowrap="nowrap">hepatites&nbsp;virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_125">125</td><td nowrap="nowrap">hepatites&nbsp;virais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_128">128</td><td nowrap="nowrap">5.1.1&nbsp;Ensaios&nbsp;imunoenzimáticos</td><td class="diff_next"></td><td class="diff_header" id="to62_126">126</td><td nowrap="nowrap">5.1.1&nbsp;Ensaios&nbsp;imunoenzimáticos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_129">129</td><td nowrap="nowrap">Incluem&nbsp;os&nbsp;ensaios&nbsp;do&nbsp;tipo&nbsp;ELISA&nbsp;(do&nbsp;inglês&nbsp;enzyme-linked&nbsp;immunosorbent&nbsp;assay)</td><td class="diff_next"></td><td class="diff_header" id="to62_127">127</td><td nowrap="nowrap">Incluem&nbsp;os&nbsp;ensaios&nbsp;do&nbsp;tipo&nbsp;ELISA&nbsp;(do&nbsp;inglês&nbsp;enzyme-linked&nbsp;immunosorbent&nbsp;assay)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_130">130</td><td nowrap="nowrap">e&nbsp;ELFA&nbsp;(do&nbsp;inglês&nbsp;enzyme-linked&nbsp;fluorescent&nbsp;assay),&nbsp;sendo&nbsp;utilizados&nbsp;no&nbsp;diagnóstico&nbsp;das</td><td class="diff_next"></td><td class="diff_header" id="to62_128">128</td><td nowrap="nowrap">e&nbsp;ELFA&nbsp;(do&nbsp;inglês&nbsp;enzyme-linked&nbsp;fluorescent&nbsp;assay),&nbsp;sendo&nbsp;utilizados&nbsp;no&nbsp;diagnóstico&nbsp;das</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_131">131</td><td nowrap="nowrap">infecções&nbsp;virais&nbsp;por&nbsp;meio&nbsp;da&nbsp;detecção&nbsp;de&nbsp;antígenos&nbsp;e/ou&nbsp;anticorpos&nbsp;específicos&nbsp;contra&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_129">129</td><td nowrap="nowrap">infecções&nbsp;virais&nbsp;por&nbsp;meio&nbsp;da&nbsp;detecção&nbsp;de&nbsp;antígenos&nbsp;e/ou&nbsp;anticorpos&nbsp;específicos&nbsp;contra&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_132">132</td><td nowrap="nowrap">patógeno,&nbsp;isoladamente&nbsp;ou&nbsp;de&nbsp;forma&nbsp;combinada.</td><td class="diff_next"></td><td class="diff_header" id="to62_130">130</td><td nowrap="nowrap">patógeno,&nbsp;isoladamente&nbsp;ou&nbsp;de&nbsp;forma&nbsp;combinada.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_133">133</td><td nowrap="nowrap">Em&nbsp;um&nbsp;teste&nbsp;ELISA,&nbsp;para&nbsp;a&nbsp;detecção&nbsp;de&nbsp;anticorpos,&nbsp;um&nbsp;antígeno&nbsp;é&nbsp;imobilizado&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_131">131</td><td nowrap="nowrap">Em&nbsp;um&nbsp;teste&nbsp;ELISA,&nbsp;para&nbsp;a&nbsp;detecção&nbsp;de&nbsp;anticorpos,&nbsp;um&nbsp;antígeno&nbsp;é&nbsp;imobilizado&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_134">134</td><td nowrap="nowrap">uma&nbsp;superfície&nbsp;sólida.&nbsp;O&nbsp;anticorpo&nbsp;presente&nbsp;na&nbsp;amostra&nbsp;do&nbsp;paciente&nbsp;se&nbsp;liga&nbsp;ao&nbsp;antígeno,</td><td class="diff_next"></td><td class="diff_header" id="to62_132">132</td><td nowrap="nowrap">uma&nbsp;superfície&nbsp;sólida.&nbsp;O&nbsp;anticorpo&nbsp;presente&nbsp;na&nbsp;amostra&nbsp;do&nbsp;paciente&nbsp;se&nbsp;liga&nbsp;ao&nbsp;antígeno,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_135">135</td><td nowrap="nowrap">ficando&nbsp;preso&nbsp;na&nbsp;superfície&nbsp;sólida.&nbsp;Acrescenta-se&nbsp;ao&nbsp;sistema&nbsp;um&nbsp;conjugado&nbsp;(anticorpo</td><td class="diff_next"></td><td class="diff_header" id="to62_133">133</td><td nowrap="nowrap">ficando&nbsp;preso&nbsp;na&nbsp;superfície&nbsp;sólida.&nbsp;Acrescenta-se&nbsp;ao&nbsp;sistema&nbsp;um&nbsp;conjugado&nbsp;(anticorpo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_136">136</td><td nowrap="nowrap">ligado&nbsp;a&nbsp;uma&nbsp;enzima),&nbsp;que&nbsp;irá&nbsp;se&nbsp;ligar&nbsp;ao&nbsp;anticorpo&nbsp;preso&nbsp;ao&nbsp;antígeno.&nbsp;A&nbsp;detecção&nbsp;ocorre</td><td class="diff_next"></td><td class="diff_header" id="to62_134">134</td><td nowrap="nowrap">ligado&nbsp;a&nbsp;uma&nbsp;enzima),&nbsp;que&nbsp;irá&nbsp;se&nbsp;ligar&nbsp;ao&nbsp;anticorpo&nbsp;preso&nbsp;ao&nbsp;antígeno.&nbsp;A&nbsp;detecção&nbsp;ocorre</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_137">137</td><td nowrap="nowrap">por&nbsp;meio&nbsp;da&nbsp;incubação&nbsp;desse&nbsp;complexo&nbsp;enzimático&nbsp;(antígeno&nbsp;+&nbsp;anticorpo&nbsp;+&nbsp;anticorpo-</td><td class="diff_next"></td><td class="diff_header" id="to62_135">135</td><td nowrap="nowrap">por&nbsp;meio&nbsp;da&nbsp;incubação&nbsp;desse&nbsp;complexo&nbsp;enzimático&nbsp;(antígeno&nbsp;+&nbsp;anticorpo&nbsp;+&nbsp;anticorpo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_138">138</td><td nowrap="nowrap">-enzima)&nbsp;com&nbsp;um&nbsp;substrato&nbsp;que,&nbsp;ao&nbsp;ser&nbsp;consumido&nbsp;pela&nbsp;enzima,&nbsp;resultará&nbsp;em&nbsp;um&nbsp;produ-</td><td class="diff_next"></td><td class="diff_header" id="to62_136">136</td><td nowrap="nowrap">-enzima)&nbsp;com&nbsp;um&nbsp;substrato&nbsp;que,&nbsp;ao&nbsp;ser&nbsp;consumido&nbsp;pela&nbsp;enzima,&nbsp;resultará&nbsp;em&nbsp;um&nbsp;produ-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_139">139</td><td nowrap="nowrap">to&nbsp;detectável&nbsp;(colorido&nbsp;ou&nbsp;insolúvel).&nbsp;O&nbsp;principal&nbsp;elemento&nbsp;para&nbsp;a&nbsp;estratégia&nbsp;de&nbsp;detecção</td><td class="diff_next"></td><td class="diff_header" id="to62_137">137</td><td nowrap="nowrap">to&nbsp;detectável&nbsp;(colorido&nbsp;ou&nbsp;insolúvel).&nbsp;O&nbsp;principal&nbsp;elemento&nbsp;para&nbsp;a&nbsp;estratégia&nbsp;de&nbsp;detecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_140">140</td><td nowrap="nowrap">é&nbsp;uma&nbsp;interação&nbsp;antígeno-anticorpo&nbsp;altamente&nbsp;específica.</td><td class="diff_next"></td><td class="diff_header" id="to62_138">138</td><td nowrap="nowrap">é&nbsp;uma&nbsp;interação&nbsp;antígeno-anticorpo&nbsp;altamente&nbsp;específica.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_141">141</td><td nowrap="nowrap">O&nbsp;teste&nbsp;ELFA&nbsp;segue&nbsp;o&nbsp;mesmo&nbsp;princípio&nbsp;do&nbsp;ELISA,&nbsp;com&nbsp;a&nbsp;diferença&nbsp;de&nbsp;utilizar&nbsp;um</td><td class="diff_next"></td><td class="diff_header" id="to62_139">139</td><td nowrap="nowrap">O&nbsp;teste&nbsp;ELFA&nbsp;segue&nbsp;o&nbsp;mesmo&nbsp;princípio&nbsp;do&nbsp;ELISA,&nbsp;com&nbsp;a&nbsp;diferença&nbsp;de&nbsp;utilizar&nbsp;um</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_142">142</td><td nowrap="nowrap">substrato&nbsp;que&nbsp;gera&nbsp;um&nbsp;sinal&nbsp;fluorescente,&nbsp;ao&nbsp;invés&nbsp;de&nbsp;colorido&nbsp;ou&nbsp;insolúvel.&nbsp;A&nbsp;fluores-</td><td class="diff_next"></td><td class="diff_header" id="to62_140">140</td><td nowrap="nowrap">substrato&nbsp;que&nbsp;gera&nbsp;um&nbsp;sinal&nbsp;fluorescente,&nbsp;ao&nbsp;invés&nbsp;de&nbsp;colorido&nbsp;ou&nbsp;insolúvel.&nbsp;A&nbsp;fluores-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_143">143</td><td nowrap="nowrap">cência&nbsp;pode&nbsp;ser&nbsp;detectada&nbsp;em&nbsp;concentrações&nbsp;menores&nbsp;que&nbsp;as&nbsp;de&nbsp;produtos&nbsp;coloridos,&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_141">141</td><td nowrap="nowrap">cência&nbsp;pode&nbsp;ser&nbsp;detectada&nbsp;em&nbsp;concentrações&nbsp;menores&nbsp;que&nbsp;as&nbsp;de&nbsp;produtos&nbsp;coloridos,&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_144">144</td><td nowrap="nowrap">que&nbsp;garante&nbsp;maior&nbsp;sensibilidade&nbsp;clínicaG&nbsp;ao&nbsp;teste&nbsp;(YOLKEN;&nbsp;STOPA,&nbsp;1979).</td><td class="diff_next"></td><td class="diff_header" id="to62_142">142</td><td nowrap="nowrap">que&nbsp;garante&nbsp;maior&nbsp;sensibilidade&nbsp;clínicaG&nbsp;ao&nbsp;teste&nbsp;(YOLKEN;&nbsp;STOPA,&nbsp;1979).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_145">145</td><td nowrap="nowrap">antígenos&nbsp;e&nbsp;anticorpos&nbsp;no&nbsp;plasma&nbsp;ou&nbsp;no&nbsp;soro&nbsp;humano,&nbsp;permitindo&nbsp;a&nbsp;detecção&nbsp;precoce</td><td class="diff_next"></td><td class="diff_header" id="to62_143">143</td><td nowrap="nowrap">antígenos&nbsp;e&nbsp;anticorpos&nbsp;no&nbsp;plasma&nbsp;ou&nbsp;no&nbsp;soro&nbsp;humano,&nbsp;permitindo&nbsp;a&nbsp;detecção&nbsp;precoce</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_146">146</td><td nowrap="nowrap">da&nbsp;infecção&nbsp;por&nbsp;combinar&nbsp;em&nbsp;uma&nbsp;única&nbsp;reação&nbsp;a&nbsp;detecção&nbsp;de&nbsp;dois&nbsp;marcadores.</td><td class="diff_next"></td><td class="diff_header" id="to62_144">144</td><td nowrap="nowrap">da&nbsp;infecção&nbsp;por&nbsp;combinar&nbsp;em&nbsp;uma&nbsp;única&nbsp;reação&nbsp;a&nbsp;detecção&nbsp;de&nbsp;dois&nbsp;marcadores.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_147">147</td><td nowrap="nowrap">5.1.2&nbsp;Ensaios&nbsp;luminescentes</td><td class="diff_next"></td><td class="diff_header" id="to62_145">145</td><td nowrap="nowrap">5.1.2&nbsp;Ensaios&nbsp;luminescentes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_148">148</td><td nowrap="nowrap">nos&nbsp;quais&nbsp;o&nbsp;evento&nbsp;excitatório&nbsp;é&nbsp;provocado&nbsp;por&nbsp;uma&nbsp;reação&nbsp;química&nbsp;ou&nbsp;eletroquímica,</td><td class="diff_next"></td><td class="diff_header" id="to62_146">146</td><td nowrap="nowrap">nos&nbsp;quais&nbsp;o&nbsp;evento&nbsp;excitatório&nbsp;é&nbsp;provocado&nbsp;por&nbsp;uma&nbsp;reação&nbsp;química&nbsp;ou&nbsp;eletroquímica,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_149">149</td><td nowrap="nowrap">respectivamente.&nbsp;O&nbsp;evento&nbsp;físico&nbsp;de&nbsp;emissão&nbsp;de&nbsp;luz&nbsp;na&nbsp;quimioluminescência&nbsp;e&nbsp;na&nbsp;eletro-</td><td class="diff_next"></td><td class="diff_header" id="to62_147">147</td><td nowrap="nowrap">respectivamente.&nbsp;O&nbsp;evento&nbsp;físico&nbsp;de&nbsp;emissão&nbsp;de&nbsp;luz&nbsp;na&nbsp;quimioluminescência&nbsp;e&nbsp;na&nbsp;eletro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_150">150</td><td nowrap="nowrap">quimioluminescência&nbsp;é&nbsp;semelhante&nbsp;ao&nbsp;da&nbsp;fluorescência.&nbsp;A&nbsp;emissão&nbsp;de&nbsp;luz&nbsp;ocorre&nbsp;a&nbsp;partir</td><td class="diff_next"></td><td class="diff_header" id="to62_148">148</td><td nowrap="nowrap">quimioluminescência&nbsp;é&nbsp;semelhante&nbsp;ao&nbsp;da&nbsp;fluorescência.&nbsp;A&nbsp;emissão&nbsp;de&nbsp;luz&nbsp;ocorre&nbsp;a&nbsp;partir</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_151">151</td><td nowrap="nowrap">de&nbsp;um&nbsp;elétron&nbsp;em&nbsp;estado&nbsp;excitado&nbsp;que&nbsp;retorna&nbsp;ao&nbsp;seu&nbsp;estado&nbsp;fundamental,&nbsp;emitindo</td><td class="diff_next"></td><td class="diff_header" id="to62_149">149</td><td nowrap="nowrap">de&nbsp;um&nbsp;elétron&nbsp;em&nbsp;estado&nbsp;excitado&nbsp;que&nbsp;retorna&nbsp;ao&nbsp;seu&nbsp;estado&nbsp;fundamental,&nbsp;emitindo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_152">152</td><td nowrap="nowrap">um&nbsp;fóton.</td><td class="diff_next"></td><td class="diff_header" id="to62_150">150</td><td nowrap="nowrap">um&nbsp;fóton.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_153">153</td><td nowrap="nowrap">Ensaio&nbsp;de&nbsp;quimioluminescência:&nbsp;Os&nbsp;ensaios&nbsp;de&nbsp;quimioluminescência&nbsp;podem&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_151">151</td><td nowrap="nowrap">Ensaio&nbsp;de&nbsp;quimioluminescência:&nbsp;Os&nbsp;ensaios&nbsp;de&nbsp;quimioluminescência&nbsp;podem&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_154">154</td><td nowrap="nowrap">qualitativos&nbsp;ou&nbsp;quantitativos.&nbsp;Esses&nbsp;ensaios&nbsp;envolvem&nbsp;o&nbsp;uso&nbsp;de&nbsp;uma&nbsp;substância&nbsp;lumines-</td><td class="diff_next"></td><td class="diff_header" id="to62_152">152</td><td nowrap="nowrap">qualitativos&nbsp;ou&nbsp;quantitativos.&nbsp;Esses&nbsp;ensaios&nbsp;envolvem&nbsp;o&nbsp;uso&nbsp;de&nbsp;uma&nbsp;substância&nbsp;lumines-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_155">155</td><td nowrap="nowrap">cente&nbsp;para&nbsp;detecção&nbsp;da&nbsp;reação&nbsp;antígeno-anticorpo&nbsp;e&nbsp;anticorpo-antígeno.&nbsp;O&nbsp;resultado</td><td class="diff_next"></td><td class="diff_header" id="to62_153">153</td><td nowrap="nowrap">cente&nbsp;para&nbsp;detecção&nbsp;da&nbsp;reação&nbsp;antígeno-anticorpo&nbsp;e&nbsp;anticorpo-antígeno.&nbsp;O&nbsp;resultado</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_156">156</td><td nowrap="nowrap">é&nbsp;definido&nbsp;pela&nbsp;emissão&nbsp;de&nbsp;luz,&nbsp;que&nbsp;é&nbsp;captada&nbsp;e&nbsp;analisada&nbsp;em&nbsp;equipamento&nbsp;próprio.&nbsp;O</td><td class="diff_next"></td><td class="diff_header" id="to62_154">154</td><td nowrap="nowrap">é&nbsp;definido&nbsp;pela&nbsp;emissão&nbsp;de&nbsp;luz,&nbsp;que&nbsp;é&nbsp;captada&nbsp;e&nbsp;analisada&nbsp;em&nbsp;equipamento&nbsp;próprio.&nbsp;O</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_157">157</td><td nowrap="nowrap">sistema&nbsp;de&nbsp;detecção&nbsp;por&nbsp;quimioluminescência&nbsp;é&nbsp;muito&nbsp;sensível&nbsp;e&nbsp;específico,&nbsp;mas&nbsp;exige</td><td class="diff_next"></td><td class="diff_header" id="to62_155">155</td><td nowrap="nowrap">sistema&nbsp;de&nbsp;detecção&nbsp;por&nbsp;quimioluminescência&nbsp;é&nbsp;muito&nbsp;sensível&nbsp;e&nbsp;específico,&nbsp;mas&nbsp;exige</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_158">158</td><td nowrap="nowrap">equipamentos&nbsp;especiais&nbsp;e&nbsp;ainda&nbsp;tem&nbsp;custo&nbsp;elevado.&nbsp;No&nbsp;entanto,&nbsp;existem&nbsp;soluções&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_156">156</td><td nowrap="nowrap">equipamentos&nbsp;especiais&nbsp;e&nbsp;ainda&nbsp;tem&nbsp;custo&nbsp;elevado.&nbsp;No&nbsp;entanto,&nbsp;existem&nbsp;soluções&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_159">159</td><td nowrap="nowrap">automação&nbsp;que&nbsp;aumentam&nbsp;a&nbsp;confiabilidade&nbsp;do&nbsp;ensaio&nbsp;e&nbsp;reduzem&nbsp;seu&nbsp;custo,&nbsp;quando</td><td class="diff_next"></td><td class="diff_header" id="to62_157">157</td><td nowrap="nowrap">automação&nbsp;que&nbsp;aumentam&nbsp;a&nbsp;confiabilidade&nbsp;do&nbsp;ensaio&nbsp;e&nbsp;reduzem&nbsp;seu&nbsp;custo,&nbsp;quando</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_160">160</td><td nowrap="nowrap">este&nbsp;é&nbsp;utilizado&nbsp;em&nbsp;larga&nbsp;escala.</td><td class="diff_next"></td><td class="diff_header" id="to62_158">158</td><td nowrap="nowrap">este&nbsp;é&nbsp;utilizado&nbsp;em&nbsp;larga&nbsp;escala.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_161">161</td><td nowrap="nowrap">Ensaio&nbsp;de&nbsp;eletroquimioluminescência:&nbsp;A&nbsp;eletroquimioluminescência&nbsp;é&nbsp;um&nbsp;pro-</td><td class="diff_next"></td><td class="diff_header" id="to62_159">159</td><td nowrap="nowrap">Ensaio&nbsp;de&nbsp;eletroquimioluminescência:&nbsp;A&nbsp;eletroquimioluminescência&nbsp;é&nbsp;um&nbsp;pro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_162">162</td><td nowrap="nowrap">cesso&nbsp;no&nbsp;qual&nbsp;a&nbsp;aplicação&nbsp;de&nbsp;uma&nbsp;corrente&nbsp;elétrica&nbsp;induz&nbsp;uma&nbsp;emissão&nbsp;quimiolumines-</td><td class="diff_next"></td><td class="diff_header" id="to62_160">160</td><td nowrap="nowrap">cesso&nbsp;no&nbsp;qual&nbsp;a&nbsp;aplicação&nbsp;de&nbsp;uma&nbsp;corrente&nbsp;elétrica&nbsp;induz&nbsp;uma&nbsp;emissão&nbsp;quimiolumines-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_163">163</td><td nowrap="nowrap">cente&nbsp;a&nbsp;partir&nbsp;dos&nbsp;complexos&nbsp;imunológicos&nbsp;(antígeno-anticorpo&nbsp;ou&nbsp;anticorpo-antíge-</td><td class="diff_next"></td><td class="diff_header" id="to62_161">161</td><td nowrap="nowrap">cente&nbsp;a&nbsp;partir&nbsp;dos&nbsp;complexos&nbsp;imunológicos&nbsp;(antígeno-anticorpo&nbsp;ou&nbsp;anticorpo-antíge-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_164">164</td><td nowrap="nowrap">no),&nbsp;contendo&nbsp;espécies&nbsp;químicasG&nbsp;altamente&nbsp;reativas&nbsp;presentes&nbsp;em&nbsp;um&nbsp;eletrodo.&nbsp;Essas</td><td class="diff_next"></td><td class="diff_header" id="to62_162">162</td><td nowrap="nowrap">no),&nbsp;contendo&nbsp;espécies&nbsp;químicasG&nbsp;altamente&nbsp;reativas&nbsp;presentes&nbsp;em&nbsp;um&nbsp;eletrodo.&nbsp;Essas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_165">165</td><td nowrap="nowrap">espécies&nbsp;reagem&nbsp;entre&nbsp;si,&nbsp;produzindo&nbsp;luz.&nbsp;A&nbsp;vantagem&nbsp;do&nbsp;emprego&nbsp;de&nbsp;uma&nbsp;corrente</td><td class="diff_next"></td><td class="diff_header" id="to62_163">163</td><td nowrap="nowrap">espécies&nbsp;reagem&nbsp;entre&nbsp;si,&nbsp;produzindo&nbsp;luz.&nbsp;A&nbsp;vantagem&nbsp;do&nbsp;emprego&nbsp;de&nbsp;uma&nbsp;corrente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_166">166</td><td nowrap="nowrap">(MATHEW;&nbsp;BIJU;&nbsp;THAPALIA,&nbsp;2005).</td><td class="diff_next"></td><td class="diff_header" id="to62_164">164</td><td nowrap="nowrap">(MATHEW;&nbsp;BIJU;&nbsp;THAPALIA,&nbsp;2005).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_167">167</td><td nowrap="nowrap">A&nbsp;vantagem&nbsp;desse&nbsp;processo&nbsp;consiste&nbsp;na&nbsp;simplicidade&nbsp;de&nbsp;preparação,&nbsp;na&nbsp;alta&nbsp;estabi-</td><td class="diff_next"></td><td class="diff_header" id="to62_165">165</td><td nowrap="nowrap">A&nbsp;vantagem&nbsp;desse&nbsp;processo&nbsp;consiste&nbsp;na&nbsp;simplicidade&nbsp;de&nbsp;preparação,&nbsp;na&nbsp;alta&nbsp;estabi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_168">168</td><td nowrap="nowrap">lidade&nbsp;dos&nbsp;reagentes&nbsp;e&nbsp;em&nbsp;uma&nbsp;grande&nbsp;sensibilidade.</td><td class="diff_next"></td><td class="diff_header" id="to62_166">166</td><td nowrap="nowrap">lidade&nbsp;dos&nbsp;reagentes&nbsp;e&nbsp;em&nbsp;uma&nbsp;grande&nbsp;sensibilidade.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_169">169</td><td nowrap="nowrap">5.1.3&nbsp;Testes&nbsp;rápidos</td><td class="diff_next"></td><td class="diff_header" id="to62_167">167</td><td nowrap="nowrap">5.1.3&nbsp;Testes&nbsp;rápidos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_170">170</td><td nowrap="nowrap">Os&nbsp;testes&nbsp;rápidos&nbsp;(TR)&nbsp;constituem&nbsp;imunoensaios&nbsp;cromatográficos&nbsp;de&nbsp;execução&nbsp;sim-</td><td class="diff_next"></td><td class="diff_header" id="to62_168">168</td><td nowrap="nowrap">Os&nbsp;testes&nbsp;rápidos&nbsp;(TR)&nbsp;constituem&nbsp;imunoensaios&nbsp;cromatográficos&nbsp;de&nbsp;execução&nbsp;sim-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_171">171</td><td nowrap="nowrap">ples,&nbsp;que&nbsp;podem&nbsp;ser&nbsp;realizados&nbsp;em&nbsp;até&nbsp;30&nbsp;minutos&nbsp;e&nbsp;que&nbsp;não&nbsp;necessitam&nbsp;de&nbsp;estrutu-</td><td class="diff_next"></td><td class="diff_header" id="to62_169">169</td><td nowrap="nowrap">ples,&nbsp;que&nbsp;podem&nbsp;ser&nbsp;realizados&nbsp;em&nbsp;até&nbsp;30&nbsp;minutos&nbsp;e&nbsp;que&nbsp;não&nbsp;necessitam&nbsp;de&nbsp;estrutu-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__6"></td><td class="diff_header" id="from62_172">172</td><td nowrap="nowrap">ra&nbsp;laboratorial.&nbsp;Os&nbsp;TR&nbsp;são&nbsp;fundamentais&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;do&nbsp;acesso&nbsp;ao&nbsp;diagnóstico&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_170">170</td><td nowrap="nowrap">ra&nbsp;laboratorial.&nbsp;Os&nbsp;TR&nbsp;são&nbsp;fundamentais&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;do&nbsp;acesso&nbsp;ao&nbsp;diagnóstico&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_173">173</td><td nowrap="nowrap">aumentam&nbsp;a&nbsp;resolutividade&nbsp;do&nbsp;sistema.&nbsp;A&nbsp;ampliação&nbsp;do&nbsp;diagnóstico&nbsp;por&nbsp;meio&nbsp;do&nbsp;uso</td><td class="diff_next"></td><td class="diff_header" id="to62_171">171</td><td nowrap="nowrap">aumentam&nbsp;a&nbsp;resolutividade&nbsp;do&nbsp;sistema.&nbsp;A&nbsp;ampliação&nbsp;do&nbsp;diagnóstico&nbsp;por&nbsp;meio&nbsp;do&nbsp;uso</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_174">174</td><td nowrap="nowrap">de&nbsp;TR&nbsp;permite&nbsp;a&nbsp;detecção&nbsp;precoce&nbsp;dos&nbsp;vírus&nbsp;causadores&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;possibili-</td><td class="diff_next"></td><td class="diff_header" id="to62_172">172</td><td nowrap="nowrap">de&nbsp;TR&nbsp;permite&nbsp;a&nbsp;detecção&nbsp;precoce&nbsp;dos&nbsp;vírus&nbsp;causadores&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;possibili-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_175">175</td><td nowrap="nowrap">diagnóstico.</td><td class="diff_next"></td><td class="diff_header" id="to62_173">173</td><td nowrap="nowrap">diagnóstico.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_176">176</td><td nowrap="nowrap">Esses&nbsp;testes&nbsp;são&nbsp;recomendados&nbsp;primariamente&nbsp;para&nbsp;testagens&nbsp;presenciais.&nbsp;Podem</td><td class="diff_next"></td><td class="diff_header" id="to62_174">174</td><td nowrap="nowrap">Esses&nbsp;testes&nbsp;são&nbsp;recomendados&nbsp;primariamente&nbsp;para&nbsp;testagens&nbsp;presenciais.&nbsp;Podem</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__7">n</a></td><td class="diff_header" id="from62_177">177</td><td nowrap="nowrap">ser&nbsp;realizados&nbsp;com&nbsp;fluido&nbsp;crevicular&nbsp;gengivalG&nbsp;<span class="diff_chg">–</span>&nbsp;mais&nbsp;conhecido&nbsp;como&nbsp;fluido&nbsp;oral&nbsp;(FO)</td><td class="diff_next"><a href="#difflib_chg_to62__7">n</a></td><td class="diff_header" id="to62_175">175</td><td nowrap="nowrap">ser&nbsp;realizados&nbsp;com&nbsp;fluido&nbsp;crevicular&nbsp;gengivalG&nbsp;<span class="diff_chg">-</span>&nbsp;mais&nbsp;conhecido&nbsp;como&nbsp;fluido&nbsp;oral&nbsp;(FO)</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__7"></td><td class="diff_header" id="from62_178">178</td><td nowrap="nowrap"><span class="diff_chg">–</span>,&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;sangue&nbsp;total&nbsp;(o&nbsp;que&nbsp;permite&nbsp;o&nbsp;uso&nbsp;de&nbsp;amostras&nbsp;obtidas&nbsp;por&nbsp;punção</td><td class="diff_next"></td><td class="diff_header" id="to62_176">176</td><td nowrap="nowrap"><span class="diff_chg">-</span>,&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;sangue&nbsp;total&nbsp;(o&nbsp;que&nbsp;permite&nbsp;o&nbsp;uso&nbsp;de&nbsp;amostras&nbsp;obtidas&nbsp;por&nbsp;punção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_179">179</td><td nowrap="nowrap">digital).&nbsp;A&nbsp;simplicidade&nbsp;de&nbsp;execução&nbsp;dos&nbsp;testes&nbsp;rápidos&nbsp;os&nbsp;transforma&nbsp;em&nbsp;ferramentas</td><td class="diff_next"></td><td class="diff_header" id="to62_177">177</td><td nowrap="nowrap">digital).&nbsp;A&nbsp;simplicidade&nbsp;de&nbsp;execução&nbsp;dos&nbsp;testes&nbsp;rápidos&nbsp;os&nbsp;transforma&nbsp;em&nbsp;ferramentas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_180">180</td><td nowrap="nowrap">fundamentais&nbsp;na&nbsp;expansão&nbsp;do&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;B&nbsp;e&nbsp;C.&nbsp;O&nbsp;Ministério&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_178">178</td><td nowrap="nowrap">fundamentais&nbsp;na&nbsp;expansão&nbsp;do&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;B&nbsp;e&nbsp;C.&nbsp;O&nbsp;Ministério&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_181">181</td><td nowrap="nowrap">Saúde&nbsp;esclarece&nbsp;que&nbsp;qualquer&nbsp;pessoa&nbsp;capacitada,&nbsp;presencialmente&nbsp;ou&nbsp;à&nbsp;distância,&nbsp;pode</td><td class="diff_next"></td><td class="diff_header" id="to62_179">179</td><td nowrap="nowrap">Saúde&nbsp;esclarece&nbsp;que&nbsp;qualquer&nbsp;pessoa&nbsp;capacitada,&nbsp;presencialmente&nbsp;ou&nbsp;à&nbsp;distância,&nbsp;pode</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_182">182</td><td nowrap="nowrap">executar&nbsp;um&nbsp;teste&nbsp;rápido.</td><td class="diff_next"></td><td class="diff_header" id="to62_180">180</td><td nowrap="nowrap">executar&nbsp;um&nbsp;teste&nbsp;rápido.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__8">n</a></td><td class="diff_header" id="from62_183">183</td><td nowrap="nowrap"><span class="diff_sub">dos&nbsp;TR&nbsp;pela&nbsp;plataforma&nbsp;Telelab,&nbsp;disponível&nbsp;no&nbsp;site&nbsp;http://www.telelab.aids.gov.br.&nbsp;A&nbsp;pes-</span></td><td class="diff_next"><a href="#difflib_chg_to62__8">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_184">184</td><td nowrap="nowrap">soa&nbsp;interessada&nbsp;em&nbsp;executar&nbsp;os&nbsp;TR&nbsp;pode&nbsp;se&nbsp;capacitar&nbsp;pela&nbsp;plataforma,&nbsp;que&nbsp;dispõe&nbsp;de&nbsp;vi-</td><td class="diff_next"></td><td class="diff_header" id="to62_181">181</td><td nowrap="nowrap">soa&nbsp;interessada&nbsp;em&nbsp;executar&nbsp;os&nbsp;TR&nbsp;pode&nbsp;se&nbsp;capacitar&nbsp;pela&nbsp;plataforma,&nbsp;que&nbsp;dispõe&nbsp;de&nbsp;vi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_185">185</td><td nowrap="nowrap">deoaulas&nbsp;e&nbsp;manuais.&nbsp;Ao&nbsp;se&nbsp;inscrever&nbsp;no&nbsp;Telelab&nbsp;e&nbsp;realizar&nbsp;as&nbsp;avaliações&nbsp;do&nbsp;curso,&nbsp;o&nbsp;aluno</td><td class="diff_next"></td><td class="diff_header" id="to62_182">182</td><td nowrap="nowrap">deoaulas&nbsp;e&nbsp;manuais.&nbsp;Ao&nbsp;se&nbsp;inscrever&nbsp;no&nbsp;Telelab&nbsp;e&nbsp;realizar&nbsp;as&nbsp;avaliações&nbsp;do&nbsp;curso,&nbsp;o&nbsp;aluno</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_186">186</td><td nowrap="nowrap">poderá&nbsp;obter&nbsp;certificado&nbsp;mediante&nbsp;aprovação&nbsp;em&nbsp;uma&nbsp;avaliação&nbsp;on-line&nbsp;e&nbsp;estará&nbsp;apto&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_183">183</td><td nowrap="nowrap">poderá&nbsp;obter&nbsp;certificado&nbsp;mediante&nbsp;aprovação&nbsp;em&nbsp;uma&nbsp;avaliação&nbsp;on-line&nbsp;e&nbsp;estará&nbsp;apto&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_187">187</td><td nowrap="nowrap">executar&nbsp;os&nbsp;TR.</td><td class="diff_next"></td><td class="diff_header" id="to62_184">184</td><td nowrap="nowrap">executar&nbsp;os&nbsp;TR.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_188">188</td><td nowrap="nowrap">infecciosos&nbsp;para&nbsp;os&nbsp;quais&nbsp;foram&nbsp;projetados.&nbsp;Caso&nbsp;o&nbsp;teste&nbsp;se&nbsp;destine&nbsp;à&nbsp;pesquisa&nbsp;de&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to62_185">185</td><td nowrap="nowrap">infecciosos&nbsp;para&nbsp;os&nbsp;quais&nbsp;foram&nbsp;projetados.&nbsp;Caso&nbsp;o&nbsp;teste&nbsp;se&nbsp;destine&nbsp;à&nbsp;pesquisa&nbsp;de&nbsp;anti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_189">189</td><td nowrap="nowrap">corpos,&nbsp;haverá&nbsp;antígenos&nbsp;(geralmente,&nbsp;proteínas&nbsp;sintéticas)&nbsp;imobilizados&nbsp;na&nbsp;membrana</td><td class="diff_next"></td><td class="diff_header" id="to62_186">186</td><td nowrap="nowrap">corpos,&nbsp;haverá&nbsp;antígenos&nbsp;(geralmente,&nbsp;proteínas&nbsp;sintéticas)&nbsp;imobilizados&nbsp;na&nbsp;membrana</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_190">190</td><td nowrap="nowrap">de&nbsp;nitrocelulose&nbsp;para&nbsp;a&nbsp;captura&nbsp;dos&nbsp;anticorpos&nbsp;presentes&nbsp;na&nbsp;amostra.&nbsp;Caso&nbsp;a&nbsp;pesquisa</td><td class="diff_next"></td><td class="diff_header" id="to62_187">187</td><td nowrap="nowrap">de&nbsp;nitrocelulose&nbsp;para&nbsp;a&nbsp;captura&nbsp;dos&nbsp;anticorpos&nbsp;presentes&nbsp;na&nbsp;amostra.&nbsp;Caso&nbsp;a&nbsp;pesquisa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_191">191</td><td nowrap="nowrap">seja&nbsp;para&nbsp;antígenos,&nbsp;haverá&nbsp;anticorpos&nbsp;imobilizados&nbsp;para&nbsp;a&nbsp;captura&nbsp;dos&nbsp;antígenos&nbsp;pre-</td><td class="diff_next"></td><td class="diff_header" id="to62_188">188</td><td nowrap="nowrap">seja&nbsp;para&nbsp;antígenos,&nbsp;haverá&nbsp;anticorpos&nbsp;imobilizados&nbsp;para&nbsp;a&nbsp;captura&nbsp;dos&nbsp;antígenos&nbsp;pre-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_192">192</td><td nowrap="nowrap">sentes&nbsp;na&nbsp;amostra.</td><td class="diff_next"></td><td class="diff_header" id="to62_189">189</td><td nowrap="nowrap">sentes&nbsp;na&nbsp;amostra.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_193">193</td><td nowrap="nowrap">Os&nbsp;testes&nbsp;rápidos&nbsp;utilizados&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C&nbsp;baseiam-se&nbsp;na</td><td class="diff_next"></td><td class="diff_header" id="to62_190">190</td><td nowrap="nowrap">Os&nbsp;testes&nbsp;rápidos&nbsp;utilizados&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;C&nbsp;baseiam-se&nbsp;na</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_194">194</td><td nowrap="nowrap">tecnologia&nbsp;de&nbsp;imunocromatografia&nbsp;de&nbsp;fluxo&nbsp;lateral.&nbsp;O&nbsp;teste&nbsp;para&nbsp;hepatite&nbsp;B&nbsp;permite&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_191">191</td><td nowrap="nowrap">tecnologia&nbsp;de&nbsp;imunocromatografia&nbsp;de&nbsp;fluxo&nbsp;lateral.&nbsp;O&nbsp;teste&nbsp;para&nbsp;hepatite&nbsp;B&nbsp;permite&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_195">195</td><td nowrap="nowrap">detecção&nbsp;do&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;HBV&nbsp;(HBsAg)&nbsp;no&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;sangue&nbsp;total.</td><td class="diff_next"></td><td class="diff_header" id="to62_192">192</td><td nowrap="nowrap">detecção&nbsp;do&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;HBV&nbsp;(HBsAg)&nbsp;no&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;sangue&nbsp;total.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_196">196</td><td nowrap="nowrap">Para&nbsp;a&nbsp;hepatite&nbsp;C,&nbsp;o&nbsp;teste&nbsp;detecta&nbsp;o&nbsp;anticorpo&nbsp;anti-HCV&nbsp;no&nbsp;soro,&nbsp;plasma,&nbsp;sangue&nbsp;total&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_193">193</td><td nowrap="nowrap">Para&nbsp;a&nbsp;hepatite&nbsp;C,&nbsp;o&nbsp;teste&nbsp;detecta&nbsp;o&nbsp;anticorpo&nbsp;anti-HCV&nbsp;no&nbsp;soro,&nbsp;plasma,&nbsp;sangue&nbsp;total&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_197">197</td><td nowrap="nowrap">fluido&nbsp;oral.</td><td class="diff_next"></td><td class="diff_header" id="to62_194">194</td><td nowrap="nowrap">fluido&nbsp;oral.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_198">198</td><td nowrap="nowrap">No&nbsp;Brasil,&nbsp;a&nbsp;utilização&nbsp;de&nbsp;TR&nbsp;em&nbsp;populações-chave&nbsp;na&nbsp;busca&nbsp;de&nbsp;infecções&nbsp;ativas&nbsp;tem</td><td class="diff_next"></td><td class="diff_header" id="to62_195">195</td><td nowrap="nowrap">No&nbsp;Brasil,&nbsp;a&nbsp;utilização&nbsp;de&nbsp;TR&nbsp;em&nbsp;populações-chave&nbsp;na&nbsp;busca&nbsp;de&nbsp;infecções&nbsp;ativas&nbsp;tem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_199">199</td><td nowrap="nowrap">demonstrado&nbsp;elevada&nbsp;sensibilidade&nbsp;(&gt;97%)&nbsp;nos&nbsp;portadores&nbsp;crônicos&nbsp;de&nbsp;hepatites&nbsp;B&nbsp;(da-</td><td class="diff_next"></td><td class="diff_header" id="to62_196">196</td><td nowrap="nowrap">demonstrado&nbsp;elevada&nbsp;sensibilidade&nbsp;(&gt;97%)&nbsp;nos&nbsp;portadores&nbsp;crônicos&nbsp;de&nbsp;hepatites&nbsp;B&nbsp;(da-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_200">200</td><td nowrap="nowrap">dos&nbsp;não&nbsp;publicados,&nbsp;Fiocruz)&nbsp;e&nbsp;C&nbsp;(DA&nbsp;ROSA&nbsp;et&nbsp;al.,&nbsp;2013;&nbsp;SCALIONI&nbsp;et&nbsp;al.,&nbsp;2014),&nbsp;além&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_197">197</td><td nowrap="nowrap">dos&nbsp;não&nbsp;publicados,&nbsp;Fiocruz)&nbsp;e&nbsp;C&nbsp;(DA&nbsp;ROSA&nbsp;et&nbsp;al.,&nbsp;2013;&nbsp;SCALIONI&nbsp;et&nbsp;al.,&nbsp;2014),&nbsp;além&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_201">201</td><td nowrap="nowrap">oferecer&nbsp;as&nbsp;vantagens&nbsp;da&nbsp;simplicidade&nbsp;de&nbsp;execução&nbsp;e&nbsp;resultados&nbsp;imediatos.&nbsp;O&nbsp;uso&nbsp;dos&nbsp;TR</td><td class="diff_next"></td><td class="diff_header" id="to62_198">198</td><td nowrap="nowrap">oferecer&nbsp;as&nbsp;vantagens&nbsp;da&nbsp;simplicidade&nbsp;de&nbsp;execução&nbsp;e&nbsp;resultados&nbsp;imediatos.&nbsp;O&nbsp;uso&nbsp;dos&nbsp;TR</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_202">202</td><td nowrap="nowrap">constitui&nbsp;uma&nbsp;ferramenta&nbsp;importante&nbsp;no&nbsp;cenário&nbsp;epidemiológico&nbsp;brasileiro,&nbsp;pois&nbsp;a&nbsp;maior</td><td class="diff_next"></td><td class="diff_header" id="to62_199">199</td><td nowrap="nowrap">constitui&nbsp;uma&nbsp;ferramenta&nbsp;importante&nbsp;no&nbsp;cenário&nbsp;epidemiológico&nbsp;brasileiro,&nbsp;pois&nbsp;a&nbsp;maior</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_203">203</td><td nowrap="nowrap">parte&nbsp;dos&nbsp;indivíduos&nbsp;é&nbsp;diagnosticada&nbsp;na&nbsp;fase&nbsp;crônica&nbsp;da&nbsp;doença.</td><td class="diff_next"></td><td class="diff_header" id="to62_200">200</td><td nowrap="nowrap">parte&nbsp;dos&nbsp;indivíduos&nbsp;é&nbsp;diagnosticada&nbsp;na&nbsp;fase&nbsp;crônica&nbsp;da&nbsp;doença.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_204">204</td><td nowrap="nowrap">A&nbsp;seguir,&nbsp;estão&nbsp;listadas&nbsp;as&nbsp;situações&nbsp;e&nbsp;locais&nbsp;em&nbsp;que&nbsp;o&nbsp;Departamento&nbsp;de&nbsp;Vigilância,</td><td class="diff_next"></td><td class="diff_header" id="to62_201">201</td><td nowrap="nowrap">A&nbsp;seguir,&nbsp;estão&nbsp;listadas&nbsp;as&nbsp;situações&nbsp;e&nbsp;locais&nbsp;em&nbsp;que&nbsp;o&nbsp;Departamento&nbsp;de&nbsp;Vigilância,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_205">205</td><td nowrap="nowrap">Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;IST,&nbsp;do&nbsp;HIV/Aids&nbsp;e&nbsp;das&nbsp;Hepatites&nbsp;Virais&nbsp;(DIAHV)&nbsp;recomenda&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_202">202</td><td nowrap="nowrap">Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;IST,&nbsp;do&nbsp;HIV/Aids&nbsp;e&nbsp;das&nbsp;Hepatites&nbsp;Virais&nbsp;(DIAHV)&nbsp;recomenda&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_206">206</td><td nowrap="nowrap">utilização&nbsp;de&nbsp;TR:</td><td class="diff_next"></td><td class="diff_header" id="to62_203">203</td><td nowrap="nowrap">utilização&nbsp;de&nbsp;TR:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_207">207</td><td nowrap="nowrap">›&nbsp;Serviços&nbsp;de&nbsp;saúde&nbsp;sem&nbsp;infraestrutura&nbsp;laboratorial&nbsp;ou&nbsp;localizados&nbsp;em&nbsp;regiões</td><td class="diff_next"></td><td class="diff_header" id="to62_204">204</td><td nowrap="nowrap">›&nbsp;Serviços&nbsp;de&nbsp;saúde&nbsp;sem&nbsp;infraestrutura&nbsp;laboratorial&nbsp;ou&nbsp;localizados&nbsp;em&nbsp;regiões</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_208">208</td><td nowrap="nowrap">de&nbsp;difícil&nbsp;acesso;</td><td class="diff_next"></td><td class="diff_header" id="to62_205">205</td><td nowrap="nowrap">de&nbsp;difícil&nbsp;acesso;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_209">209</td><td nowrap="nowrap">›&nbsp;Instituições&nbsp;da&nbsp;Atenção&nbsp;Primária&nbsp;à&nbsp;Saúde&nbsp;(ex:&nbsp;UBS)&nbsp;e&nbsp;outras&nbsp;instituições&nbsp;per-</td><td class="diff_next"></td><td class="diff_header" id="to62_206">206</td><td nowrap="nowrap">›&nbsp;Instituições&nbsp;da&nbsp;Atenção&nbsp;Primária&nbsp;à&nbsp;Saúde&nbsp;(ex:&nbsp;UBS)&nbsp;e&nbsp;outras&nbsp;instituições&nbsp;per-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_210">210</td><td nowrap="nowrap">tencentes&nbsp;a&nbsp;Programas&nbsp;do&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;tais&nbsp;como&nbsp;Rede&nbsp;Cegonha,&nbsp;Pro-</td><td class="diff_next"></td><td class="diff_header" id="to62_207">207</td><td nowrap="nowrap">tencentes&nbsp;a&nbsp;Programas&nbsp;do&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;tais&nbsp;como&nbsp;Rede&nbsp;Cegonha,&nbsp;Pro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_211">211</td><td nowrap="nowrap">grama&nbsp;de&nbsp;Saúde&nbsp;da&nbsp;Família,&nbsp;Consultório&nbsp;na&nbsp;Rua,&nbsp;Quero&nbsp;Fazer,&nbsp;dentre&nbsp;outros</td><td class="diff_next"></td><td class="diff_header" id="to62_208">208</td><td nowrap="nowrap">grama&nbsp;de&nbsp;Saúde&nbsp;da&nbsp;Família,&nbsp;Consultório&nbsp;na&nbsp;Rua,&nbsp;Quero&nbsp;Fazer,&nbsp;dentre&nbsp;outros</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_212">212</td><td nowrap="nowrap">programas;</td><td class="diff_next"></td><td class="diff_header" id="to62_209">209</td><td nowrap="nowrap">programas;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_213">213</td><td nowrap="nowrap">›&nbsp;Centro&nbsp;de&nbsp;Testagem&nbsp;e&nbsp;Aconselhamento&nbsp;(CTA),&nbsp;Unidade&nbsp;de&nbsp;Testagem&nbsp;Móvel</td><td class="diff_next"></td><td class="diff_header" id="to62_210">210</td><td nowrap="nowrap">›&nbsp;Centro&nbsp;de&nbsp;Testagem&nbsp;e&nbsp;Aconselhamento&nbsp;(CTA),&nbsp;Unidade&nbsp;de&nbsp;Testagem&nbsp;Móvel</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_214">214</td><td nowrap="nowrap">(UTM),&nbsp;Centro&nbsp;de&nbsp;Atenção&nbsp;Psicossocial&nbsp;(Caps),&nbsp;serviços&nbsp;de&nbsp;atendimento&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_211">211</td><td nowrap="nowrap">(UTM),&nbsp;Centro&nbsp;de&nbsp;Atenção&nbsp;Psicossocial&nbsp;(Caps),&nbsp;serviços&nbsp;de&nbsp;atendimento&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_215">215</td><td nowrap="nowrap">emergência,&nbsp;pronto-socorro,&nbsp;hospitais&nbsp;e&nbsp;maternidades;</td><td class="diff_next"></td><td class="diff_header" id="to62_212">212</td><td nowrap="nowrap">emergência,&nbsp;pronto-socorro,&nbsp;hospitais&nbsp;e&nbsp;maternidades;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_216">216</td><td nowrap="nowrap">›&nbsp;Segmentos&nbsp;populacionais&nbsp;flutuantes;</td><td class="diff_next"></td><td class="diff_header" id="to62_213">213</td><td nowrap="nowrap">›&nbsp;Segmentos&nbsp;populacionais&nbsp;flutuantes;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_217">217</td><td nowrap="nowrap">›&nbsp;Populações&nbsp;vulneráveisG:</td><td class="diff_next"></td><td class="diff_header" id="to62_214">214</td><td nowrap="nowrap">›&nbsp;Populações&nbsp;vulneráveisG:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_218">218</td><td nowrap="nowrap">»&nbsp;Hepatite&nbsp;B:&nbsp;homens&nbsp;que&nbsp;fazem&nbsp;sexo&nbsp;com&nbsp;homens,&nbsp;profissionais&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_215">215</td><td nowrap="nowrap">»&nbsp;Hepatite&nbsp;B:&nbsp;homens&nbsp;que&nbsp;fazem&nbsp;sexo&nbsp;com&nbsp;homens,&nbsp;profissionais&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_219">219</td><td nowrap="nowrap">sexo,&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas,&nbsp;pessoas&nbsp;privadas&nbsp;de&nbsp;liberdade,&nbsp;indi-</td><td class="diff_next"></td><td class="diff_header" id="to62_216">216</td><td nowrap="nowrap">sexo,&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas,&nbsp;pessoas&nbsp;privadas&nbsp;de&nbsp;liberdade,&nbsp;indi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_220">220</td><td nowrap="nowrap">víduos&nbsp;em&nbsp;situação&nbsp;de&nbsp;rua,&nbsp;indígenas,&nbsp;quilombolas,&nbsp;indivíduos&nbsp;nasci-</td><td class="diff_next"></td><td class="diff_header" id="to62_217">217</td><td nowrap="nowrap">víduos&nbsp;em&nbsp;situação&nbsp;de&nbsp;rua,&nbsp;indígenas,&nbsp;quilombolas,&nbsp;indivíduos&nbsp;nasci-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_221">221</td><td nowrap="nowrap">dos&nbsp;em&nbsp;áreas&nbsp;endêmicasG;</td><td class="diff_next"></td><td class="diff_header" id="to62_218">218</td><td nowrap="nowrap">dos&nbsp;em&nbsp;áreas&nbsp;endêmicasG;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_222">222</td><td nowrap="nowrap">»&nbsp;Hepatite&nbsp;C:&nbsp;indivíduos&nbsp;com&nbsp;40&nbsp;anos&nbsp;de&nbsp;idade&nbsp;ou&nbsp;mais,&nbsp;indivíduos&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_219">219</td><td nowrap="nowrap">»&nbsp;Hepatite&nbsp;C:&nbsp;indivíduos&nbsp;com&nbsp;40&nbsp;anos&nbsp;de&nbsp;idade&nbsp;ou&nbsp;mais,&nbsp;indivíduos&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_223">223</td><td nowrap="nowrap">realizaram&nbsp;transfusão,&nbsp;transplante,&nbsp;indivíduos&nbsp;em&nbsp;situação&nbsp;de&nbsp;com-</td><td class="diff_next"></td><td class="diff_header" id="to62_220">220</td><td nowrap="nowrap">realizaram&nbsp;transfusão,&nbsp;transplante,&nbsp;indivíduos&nbsp;em&nbsp;situação&nbsp;de&nbsp;com-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_224">224</td><td nowrap="nowrap">partilhamento&nbsp;de&nbsp;material&nbsp;de&nbsp;injeção.</td><td class="diff_next"></td><td class="diff_header" id="to62_221">221</td><td nowrap="nowrap">partilhamento&nbsp;de&nbsp;material&nbsp;de&nbsp;injeção.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_225">225</td><td nowrap="nowrap">›&nbsp;ComunicantesG&nbsp;de&nbsp;pessoas&nbsp;vivendo&nbsp;com&nbsp;hepatites&nbsp;virais;</td><td class="diff_next"></td><td class="diff_header" id="to62_222">222</td><td nowrap="nowrap">›&nbsp;ComunicantesG&nbsp;de&nbsp;pessoas&nbsp;vivendo&nbsp;com&nbsp;hepatites&nbsp;virais;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_226">226</td><td nowrap="nowrap">›&nbsp;Acidentes&nbsp;biológicos&nbsp;ocupacionais;</td><td class="diff_next"></td><td class="diff_header" id="to62_223">223</td><td nowrap="nowrap">›&nbsp;Acidentes&nbsp;biológicos&nbsp;ocupacionais;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_227">227</td><td nowrap="nowrap">›&nbsp;Gestantes&nbsp;durante&nbsp;o&nbsp;pré-natal,&nbsp;parturientes&nbsp;e&nbsp;puérperas;</td><td class="diff_next"></td><td class="diff_header" id="to62_224">224</td><td nowrap="nowrap">›&nbsp;Gestantes&nbsp;durante&nbsp;o&nbsp;pré-natal,&nbsp;parturientes&nbsp;e&nbsp;puérperas;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_228">228</td><td nowrap="nowrap">›&nbsp;Situação&nbsp;de&nbsp;abortamento&nbsp;espontâneo,&nbsp;independentemente&nbsp;da&nbsp;idade&nbsp;gesta-</td><td class="diff_next"></td><td class="diff_header" id="to62_225">225</td><td nowrap="nowrap">›&nbsp;Situação&nbsp;de&nbsp;abortamento&nbsp;espontâneo,&nbsp;independentemente&nbsp;da&nbsp;idade&nbsp;gesta-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_229">229</td><td nowrap="nowrap">cional;</td><td class="diff_next"></td><td class="diff_header" id="to62_226">226</td><td nowrap="nowrap">cional;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_230">230</td><td nowrap="nowrap">›&nbsp;Laboratórios&nbsp;que&nbsp;realizam&nbsp;pequenas&nbsp;rotinas&nbsp;(rotinas&nbsp;com&nbsp;até&nbsp;cinco&nbsp;amostras</td><td class="diff_next"></td><td class="diff_header" id="to62_227">227</td><td nowrap="nowrap">›&nbsp;Laboratórios&nbsp;que&nbsp;realizam&nbsp;pequenas&nbsp;rotinas&nbsp;(rotinas&nbsp;com&nbsp;até&nbsp;cinco&nbsp;amostras</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_231">231</td><td nowrap="nowrap">diárias&nbsp;para&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pela&nbsp;hepatite&nbsp;B&nbsp;ou&nbsp;C);</td><td class="diff_next"></td><td class="diff_header" id="to62_228">228</td><td nowrap="nowrap">diárias&nbsp;para&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pela&nbsp;hepatite&nbsp;B&nbsp;ou&nbsp;C);</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_232">232</td><td nowrap="nowrap">›&nbsp;Pessoas&nbsp;em&nbsp;situação&nbsp;de&nbsp;violência&nbsp;sexual;</td><td class="diff_next"></td><td class="diff_header" id="to62_229">229</td><td nowrap="nowrap">›&nbsp;Pessoas&nbsp;em&nbsp;situação&nbsp;de&nbsp;violência&nbsp;sexual;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_233">233</td><td nowrap="nowrap">›&nbsp;Outras&nbsp;situações&nbsp;especiais&nbsp;definidas&nbsp;pelo&nbsp;DIAHV&nbsp;para&nbsp;ações&nbsp;de&nbsp;vigilância,</td><td class="diff_next"></td><td class="diff_header" id="to62_230">230</td><td nowrap="nowrap">›&nbsp;Outras&nbsp;situações&nbsp;especiais&nbsp;definidas&nbsp;pelo&nbsp;DIAHV&nbsp;para&nbsp;ações&nbsp;de&nbsp;vigilância,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_234">234</td><td nowrap="nowrap">prevenção&nbsp;e&nbsp;controle&nbsp;das&nbsp;infecções&nbsp;sexualmente&nbsp;transmissíveis&nbsp;(IST),&nbsp;do&nbsp;HIV</td><td class="diff_next"></td><td class="diff_header" id="to62_231">231</td><td nowrap="nowrap">prevenção&nbsp;e&nbsp;controle&nbsp;das&nbsp;infecções&nbsp;sexualmente&nbsp;transmissíveis&nbsp;(IST),&nbsp;do&nbsp;HIV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_235">235</td><td nowrap="nowrap">aids&nbsp;e&nbsp;das&nbsp;hepatites&nbsp;virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_232">232</td><td nowrap="nowrap">aids&nbsp;e&nbsp;das&nbsp;hepatites&nbsp;virais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_236">236</td><td nowrap="nowrap">Federação.&nbsp;A&nbsp;solicitação&nbsp;de&nbsp;testes&nbsp;é&nbsp;feita&nbsp;pelo&nbsp;Sisloglab.</td><td class="diff_next"></td><td class="diff_header" id="to62_233">233</td><td nowrap="nowrap">Federação.&nbsp;A&nbsp;solicitação&nbsp;de&nbsp;testes&nbsp;é&nbsp;feita&nbsp;pelo&nbsp;Sisloglab.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_237">237</td><td nowrap="nowrap">Sisloglab&nbsp;-&nbsp;Sistema&nbsp;de&nbsp;Controle&nbsp;Logístico&nbsp;de&nbsp;Insumos&nbsp;Laboratoriais</td><td class="diff_next"></td><td class="diff_header" id="to62_234">234</td><td nowrap="nowrap">Sisloglab&nbsp;-&nbsp;Sistema&nbsp;de&nbsp;Controle&nbsp;Logístico&nbsp;de&nbsp;Insumos&nbsp;Laboratoriais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_238">238</td><td nowrap="nowrap">municipal,&nbsp;estadual&nbsp;e&nbsp;federal&nbsp;para&nbsp;o&nbsp;planejamento&nbsp;da&nbsp;programação,&nbsp;aquisição,</td><td class="diff_next"></td><td class="diff_header" id="to62_235">235</td><td nowrap="nowrap">municipal,&nbsp;estadual&nbsp;e&nbsp;federal&nbsp;para&nbsp;o&nbsp;planejamento&nbsp;da&nbsp;programação,&nbsp;aquisição,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_239">239</td><td nowrap="nowrap">distribuição&nbsp;e&nbsp;uso&nbsp;de&nbsp;kits.</td><td class="diff_next"></td><td class="diff_header" id="to62_236">236</td><td nowrap="nowrap">distribuição&nbsp;e&nbsp;uso&nbsp;de&nbsp;kits.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__8"></td><td class="diff_header" id="from62_240">240</td><td nowrap="nowrap">Comunique-se&nbsp;com&nbsp;a&nbsp;coordenação&nbsp;de&nbsp;IST,&nbsp;HIV/Aids&nbsp;e&nbsp;Hepatites&nbsp;Virais&nbsp;local&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_237">237</td><td nowrap="nowrap">Comunique-se&nbsp;com&nbsp;a&nbsp;coordenação&nbsp;de&nbsp;IST,&nbsp;HIV/Aids&nbsp;e&nbsp;Hepatites&nbsp;Virais&nbsp;local&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_241">241</td><td nowrap="nowrap">receber&nbsp;login&nbsp;e&nbsp;senha&nbsp;de&nbsp;acesso&nbsp;ao&nbsp;SISLOGLAB.</td><td class="diff_next"></td><td class="diff_header" id="to62_238">238</td><td nowrap="nowrap">receber&nbsp;login&nbsp;e&nbsp;senha&nbsp;de&nbsp;acesso&nbsp;ao&nbsp;SISLOGLAB.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_242">242</td><td nowrap="nowrap">Desde&nbsp;1988,&nbsp;a&nbsp;Organização&nbsp;Mundial&nbsp;da&nbsp;Saúde&nbsp;(OMS)&nbsp;realiza&nbsp;avaliações&nbsp;de&nbsp;qualidade</td><td class="diff_next"></td><td class="diff_header" id="to62_239">239</td><td nowrap="nowrap">Desde&nbsp;1988,&nbsp;a&nbsp;Organização&nbsp;Mundial&nbsp;da&nbsp;Saúde&nbsp;(OMS)&nbsp;realiza&nbsp;avaliações&nbsp;de&nbsp;qualidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_243">243</td><td nowrap="nowrap">dos&nbsp;conjuntos&nbsp;diagnósticos&nbsp;disponíveis&nbsp;comercialmente&nbsp;para&nbsp;hepatite&nbsp;B,&nbsp;hepatite&nbsp;C&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_240">240</td><td nowrap="nowrap">dos&nbsp;conjuntos&nbsp;diagnósticos&nbsp;disponíveis&nbsp;comercialmente&nbsp;para&nbsp;hepatite&nbsp;B,&nbsp;hepatite&nbsp;C&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_244">244</td><td nowrap="nowrap">outros&nbsp;agravos.&nbsp;Atualmente,&nbsp;os&nbsp;produtos&nbsp;que&nbsp;atendem&nbsp;aos&nbsp;critérios&nbsp;mínimos&nbsp;de&nbsp;seleção</td><td class="diff_next"></td><td class="diff_header" id="to62_241">241</td><td nowrap="nowrap">outros&nbsp;agravos.&nbsp;Atualmente,&nbsp;os&nbsp;produtos&nbsp;que&nbsp;atendem&nbsp;aos&nbsp;critérios&nbsp;mínimos&nbsp;de&nbsp;seleção</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__9">n</a></td><td class="diff_header" id="from62_245">245</td><td nowrap="nowrap"><span class="diff_sub">B&nbsp;e&nbsp;C&nbsp;podem&nbsp;ser&nbsp;acessadas&nbsp;na&nbsp;página&nbsp;da&nbsp;Organização&nbsp;Mundial&nbsp;da&nbsp;Saúde:&nbsp;http://www.</span></td><td class="diff_next"><a href="#difflib_chg_to62__9">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_246">246</td><td nowrap="nowrap">who.int/diagnostics_laboratory/publications/evaluations/en/.</td><td class="diff_next"></td><td class="diff_header" id="to62_242">242</td><td nowrap="nowrap">who.int/diagnostics_laboratory/publications/evaluations/en/.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_247">247</td><td nowrap="nowrap">(OMS)</td><td class="diff_next"></td><td class="diff_header" id="to62_243">243</td><td nowrap="nowrap">(OMS)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_248">248</td><td nowrap="nowrap">Sensibilidade:&nbsp;100%</td><td class="diff_next"></td><td class="diff_header" id="to62_244">244</td><td nowrap="nowrap">Sensibilidade:&nbsp;100%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_249">249</td><td nowrap="nowrap">Especificidade:&nbsp;≥98%</td><td class="diff_next"></td><td class="diff_header" id="to62_245">245</td><td nowrap="nowrap">Especificidade:&nbsp;≥98%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_250">250</td><td nowrap="nowrap">HBsAg1</td><td class="diff_next"></td><td class="diff_header" id="to62_246">246</td><td nowrap="nowrap">HBsAg1</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_251">251</td><td nowrap="nowrap">Variabilidade&nbsp;entre&nbsp;leituras:&nbsp;≤5%</td><td class="diff_next"></td><td class="diff_header" id="to62_247">247</td><td nowrap="nowrap">Variabilidade&nbsp;entre&nbsp;leituras:&nbsp;≤5%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_252">252</td><td nowrap="nowrap">Taxa&nbsp;de&nbsp;inválidos:&nbsp;≤5%</td><td class="diff_next"></td><td class="diff_header" id="to62_248">248</td><td nowrap="nowrap">Taxa&nbsp;de&nbsp;inválidos:&nbsp;≤5%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_253">253</td><td nowrap="nowrap">Sensibilidade:&nbsp;≥98%</td><td class="diff_next"></td><td class="diff_header" id="to62_249">249</td><td nowrap="nowrap">Sensibilidade:&nbsp;≥98%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_254">254</td><td nowrap="nowrap">Especificidade:&nbsp;≥97%</td><td class="diff_next"></td><td class="diff_header" id="to62_250">250</td><td nowrap="nowrap">Especificidade:&nbsp;≥97%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_255">255</td><td nowrap="nowrap">Anti-HCV2</td><td class="diff_next"></td><td class="diff_header" id="to62_251">251</td><td nowrap="nowrap">Anti-HCV2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_256">256</td><td nowrap="nowrap">Variabilidade&nbsp;entre&nbsp;leituras:&nbsp;≤5%</td><td class="diff_next"></td><td class="diff_header" id="to62_252">252</td><td nowrap="nowrap">Variabilidade&nbsp;entre&nbsp;leituras:&nbsp;≤5%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_257">257</td><td nowrap="nowrap">Taxa&nbsp;de&nbsp;inválidos:&nbsp;≤5%</td><td class="diff_next"></td><td class="diff_header" id="to62_253">253</td><td nowrap="nowrap">Taxa&nbsp;de&nbsp;inválidos:&nbsp;≤5%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_258">258</td><td nowrap="nowrap">Fonte:&nbsp;WHO,&nbsp;2013.</td><td class="diff_next"></td><td class="diff_header" id="to62_254">254</td><td nowrap="nowrap">Fonte:&nbsp;WHO,&nbsp;2013.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_259">259</td><td nowrap="nowrap">1Antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B.</td><td class="diff_next"></td><td class="diff_header" id="to62_255">255</td><td nowrap="nowrap">1Antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_260">260</td><td nowrap="nowrap">2Anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C.</td><td class="diff_next"></td><td class="diff_header" id="to62_256">256</td><td nowrap="nowrap">2Anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_261">261</td><td nowrap="nowrap">O&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;adquire&nbsp;e&nbsp;distribui&nbsp;testes&nbsp;rápidos&nbsp;para&nbsp;as&nbsp;hepatites&nbsp;virais&nbsp;des-</td><td class="diff_next"></td><td class="diff_header" id="to62_257">257</td><td nowrap="nowrap">O&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;adquire&nbsp;e&nbsp;distribui&nbsp;testes&nbsp;rápidos&nbsp;para&nbsp;as&nbsp;hepatites&nbsp;virais&nbsp;des-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_262">262</td><td nowrap="nowrap">de&nbsp;2011.&nbsp;Além&nbsp;disso,&nbsp;estabelece&nbsp;os&nbsp;critérios&nbsp;mínimos&nbsp;de&nbsp;sensibilidade&nbsp;e&nbsp;especificidade</td><td class="diff_next"></td><td class="diff_header" id="to62_258">258</td><td nowrap="nowrap">de&nbsp;2011.&nbsp;Além&nbsp;disso,&nbsp;estabelece&nbsp;os&nbsp;critérios&nbsp;mínimos&nbsp;de&nbsp;sensibilidade&nbsp;e&nbsp;especificidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_263">263</td><td nowrap="nowrap">Especificidade&nbsp;clínicaG&nbsp;99,4%&nbsp;99,4%</td><td class="diff_next"></td><td class="diff_header" id="to62_259">259</td><td nowrap="nowrap">Especificidade&nbsp;clínicaG&nbsp;99,4%&nbsp;99,4%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_264">264</td><td nowrap="nowrap">Sensibilidade&nbsp;clínicaG&nbsp;99,5%&nbsp;99,4%</td><td class="diff_next"></td><td class="diff_header" id="to62_260">260</td><td nowrap="nowrap">Sensibilidade&nbsp;clínicaG&nbsp;99,5%&nbsp;99,4%</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__9"></td><td class="diff_header" id="from62_265">265</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_261">261</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_266">266</td><td nowrap="nowrap">5.1.4&nbsp;Avaliação&nbsp;Externa&nbsp;da&nbsp;Qualidade&nbsp;dos&nbsp;testes&nbsp;rápidos</td><td class="diff_next"></td><td class="diff_header" id="to62_262">262</td><td nowrap="nowrap">5.1.4&nbsp;Avaliação&nbsp;Externa&nbsp;da&nbsp;Qualidade&nbsp;dos&nbsp;testes&nbsp;rápidos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_267">267</td><td nowrap="nowrap">Para&nbsp;garantir&nbsp;a&nbsp;qualidade&nbsp;da&nbsp;execução&nbsp;dos&nbsp;testes&nbsp;rápidos&nbsp;nas&nbsp;unidades&nbsp;de&nbsp;saú-</td><td class="diff_next"></td><td class="diff_header" id="to62_263">263</td><td nowrap="nowrap">Para&nbsp;garantir&nbsp;a&nbsp;qualidade&nbsp;da&nbsp;execução&nbsp;dos&nbsp;testes&nbsp;rápidos&nbsp;nas&nbsp;unidades&nbsp;de&nbsp;saú-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_268">268</td><td nowrap="nowrap">de&nbsp;atendidas&nbsp;pelo&nbsp;SUS,&nbsp;o&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;conta&nbsp;com&nbsp;um&nbsp;programa&nbsp;de&nbsp;Avaliação</td><td class="diff_next"></td><td class="diff_header" id="to62_264">264</td><td nowrap="nowrap">de&nbsp;atendidas&nbsp;pelo&nbsp;SUS,&nbsp;o&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;conta&nbsp;com&nbsp;um&nbsp;programa&nbsp;de&nbsp;Avaliação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_269">269</td><td nowrap="nowrap">Externa&nbsp;da&nbsp;Qualidade.&nbsp;Inscreva&nbsp;sua&nbsp;instituição&nbsp;no&nbsp;programa&nbsp;para&nbsp;avaliar&nbsp;a&nbsp;qualidade&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_265">265</td><td nowrap="nowrap">Externa&nbsp;da&nbsp;Qualidade.&nbsp;Inscreva&nbsp;sua&nbsp;instituição&nbsp;no&nbsp;programa&nbsp;para&nbsp;avaliar&nbsp;a&nbsp;qualidade&nbsp;da</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__10">n</a></td><td class="diff_header" id="from62_270">270</td><td nowrap="nowrap"><span class="diff_sub">execução&nbsp;dos&nbsp;testes&nbsp;realizados&nbsp;por&nbsp;sua&nbsp;equipe.&nbsp;Cadastre-se&nbsp;em:&nbsp;http://qualitr.paginas.</span></td><td class="diff_next"><a href="#difflib_chg_to62__10">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_271">271</td><td nowrap="nowrap">ufsc.br/.</td><td class="diff_next"></td><td class="diff_header" id="to62_266">266</td><td nowrap="nowrap">ufsc.br/.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__10"></td><td class="diff_header" id="from62_272">272</td><td nowrap="nowrap">É&nbsp;considerada&nbsp;intercorrência&nbsp;com&nbsp;testes&nbsp;rápidos&nbsp;qualquer&nbsp;observação&nbsp;de&nbsp;ava-</td><td class="diff_next"></td><td class="diff_header" id="to62_267">267</td><td nowrap="nowrap">É&nbsp;considerada&nbsp;intercorrência&nbsp;com&nbsp;testes&nbsp;rápidos&nbsp;qualquer&nbsp;observação&nbsp;de&nbsp;ava-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_273">273</td><td nowrap="nowrap">ria&nbsp;no&nbsp;kit&nbsp;ou&nbsp;a&nbsp;apresentação&nbsp;de&nbsp;resultados&nbsp;falsos.&nbsp;Entende-se&nbsp;por&nbsp;avaria&nbsp;a&nbsp;falta&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_268">268</td><td nowrap="nowrap">ria&nbsp;no&nbsp;kit&nbsp;ou&nbsp;a&nbsp;apresentação&nbsp;de&nbsp;resultados&nbsp;falsos.&nbsp;Entende-se&nbsp;por&nbsp;avaria&nbsp;a&nbsp;falta&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_274">274</td><td nowrap="nowrap">insumos&nbsp;no&nbsp;kit,&nbsp;a&nbsp;mudança&nbsp;de&nbsp;coloração&nbsp;dos&nbsp;reagentes&nbsp;desde&nbsp;que&nbsp;não&nbsp;prevista&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_269">269</td><td nowrap="nowrap">insumos&nbsp;no&nbsp;kit,&nbsp;a&nbsp;mudança&nbsp;de&nbsp;coloração&nbsp;dos&nbsp;reagentes&nbsp;desde&nbsp;que&nbsp;não&nbsp;prevista&nbsp;em</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__11"></td><td class="diff_header" id="from62_275">275</td><td nowrap="nowrap">b&nbsp;ula&nbsp;ou&nbsp;qualquer&nbsp;outra&nbsp;situação&nbsp;inusitada.&nbsp;Conclui-se&nbsp;que&nbsp;um&nbsp;resultado&nbsp;é&nbsp;falso&nbsp;no&nbsp;TR</td><td class="diff_next"></td><td class="diff_header" id="to62_270">270</td><td nowrap="nowrap">b&nbsp;ula&nbsp;ou&nbsp;qualquer&nbsp;outra&nbsp;situação&nbsp;inusitada.&nbsp;Conclui-se&nbsp;que&nbsp;um&nbsp;resultado&nbsp;é&nbsp;falso&nbsp;no&nbsp;TR</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_276">276</td><td nowrap="nowrap">na&nbsp;testagem&nbsp;rápida.&nbsp;Portanto,&nbsp;fique&nbsp;atento.&nbsp;Toda&nbsp;intercorrência&nbsp;com&nbsp;os&nbsp;TR&nbsp;deverá&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_271">271</td><td nowrap="nowrap">na&nbsp;testagem&nbsp;rápida.&nbsp;Portanto,&nbsp;fique&nbsp;atento.&nbsp;Toda&nbsp;intercorrência&nbsp;com&nbsp;os&nbsp;TR&nbsp;deverá&nbsp;ser</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__11">n</a></td><td class="diff_header" id="from62_277">277</td><td nowrap="nowrap"><span class="diff_sub">reportada&nbsp;no&nbsp;formulário&nbsp;específico,&nbsp;disponível&nbsp;em:&nbsp;http://www.aids.gov.br/pt-br/</span></td><td class="diff_next"><a href="#difflib_chg_to62__11">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_278">278</td><td nowrap="nowrap">pub/2017/formulario-de-notificacao-de-nao-conformidade-de-teste-rapido-0</td><td class="diff_next"></td><td class="diff_header" id="to62_272">272</td><td nowrap="nowrap">pub/2017/formulario-de-notificacao-de-nao-conformidade-de-teste-rapido-0</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_279">279</td><td nowrap="nowrap">IST/HIV,&nbsp;HIV&nbsp;e&nbsp;Hepatites&nbsp;Virais&nbsp;do&nbsp;seu&nbsp;estado.&nbsp;Caberá&nbsp;a&nbsp;essa&nbsp;coordenação&nbsp;a&nbsp;pri-</td><td class="diff_next"></td><td class="diff_header" id="to62_273">273</td><td nowrap="nowrap">IST/HIV,&nbsp;HIV&nbsp;e&nbsp;Hepatites&nbsp;Virais&nbsp;do&nbsp;seu&nbsp;estado.&nbsp;Caberá&nbsp;a&nbsp;essa&nbsp;coordenação&nbsp;a&nbsp;pri-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__12">n</a></td><td class="diff_header" id="from62_280">280</td><td nowrap="nowrap">Atendimento&nbsp;ao&nbsp;Cliente&nbsp;<span class="diff_chg">–</span>&nbsp;SAC&nbsp;da&nbsp;empresa.&nbsp;Recomenda-se&nbsp;que&nbsp;o&nbsp;fluxo&nbsp;de&nbsp;infor-</td><td class="diff_next"><a href="#difflib_chg_to62__12">n</a></td><td class="diff_header" id="to62_274">274</td><td nowrap="nowrap">Atendimento&nbsp;ao&nbsp;Cliente&nbsp;<span class="diff_chg">-</span>&nbsp;SAC&nbsp;da&nbsp;empresa.&nbsp;Recomenda-se&nbsp;que&nbsp;o&nbsp;fluxo&nbsp;de&nbsp;infor-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_281">281</td><td nowrap="nowrap">imediato&nbsp;ao&nbsp;diagnóstico&nbsp;do&nbsp;paciente,&nbsp;se&nbsp;necessário,&nbsp;até&nbsp;que&nbsp;a&nbsp;investigação&nbsp;da&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_275">275</td><td nowrap="nowrap">imediato&nbsp;ao&nbsp;diagnóstico&nbsp;do&nbsp;paciente,&nbsp;se&nbsp;necessário,&nbsp;até&nbsp;que&nbsp;a&nbsp;investigação&nbsp;da&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_282">282</td><td nowrap="nowrap">tercorrência&nbsp;seja&nbsp;elucidada&nbsp;pelo&nbsp;fabricante.</td><td class="diff_next"></td><td class="diff_header" id="to62_276">276</td><td nowrap="nowrap">tercorrência&nbsp;seja&nbsp;elucidada&nbsp;pelo&nbsp;fabricante.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_283">283</td><td nowrap="nowrap">5.2&nbsp;Teste&nbsp;molecular</td><td class="diff_next"></td><td class="diff_header" id="to62_277">277</td><td nowrap="nowrap">5.2&nbsp;Teste&nbsp;molecular</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_284">284</td><td nowrap="nowrap">A&nbsp;reação&nbsp;em&nbsp;cadeia&nbsp;da&nbsp;polimerase&nbsp;(PCR,&nbsp;do&nbsp;inglês&nbsp;polymerase&nbsp;chain&nbsp;reaction)&nbsp;é&nbsp;uma</td><td class="diff_next"></td><td class="diff_header" id="to62_278">278</td><td nowrap="nowrap">A&nbsp;reação&nbsp;em&nbsp;cadeia&nbsp;da&nbsp;polimerase&nbsp;(PCR,&nbsp;do&nbsp;inglês&nbsp;polymerase&nbsp;chain&nbsp;reaction)&nbsp;é&nbsp;uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_285">285</td><td nowrap="nowrap">das&nbsp;técnicas&nbsp;mais&nbsp;utilizadas&nbsp;no&nbsp;diagnóstico&nbsp;molecular&nbsp;laboratorial.&nbsp;Por&nbsp;meio&nbsp;dessa&nbsp;téc-</td><td class="diff_next"></td><td class="diff_header" id="to62_279">279</td><td nowrap="nowrap">das&nbsp;técnicas&nbsp;mais&nbsp;utilizadas&nbsp;no&nbsp;diagnóstico&nbsp;molecular&nbsp;laboratorial.&nbsp;Por&nbsp;meio&nbsp;dessa&nbsp;téc-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_286">286</td><td nowrap="nowrap">nica,&nbsp;é&nbsp;possível&nbsp;amplificar&nbsp;uma&nbsp;região&nbsp;de&nbsp;interesse&nbsp;em&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;DNA&nbsp;utilizan-</td><td class="diff_next"></td><td class="diff_header" id="to62_280">280</td><td nowrap="nowrap">nica,&nbsp;é&nbsp;possível&nbsp;amplificar&nbsp;uma&nbsp;região&nbsp;de&nbsp;interesse&nbsp;em&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;DNA&nbsp;utilizan-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_287">287</td><td nowrap="nowrap">do&nbsp;um&nbsp;par&nbsp;de&nbsp;sequências&nbsp;curtas&nbsp;de&nbsp;nucleotídeos&nbsp;(oligonucleotídeos&nbsp;iniciadores)&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_281">281</td><td nowrap="nowrap">do&nbsp;um&nbsp;par&nbsp;de&nbsp;sequências&nbsp;curtas&nbsp;de&nbsp;nucleotídeos&nbsp;(oligonucleotídeos&nbsp;iniciadores)&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_288">288</td><td nowrap="nowrap">se&nbsp;localizam&nbsp;nos&nbsp;flancos&nbsp;dessa&nbsp;região,&nbsp;em&nbsp;conjunto&nbsp;com&nbsp;uma&nbsp;enzima&nbsp;DNA&nbsp;polimerase</td><td class="diff_next"></td><td class="diff_header" id="to62_282">282</td><td nowrap="nowrap">se&nbsp;localizam&nbsp;nos&nbsp;flancos&nbsp;dessa&nbsp;região,&nbsp;em&nbsp;conjunto&nbsp;com&nbsp;uma&nbsp;enzima&nbsp;DNA&nbsp;polimerase</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_289">289</td><td nowrap="nowrap">termorresistente.&nbsp;Dessa&nbsp;forma,&nbsp;podem-se&nbsp;produzir&nbsp;múltiplas&nbsp;cópias&nbsp;dessa&nbsp;região&nbsp;de&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_283">283</td><td nowrap="nowrap">termorresistente.&nbsp;Dessa&nbsp;forma,&nbsp;podem-se&nbsp;produzir&nbsp;múltiplas&nbsp;cópias&nbsp;dessa&nbsp;região&nbsp;de&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_290">290</td><td nowrap="nowrap">teresse.&nbsp;A&nbsp;reação&nbsp;acontece&nbsp;em&nbsp;ciclos,&nbsp;marcados&nbsp;por&nbsp;variações&nbsp;de&nbsp;temperatura&nbsp;que&nbsp;deter-</td><td class="diff_next"></td><td class="diff_header" id="to62_284">284</td><td nowrap="nowrap">teresse.&nbsp;A&nbsp;reação&nbsp;acontece&nbsp;em&nbsp;ciclos,&nbsp;marcados&nbsp;por&nbsp;variações&nbsp;de&nbsp;temperatura&nbsp;que&nbsp;deter-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_291">291</td><td nowrap="nowrap">minam&nbsp;os&nbsp;eventos&nbsp;da&nbsp;reação:&nbsp;desnaturação,&nbsp;anelamento&nbsp;e&nbsp;polimerização.&nbsp;Na&nbsp;desnatura-</td><td class="diff_next"></td><td class="diff_header" id="to62_285">285</td><td nowrap="nowrap">minam&nbsp;os&nbsp;eventos&nbsp;da&nbsp;reação:&nbsp;desnaturação,&nbsp;anelamento&nbsp;e&nbsp;polimerização.&nbsp;Na&nbsp;desnatura-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_292">292</td><td nowrap="nowrap">ção,&nbsp;a&nbsp;alta&nbsp;temperatura&nbsp;(entre&nbsp;90°C&nbsp;e&nbsp;95°C)&nbsp;separa&nbsp;as&nbsp;fitas&nbsp;complementares&nbsp;da&nbsp;molécula</td><td class="diff_next"></td><td class="diff_header" id="to62_286">286</td><td nowrap="nowrap">ção,&nbsp;a&nbsp;alta&nbsp;temperatura&nbsp;(entre&nbsp;90°C&nbsp;e&nbsp;95°C)&nbsp;separa&nbsp;as&nbsp;fitas&nbsp;complementares&nbsp;da&nbsp;molécula</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_293">293</td><td nowrap="nowrap">de&nbsp;DNA&nbsp;alvo.&nbsp;O&nbsp;anelamento&nbsp;ocorre&nbsp;a&nbsp;uma&nbsp;temperatura&nbsp;menor&nbsp;(por&nbsp;volta&nbsp;de&nbsp;55°C)&nbsp;e,&nbsp;nes-</td><td class="diff_next"></td><td class="diff_header" id="to62_287">287</td><td nowrap="nowrap">de&nbsp;DNA&nbsp;alvo.&nbsp;O&nbsp;anelamento&nbsp;ocorre&nbsp;a&nbsp;uma&nbsp;temperatura&nbsp;menor&nbsp;(por&nbsp;volta&nbsp;de&nbsp;55°C)&nbsp;e,&nbsp;nes-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_294">294</td><td nowrap="nowrap">sa&nbsp;essa&nbsp;fase,&nbsp;os&nbsp;oligonucleotídeos&nbsp;iniciadores&nbsp;se&nbsp;ligam&nbsp;às&nbsp;suas&nbsp;regiões&nbsp;complementares</td><td class="diff_next"></td><td class="diff_header" id="to62_288">288</td><td nowrap="nowrap">sa&nbsp;essa&nbsp;fase,&nbsp;os&nbsp;oligonucleotídeos&nbsp;iniciadores&nbsp;se&nbsp;ligam&nbsp;às&nbsp;suas&nbsp;regiões&nbsp;complementares</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_295">295</td><td nowrap="nowrap">nas&nbsp;fitas&nbsp;de&nbsp;DNA&nbsp;alvo.&nbsp;Finalmente,&nbsp;na&nbsp;polimerização&nbsp;(que&nbsp;acontece&nbsp;a&nbsp;75°C),&nbsp;a&nbsp;DNA&nbsp;poli-</td><td class="diff_next"></td><td class="diff_header" id="to62_289">289</td><td nowrap="nowrap">nas&nbsp;fitas&nbsp;de&nbsp;DNA&nbsp;alvo.&nbsp;Finalmente,&nbsp;na&nbsp;polimerização&nbsp;(que&nbsp;acontece&nbsp;a&nbsp;75°C),&nbsp;a&nbsp;DNA&nbsp;poli-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_296">296</td><td nowrap="nowrap">novas&nbsp;fitas&nbsp;a&nbsp;partir&nbsp;do&nbsp;molde.&nbsp;Cada&nbsp;ciclo&nbsp;será&nbsp;repetido&nbsp;de&nbsp;40&nbsp;a&nbsp;50&nbsp;vezes&nbsp;e&nbsp;durante&nbsp;cada</td><td class="diff_next"></td><td class="diff_header" id="to62_290">290</td><td nowrap="nowrap">novas&nbsp;fitas&nbsp;a&nbsp;partir&nbsp;do&nbsp;molde.&nbsp;Cada&nbsp;ciclo&nbsp;será&nbsp;repetido&nbsp;de&nbsp;40&nbsp;a&nbsp;50&nbsp;vezes&nbsp;e&nbsp;durante&nbsp;cada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_297">297</td><td nowrap="nowrap">repetição&nbsp;a&nbsp;quantidade&nbsp;de&nbsp;cópias&nbsp;da&nbsp;região&nbsp;alvo&nbsp;irá&nbsp;ser&nbsp;duplicada.&nbsp;A&nbsp;partir&nbsp;daí,&nbsp;o&nbsp;material</td><td class="diff_next"></td><td class="diff_header" id="to62_291">291</td><td nowrap="nowrap">repetição&nbsp;a&nbsp;quantidade&nbsp;de&nbsp;cópias&nbsp;da&nbsp;região&nbsp;alvo&nbsp;irá&nbsp;ser&nbsp;duplicada.&nbsp;A&nbsp;partir&nbsp;daí,&nbsp;o&nbsp;material</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_298">298</td><td nowrap="nowrap">amplificado&nbsp;poderá&nbsp;ser&nbsp;visualizado&nbsp;por&nbsp;meio&nbsp;de&nbsp;diversas&nbsp;técnicas,&nbsp;como&nbsp;eletroforese&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_292">292</td><td nowrap="nowrap">amplificado&nbsp;poderá&nbsp;ser&nbsp;visualizado&nbsp;por&nbsp;meio&nbsp;de&nbsp;diversas&nbsp;técnicas,&nbsp;como&nbsp;eletroforese&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_299">299</td><td nowrap="nowrap">géis&nbsp;de&nbsp;agarose&nbsp;(NETTO;&nbsp;SAAD;&nbsp;DYSERT,&nbsp;2003).</td><td class="diff_next"></td><td class="diff_header" id="to62_293">293</td><td nowrap="nowrap">géis&nbsp;de&nbsp;agarose&nbsp;(NETTO;&nbsp;SAAD;&nbsp;DYSERT,&nbsp;2003).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_300">300</td><td nowrap="nowrap">Na&nbsp;PCR&nbsp;em&nbsp;tempo&nbsp;real,&nbsp;podem&nbsp;ser&nbsp;utilizadas&nbsp;sondas&nbsp;ou&nbsp;marcações&nbsp;fluorescentes</td><td class="diff_next"></td><td class="diff_header" id="to62_294">294</td><td nowrap="nowrap">Na&nbsp;PCR&nbsp;em&nbsp;tempo&nbsp;real,&nbsp;podem&nbsp;ser&nbsp;utilizadas&nbsp;sondas&nbsp;ou&nbsp;marcações&nbsp;fluorescentes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_301">301</td><td nowrap="nowrap">nos&nbsp;próprios&nbsp;oligonucleotídeos;&nbsp;a&nbsp;cada&nbsp;ciclo,&nbsp;a&nbsp;fluorescência&nbsp;liberada&nbsp;é&nbsp;detectada&nbsp;por</td><td class="diff_next"></td><td class="diff_header" id="to62_295">295</td><td nowrap="nowrap">nos&nbsp;próprios&nbsp;oligonucleotídeos;&nbsp;a&nbsp;cada&nbsp;ciclo,&nbsp;a&nbsp;fluorescência&nbsp;liberada&nbsp;é&nbsp;detectada&nbsp;por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_302">302</td><td nowrap="nowrap">um&nbsp;equipamento&nbsp;específico,&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;e/ou&nbsp;estimar&nbsp;o&nbsp;quantitativo&nbsp;inicial&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_296">296</td><td nowrap="nowrap">um&nbsp;equipamento&nbsp;específico,&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;e/ou&nbsp;estimar&nbsp;o&nbsp;quantitativo&nbsp;inicial&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_303">303</td><td nowrap="nowrap">DNA&nbsp;alvo&nbsp;na&nbsp;reação.&nbsp;O&nbsp;desenvolvimento&nbsp;dessa&nbsp;metodologia&nbsp;foi&nbsp;um&nbsp;grande&nbsp;avanço&nbsp;no</td><td class="diff_next"></td><td class="diff_header" id="to62_297">297</td><td nowrap="nowrap">DNA&nbsp;alvo&nbsp;na&nbsp;reação.&nbsp;O&nbsp;desenvolvimento&nbsp;dessa&nbsp;metodologia&nbsp;foi&nbsp;um&nbsp;grande&nbsp;avanço&nbsp;no</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_304">304</td><td nowrap="nowrap">laboratório&nbsp;clínico&nbsp;de&nbsp;biologia&nbsp;molecular,&nbsp;influenciando&nbsp;áreas&nbsp;como&nbsp;a&nbsp;oncologia&nbsp;e&nbsp;a&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_298">298</td><td nowrap="nowrap">laboratório&nbsp;clínico&nbsp;de&nbsp;biologia&nbsp;molecular,&nbsp;influenciando&nbsp;áreas&nbsp;como&nbsp;a&nbsp;oncologia&nbsp;e&nbsp;a&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_305">305</td><td nowrap="nowrap">fectologia&nbsp;(CHEVALIEZ;&nbsp;RODRIGUEZ;&nbsp;PAWLOTSKY,&nbsp;2012).</td><td class="diff_next"></td><td class="diff_header" id="to62_299">299</td><td nowrap="nowrap">fectologia&nbsp;(CHEVALIEZ;&nbsp;RODRIGUEZ;&nbsp;PAWLOTSKY,&nbsp;2012).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_306">306</td><td nowrap="nowrap">Na&nbsp;escolha&nbsp;de&nbsp;um&nbsp;teste&nbsp;molecular,&nbsp;deve-se&nbsp;levar&nbsp;em&nbsp;consideração&nbsp;a&nbsp;diversidade</td><td class="diff_next"></td><td class="diff_header" id="to62_300">300</td><td nowrap="nowrap">Na&nbsp;escolha&nbsp;de&nbsp;um&nbsp;teste&nbsp;molecular,&nbsp;deve-se&nbsp;levar&nbsp;em&nbsp;consideração&nbsp;a&nbsp;diversidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_307">307</td><td nowrap="nowrap">genética&nbsp;do&nbsp;agente&nbsp;patogênico&nbsp;circulante&nbsp;na&nbsp;população.&nbsp;Esse&nbsp;conhecimento&nbsp;é&nbsp;funda-</td><td class="diff_next"></td><td class="diff_header" id="to62_301">301</td><td nowrap="nowrap">genética&nbsp;do&nbsp;agente&nbsp;patogênico&nbsp;circulante&nbsp;na&nbsp;população.&nbsp;Esse&nbsp;conhecimento&nbsp;é&nbsp;funda-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_308">308</td><td nowrap="nowrap">localidade,&nbsp;evitando&nbsp;assim&nbsp;a&nbsp;não&nbsp;detecção&nbsp;de&nbsp;certas&nbsp;populações&nbsp;virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_302">302</td><td nowrap="nowrap">localidade,&nbsp;evitando&nbsp;assim&nbsp;a&nbsp;não&nbsp;detecção&nbsp;de&nbsp;certas&nbsp;populações&nbsp;virais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_309">309</td><td nowrap="nowrap">6.&nbsp;PERÍODO&nbsp;DE&nbsp;INCUBAÇÃO&nbsp;E&nbsp;JANELA&nbsp;DIAGNÓSTICA</td><td class="diff_next"></td><td class="diff_header" id="to62_303">303</td><td nowrap="nowrap">6.&nbsp;PERÍODO&nbsp;DE&nbsp;INCUBAÇÃO&nbsp;E&nbsp;JANELA&nbsp;DIAGNÓSTICA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_310">310</td><td nowrap="nowrap">Cada&nbsp;um&nbsp;dos&nbsp;vírus&nbsp;hepatotrópicos&nbsp;possui&nbsp;características&nbsp;infecciosas&nbsp;diferenciadas,</td><td class="diff_next"></td><td class="diff_header" id="to62_304">304</td><td nowrap="nowrap">Cada&nbsp;um&nbsp;dos&nbsp;vírus&nbsp;hepatotrópicos&nbsp;possui&nbsp;características&nbsp;infecciosas&nbsp;diferenciadas,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_311">311</td><td nowrap="nowrap">incluindo&nbsp;patogênese&nbsp;e&nbsp;período&nbsp;de&nbsp;incubação.&nbsp;As&nbsp;Tabelas&nbsp;3&nbsp;e&nbsp;4&nbsp;descrevem&nbsp;o&nbsp;período&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_305">305</td><td nowrap="nowrap">incluindo&nbsp;patogênese&nbsp;e&nbsp;período&nbsp;de&nbsp;incubação.&nbsp;As&nbsp;Tabelas&nbsp;3&nbsp;e&nbsp;4&nbsp;descrevem&nbsp;o&nbsp;período&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_312">312</td><td nowrap="nowrap">os&nbsp;testes&nbsp;disponíveis&nbsp;no&nbsp;Brasil&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais,&nbsp;respectivamente.</td><td class="diff_next"></td><td class="diff_header" id="to62_306">306</td><td nowrap="nowrap">os&nbsp;testes&nbsp;disponíveis&nbsp;no&nbsp;Brasil&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;virais,&nbsp;respectivamente.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_313">313</td><td nowrap="nowrap">5%&nbsp;a&nbsp;10%&nbsp;em&nbsp;menores</td><td class="diff_next"></td><td class="diff_header" id="to62_307">307</td><td nowrap="nowrap">5%&nbsp;a&nbsp;10%&nbsp;em&nbsp;menores</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_314">314</td><td nowrap="nowrap">HAV&nbsp;15&nbsp;a&nbsp;45&nbsp;dias&nbsp;de&nbsp;6&nbsp;anos;&nbsp;Não&nbsp;existem&nbsp;relatos&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_308">308</td><td nowrap="nowrap">HAV&nbsp;15&nbsp;a&nbsp;45&nbsp;dias&nbsp;de&nbsp;6&nbsp;anos;&nbsp;Não&nbsp;existem&nbsp;relatos&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_315">315</td><td nowrap="nowrap">70%&nbsp;a&nbsp;80%&nbsp;em&nbsp;adultos</td><td class="diff_next"></td><td class="diff_header" id="to62_309">309</td><td nowrap="nowrap">70%&nbsp;a&nbsp;80%&nbsp;em&nbsp;adultos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_316">316</td><td nowrap="nowrap">90%&nbsp;em&nbsp;recém-nascidos;</td><td class="diff_next"></td><td class="diff_header" id="to62_310">310</td><td nowrap="nowrap">90%&nbsp;em&nbsp;recém-nascidos;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_317">317</td><td nowrap="nowrap">HBV&nbsp;30&nbsp;a&nbsp;180&nbsp;dias&nbsp;30%&nbsp;5%&nbsp;a&nbsp;10%&nbsp;após&nbsp;5&nbsp;anos&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_311">311</td><td nowrap="nowrap">HBV&nbsp;30&nbsp;a&nbsp;180&nbsp;dias&nbsp;30%&nbsp;5%&nbsp;a&nbsp;10%&nbsp;após&nbsp;5&nbsp;anos&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_318">318</td><td nowrap="nowrap">HCV&nbsp;15&nbsp;a&nbsp;150&nbsp;dias&nbsp;Cerca&nbsp;de&nbsp;20%&nbsp;70%&nbsp;a&nbsp;85%</td><td class="diff_next"></td><td class="diff_header" id="to62_312">312</td><td nowrap="nowrap">HCV&nbsp;15&nbsp;a&nbsp;150&nbsp;dias&nbsp;Cerca&nbsp;de&nbsp;20%&nbsp;70%&nbsp;a&nbsp;85%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_319">319</td><td nowrap="nowrap">hepatite&nbsp;B,&nbsp;porém&nbsp;menor</td><td class="diff_next"></td><td class="diff_header" id="to62_313">313</td><td nowrap="nowrap">hepatite&nbsp;B,&nbsp;porém&nbsp;menor</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_320">320</td><td nowrap="nowrap">na&nbsp;superinfecção:&nbsp;15&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_314">314</td><td nowrap="nowrap">na&nbsp;superinfecção:&nbsp;15&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_321">321</td><td nowrap="nowrap">56&nbsp;dias</td><td class="diff_next"></td><td class="diff_header" id="to62_315">315</td><td nowrap="nowrap">56&nbsp;dias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_322">322</td><td nowrap="nowrap">15&nbsp;a&nbsp;60&nbsp;dias&nbsp;apenas&nbsp;em&nbsp;indivíduos</td><td class="diff_next"></td><td class="diff_header" id="to62_316">316</td><td nowrap="nowrap">15&nbsp;a&nbsp;60&nbsp;dias&nbsp;apenas&nbsp;em&nbsp;indivíduos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_323">323</td><td nowrap="nowrap">(média&nbsp;de&nbsp;42&nbsp;dias)&nbsp;imunossuprimidos/</td><td class="diff_next"></td><td class="diff_header" id="to62_317">317</td><td nowrap="nowrap">(média&nbsp;de&nbsp;42&nbsp;dias)&nbsp;imunossuprimidos/</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_324">324</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_318">318</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_325">325</td><td nowrap="nowrap">HAV1&nbsp;5&nbsp;a&nbsp;10&nbsp;dias1&nbsp;-&nbsp;-</td><td class="diff_next"></td><td class="diff_header" id="to62_319">319</td><td nowrap="nowrap">HAV1&nbsp;5&nbsp;a&nbsp;10&nbsp;dias1&nbsp;-&nbsp;-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_326">326</td><td nowrap="nowrap">HBV2&nbsp;30&nbsp;a&nbsp;60&nbsp;dias&nbsp;30&nbsp;dias&nbsp;(HBsAg)&nbsp;25&nbsp;dias</td><td class="diff_next"></td><td class="diff_header" id="to62_320">320</td><td nowrap="nowrap">HBV2&nbsp;30&nbsp;a&nbsp;60&nbsp;dias&nbsp;30&nbsp;dias&nbsp;(HBsAg)&nbsp;25&nbsp;dias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_327">327</td><td nowrap="nowrap">HCV3&nbsp;33&nbsp;a&nbsp;129&nbsp;dias2&nbsp;22&nbsp;a&nbsp;30&nbsp;dias&nbsp;22&nbsp;dias</td><td class="diff_next"></td><td class="diff_header" id="to62_321">321</td><td nowrap="nowrap">HCV3&nbsp;33&nbsp;a&nbsp;129&nbsp;dias2&nbsp;22&nbsp;a&nbsp;30&nbsp;dias&nbsp;22&nbsp;dias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_328">328</td><td nowrap="nowrap">HDV4&nbsp;84&nbsp;dias&nbsp;-&nbsp;-</td><td class="diff_next"></td><td class="diff_header" id="to62_322">322</td><td nowrap="nowrap">HDV4&nbsp;84&nbsp;dias&nbsp;-&nbsp;-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_329">329</td><td nowrap="nowrap">HEV5&nbsp;14&nbsp;dias&nbsp;-&nbsp;-</td><td class="diff_next"></td><td class="diff_header" id="to62_323">323</td><td nowrap="nowrap">HEV5&nbsp;14&nbsp;dias&nbsp;-&nbsp;-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_330">330</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_324">324</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_331">331</td><td nowrap="nowrap">1Os&nbsp;anticorpos&nbsp;IgM&nbsp;anti-HAV&nbsp;podem&nbsp;se&nbsp;tornar&nbsp;indetectáveis&nbsp;após&nbsp;a&nbsp;fase&nbsp;aguda.</td><td class="diff_next"></td><td class="diff_header" id="to62_325">325</td><td nowrap="nowrap">1Os&nbsp;anticorpos&nbsp;IgM&nbsp;anti-HAV&nbsp;podem&nbsp;se&nbsp;tornar&nbsp;indetectáveis&nbsp;após&nbsp;a&nbsp;fase&nbsp;aguda.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_332">332</td><td nowrap="nowrap">2Janela&nbsp;referente&nbsp;aos&nbsp;ensaios&nbsp;de&nbsp;segunda&nbsp;geração;&nbsp;os&nbsp;ensaios&nbsp;de&nbsp;terceira&nbsp;e&nbsp;quarta&nbsp;geração&nbsp;podem&nbsp;apresentar&nbsp;período</td><td class="diff_next"></td><td class="diff_header" id="to62_326">326</td><td nowrap="nowrap">2Janela&nbsp;referente&nbsp;aos&nbsp;ensaios&nbsp;de&nbsp;segunda&nbsp;geração;&nbsp;os&nbsp;ensaios&nbsp;de&nbsp;terceira&nbsp;e&nbsp;quarta&nbsp;geração&nbsp;podem&nbsp;apresentar&nbsp;período</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_333">333</td><td nowrap="nowrap">menor&nbsp;de&nbsp;janela.</td><td class="diff_next"></td><td class="diff_header" id="to62_327">327</td><td nowrap="nowrap">menor&nbsp;de&nbsp;janela.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_334">334</td><td nowrap="nowrap">7.&nbsp;FLUXOGRAMAS&nbsp;PARA&nbsp;O&nbsp;DIAGNÓSTICO&nbsp;LABORATORIAL&nbsp;DAS</td><td class="diff_next"></td><td class="diff_header" id="to62_328">328</td><td nowrap="nowrap">7.&nbsp;FLUXOGRAMAS&nbsp;PARA&nbsp;O&nbsp;DIAGNÓSTICO&nbsp;LABORATORIAL&nbsp;DAS</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_335">335</td><td nowrap="nowrap">Um&nbsp;algoritmoG&nbsp;é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;sequência&nbsp;de&nbsp;instruções&nbsp;bem&nbsp;definidas&nbsp;a&nbsp;se-</td><td class="diff_next"></td><td class="diff_header" id="to62_329">329</td><td nowrap="nowrap">Um&nbsp;algoritmoG&nbsp;é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;sequência&nbsp;de&nbsp;instruções&nbsp;bem&nbsp;definidas&nbsp;a&nbsp;se-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_336">336</td><td nowrap="nowrap">rem&nbsp;executadas&nbsp;para&nbsp;que&nbsp;se&nbsp;possa&nbsp;completar&nbsp;uma&nbsp;tarefa.&nbsp;Graficamente,&nbsp;o&nbsp;algoritmo&nbsp;pode</td><td class="diff_next"></td><td class="diff_header" id="to62_330">330</td><td nowrap="nowrap">rem&nbsp;executadas&nbsp;para&nbsp;que&nbsp;se&nbsp;possa&nbsp;completar&nbsp;uma&nbsp;tarefa.&nbsp;Graficamente,&nbsp;o&nbsp;algoritmo&nbsp;pode</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_337">337</td><td nowrap="nowrap">ser&nbsp;representado&nbsp;por&nbsp;um&nbsp;fluxogramaG,&nbsp;constituído&nbsp;de&nbsp;formas&nbsp;geométricas&nbsp;e&nbsp;linhas&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_331">331</td><td nowrap="nowrap">ser&nbsp;representado&nbsp;por&nbsp;um&nbsp;fluxogramaG,&nbsp;constituído&nbsp;de&nbsp;formas&nbsp;geométricas&nbsp;e&nbsp;linhas&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_338">338</td><td nowrap="nowrap">demonstram&nbsp;a&nbsp;transição&nbsp;de&nbsp;tarefas&nbsp;e&nbsp;informações&nbsp;entre&nbsp;os&nbsp;elementos&nbsp;que&nbsp;o&nbsp;compõem.</td><td class="diff_next"></td><td class="diff_header" id="to62_332">332</td><td nowrap="nowrap">demonstram&nbsp;a&nbsp;transição&nbsp;de&nbsp;tarefas&nbsp;e&nbsp;informações&nbsp;entre&nbsp;os&nbsp;elementos&nbsp;que&nbsp;o&nbsp;compõem.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_339">339</td><td nowrap="nowrap">claras&nbsp;as&nbsp;orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;e&nbsp;tratamento&nbsp;de&nbsp;doenças&nbsp;ou&nbsp;infecções.</td><td class="diff_next"></td><td class="diff_header" id="to62_333">333</td><td nowrap="nowrap">claras&nbsp;as&nbsp;orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;e&nbsp;tratamento&nbsp;de&nbsp;doenças&nbsp;ou&nbsp;infecções.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_340">340</td><td nowrap="nowrap">O&nbsp;diagnóstico&nbsp;sorológico&nbsp;das&nbsp;doenças&nbsp;infecciosas&nbsp;pode&nbsp;ser&nbsp;realizado&nbsp;com,&nbsp;pelo</td><td class="diff_next"></td><td class="diff_header" id="to62_334">334</td><td nowrap="nowrap">O&nbsp;diagnóstico&nbsp;sorológico&nbsp;das&nbsp;doenças&nbsp;infecciosas&nbsp;pode&nbsp;ser&nbsp;realizado&nbsp;com,&nbsp;pelo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_341">341</td><td nowrap="nowrap">menos,&nbsp;dois&nbsp;testes,&nbsp;um&nbsp;para&nbsp;triagem&nbsp;e&nbsp;um&nbsp;segundo&nbsp;confirmatório.&nbsp;Dois&nbsp;ou&nbsp;mais&nbsp;testes</td><td class="diff_next"></td><td class="diff_header" id="to62_335">335</td><td nowrap="nowrap">menos,&nbsp;dois&nbsp;testes,&nbsp;um&nbsp;para&nbsp;triagem&nbsp;e&nbsp;um&nbsp;segundo&nbsp;confirmatório.&nbsp;Dois&nbsp;ou&nbsp;mais&nbsp;testes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_342">342</td><td nowrap="nowrap">combinados,&nbsp;formando&nbsp;um&nbsp;fluxograma,&nbsp;têm&nbsp;o&nbsp;objetivo&nbsp;de&nbsp;aumentar&nbsp;o&nbsp;valor&nbsp;preditivo</td><td class="diff_next"></td><td class="diff_header" id="to62_336">336</td><td nowrap="nowrap">combinados,&nbsp;formando&nbsp;um&nbsp;fluxograma,&nbsp;têm&nbsp;o&nbsp;objetivo&nbsp;de&nbsp;aumentar&nbsp;o&nbsp;valor&nbsp;preditivo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_343">343</td><td nowrap="nowrap">positivoG&nbsp;(VPP)&nbsp;de&nbsp;um&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;teste&nbsp;inicial.&nbsp;Na&nbsp;maioria&nbsp;das&nbsp;situações,&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_337">337</td><td nowrap="nowrap">positivoG&nbsp;(VPP)&nbsp;de&nbsp;um&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;teste&nbsp;inicial.&nbsp;Na&nbsp;maioria&nbsp;das&nbsp;situações,&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_344">344</td><td nowrap="nowrap">fluxograma&nbsp;mais&nbsp;comumente&nbsp;utilizado&nbsp;inclui&nbsp;o&nbsp;emprego&nbsp;de&nbsp;testes&nbsp;em&nbsp;série&nbsp;ou&nbsp;sequen-</td><td class="diff_next"></td><td class="diff_header" id="to62_338">338</td><td nowrap="nowrap">fluxograma&nbsp;mais&nbsp;comumente&nbsp;utilizado&nbsp;inclui&nbsp;o&nbsp;emprego&nbsp;de&nbsp;testes&nbsp;em&nbsp;série&nbsp;ou&nbsp;sequen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_345">345</td><td nowrap="nowrap">ciais&nbsp;(fluxograma&nbsp;em&nbsp;série).&nbsp;Por&nbsp;outro&nbsp;lado,&nbsp;ao&nbsp;definirmos&nbsp;o&nbsp;fluxograma&nbsp;como&nbsp;“um&nbsp;mé-</td><td class="diff_next"></td><td class="diff_header" id="to62_339">339</td><td nowrap="nowrap">ciais&nbsp;(fluxograma&nbsp;em&nbsp;série).&nbsp;Por&nbsp;outro&nbsp;lado,&nbsp;ao&nbsp;definirmos&nbsp;o&nbsp;fluxograma&nbsp;como&nbsp;“um&nbsp;mé-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_346">346</td><td nowrap="nowrap">todo&nbsp;para&nbsp;resolver&nbsp;um&nbsp;problema&nbsp;utilizando&nbsp;um&nbsp;número&nbsp;definido&nbsp;de&nbsp;etapas”,&nbsp;fica&nbsp;claro</td><td class="diff_next"></td><td class="diff_header" id="to62_340">340</td><td nowrap="nowrap">todo&nbsp;para&nbsp;resolver&nbsp;um&nbsp;problema&nbsp;utilizando&nbsp;um&nbsp;número&nbsp;definido&nbsp;de&nbsp;etapas”,&nbsp;fica&nbsp;claro</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_347">347</td><td nowrap="nowrap">confirmação&nbsp;da&nbsp;infecção&nbsp;pelas&nbsp;hepatites&nbsp;virais,&nbsp;nas&nbsp;diferentes&nbsp;configurações&nbsp;de&nbsp;testes&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_341">341</td><td nowrap="nowrap">confirmação&nbsp;da&nbsp;infecção&nbsp;pelas&nbsp;hepatites&nbsp;virais,&nbsp;nas&nbsp;diferentes&nbsp;configurações&nbsp;de&nbsp;testes&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_348">348</td><td nowrap="nowrap">perfis&nbsp;de&nbsp;pacientes&nbsp;que&nbsp;esse&nbsp;diagnóstico&nbsp;requer.</td><td class="diff_next"></td><td class="diff_header" id="to62_342">342</td><td nowrap="nowrap">perfis&nbsp;de&nbsp;pacientes&nbsp;que&nbsp;esse&nbsp;diagnóstico&nbsp;requer.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_349">349</td><td nowrap="nowrap">Nos&nbsp;fluxogramas&nbsp;de&nbsp;diagnóstico,&nbsp;a&nbsp;conclusão&nbsp;do&nbsp;fluxograma&nbsp;como&nbsp;não&nbsp;reagente&nbsp;é</td><td class="diff_next"></td><td class="diff_header" id="to62_343">343</td><td nowrap="nowrap">Nos&nbsp;fluxogramas&nbsp;de&nbsp;diagnóstico,&nbsp;a&nbsp;conclusão&nbsp;do&nbsp;fluxograma&nbsp;como&nbsp;não&nbsp;reagente&nbsp;é</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_350">350</td><td nowrap="nowrap">liberada&nbsp;com&nbsp;base&nbsp;no&nbsp;resultado&nbsp;de&nbsp;um&nbsp;único&nbsp;teste.&nbsp;Entretanto,&nbsp;caso&nbsp;persista&nbsp;a&nbsp;suspeita&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_344">344</td><td nowrap="nowrap">liberada&nbsp;com&nbsp;base&nbsp;no&nbsp;resultado&nbsp;de&nbsp;um&nbsp;único&nbsp;teste.&nbsp;Entretanto,&nbsp;caso&nbsp;persista&nbsp;a&nbsp;suspeita&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_351">351</td><td nowrap="nowrap">infecção,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;da&nbsp;primeira</td><td class="diff_next"></td><td class="diff_header" id="to62_345">345</td><td nowrap="nowrap">infecção,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;da&nbsp;primeira</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_352">352</td><td nowrap="nowrap">amostra.&nbsp;A&nbsp;conclusão&nbsp;do&nbsp;fluxograma&nbsp;como&nbsp;reagente,&nbsp;no&nbsp;caso&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;B&nbsp;e&nbsp;C,&nbsp;só</td><td class="diff_next"></td><td class="diff_header" id="to62_346">346</td><td nowrap="nowrap">amostra.&nbsp;A&nbsp;conclusão&nbsp;do&nbsp;fluxograma&nbsp;como&nbsp;reagente,&nbsp;no&nbsp;caso&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;B&nbsp;e&nbsp;C,&nbsp;só</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_353">353</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;liberada&nbsp;com&nbsp;base&nbsp;no&nbsp;resultado&nbsp;de,&nbsp;pelo&nbsp;menos,&nbsp;dois&nbsp;testes&nbsp;sequenciais.</td><td class="diff_next"></td><td class="diff_header" id="to62_347">347</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;liberada&nbsp;com&nbsp;base&nbsp;no&nbsp;resultado&nbsp;de,&nbsp;pelo&nbsp;menos,&nbsp;dois&nbsp;testes&nbsp;sequenciais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_354">354</td><td nowrap="nowrap">No&nbsp;caso&nbsp;de&nbsp;resultados&nbsp;discordantes,&nbsp;os&nbsp;testes&nbsp;devem&nbsp;ser&nbsp;repetidos&nbsp;e,&nbsp;permanecen-</td><td class="diff_next"></td><td class="diff_header" id="to62_348">348</td><td nowrap="nowrap">No&nbsp;caso&nbsp;de&nbsp;resultados&nbsp;discordantes,&nbsp;os&nbsp;testes&nbsp;devem&nbsp;ser&nbsp;repetidos&nbsp;e,&nbsp;permanecen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_355">355</td><td nowrap="nowrap">do&nbsp;a&nbsp;discordância,&nbsp;a&nbsp;pessoa&nbsp;deve&nbsp;ser&nbsp;testada&nbsp;após&nbsp;aproximadamente&nbsp;30&nbsp;dias&nbsp;para&nbsp;confir-</td><td class="diff_next"></td><td class="diff_header" id="to62_349">349</td><td nowrap="nowrap">do&nbsp;a&nbsp;discordância,&nbsp;a&nbsp;pessoa&nbsp;deve&nbsp;ser&nbsp;testada&nbsp;após&nbsp;aproximadamente&nbsp;30&nbsp;dias&nbsp;para&nbsp;confir-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_356">356</td><td nowrap="nowrap">mar&nbsp;ou&nbsp;descartar&nbsp;a&nbsp;infecção.&nbsp;Finalmente,&nbsp;é&nbsp;importante&nbsp;selecionar&nbsp;a&nbsp;correta&nbsp;combinação</td><td class="diff_next"></td><td class="diff_header" id="to62_350">350</td><td nowrap="nowrap">mar&nbsp;ou&nbsp;descartar&nbsp;a&nbsp;infecção.&nbsp;Finalmente,&nbsp;é&nbsp;importante&nbsp;selecionar&nbsp;a&nbsp;correta&nbsp;combinação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_357">357</td><td nowrap="nowrap">de&nbsp;testes&nbsp;para&nbsp;garantir&nbsp;o&nbsp;diagnóstico&nbsp;preciso.</td><td class="diff_next"></td><td class="diff_header" id="to62_351">351</td><td nowrap="nowrap">de&nbsp;testes&nbsp;para&nbsp;garantir&nbsp;o&nbsp;diagnóstico&nbsp;preciso.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_358">358</td><td nowrap="nowrap">Neste&nbsp;Manual&nbsp;Técnico&nbsp;serão&nbsp;apresentados&nbsp;oito&nbsp;fluxogramas&nbsp;para&nbsp;a&nbsp;testagem&nbsp;das&nbsp;he-</td><td class="diff_next"></td><td class="diff_header" id="to62_352">352</td><td nowrap="nowrap">Neste&nbsp;Manual&nbsp;Técnico&nbsp;serão&nbsp;apresentados&nbsp;oito&nbsp;fluxogramas&nbsp;para&nbsp;a&nbsp;testagem&nbsp;das&nbsp;he-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_359">359</td><td nowrap="nowrap">patites&nbsp;virais,&nbsp;considerando&nbsp;a&nbsp;melhor&nbsp;relação&nbsp;custo-efetividadeG&nbsp;para&nbsp;as&nbsp;diversas&nbsp;situa-</td><td class="diff_next"></td><td class="diff_header" id="to62_353">353</td><td nowrap="nowrap">patites&nbsp;virais,&nbsp;considerando&nbsp;a&nbsp;melhor&nbsp;relação&nbsp;custo-efetividadeG&nbsp;para&nbsp;as&nbsp;diversas&nbsp;situa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_360">360</td><td nowrap="nowrap">ções&nbsp;nas&nbsp;quais&nbsp;se&nbsp;faz&nbsp;necessária&nbsp;a&nbsp;realização&nbsp;do&nbsp;diagnóstico&nbsp;da&nbsp;infecção,&nbsp;e&nbsp;suas&nbsp;respec-</td><td class="diff_next"></td><td class="diff_header" id="to62_354">354</td><td nowrap="nowrap">ções&nbsp;nas&nbsp;quais&nbsp;se&nbsp;faz&nbsp;necessária&nbsp;a&nbsp;realização&nbsp;do&nbsp;diagnóstico&nbsp;da&nbsp;infecção,&nbsp;e&nbsp;suas&nbsp;respec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_361">361</td><td nowrap="nowrap">tivas&nbsp;fundamentações&nbsp;técnicas.&nbsp;Por&nbsp;esse&nbsp;motivo,&nbsp;são&nbsp;indicados&nbsp;pelo&nbsp;DIAHV&nbsp;como&nbsp;sendo</td><td class="diff_next"></td><td class="diff_header" id="to62_355">355</td><td nowrap="nowrap">tivas&nbsp;fundamentações&nbsp;técnicas.&nbsp;Por&nbsp;esse&nbsp;motivo,&nbsp;são&nbsp;indicados&nbsp;pelo&nbsp;DIAHV&nbsp;como&nbsp;sendo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_362">362</td><td nowrap="nowrap">os&nbsp;de&nbsp;primeira&nbsp;escolha&nbsp;nas&nbsp;situações&nbsp;para&nbsp;as&nbsp;quais&nbsp;está&nbsp;recomendada&nbsp;a&nbsp;sua&nbsp;aplicação.</td><td class="diff_next"></td><td class="diff_header" id="to62_356">356</td><td nowrap="nowrap">os&nbsp;de&nbsp;primeira&nbsp;escolha&nbsp;nas&nbsp;situações&nbsp;para&nbsp;as&nbsp;quais&nbsp;está&nbsp;recomendada&nbsp;a&nbsp;sua&nbsp;aplicação.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_363">363</td><td nowrap="nowrap">A&nbsp;orientação&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;e&nbsp;os&nbsp;Fluxogramas&nbsp;2&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_357">357</td><td nowrap="nowrap">A&nbsp;orientação&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;e&nbsp;os&nbsp;Fluxogramas&nbsp;2&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_364">364</td><td nowrap="nowrap">5&nbsp;são&nbsp;os&nbsp;preferenciais&nbsp;para&nbsp;serem&nbsp;adotados&nbsp;pelos&nbsp;serviços&nbsp;quando&nbsp;estes&nbsp;se&nbsp;depa-</td><td class="diff_next"></td><td class="diff_header" id="to62_358">358</td><td nowrap="nowrap">5&nbsp;são&nbsp;os&nbsp;preferenciais&nbsp;para&nbsp;serem&nbsp;adotados&nbsp;pelos&nbsp;serviços&nbsp;quando&nbsp;estes&nbsp;se&nbsp;depa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_365">365</td><td nowrap="nowrap">ram&nbsp;com&nbsp;pedidos&nbsp;médicos&nbsp;que&nbsp;solicitam&nbsp;“sorologia&nbsp;de&nbsp;hepatite”,&nbsp;sem&nbsp;explicitar</td><td class="diff_next"></td><td class="diff_header" id="to62_359">359</td><td nowrap="nowrap">ram&nbsp;com&nbsp;pedidos&nbsp;médicos&nbsp;que&nbsp;solicitam&nbsp;“sorologia&nbsp;de&nbsp;hepatite”,&nbsp;sem&nbsp;explicitar</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_366">366</td><td nowrap="nowrap">quais&nbsp;os&nbsp;marcadores&nbsp;a&nbsp;serem&nbsp;investigados.&nbsp;Esses&nbsp;fluxogramas&nbsp;agilizam&nbsp;o&nbsp;diagnós-</td><td class="diff_next"></td><td class="diff_header" id="to62_360">360</td><td nowrap="nowrap">quais&nbsp;os&nbsp;marcadores&nbsp;a&nbsp;serem&nbsp;investigados.&nbsp;Esses&nbsp;fluxogramas&nbsp;agilizam&nbsp;o&nbsp;diagnós-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_367">367</td><td nowrap="nowrap">tico&nbsp;da&nbsp;infecção&nbsp;e&nbsp;também&nbsp;apresentam&nbsp;a&nbsp;melhor&nbsp;resolutividade.</td><td class="diff_next"></td><td class="diff_header" id="to62_361">361</td><td nowrap="nowrap">tico&nbsp;da&nbsp;infecção&nbsp;e&nbsp;também&nbsp;apresentam&nbsp;a&nbsp;melhor&nbsp;resolutividade.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_368">368</td><td nowrap="nowrap">8.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;A&nbsp;(HAV)</td><td class="diff_next"></td><td class="diff_header" id="to62_362">362</td><td nowrap="nowrap">8.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;A&nbsp;(HAV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_369">369</td><td nowrap="nowrap">A&nbsp;principal&nbsp;via&nbsp;de&nbsp;contágio&nbsp;do&nbsp;HAV&nbsp;é&nbsp;a&nbsp;fecal-oral,&nbsp;por&nbsp;contato&nbsp;inter-humano&nbsp;ou&nbsp;por</td><td class="diff_next"></td><td class="diff_header" id="to62_363">363</td><td nowrap="nowrap">A&nbsp;principal&nbsp;via&nbsp;de&nbsp;contágio&nbsp;do&nbsp;HAV&nbsp;é&nbsp;a&nbsp;fecal-oral,&nbsp;por&nbsp;contato&nbsp;inter-humano&nbsp;ou&nbsp;por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_370">370</td><td nowrap="nowrap">meio&nbsp;de&nbsp;água&nbsp;e&nbsp;alimentos&nbsp;contaminados.&nbsp;Contribuem&nbsp;para&nbsp;a&nbsp;transmissão&nbsp;a&nbsp;estabilida-</td><td class="diff_next"></td><td class="diff_header" id="to62_364">364</td><td nowrap="nowrap">meio&nbsp;de&nbsp;água&nbsp;e&nbsp;alimentos&nbsp;contaminados.&nbsp;Contribuem&nbsp;para&nbsp;a&nbsp;transmissão&nbsp;a&nbsp;estabilida-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_371">371</td><td nowrap="nowrap">indivíduos&nbsp;infectados.&nbsp;A&nbsp;transmissão&nbsp;por&nbsp;via&nbsp;parenteralG&nbsp;é&nbsp;rara,&nbsp;mas&nbsp;pode&nbsp;ocorrer&nbsp;se&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_365">365</td><td nowrap="nowrap">indivíduos&nbsp;infectados.&nbsp;A&nbsp;transmissão&nbsp;por&nbsp;via&nbsp;parenteralG&nbsp;é&nbsp;rara,&nbsp;mas&nbsp;pode&nbsp;ocorrer&nbsp;se&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_372">372</td><td nowrap="nowrap">doador&nbsp;estiver&nbsp;na&nbsp;fase&nbsp;de&nbsp;viremia&nbsp;do&nbsp;período&nbsp;de&nbsp;incubação.&nbsp;A&nbsp;disseminação&nbsp;está&nbsp;rela-</td><td class="diff_next"></td><td class="diff_header" id="to62_366">366</td><td nowrap="nowrap">doador&nbsp;estiver&nbsp;na&nbsp;fase&nbsp;de&nbsp;viremia&nbsp;do&nbsp;período&nbsp;de&nbsp;incubação.&nbsp;A&nbsp;disseminação&nbsp;está&nbsp;rela-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_373">373</td><td nowrap="nowrap">higiene&nbsp;praticadas.&nbsp;Nas&nbsp;regiões&nbsp;com&nbsp;mais&nbsp;problemas&nbsp;de&nbsp;infraestrutura&nbsp;de&nbsp;saneamento</td><td class="diff_next"></td><td class="diff_header" id="to62_367">367</td><td nowrap="nowrap">higiene&nbsp;praticadas.&nbsp;Nas&nbsp;regiões&nbsp;com&nbsp;mais&nbsp;problemas&nbsp;de&nbsp;infraestrutura&nbsp;de&nbsp;saneamento</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_374">374</td><td nowrap="nowrap">básico&nbsp;e&nbsp;de&nbsp;tratamento&nbsp;da&nbsp;água,&nbsp;as&nbsp;pessoas&nbsp;são&nbsp;expostas&nbsp;ao&nbsp;HAV&nbsp;em&nbsp;idades&nbsp;mais&nbsp;pre-</td><td class="diff_next"></td><td class="diff_header" id="to62_368">368</td><td nowrap="nowrap">básico&nbsp;e&nbsp;de&nbsp;tratamento&nbsp;da&nbsp;água,&nbsp;as&nbsp;pessoas&nbsp;são&nbsp;expostas&nbsp;ao&nbsp;HAV&nbsp;em&nbsp;idades&nbsp;mais&nbsp;pre-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_375">375</td><td nowrap="nowrap">coces,&nbsp;apresentando&nbsp;formas&nbsp;subclínicas&nbsp;ou&nbsp;anictéricas&nbsp;da&nbsp;doença.&nbsp;Na&nbsp;maioria&nbsp;dos&nbsp;casos,</td><td class="diff_next"></td><td class="diff_header" id="to62_369">369</td><td nowrap="nowrap">coces,&nbsp;apresentando&nbsp;formas&nbsp;subclínicas&nbsp;ou&nbsp;anictéricas&nbsp;da&nbsp;doença.&nbsp;Na&nbsp;maioria&nbsp;dos&nbsp;casos,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_376">376</td><td nowrap="nowrap">a&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;autolimitada&nbsp;e&nbsp;de&nbsp;caráter&nbsp;benigno,&nbsp;sendo&nbsp;que&nbsp;a&nbsp;insuficiência&nbsp;hepática</td><td class="diff_next"></td><td class="diff_header" id="to62_370">370</td><td nowrap="nowrap">a&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;autolimitada&nbsp;e&nbsp;de&nbsp;caráter&nbsp;benigno,&nbsp;sendo&nbsp;que&nbsp;a&nbsp;insuficiência&nbsp;hepática</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_377">377</td><td nowrap="nowrap">aguda&nbsp;grave&nbsp;ocorre&nbsp;em&nbsp;menos&nbsp;de&nbsp;1%&nbsp;dos&nbsp;casos.&nbsp;Esse&nbsp;percentual&nbsp;é&nbsp;maior&nbsp;em&nbsp;pacien-</td><td class="diff_next"></td><td class="diff_header" id="to62_371">371</td><td nowrap="nowrap">aguda&nbsp;grave&nbsp;ocorre&nbsp;em&nbsp;menos&nbsp;de&nbsp;1%&nbsp;dos&nbsp;casos.&nbsp;Esse&nbsp;percentual&nbsp;é&nbsp;maior&nbsp;em&nbsp;pacien-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_378">378</td><td nowrap="nowrap">tes&nbsp;idosos.&nbsp;Normalmente,&nbsp;os&nbsp;pacientes&nbsp;mais&nbsp;velhos&nbsp;apresentam&nbsp;a&nbsp;forma&nbsp;sintomática&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_372">372</td><td nowrap="nowrap">tes&nbsp;idosos.&nbsp;Normalmente,&nbsp;os&nbsp;pacientes&nbsp;mais&nbsp;velhos&nbsp;apresentam&nbsp;a&nbsp;forma&nbsp;sintomática&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_379">379</td><td nowrap="nowrap">doença,&nbsp;com&nbsp;resolução&nbsp;lenta.</td><td class="diff_next"></td><td class="diff_header" id="to62_373">373</td><td nowrap="nowrap">doença,&nbsp;com&nbsp;resolução&nbsp;lenta.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_380">380</td><td nowrap="nowrap">Pessoas&nbsp;que&nbsp;já&nbsp;tiveram&nbsp;hepatite&nbsp;A&nbsp;apresentam&nbsp;imunidade&nbsp;para&nbsp;essa&nbsp;doença,&nbsp;mas</td><td class="diff_next"></td><td class="diff_header" id="to62_374">374</td><td nowrap="nowrap">Pessoas&nbsp;que&nbsp;já&nbsp;tiveram&nbsp;hepatite&nbsp;A&nbsp;apresentam&nbsp;imunidade&nbsp;para&nbsp;essa&nbsp;doença,&nbsp;mas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_381">381</td><td nowrap="nowrap">permanecem&nbsp;susceptíveis&nbsp;às&nbsp;outras&nbsp;hepatites&nbsp;virais&nbsp;(BRASIL,&nbsp;2009).</td><td class="diff_next"></td><td class="diff_header" id="to62_375">375</td><td nowrap="nowrap">permanecem&nbsp;susceptíveis&nbsp;às&nbsp;outras&nbsp;hepatites&nbsp;virais&nbsp;(BRASIL,&nbsp;2009).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_382">382</td><td nowrap="nowrap">Embora&nbsp;a&nbsp;transmissão&nbsp;sexual&nbsp;do&nbsp;HAV&nbsp;não&nbsp;seja&nbsp;comum,&nbsp;foram&nbsp;reportados&nbsp;surtos&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_376">376</td><td nowrap="nowrap">Embora&nbsp;a&nbsp;transmissão&nbsp;sexual&nbsp;do&nbsp;HAV&nbsp;não&nbsp;seja&nbsp;comum,&nbsp;foram&nbsp;reportados&nbsp;surtos&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_383">383</td><td nowrap="nowrap">hepatite&nbsp;A&nbsp;relacionados&nbsp;à&nbsp;transmissão&nbsp;sexual&nbsp;nas&nbsp;Américas&nbsp;e&nbsp;na&nbsp;Europa.&nbsp;A&nbsp;existência</td><td class="diff_next"></td><td class="diff_header" id="to62_377">377</td><td nowrap="nowrap">hepatite&nbsp;A&nbsp;relacionados&nbsp;à&nbsp;transmissão&nbsp;sexual&nbsp;nas&nbsp;Américas&nbsp;e&nbsp;na&nbsp;Europa.&nbsp;A&nbsp;existência</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_384">384</td><td nowrap="nowrap">desses&nbsp;eventos&nbsp;indica&nbsp;a&nbsp;necessidade&nbsp;de&nbsp;atenção&nbsp;por&nbsp;parte&nbsp;da&nbsp;vigilância&nbsp;epidemiológica,</td><td class="diff_next"></td><td class="diff_header" id="to62_378">378</td><td nowrap="nowrap">desses&nbsp;eventos&nbsp;indica&nbsp;a&nbsp;necessidade&nbsp;de&nbsp;atenção&nbsp;por&nbsp;parte&nbsp;da&nbsp;vigilância&nbsp;epidemiológica,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_385">385</td><td nowrap="nowrap">principalmente&nbsp;junto&nbsp;a&nbsp;populações-chave&nbsp;para&nbsp;IST&nbsp;(ECDC,&nbsp;2017;&nbsp;WHO,&nbsp;2017a).</td><td class="diff_next"></td><td class="diff_header" id="to62_379">379</td><td nowrap="nowrap">principalmente&nbsp;junto&nbsp;a&nbsp;populações-chave&nbsp;para&nbsp;IST&nbsp;(ECDC,&nbsp;2017;&nbsp;WHO,&nbsp;2017a).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_386">386</td><td nowrap="nowrap">8.1&nbsp;Partícula&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_380">380</td><td nowrap="nowrap">8.1&nbsp;Partícula&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_387">387</td><td nowrap="nowrap">O&nbsp;HAV&nbsp;pertence&nbsp;à&nbsp;família&nbsp;Picornaviridae,&nbsp;sendo&nbsp;representante&nbsp;único&nbsp;do&nbsp;gênero</td><td class="diff_next"></td><td class="diff_header" id="to62_381">381</td><td nowrap="nowrap">O&nbsp;HAV&nbsp;pertence&nbsp;à&nbsp;família&nbsp;Picornaviridae,&nbsp;sendo&nbsp;representante&nbsp;único&nbsp;do&nbsp;gênero</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_388">388</td><td nowrap="nowrap">Hepatovirus&nbsp;(ICTV,&nbsp;2014).&nbsp;O&nbsp;HAV&nbsp;é&nbsp;formado&nbsp;por&nbsp;um&nbsp;capsídeo&nbsp;de&nbsp;formato&nbsp;icosaédrico</td><td class="diff_next"></td><td class="diff_header" id="to62_382">382</td><td nowrap="nowrap">Hepatovirus&nbsp;(ICTV,&nbsp;2014).&nbsp;O&nbsp;HAV&nbsp;é&nbsp;formado&nbsp;por&nbsp;um&nbsp;capsídeo&nbsp;de&nbsp;formato&nbsp;icosaédrico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_389">389</td><td nowrap="nowrap">composto&nbsp;pelas&nbsp;proteínas&nbsp;estruturais&nbsp;VP1,&nbsp;VP2&nbsp;e&nbsp;VP3,&nbsp;o&nbsp;qual&nbsp;envolve&nbsp;o&nbsp;genoma&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_383">383</td><td nowrap="nowrap">composto&nbsp;pelas&nbsp;proteínas&nbsp;estruturais&nbsp;VP1,&nbsp;VP2&nbsp;e&nbsp;VP3,&nbsp;o&nbsp;qual&nbsp;envolve&nbsp;o&nbsp;genoma&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_390">390</td><td nowrap="nowrap">(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013)&nbsp;(Figura&nbsp;1).</td><td class="diff_next"></td><td class="diff_header" id="to62_384">384</td><td nowrap="nowrap">(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013)&nbsp;(Figura&nbsp;1).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_391">391</td><td nowrap="nowrap">Figura&nbsp;1.&nbsp;Estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td><td class="diff_next"></td><td class="diff_header" id="to62_385">385</td><td nowrap="nowrap">Figura&nbsp;1.&nbsp;Estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_392">392</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_386">386</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_393">393</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;do&nbsp;HAV&nbsp;é&nbsp;constituído&nbsp;por&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;RNA&nbsp;de&nbsp;fita&nbsp;simples,&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to62_387">387</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;do&nbsp;HAV&nbsp;é&nbsp;constituído&nbsp;por&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;RNA&nbsp;de&nbsp;fita&nbsp;simples,&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_394">394</td><td nowrap="nowrap">polaridade&nbsp;positiva,&nbsp;que&nbsp;também&nbsp;funciona&nbsp;como&nbsp;RNA&nbsp;mensageiro,&nbsp;com&nbsp;aproximada-</td><td class="diff_next"></td><td class="diff_header" id="to62_388">388</td><td nowrap="nowrap">polaridade&nbsp;positiva,&nbsp;que&nbsp;também&nbsp;funciona&nbsp;como&nbsp;RNA&nbsp;mensageiro,&nbsp;com&nbsp;aproximada-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_395">395</td><td nowrap="nowrap">mente&nbsp;7,5&nbsp;kilobases&nbsp;(kb).&nbsp;O&nbsp;genoma&nbsp;viral&nbsp;apresenta&nbsp;uma&nbsp;única&nbsp;fase&nbsp;de&nbsp;leitura&nbsp;aberta</td><td class="diff_next"></td><td class="diff_header" id="to62_389">389</td><td nowrap="nowrap">mente&nbsp;7,5&nbsp;kilobases&nbsp;(kb).&nbsp;O&nbsp;genoma&nbsp;viral&nbsp;apresenta&nbsp;uma&nbsp;única&nbsp;fase&nbsp;de&nbsp;leitura&nbsp;aberta</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_396">396</td><td nowrap="nowrap">(ORFG,&nbsp;do&nbsp;inglês&nbsp;open&nbsp;reading&nbsp;frame),&nbsp;com&nbsp;três&nbsp;regiões&nbsp;distintas&nbsp;(P1,&nbsp;P2&nbsp;e&nbsp;P3),&nbsp;flanqueada</td><td class="diff_next"></td><td class="diff_header" id="to62_390">390</td><td nowrap="nowrap">(ORFG,&nbsp;do&nbsp;inglês&nbsp;open&nbsp;reading&nbsp;frame),&nbsp;com&nbsp;três&nbsp;regiões&nbsp;distintas&nbsp;(P1,&nbsp;P2&nbsp;e&nbsp;P3),&nbsp;flanqueada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_397">397</td><td nowrap="nowrap">por&nbsp;regiões&nbsp;não&nbsp;traduzidas&nbsp;(NT):&nbsp;a&nbsp;região&nbsp;3´NT&nbsp;e&nbsp;a&nbsp;5´NT.&nbsp;A&nbsp;ORF&nbsp;é&nbsp;traduzida&nbsp;em&nbsp;uma&nbsp;única</td><td class="diff_next"></td><td class="diff_header" id="to62_391">391</td><td nowrap="nowrap">por&nbsp;regiões&nbsp;não&nbsp;traduzidas&nbsp;(NT):&nbsp;a&nbsp;região&nbsp;3´NT&nbsp;e&nbsp;a&nbsp;5´NT.&nbsp;A&nbsp;ORF&nbsp;é&nbsp;traduzida&nbsp;em&nbsp;uma&nbsp;única</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_398">398</td><td nowrap="nowrap">poliproteína&nbsp;com,&nbsp;aproximadamente,&nbsp;2.225&nbsp;aminoácidos.&nbsp;Seguindo&nbsp;a&nbsp;região&nbsp;5´NT,&nbsp;a&nbsp;re-</td><td class="diff_next"></td><td class="diff_header" id="to62_392">392</td><td nowrap="nowrap">poliproteína&nbsp;com,&nbsp;aproximadamente,&nbsp;2.225&nbsp;aminoácidos.&nbsp;Seguindo&nbsp;a&nbsp;região&nbsp;5´NT,&nbsp;a&nbsp;re-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_399">399</td><td nowrap="nowrap">gião&nbsp;P1&nbsp;codifica&nbsp;as&nbsp;três&nbsp;principais&nbsp;proteínas&nbsp;estruturais&nbsp;do&nbsp;capsídeo,&nbsp;VP1,&nbsp;VP2&nbsp;e&nbsp;VP3.&nbsp;Uma</td><td class="diff_next"></td><td class="diff_header" id="to62_393">393</td><td nowrap="nowrap">gião&nbsp;P1&nbsp;codifica&nbsp;as&nbsp;três&nbsp;principais&nbsp;proteínas&nbsp;estruturais&nbsp;do&nbsp;capsídeo,&nbsp;VP1,&nbsp;VP2&nbsp;e&nbsp;VP3.&nbsp;Uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_400">400</td><td nowrap="nowrap">quarta&nbsp;proteína&nbsp;viral&nbsp;do&nbsp;capsídeo,&nbsp;a&nbsp;VP4,&nbsp;que&nbsp;é&nbsp;essencial&nbsp;para&nbsp;a&nbsp;formação&nbsp;do&nbsp;vírionG,&nbsp;não</td><td class="diff_next"></td><td class="diff_header" id="to62_394">394</td><td nowrap="nowrap">quarta&nbsp;proteína&nbsp;viral&nbsp;do&nbsp;capsídeo,&nbsp;a&nbsp;VP4,&nbsp;que&nbsp;é&nbsp;essencial&nbsp;para&nbsp;a&nbsp;formação&nbsp;do&nbsp;vírionG,&nbsp;não</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_401">401</td><td nowrap="nowrap">é&nbsp;detectada&nbsp;nas&nbsp;partículas&nbsp;virais&nbsp;maduras.&nbsp;As&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;necessárias&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_395">395</td><td nowrap="nowrap">é&nbsp;detectada&nbsp;nas&nbsp;partículas&nbsp;virais&nbsp;maduras.&nbsp;As&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;necessárias&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_402">402</td><td nowrap="nowrap">replicação&nbsp;viral&nbsp;são&nbsp;codificadas&nbsp;pelas&nbsp;regiões&nbsp;P2&nbsp;(2A,&nbsp;2B,&nbsp;2C)&nbsp;e&nbsp;P3&nbsp;(3A,&nbsp;3B,&nbsp;3Cpro,&nbsp;3Dpol)</td><td class="diff_next"></td><td class="diff_header" id="to62_396">396</td><td nowrap="nowrap">replicação&nbsp;viral&nbsp;são&nbsp;codificadas&nbsp;pelas&nbsp;regiões&nbsp;P2&nbsp;(2A,&nbsp;2B,&nbsp;2C)&nbsp;e&nbsp;P3&nbsp;(3A,&nbsp;3B,&nbsp;3Cpro,&nbsp;3Dpol)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_403">403</td><td nowrap="nowrap">(Figura&nbsp;2).&nbsp;O&nbsp;processamento&nbsp;da&nbsp;poliproteína&nbsp;ocorre&nbsp;simultaneamente&nbsp;à&nbsp;tradução,&nbsp;sob&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_397">397</td><td nowrap="nowrap">(Figura&nbsp;2).&nbsp;O&nbsp;processamento&nbsp;da&nbsp;poliproteína&nbsp;ocorre&nbsp;simultaneamente&nbsp;à&nbsp;tradução,&nbsp;sob&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_404">404</td><td nowrap="nowrap">atividade&nbsp;da&nbsp;protease&nbsp;viral&nbsp;3Cpro&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013;&nbsp;LEMON,&nbsp;1997;</td><td class="diff_next"></td><td class="diff_header" id="to62_398">398</td><td nowrap="nowrap">atividade&nbsp;da&nbsp;protease&nbsp;viral&nbsp;3Cpro&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013;&nbsp;LEMON,&nbsp;1997;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_405">405</td><td nowrap="nowrap">NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td><td class="diff_next"></td><td class="diff_header" id="to62_399">399</td><td nowrap="nowrap">NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_406">406</td><td nowrap="nowrap">Figura&nbsp;2.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;organização&nbsp;genômica&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td><td class="diff_next"></td><td class="diff_header" id="to62_400">400</td><td nowrap="nowrap">Figura&nbsp;2.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;organização&nbsp;genômica&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_407">407</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;DOMINGO;&nbsp;PARRISH,&nbsp;HOLLAND,&nbsp;2008.</td><td class="diff_next"></td><td class="diff_header" id="to62_401">401</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;DOMINGO;&nbsp;PARRISH,&nbsp;HOLLAND,&nbsp;2008.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_408">408</td><td nowrap="nowrap">8.2&nbsp;Ciclo&nbsp;replicativo</td><td class="diff_next"></td><td class="diff_header" id="to62_402">402</td><td nowrap="nowrap">8.2&nbsp;Ciclo&nbsp;replicativo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_409">409</td><td nowrap="nowrap">Após&nbsp;o&nbsp;contato&nbsp;inicial&nbsp;com&nbsp;as&nbsp;células&nbsp;do&nbsp;fígado,&nbsp;o&nbsp;vírus&nbsp;é&nbsp;internalizado&nbsp;por&nbsp;meio&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_403">403</td><td nowrap="nowrap">Após&nbsp;o&nbsp;contato&nbsp;inicial&nbsp;com&nbsp;as&nbsp;células&nbsp;do&nbsp;fígado,&nbsp;o&nbsp;vírus&nbsp;é&nbsp;internalizado&nbsp;por&nbsp;meio&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_410">410</td><td nowrap="nowrap">vesículas.&nbsp;Uma&nbsp;vez&nbsp;no&nbsp;citoplasma,&nbsp;ocorre&nbsp;uma&nbsp;alteração&nbsp;no&nbsp;pH&nbsp;do&nbsp;interior&nbsp;dessas&nbsp;vesí-</td><td class="diff_next"></td><td class="diff_header" id="to62_404">404</td><td nowrap="nowrap">vesículas.&nbsp;Uma&nbsp;vez&nbsp;no&nbsp;citoplasma,&nbsp;ocorre&nbsp;uma&nbsp;alteração&nbsp;no&nbsp;pH&nbsp;do&nbsp;interior&nbsp;dessas&nbsp;vesí-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_411">411</td><td nowrap="nowrap">culas,&nbsp;que&nbsp;irão&nbsp;conduzir&nbsp;a&nbsp;liberação&nbsp;do&nbsp;RNA&nbsp;do&nbsp;vírus&nbsp;no&nbsp;citoplasma.&nbsp;A&nbsp;partir&nbsp;daí&nbsp;o&nbsp;ma-</td><td class="diff_next"></td><td class="diff_header" id="to62_405">405</td><td nowrap="nowrap">culas,&nbsp;que&nbsp;irão&nbsp;conduzir&nbsp;a&nbsp;liberação&nbsp;do&nbsp;RNA&nbsp;do&nbsp;vírus&nbsp;no&nbsp;citoplasma.&nbsp;A&nbsp;partir&nbsp;daí&nbsp;o&nbsp;ma-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_412">412</td><td nowrap="nowrap">quinário&nbsp;celular&nbsp;irá&nbsp;produzir&nbsp;a&nbsp;poliproteína&nbsp;viral&nbsp;a&nbsp;partir&nbsp;do&nbsp;RNA&nbsp;viral.&nbsp;Para&nbsp;a&nbsp;replicação</td><td class="diff_next"></td><td class="diff_header" id="to62_406">406</td><td nowrap="nowrap">quinário&nbsp;celular&nbsp;irá&nbsp;produzir&nbsp;a&nbsp;poliproteína&nbsp;viral&nbsp;a&nbsp;partir&nbsp;do&nbsp;RNA&nbsp;viral.&nbsp;Para&nbsp;a&nbsp;replicação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_413">413</td><td nowrap="nowrap">do&nbsp;genoma,&nbsp;o&nbsp;HAV&nbsp;sintetiza&nbsp;uma&nbsp;cópia&nbsp;de&nbsp;RNA&nbsp;complementar&nbsp;de&nbsp;polaridade&nbsp;negativa</td><td class="diff_next"></td><td class="diff_header" id="to62_407">407</td><td nowrap="nowrap">do&nbsp;genoma,&nbsp;o&nbsp;HAV&nbsp;sintetiza&nbsp;uma&nbsp;cópia&nbsp;de&nbsp;RNA&nbsp;complementar&nbsp;de&nbsp;polaridade&nbsp;negativa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_414">414</td><td nowrap="nowrap">(intermediário&nbsp;replicativo),&nbsp;a&nbsp;qual&nbsp;servirá&nbsp;de&nbsp;molde&nbsp;para&nbsp;a&nbsp;síntese&nbsp;de&nbsp;novas&nbsp;fitas&nbsp;de&nbsp;po-</td><td class="diff_next"></td><td class="diff_header" id="to62_408">408</td><td nowrap="nowrap">(intermediário&nbsp;replicativo),&nbsp;a&nbsp;qual&nbsp;servirá&nbsp;de&nbsp;molde&nbsp;para&nbsp;a&nbsp;síntese&nbsp;de&nbsp;novas&nbsp;fitas&nbsp;de&nbsp;po-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_415">415</td><td nowrap="nowrap">laridade&nbsp;positiva.&nbsp;A&nbsp;síntese&nbsp;das&nbsp;fitas&nbsp;positivas&nbsp;ocorre&nbsp;dentro&nbsp;do&nbsp;retículo&nbsp;endoplasmático</td><td class="diff_next"></td><td class="diff_header" id="to62_409">409</td><td nowrap="nowrap">laridade&nbsp;positiva.&nbsp;A&nbsp;síntese&nbsp;das&nbsp;fitas&nbsp;positivas&nbsp;ocorre&nbsp;dentro&nbsp;do&nbsp;retículo&nbsp;endoplasmático</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_416">416</td><td nowrap="nowrap">liso&nbsp;e&nbsp;é&nbsp;auxiliada&nbsp;pelas&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;recém-formadas.&nbsp;Essas&nbsp;novas&nbsp;moléculas</td><td class="diff_next"></td><td class="diff_header" id="to62_410">410</td><td nowrap="nowrap">liso&nbsp;e&nbsp;é&nbsp;auxiliada&nbsp;pelas&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;recém-formadas.&nbsp;Essas&nbsp;novas&nbsp;moléculas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_417">417</td><td nowrap="nowrap">de&nbsp;RNA&nbsp;positivas&nbsp;podem&nbsp;ser&nbsp;traduzidas&nbsp;para&nbsp;a&nbsp;síntese&nbsp;de&nbsp;novas&nbsp;proteínas&nbsp;virais,&nbsp;servir</td><td class="diff_next"></td><td class="diff_header" id="to62_411">411</td><td nowrap="nowrap">de&nbsp;RNA&nbsp;positivas&nbsp;podem&nbsp;ser&nbsp;traduzidas&nbsp;para&nbsp;a&nbsp;síntese&nbsp;de&nbsp;novas&nbsp;proteínas&nbsp;virais,&nbsp;servir</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_418">418</td><td nowrap="nowrap">de&nbsp;molde&nbsp;para&nbsp;a&nbsp;síntese&nbsp;de&nbsp;outras&nbsp;proteínas&nbsp;virais&nbsp;ou,&nbsp;ainda,&nbsp;ser&nbsp;empacotadas&nbsp;para&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_412">412</td><td nowrap="nowrap">de&nbsp;molde&nbsp;para&nbsp;a&nbsp;síntese&nbsp;de&nbsp;outras&nbsp;proteínas&nbsp;virais&nbsp;ou,&nbsp;ainda,&nbsp;ser&nbsp;empacotadas&nbsp;para&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_419">419</td><td nowrap="nowrap">formação&nbsp;de&nbsp;novas&nbsp;partículas&nbsp;virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_413">413</td><td nowrap="nowrap">formação&nbsp;de&nbsp;novas&nbsp;partículas&nbsp;virais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_420">420</td><td nowrap="nowrap">A&nbsp;última&nbsp;etapa&nbsp;do&nbsp;ciclo&nbsp;replicativo&nbsp;consiste&nbsp;na&nbsp;montagem&nbsp;da&nbsp;partícula&nbsp;viral.&nbsp;As&nbsp;três</td><td class="diff_next"></td><td class="diff_header" id="to62_414">414</td><td nowrap="nowrap">A&nbsp;última&nbsp;etapa&nbsp;do&nbsp;ciclo&nbsp;replicativo&nbsp;consiste&nbsp;na&nbsp;montagem&nbsp;da&nbsp;partícula&nbsp;viral.&nbsp;As&nbsp;três</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_421">421</td><td nowrap="nowrap">proteínas&nbsp;do&nbsp;capsídeo,&nbsp;VP1,&nbsp;VP2&nbsp;e&nbsp;VP3,&nbsp;são&nbsp;montadas&nbsp;em&nbsp;uma&nbsp;estrutura&nbsp;icosaédrica,</td><td class="diff_next"></td><td class="diff_header" id="to62_415">415</td><td nowrap="nowrap">proteínas&nbsp;do&nbsp;capsídeo,&nbsp;VP1,&nbsp;VP2&nbsp;e&nbsp;VP3,&nbsp;são&nbsp;montadas&nbsp;em&nbsp;uma&nbsp;estrutura&nbsp;icosaédrica,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_422">422</td><td nowrap="nowrap">contendo&nbsp;60&nbsp;cópias&nbsp;de&nbsp;cada&nbsp;proteína&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_416">416</td><td nowrap="nowrap">contendo&nbsp;60&nbsp;cópias&nbsp;de&nbsp;cada&nbsp;proteína&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_423">423</td><td nowrap="nowrap">A&nbsp;Figura&nbsp;3&nbsp;ilustra&nbsp;as&nbsp;principais&nbsp;etapas&nbsp;do&nbsp;ciclo&nbsp;replicativo&nbsp;do&nbsp;HAV.</td><td class="diff_next"></td><td class="diff_header" id="to62_417">417</td><td nowrap="nowrap">A&nbsp;Figura&nbsp;3&nbsp;ilustra&nbsp;as&nbsp;principais&nbsp;etapas&nbsp;do&nbsp;ciclo&nbsp;replicativo&nbsp;do&nbsp;HAV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_424">424</td><td nowrap="nowrap">Figura&nbsp;3.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td><td class="diff_next"></td><td class="diff_header" id="to62_418">418</td><td nowrap="nowrap">Figura&nbsp;3.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_425">425</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_419">419</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_426">426</td><td nowrap="nowrap">8.3&nbsp;Variabilidade&nbsp;genética</td><td class="diff_next"></td><td class="diff_header" id="to62_420">420</td><td nowrap="nowrap">8.3&nbsp;Variabilidade&nbsp;genética</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_427">427</td><td nowrap="nowrap">Estudos&nbsp;de&nbsp;variabilidade&nbsp;genética&nbsp;do&nbsp;HAV&nbsp;permitiram&nbsp;sua&nbsp;classificação&nbsp;em&nbsp;seis&nbsp;ge-</td><td class="diff_next"></td><td class="diff_header" id="to62_421">421</td><td nowrap="nowrap">Estudos&nbsp;de&nbsp;variabilidade&nbsp;genética&nbsp;do&nbsp;HAV&nbsp;permitiram&nbsp;sua&nbsp;classificação&nbsp;em&nbsp;seis&nbsp;ge-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_428">428</td><td nowrap="nowrap">nótipos:&nbsp;três&nbsp;de&nbsp;origem&nbsp;humana&nbsp;(I,&nbsp;II&nbsp;e&nbsp;III)&nbsp;e&nbsp;três&nbsp;de&nbsp;origem&nbsp;símia&nbsp;(IV,&nbsp;V&nbsp;e&nbsp;VI)&nbsp;(GASPAR;</td><td class="diff_next"></td><td class="diff_header" id="to62_422">422</td><td nowrap="nowrap">nótipos:&nbsp;três&nbsp;de&nbsp;origem&nbsp;humana&nbsp;(I,&nbsp;II&nbsp;e&nbsp;III)&nbsp;e&nbsp;três&nbsp;de&nbsp;origem&nbsp;símia&nbsp;(IV,&nbsp;V&nbsp;e&nbsp;VI)&nbsp;(GASPAR;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_429">429</td><td nowrap="nowrap">VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013;&nbsp;NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td><td class="diff_next"></td><td class="diff_header" id="to62_423">423</td><td nowrap="nowrap">VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013;&nbsp;NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_430">430</td><td nowrap="nowrap">A&nbsp;distribuição&nbsp;geográfica&nbsp;dos&nbsp;genótipos&nbsp;do&nbsp;HAV&nbsp;é&nbsp;variável.&nbsp;O&nbsp;genótipo&nbsp;I&nbsp;apresenta</td><td class="diff_next"></td><td class="diff_header" id="to62_424">424</td><td nowrap="nowrap">A&nbsp;distribuição&nbsp;geográfica&nbsp;dos&nbsp;genótipos&nbsp;do&nbsp;HAV&nbsp;é&nbsp;variável.&nbsp;O&nbsp;genótipo&nbsp;I&nbsp;apresenta</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_431">431</td><td nowrap="nowrap">distribuição&nbsp;global.&nbsp;Na&nbsp;América&nbsp;do&nbsp;Norte,&nbsp;China,&nbsp;Japão&nbsp;e&nbsp;diversos&nbsp;países&nbsp;da&nbsp;Europa,&nbsp;os</td><td class="diff_next"></td><td class="diff_header" id="to62_425">425</td><td nowrap="nowrap">distribuição&nbsp;global.&nbsp;Na&nbsp;América&nbsp;do&nbsp;Norte,&nbsp;China,&nbsp;Japão&nbsp;e&nbsp;diversos&nbsp;países&nbsp;da&nbsp;Europa,&nbsp;os</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_432">432</td><td nowrap="nowrap">subgenótipos&nbsp;IA&nbsp;e&nbsp;IB&nbsp;são&nbsp;os&nbsp;mais&nbsp;frequentes.&nbsp;Já&nbsp;na&nbsp;América&nbsp;do&nbsp;Sul,&nbsp;observa-se&nbsp;a&nbsp;circula-</td><td class="diff_next"></td><td class="diff_header" id="to62_426">426</td><td nowrap="nowrap">subgenótipos&nbsp;IA&nbsp;e&nbsp;IB&nbsp;são&nbsp;os&nbsp;mais&nbsp;frequentes.&nbsp;Já&nbsp;na&nbsp;América&nbsp;do&nbsp;Sul,&nbsp;observa-se&nbsp;a&nbsp;circula-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_433">433</td><td nowrap="nowrap">ção&nbsp;exclusiva&nbsp;do&nbsp;subgenótipo&nbsp;IA&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013).&nbsp;Diferentemente</td><td class="diff_next"></td><td class="diff_header" id="to62_427">427</td><td nowrap="nowrap">ção&nbsp;exclusiva&nbsp;do&nbsp;subgenótipo&nbsp;IA&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013).&nbsp;Diferentemente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_434">434</td><td nowrap="nowrap">do&nbsp;restante&nbsp;da&nbsp;América&nbsp;do&nbsp;Sul,&nbsp;no&nbsp;Brasil&nbsp;é&nbsp;possível&nbsp;identificar&nbsp;os&nbsp;genótipos&nbsp;IA&nbsp;e&nbsp;IB&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_428">428</td><td nowrap="nowrap">do&nbsp;restante&nbsp;da&nbsp;América&nbsp;do&nbsp;Sul,&nbsp;no&nbsp;Brasil&nbsp;é&nbsp;possível&nbsp;identificar&nbsp;os&nbsp;genótipos&nbsp;IA&nbsp;e&nbsp;IB&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_435">435</td><td nowrap="nowrap">circulação&nbsp;(VILLAR&nbsp;et&nbsp;al.,&nbsp;2006).</td><td class="diff_next"></td><td class="diff_header" id="to62_429">429</td><td nowrap="nowrap">circulação&nbsp;(VILLAR&nbsp;et&nbsp;al.,&nbsp;2006).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_436">436</td><td nowrap="nowrap">8.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td><td class="diff_next"></td><td class="diff_header" id="to62_430">430</td><td nowrap="nowrap">8.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_437">437</td><td nowrap="nowrap">A&nbsp;manifestação&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;abrupta&nbsp;e&nbsp;os&nbsp;sintomas&nbsp;da&nbsp;doença&nbsp;incluem:&nbsp;indispo-</td><td class="diff_next"></td><td class="diff_header" id="to62_431">431</td><td nowrap="nowrap">A&nbsp;manifestação&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;abrupta&nbsp;e&nbsp;os&nbsp;sintomas&nbsp;da&nbsp;doença&nbsp;incluem:&nbsp;indispo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_438">438</td><td nowrap="nowrap">sição,&nbsp;fadiga,&nbsp;anorexia,&nbsp;náuseas,&nbsp;vômito,&nbsp;desconforto&nbsp;abdominal,&nbsp;febre,&nbsp;urina&nbsp;escura,&nbsp;fe-</td><td class="diff_next"></td><td class="diff_header" id="to62_432">432</td><td nowrap="nowrap">sição,&nbsp;fadiga,&nbsp;anorexia,&nbsp;náuseas,&nbsp;vômito,&nbsp;desconforto&nbsp;abdominal,&nbsp;febre,&nbsp;urina&nbsp;escura,&nbsp;fe-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_439">439</td><td nowrap="nowrap">zes&nbsp;pálidas&nbsp;e&nbsp;icterícia&nbsp;do&nbsp;recobrimento&nbsp;conjuntival&nbsp;da&nbsp;esclera&nbsp;(LEMON,&nbsp;1997;&nbsp;MATHENY;</td><td class="diff_next"></td><td class="diff_header" id="to62_433">433</td><td nowrap="nowrap">zes&nbsp;pálidas&nbsp;e&nbsp;icterícia&nbsp;do&nbsp;recobrimento&nbsp;conjuntival&nbsp;da&nbsp;esclera&nbsp;(LEMON,&nbsp;1997;&nbsp;MATHENY;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_440">440</td><td nowrap="nowrap">KINGERY,&nbsp;2012;&nbsp;NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).&nbsp;Pode&nbsp;ainda&nbsp;ocorrer&nbsp;diarreia&nbsp;em&nbsp;cerca&nbsp;de&nbsp;metade</td><td class="diff_next"></td><td class="diff_header" id="to62_434">434</td><td nowrap="nowrap">KINGERY,&nbsp;2012;&nbsp;NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).&nbsp;Pode&nbsp;ainda&nbsp;ocorrer&nbsp;diarreia&nbsp;em&nbsp;cerca&nbsp;de&nbsp;metade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_441">441</td><td nowrap="nowrap">das&nbsp;crianças&nbsp;infectadas,&nbsp;o&nbsp;que,&nbsp;entretanto,&nbsp;é&nbsp;incomum&nbsp;em&nbsp;adultos&nbsp;(LEMON,&nbsp;1997).</td><td class="diff_next"></td><td class="diff_header" id="to62_435">435</td><td nowrap="nowrap">das&nbsp;crianças&nbsp;infectadas,&nbsp;o&nbsp;que,&nbsp;entretanto,&nbsp;é&nbsp;incomum&nbsp;em&nbsp;adultos&nbsp;(LEMON,&nbsp;1997).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_442">442</td><td nowrap="nowrap">Por&nbsp;causa&nbsp;da&nbsp;sua&nbsp;capacidade&nbsp;de&nbsp;resistir&nbsp;ao&nbsp;pH&nbsp;ácido,&nbsp;o&nbsp;HAV&nbsp;passa&nbsp;pelo&nbsp;estôma-</td><td class="diff_next"></td><td class="diff_header" id="to62_436">436</td><td nowrap="nowrap">Por&nbsp;causa&nbsp;da&nbsp;sua&nbsp;capacidade&nbsp;de&nbsp;resistir&nbsp;ao&nbsp;pH&nbsp;ácido,&nbsp;o&nbsp;HAV&nbsp;passa&nbsp;pelo&nbsp;estôma-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_443">443</td><td nowrap="nowrap">go,&nbsp;replicando-se&nbsp;no&nbsp;trato&nbsp;digestivo,&nbsp;e&nbsp;atravessa&nbsp;o&nbsp;epitélio&nbsp;intestinal,&nbsp;chegando&nbsp;às&nbsp;vias</td><td class="diff_next"></td><td class="diff_header" id="to62_437">437</td><td nowrap="nowrap">go,&nbsp;replicando-se&nbsp;no&nbsp;trato&nbsp;digestivo,&nbsp;e&nbsp;atravessa&nbsp;o&nbsp;epitélio&nbsp;intestinal,&nbsp;chegando&nbsp;às&nbsp;vias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_444">444</td><td nowrap="nowrap">mesentéricas&nbsp;e&nbsp;ao&nbsp;fígado&nbsp;pelo&nbsp;sistema&nbsp;porta.&nbsp;O&nbsp;vírus&nbsp;se&nbsp;replica&nbsp;no&nbsp;hepatócito&nbsp;e&nbsp;é&nbsp;ex-</td><td class="diff_next"></td><td class="diff_header" id="to62_438">438</td><td nowrap="nowrap">mesentéricas&nbsp;e&nbsp;ao&nbsp;fígado&nbsp;pelo&nbsp;sistema&nbsp;porta.&nbsp;O&nbsp;vírus&nbsp;se&nbsp;replica&nbsp;no&nbsp;hepatócito&nbsp;e&nbsp;é&nbsp;ex-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_445">445</td><td nowrap="nowrap">cretado&nbsp;pelos&nbsp;canais&nbsp;biliares,&nbsp;atingindo&nbsp;o&nbsp;intestino&nbsp;por&nbsp;meio&nbsp;da&nbsp;bile,&nbsp;onde,&nbsp;finalmente,</td><td class="diff_next"></td><td class="diff_header" id="to62_439">439</td><td nowrap="nowrap">cretado&nbsp;pelos&nbsp;canais&nbsp;biliares,&nbsp;atingindo&nbsp;o&nbsp;intestino&nbsp;por&nbsp;meio&nbsp;da&nbsp;bile,&nbsp;onde,&nbsp;finalmente,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_446">446</td><td nowrap="nowrap">é&nbsp;eliminado&nbsp;nas&nbsp;fezes&nbsp;(NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).&nbsp;Apesar&nbsp;da&nbsp;possibilidade&nbsp;de&nbsp;existência&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_440">440</td><td nowrap="nowrap">é&nbsp;eliminado&nbsp;nas&nbsp;fezes&nbsp;(NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).&nbsp;Apesar&nbsp;da&nbsp;possibilidade&nbsp;de&nbsp;existência&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_447">447</td><td nowrap="nowrap">replicação&nbsp;extra-hepática,&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;órgão-específico,&nbsp;e&nbsp;a&nbsp;patologia&nbsp;rela-</td><td class="diff_next"></td><td class="diff_header" id="to62_441">441</td><td nowrap="nowrap">replicação&nbsp;extra-hepática,&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;órgão-específico,&nbsp;e&nbsp;a&nbsp;patologia&nbsp;rela-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_448">448</td><td nowrap="nowrap">cionada&nbsp;à&nbsp;infecção&nbsp;está&nbsp;praticamente&nbsp;restrita&nbsp;ao&nbsp;fígado&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,</td><td class="diff_next"></td><td class="diff_header" id="to62_442">442</td><td nowrap="nowrap">cionada&nbsp;à&nbsp;infecção&nbsp;está&nbsp;praticamente&nbsp;restrita&nbsp;ao&nbsp;fígado&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_449">449</td><td nowrap="nowrap">2013;&nbsp;NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td><td class="diff_next"></td><td class="diff_header" id="to62_443">443</td><td nowrap="nowrap">2013;&nbsp;NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_450">450</td><td nowrap="nowrap">A&nbsp;idade&nbsp;na&nbsp;qual&nbsp;se&nbsp;dá&nbsp;o&nbsp;contato&nbsp;com&nbsp;o&nbsp;vírus&nbsp;exerce&nbsp;importante&nbsp;influência&nbsp;na&nbsp;evolu-</td><td class="diff_next"></td><td class="diff_header" id="to62_444">444</td><td nowrap="nowrap">A&nbsp;idade&nbsp;na&nbsp;qual&nbsp;se&nbsp;dá&nbsp;o&nbsp;contato&nbsp;com&nbsp;o&nbsp;vírus&nbsp;exerce&nbsp;importante&nbsp;influência&nbsp;na&nbsp;evolu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_451">451</td><td nowrap="nowrap">ção&nbsp;clínica.&nbsp;A&nbsp;infecção,&nbsp;quando&nbsp;ocorre&nbsp;em&nbsp;crianças&nbsp;menores&nbsp;de&nbsp;seis&nbsp;anos,&nbsp;está,&nbsp;frequen-</td><td class="diff_next"></td><td class="diff_header" id="to62_445">445</td><td nowrap="nowrap">ção&nbsp;clínica.&nbsp;A&nbsp;infecção,&nbsp;quando&nbsp;ocorre&nbsp;em&nbsp;crianças&nbsp;menores&nbsp;de&nbsp;seis&nbsp;anos,&nbsp;está,&nbsp;frequen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_452">452</td><td nowrap="nowrap">temente,&nbsp;associada&nbsp;a&nbsp;quadro&nbsp;clínico&nbsp;pouco&nbsp;sintomático&nbsp;ou&nbsp;assintomático.&nbsp;Já&nbsp;a&nbsp;infecção</td><td class="diff_next"></td><td class="diff_header" id="to62_446">446</td><td nowrap="nowrap">temente,&nbsp;associada&nbsp;a&nbsp;quadro&nbsp;clínico&nbsp;pouco&nbsp;sintomático&nbsp;ou&nbsp;assintomático.&nbsp;Já&nbsp;a&nbsp;infecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_453">453</td><td nowrap="nowrap">em&nbsp;indivíduos&nbsp;com&nbsp;mais&nbsp;de&nbsp;50&nbsp;anos&nbsp;evolui&nbsp;de&nbsp;forma&nbsp;mais&nbsp;grave&nbsp;e&nbsp;sintomática,&nbsp;ocorren-</td><td class="diff_next"></td><td class="diff_header" id="to62_447">447</td><td nowrap="nowrap">em&nbsp;indivíduos&nbsp;com&nbsp;mais&nbsp;de&nbsp;50&nbsp;anos&nbsp;evolui&nbsp;de&nbsp;forma&nbsp;mais&nbsp;grave&nbsp;e&nbsp;sintomática,&nbsp;ocorren-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_454">454</td><td nowrap="nowrap">do&nbsp;icterícia&nbsp;em&nbsp;mais&nbsp;de&nbsp;70%&nbsp;dos&nbsp;pacientes.&nbsp;O&nbsp;período&nbsp;de&nbsp;incubação&nbsp;é,&nbsp;em&nbsp;média,&nbsp;de&nbsp;28</td><td class="diff_next"></td><td class="diff_header" id="to62_448">448</td><td nowrap="nowrap">do&nbsp;icterícia&nbsp;em&nbsp;mais&nbsp;de&nbsp;70%&nbsp;dos&nbsp;pacientes.&nbsp;O&nbsp;período&nbsp;de&nbsp;incubação&nbsp;é,&nbsp;em&nbsp;média,&nbsp;de&nbsp;28</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_455">455</td><td nowrap="nowrap">dias,&nbsp;podendo&nbsp;variar&nbsp;de&nbsp;15&nbsp;a&nbsp;50&nbsp;dias.&nbsp;Não&nbsp;existem&nbsp;relatos&nbsp;de&nbsp;infecção&nbsp;por&nbsp;HAV&nbsp;levando</td><td class="diff_next"></td><td class="diff_header" id="to62_449">449</td><td nowrap="nowrap">dias,&nbsp;podendo&nbsp;variar&nbsp;de&nbsp;15&nbsp;a&nbsp;50&nbsp;dias.&nbsp;Não&nbsp;existem&nbsp;relatos&nbsp;de&nbsp;infecção&nbsp;por&nbsp;HAV&nbsp;levando</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_456">456</td><td nowrap="nowrap">a&nbsp;hepatite&nbsp;crônica&nbsp;ou&nbsp;hepatocarcinoma.&nbsp;No&nbsp;entanto,&nbsp;existem&nbsp;casos&nbsp;de&nbsp;evolução&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_450">450</td><td nowrap="nowrap">a&nbsp;hepatite&nbsp;crônica&nbsp;ou&nbsp;hepatocarcinoma.&nbsp;No&nbsp;entanto,&nbsp;existem&nbsp;casos&nbsp;de&nbsp;evolução&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_457">457</td><td nowrap="nowrap">hepatite&nbsp;fulminante&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_451">451</td><td nowrap="nowrap">hepatite&nbsp;fulminante&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_458">458</td><td nowrap="nowrap">Durante&nbsp;a&nbsp;fase&nbsp;aguda,&nbsp;ocorre&nbsp;replicação&nbsp;viral&nbsp;inicial,&nbsp;acompanhada&nbsp;de&nbsp;eliminação</td><td class="diff_next"></td><td class="diff_header" id="to62_452">452</td><td nowrap="nowrap">Durante&nbsp;a&nbsp;fase&nbsp;aguda,&nbsp;ocorre&nbsp;replicação&nbsp;viral&nbsp;inicial,&nbsp;acompanhada&nbsp;de&nbsp;eliminação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_459">459</td><td nowrap="nowrap">fecal&nbsp;do&nbsp;vírus.&nbsp;A&nbsp;fase&nbsp;de&nbsp;transmissão&nbsp;da&nbsp;infecção&nbsp;pode&nbsp;acontecer&nbsp;a&nbsp;partir&nbsp;de&nbsp;duas&nbsp;sema-</td><td class="diff_next"></td><td class="diff_header" id="to62_453">453</td><td nowrap="nowrap">fecal&nbsp;do&nbsp;vírus.&nbsp;A&nbsp;fase&nbsp;de&nbsp;transmissão&nbsp;da&nbsp;infecção&nbsp;pode&nbsp;acontecer&nbsp;a&nbsp;partir&nbsp;de&nbsp;duas&nbsp;sema-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_460">460</td><td nowrap="nowrap">nas&nbsp;antes,&nbsp;até&nbsp;pelo&nbsp;menos&nbsp;uma&nbsp;semana&nbsp;após&nbsp;o&nbsp;início&nbsp;da&nbsp;icterícia,&nbsp;de&nbsp;outros&nbsp;sintomas</td><td class="diff_next"></td><td class="diff_header" id="to62_454">454</td><td nowrap="nowrap">nas&nbsp;antes,&nbsp;até&nbsp;pelo&nbsp;menos&nbsp;uma&nbsp;semana&nbsp;após&nbsp;o&nbsp;início&nbsp;da&nbsp;icterícia,&nbsp;de&nbsp;outros&nbsp;sintomas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_461">461</td><td nowrap="nowrap">clínicos&nbsp;ou&nbsp;da&nbsp;elevação&nbsp;dos&nbsp;níveis&nbsp;das&nbsp;enzimas&nbsp;hepáticas.&nbsp;O&nbsp;vírus&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;nas</td><td class="diff_next"></td><td class="diff_header" id="to62_455">455</td><td nowrap="nowrap">clínicos&nbsp;ou&nbsp;da&nbsp;elevação&nbsp;dos&nbsp;níveis&nbsp;das&nbsp;enzimas&nbsp;hepáticas.&nbsp;O&nbsp;vírus&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;nas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_462">462</td><td nowrap="nowrap">fezes&nbsp;após&nbsp;cerca&nbsp;de&nbsp;uma&nbsp;a&nbsp;duas&nbsp;semanas&nbsp;após&nbsp;a&nbsp;exposição&nbsp;ao&nbsp;HAV&nbsp;e&nbsp;persiste,&nbsp;em&nbsp;mé-</td><td class="diff_next"></td><td class="diff_header" id="to62_456">456</td><td nowrap="nowrap">fezes&nbsp;após&nbsp;cerca&nbsp;de&nbsp;uma&nbsp;a&nbsp;duas&nbsp;semanas&nbsp;após&nbsp;a&nbsp;exposição&nbsp;ao&nbsp;HAV&nbsp;e&nbsp;persiste,&nbsp;em&nbsp;mé-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_463">463</td><td nowrap="nowrap">dia,&nbsp;por&nbsp;79&nbsp;dias&nbsp;após&nbsp;o&nbsp;pico&nbsp;de&nbsp;ALT&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013;&nbsp;NAINAN&nbsp;et&nbsp;al.,</td><td class="diff_next"></td><td class="diff_header" id="to62_457">457</td><td nowrap="nowrap">dia,&nbsp;por&nbsp;79&nbsp;dias&nbsp;após&nbsp;o&nbsp;pico&nbsp;de&nbsp;ALT&nbsp;(GASPAR;&nbsp;VITRAL;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;2013;&nbsp;NAINAN&nbsp;et&nbsp;al.,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_464">464</td><td nowrap="nowrap">2006).&nbsp;O&nbsp;período&nbsp;total&nbsp;da&nbsp;viremia&nbsp;é,&nbsp;em&nbsp;média,&nbsp;de&nbsp;79&nbsp;dias&nbsp;(variando&nbsp;de&nbsp;36&nbsp;a&nbsp;391&nbsp;dias).&nbsp;A</td><td class="diff_next"></td><td class="diff_header" id="to62_458">458</td><td nowrap="nowrap">2006).&nbsp;O&nbsp;período&nbsp;total&nbsp;da&nbsp;viremia&nbsp;é,&nbsp;em&nbsp;média,&nbsp;de&nbsp;79&nbsp;dias&nbsp;(variando&nbsp;de&nbsp;36&nbsp;a&nbsp;391&nbsp;dias).&nbsp;A</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_465">465</td><td nowrap="nowrap">concentração&nbsp;viral&nbsp;no&nbsp;soro&nbsp;é&nbsp;de&nbsp;duas&nbsp;a&nbsp;três&nbsp;unidades&nbsp;logarítmicas&nbsp;(log&nbsp;)&nbsp;menor&nbsp;que&nbsp;nas</td><td class="diff_next"></td><td class="diff_header" id="to62_459">459</td><td nowrap="nowrap">concentração&nbsp;viral&nbsp;no&nbsp;soro&nbsp;é&nbsp;de&nbsp;duas&nbsp;a&nbsp;três&nbsp;unidades&nbsp;logarítmicas&nbsp;(log&nbsp;)&nbsp;menor&nbsp;que&nbsp;nas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_466">466</td><td nowrap="nowrap">fezes.&nbsp;O&nbsp;vírus&nbsp;também&nbsp;é&nbsp;liberado&nbsp;na&nbsp;saliva&nbsp;da&nbsp;maioria&nbsp;dos&nbsp;pacientes,&nbsp;mas&nbsp;nenhum&nbsp;dado</td><td class="diff_next"></td><td class="diff_header" id="to62_460">460</td><td nowrap="nowrap">fezes.&nbsp;O&nbsp;vírus&nbsp;também&nbsp;é&nbsp;liberado&nbsp;na&nbsp;saliva&nbsp;da&nbsp;maioria&nbsp;dos&nbsp;pacientes,&nbsp;mas&nbsp;nenhum&nbsp;dado</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_467">467</td><td nowrap="nowrap">HAV&nbsp;(NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td><td class="diff_next"></td><td class="diff_header" id="to62_461">461</td><td nowrap="nowrap">HAV&nbsp;(NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_468">468</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;por&nbsp;HAV,&nbsp;tradicionalmente,&nbsp;é&nbsp;dividida&nbsp;em&nbsp;duas&nbsp;fases.&nbsp;A&nbsp;primeira&nbsp;consiste</td><td class="diff_next"></td><td class="diff_header" id="to62_462">462</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;por&nbsp;HAV,&nbsp;tradicionalmente,&nbsp;é&nbsp;dividida&nbsp;em&nbsp;duas&nbsp;fases.&nbsp;A&nbsp;primeira&nbsp;consiste</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_469">469</td><td nowrap="nowrap">na&nbsp;fase&nbsp;não&nbsp;citopática,&nbsp;durante&nbsp;a&nbsp;qual&nbsp;a&nbsp;replicação&nbsp;viral&nbsp;ocorre&nbsp;exclusivamente&nbsp;no&nbsp;cito-</td><td class="diff_next"></td><td class="diff_header" id="to62_463">463</td><td nowrap="nowrap">na&nbsp;fase&nbsp;não&nbsp;citopática,&nbsp;durante&nbsp;a&nbsp;qual&nbsp;a&nbsp;replicação&nbsp;viral&nbsp;ocorre&nbsp;exclusivamente&nbsp;no&nbsp;cito-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_470">470</td><td nowrap="nowrap">plasma&nbsp;do&nbsp;hepatócito.&nbsp;A&nbsp;segunda&nbsp;corresponde&nbsp;à&nbsp;fase&nbsp;citopática,&nbsp;a&nbsp;qual&nbsp;apresenta&nbsp;infil-</td><td class="diff_next"></td><td class="diff_header" id="to62_464">464</td><td nowrap="nowrap">plasma&nbsp;do&nbsp;hepatócito.&nbsp;A&nbsp;segunda&nbsp;corresponde&nbsp;à&nbsp;fase&nbsp;citopática,&nbsp;a&nbsp;qual&nbsp;apresenta&nbsp;infil-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_471">471</td><td nowrap="nowrap">tração&nbsp;no&nbsp;tecido&nbsp;hepático.&nbsp;O&nbsp;dano&nbsp;hepatocelular&nbsp;não&nbsp;é&nbsp;resultado&nbsp;de&nbsp;um&nbsp;efeito&nbsp;citopático</td><td class="diff_next"></td><td class="diff_header" id="to62_465">465</td><td nowrap="nowrap">tração&nbsp;no&nbsp;tecido&nbsp;hepático.&nbsp;O&nbsp;dano&nbsp;hepatocelular&nbsp;não&nbsp;é&nbsp;resultado&nbsp;de&nbsp;um&nbsp;efeito&nbsp;citopático</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_472">472</td><td nowrap="nowrap">direto&nbsp;do&nbsp;HAV,&nbsp;mas&nbsp;de&nbsp;um&nbsp;processo&nbsp;mediado&nbsp;pela&nbsp;resposta&nbsp;imune&nbsp;do&nbsp;hospedeiro.&nbsp;Uma</td><td class="diff_next"></td><td class="diff_header" id="to62_466">466</td><td nowrap="nowrap">direto&nbsp;do&nbsp;HAV,&nbsp;mas&nbsp;de&nbsp;um&nbsp;processo&nbsp;mediado&nbsp;pela&nbsp;resposta&nbsp;imune&nbsp;do&nbsp;hospedeiro.&nbsp;Uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_473">473</td><td nowrap="nowrap">resposta&nbsp;imunológica&nbsp;forte,&nbsp;que&nbsp;que&nbsp;se&nbsp;reflete&nbsp;em&nbsp;uma&nbsp;redução&nbsp;acentuada&nbsp;do&nbsp;RNA&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_467">467</td><td nowrap="nowrap">resposta&nbsp;imunológica&nbsp;forte,&nbsp;que&nbsp;que&nbsp;se&nbsp;reflete&nbsp;em&nbsp;uma&nbsp;redução&nbsp;acentuada&nbsp;do&nbsp;RNA&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_474">474</td><td nowrap="nowrap">durante&nbsp;a&nbsp;infecção&nbsp;aguda,&nbsp;está&nbsp;associada&nbsp;com&nbsp;a&nbsp;hepatite&nbsp;aguda&nbsp;e,&nbsp;eventualmente,&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to62_468">468</td><td nowrap="nowrap">durante&nbsp;a&nbsp;infecção&nbsp;aguda,&nbsp;está&nbsp;associada&nbsp;com&nbsp;a&nbsp;hepatite&nbsp;aguda&nbsp;e,&nbsp;eventualmente,&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_475">475</td><td nowrap="nowrap">a&nbsp;forma&nbsp;fulminante&nbsp;da&nbsp;doença&nbsp;(DA&nbsp;CONCEIÇÃO;&nbsp;SICILIANO;&nbsp;FOCACCIA,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_469">469</td><td nowrap="nowrap">a&nbsp;forma&nbsp;fulminante&nbsp;da&nbsp;doença&nbsp;(DA&nbsp;CONCEIÇÃO;&nbsp;SICILIANO;&nbsp;FOCACCIA,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_476">476</td><td nowrap="nowrap">8.5&nbsp;Resposta&nbsp;imune&nbsp;contra&nbsp;o&nbsp;HAV</td><td class="diff_next"></td><td class="diff_header" id="to62_470">470</td><td nowrap="nowrap">8.5&nbsp;Resposta&nbsp;imune&nbsp;contra&nbsp;o&nbsp;HAV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_477">477</td><td nowrap="nowrap">As&nbsp;respostas&nbsp;imunes&nbsp;humorais&nbsp;e&nbsp;celulares&nbsp;costumam&nbsp;manifestar-se&nbsp;pouco&nbsp;antes&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_471">471</td><td nowrap="nowrap">As&nbsp;respostas&nbsp;imunes&nbsp;humorais&nbsp;e&nbsp;celulares&nbsp;costumam&nbsp;manifestar-se&nbsp;pouco&nbsp;antes&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_478">478</td><td nowrap="nowrap">elevação&nbsp;das&nbsp;transaminases&nbsp;(Figura&nbsp;4).&nbsp;A&nbsp;imunoglobulina&nbsp;da&nbsp;classe&nbsp;IgM&nbsp;anti-HAV&nbsp;pode</td><td class="diff_next"></td><td class="diff_header" id="to62_472">472</td><td nowrap="nowrap">elevação&nbsp;das&nbsp;transaminases&nbsp;(Figura&nbsp;4).&nbsp;A&nbsp;imunoglobulina&nbsp;da&nbsp;classe&nbsp;IgM&nbsp;anti-HAV&nbsp;pode</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_479">479</td><td nowrap="nowrap">cerca&nbsp;de&nbsp;três&nbsp;a&nbsp;seis&nbsp;meses,&nbsp;tornando-se&nbsp;indetectável&nbsp;pelos&nbsp;testes&nbsp;diagnósticos&nbsp;comerciais</td><td class="diff_next"></td><td class="diff_header" id="to62_473">473</td><td nowrap="nowrap">cerca&nbsp;de&nbsp;três&nbsp;a&nbsp;seis&nbsp;meses,&nbsp;tornando-se&nbsp;indetectável&nbsp;pelos&nbsp;testes&nbsp;diagnósticos&nbsp;comerciais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_480">480</td><td nowrap="nowrap">disponíveis.&nbsp;A&nbsp;imunoglobulina&nbsp;da&nbsp;classe&nbsp;IgG&nbsp;anti-HAV&nbsp;surge&nbsp;logo&nbsp;após&nbsp;o&nbsp;aparecimento</td><td class="diff_next"></td><td class="diff_header" id="to62_474">474</td><td nowrap="nowrap">disponíveis.&nbsp;A&nbsp;imunoglobulina&nbsp;da&nbsp;classe&nbsp;IgG&nbsp;anti-HAV&nbsp;surge&nbsp;logo&nbsp;após&nbsp;o&nbsp;aparecimento</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_481">481</td><td nowrap="nowrap">da&nbsp;IgM&nbsp;e&nbsp;pode&nbsp;persistir&nbsp;indefinidamente,&nbsp;conferindo&nbsp;imunidade&nbsp;ao&nbsp;indivíduo.&nbsp;Dessa&nbsp;for-</td><td class="diff_next"></td><td class="diff_header" id="to62_475">475</td><td nowrap="nowrap">da&nbsp;IgM&nbsp;e&nbsp;pode&nbsp;persistir&nbsp;indefinidamente,&nbsp;conferindo&nbsp;imunidade&nbsp;ao&nbsp;indivíduo.&nbsp;Dessa&nbsp;for-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_482">482</td><td nowrap="nowrap">ma,&nbsp;na&nbsp;fase&nbsp;aguda&nbsp;de&nbsp;infecção,&nbsp;são&nbsp;encontradas&nbsp;ambas&nbsp;IgM&nbsp;e&nbsp;IgG.&nbsp;Em&nbsp;indivíduos&nbsp;previa-</td><td class="diff_next"></td><td class="diff_header" id="to62_476">476</td><td nowrap="nowrap">ma,&nbsp;na&nbsp;fase&nbsp;aguda&nbsp;de&nbsp;infecção,&nbsp;são&nbsp;encontradas&nbsp;ambas&nbsp;IgM&nbsp;e&nbsp;IgG.&nbsp;Em&nbsp;indivíduos&nbsp;previa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_483">483</td><td nowrap="nowrap">mente&nbsp;infectados,&nbsp;encontra-se&nbsp;somente&nbsp;a&nbsp;IgG&nbsp;(DA&nbsp;CONCEIÇÃO;&nbsp;SICILIANO;&nbsp;FOCACCIA,</td><td class="diff_next"></td><td class="diff_header" id="to62_477">477</td><td nowrap="nowrap">mente&nbsp;infectados,&nbsp;encontra-se&nbsp;somente&nbsp;a&nbsp;IgG&nbsp;(DA&nbsp;CONCEIÇÃO;&nbsp;SICILIANO;&nbsp;FOCACCIA,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_484">484</td><td nowrap="nowrap">2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_478">478</td><td nowrap="nowrap">2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_485">485</td><td nowrap="nowrap">Figura&nbsp;4.&nbsp;Curso&nbsp;natural&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td><td class="diff_next"></td><td class="diff_header" id="to62_479">479</td><td nowrap="nowrap">Figura&nbsp;4.&nbsp;Curso&nbsp;natural&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_486">486</td><td nowrap="nowrap">Fonte:&nbsp;MATHENY;&nbsp;KINGERY,&nbsp;2012.</td><td class="diff_next"></td><td class="diff_header" id="to62_480">480</td><td nowrap="nowrap">Fonte:&nbsp;MATHENY;&nbsp;KINGERY,&nbsp;2012.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_487">487</td><td nowrap="nowrap">Os&nbsp;anticorpos&nbsp;neutralizantes&nbsp;representam&nbsp;o&nbsp;principal&nbsp;mecanismo&nbsp;de&nbsp;proteção&nbsp;con-</td><td class="diff_next"></td><td class="diff_header" id="to62_481">481</td><td nowrap="nowrap">Os&nbsp;anticorpos&nbsp;neutralizantes&nbsp;representam&nbsp;o&nbsp;principal&nbsp;mecanismo&nbsp;de&nbsp;proteção&nbsp;con-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_488">488</td><td nowrap="nowrap">tra&nbsp;o&nbsp;vírus.&nbsp;Estes&nbsp;podem&nbsp;ser&nbsp;adquiridos&nbsp;após&nbsp;uma&nbsp;infecção&nbsp;resolvida&nbsp;ou&nbsp;por&nbsp;vacinação</td><td class="diff_next"></td><td class="diff_header" id="to62_482">482</td><td nowrap="nowrap">tra&nbsp;o&nbsp;vírus.&nbsp;Estes&nbsp;podem&nbsp;ser&nbsp;adquiridos&nbsp;após&nbsp;uma&nbsp;infecção&nbsp;resolvida&nbsp;ou&nbsp;por&nbsp;vacinação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_489">489</td><td nowrap="nowrap">(CUTHBERT,&nbsp;2001).</td><td class="diff_next"></td><td class="diff_header" id="to62_483">483</td><td nowrap="nowrap">(CUTHBERT,&nbsp;2001).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_490">490</td><td nowrap="nowrap">8.6&nbsp;Diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_484">484</td><td nowrap="nowrap">8.6&nbsp;Diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_491">491</td><td nowrap="nowrap">O&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;realizado&nbsp;por&nbsp;meio&nbsp;de&nbsp;imu-</td><td class="diff_next"></td><td class="diff_header" id="to62_485">485</td><td nowrap="nowrap">O&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;realizado&nbsp;por&nbsp;meio&nbsp;de&nbsp;imu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_492">492</td><td nowrap="nowrap">noensaios&nbsp;que&nbsp;detectam&nbsp;anticorpos&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;em&nbsp;amostras&nbsp;de&nbsp;soro.&nbsp;A&nbsp;detecção&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_486">486</td><td nowrap="nowrap">noensaios&nbsp;que&nbsp;detectam&nbsp;anticorpos&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;em&nbsp;amostras&nbsp;de&nbsp;soro.&nbsp;A&nbsp;detecção&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_493">493</td><td nowrap="nowrap">anticorpos&nbsp;do&nbsp;tipo&nbsp;IgM&nbsp;sugere&nbsp;uma&nbsp;infecção&nbsp;recente.&nbsp;Esses&nbsp;testes&nbsp;são&nbsp;capazes&nbsp;de&nbsp;detec-</td><td class="diff_next"></td><td class="diff_header" id="to62_487">487</td><td nowrap="nowrap">anticorpos&nbsp;do&nbsp;tipo&nbsp;IgM&nbsp;sugere&nbsp;uma&nbsp;infecção&nbsp;recente.&nbsp;Esses&nbsp;testes&nbsp;são&nbsp;capazes&nbsp;de&nbsp;detec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_494">494</td><td nowrap="nowrap">tar&nbsp;o&nbsp;anti-HAV&nbsp;IgM&nbsp;entre&nbsp;cinco&nbsp;e&nbsp;dez&nbsp;dias&nbsp;após&nbsp;a&nbsp;infecção.&nbsp;A&nbsp;detectabilidade&nbsp;se&nbsp;mantém</td><td class="diff_next"></td><td class="diff_header" id="to62_488">488</td><td nowrap="nowrap">tar&nbsp;o&nbsp;anti-HAV&nbsp;IgM&nbsp;entre&nbsp;cinco&nbsp;e&nbsp;dez&nbsp;dias&nbsp;após&nbsp;a&nbsp;infecção.&nbsp;A&nbsp;detectabilidade&nbsp;se&nbsp;mantém</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_495">495</td><td nowrap="nowrap">por&nbsp;um&nbsp;período&nbsp;entre&nbsp;quatro&nbsp;e&nbsp;seis&nbsp;meses&nbsp;após&nbsp;o&nbsp;contato&nbsp;com&nbsp;o&nbsp;vírus,&nbsp;quando&nbsp;os&nbsp;títu-</td><td class="diff_next"></td><td class="diff_header" id="to62_489">489</td><td nowrap="nowrap">por&nbsp;um&nbsp;período&nbsp;entre&nbsp;quatro&nbsp;e&nbsp;seis&nbsp;meses&nbsp;após&nbsp;o&nbsp;contato&nbsp;com&nbsp;o&nbsp;vírus,&nbsp;quando&nbsp;os&nbsp;títu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_496">496</td><td nowrap="nowrap">los&nbsp;desses&nbsp;anticorpos&nbsp;caem&nbsp;a&nbsp;níveis&nbsp;indetectáveis.&nbsp;Os&nbsp;imunoensaios&nbsp;para&nbsp;IgM&nbsp;anti-HAV</td><td class="diff_next"></td><td class="diff_header" id="to62_490">490</td><td nowrap="nowrap">los&nbsp;desses&nbsp;anticorpos&nbsp;caem&nbsp;a&nbsp;níveis&nbsp;indetectáveis.&nbsp;Os&nbsp;imunoensaios&nbsp;para&nbsp;IgM&nbsp;anti-HAV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_497">497</td><td nowrap="nowrap">apresentam&nbsp;sensibilidade&nbsp;de&nbsp;100%,&nbsp;especificidade&nbsp;de&nbsp;99%&nbsp;e&nbsp;valor&nbsp;preditivo&nbsp;positivo&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_491">491</td><td nowrap="nowrap">apresentam&nbsp;sensibilidade&nbsp;de&nbsp;100%,&nbsp;especificidade&nbsp;de&nbsp;99%&nbsp;e&nbsp;valor&nbsp;preditivo&nbsp;positivo&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_498">498</td><td nowrap="nowrap">88%.&nbsp;Resultados&nbsp;falso-reagentes&nbsp;podem&nbsp;ocorrer&nbsp;e,&nbsp;portanto,&nbsp;o&nbsp;teste&nbsp;sorológico&nbsp;deve&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_492">492</td><td nowrap="nowrap">88%.&nbsp;Resultados&nbsp;falso-reagentes&nbsp;podem&nbsp;ocorrer&nbsp;e,&nbsp;portanto,&nbsp;o&nbsp;teste&nbsp;sorológico&nbsp;deve&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_499">499</td><td nowrap="nowrap">realizado&nbsp;apenas&nbsp;em&nbsp;indivíduos&nbsp;sintomáticos.</td><td class="diff_next"></td><td class="diff_header" id="to62_493">493</td><td nowrap="nowrap">realizado&nbsp;apenas&nbsp;em&nbsp;indivíduos&nbsp;sintomáticos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_500">500</td><td nowrap="nowrap">Os&nbsp;testes&nbsp;para&nbsp;anti-HAV&nbsp;total&nbsp;(IgM&nbsp;e&nbsp;IgG)&nbsp;ou&nbsp;para&nbsp;o&nbsp;anti-HAV&nbsp;IgG&nbsp;permanecem&nbsp;rea-</td><td class="diff_next"></td><td class="diff_header" id="to62_494">494</td><td nowrap="nowrap">Os&nbsp;testes&nbsp;para&nbsp;anti-HAV&nbsp;total&nbsp;(IgM&nbsp;e&nbsp;IgG)&nbsp;ou&nbsp;para&nbsp;o&nbsp;anti-HAV&nbsp;IgG&nbsp;permanecem&nbsp;rea-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_501">501</td><td nowrap="nowrap">gentes&nbsp;após&nbsp;a&nbsp;infecção&nbsp;ou&nbsp;imunização&nbsp;durante&nbsp;toda&nbsp;a&nbsp;vida&nbsp;do&nbsp;paciente,&nbsp;sendo&nbsp;úteis&nbsp;ape-</td><td class="diff_next"></td><td class="diff_header" id="to62_495">495</td><td nowrap="nowrap">gentes&nbsp;após&nbsp;a&nbsp;infecção&nbsp;ou&nbsp;imunização&nbsp;durante&nbsp;toda&nbsp;a&nbsp;vida&nbsp;do&nbsp;paciente,&nbsp;sendo&nbsp;úteis&nbsp;ape-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_502">502</td><td nowrap="nowrap">nas&nbsp;para&nbsp;identificar&nbsp;indivíduos&nbsp;em&nbsp;risco&nbsp;por&nbsp;não&nbsp;terem&nbsp;sido&nbsp;previamente&nbsp;imunizados.</td><td class="diff_next"></td><td class="diff_header" id="to62_496">496</td><td nowrap="nowrap">nas&nbsp;para&nbsp;identificar&nbsp;indivíduos&nbsp;em&nbsp;risco&nbsp;por&nbsp;não&nbsp;terem&nbsp;sido&nbsp;previamente&nbsp;imunizados.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_503">503</td><td nowrap="nowrap">infectados&nbsp;enquanto&nbsp;houver&nbsp;viremia&nbsp;(CUTHBERT,&nbsp;2001;&nbsp;MATHENY;&nbsp;KINGERY,&nbsp;2012).</td><td class="diff_next"></td><td class="diff_header" id="to62_497">497</td><td nowrap="nowrap">infectados&nbsp;enquanto&nbsp;houver&nbsp;viremia&nbsp;(CUTHBERT,&nbsp;2001;&nbsp;MATHENY;&nbsp;KINGERY,&nbsp;2012).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_504">504</td><td nowrap="nowrap">Os&nbsp;anticorpos&nbsp;IgG&nbsp;anti-HAV&nbsp;podem&nbsp;ser&nbsp;detectados&nbsp;no&nbsp;fluido&nbsp;oral&nbsp;(FO),&nbsp;soro,&nbsp;urina&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_498">498</td><td nowrap="nowrap">Os&nbsp;anticorpos&nbsp;IgG&nbsp;anti-HAV&nbsp;podem&nbsp;ser&nbsp;detectados&nbsp;no&nbsp;fluido&nbsp;oral&nbsp;(FO),&nbsp;soro,&nbsp;urina&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_505">505</td><td nowrap="nowrap">fezes.&nbsp;Os&nbsp;testes&nbsp;que&nbsp;utilizam&nbsp;FO&nbsp;são&nbsp;indicados&nbsp;como&nbsp;uma&nbsp;alternativa&nbsp;ao&nbsp;teste&nbsp;sorológico</td><td class="diff_next"></td><td class="diff_header" id="to62_499">499</td><td nowrap="nowrap">fezes.&nbsp;Os&nbsp;testes&nbsp;que&nbsp;utilizam&nbsp;FO&nbsp;são&nbsp;indicados&nbsp;como&nbsp;uma&nbsp;alternativa&nbsp;ao&nbsp;teste&nbsp;sorológico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_506">506</td><td nowrap="nowrap">convencional,&nbsp;devido&nbsp;à&nbsp;simplicidade&nbsp;da&nbsp;coleta&nbsp;de&nbsp;amostra.&nbsp;Estudos&nbsp;já&nbsp;demonstraram</td><td class="diff_next"></td><td class="diff_header" id="to62_500">500</td><td nowrap="nowrap">convencional,&nbsp;devido&nbsp;à&nbsp;simplicidade&nbsp;da&nbsp;coleta&nbsp;de&nbsp;amostra.&nbsp;Estudos&nbsp;já&nbsp;demonstraram</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_507">507</td><td nowrap="nowrap">de&nbsp;surtos&nbsp;e&nbsp;em&nbsp;estudos&nbsp;epidemiológicos.&nbsp;A&nbsp;sensibilidade&nbsp;de&nbsp;detecção&nbsp;do&nbsp;anti-HAV&nbsp;IgG</td><td class="diff_next"></td><td class="diff_header" id="to62_501">501</td><td nowrap="nowrap">de&nbsp;surtos&nbsp;e&nbsp;em&nbsp;estudos&nbsp;epidemiológicos.&nbsp;A&nbsp;sensibilidade&nbsp;de&nbsp;detecção&nbsp;do&nbsp;anti-HAV&nbsp;IgG</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_508">508</td><td nowrap="nowrap">no&nbsp;FO&nbsp;é&nbsp;de&nbsp;uma&nbsp;a&nbsp;três&nbsp;unidades&nbsp;logarítmicas&nbsp;menores&nbsp;que&nbsp;no&nbsp;soro,&nbsp;e,&nbsp;entretanto,&nbsp;essa</td><td class="diff_next"></td><td class="diff_header" id="to62_502">502</td><td nowrap="nowrap">no&nbsp;FO&nbsp;é&nbsp;de&nbsp;uma&nbsp;a&nbsp;três&nbsp;unidades&nbsp;logarítmicas&nbsp;menores&nbsp;que&nbsp;no&nbsp;soro,&nbsp;e,&nbsp;entretanto,&nbsp;essa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_509">509</td><td nowrap="nowrap">sensibilidade&nbsp;ainda&nbsp;é&nbsp;aceitável&nbsp;para&nbsp;utilização&nbsp;nas&nbsp;situações&nbsp;acima&nbsp;(NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td><td class="diff_next"></td><td class="diff_header" id="to62_503">503</td><td nowrap="nowrap">sensibilidade&nbsp;ainda&nbsp;é&nbsp;aceitável&nbsp;para&nbsp;utilização&nbsp;nas&nbsp;situações&nbsp;acima&nbsp;(NAINAN&nbsp;et&nbsp;al.,&nbsp;2006).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_510">510</td><td nowrap="nowrap">8.7&nbsp;Orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td><td class="diff_next"></td><td class="diff_header" id="to62_504">504</td><td nowrap="nowrap">8.7&nbsp;Orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_511">511</td><td nowrap="nowrap">Conforme&nbsp;o&nbsp;“Boletim&nbsp;Epidemiológico&nbsp;de&nbsp;Hepatites&nbsp;Virais”&nbsp;(BRASIL,&nbsp;2017b),&nbsp;a&nbsp;maior</td><td class="diff_next"></td><td class="diff_header" id="to62_505">505</td><td nowrap="nowrap">Conforme&nbsp;o&nbsp;“Boletim&nbsp;Epidemiológico&nbsp;de&nbsp;Hepatites&nbsp;Virais”&nbsp;(BRASIL,&nbsp;2017b),&nbsp;a&nbsp;maior</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_512">512</td><td nowrap="nowrap">parte&nbsp;dos&nbsp;casos&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;se&nbsp;concentram&nbsp;na&nbsp;faixa&nbsp;etária&nbsp;de&nbsp;0&nbsp;a&nbsp;14&nbsp;anos.</td><td class="diff_next"></td><td class="diff_header" id="to62_506">506</td><td nowrap="nowrap">parte&nbsp;dos&nbsp;casos&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;se&nbsp;concentram&nbsp;na&nbsp;faixa&nbsp;etária&nbsp;de&nbsp;0&nbsp;a&nbsp;14&nbsp;anos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_513">513</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;é&nbsp;um&nbsp;agravo&nbsp;imunoprevenível,&nbsp;e&nbsp;todas&nbsp;as&nbsp;pessoas&nbsp;não&nbsp;vacinadas</td><td class="diff_next"></td><td class="diff_header" id="to62_507">507</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;é&nbsp;um&nbsp;agravo&nbsp;imunoprevenível,&nbsp;e&nbsp;todas&nbsp;as&nbsp;pessoas&nbsp;não&nbsp;vacinadas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_514">514</td><td nowrap="nowrap">são&nbsp;susceptíveis&nbsp;à&nbsp;infecção.&nbsp;Aqueles&nbsp;que&nbsp;conseguem&nbsp;se&nbsp;recuperar&nbsp;da&nbsp;infecção&nbsp;adquirem</td><td class="diff_next"></td><td class="diff_header" id="to62_508">508</td><td nowrap="nowrap">são&nbsp;susceptíveis&nbsp;à&nbsp;infecção.&nbsp;Aqueles&nbsp;que&nbsp;conseguem&nbsp;se&nbsp;recuperar&nbsp;da&nbsp;infecção&nbsp;adquirem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_515">515</td><td nowrap="nowrap">imunidade&nbsp;duradoura&nbsp;contra&nbsp;o&nbsp;HAV.&nbsp;Os&nbsp;casos&nbsp;de&nbsp;infecção&nbsp;estão,&nbsp;na&nbsp;maior&nbsp;parte&nbsp;das&nbsp;ve-</td><td class="diff_next"></td><td class="diff_header" id="to62_509">509</td><td nowrap="nowrap">imunidade&nbsp;duradoura&nbsp;contra&nbsp;o&nbsp;HAV.&nbsp;Os&nbsp;casos&nbsp;de&nbsp;infecção&nbsp;estão,&nbsp;na&nbsp;maior&nbsp;parte&nbsp;das&nbsp;ve-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_516">516</td><td nowrap="nowrap">zes,&nbsp;associados&nbsp;a&nbsp;condições&nbsp;precárias&nbsp;de&nbsp;saneamento&nbsp;básico&nbsp;e&nbsp;higiene.&nbsp;Também&nbsp;já&nbsp;foram</td><td class="diff_next"></td><td class="diff_header" id="to62_510">510</td><td nowrap="nowrap">zes,&nbsp;associados&nbsp;a&nbsp;condições&nbsp;precárias&nbsp;de&nbsp;saneamento&nbsp;básico&nbsp;e&nbsp;higiene.&nbsp;Também&nbsp;já&nbsp;foram</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_517">517</td><td nowrap="nowrap">relatados&nbsp;casos&nbsp;de&nbsp;transmissão&nbsp;sexual&nbsp;do&nbsp;HAV.&nbsp;Dada&nbsp;a&nbsp;natureza&nbsp;aguda&nbsp;e&nbsp;autolimitante</td><td class="diff_next"></td><td class="diff_header" id="to62_511">511</td><td nowrap="nowrap">relatados&nbsp;casos&nbsp;de&nbsp;transmissão&nbsp;sexual&nbsp;do&nbsp;HAV.&nbsp;Dada&nbsp;a&nbsp;natureza&nbsp;aguda&nbsp;e&nbsp;autolimitante</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_518">518</td><td nowrap="nowrap">da&nbsp;infecção,&nbsp;recomenda-se&nbsp;que&nbsp;a&nbsp;investigação&nbsp;seja&nbsp;realizada&nbsp;utilizando&nbsp;a&nbsp;pesquisa&nbsp;pelo</td><td class="diff_next"></td><td class="diff_header" id="to62_512">512</td><td nowrap="nowrap">da&nbsp;infecção,&nbsp;recomenda-se&nbsp;que&nbsp;a&nbsp;investigação&nbsp;seja&nbsp;realizada&nbsp;utilizando&nbsp;a&nbsp;pesquisa&nbsp;pelo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_519">519</td><td nowrap="nowrap">anticorpo&nbsp;IgM&nbsp;contra&nbsp;o&nbsp;HAV&nbsp;(anti-HAV&nbsp;IgM).</td><td class="diff_next"></td><td class="diff_header" id="to62_513">513</td><td nowrap="nowrap">anticorpo&nbsp;IgM&nbsp;contra&nbsp;o&nbsp;HAV&nbsp;(anti-HAV&nbsp;IgM).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_520">520</td><td nowrap="nowrap">Deve-se&nbsp;utilizar&nbsp;a&nbsp;pesquisa&nbsp;por&nbsp;esse&nbsp;marcador&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_514">514</td><td nowrap="nowrap">Deve-se&nbsp;utilizar&nbsp;a&nbsp;pesquisa&nbsp;por&nbsp;esse&nbsp;marcador&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_521">521</td><td nowrap="nowrap">“sorologia&nbsp;da&nbsp;hepatite&nbsp;A”,&nbsp;“diagnóstico&nbsp;de&nbsp;HAV”&nbsp;ou&nbsp;termos&nbsp;afins.</td><td class="diff_next"></td><td class="diff_header" id="to62_515">515</td><td nowrap="nowrap">“sorologia&nbsp;da&nbsp;hepatite&nbsp;A”,&nbsp;“diagnóstico&nbsp;de&nbsp;HAV”&nbsp;ou&nbsp;termos&nbsp;afins.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_522">522</td><td nowrap="nowrap">A&nbsp;pesquisa&nbsp;pelo&nbsp;anti-HAV&nbsp;IgM&nbsp;deve&nbsp;ser&nbsp;realizada&nbsp;em&nbsp;conjunto&nbsp;com&nbsp;os&nbsp;Fluxogramas</td><td class="diff_next"></td><td class="diff_header" id="to62_516">516</td><td nowrap="nowrap">A&nbsp;pesquisa&nbsp;pelo&nbsp;anti-HAV&nbsp;IgM&nbsp;deve&nbsp;ser&nbsp;realizada&nbsp;em&nbsp;conjunto&nbsp;com&nbsp;os&nbsp;Fluxogramas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_523">523</td><td nowrap="nowrap">2&nbsp;e&nbsp;5,&nbsp;indicados&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;e&nbsp;pelo&nbsp;HCV,&nbsp;quando&nbsp;houver</td><td class="diff_next"></td><td class="diff_header" id="to62_517">517</td><td nowrap="nowrap">2&nbsp;e&nbsp;5,&nbsp;indicados&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;e&nbsp;pelo&nbsp;HCV,&nbsp;quando&nbsp;houver</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_524">524</td><td nowrap="nowrap">uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia&nbsp;de&nbsp;hepatite”&nbsp;sem&nbsp;explicitar&nbsp;quais&nbsp;os&nbsp;marcadores&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_518">518</td><td nowrap="nowrap">uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia&nbsp;de&nbsp;hepatite”&nbsp;sem&nbsp;explicitar&nbsp;quais&nbsp;os&nbsp;marcadores&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_525">525</td><td nowrap="nowrap">ser&nbsp;investigados.</td><td class="diff_next"></td><td class="diff_header" id="to62_519">519</td><td nowrap="nowrap">ser&nbsp;investigados.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_526">526</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_520">520</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_527">527</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_521">521</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_528">528</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;IgM&nbsp;anti-HAV&nbsp;será&nbsp;de-</td><td class="diff_next"></td><td class="diff_header" id="to62_522">522</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;IgM&nbsp;anti-HAV&nbsp;será&nbsp;de-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_529">529</td><td nowrap="nowrap">finida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;HAV&nbsp;IgM”.</td><td class="diff_next"></td><td class="diff_header" id="to62_523">523</td><td nowrap="nowrap">finida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;HAV&nbsp;IgM”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_530">530</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;IgM&nbsp;anti-HAV&nbsp;será&nbsp;definida</td><td class="diff_next"></td><td class="diff_header" id="to62_524">524</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;IgM&nbsp;anti-HAV&nbsp;será&nbsp;definida</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_531">531</td><td nowrap="nowrap">como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;HAV&nbsp;IgM”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte</td><td class="diff_next"></td><td class="diff_header" id="to62_525">525</td><td nowrap="nowrap">como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;HAV&nbsp;IgM”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_532">532</td><td nowrap="nowrap">ressalva:&nbsp;“O&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HAV&nbsp;IgM&nbsp;indica&nbsp;infecção&nbsp;aguda&nbsp;pelo&nbsp;vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_526">526</td><td nowrap="nowrap">ressalva:&nbsp;“O&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HAV&nbsp;IgM&nbsp;indica&nbsp;infecção&nbsp;aguda&nbsp;pelo&nbsp;vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_533">533</td><td nowrap="nowrap">hepatite&nbsp;A”.</td><td class="diff_next"></td><td class="diff_header" id="to62_527">527</td><td nowrap="nowrap">hepatite&nbsp;A”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_534">534</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td><td class="diff_next"></td><td class="diff_header" id="to62_528">528</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__12"></td><td class="diff_header" id="from62_535">535</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;o&nbsp;ponto&nbsp;de&nbsp;corte&nbsp;(CO,&nbsp;do&nbsp;inglês&nbsp;cut-off)&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_529">529</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;o&nbsp;ponto&nbsp;de&nbsp;corte&nbsp;(CO,&nbsp;do&nbsp;inglês&nbsp;cut-off)&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_536">536</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_530">530</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_537">537</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_531">531</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_538">538</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_532">532</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__13"></td><td class="diff_header" id="from62_539">539</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_533">533</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__13">n</a></td><td class="diff_header" id="from62_540">540</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__13">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_541">541</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_534">534</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_542">542</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_535">535</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_543">543</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_536">536</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__14">n</a></td><td class="diff_header" id="from62_544">544</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__14">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_545">545</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_537">537</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_546">546</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_538">538</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_547">547</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_539">539</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_548">548</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_540">540</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_549">549</td><td nowrap="nowrap">›&nbsp;As&nbsp;orientações&nbsp;acima&nbsp;destinam-se&nbsp;à&nbsp;investigação&nbsp;de&nbsp;uma&nbsp;infecção&nbsp;aguda</td><td class="diff_next"></td><td class="diff_header" id="to62_541">541</td><td nowrap="nowrap">›&nbsp;As&nbsp;orientações&nbsp;acima&nbsp;destinam-se&nbsp;à&nbsp;investigação&nbsp;de&nbsp;uma&nbsp;infecção&nbsp;aguda</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_550">550</td><td nowrap="nowrap">pelo&nbsp;HAV.&nbsp;Caso&nbsp;o&nbsp;indivíduo&nbsp;não&nbsp;esteja&nbsp;na&nbsp;fase&nbsp;aguda&nbsp;da&nbsp;infecção,&nbsp;o&nbsp;resultado</td><td class="diff_next"></td><td class="diff_header" id="to62_542">542</td><td nowrap="nowrap">pelo&nbsp;HAV.&nbsp;Caso&nbsp;o&nbsp;indivíduo&nbsp;não&nbsp;esteja&nbsp;na&nbsp;fase&nbsp;aguda&nbsp;da&nbsp;infecção,&nbsp;o&nbsp;resultado</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_551">551</td><td nowrap="nowrap">do&nbsp;anti-HAV&nbsp;IgM&nbsp;poderá&nbsp;ser&nbsp;não&nbsp;reagente.</td><td class="diff_next"></td><td class="diff_header" id="to62_543">543</td><td nowrap="nowrap">do&nbsp;anti-HAV&nbsp;IgM&nbsp;poderá&nbsp;ser&nbsp;não&nbsp;reagente.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_552">552</td><td nowrap="nowrap">›&nbsp;O&nbsp;resultado&nbsp;reagente&nbsp;em&nbsp;uma&nbsp;amostra&nbsp;na&nbsp;pesquisa&nbsp;pelo&nbsp;anticorpo&nbsp;IgM&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to62_544">544</td><td nowrap="nowrap">›&nbsp;O&nbsp;resultado&nbsp;reagente&nbsp;em&nbsp;uma&nbsp;amostra&nbsp;na&nbsp;pesquisa&nbsp;pelo&nbsp;anticorpo&nbsp;IgM&nbsp;anti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_553">553</td><td nowrap="nowrap">HAV&nbsp;sugere&nbsp;exposição&nbsp;recente&nbsp;ao&nbsp;HAV.</td><td class="diff_next"></td><td class="diff_header" id="to62_545">545</td><td nowrap="nowrap">HAV&nbsp;sugere&nbsp;exposição&nbsp;recente&nbsp;ao&nbsp;HAV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_554">554</td><td nowrap="nowrap">›&nbsp;Os&nbsp;resultados&nbsp;dos&nbsp;testes&nbsp;devem&nbsp;ser&nbsp;avaliados&nbsp;com&nbsp;cuidado&nbsp;quando&nbsp;se&nbsp;tratar</td><td class="diff_next"></td><td class="diff_header" id="to62_546">546</td><td nowrap="nowrap">›&nbsp;Os&nbsp;resultados&nbsp;dos&nbsp;testes&nbsp;devem&nbsp;ser&nbsp;avaliados&nbsp;com&nbsp;cuidado&nbsp;quando&nbsp;se&nbsp;tratar</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_555">555</td><td nowrap="nowrap">de&nbsp;investigação&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;em&nbsp;indivíduos&nbsp;imunossuprimidos/</td><td class="diff_next"></td><td class="diff_header" id="to62_547">547</td><td nowrap="nowrap">de&nbsp;investigação&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HAV&nbsp;em&nbsp;indivíduos&nbsp;imunossuprimidos/</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_556">556</td><td nowrap="nowrap">imunodeprimidosG.</td><td class="diff_next"></td><td class="diff_header" id="to62_548">548</td><td nowrap="nowrap">imunodeprimidosG.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_557">557</td><td nowrap="nowrap">9.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;B&nbsp;(HBV)</td><td class="diff_next"></td><td class="diff_header" id="to62_549">549</td><td nowrap="nowrap">9.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_558">558</td><td nowrap="nowrap">A&nbsp;transmissão&nbsp;do&nbsp;HBV&nbsp;se&nbsp;dá&nbsp;por&nbsp;via&nbsp;parenteral&nbsp;e,&nbsp;sobretudo,&nbsp;pela&nbsp;via&nbsp;sexual,&nbsp;sendo</td><td class="diff_next"></td><td class="diff_header" id="to62_550">550</td><td nowrap="nowrap">A&nbsp;transmissão&nbsp;do&nbsp;HBV&nbsp;se&nbsp;dá&nbsp;por&nbsp;via&nbsp;parenteral&nbsp;e,&nbsp;sobretudo,&nbsp;pela&nbsp;via&nbsp;sexual,&nbsp;sendo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_559">559</td><td nowrap="nowrap">a&nbsp;hepatite&nbsp;B&nbsp;considerada&nbsp;uma&nbsp;IST.&nbsp;Dessa&nbsp;forma,&nbsp;o&nbsp;HBV&nbsp;pode&nbsp;ser&nbsp;transmitido&nbsp;por&nbsp;solução</td><td class="diff_next"></td><td class="diff_header" id="to62_551">551</td><td nowrap="nowrap">a&nbsp;hepatite&nbsp;B&nbsp;considerada&nbsp;uma&nbsp;IST.&nbsp;Dessa&nbsp;forma,&nbsp;o&nbsp;HBV&nbsp;pode&nbsp;ser&nbsp;transmitido&nbsp;por&nbsp;solução</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_560">560</td><td nowrap="nowrap">de&nbsp;continuidade&nbsp;(pele&nbsp;e&nbsp;mucosa),&nbsp;relações&nbsp;sexuais&nbsp;desprotegidas&nbsp;e&nbsp;por&nbsp;via&nbsp;parenteral</td><td class="diff_next"></td><td class="diff_header" id="to62_552">552</td><td nowrap="nowrap">de&nbsp;continuidade&nbsp;(pele&nbsp;e&nbsp;mucosa),&nbsp;relações&nbsp;sexuais&nbsp;desprotegidas&nbsp;e&nbsp;por&nbsp;via&nbsp;parenteral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_561">561</td><td nowrap="nowrap">(compartilhamento&nbsp;de&nbsp;agulhas&nbsp;e&nbsp;seringas,&nbsp;tatuagens,&nbsp;piercings,&nbsp;procedimentos&nbsp;odonto-</td><td class="diff_next"></td><td class="diff_header" id="to62_553">553</td><td nowrap="nowrap">(compartilhamento&nbsp;de&nbsp;agulhas&nbsp;e&nbsp;seringas,&nbsp;tatuagens,&nbsp;piercings,&nbsp;procedimentos&nbsp;odonto-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_562">562</td><td nowrap="nowrap">lógicos&nbsp;ou&nbsp;cirúrgicos,&nbsp;etc.).&nbsp;Outros&nbsp;líquidos&nbsp;orgânicos,&nbsp;como&nbsp;sêmen,&nbsp;secreção&nbsp;vaginal&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_554">554</td><td nowrap="nowrap">lógicos&nbsp;ou&nbsp;cirúrgicos,&nbsp;etc.).&nbsp;Outros&nbsp;líquidos&nbsp;orgânicos,&nbsp;como&nbsp;sêmen,&nbsp;secreção&nbsp;vaginal&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_563">563</td><td nowrap="nowrap">leite&nbsp;materno&nbsp;podem&nbsp;igualmente&nbsp;conter&nbsp;o&nbsp;vírus&nbsp;e&nbsp;constituir&nbsp;fontes&nbsp;de&nbsp;infecção.&nbsp;A&nbsp;trans-</td><td class="diff_next"></td><td class="diff_header" id="to62_555">555</td><td nowrap="nowrap">leite&nbsp;materno&nbsp;podem&nbsp;igualmente&nbsp;conter&nbsp;o&nbsp;vírus&nbsp;e&nbsp;constituir&nbsp;fontes&nbsp;de&nbsp;infecção.&nbsp;A&nbsp;trans-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_564">564</td><td nowrap="nowrap">missão&nbsp;vertical&nbsp;(de&nbsp;mãe&nbsp;para&nbsp;filho)&nbsp;também&nbsp;é&nbsp;causa&nbsp;frequente&nbsp;de&nbsp;disseminação&nbsp;do&nbsp;HBV</td><td class="diff_next"></td><td class="diff_header" id="to62_556">556</td><td nowrap="nowrap">missão&nbsp;vertical&nbsp;(de&nbsp;mãe&nbsp;para&nbsp;filho)&nbsp;também&nbsp;é&nbsp;causa&nbsp;frequente&nbsp;de&nbsp;disseminação&nbsp;do&nbsp;HBV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_565">565</td><td nowrap="nowrap">em&nbsp;regiões&nbsp;de&nbsp;alta&nbsp;endemicidade.&nbsp;De&nbsp;maneira&nbsp;semelhante&nbsp;às&nbsp;outras&nbsp;hepatites,&nbsp;as&nbsp;infec-</td><td class="diff_next"></td><td class="diff_header" id="to62_557">557</td><td nowrap="nowrap">em&nbsp;regiões&nbsp;de&nbsp;alta&nbsp;endemicidade.&nbsp;De&nbsp;maneira&nbsp;semelhante&nbsp;às&nbsp;outras&nbsp;hepatites,&nbsp;as&nbsp;infec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_566">566</td><td nowrap="nowrap">ções&nbsp;causadas&nbsp;pelo&nbsp;HBV&nbsp;são&nbsp;habitualmente&nbsp;anictéricas.&nbsp;A&nbsp;cronificação&nbsp;da&nbsp;doença,&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_558">558</td><td nowrap="nowrap">ções&nbsp;causadas&nbsp;pelo&nbsp;HBV&nbsp;são&nbsp;habitualmente&nbsp;anictéricas.&nbsp;A&nbsp;cronificação&nbsp;da&nbsp;doença,&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_567">567</td><td nowrap="nowrap">seja,&nbsp;a&nbsp;persistência&nbsp;do&nbsp;vírus&nbsp;por&nbsp;mais&nbsp;de&nbsp;seis&nbsp;meses,&nbsp;ocorre&nbsp;em,&nbsp;aproximadamente,&nbsp;5%&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_559">559</td><td nowrap="nowrap">seja,&nbsp;a&nbsp;persistência&nbsp;do&nbsp;vírus&nbsp;por&nbsp;mais&nbsp;de&nbsp;seis&nbsp;meses,&nbsp;ocorre&nbsp;em,&nbsp;aproximadamente,&nbsp;5%&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_568">568</td><td nowrap="nowrap">10%&nbsp;dos&nbsp;indivíduos&nbsp;adultos&nbsp;infectados.&nbsp;Caso&nbsp;a&nbsp;infecção&nbsp;ocorra&nbsp;por&nbsp;transmissão&nbsp;vertical,</td><td class="diff_next"></td><td class="diff_header" id="to62_560">560</td><td nowrap="nowrap">10%&nbsp;dos&nbsp;indivíduos&nbsp;adultos&nbsp;infectados.&nbsp;Caso&nbsp;a&nbsp;infecção&nbsp;ocorra&nbsp;por&nbsp;transmissão&nbsp;vertical,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_569">569</td><td nowrap="nowrap">o&nbsp;risco&nbsp;de&nbsp;cronificação&nbsp;dos&nbsp;recém-nascidos&nbsp;de&nbsp;gestantes&nbsp;com&nbsp;evidências&nbsp;de&nbsp;replicação</td><td class="diff_next"></td><td class="diff_header" id="to62_561">561</td><td nowrap="nowrap">o&nbsp;risco&nbsp;de&nbsp;cronificação&nbsp;dos&nbsp;recém-nascidos&nbsp;de&nbsp;gestantes&nbsp;com&nbsp;evidências&nbsp;de&nbsp;replicação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_570">570</td><td nowrap="nowrap">viral&nbsp;(HBeAg&nbsp;reagente&nbsp;e/ou&nbsp;HBV&nbsp;DNA&nbsp;&gt;104)&nbsp;é&nbsp;de&nbsp;cerca&nbsp;de&nbsp;70%&nbsp;a&nbsp;90%,&nbsp;e&nbsp;de&nbsp;10%&nbsp;a&nbsp;40%</td><td class="diff_next"></td><td class="diff_header" id="to62_562">562</td><td nowrap="nowrap">viral&nbsp;(HBeAg&nbsp;reagente&nbsp;e/ou&nbsp;HBV&nbsp;DNA&nbsp;&gt;104)&nbsp;é&nbsp;de&nbsp;cerca&nbsp;de&nbsp;70%&nbsp;a&nbsp;90%,&nbsp;e&nbsp;de&nbsp;10%&nbsp;a&nbsp;40%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_571">571</td><td nowrap="nowrap">nos&nbsp;casos&nbsp;sem&nbsp;evidências&nbsp;de&nbsp;replicação&nbsp;do&nbsp;vírus.&nbsp;Cerca&nbsp;de&nbsp;70%&nbsp;a&nbsp;90%&nbsp;das&nbsp;infecções</td><td class="diff_next"></td><td class="diff_header" id="to62_563">563</td><td nowrap="nowrap">nos&nbsp;casos&nbsp;sem&nbsp;evidências&nbsp;de&nbsp;replicação&nbsp;do&nbsp;vírus.&nbsp;Cerca&nbsp;de&nbsp;70%&nbsp;a&nbsp;90%&nbsp;das&nbsp;infecções</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_572">572</td><td nowrap="nowrap">ocorridas&nbsp;em&nbsp;menores&nbsp;de&nbsp;cinco&nbsp;anos&nbsp;se&nbsp;cronificam,&nbsp;e&nbsp;20%&nbsp;a&nbsp;25%&nbsp;dos&nbsp;casos&nbsp;crônicos</td><td class="diff_next"></td><td class="diff_header" id="to62_564">564</td><td nowrap="nowrap">ocorridas&nbsp;em&nbsp;menores&nbsp;de&nbsp;cinco&nbsp;anos&nbsp;se&nbsp;cronificam,&nbsp;e&nbsp;20%&nbsp;a&nbsp;25%&nbsp;dos&nbsp;casos&nbsp;crônicos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_573">573</td><td nowrap="nowrap">com&nbsp;evidências&nbsp;de&nbsp;replicação&nbsp;viral&nbsp;evoluem&nbsp;para&nbsp;doença&nbsp;hepática&nbsp;avançada&nbsp;(cirrose&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_565">565</td><td nowrap="nowrap">com&nbsp;evidências&nbsp;de&nbsp;replicação&nbsp;viral&nbsp;evoluem&nbsp;para&nbsp;doença&nbsp;hepática&nbsp;avançada&nbsp;(cirrose&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_574">574</td><td nowrap="nowrap">hepatocarcinoma).&nbsp;Uma&nbsp;particularidade&nbsp;dessa&nbsp;infecção&nbsp;viral&nbsp;crônica&nbsp;é&nbsp;a&nbsp;possibilidade&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_566">566</td><td nowrap="nowrap">hepatocarcinoma).&nbsp;Uma&nbsp;particularidade&nbsp;dessa&nbsp;infecção&nbsp;viral&nbsp;crônica&nbsp;é&nbsp;a&nbsp;possibilidade&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_575">575</td><td nowrap="nowrap">evolução&nbsp;para&nbsp;câncer&nbsp;hepático,&nbsp;independentemente&nbsp;da&nbsp;ocorrência&nbsp;de&nbsp;cirrose,&nbsp;fato&nbsp;con-</td><td class="diff_next"></td><td class="diff_header" id="to62_567">567</td><td nowrap="nowrap">evolução&nbsp;para&nbsp;câncer&nbsp;hepático,&nbsp;independentemente&nbsp;da&nbsp;ocorrência&nbsp;de&nbsp;cirrose,&nbsp;fato&nbsp;con-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_576">576</td><td nowrap="nowrap">siderado&nbsp;pré-requisito&nbsp;nos&nbsp;casos&nbsp;de&nbsp;surgimento&nbsp;de&nbsp;carcinoma&nbsp;hepatocelular&nbsp;nas&nbsp;demais</td><td class="diff_next"></td><td class="diff_header" id="to62_568">568</td><td nowrap="nowrap">siderado&nbsp;pré-requisito&nbsp;nos&nbsp;casos&nbsp;de&nbsp;surgimento&nbsp;de&nbsp;carcinoma&nbsp;hepatocelular&nbsp;nas&nbsp;demais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_577">577</td><td nowrap="nowrap">infecções&nbsp;virais&nbsp;crônicas,&nbsp;como&nbsp;a&nbsp;hepatite&nbsp;C.</td><td class="diff_next"></td><td class="diff_header" id="to62_569">569</td><td nowrap="nowrap">infecções&nbsp;virais&nbsp;crônicas,&nbsp;como&nbsp;a&nbsp;hepatite&nbsp;C.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_578">578</td><td nowrap="nowrap">9.1&nbsp;Partícula&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_570">570</td><td nowrap="nowrap">9.1&nbsp;Partícula&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_579">579</td><td nowrap="nowrap">O&nbsp;HBV&nbsp;pertence&nbsp;à&nbsp;família&nbsp;Hepadnaviridae&nbsp;(vírus&nbsp;de&nbsp;DNA&nbsp;hepatotrópicos),&nbsp;que&nbsp;inclui</td><td class="diff_next"></td><td class="diff_header" id="to62_571">571</td><td nowrap="nowrap">O&nbsp;HBV&nbsp;pertence&nbsp;à&nbsp;família&nbsp;Hepadnaviridae&nbsp;(vírus&nbsp;de&nbsp;DNA&nbsp;hepatotrópicos),&nbsp;que&nbsp;inclui</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_580">580</td><td nowrap="nowrap">vírus&nbsp;capazes&nbsp;de&nbsp;infectar&nbsp;diferentes&nbsp;animais.&nbsp;A&nbsp;partícula&nbsp;viral&nbsp;infecciosa&nbsp;do&nbsp;HBV&nbsp;(Figura</td><td class="diff_next"></td><td class="diff_header" id="to62_572">572</td><td nowrap="nowrap">vírus&nbsp;capazes&nbsp;de&nbsp;infectar&nbsp;diferentes&nbsp;animais.&nbsp;A&nbsp;partícula&nbsp;viral&nbsp;infecciosa&nbsp;do&nbsp;HBV&nbsp;(Figura</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_581">581</td><td nowrap="nowrap">5)&nbsp;tem,&nbsp;aproximadamente,&nbsp;42nm&nbsp;e&nbsp;inclui&nbsp;um&nbsp;nucleocapsídeo&nbsp;proteico&nbsp;(HBcAg)&nbsp;de&nbsp;apro-</td><td class="diff_next"></td><td class="diff_header" id="to62_573">573</td><td nowrap="nowrap">5)&nbsp;tem,&nbsp;aproximadamente,&nbsp;42nm&nbsp;e&nbsp;inclui&nbsp;um&nbsp;nucleocapsídeo&nbsp;proteico&nbsp;(HBcAg)&nbsp;de&nbsp;apro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_582">582</td><td nowrap="nowrap">ximadamente&nbsp;27nm.&nbsp;A&nbsp;partícula&nbsp;viral&nbsp;é&nbsp;envolta&nbsp;por&nbsp;um&nbsp;envelope&nbsp;lipoproteico&nbsp;originado</td><td class="diff_next"></td><td class="diff_header" id="to62_574">574</td><td nowrap="nowrap">ximadamente&nbsp;27nm.&nbsp;A&nbsp;partícula&nbsp;viral&nbsp;é&nbsp;envolta&nbsp;por&nbsp;um&nbsp;envelope&nbsp;lipoproteico&nbsp;originado</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_583">583</td><td nowrap="nowrap">da&nbsp;última&nbsp;célula&nbsp;infectada&nbsp;pelo&nbsp;vírus,&nbsp;contendo&nbsp;as&nbsp;três&nbsp;formas&nbsp;do&nbsp;antígeno&nbsp;de&nbsp;superfície</td><td class="diff_next"></td><td class="diff_header" id="to62_575">575</td><td nowrap="nowrap">da&nbsp;última&nbsp;célula&nbsp;infectada&nbsp;pelo&nbsp;vírus,&nbsp;contendo&nbsp;as&nbsp;três&nbsp;formas&nbsp;do&nbsp;antígeno&nbsp;de&nbsp;superfície</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_584">584</td><td nowrap="nowrap">viral&nbsp;(HBsAg).&nbsp;Ainda&nbsp;dentro&nbsp;da&nbsp;partícula,&nbsp;está&nbsp;presente&nbsp;a&nbsp;enzima&nbsp;DNA&nbsp;polimerase&nbsp;viral,</td><td class="diff_next"></td><td class="diff_header" id="to62_576">576</td><td nowrap="nowrap">viral&nbsp;(HBsAg).&nbsp;Ainda&nbsp;dentro&nbsp;da&nbsp;partícula,&nbsp;está&nbsp;presente&nbsp;a&nbsp;enzima&nbsp;DNA&nbsp;polimerase&nbsp;viral,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_585">585</td><td nowrap="nowrap">que&nbsp;irá&nbsp;completar&nbsp;o&nbsp;genoma&nbsp;do&nbsp;vírus&nbsp;durante&nbsp;a&nbsp;infecção&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).</td><td class="diff_next"></td><td class="diff_header" id="to62_577">577</td><td nowrap="nowrap">que&nbsp;irá&nbsp;completar&nbsp;o&nbsp;genoma&nbsp;do&nbsp;vírus&nbsp;durante&nbsp;a&nbsp;infecção&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_586">586</td><td nowrap="nowrap">Figura&nbsp;5.&nbsp;Estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td><td class="diff_next"></td><td class="diff_header" id="to62_578">578</td><td nowrap="nowrap">Figura&nbsp;5.&nbsp;Estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_587">587</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_579">579</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_588">588</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;do&nbsp;HBV&nbsp;(Figura&nbsp;6)&nbsp;é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;DNA&nbsp;parcialmente</td><td class="diff_next"></td><td class="diff_header" id="to62_580">580</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;do&nbsp;HBV&nbsp;(Figura&nbsp;6)&nbsp;é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;DNA&nbsp;parcialmente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_589">589</td><td nowrap="nowrap">duplicada&nbsp;de,&nbsp;aproximadamente,&nbsp;3.200&nbsp;pares&nbsp;de&nbsp;bases&nbsp;(3,2kb).&nbsp;O&nbsp;genoma&nbsp;viral&nbsp;possui</td><td class="diff_next"></td><td class="diff_header" id="to62_581">581</td><td nowrap="nowrap">duplicada&nbsp;de,&nbsp;aproximadamente,&nbsp;3.200&nbsp;pares&nbsp;de&nbsp;bases&nbsp;(3,2kb).&nbsp;O&nbsp;genoma&nbsp;viral&nbsp;possui</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_590">590</td><td nowrap="nowrap">quatro&nbsp;fases&nbsp;de&nbsp;leitura&nbsp;aberta&nbsp;(ORF)&nbsp;para&nbsp;a&nbsp;produção&nbsp;das&nbsp;proteínas&nbsp;virais:&nbsp;capsídeo,&nbsp;en-</td><td class="diff_next"></td><td class="diff_header" id="to62_582">582</td><td nowrap="nowrap">quatro&nbsp;fases&nbsp;de&nbsp;leitura&nbsp;aberta&nbsp;(ORF)&nbsp;para&nbsp;a&nbsp;produção&nbsp;das&nbsp;proteínas&nbsp;virais:&nbsp;capsídeo,&nbsp;en-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_591">591</td><td nowrap="nowrap">velope,&nbsp;DNA&nbsp;polimerase&nbsp;e&nbsp;proteína&nbsp;regulatória&nbsp;X.&nbsp;A&nbsp;tradução&nbsp;do&nbsp;produto&nbsp;da&nbsp;ORF&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_583">583</td><td nowrap="nowrap">velope,&nbsp;DNA&nbsp;polimerase&nbsp;e&nbsp;proteína&nbsp;regulatória&nbsp;X.&nbsp;A&nbsp;tradução&nbsp;do&nbsp;produto&nbsp;da&nbsp;ORF&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_592">592</td><td nowrap="nowrap">codifica&nbsp;a&nbsp;proteína&nbsp;de&nbsp;envelope&nbsp;pode&nbsp;produzir&nbsp;as&nbsp;três&nbsp;formas&nbsp;dessa&nbsp;proteína:&nbsp;pequena</td><td class="diff_next"></td><td class="diff_header" id="to62_584">584</td><td nowrap="nowrap">codifica&nbsp;a&nbsp;proteína&nbsp;de&nbsp;envelope&nbsp;pode&nbsp;produzir&nbsp;as&nbsp;três&nbsp;formas&nbsp;dessa&nbsp;proteína:&nbsp;pequena</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_593">593</td><td nowrap="nowrap">(pré-S1),&nbsp;média&nbsp;(pré-S2)&nbsp;e&nbsp;grande&nbsp;(S).&nbsp;As&nbsp;três&nbsp;formas&nbsp;da&nbsp;proteína&nbsp;de&nbsp;envelope&nbsp;do&nbsp;vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_585">585</td><td nowrap="nowrap">(pré-S1),&nbsp;média&nbsp;(pré-S2)&nbsp;e&nbsp;grande&nbsp;(S).&nbsp;As&nbsp;três&nbsp;formas&nbsp;da&nbsp;proteína&nbsp;de&nbsp;envelope&nbsp;do&nbsp;vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_594">594</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;dão&nbsp;origem&nbsp;ao&nbsp;antígeno&nbsp;“s”&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg).&nbsp;A&nbsp;ORF&nbsp;da&nbsp;proteína</td><td class="diff_next"></td><td class="diff_header" id="to62_586">586</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;dão&nbsp;origem&nbsp;ao&nbsp;antígeno&nbsp;“s”&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg).&nbsp;A&nbsp;ORF&nbsp;da&nbsp;proteína</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_595">595</td><td nowrap="nowrap">de&nbsp;capsídeo&nbsp;pode&nbsp;ser&nbsp;traduzida&nbsp;tanto&nbsp;na&nbsp;região&nbsp;pré-core&nbsp;(PréC)&nbsp;quanto&nbsp;na&nbsp;região&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_587">587</td><td nowrap="nowrap">de&nbsp;capsídeo&nbsp;pode&nbsp;ser&nbsp;traduzida&nbsp;tanto&nbsp;na&nbsp;região&nbsp;pré-core&nbsp;(PréC)&nbsp;quanto&nbsp;na&nbsp;região&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_596">596</td><td nowrap="nowrap">capsídeo&nbsp;(ou&nbsp;core).&nbsp;Os&nbsp;produtos&nbsp;de&nbsp;PréC&nbsp;são&nbsp;processados&nbsp;no&nbsp;retículo&nbsp;endoplasmático&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_588">588</td><td nowrap="nowrap">capsídeo&nbsp;(ou&nbsp;core).&nbsp;Os&nbsp;produtos&nbsp;de&nbsp;PréC&nbsp;são&nbsp;processados&nbsp;no&nbsp;retículo&nbsp;endoplasmático&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_597">597</td><td nowrap="nowrap">um&nbsp;dos&nbsp;produtos&nbsp;de&nbsp;processamento&nbsp;é&nbsp;secretado&nbsp;da&nbsp;célula,&nbsp;dando&nbsp;origem&nbsp;ao&nbsp;antígeno</td><td class="diff_next"></td><td class="diff_header" id="to62_589">589</td><td nowrap="nowrap">um&nbsp;dos&nbsp;produtos&nbsp;de&nbsp;processamento&nbsp;é&nbsp;secretado&nbsp;da&nbsp;célula,&nbsp;dando&nbsp;origem&nbsp;ao&nbsp;antígeno</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_598">598</td><td nowrap="nowrap">“e”&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBeAg)&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007;&nbsp;LIANG,&nbsp;2009).</td><td class="diff_next"></td><td class="diff_header" id="to62_590">590</td><td nowrap="nowrap">“e”&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBeAg)&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007;&nbsp;LIANG,&nbsp;2009).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_599">599</td><td nowrap="nowrap">9.2&nbsp;Variabilidade&nbsp;genética</td><td class="diff_next"></td><td class="diff_header" id="to62_591">591</td><td nowrap="nowrap">9.2&nbsp;Variabilidade&nbsp;genética</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_600">600</td><td nowrap="nowrap">Apesar&nbsp;de&nbsp;o&nbsp;HBV&nbsp;ser&nbsp;um&nbsp;vírus&nbsp;de&nbsp;DNA,&nbsp;a&nbsp;ausência&nbsp;de&nbsp;atividade&nbsp;revisora&nbsp;da&nbsp;DNA</td><td class="diff_next"></td><td class="diff_header" id="to62_592">592</td><td nowrap="nowrap">Apesar&nbsp;de&nbsp;o&nbsp;HBV&nbsp;ser&nbsp;um&nbsp;vírus&nbsp;de&nbsp;DNA,&nbsp;a&nbsp;ausência&nbsp;de&nbsp;atividade&nbsp;revisora&nbsp;da&nbsp;DNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_601">601</td><td nowrap="nowrap">polimerase&nbsp;viral&nbsp;(que&nbsp;também&nbsp;tem&nbsp;função&nbsp;de&nbsp;transcriptase&nbsp;reversa)&nbsp;lhe&nbsp;confere&nbsp;uma</td><td class="diff_next"></td><td class="diff_header" id="to62_593">593</td><td nowrap="nowrap">polimerase&nbsp;viral&nbsp;(que&nbsp;também&nbsp;tem&nbsp;função&nbsp;de&nbsp;transcriptase&nbsp;reversa)&nbsp;lhe&nbsp;confere&nbsp;uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_602">602</td><td nowrap="nowrap">grande&nbsp;diversidade&nbsp;genética.&nbsp;O&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;complexo,&nbsp;contando&nbsp;com&nbsp;quatro&nbsp;fases</td><td class="diff_next"></td><td class="diff_header" id="to62_594">594</td><td nowrap="nowrap">grande&nbsp;diversidade&nbsp;genética.&nbsp;O&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;complexo,&nbsp;contando&nbsp;com&nbsp;quatro&nbsp;fases</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_603">603</td><td nowrap="nowrap">de&nbsp;leitura&nbsp;aberta&nbsp;sobrepostas&nbsp;que&nbsp;codificam&nbsp;as&nbsp;proteínas&nbsp;virais&nbsp;(Figura&nbsp;6).&nbsp;São&nbsp;identifi-</td><td class="diff_next"></td><td class="diff_header" id="to62_595">595</td><td nowrap="nowrap">de&nbsp;leitura&nbsp;aberta&nbsp;sobrepostas&nbsp;que&nbsp;codificam&nbsp;as&nbsp;proteínas&nbsp;virais&nbsp;(Figura&nbsp;6).&nbsp;São&nbsp;identifi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_604">604</td><td nowrap="nowrap">cados&nbsp;oito&nbsp;genótipos&nbsp;do&nbsp;vírus,&nbsp;denominados&nbsp;pelas&nbsp;letras&nbsp;de&nbsp;A&nbsp;até&nbsp;J,&nbsp;com&nbsp;distribuição</td><td class="diff_next"></td><td class="diff_header" id="to62_596">596</td><td nowrap="nowrap">cados&nbsp;oito&nbsp;genótipos&nbsp;do&nbsp;vírus,&nbsp;denominados&nbsp;pelas&nbsp;letras&nbsp;de&nbsp;A&nbsp;até&nbsp;J,&nbsp;com&nbsp;distribuição</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_605">605</td><td nowrap="nowrap">geográfica&nbsp;distinta,&nbsp;podendo&nbsp;apresentar&nbsp;uma&nbsp;divergência&nbsp;de&nbsp;8%&nbsp;ou&nbsp;mais&nbsp;em&nbsp;relação&nbsp;às</td><td class="diff_next"></td><td class="diff_header" id="to62_597">597</td><td nowrap="nowrap">geográfica&nbsp;distinta,&nbsp;podendo&nbsp;apresentar&nbsp;uma&nbsp;divergência&nbsp;de&nbsp;8%&nbsp;ou&nbsp;mais&nbsp;em&nbsp;relação&nbsp;às</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_606">606</td><td nowrap="nowrap">suas&nbsp;sequências&nbsp;nucleotídicas&nbsp;completas&nbsp;(MELLO&nbsp;et&nbsp;al.,&nbsp;2007;&nbsp;SABLON;&nbsp;SHAPIRO,&nbsp;2005;</td><td class="diff_next"></td><td class="diff_header" id="to62_598">598</td><td nowrap="nowrap">suas&nbsp;sequências&nbsp;nucleotídicas&nbsp;completas&nbsp;(MELLO&nbsp;et&nbsp;al.,&nbsp;2007;&nbsp;SABLON;&nbsp;SHAPIRO,&nbsp;2005;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_607">607</td><td nowrap="nowrap">TATEMATSU&nbsp;et&nbsp;al.,&nbsp;2009;&nbsp;TRAN;&nbsp;TRINH;&nbsp;ABE,&nbsp;2008).</td><td class="diff_next"></td><td class="diff_header" id="to62_599">599</td><td nowrap="nowrap">TATEMATSU&nbsp;et&nbsp;al.,&nbsp;2009;&nbsp;TRAN;&nbsp;TRINH;&nbsp;ABE,&nbsp;2008).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_608">608</td><td nowrap="nowrap">Figura&nbsp;6.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;organização&nbsp;genômica&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td><td class="diff_next"></td><td class="diff_header" id="to62_600">600</td><td nowrap="nowrap">Figura&nbsp;6.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;organização&nbsp;genômica&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_609">609</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_601">601</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_610">610</td><td nowrap="nowrap">Nota:&nbsp;o&nbsp;esquema&nbsp;mostra&nbsp;as&nbsp;fases&nbsp;de&nbsp;leitura&nbsp;aberta&nbsp;(open&nbsp;reading&nbsp;frames&nbsp;-&nbsp;ORF)&nbsp;existentes.</td><td class="diff_next"></td><td class="diff_header" id="to62_602">602</td><td nowrap="nowrap">Nota:&nbsp;o&nbsp;esquema&nbsp;mostra&nbsp;as&nbsp;fases&nbsp;de&nbsp;leitura&nbsp;aberta&nbsp;(open&nbsp;reading&nbsp;frames&nbsp;-&nbsp;ORF)&nbsp;existentes.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_611">611</td><td nowrap="nowrap">A&nbsp;história&nbsp;evolutiva&nbsp;do&nbsp;HBV&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;totalmente&nbsp;elucidada,&nbsp;mas&nbsp;estudos&nbsp;basea-</td><td class="diff_next"></td><td class="diff_header" id="to62_603">603</td><td nowrap="nowrap">A&nbsp;história&nbsp;evolutiva&nbsp;do&nbsp;HBV&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;totalmente&nbsp;elucidada,&nbsp;mas&nbsp;estudos&nbsp;basea-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_612">612</td><td nowrap="nowrap">dos&nbsp;em&nbsp;reconstruções&nbsp;filogenéticas&nbsp;do&nbsp;vírus&nbsp;estimam&nbsp;que&nbsp;a&nbsp;divergência&nbsp;entre&nbsp;os&nbsp;sub-</td><td class="diff_next"></td><td class="diff_header" id="to62_604">604</td><td nowrap="nowrap">dos&nbsp;em&nbsp;reconstruções&nbsp;filogenéticas&nbsp;do&nbsp;vírus&nbsp;estimam&nbsp;que&nbsp;a&nbsp;divergência&nbsp;entre&nbsp;os&nbsp;sub-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_613">613</td><td nowrap="nowrap">tipos&nbsp;tenha&nbsp;ocorrido&nbsp;há&nbsp;menos&nbsp;de&nbsp;6.000&nbsp;anos.&nbsp;Ainda&nbsp;são&nbsp;necessárias&nbsp;análises&nbsp;extensas</td><td class="diff_next"></td><td class="diff_header" id="to62_605">605</td><td nowrap="nowrap">tipos&nbsp;tenha&nbsp;ocorrido&nbsp;há&nbsp;menos&nbsp;de&nbsp;6.000&nbsp;anos.&nbsp;Ainda&nbsp;são&nbsp;necessárias&nbsp;análises&nbsp;extensas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_614">614</td><td nowrap="nowrap">para&nbsp;que&nbsp;as&nbsp;divergências&nbsp;evolutivas&nbsp;do&nbsp;vírus&nbsp;sejam&nbsp;identificadas&nbsp;(GÜNTHER,&nbsp;2006).</td><td class="diff_next"></td><td class="diff_header" id="to62_606">606</td><td nowrap="nowrap">para&nbsp;que&nbsp;as&nbsp;divergências&nbsp;evolutivas&nbsp;do&nbsp;vírus&nbsp;sejam&nbsp;identificadas&nbsp;(GÜNTHER,&nbsp;2006).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_615">615</td><td nowrap="nowrap">Segundo&nbsp;estimativas&nbsp;baseadas&nbsp;em&nbsp;doadores&nbsp;de&nbsp;sangue,&nbsp;a&nbsp;distribuição&nbsp;dos&nbsp;genóti-</td><td class="diff_next"></td><td class="diff_header" id="to62_607">607</td><td nowrap="nowrap">Segundo&nbsp;estimativas&nbsp;baseadas&nbsp;em&nbsp;doadores&nbsp;de&nbsp;sangue,&nbsp;a&nbsp;distribuição&nbsp;dos&nbsp;genóti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_616">616</td><td nowrap="nowrap">pos&nbsp;no&nbsp;Brasil&nbsp;é&nbsp;variada,&nbsp;com&nbsp;circulação&nbsp;predominante&nbsp;dos&nbsp;genótipos&nbsp;A,&nbsp;D&nbsp;e&nbsp;F&nbsp;(ARAÚJO</td><td class="diff_next"></td><td class="diff_header" id="to62_608">608</td><td nowrap="nowrap">pos&nbsp;no&nbsp;Brasil&nbsp;é&nbsp;variada,&nbsp;com&nbsp;circulação&nbsp;predominante&nbsp;dos&nbsp;genótipos&nbsp;A,&nbsp;D&nbsp;e&nbsp;F&nbsp;(ARAÚJO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_617">617</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2004;&nbsp;MELLO&nbsp;et&nbsp;al.,&nbsp;2007).</td><td class="diff_next"></td><td class="diff_header" id="to62_609">609</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2004;&nbsp;MELLO&nbsp;et&nbsp;al.,&nbsp;2007).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_618">618</td><td nowrap="nowrap">9.3&nbsp;Ciclo&nbsp;replicativo</td><td class="diff_next"></td><td class="diff_header" id="to62_610">610</td><td nowrap="nowrap">9.3&nbsp;Ciclo&nbsp;replicativo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_619">619</td><td nowrap="nowrap">O&nbsp;HBV&nbsp;é&nbsp;capaz&nbsp;de&nbsp;infectar,&nbsp;primariamente,&nbsp;células&nbsp;hepáticas.&nbsp;Os&nbsp;receptores&nbsp;de&nbsp;mem-</td><td class="diff_next"></td><td class="diff_header" id="to62_611">611</td><td nowrap="nowrap">O&nbsp;HBV&nbsp;é&nbsp;capaz&nbsp;de&nbsp;infectar,&nbsp;primariamente,&nbsp;células&nbsp;hepáticas.&nbsp;Os&nbsp;receptores&nbsp;de&nbsp;mem-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_620">620</td><td nowrap="nowrap">brana&nbsp;usados&nbsp;pelo&nbsp;vírus&nbsp;ainda&nbsp;não&nbsp;estão&nbsp;completamente&nbsp;elucidados.&nbsp;O&nbsp;ciclo&nbsp;replicativo</td><td class="diff_next"></td><td class="diff_header" id="to62_612">612</td><td nowrap="nowrap">brana&nbsp;usados&nbsp;pelo&nbsp;vírus&nbsp;ainda&nbsp;não&nbsp;estão&nbsp;completamente&nbsp;elucidados.&nbsp;O&nbsp;ciclo&nbsp;replicativo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_621">621</td><td nowrap="nowrap">viral&nbsp;encontra-se&nbsp;esquematicamente&nbsp;representado&nbsp;na&nbsp;Figura&nbsp;7.&nbsp;Após&nbsp;o&nbsp;reconhecimento</td><td class="diff_next"></td><td class="diff_header" id="to62_613">613</td><td nowrap="nowrap">viral&nbsp;encontra-se&nbsp;esquematicamente&nbsp;representado&nbsp;na&nbsp;Figura&nbsp;7.&nbsp;Após&nbsp;o&nbsp;reconhecimento</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_622">622</td><td nowrap="nowrap">dos&nbsp;receptores,&nbsp;a&nbsp;partícula&nbsp;viral&nbsp;é&nbsp;internalizada&nbsp;por&nbsp;endocitose,&nbsp;o&nbsp;envelope&nbsp;viral&nbsp;é&nbsp;remo-</td><td class="diff_next"></td><td class="diff_header" id="to62_614">614</td><td nowrap="nowrap">dos&nbsp;receptores,&nbsp;a&nbsp;partícula&nbsp;viral&nbsp;é&nbsp;internalizada&nbsp;por&nbsp;endocitose,&nbsp;o&nbsp;envelope&nbsp;viral&nbsp;é&nbsp;remo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_623">623</td><td nowrap="nowrap">vido&nbsp;e&nbsp;o&nbsp;capsídeo&nbsp;é&nbsp;liberado&nbsp;no&nbsp;citoplasma.&nbsp;Após&nbsp;ser&nbsp;transportado&nbsp;para&nbsp;o&nbsp;poro&nbsp;nuclear,</td><td class="diff_next"></td><td class="diff_header" id="to62_615">615</td><td nowrap="nowrap">vido&nbsp;e&nbsp;o&nbsp;capsídeo&nbsp;é&nbsp;liberado&nbsp;no&nbsp;citoplasma.&nbsp;Após&nbsp;ser&nbsp;transportado&nbsp;para&nbsp;o&nbsp;poro&nbsp;nuclear,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_624">624</td><td nowrap="nowrap">o&nbsp;capsídeo&nbsp;libera&nbsp;o&nbsp;genoma&nbsp;no&nbsp;interior&nbsp;do&nbsp;núcleo&nbsp;celular.&nbsp;Uma&nbsp;vez&nbsp;no&nbsp;núcleo,&nbsp;o&nbsp;genoma</td><td class="diff_next"></td><td class="diff_header" id="to62_616">616</td><td nowrap="nowrap">o&nbsp;capsídeo&nbsp;libera&nbsp;o&nbsp;genoma&nbsp;no&nbsp;interior&nbsp;do&nbsp;núcleo&nbsp;celular.&nbsp;Uma&nbsp;vez&nbsp;no&nbsp;núcleo,&nbsp;o&nbsp;genoma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_625">625</td><td nowrap="nowrap">covalentemente&nbsp;fechado&nbsp;(cccDNA,&nbsp;do&nbsp;inglês&nbsp;circular&nbsp;covalently&nbsp;closed&nbsp;DNA).&nbsp;Essas&nbsp;molé-</td><td class="diff_next"></td><td class="diff_header" id="to62_617">617</td><td nowrap="nowrap">covalentemente&nbsp;fechado&nbsp;(cccDNA,&nbsp;do&nbsp;inglês&nbsp;circular&nbsp;covalently&nbsp;closed&nbsp;DNA).&nbsp;Essas&nbsp;molé-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_626">626</td><td nowrap="nowrap">culas&nbsp;se&nbsp;mantêm&nbsp;de&nbsp;forma&nbsp;epissômica&nbsp;no&nbsp;núcleo&nbsp;celular&nbsp;e&nbsp;são&nbsp;usadas&nbsp;pela&nbsp;RNA&nbsp;polime-</td><td class="diff_next"></td><td class="diff_header" id="to62_618">618</td><td nowrap="nowrap">culas&nbsp;se&nbsp;mantêm&nbsp;de&nbsp;forma&nbsp;epissômica&nbsp;no&nbsp;núcleo&nbsp;celular&nbsp;e&nbsp;são&nbsp;usadas&nbsp;pela&nbsp;RNA&nbsp;polime-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_627">627</td><td nowrap="nowrap">rase&nbsp;II&nbsp;celular&nbsp;para&nbsp;transcrever&nbsp;RNA&nbsp;mensageiros&nbsp;pré-genômicos&nbsp;e&nbsp;subgenômicos,&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_619">619</td><td nowrap="nowrap">rase&nbsp;II&nbsp;celular&nbsp;para&nbsp;transcrever&nbsp;RNA&nbsp;mensageiros&nbsp;pré-genômicos&nbsp;e&nbsp;subgenômicos,&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_628">628</td><td nowrap="nowrap">são&nbsp;transportados&nbsp;ao&nbsp;citoplasma&nbsp;para&nbsp;ser&nbsp;traduzidos&nbsp;em&nbsp;proteínas&nbsp;virais.&nbsp;Essas&nbsp;últimas</td><td class="diff_next"></td><td class="diff_header" id="to62_620">620</td><td nowrap="nowrap">são&nbsp;transportados&nbsp;ao&nbsp;citoplasma&nbsp;para&nbsp;ser&nbsp;traduzidos&nbsp;em&nbsp;proteínas&nbsp;virais.&nbsp;Essas&nbsp;últimas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_629">629</td><td nowrap="nowrap">são&nbsp;usadas&nbsp;para&nbsp;a&nbsp;produção&nbsp;de&nbsp;novas&nbsp;partículas&nbsp;virais,&nbsp;ou&nbsp;são&nbsp;encapsuladas&nbsp;nas&nbsp;partícu-</td><td class="diff_next"></td><td class="diff_header" id="to62_621">621</td><td nowrap="nowrap">são&nbsp;usadas&nbsp;para&nbsp;a&nbsp;produção&nbsp;de&nbsp;novas&nbsp;partículas&nbsp;virais,&nbsp;ou&nbsp;são&nbsp;encapsuladas&nbsp;nas&nbsp;partícu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_630">630</td><td nowrap="nowrap">las&nbsp;nascentes&nbsp;junto&nbsp;à&nbsp;polimerase&nbsp;viral&nbsp;para,&nbsp;então,&nbsp;serem&nbsp;submetidas&nbsp;a&nbsp;retrotranscrição,</td><td class="diff_next"></td><td class="diff_header" id="to62_622">622</td><td nowrap="nowrap">las&nbsp;nascentes&nbsp;junto&nbsp;à&nbsp;polimerase&nbsp;viral&nbsp;para,&nbsp;então,&nbsp;serem&nbsp;submetidas&nbsp;a&nbsp;retrotranscrição,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_631">631</td><td nowrap="nowrap">gerando&nbsp;assim&nbsp;novos&nbsp;genomas&nbsp;virais&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).</td><td class="diff_next"></td><td class="diff_header" id="to62_623">623</td><td nowrap="nowrap">gerando&nbsp;assim&nbsp;novos&nbsp;genomas&nbsp;virais&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_632">632</td><td nowrap="nowrap">Figura&nbsp;7.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td><td class="diff_next"></td><td class="diff_header" id="to62_624">624</td><td nowrap="nowrap">Figura&nbsp;7.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_633">633</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;GERLICH,&nbsp;2013.</td><td class="diff_next"></td><td class="diff_header" id="to62_625">625</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;GERLICH,&nbsp;2013.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_634">634</td><td nowrap="nowrap">Os&nbsp;capsídeos&nbsp;virais&nbsp;montados&nbsp;podem&nbsp;migrar&nbsp;novamente&nbsp;para&nbsp;o&nbsp;núcleo,&nbsp;liberando</td><td class="diff_next"></td><td class="diff_header" id="to62_626">626</td><td nowrap="nowrap">Os&nbsp;capsídeos&nbsp;virais&nbsp;montados&nbsp;podem&nbsp;migrar&nbsp;novamente&nbsp;para&nbsp;o&nbsp;núcleo,&nbsp;liberando</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_635">635</td><td nowrap="nowrap">novos&nbsp;genomas&nbsp;virais&nbsp;no&nbsp;nucleoplasma,&nbsp;ou&nbsp;podem&nbsp;ser&nbsp;usados&nbsp;para&nbsp;a&nbsp;montagem&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_627">627</td><td nowrap="nowrap">novos&nbsp;genomas&nbsp;virais&nbsp;no&nbsp;nucleoplasma,&nbsp;ou&nbsp;podem&nbsp;ser&nbsp;usados&nbsp;para&nbsp;a&nbsp;montagem&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_636">636</td><td nowrap="nowrap">novos&nbsp;vírions&nbsp;em&nbsp;corpos&nbsp;multivesiculares,&nbsp;que&nbsp;serão&nbsp;liberados&nbsp;no&nbsp;meio&nbsp;extracelular.</td><td class="diff_next"></td><td class="diff_header" id="to62_628">628</td><td nowrap="nowrap">novos&nbsp;vírions&nbsp;em&nbsp;corpos&nbsp;multivesiculares,&nbsp;que&nbsp;serão&nbsp;liberados&nbsp;no&nbsp;meio&nbsp;extracelular.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_637">637</td><td nowrap="nowrap">Adicionalmente,&nbsp;partículas&nbsp;subvirais&nbsp;são&nbsp;liberadas&nbsp;pela&nbsp;via&nbsp;trans-Golgi.&nbsp;Tais&nbsp;partículas</td><td class="diff_next"></td><td class="diff_header" id="to62_629">629</td><td nowrap="nowrap">Adicionalmente,&nbsp;partículas&nbsp;subvirais&nbsp;são&nbsp;liberadas&nbsp;pela&nbsp;via&nbsp;trans-Golgi.&nbsp;Tais&nbsp;partículas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_638">638</td><td nowrap="nowrap">podem&nbsp;ser&nbsp;filamentosas&nbsp;ou&nbsp;esféricas&nbsp;e,&nbsp;diferentemente&nbsp;da&nbsp;partícula&nbsp;de&nbsp;Dane&nbsp;(partícula</td><td class="diff_next"></td><td class="diff_header" id="to62_630">630</td><td nowrap="nowrap">podem&nbsp;ser&nbsp;filamentosas&nbsp;ou&nbsp;esféricas&nbsp;e,&nbsp;diferentemente&nbsp;da&nbsp;partícula&nbsp;de&nbsp;Dane&nbsp;(partícula</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_639">639</td><td nowrap="nowrap">viral&nbsp;completa),&nbsp;não&nbsp;são&nbsp;infecciosas&nbsp;(Figura&nbsp;8).&nbsp;Essas&nbsp;partículas&nbsp;subvirais&nbsp;correspondem</td><td class="diff_next"></td><td class="diff_header" id="to62_631">631</td><td nowrap="nowrap">viral&nbsp;completa),&nbsp;não&nbsp;são&nbsp;infecciosas&nbsp;(Figura&nbsp;8).&nbsp;Essas&nbsp;partículas&nbsp;subvirais&nbsp;correspondem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_640">640</td><td nowrap="nowrap">HBV&nbsp;(GERLICH,&nbsp;2013;&nbsp;LEE;&nbsp;AHN,&nbsp;2011).</td><td class="diff_next"></td><td class="diff_header" id="to62_632">632</td><td nowrap="nowrap">HBV&nbsp;(GERLICH,&nbsp;2013;&nbsp;LEE;&nbsp;AHN,&nbsp;2011).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_641">641</td><td nowrap="nowrap">Figura&nbsp;8.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;estrutura&nbsp;das&nbsp;partículas&nbsp;virais&nbsp;e&nbsp;subvirais&nbsp;do&nbsp;vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_633">633</td><td nowrap="nowrap">Figura&nbsp;8.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;estrutura&nbsp;das&nbsp;partículas&nbsp;virais&nbsp;e&nbsp;subvirais&nbsp;do&nbsp;vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_642">642</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(HBV)</td><td class="diff_next"></td><td class="diff_header" id="to62_634">634</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_643">643</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;LEE;&nbsp;AHN,&nbsp;2011.</td><td class="diff_next"></td><td class="diff_header" id="to62_635">635</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;LEE;&nbsp;AHN,&nbsp;2011.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_644">644</td><td nowrap="nowrap">9.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td><td class="diff_next"></td><td class="diff_header" id="to62_636">636</td><td nowrap="nowrap">9.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_645">645</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;B&nbsp;pode&nbsp;se&nbsp;apresentar&nbsp;de&nbsp;forma&nbsp;aguda&nbsp;ou&nbsp;crônica&nbsp;nos&nbsp;indivíduos&nbsp;infec-</td><td class="diff_next"></td><td class="diff_header" id="to62_637">637</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;B&nbsp;pode&nbsp;se&nbsp;apresentar&nbsp;de&nbsp;forma&nbsp;aguda&nbsp;ou&nbsp;crônica&nbsp;nos&nbsp;indivíduos&nbsp;infec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_646">646</td><td nowrap="nowrap">tados.&nbsp;As&nbsp;hepatites&nbsp;agudas&nbsp;benignas&nbsp;costumam&nbsp;ser&nbsp;identificadas&nbsp;pelo&nbsp;aumento&nbsp;dos</td><td class="diff_next"></td><td class="diff_header" id="to62_638">638</td><td nowrap="nowrap">tados.&nbsp;As&nbsp;hepatites&nbsp;agudas&nbsp;benignas&nbsp;costumam&nbsp;ser&nbsp;identificadas&nbsp;pelo&nbsp;aumento&nbsp;dos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_647">647</td><td nowrap="nowrap">níveis&nbsp;séricos&nbsp;das&nbsp;aminotransferases,&nbsp;o&nbsp;que&nbsp;leva&nbsp;o&nbsp;indivíduo&nbsp;a&nbsp;apresentar&nbsp;sintomas&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_639">639</td><td nowrap="nowrap">níveis&nbsp;séricos&nbsp;das&nbsp;aminotransferases,&nbsp;o&nbsp;que&nbsp;leva&nbsp;o&nbsp;indivíduo&nbsp;a&nbsp;apresentar&nbsp;sintomas&nbsp;de</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__14"></td><td class="diff_header" id="from62_648">648</td><td nowrap="nowrap">uma&nbsp;infecção&nbsp;viral&nbsp;inespecífica,&nbsp;com&nbsp;leves&nbsp;alterações&nbsp;gastrintestinais.&nbsp;Após&nbsp;essa&nbsp;fase&nbsp;ini-</td><td class="diff_next"></td><td class="diff_header" id="to62_640">640</td><td nowrap="nowrap">uma&nbsp;infecção&nbsp;viral&nbsp;inespecífica,&nbsp;com&nbsp;leves&nbsp;alterações&nbsp;gastrintestinais.&nbsp;Após&nbsp;essa&nbsp;fase&nbsp;ini-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_649">649</td><td nowrap="nowrap">cial,&nbsp;pode&nbsp;ocorrer&nbsp;a&nbsp;forma&nbsp;ictérica&nbsp;da&nbsp;doença,&nbsp;seguida&nbsp;de&nbsp;uma&nbsp;fase&nbsp;de&nbsp;convalescença,</td><td class="diff_next"></td><td class="diff_header" id="to62_641">641</td><td nowrap="nowrap">cial,&nbsp;pode&nbsp;ocorrer&nbsp;a&nbsp;forma&nbsp;ictérica&nbsp;da&nbsp;doença,&nbsp;seguida&nbsp;de&nbsp;uma&nbsp;fase&nbsp;de&nbsp;convalescença,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_650">650</td><td nowrap="nowrap">com&nbsp;melhora&nbsp;progressiva&nbsp;do&nbsp;quadro&nbsp;clínico&nbsp;do&nbsp;indivíduo&nbsp;(GONÇALVES&nbsp;JUNIOR,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_642">642</td><td nowrap="nowrap">com&nbsp;melhora&nbsp;progressiva&nbsp;do&nbsp;quadro&nbsp;clínico&nbsp;do&nbsp;indivíduo&nbsp;(GONÇALVES&nbsp;JUNIOR,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_651">651</td><td nowrap="nowrap">Tipicamente,&nbsp;durante&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;aguda,&nbsp;o&nbsp;DNA&nbsp;viral&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;no&nbsp;sangue</td><td class="diff_next"></td><td class="diff_header" id="to62_643">643</td><td nowrap="nowrap">Tipicamente,&nbsp;durante&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;aguda,&nbsp;o&nbsp;DNA&nbsp;viral&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;no&nbsp;sangue</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_652">652</td><td nowrap="nowrap">com&nbsp;o&nbsp;uso&nbsp;de&nbsp;técnicas&nbsp;moleculares&nbsp;durante&nbsp;um&nbsp;período&nbsp;de&nbsp;um&nbsp;mês&nbsp;a&nbsp;partir&nbsp;da&nbsp;infecção.</td><td class="diff_next"></td><td class="diff_header" id="to62_644">644</td><td nowrap="nowrap">com&nbsp;o&nbsp;uso&nbsp;de&nbsp;técnicas&nbsp;moleculares&nbsp;durante&nbsp;um&nbsp;período&nbsp;de&nbsp;um&nbsp;mês&nbsp;a&nbsp;partir&nbsp;da&nbsp;infecção.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__15">n</a></td><td class="diff_header" id="from62_653">653</td><td nowrap="nowrap">No&nbsp;entanto,&nbsp;por&nbsp;um&nbsp;período&nbsp;de&nbsp;seis&nbsp;semanas,&nbsp;esses&nbsp;níveis&nbsp;serão&nbsp;relativamente&nbsp;baixos&nbsp;<span class="diff_chg">–</span></td><td class="diff_next"><a href="#difflib_chg_to62__15">n</a></td><td class="diff_header" id="to62_645">645</td><td nowrap="nowrap">No&nbsp;entanto,&nbsp;por&nbsp;um&nbsp;período&nbsp;de&nbsp;seis&nbsp;semanas,&nbsp;esses&nbsp;níveis&nbsp;serão&nbsp;relativamente&nbsp;baixos&nbsp;<span class="diff_chg">-</span></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_654">654</td><td nowrap="nowrap">102&nbsp;a&nbsp;104&nbsp;cópias&nbsp;de&nbsp;genoma&nbsp;viral&nbsp;por&nbsp;mililitro.&nbsp;Os&nbsp;picos&nbsp;de&nbsp;detecção&nbsp;para&nbsp;o&nbsp;DNA&nbsp;do&nbsp;HBV</td><td class="diff_next"></td><td class="diff_header" id="to62_646">646</td><td nowrap="nowrap">102&nbsp;a&nbsp;104&nbsp;cópias&nbsp;de&nbsp;genoma&nbsp;viral&nbsp;por&nbsp;mililitro.&nbsp;Os&nbsp;picos&nbsp;de&nbsp;detecção&nbsp;para&nbsp;o&nbsp;DNA&nbsp;do&nbsp;HBV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_655">655</td><td nowrap="nowrap">e&nbsp;dos&nbsp;antígenos&nbsp;virais&nbsp;(HBeAg&nbsp;e&nbsp;HBsAg)&nbsp;acontecem&nbsp;após&nbsp;esse&nbsp;período&nbsp;de&nbsp;seis&nbsp;semanas.&nbsp;A</td><td class="diff_next"></td><td class="diff_header" id="to62_647">647</td><td nowrap="nowrap">e&nbsp;dos&nbsp;antígenos&nbsp;virais&nbsp;(HBeAg&nbsp;e&nbsp;HBsAg)&nbsp;acontecem&nbsp;após&nbsp;esse&nbsp;período&nbsp;de&nbsp;seis&nbsp;semanas.&nbsp;A</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_656">656</td><td nowrap="nowrap">presença&nbsp;dos&nbsp;antígenos&nbsp;virais&nbsp;é&nbsp;variável&nbsp;e,&nbsp;dependendo&nbsp;da&nbsp;fase&nbsp;da&nbsp;doença,&nbsp;eles&nbsp;poderão</td><td class="diff_next"></td><td class="diff_header" id="to62_648">648</td><td nowrap="nowrap">presença&nbsp;dos&nbsp;antígenos&nbsp;virais&nbsp;é&nbsp;variável&nbsp;e,&nbsp;dependendo&nbsp;da&nbsp;fase&nbsp;da&nbsp;doença,&nbsp;eles&nbsp;poderão</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_657">657</td><td nowrap="nowrap">não&nbsp;ser&nbsp;detectados&nbsp;(ASPINALL&nbsp;et&nbsp;al.,&nbsp;2011).&nbsp;A&nbsp;primeira&nbsp;resposta&nbsp;humoral,&nbsp;normalmente,</td><td class="diff_next"></td><td class="diff_header" id="to62_649">649</td><td nowrap="nowrap">não&nbsp;ser&nbsp;detectados&nbsp;(ASPINALL&nbsp;et&nbsp;al.,&nbsp;2011).&nbsp;A&nbsp;primeira&nbsp;resposta&nbsp;humoral,&nbsp;normalmente,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_658">658</td><td nowrap="nowrap">ocorre&nbsp;contra&nbsp;o&nbsp;antígeno&nbsp;core&nbsp;do&nbsp;HBV&nbsp;(HBcAg)&nbsp;e&nbsp;os&nbsp;anticorpos&nbsp;IgM&nbsp;surgem&nbsp;precoce-</td><td class="diff_next"></td><td class="diff_header" id="to62_650">650</td><td nowrap="nowrap">ocorre&nbsp;contra&nbsp;o&nbsp;antígeno&nbsp;core&nbsp;do&nbsp;HBV&nbsp;(HBcAg)&nbsp;e&nbsp;os&nbsp;anticorpos&nbsp;IgM&nbsp;surgem&nbsp;precoce-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_659">659</td><td nowrap="nowrap">mente.&nbsp;Mais&nbsp;tardiamente,&nbsp;surgem&nbsp;os&nbsp;anticorpos&nbsp;IgG-Anti-HBc,&nbsp;que&nbsp;persistem&nbsp;por&nbsp;toda&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_651">651</td><td nowrap="nowrap">mente.&nbsp;Mais&nbsp;tardiamente,&nbsp;surgem&nbsp;os&nbsp;anticorpos&nbsp;IgG-Anti-HBc,&nbsp;que&nbsp;persistem&nbsp;por&nbsp;toda&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_660">660</td><td nowrap="nowrap">vida&nbsp;do&nbsp;paciente,&nbsp;independentemente&nbsp;do&nbsp;curso&nbsp;da&nbsp;infecção.&nbsp;Entre&nbsp;10&nbsp;e&nbsp;15&nbsp;semanas&nbsp;após</td><td class="diff_next"></td><td class="diff_header" id="to62_652">652</td><td nowrap="nowrap">vida&nbsp;do&nbsp;paciente,&nbsp;independentemente&nbsp;do&nbsp;curso&nbsp;da&nbsp;infecção.&nbsp;Entre&nbsp;10&nbsp;e&nbsp;15&nbsp;semanas&nbsp;após</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_661">661</td><td nowrap="nowrap">a&nbsp;infecção,&nbsp;os&nbsp;níveis&nbsp;séricos&nbsp;de&nbsp;ALT&nbsp;e&nbsp;AST&nbsp;começam&nbsp;a&nbsp;se&nbsp;elevar,&nbsp;indicando&nbsp;dano&nbsp;hepático</td><td class="diff_next"></td><td class="diff_header" id="to62_653">653</td><td nowrap="nowrap">a&nbsp;infecção,&nbsp;os&nbsp;níveis&nbsp;séricos&nbsp;de&nbsp;ALT&nbsp;e&nbsp;AST&nbsp;começam&nbsp;a&nbsp;se&nbsp;elevar,&nbsp;indicando&nbsp;dano&nbsp;hepático</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_662">662</td><td nowrap="nowrap">mediado&nbsp;por&nbsp;resposta&nbsp;a&nbsp;células&nbsp;T.&nbsp;Experimentos&nbsp;em&nbsp;animais&nbsp;demonstraram&nbsp;que&nbsp;o&nbsp;DNA</td><td class="diff_next"></td><td class="diff_header" id="to62_654">654</td><td nowrap="nowrap">mediado&nbsp;por&nbsp;resposta&nbsp;a&nbsp;células&nbsp;T.&nbsp;Experimentos&nbsp;em&nbsp;animais&nbsp;demonstraram&nbsp;que&nbsp;o&nbsp;DNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_663">663</td><td nowrap="nowrap">atingido&nbsp;(GUIDOTTI&nbsp;et&nbsp;al.,&nbsp;1999).&nbsp;No&nbsp;entanto,&nbsp;técnicas&nbsp;moleculares&nbsp;modernas&nbsp;são&nbsp;capa-</td><td class="diff_next"></td><td class="diff_header" id="to62_655">655</td><td nowrap="nowrap">atingido&nbsp;(GUIDOTTI&nbsp;et&nbsp;al.,&nbsp;1999).&nbsp;No&nbsp;entanto,&nbsp;técnicas&nbsp;moleculares&nbsp;modernas&nbsp;são&nbsp;capa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_664">664</td><td nowrap="nowrap">zes&nbsp;de&nbsp;detectar&nbsp;uma&nbsp;carga&nbsp;viralG&nbsp;abaixo&nbsp;de&nbsp;100&nbsp;cópias&nbsp;de&nbsp;genomas&nbsp;virais&nbsp;por&nbsp;mililitro</td><td class="diff_next"></td><td class="diff_header" id="to62_656">656</td><td nowrap="nowrap">zes&nbsp;de&nbsp;detectar&nbsp;uma&nbsp;carga&nbsp;viralG&nbsp;abaixo&nbsp;de&nbsp;100&nbsp;cópias&nbsp;de&nbsp;genomas&nbsp;virais&nbsp;por&nbsp;mililitro</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_665">665</td><td nowrap="nowrap">de&nbsp;sangue&nbsp;(SILVA&nbsp;et&nbsp;al.,&nbsp;2004).&nbsp;Mais&nbsp;de&nbsp;90%&nbsp;dos&nbsp;adultos&nbsp;infectados&nbsp;conseguem&nbsp;reverter</td><td class="diff_next"></td><td class="diff_header" id="to62_657">657</td><td nowrap="nowrap">de&nbsp;sangue&nbsp;(SILVA&nbsp;et&nbsp;al.,&nbsp;2004).&nbsp;Mais&nbsp;de&nbsp;90%&nbsp;dos&nbsp;adultos&nbsp;infectados&nbsp;conseguem&nbsp;reverter</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_666">666</td><td nowrap="nowrap">circulantes,&nbsp;que&nbsp;garantem&nbsp;proteção&nbsp;de&nbsp;longo&nbsp;prazo&nbsp;contra&nbsp;a&nbsp;doença.&nbsp;Apesar&nbsp;da&nbsp;recupe-</td><td class="diff_next"></td><td class="diff_header" id="to62_658">658</td><td nowrap="nowrap">circulantes,&nbsp;que&nbsp;garantem&nbsp;proteção&nbsp;de&nbsp;longo&nbsp;prazo&nbsp;contra&nbsp;a&nbsp;doença.&nbsp;Apesar&nbsp;da&nbsp;recupe-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_667">667</td><td nowrap="nowrap">ração&nbsp;clínica,&nbsp;o&nbsp;DNA&nbsp;do&nbsp;HBV&nbsp;ainda&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;em&nbsp;níveis&nbsp;basais&nbsp;e&nbsp;sua&nbsp;expressão</td><td class="diff_next"></td><td class="diff_header" id="to62_659">659</td><td nowrap="nowrap">ração&nbsp;clínica,&nbsp;o&nbsp;DNA&nbsp;do&nbsp;HBV&nbsp;ainda&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;em&nbsp;níveis&nbsp;basais&nbsp;e&nbsp;sua&nbsp;expressão</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_668">668</td><td nowrap="nowrap">é&nbsp;controlada&nbsp;pela&nbsp;imunidade&nbsp;humoral&nbsp;e&nbsp;celular&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).&nbsp;No&nbsp;caso</td><td class="diff_next"></td><td class="diff_header" id="to62_660">660</td><td nowrap="nowrap">é&nbsp;controlada&nbsp;pela&nbsp;imunidade&nbsp;humoral&nbsp;e&nbsp;celular&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).&nbsp;No&nbsp;caso</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_669">669</td><td nowrap="nowrap">da&nbsp;ocorrência&nbsp;de&nbsp;mutantes&nbsp;nas&nbsp;regiões&nbsp;pré-core&nbsp;e&nbsp;core&nbsp;basal,&nbsp;a&nbsp;expressão&nbsp;do&nbsp;HBeAg&nbsp;será</td><td class="diff_next"></td><td class="diff_header" id="to62_661">661</td><td nowrap="nowrap">da&nbsp;ocorrência&nbsp;de&nbsp;mutantes&nbsp;nas&nbsp;regiões&nbsp;pré-core&nbsp;e&nbsp;core&nbsp;basal,&nbsp;a&nbsp;expressão&nbsp;do&nbsp;HBeAg&nbsp;será</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_670">670</td><td nowrap="nowrap">alterada&nbsp;e&nbsp;esse&nbsp;marcador&nbsp;pode&nbsp;não&nbsp;ser&nbsp;detectado,&nbsp;assim&nbsp;como&nbsp;não&nbsp;ocorrerá&nbsp;a&nbsp;sorocon-</td><td class="diff_next"></td><td class="diff_header" id="to62_662">662</td><td nowrap="nowrap">alterada&nbsp;e&nbsp;esse&nbsp;marcador&nbsp;pode&nbsp;não&nbsp;ser&nbsp;detectado,&nbsp;assim&nbsp;como&nbsp;não&nbsp;ocorrerá&nbsp;a&nbsp;sorocon-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_671">671</td><td nowrap="nowrap">versão&nbsp;para&nbsp;o&nbsp;anti-HBe&nbsp;(SITNIK;&nbsp;PINHO,&nbsp;2004).</td><td class="diff_next"></td><td class="diff_header" id="to62_663">663</td><td nowrap="nowrap">versão&nbsp;para&nbsp;o&nbsp;anti-HBe&nbsp;(SITNIK;&nbsp;PINHO,&nbsp;2004).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_672">672</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;crônica&nbsp;pelo&nbsp;HBV&nbsp;ocorre,&nbsp;primariamente,&nbsp;por&nbsp;transmissão&nbsp;vertical&nbsp;ou&nbsp;pela</td><td class="diff_next"></td><td class="diff_header" id="to62_664">664</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;crônica&nbsp;pelo&nbsp;HBV&nbsp;ocorre,&nbsp;primariamente,&nbsp;por&nbsp;transmissão&nbsp;vertical&nbsp;ou&nbsp;pela</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_673">673</td><td nowrap="nowrap">infecção&nbsp;na&nbsp;infância.&nbsp;A&nbsp;infecção&nbsp;do&nbsp;feto&nbsp;ou&nbsp;do&nbsp;neonato&nbsp;pelo&nbsp;HBV&nbsp;é&nbsp;dependente&nbsp;do&nbsp;esta-</td><td class="diff_next"></td><td class="diff_header" id="to62_665">665</td><td nowrap="nowrap">infecção&nbsp;na&nbsp;infância.&nbsp;A&nbsp;infecção&nbsp;do&nbsp;feto&nbsp;ou&nbsp;do&nbsp;neonato&nbsp;pelo&nbsp;HBV&nbsp;é&nbsp;dependente&nbsp;do&nbsp;esta-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_674">674</td><td nowrap="nowrap">do&nbsp;imune&nbsp;e&nbsp;da&nbsp;carga&nbsp;viral&nbsp;da&nbsp;mãe.&nbsp;Situações&nbsp;que&nbsp;levam&nbsp;à&nbsp;mistura&nbsp;do&nbsp;sangue&nbsp;da&nbsp;mãe&nbsp;e&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_666">666</td><td nowrap="nowrap">do&nbsp;imune&nbsp;e&nbsp;da&nbsp;carga&nbsp;viral&nbsp;da&nbsp;mãe.&nbsp;Situações&nbsp;que&nbsp;levam&nbsp;à&nbsp;mistura&nbsp;do&nbsp;sangue&nbsp;da&nbsp;mãe&nbsp;e&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_675">675</td><td nowrap="nowrap">feto&nbsp;também&nbsp;possibilitam&nbsp;a&nbsp;infecção&nbsp;(JONAS,&nbsp;2009).&nbsp;Para&nbsp;mais&nbsp;informações,&nbsp;consultar&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_667">667</td><td nowrap="nowrap">feto&nbsp;também&nbsp;possibilitam&nbsp;a&nbsp;infecção&nbsp;(JONAS,&nbsp;2009).&nbsp;Para&nbsp;mais&nbsp;informações,&nbsp;consultar&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_676">676</td><td nowrap="nowrap">“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Prevenção&nbsp;da&nbsp;Transmissão&nbsp;Vertical&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_668">668</td><td nowrap="nowrap">“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Prevenção&nbsp;da&nbsp;Transmissão&nbsp;Vertical&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_677">677</td><td nowrap="nowrap">HIV,&nbsp;Sífilis&nbsp;e&nbsp;Hepatites&nbsp;Virais”&nbsp;(BRASIL,&nbsp;2017e).</td><td class="diff_next"></td><td class="diff_header" id="to62_669">669</td><td nowrap="nowrap">HIV,&nbsp;Sífilis&nbsp;e&nbsp;Hepatites&nbsp;Virais”&nbsp;(BRASIL,&nbsp;2017e).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_678">678</td><td nowrap="nowrap">indivíduo&nbsp;por&nbsp;um&nbsp;período&nbsp;de&nbsp;seis&nbsp;meses&nbsp;ou&nbsp;mais.&nbsp;Durante&nbsp;o&nbsp;curso&nbsp;da&nbsp;infecção,&nbsp;podem</td><td class="diff_next"></td><td class="diff_header" id="to62_670">670</td><td nowrap="nowrap">indivíduo&nbsp;por&nbsp;um&nbsp;período&nbsp;de&nbsp;seis&nbsp;meses&nbsp;ou&nbsp;mais.&nbsp;Durante&nbsp;o&nbsp;curso&nbsp;da&nbsp;infecção,&nbsp;podem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_679">679</td><td nowrap="nowrap">ocorrer&nbsp;integrações&nbsp;de&nbsp;parte&nbsp;do&nbsp;genoma&nbsp;do&nbsp;HBV&nbsp;ao&nbsp;genoma&nbsp;do&nbsp;hospedeiro;&nbsp;é&nbsp;possível</td><td class="diff_next"></td><td class="diff_header" id="to62_671">671</td><td nowrap="nowrap">ocorrer&nbsp;integrações&nbsp;de&nbsp;parte&nbsp;do&nbsp;genoma&nbsp;do&nbsp;HBV&nbsp;ao&nbsp;genoma&nbsp;do&nbsp;hospedeiro;&nbsp;é&nbsp;possível</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_680">680</td><td nowrap="nowrap">haver&nbsp;indivíduos&nbsp;com&nbsp;HBsAg&nbsp;circulante,&nbsp;mesmo&nbsp;com&nbsp;replicação&nbsp;viral&nbsp;mínima&nbsp;ou&nbsp;inexis-</td><td class="diff_next"></td><td class="diff_header" id="to62_672">672</td><td nowrap="nowrap">haver&nbsp;indivíduos&nbsp;com&nbsp;HBsAg&nbsp;circulante,&nbsp;mesmo&nbsp;com&nbsp;replicação&nbsp;viral&nbsp;mínima&nbsp;ou&nbsp;inexis-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_681">681</td><td nowrap="nowrap">tente&nbsp;no&nbsp;fígado.&nbsp;Por&nbsp;isso,&nbsp;o&nbsp;critério&nbsp;de&nbsp;definição&nbsp;da&nbsp;infecção&nbsp;crônica&nbsp;com&nbsp;base&nbsp;na&nbsp;pre-</td><td class="diff_next"></td><td class="diff_header" id="to62_673">673</td><td nowrap="nowrap">tente&nbsp;no&nbsp;fígado.&nbsp;Por&nbsp;isso,&nbsp;o&nbsp;critério&nbsp;de&nbsp;definição&nbsp;da&nbsp;infecção&nbsp;crônica&nbsp;com&nbsp;base&nbsp;na&nbsp;pre-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_682">682</td><td nowrap="nowrap">(ASPINALL&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;BRASIL,&nbsp;2016;&nbsp;SEEGER;&nbsp;MASON,&nbsp;2000).</td><td class="diff_next"></td><td class="diff_header" id="to62_674">674</td><td nowrap="nowrap">(ASPINALL&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;BRASIL,&nbsp;2016;&nbsp;SEEGER;&nbsp;MASON,&nbsp;2000).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_683">683</td><td nowrap="nowrap">vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg)&nbsp;detectável&nbsp;é&nbsp;denominada&nbsp;de&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_675">675</td><td nowrap="nowrap">vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg)&nbsp;detectável&nbsp;é&nbsp;denominada&nbsp;de&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_684">684</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(IOBG).&nbsp;Estudos&nbsp;afirmam&nbsp;que&nbsp;a&nbsp;prevalência&nbsp;desse&nbsp;tipo&nbsp;de&nbsp;infecção&nbsp;é&nbsp;reduzi-</td><td class="diff_next"></td><td class="diff_header" id="to62_676">676</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(IOBG).&nbsp;Estudos&nbsp;afirmam&nbsp;que&nbsp;a&nbsp;prevalência&nbsp;desse&nbsp;tipo&nbsp;de&nbsp;infecção&nbsp;é&nbsp;reduzi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_685">685</td><td nowrap="nowrap">da&nbsp;na&nbsp;população&nbsp;geral,&nbsp;sendo&nbsp;mais&nbsp;presente&nbsp;entre&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,</td><td class="diff_next"></td><td class="diff_header" id="to62_677">677</td><td nowrap="nowrap">da&nbsp;na&nbsp;população&nbsp;geral,&nbsp;sendo&nbsp;mais&nbsp;presente&nbsp;entre&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_686">686</td><td nowrap="nowrap">pessoas&nbsp;imunossuprimidas&nbsp;e&nbsp;pessoas&nbsp;que&nbsp;fazem&nbsp;hemodiálise&nbsp;(FERREIRA&nbsp;et&nbsp;al.,&nbsp;2009;</td><td class="diff_next"></td><td class="diff_header" id="to62_678">678</td><td nowrap="nowrap">pessoas&nbsp;imunossuprimidas&nbsp;e&nbsp;pessoas&nbsp;que&nbsp;fazem&nbsp;hemodiálise&nbsp;(FERREIRA&nbsp;et&nbsp;al.,&nbsp;2009;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_687">687</td><td nowrap="nowrap">MATOS&nbsp;et&nbsp;al.,&nbsp;2013;&nbsp;OCANA&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;SILVA&nbsp;et&nbsp;al.,&nbsp;2004).</td><td class="diff_next"></td><td class="diff_header" id="to62_679">679</td><td nowrap="nowrap">MATOS&nbsp;et&nbsp;al.,&nbsp;2013;&nbsp;OCANA&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;SILVA&nbsp;et&nbsp;al.,&nbsp;2004).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_688">688</td><td nowrap="nowrap">De&nbsp;forma&nbsp;geral,&nbsp;a&nbsp;infecção&nbsp;crônica&nbsp;pelo&nbsp;HBV&nbsp;pode&nbsp;ser&nbsp;dividida&nbsp;em&nbsp;quatro&nbsp;fases</td><td class="diff_next"></td><td class="diff_header" id="to62_680">680</td><td nowrap="nowrap">De&nbsp;forma&nbsp;geral,&nbsp;a&nbsp;infecção&nbsp;crônica&nbsp;pelo&nbsp;HBV&nbsp;pode&nbsp;ser&nbsp;dividida&nbsp;em&nbsp;quatro&nbsp;fases</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_689">689</td><td nowrap="nowrap">(BRASIL,&nbsp;2017c):</td><td class="diff_next"></td><td class="diff_header" id="to62_681">681</td><td nowrap="nowrap">(BRASIL,&nbsp;2017c):</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_690">690</td><td nowrap="nowrap">›&nbsp;Imunotolerância:&nbsp;ocorre&nbsp;elevada&nbsp;replicação&nbsp;viral,&nbsp;com&nbsp;tolerância&nbsp;do&nbsp;sistema</td><td class="diff_next"></td><td class="diff_header" id="to62_682">682</td><td nowrap="nowrap">›&nbsp;Imunotolerância:&nbsp;ocorre&nbsp;elevada&nbsp;replicação&nbsp;viral,&nbsp;com&nbsp;tolerância&nbsp;do&nbsp;sistema</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_691">691</td><td nowrap="nowrap">imune&nbsp;e&nbsp;sem&nbsp;evidência&nbsp;de&nbsp;agressão&nbsp;hepatocelular&nbsp;(transaminases&nbsp;normais</td><td class="diff_next"></td><td class="diff_header" id="to62_683">683</td><td nowrap="nowrap">imune&nbsp;e&nbsp;sem&nbsp;evidência&nbsp;de&nbsp;agressão&nbsp;hepatocelular&nbsp;(transaminases&nbsp;normais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_692">692</td><td nowrap="nowrap">ou&nbsp;próximas&nbsp;do&nbsp;normal);</td><td class="diff_next"></td><td class="diff_header" id="to62_684">684</td><td nowrap="nowrap">ou&nbsp;próximas&nbsp;do&nbsp;normal);</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_693">693</td><td nowrap="nowrap">›&nbsp;Imunorreação:&nbsp;com&nbsp;o&nbsp;esgotamento&nbsp;da&nbsp;tolerância&nbsp;imunológica,&nbsp;ocorre&nbsp;agres-</td><td class="diff_next"></td><td class="diff_header" id="to62_685">685</td><td nowrap="nowrap">›&nbsp;Imunorreação:&nbsp;com&nbsp;o&nbsp;esgotamento&nbsp;da&nbsp;tolerância&nbsp;imunológica,&nbsp;ocorre&nbsp;agres-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_694">694</td><td nowrap="nowrap">são&nbsp;aos&nbsp;hepatócitos,&nbsp;nos&nbsp;quais&nbsp;ocorre&nbsp;a&nbsp;replicação&nbsp;viral,&nbsp;gerando&nbsp;elevação&nbsp;das</td><td class="diff_next"></td><td class="diff_header" id="to62_686">686</td><td nowrap="nowrap">são&nbsp;aos&nbsp;hepatócitos,&nbsp;nos&nbsp;quais&nbsp;ocorre&nbsp;a&nbsp;replicação&nbsp;viral,&nbsp;gerando&nbsp;elevação&nbsp;das</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_695">695</td><td nowrap="nowrap">transaminases;</td><td class="diff_next"></td><td class="diff_header" id="to62_687">687</td><td nowrap="nowrap">transaminases;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_696">696</td><td nowrap="nowrap">›&nbsp;Portador&nbsp;inativo:&nbsp;essa&nbsp;fase&nbsp;é&nbsp;caracterizada&nbsp;por&nbsp;níveis&nbsp;baixos&nbsp;ou&nbsp;indetectáveis</td><td class="diff_next"></td><td class="diff_header" id="to62_688">688</td><td nowrap="nowrap">›&nbsp;Portador&nbsp;inativo:&nbsp;essa&nbsp;fase&nbsp;é&nbsp;caracterizada&nbsp;por&nbsp;níveis&nbsp;baixos&nbsp;ou&nbsp;indetectáveis</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_697">697</td><td nowrap="nowrap">de&nbsp;replicação&nbsp;viral,&nbsp;com&nbsp;normalização&nbsp;das&nbsp;transaminases&nbsp;e,&nbsp;habitualmente,</td><td class="diff_next"></td><td class="diff_header" id="to62_689">689</td><td nowrap="nowrap">de&nbsp;replicação&nbsp;viral,&nbsp;com&nbsp;normalização&nbsp;das&nbsp;transaminases&nbsp;e,&nbsp;habitualmente,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_698">698</td><td nowrap="nowrap">soroconversão&nbsp;para&nbsp;anti-HBe.&nbsp;O&nbsp;escape&nbsp;viral&nbsp;pode&nbsp;ocorrer&nbsp;por&nbsp;integração&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_690">690</td><td nowrap="nowrap">soroconversão&nbsp;para&nbsp;anti-HBe.&nbsp;O&nbsp;escape&nbsp;viral&nbsp;pode&nbsp;ocorrer&nbsp;por&nbsp;integração&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_699">699</td><td nowrap="nowrap">imunológica&nbsp;do&nbsp;hospedeiro,&nbsp;seja&nbsp;por&nbsp;meio&nbsp;de&nbsp;mutações&nbsp;virais,&nbsp;seja&nbsp;por&nbsp;tratar-</td><td class="diff_next"></td><td class="diff_header" id="to62_691">691</td><td nowrap="nowrap">imunológica&nbsp;do&nbsp;hospedeiro,&nbsp;seja&nbsp;por&nbsp;meio&nbsp;de&nbsp;mutações&nbsp;virais,&nbsp;seja&nbsp;por&nbsp;tratar-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_700">700</td><td nowrap="nowrap">-se&nbsp;de&nbsp;pacientes&nbsp;imunodeprimidos;</td><td class="diff_next"></td><td class="diff_header" id="to62_692">692</td><td nowrap="nowrap">-se&nbsp;de&nbsp;pacientes&nbsp;imunodeprimidos;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_701">701</td><td nowrap="nowrap">›&nbsp;Reativação:&nbsp;em&nbsp;seguida&nbsp;à&nbsp;fase&nbsp;do&nbsp;portador&nbsp;inativo,&nbsp;pode&nbsp;ocorrer&nbsp;reativação</td><td class="diff_next"></td><td class="diff_header" id="to62_693">693</td><td nowrap="nowrap">›&nbsp;Reativação:&nbsp;em&nbsp;seguida&nbsp;à&nbsp;fase&nbsp;do&nbsp;portador&nbsp;inativo,&nbsp;pode&nbsp;ocorrer&nbsp;reativação</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__15"></td><td class="diff_header" id="from62_702">702</td><td nowrap="nowrap">viral,&nbsp;com&nbsp;retorno&nbsp;da&nbsp;replicação.</td><td class="diff_next"></td><td class="diff_header" id="to62_694">694</td><td nowrap="nowrap">viral,&nbsp;com&nbsp;retorno&nbsp;da&nbsp;replicação.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_703">703</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;B&nbsp;é&nbsp;uma&nbsp;doença&nbsp;imunoprevenível;&nbsp;a&nbsp;vacina,&nbsp;altamente&nbsp;eficiente,&nbsp;é&nbsp;dispo-</td><td class="diff_next"></td><td class="diff_header" id="to62_695">695</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;B&nbsp;é&nbsp;uma&nbsp;doença&nbsp;imunoprevenível;&nbsp;a&nbsp;vacina,&nbsp;altamente&nbsp;eficiente,&nbsp;é&nbsp;dispo-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__16"></td><td class="diff_header" id="from62_704">704</td><td nowrap="nowrap">nibilizada&nbsp;pelo&nbsp;governo&nbsp;brasileiro&nbsp;em&nbsp;seus&nbsp;serviços&nbsp;de&nbsp;saúde,&nbsp;fazendo&nbsp;parte&nbsp;do&nbsp;calen-</td><td class="diff_next"></td><td class="diff_header" id="to62_696">696</td><td nowrap="nowrap">nibilizada&nbsp;pelo&nbsp;governo&nbsp;brasileiro&nbsp;em&nbsp;seus&nbsp;serviços&nbsp;de&nbsp;saúde,&nbsp;fazendo&nbsp;parte&nbsp;do&nbsp;calen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_705">705</td><td nowrap="nowrap">dário&nbsp;de&nbsp;vacinações&nbsp;infantis.&nbsp;Qualquer&nbsp;indivíduo&nbsp;que&nbsp;se&nbsp;enquadre&nbsp;nos&nbsp;critérios&nbsp;estabe-</td><td class="diff_next"></td><td class="diff_header" id="to62_697">697</td><td nowrap="nowrap">dário&nbsp;de&nbsp;vacinações&nbsp;infantis.&nbsp;Qualquer&nbsp;indivíduo&nbsp;que&nbsp;se&nbsp;enquadre&nbsp;nos&nbsp;critérios&nbsp;estabe-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_706">706</td><td nowrap="nowrap">lecidos&nbsp;pelo&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;tem&nbsp;acesso&nbsp;à&nbsp;vacina.&nbsp;Para&nbsp;mais&nbsp;informações,&nbsp;consultar</td><td class="diff_next"></td><td class="diff_header" id="to62_698">698</td><td nowrap="nowrap">lecidos&nbsp;pelo&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;tem&nbsp;acesso&nbsp;à&nbsp;vacina.&nbsp;Para&nbsp;mais&nbsp;informações,&nbsp;consultar</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__16">n</a></td><td class="diff_header" id="from62_707">707</td><td nowrap="nowrap"><span class="diff_sub">a&nbsp;página&nbsp;do&nbsp;Programa&nbsp;Nacional&nbsp;de&nbsp;Imunizações&nbsp;(http://portalarquivos.saude.gov.br/</span></td><td class="diff_next"><a href="#difflib_chg_to62__16">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_708">708</td><td nowrap="nowrap">campanhas/pni/)&nbsp;e&nbsp;o&nbsp;“Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;em&nbsp;Imunobiológicos&nbsp;Especiais”</td><td class="diff_next"></td><td class="diff_header" id="to62_699">699</td><td nowrap="nowrap">campanhas/pni/)&nbsp;e&nbsp;o&nbsp;“Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;em&nbsp;Imunobiológicos&nbsp;Especiais”</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__17">n</a></td><td class="diff_header" id="from62_709">709</td><td nowrap="nowrap"><span class="diff_sub">(http://pesquisa.bvsalud.org/bvsms/resource/pt/mis-37499).</span></td><td class="diff_next"><a href="#difflib_chg_to62__17">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_710">710</td><td nowrap="nowrap">Listam-se&nbsp;a&nbsp;seguir&nbsp;outras&nbsp;formas&nbsp;de&nbsp;prevenir&nbsp;a&nbsp;infecção:</td><td class="diff_next"></td><td class="diff_header" id="to62_700">700</td><td nowrap="nowrap">Listam-se&nbsp;a&nbsp;seguir&nbsp;outras&nbsp;formas&nbsp;de&nbsp;prevenir&nbsp;a&nbsp;infecção:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_711">711</td><td nowrap="nowrap">›&nbsp;Adotar&nbsp;práticas&nbsp;sexuais&nbsp;mais&nbsp;seguras,&nbsp;com&nbsp;o&nbsp;uso&nbsp;de&nbsp;preservativo;</td><td class="diff_next"></td><td class="diff_header" id="to62_701">701</td><td nowrap="nowrap">›&nbsp;Adotar&nbsp;práticas&nbsp;sexuais&nbsp;mais&nbsp;seguras,&nbsp;com&nbsp;o&nbsp;uso&nbsp;de&nbsp;preservativo;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_712">712</td><td nowrap="nowrap">›&nbsp;Não&nbsp;compartilhar&nbsp;objetos&nbsp;de&nbsp;uso&nbsp;pessoal,&nbsp;como&nbsp;lâminas&nbsp;de&nbsp;barbear&nbsp;e&nbsp;depilar,</td><td class="diff_next"></td><td class="diff_header" id="to62_702">702</td><td nowrap="nowrap">›&nbsp;Não&nbsp;compartilhar&nbsp;objetos&nbsp;de&nbsp;uso&nbsp;pessoal,&nbsp;como&nbsp;lâminas&nbsp;de&nbsp;barbear&nbsp;e&nbsp;depilar,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_713">713</td><td nowrap="nowrap">escovas&nbsp;de&nbsp;dente,&nbsp;material&nbsp;de&nbsp;manicure&nbsp;e&nbsp;pedicure;</td><td class="diff_next"></td><td class="diff_header" id="to62_703">703</td><td nowrap="nowrap">escovas&nbsp;de&nbsp;dente,&nbsp;material&nbsp;de&nbsp;manicure&nbsp;e&nbsp;pedicure;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_714">714</td><td nowrap="nowrap">›&nbsp;Não&nbsp;compartilhar&nbsp;agulhas&nbsp;e&nbsp;seringas;</td><td class="diff_next"></td><td class="diff_header" id="to62_704">704</td><td nowrap="nowrap">›&nbsp;Não&nbsp;compartilhar&nbsp;agulhas&nbsp;e&nbsp;seringas;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_715">715</td><td nowrap="nowrap">›&nbsp;Não&nbsp;reutilizar&nbsp;material&nbsp;para&nbsp;confecção&nbsp;de&nbsp;tatuagem&nbsp;e&nbsp;colocação&nbsp;de&nbsp;piercings.</td><td class="diff_next"></td><td class="diff_header" id="to62_705">705</td><td nowrap="nowrap">›&nbsp;Não&nbsp;reutilizar&nbsp;material&nbsp;para&nbsp;confecção&nbsp;de&nbsp;tatuagem&nbsp;e&nbsp;colocação&nbsp;de&nbsp;piercings.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_716">716</td><td nowrap="nowrap">9.5&nbsp;Resposta&nbsp;imune</td><td class="diff_next"></td><td class="diff_header" id="to62_706">706</td><td nowrap="nowrap">9.5&nbsp;Resposta&nbsp;imune</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_717">717</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;pode&nbsp;ser&nbsp;espontaneamente&nbsp;curada&nbsp;(desaparecimento&nbsp;viral)&nbsp;an-</td><td class="diff_next"></td><td class="diff_header" id="to62_707">707</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;pode&nbsp;ser&nbsp;espontaneamente&nbsp;curada&nbsp;(desaparecimento&nbsp;viral)&nbsp;an-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_718">718</td><td nowrap="nowrap">tes&nbsp;do&nbsp;desenvolvimento&nbsp;de&nbsp;uma&nbsp;resposta&nbsp;imune&nbsp;humoral.&nbsp;O&nbsp;papel&nbsp;da&nbsp;resposta&nbsp;imune</td><td class="diff_next"></td><td class="diff_header" id="to62_708">708</td><td nowrap="nowrap">tes&nbsp;do&nbsp;desenvolvimento&nbsp;de&nbsp;uma&nbsp;resposta&nbsp;imune&nbsp;humoral.&nbsp;O&nbsp;papel&nbsp;da&nbsp;resposta&nbsp;imune</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_719">719</td><td nowrap="nowrap">inata&nbsp;na&nbsp;resolução&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;ainda&nbsp;não&nbsp;está&nbsp;totalmente&nbsp;elucidado.&nbsp;No&nbsp;entan-</td><td class="diff_next"></td><td class="diff_header" id="to62_709">709</td><td nowrap="nowrap">inata&nbsp;na&nbsp;resolução&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;ainda&nbsp;não&nbsp;está&nbsp;totalmente&nbsp;elucidado.&nbsp;No&nbsp;entan-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_720">720</td><td nowrap="nowrap">to,&nbsp;esta&nbsp;não&nbsp;pode&nbsp;ser&nbsp;descartada,&nbsp;em&nbsp;virtude&nbsp;de&nbsp;observações&nbsp;laboratoriais&nbsp;em&nbsp;que&nbsp;o&nbsp;HBV</td><td class="diff_next"></td><td class="diff_header" id="to62_710">710</td><td nowrap="nowrap">to,&nbsp;esta&nbsp;não&nbsp;pode&nbsp;ser&nbsp;descartada,&nbsp;em&nbsp;virtude&nbsp;de&nbsp;observações&nbsp;laboratoriais&nbsp;em&nbsp;que&nbsp;o&nbsp;HBV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_721">721</td><td nowrap="nowrap">imune&nbsp;adaptativa&nbsp;(GUIDOTTI&nbsp;et&nbsp;al.,&nbsp;1999).&nbsp;Os&nbsp;efeitos&nbsp;antivirais&nbsp;dos&nbsp;interferonsG&nbsp;de&nbsp;tipo</td><td class="diff_next"></td><td class="diff_header" id="to62_711">711</td><td nowrap="nowrap">imune&nbsp;adaptativa&nbsp;(GUIDOTTI&nbsp;et&nbsp;al.,&nbsp;1999).&nbsp;Os&nbsp;efeitos&nbsp;antivirais&nbsp;dos&nbsp;interferonsG&nbsp;de&nbsp;tipo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_722">722</td><td nowrap="nowrap">I&nbsp;(IFN-α&nbsp;e&nbsp;IFN-β)&nbsp;já&nbsp;foram&nbsp;demonstrados&nbsp;em&nbsp;laboratório.&nbsp;Nesses&nbsp;modelos&nbsp;laboratoriais,</td><td class="diff_next"></td><td class="diff_header" id="to62_712">712</td><td nowrap="nowrap">I&nbsp;(IFN-α&nbsp;e&nbsp;IFN-β)&nbsp;já&nbsp;foram&nbsp;demonstrados&nbsp;em&nbsp;laboratório.&nbsp;Nesses&nbsp;modelos&nbsp;laboratoriais,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_723">723</td><td nowrap="nowrap">o&nbsp;IFN-α&nbsp;e&nbsp;o&nbsp;IFN-β&nbsp;foram&nbsp;capazes&nbsp;de&nbsp;induzir&nbsp;um&nbsp;mecanismo&nbsp;de&nbsp;inibição&nbsp;na&nbsp;formação&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_713">713</td><td nowrap="nowrap">o&nbsp;IFN-α&nbsp;e&nbsp;o&nbsp;IFN-β&nbsp;foram&nbsp;capazes&nbsp;de&nbsp;induzir&nbsp;um&nbsp;mecanismo&nbsp;de&nbsp;inibição&nbsp;na&nbsp;formação&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_724">724</td><td nowrap="nowrap">novos&nbsp;capsídeos&nbsp;do&nbsp;HBV,&nbsp;bem&nbsp;como&nbsp;de&nbsp;desestabilizar&nbsp;os&nbsp;capsídeos&nbsp;existentes&nbsp;e&nbsp;degra-</td><td class="diff_next"></td><td class="diff_header" id="to62_714">714</td><td nowrap="nowrap">novos&nbsp;capsídeos&nbsp;do&nbsp;HBV,&nbsp;bem&nbsp;como&nbsp;de&nbsp;desestabilizar&nbsp;os&nbsp;capsídeos&nbsp;existentes&nbsp;e&nbsp;degra-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_725">725</td><td nowrap="nowrap">dar&nbsp;RNA&nbsp;do&nbsp;HBV&nbsp;recentemente&nbsp;sintetizado&nbsp;(MCCLARY&nbsp;et&nbsp;al.,&nbsp;2000).&nbsp;Adicionalmente,&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_715">715</td><td nowrap="nowrap">dar&nbsp;RNA&nbsp;do&nbsp;HBV&nbsp;recentemente&nbsp;sintetizado&nbsp;(MCCLARY&nbsp;et&nbsp;al.,&nbsp;2000).&nbsp;Adicionalmente,&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_726">726</td><td nowrap="nowrap">inibição&nbsp;da&nbsp;replicação&nbsp;do&nbsp;HBV&nbsp;pode&nbsp;também&nbsp;ser&nbsp;mediada&nbsp;pela&nbsp;ação&nbsp;do&nbsp;IFN-γ,&nbsp;que&nbsp;é&nbsp;pro-</td><td class="diff_next"></td><td class="diff_header" id="to62_716">716</td><td nowrap="nowrap">inibição&nbsp;da&nbsp;replicação&nbsp;do&nbsp;HBV&nbsp;pode&nbsp;também&nbsp;ser&nbsp;mediada&nbsp;pela&nbsp;ação&nbsp;do&nbsp;IFN-γ,&nbsp;que&nbsp;é&nbsp;pro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_727">727</td><td nowrap="nowrap">duzido&nbsp;por&nbsp;células&nbsp;NK&nbsp;e&nbsp;por&nbsp;células&nbsp;T&nbsp;ativadas&nbsp;(BARON&nbsp;et&nbsp;al.,&nbsp;2002;&nbsp;KAKIMI&nbsp;et&nbsp;al.,&nbsp;2001).</td><td class="diff_next"></td><td class="diff_header" id="to62_717">717</td><td nowrap="nowrap">duzido&nbsp;por&nbsp;células&nbsp;NK&nbsp;e&nbsp;por&nbsp;células&nbsp;T&nbsp;ativadas&nbsp;(BARON&nbsp;et&nbsp;al.,&nbsp;2002;&nbsp;KAKIMI&nbsp;et&nbsp;al.,&nbsp;2001).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_728">728</td><td nowrap="nowrap">Pacientes&nbsp;capazes&nbsp;de&nbsp;recuperar-se&nbsp;espontaneamente&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;normal-</td><td class="diff_next"></td><td class="diff_header" id="to62_718">718</td><td nowrap="nowrap">Pacientes&nbsp;capazes&nbsp;de&nbsp;recuperar-se&nbsp;espontaneamente&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;normal-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_729">729</td><td nowrap="nowrap">mente,&nbsp;apresentam&nbsp;uma&nbsp;resposta&nbsp;imunológica&nbsp;vigorosa&nbsp;e&nbsp;multi-epitopo,&nbsp;mediada&nbsp;por</td><td class="diff_next"></td><td class="diff_header" id="to62_719">719</td><td nowrap="nowrap">mente,&nbsp;apresentam&nbsp;uma&nbsp;resposta&nbsp;imunológica&nbsp;vigorosa&nbsp;e&nbsp;multi-epitopo,&nbsp;mediada&nbsp;por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_730">730</td><td nowrap="nowrap">células&nbsp;T&nbsp;CD4+&nbsp;e&nbsp;CD8+&nbsp;detectáveis&nbsp;no&nbsp;sangue&nbsp;circulante.&nbsp;Essa&nbsp;resposta&nbsp;de&nbsp;CD8+&nbsp;é&nbsp;deter-</td><td class="diff_next"></td><td class="diff_header" id="to62_720">720</td><td nowrap="nowrap">células&nbsp;T&nbsp;CD4+&nbsp;e&nbsp;CD8+&nbsp;detectáveis&nbsp;no&nbsp;sangue&nbsp;circulante.&nbsp;Essa&nbsp;resposta&nbsp;de&nbsp;CD8+&nbsp;é&nbsp;deter-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_731">731</td><td nowrap="nowrap">minante&nbsp;na&nbsp;recuperação&nbsp;do&nbsp;paciente&nbsp;(KAKIMI&nbsp;et&nbsp;al.,&nbsp;2001;&nbsp;THIMME&nbsp;et&nbsp;al.,&nbsp;2003).</td><td class="diff_next"></td><td class="diff_header" id="to62_721">721</td><td nowrap="nowrap">minante&nbsp;na&nbsp;recuperação&nbsp;do&nbsp;paciente&nbsp;(KAKIMI&nbsp;et&nbsp;al.,&nbsp;2001;&nbsp;THIMME&nbsp;et&nbsp;al.,&nbsp;2003).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_732">732</td><td nowrap="nowrap">Anticorpos&nbsp;específicos&nbsp;contra&nbsp;o&nbsp;HBV,&nbsp;juntamente&nbsp;com&nbsp;a&nbsp;pesquisa&nbsp;por&nbsp;antígenos&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_722">722</td><td nowrap="nowrap">Anticorpos&nbsp;específicos&nbsp;contra&nbsp;o&nbsp;HBV,&nbsp;juntamente&nbsp;com&nbsp;a&nbsp;pesquisa&nbsp;por&nbsp;antígenos&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_733">733</td><td nowrap="nowrap">ácidos&nbsp;nucleicos&nbsp;virais,&nbsp;são&nbsp;importantes&nbsp;indicadores&nbsp;para&nbsp;estágios&nbsp;específicos&nbsp;da&nbsp;doença</td><td class="diff_next"></td><td class="diff_header" id="to62_723">723</td><td nowrap="nowrap">ácidos&nbsp;nucleicos&nbsp;virais,&nbsp;são&nbsp;importantes&nbsp;indicadores&nbsp;para&nbsp;estágios&nbsp;específicos&nbsp;da&nbsp;doença</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_734">734</td><td nowrap="nowrap">(Figura&nbsp;9).&nbsp;A&nbsp;IgM&nbsp;anti-HBc&nbsp;é&nbsp;um&nbsp;marcador&nbsp;do&nbsp;início&nbsp;da&nbsp;infecção,&nbsp;enquanto&nbsp;que&nbsp;anticor-</td><td class="diff_next"></td><td class="diff_header" id="to62_724">724</td><td nowrap="nowrap">(Figura&nbsp;9).&nbsp;A&nbsp;IgM&nbsp;anti-HBc&nbsp;é&nbsp;um&nbsp;marcador&nbsp;do&nbsp;início&nbsp;da&nbsp;infecção,&nbsp;enquanto&nbsp;que&nbsp;anticor-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_735">735</td><td nowrap="nowrap">infecção&nbsp;(FUNG&nbsp;et&nbsp;al.,&nbsp;2014;&nbsp;MARUYAMA&nbsp;et&nbsp;al.,&nbsp;1993)&nbsp;.&nbsp;Estudos&nbsp;recentes&nbsp;mostram&nbsp;que&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_725">725</td><td nowrap="nowrap">infecção&nbsp;(FUNG&nbsp;et&nbsp;al.,&nbsp;2014;&nbsp;MARUYAMA&nbsp;et&nbsp;al.,&nbsp;1993)&nbsp;.&nbsp;Estudos&nbsp;recentes&nbsp;mostram&nbsp;que&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_736">736</td><td nowrap="nowrap">doença&nbsp;hepática&nbsp;causada&nbsp;pelo&nbsp;HBV&nbsp;(GONÇALVES&nbsp;JUNIOR,&nbsp;2013;&nbsp;NGUYEN;&nbsp;KEEFFE,&nbsp;2008;</td><td class="diff_next"></td><td class="diff_header" id="to62_726">726</td><td nowrap="nowrap">doença&nbsp;hepática&nbsp;causada&nbsp;pelo&nbsp;HBV&nbsp;(GONÇALVES&nbsp;JUNIOR,&nbsp;2013;&nbsp;NGUYEN;&nbsp;KEEFFE,&nbsp;2008;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_737">737</td><td nowrap="nowrap">NGUYEN;&nbsp;LOCARNINI,&nbsp;2009).&nbsp;Os&nbsp;anticorpos&nbsp;anti-HBs&nbsp;são&nbsp;neutralizantes&nbsp;e&nbsp;capazes&nbsp;de&nbsp;me-</td><td class="diff_next"></td><td class="diff_header" id="to62_727">727</td><td nowrap="nowrap">NGUYEN;&nbsp;LOCARNINI,&nbsp;2009).&nbsp;Os&nbsp;anticorpos&nbsp;anti-HBs&nbsp;são&nbsp;neutralizantes&nbsp;e&nbsp;capazes&nbsp;de&nbsp;me-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_738">738</td><td nowrap="nowrap">diar&nbsp;imunidade&nbsp;preventiva,&nbsp;sendo&nbsp;induzidos&nbsp;pela&nbsp;vacinação.&nbsp;Os&nbsp;anticorpos&nbsp;anti-HBc&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_728">728</td><td nowrap="nowrap">diar&nbsp;imunidade&nbsp;preventiva,&nbsp;sendo&nbsp;induzidos&nbsp;pela&nbsp;vacinação.&nbsp;Os&nbsp;anticorpos&nbsp;anti-HBc&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_739">739</td><td nowrap="nowrap">anti-HBs&nbsp;persistem&nbsp;por&nbsp;longos&nbsp;períodos&nbsp;no&nbsp;indivíduo,&nbsp;sendo&nbsp;que&nbsp;o&nbsp;anticorpo&nbsp;anti-HBs</td><td class="diff_next"></td><td class="diff_header" id="to62_729">729</td><td nowrap="nowrap">anti-HBs&nbsp;persistem&nbsp;por&nbsp;longos&nbsp;períodos&nbsp;no&nbsp;indivíduo,&nbsp;sendo&nbsp;que&nbsp;o&nbsp;anticorpo&nbsp;anti-HBs</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_740">740</td><td nowrap="nowrap">confere&nbsp;proteção&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;(MARUYAMA&nbsp;et&nbsp;al.,&nbsp;1993).</td><td class="diff_next"></td><td class="diff_header" id="to62_730">730</td><td nowrap="nowrap">confere&nbsp;proteção&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;(MARUYAMA&nbsp;et&nbsp;al.,&nbsp;1993).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_741">741</td><td nowrap="nowrap">Figura&nbsp;9.&nbsp;Evolução&nbsp;dos&nbsp;marcadores&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)&nbsp;nas&nbsp;infecções&nbsp;agudas&nbsp;e&nbsp;crônicas</td><td class="diff_next"></td><td class="diff_header" id="to62_731">731</td><td nowrap="nowrap">Figura&nbsp;9.&nbsp;Evolução&nbsp;dos&nbsp;marcadores&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)&nbsp;nas&nbsp;infecções&nbsp;agudas&nbsp;e&nbsp;crônicas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_742">742</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;SABLON;&nbsp;SHAPIRO,&nbsp;2005.</td><td class="diff_next"></td><td class="diff_header" id="to62_732">732</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;SABLON;&nbsp;SHAPIRO,&nbsp;2005.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_743">743</td><td nowrap="nowrap">Apesar&nbsp;da&nbsp;ação&nbsp;protetora&nbsp;da&nbsp;imunidade&nbsp;adquirida&nbsp;por&nbsp;meio&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV,</td><td class="diff_next"></td><td class="diff_header" id="to62_733">733</td><td nowrap="nowrap">Apesar&nbsp;da&nbsp;ação&nbsp;protetora&nbsp;da&nbsp;imunidade&nbsp;adquirida&nbsp;por&nbsp;meio&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_744">744</td><td nowrap="nowrap">traços&nbsp;do&nbsp;vírus&nbsp;podem&nbsp;ser&nbsp;detectados&nbsp;na&nbsp;corrente&nbsp;sanguínea&nbsp;de&nbsp;alguns&nbsp;indivíduos,&nbsp;indi-</td><td class="diff_next"></td><td class="diff_header" id="to62_734">734</td><td nowrap="nowrap">traços&nbsp;do&nbsp;vírus&nbsp;podem&nbsp;ser&nbsp;detectados&nbsp;na&nbsp;corrente&nbsp;sanguínea&nbsp;de&nbsp;alguns&nbsp;indivíduos,&nbsp;indi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_745">745</td><td nowrap="nowrap">cando&nbsp;manutenção&nbsp;da&nbsp;replicação&nbsp;viral.&nbsp;Essa&nbsp;viremia&nbsp;seria&nbsp;controlada&nbsp;pela&nbsp;resposta&nbsp;imu-</td><td class="diff_next"></td><td class="diff_header" id="to62_735">735</td><td nowrap="nowrap">cando&nbsp;manutenção&nbsp;da&nbsp;replicação&nbsp;viral.&nbsp;Essa&nbsp;viremia&nbsp;seria&nbsp;controlada&nbsp;pela&nbsp;resposta&nbsp;imu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_746">746</td><td nowrap="nowrap">ne&nbsp;celular&nbsp;e&nbsp;humoral.&nbsp;Um&nbsp;fato&nbsp;que&nbsp;corrobora&nbsp;essa&nbsp;hipótese&nbsp;é&nbsp;a&nbsp;observação&nbsp;de&nbsp;reativação</td><td class="diff_next"></td><td class="diff_header" id="to62_736">736</td><td nowrap="nowrap">ne&nbsp;celular&nbsp;e&nbsp;humoral.&nbsp;Um&nbsp;fato&nbsp;que&nbsp;corrobora&nbsp;essa&nbsp;hipótese&nbsp;é&nbsp;a&nbsp;observação&nbsp;de&nbsp;reativação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_747">747</td><td nowrap="nowrap">do&nbsp;HBV&nbsp;em&nbsp;alguns&nbsp;indivíduos&nbsp;imunossuprimidos/imunodeprimidosG&nbsp;em&nbsp;virtude&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_737">737</td><td nowrap="nowrap">do&nbsp;HBV&nbsp;em&nbsp;alguns&nbsp;indivíduos&nbsp;imunossuprimidos/imunodeprimidosG&nbsp;em&nbsp;virtude&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_748">748</td><td nowrap="nowrap">quimioterapia&nbsp;(KAWATANI&nbsp;et&nbsp;al.,&nbsp;2001;&nbsp;LAU,&nbsp;2002).&nbsp;Essa&nbsp;viremia&nbsp;residual&nbsp;pode&nbsp;estar&nbsp;en-</td><td class="diff_next"></td><td class="diff_header" id="to62_738">738</td><td nowrap="nowrap">quimioterapia&nbsp;(KAWATANI&nbsp;et&nbsp;al.,&nbsp;2001;&nbsp;LAU,&nbsp;2002).&nbsp;Essa&nbsp;viremia&nbsp;residual&nbsp;pode&nbsp;estar&nbsp;en-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_749">749</td><td nowrap="nowrap">volvida&nbsp;na&nbsp;manutenção&nbsp;da&nbsp;imunidade&nbsp;específica&nbsp;ao&nbsp;HBV&nbsp;em&nbsp;indivíduos&nbsp;que&nbsp;se&nbsp;recupe-</td><td class="diff_next"></td><td class="diff_header" id="to62_739">739</td><td nowrap="nowrap">volvida&nbsp;na&nbsp;manutenção&nbsp;da&nbsp;imunidade&nbsp;específica&nbsp;ao&nbsp;HBV&nbsp;em&nbsp;indivíduos&nbsp;que&nbsp;se&nbsp;recupe-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_750">750</td><td nowrap="nowrap">ram&nbsp;da&nbsp;infecção&nbsp;(REHERMANN&nbsp;et&nbsp;al.,&nbsp;1996).</td><td class="diff_next"></td><td class="diff_header" id="to62_740">740</td><td nowrap="nowrap">ram&nbsp;da&nbsp;infecção&nbsp;(REHERMANN&nbsp;et&nbsp;al.,&nbsp;1996).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_751">751</td><td nowrap="nowrap">Durante&nbsp;o&nbsp;curso&nbsp;da&nbsp;infecção,&nbsp;podem&nbsp;ser&nbsp;selecionadas&nbsp;variantes&nbsp;do&nbsp;HBV&nbsp;que&nbsp;pos-</td><td class="diff_next"></td><td class="diff_header" id="to62_741">741</td><td nowrap="nowrap">Durante&nbsp;o&nbsp;curso&nbsp;da&nbsp;infecção,&nbsp;podem&nbsp;ser&nbsp;selecionadas&nbsp;variantes&nbsp;do&nbsp;HBV&nbsp;que&nbsp;pos-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_752">752</td><td nowrap="nowrap">suem&nbsp;mutações&nbsp;nos&nbsp;epítopos&nbsp;imunogênicos&nbsp;virais.&nbsp;Apesar&nbsp;de&nbsp;estarem&nbsp;predominante-</td><td class="diff_next"></td><td class="diff_header" id="to62_742">742</td><td nowrap="nowrap">suem&nbsp;mutações&nbsp;nos&nbsp;epítopos&nbsp;imunogênicos&nbsp;virais.&nbsp;Apesar&nbsp;de&nbsp;estarem&nbsp;predominante-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_753">753</td><td nowrap="nowrap">mente&nbsp;relacionadas&nbsp;ao&nbsp;escape&nbsp;da&nbsp;imunidade&nbsp;induzida&nbsp;por&nbsp;vacinação,&nbsp;essas&nbsp;variantes</td><td class="diff_next"></td><td class="diff_header" id="to62_743">743</td><td nowrap="nowrap">mente&nbsp;relacionadas&nbsp;ao&nbsp;escape&nbsp;da&nbsp;imunidade&nbsp;induzida&nbsp;por&nbsp;vacinação,&nbsp;essas&nbsp;variantes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_754">754</td><td nowrap="nowrap">se&nbsp;mantêm&nbsp;em&nbsp;baixos&nbsp;títulos,&nbsp;não&nbsp;afetando,&nbsp;necessariamente,&nbsp;a&nbsp;recuperação&nbsp;clínica&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_744">744</td><td nowrap="nowrap">se&nbsp;mantêm&nbsp;em&nbsp;baixos&nbsp;títulos,&nbsp;não&nbsp;afetando,&nbsp;necessariamente,&nbsp;a&nbsp;recuperação&nbsp;clínica&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_755">755</td><td nowrap="nowrap">paciente.&nbsp;Mesmo&nbsp;na&nbsp;hepatite&nbsp;B&nbsp;crônica,&nbsp;tais&nbsp;variantes&nbsp;não&nbsp;são&nbsp;comuns,&nbsp;sendo&nbsp;observa-</td><td class="diff_next"></td><td class="diff_header" id="to62_745">745</td><td nowrap="nowrap">paciente.&nbsp;Mesmo&nbsp;na&nbsp;hepatite&nbsp;B&nbsp;crônica,&nbsp;tais&nbsp;variantes&nbsp;não&nbsp;são&nbsp;comuns,&nbsp;sendo&nbsp;observa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_756">756</td><td nowrap="nowrap">das&nbsp;apenas&nbsp;nos&nbsp;indivíduos&nbsp;que&nbsp;apresentam&nbsp;respostas&nbsp;imunes&nbsp;vigorosas&nbsp;e&nbsp;direcionadas,</td><td class="diff_next"></td><td class="diff_header" id="to62_746">746</td><td nowrap="nowrap">das&nbsp;apenas&nbsp;nos&nbsp;indivíduos&nbsp;que&nbsp;apresentam&nbsp;respostas&nbsp;imunes&nbsp;vigorosas&nbsp;e&nbsp;direcionadas,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_757">757</td><td nowrap="nowrap">o&nbsp;que&nbsp;pode&nbsp;exercer&nbsp;uma&nbsp;forte&nbsp;pressão&nbsp;seletiva&nbsp;sobre&nbsp;essas&nbsp;populações&nbsp;virais,&nbsp;possibili-</td><td class="diff_next"></td><td class="diff_header" id="to62_747">747</td><td nowrap="nowrap">o&nbsp;que&nbsp;pode&nbsp;exercer&nbsp;uma&nbsp;forte&nbsp;pressão&nbsp;seletiva&nbsp;sobre&nbsp;essas&nbsp;populações&nbsp;virais,&nbsp;possibili-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_758">758</td><td nowrap="nowrap">tando&nbsp;a&nbsp;sua&nbsp;emergência&nbsp;(GUIDOTTI&nbsp;et&nbsp;al.,&nbsp;1996;&nbsp;REHERMANN&nbsp;et&nbsp;al.,&nbsp;1995).</td><td class="diff_next"></td><td class="diff_header" id="to62_748">748</td><td nowrap="nowrap">tando&nbsp;a&nbsp;sua&nbsp;emergência&nbsp;(GUIDOTTI&nbsp;et&nbsp;al.,&nbsp;1996;&nbsp;REHERMANN&nbsp;et&nbsp;al.,&nbsp;1995).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_759">759</td><td nowrap="nowrap">9.6&nbsp;Diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_749">749</td><td nowrap="nowrap">9.6&nbsp;Diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_760">760</td><td nowrap="nowrap">indicar&nbsp;diferentes&nbsp;estágios&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV:&nbsp;infecção&nbsp;aguda,&nbsp;infecção&nbsp;crônica,&nbsp;res-</td><td class="diff_next"></td><td class="diff_header" id="to62_750">750</td><td nowrap="nowrap">indicar&nbsp;diferentes&nbsp;estágios&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV:&nbsp;infecção&nbsp;aguda,&nbsp;infecção&nbsp;crônica,&nbsp;res-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_761">761</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;B,&nbsp;o&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;recomenda&nbsp;a&nbsp;execução&nbsp;dos&nbsp;flu-</td><td class="diff_next"></td><td class="diff_header" id="to62_751">751</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;B,&nbsp;o&nbsp;Ministério&nbsp;da&nbsp;Saúde&nbsp;recomenda&nbsp;a&nbsp;execução&nbsp;dos&nbsp;flu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_762">762</td><td nowrap="nowrap">xogramas&nbsp;de&nbsp;diagnóstico&nbsp;ilustrados&nbsp;nos&nbsp;itens&nbsp;9.7.1,&nbsp;9.7.2&nbsp;ou&nbsp;9.7.3&nbsp;a&nbsp;fim&nbsp;de&nbsp;tornar&nbsp;rápi-</td><td class="diff_next"></td><td class="diff_header" id="to62_752">752</td><td nowrap="nowrap">xogramas&nbsp;de&nbsp;diagnóstico&nbsp;ilustrados&nbsp;nos&nbsp;itens&nbsp;9.7.1,&nbsp;9.7.2&nbsp;ou&nbsp;9.7.3&nbsp;a&nbsp;fim&nbsp;de&nbsp;tornar&nbsp;rápi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_763">763</td><td nowrap="nowrap">do&nbsp;o&nbsp;encaminhamento&nbsp;do&nbsp;paciente&nbsp;a&nbsp;um&nbsp;especialista,&nbsp;quando&nbsp;necessário.&nbsp;A&nbsp;solicitação</td><td class="diff_next"></td><td class="diff_header" id="to62_753">753</td><td nowrap="nowrap">do&nbsp;o&nbsp;encaminhamento&nbsp;do&nbsp;paciente&nbsp;a&nbsp;um&nbsp;especialista,&nbsp;quando&nbsp;necessário.&nbsp;A&nbsp;solicitação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_764">764</td><td nowrap="nowrap">pelo&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;B&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,</td><td class="diff_next"></td><td class="diff_header" id="to62_754">754</td><td nowrap="nowrap">pelo&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;B&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_765">765</td><td nowrap="nowrap">2017c).&nbsp;Quando&nbsp;da&nbsp;solicitação&nbsp;de&nbsp;marcadores&nbsp;da&nbsp;infecção,&nbsp;é&nbsp;preciso&nbsp;sempre&nbsp;ponderar&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_755">755</td><td nowrap="nowrap">2017c).&nbsp;Quando&nbsp;da&nbsp;solicitação&nbsp;de&nbsp;marcadores&nbsp;da&nbsp;infecção,&nbsp;é&nbsp;preciso&nbsp;sempre&nbsp;ponderar&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_766">766</td><td nowrap="nowrap">critério&nbsp;para&nbsp;definição&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;crônica,&nbsp;que&nbsp;é&nbsp;a&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;em&nbsp;dois&nbsp;exames</td><td class="diff_next"></td><td class="diff_header" id="to62_756">756</td><td nowrap="nowrap">critério&nbsp;para&nbsp;definição&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;crônica,&nbsp;que&nbsp;é&nbsp;a&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;em&nbsp;dois&nbsp;exames</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_767">767</td><td nowrap="nowrap">consecutivos,&nbsp;executados&nbsp;em&nbsp;um&nbsp;espaço&nbsp;de&nbsp;pelo&nbsp;menos&nbsp;seis&nbsp;meses.</td><td class="diff_next"></td><td class="diff_header" id="to62_757">757</td><td nowrap="nowrap">consecutivos,&nbsp;executados&nbsp;em&nbsp;um&nbsp;espaço&nbsp;de&nbsp;pelo&nbsp;menos&nbsp;seis&nbsp;meses.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_768">768</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente&nbsp;Ausência&nbsp;de&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;HBV</td><td class="diff_next"></td><td class="diff_header" id="to62_758">758</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente&nbsp;Ausência&nbsp;de&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;HBV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_769">769</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Não&nbsp;reagente&nbsp;Susceptível&nbsp;à&nbsp;infecção&nbsp;pelo&nbsp;HBV</td><td class="diff_next"></td><td class="diff_header" id="to62_759">759</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Não&nbsp;reagente&nbsp;Susceptível&nbsp;à&nbsp;infecção&nbsp;pelo&nbsp;HBV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_770">770</td><td nowrap="nowrap">Anti-HBs&nbsp;Não&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_760">760</td><td nowrap="nowrap">Anti-HBs&nbsp;Não&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_771">771</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_761">761</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_772">772</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_762">762</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_773">773</td><td nowrap="nowrap">Anti-HBs&nbsp;Reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_763">763</td><td nowrap="nowrap">Anti-HBs&nbsp;Reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_774">774</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_764">764</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_775">775</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Não&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_765">765</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Não&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_776">776</td><td nowrap="nowrap">Anti-HBs&nbsp;Reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_766">766</td><td nowrap="nowrap">Anti-HBs&nbsp;Reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_777">777</td><td nowrap="nowrap">HBsAg1&nbsp;Reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_767">767</td><td nowrap="nowrap">HBsAg1&nbsp;Reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_778">778</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Reagente&nbsp;Infecção&nbsp;recente&nbsp;pelo&nbsp;HBV&nbsp;(menos&nbsp;de&nbsp;seis</td><td class="diff_next"></td><td class="diff_header" id="to62_768">768</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Reagente&nbsp;Infecção&nbsp;recente&nbsp;pelo&nbsp;HBV&nbsp;(menos&nbsp;de&nbsp;seis</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_779">779</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Reagente/Não&nbsp;reagent&nbsp;meses)</td><td class="diff_next"></td><td class="diff_header" id="to62_769">769</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Reagente/Não&nbsp;reagent&nbsp;meses)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_780">780</td><td nowrap="nowrap">Anti-HBs&nbsp;Não&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_770">770</td><td nowrap="nowrap">Anti-HBs&nbsp;Não&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_781">781</td><td nowrap="nowrap">HBsAg1&nbsp;Reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_771">771</td><td nowrap="nowrap">HBsAg1&nbsp;Reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_782">782</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_772">772</td><td nowrap="nowrap">Anti-HBc&nbsp;IgM&nbsp;Não&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_783">783</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Reagente/Não&nbsp;reagent</td><td class="diff_next"></td><td class="diff_header" id="to62_773">773</td><td nowrap="nowrap">Anti-HBc&nbsp;total&nbsp;Reagente/Não&nbsp;reagent</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_784">784</td><td nowrap="nowrap">Anti-HBs&nbsp;Não&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_774">774</td><td nowrap="nowrap">Anti-HBs&nbsp;Não&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_785">785</td><td nowrap="nowrap">Fonte:&nbsp;DA&nbsp;CONCEIÇÃO;&nbsp;SICILIANO;&nbsp;FOCACCIA,&nbsp;2013.</td><td class="diff_next"></td><td class="diff_header" id="to62_775">775</td><td nowrap="nowrap">Fonte:&nbsp;DA&nbsp;CONCEIÇÃO;&nbsp;SICILIANO;&nbsp;FOCACCIA,&nbsp;2013.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_786">786</td><td nowrap="nowrap">1A&nbsp;hepatite&nbsp;B&nbsp;crônica&nbsp;é&nbsp;definida&nbsp;pela&nbsp;presença&nbsp;continuada&nbsp;do&nbsp;HBsAg&nbsp;no&nbsp;sangue&nbsp;por&nbsp;um&nbsp;período&nbsp;superior&nbsp;a&nbsp;seis&nbsp;meses.</td><td class="diff_next"></td><td class="diff_header" id="to62_776">776</td><td nowrap="nowrap">1A&nbsp;hepatite&nbsp;B&nbsp;crônica&nbsp;é&nbsp;definida&nbsp;pela&nbsp;presença&nbsp;continuada&nbsp;do&nbsp;HBsAg&nbsp;no&nbsp;sangue&nbsp;por&nbsp;um&nbsp;período&nbsp;superior&nbsp;a&nbsp;seis&nbsp;meses.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_787">787</td><td nowrap="nowrap">Os&nbsp;marcadores&nbsp;sorológicos&nbsp;circulantes&nbsp;podem&nbsp;ser&nbsp;detectados&nbsp;no&nbsp;soro,&nbsp;plasma&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_777">777</td><td nowrap="nowrap">Os&nbsp;marcadores&nbsp;sorológicos&nbsp;circulantes&nbsp;podem&nbsp;ser&nbsp;detectados&nbsp;no&nbsp;soro,&nbsp;plasma&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_788">788</td><td nowrap="nowrap">sangue&nbsp;de&nbsp;pacientes&nbsp;infectados,&nbsp;por&nbsp;meio&nbsp;de&nbsp;imunoensaios&nbsp;que&nbsp;apresentam,&nbsp;em&nbsp;média,</td><td class="diff_next"></td><td class="diff_header" id="to62_778">778</td><td nowrap="nowrap">sangue&nbsp;de&nbsp;pacientes&nbsp;infectados,&nbsp;por&nbsp;meio&nbsp;de&nbsp;imunoensaios&nbsp;que&nbsp;apresentam,&nbsp;em&nbsp;média,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_789">789</td><td nowrap="nowrap">especificidade&nbsp;acima&nbsp;de&nbsp;99%&nbsp;e&nbsp;sensibilidade&nbsp;acima&nbsp;de&nbsp;98%.&nbsp;O&nbsp;HBsAg&nbsp;também&nbsp;pode&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_779">779</td><td nowrap="nowrap">especificidade&nbsp;acima&nbsp;de&nbsp;99%&nbsp;e&nbsp;sensibilidade&nbsp;acima&nbsp;de&nbsp;98%.&nbsp;O&nbsp;HBsAg&nbsp;também&nbsp;pode&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_790">790</td><td nowrap="nowrap">detectado&nbsp;por&nbsp;meio&nbsp;de&nbsp;testes&nbsp;rápidos&nbsp;(TR),&nbsp;que&nbsp;usam&nbsp;a&nbsp;tecnologia&nbsp;de&nbsp;imunocromato-</td><td class="diff_next"></td><td class="diff_header" id="to62_780">780</td><td nowrap="nowrap">detectado&nbsp;por&nbsp;meio&nbsp;de&nbsp;testes&nbsp;rápidos&nbsp;(TR),&nbsp;que&nbsp;usam&nbsp;a&nbsp;tecnologia&nbsp;de&nbsp;imunocromato-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_791">791</td><td nowrap="nowrap">grafia&nbsp;de&nbsp;fluxo&nbsp;lateral.</td><td class="diff_next"></td><td class="diff_header" id="to62_781">781</td><td nowrap="nowrap">grafia&nbsp;de&nbsp;fluxo&nbsp;lateral.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_792">792</td><td nowrap="nowrap">HBsAg,&nbsp;enquanto&nbsp;o&nbsp;anti-HBc&nbsp;é&nbsp;detectado&nbsp;apenas&nbsp;por&nbsp;imunoensaio&nbsp;laboratorial.&nbsp;Com</td><td class="diff_next"></td><td class="diff_header" id="to62_782">782</td><td nowrap="nowrap">HBsAg,&nbsp;enquanto&nbsp;o&nbsp;anti-HBc&nbsp;é&nbsp;detectado&nbsp;apenas&nbsp;por&nbsp;imunoensaio&nbsp;laboratorial.&nbsp;Com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_793">793</td><td nowrap="nowrap">raras&nbsp;exceções,&nbsp;ambos&nbsp;os&nbsp;marcadores&nbsp;estão&nbsp;presentes&nbsp;em&nbsp;todas&nbsp;as&nbsp;fases&nbsp;da&nbsp;infecção</td><td class="diff_next"></td><td class="diff_header" id="to62_783">783</td><td nowrap="nowrap">raras&nbsp;exceções,&nbsp;ambos&nbsp;os&nbsp;marcadores&nbsp;estão&nbsp;presentes&nbsp;em&nbsp;todas&nbsp;as&nbsp;fases&nbsp;da&nbsp;infecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_794">794</td><td nowrap="nowrap">pelo&nbsp;HBV.</td><td class="diff_next"></td><td class="diff_header" id="to62_784">784</td><td nowrap="nowrap">pelo&nbsp;HBV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_795">795</td><td nowrap="nowrap">No&nbsp;curso&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;o&nbsp;HBsAg&nbsp;é&nbsp;produzido&nbsp;em&nbsp;grandes&nbsp;quantidades&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_785">785</td><td nowrap="nowrap">No&nbsp;curso&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;o&nbsp;HBsAg&nbsp;é&nbsp;produzido&nbsp;em&nbsp;grandes&nbsp;quantidades&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_796">796</td><td nowrap="nowrap">pode&nbsp;ser&nbsp;detectado&nbsp;no&nbsp;sangue&nbsp;da&nbsp;maioria&nbsp;dos&nbsp;indivíduos&nbsp;infectados&nbsp;cerca&nbsp;de&nbsp;30&nbsp;dias</td><td class="diff_next"></td><td class="diff_header" id="to62_786">786</td><td nowrap="nowrap">pode&nbsp;ser&nbsp;detectado&nbsp;no&nbsp;sangue&nbsp;da&nbsp;maioria&nbsp;dos&nbsp;indivíduos&nbsp;infectados&nbsp;cerca&nbsp;de&nbsp;30&nbsp;dias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_797">797</td><td nowrap="nowrap">após&nbsp;a&nbsp;infecção.&nbsp;A&nbsp;cronificação&nbsp;da&nbsp;infecção&nbsp;é&nbsp;definida&nbsp;pela&nbsp;persistência&nbsp;do&nbsp;vírus,&nbsp;ou&nbsp;seja,</td><td class="diff_next"></td><td class="diff_header" id="to62_787">787</td><td nowrap="nowrap">após&nbsp;a&nbsp;infecção.&nbsp;A&nbsp;cronificação&nbsp;da&nbsp;infecção&nbsp;é&nbsp;definida&nbsp;pela&nbsp;persistência&nbsp;do&nbsp;vírus,&nbsp;ou&nbsp;seja,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_798">798</td><td nowrap="nowrap">pela&nbsp;presença&nbsp;do&nbsp;HBsAg&nbsp;por&nbsp;mais&nbsp;de&nbsp;seis&nbsp;meses,&nbsp;detectada&nbsp;por&nbsp;meio&nbsp;de&nbsp;testes&nbsp;labo-</td><td class="diff_next"></td><td class="diff_header" id="to62_788">788</td><td nowrap="nowrap">pela&nbsp;presença&nbsp;do&nbsp;HBsAg&nbsp;por&nbsp;mais&nbsp;de&nbsp;seis&nbsp;meses,&nbsp;detectada&nbsp;por&nbsp;meio&nbsp;de&nbsp;testes&nbsp;labo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_799">799</td><td nowrap="nowrap">ratoriais&nbsp;ou&nbsp;TR.&nbsp;O&nbsp;anti-HBc&nbsp;total,&nbsp;isoladamente,&nbsp;indica&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;vírus.&nbsp;Por</td><td class="diff_next"></td><td class="diff_header" id="to62_789">789</td><td nowrap="nowrap">ratoriais&nbsp;ou&nbsp;TR.&nbsp;O&nbsp;anti-HBc&nbsp;total,&nbsp;isoladamente,&nbsp;indica&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;vírus.&nbsp;Por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_800">800</td><td nowrap="nowrap">isso,&nbsp;o&nbsp;resultado&nbsp;reagente&nbsp;desse&nbsp;marcador&nbsp;não&nbsp;pode&nbsp;ser&nbsp;interpretado&nbsp;sem&nbsp;a&nbsp;realização</td><td class="diff_next"></td><td class="diff_header" id="to62_790">790</td><td nowrap="nowrap">isso,&nbsp;o&nbsp;resultado&nbsp;reagente&nbsp;desse&nbsp;marcador&nbsp;não&nbsp;pode&nbsp;ser&nbsp;interpretado&nbsp;sem&nbsp;a&nbsp;realização</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_801">801</td><td nowrap="nowrap">de&nbsp;outros&nbsp;marcadores&nbsp;diretos&nbsp;da&nbsp;presença&nbsp;do&nbsp;vírus.&nbsp;Além&nbsp;disso,&nbsp;a&nbsp;janela&nbsp;imunológicaG</td><td class="diff_next"></td><td class="diff_header" id="to62_791">791</td><td nowrap="nowrap">de&nbsp;outros&nbsp;marcadores&nbsp;diretos&nbsp;da&nbsp;presença&nbsp;do&nbsp;vírus.&nbsp;Além&nbsp;disso,&nbsp;a&nbsp;janela&nbsp;imunológicaG</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_802">802</td><td nowrap="nowrap">para&nbsp;os&nbsp;anticorpos&nbsp;contra&nbsp;o&nbsp;core&nbsp;viral&nbsp;é&nbsp;de&nbsp;aproximadamente&nbsp;45&nbsp;dias,&nbsp;posterior&nbsp;ao&nbsp;apa-</td><td class="diff_next"></td><td class="diff_header" id="to62_792">792</td><td nowrap="nowrap">para&nbsp;os&nbsp;anticorpos&nbsp;contra&nbsp;o&nbsp;core&nbsp;viral&nbsp;é&nbsp;de&nbsp;aproximadamente&nbsp;45&nbsp;dias,&nbsp;posterior&nbsp;ao&nbsp;apa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_803">803</td><td nowrap="nowrap">recimento&nbsp;do&nbsp;HBsAg.</td><td class="diff_next"></td><td class="diff_header" id="to62_793">793</td><td nowrap="nowrap">recimento&nbsp;do&nbsp;HBsAg.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_804">804</td><td nowrap="nowrap">Além&nbsp;dos&nbsp;imunoensaios&nbsp;laboratoriais&nbsp;e&nbsp;dos&nbsp;TR,&nbsp;os&nbsp;testes&nbsp;moleculares&nbsp;oferecem&nbsp;uma</td><td class="diff_next"></td><td class="diff_header" id="to62_794">794</td><td nowrap="nowrap">Além&nbsp;dos&nbsp;imunoensaios&nbsp;laboratoriais&nbsp;e&nbsp;dos&nbsp;TR,&nbsp;os&nbsp;testes&nbsp;moleculares&nbsp;oferecem&nbsp;uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_805">805</td><td nowrap="nowrap">alternativa&nbsp;para&nbsp;a&nbsp;detecção&nbsp;cada&nbsp;vez&nbsp;mais&nbsp;precoce&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV.&nbsp;Esses&nbsp;ensaios</td><td class="diff_next"></td><td class="diff_header" id="to62_795">795</td><td nowrap="nowrap">alternativa&nbsp;para&nbsp;a&nbsp;detecção&nbsp;cada&nbsp;vez&nbsp;mais&nbsp;precoce&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV.&nbsp;Esses&nbsp;ensaios</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_806">806</td><td nowrap="nowrap">também&nbsp;servem&nbsp;para&nbsp;a&nbsp;confirmação&nbsp;de&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;em&nbsp;que&nbsp;o&nbsp;HBsAg&nbsp;não&nbsp;é&nbsp;de-</td><td class="diff_next"></td><td class="diff_header" id="to62_796">796</td><td nowrap="nowrap">também&nbsp;servem&nbsp;para&nbsp;a&nbsp;confirmação&nbsp;de&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;em&nbsp;que&nbsp;o&nbsp;HBsAg&nbsp;não&nbsp;é&nbsp;de-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_807">807</td><td nowrap="nowrap">tectado,&nbsp;como,&nbsp;por&nbsp;exemplo,&nbsp;nos&nbsp;casos&nbsp;de&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;HBV.</td><td class="diff_next"></td><td class="diff_header" id="to62_797">797</td><td nowrap="nowrap">tectado,&nbsp;como,&nbsp;por&nbsp;exemplo,&nbsp;nos&nbsp;casos&nbsp;de&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;HBV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_808">808</td><td nowrap="nowrap">real,&nbsp;que&nbsp;possuem&nbsp;limite&nbsp;de&nbsp;detecção&nbsp;médio&nbsp;de&nbsp;10&nbsp;UI/mL&nbsp;de&nbsp;plasma&nbsp;ou&nbsp;soro&nbsp;e&nbsp;especifi-</td><td class="diff_next"></td><td class="diff_header" id="to62_798">798</td><td nowrap="nowrap">real,&nbsp;que&nbsp;possuem&nbsp;limite&nbsp;de&nbsp;detecção&nbsp;médio&nbsp;de&nbsp;10&nbsp;UI/mL&nbsp;de&nbsp;plasma&nbsp;ou&nbsp;soro&nbsp;e&nbsp;especifi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_809">809</td><td nowrap="nowrap">cidade&nbsp;acima&nbsp;de&nbsp;99%&nbsp;(CALIENDO&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;ISMAIL&nbsp;et&nbsp;al.,&nbsp;2011).</td><td class="diff_next"></td><td class="diff_header" id="to62_799">799</td><td nowrap="nowrap">cidade&nbsp;acima&nbsp;de&nbsp;99%&nbsp;(CALIENDO&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;ISMAIL&nbsp;et&nbsp;al.,&nbsp;2011).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_810">810</td><td nowrap="nowrap">Conforme&nbsp;a&nbsp;Portaria&nbsp;MS&nbsp;nº&nbsp;158,&nbsp;de&nbsp;4&nbsp;de&nbsp;fevereiro&nbsp;de&nbsp;2016&nbsp;(DOU&nbsp;05/02/2016,&nbsp;nº&nbsp;25,</td><td class="diff_next"></td><td class="diff_header" id="to62_800">800</td><td nowrap="nowrap">Conforme&nbsp;a&nbsp;Portaria&nbsp;MS&nbsp;nº&nbsp;158,&nbsp;de&nbsp;4&nbsp;de&nbsp;fevereiro&nbsp;de&nbsp;2016&nbsp;(DOU&nbsp;05/02/2016,&nbsp;nº&nbsp;25,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_811">811</td><td nowrap="nowrap">seção&nbsp;1,&nbsp;pág.&nbsp;37),&nbsp;amostras&nbsp;de&nbsp;banco&nbsp;de&nbsp;sangue&nbsp;devem&nbsp;ser&nbsp;investigadas&nbsp;utilizando&nbsp;testes</td><td class="diff_next"></td><td class="diff_header" id="to62_801">801</td><td nowrap="nowrap">seção&nbsp;1,&nbsp;pág.&nbsp;37),&nbsp;amostras&nbsp;de&nbsp;banco&nbsp;de&nbsp;sangue&nbsp;devem&nbsp;ser&nbsp;investigadas&nbsp;utilizando&nbsp;testes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_812">812</td><td nowrap="nowrap">de&nbsp;ácidos&nbsp;nucleicos&nbsp;(NAT).&nbsp;Indivíduos&nbsp;com&nbsp;amostras&nbsp;reagentes&nbsp;para&nbsp;ambos&nbsp;os&nbsp;marcado-</td><td class="diff_next"></td><td class="diff_header" id="to62_802">802</td><td nowrap="nowrap">de&nbsp;ácidos&nbsp;nucleicos&nbsp;(NAT).&nbsp;Indivíduos&nbsp;com&nbsp;amostras&nbsp;reagentes&nbsp;para&nbsp;ambos&nbsp;os&nbsp;marcado-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_813">813</td><td nowrap="nowrap">ser&nbsp;avaliado.&nbsp;Amostras&nbsp;reagentes&nbsp;para&nbsp;apenas&nbsp;um&nbsp;dos&nbsp;marcadores&nbsp;devem&nbsp;também&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_803">803</td><td nowrap="nowrap">ser&nbsp;avaliado.&nbsp;Amostras&nbsp;reagentes&nbsp;para&nbsp;apenas&nbsp;um&nbsp;dos&nbsp;marcadores&nbsp;devem&nbsp;também&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_814">814</td><td nowrap="nowrap">encaminhadas&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde&nbsp;para&nbsp;confirmação&nbsp;diagnóstica,&nbsp;usando&nbsp;um&nbsp;dos&nbsp;fluxo-</td><td class="diff_next"></td><td class="diff_header" id="to62_804">804</td><td nowrap="nowrap">encaminhadas&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde&nbsp;para&nbsp;confirmação&nbsp;diagnóstica,&nbsp;usando&nbsp;um&nbsp;dos&nbsp;fluxo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_815">815</td><td nowrap="nowrap">gramas&nbsp;disponíveis&nbsp;e&nbsp;avaliando&nbsp;a&nbsp;necessidade&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;indivíduo.</td><td class="diff_next"></td><td class="diff_header" id="to62_805">805</td><td nowrap="nowrap">gramas&nbsp;disponíveis&nbsp;e&nbsp;avaliando&nbsp;a&nbsp;necessidade&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;indivíduo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_816">816</td><td nowrap="nowrap">Diante&nbsp;da&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B,&nbsp;o&nbsp;Ministério&nbsp;da&nbsp;Saúde</td><td class="diff_next"></td><td class="diff_header" id="to62_806">806</td><td nowrap="nowrap">Diante&nbsp;da&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B,&nbsp;o&nbsp;Ministério&nbsp;da&nbsp;Saúde</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_817">817</td><td nowrap="nowrap">recomenda&nbsp;a&nbsp;execução&nbsp;dos&nbsp;fluxogramas&nbsp;de&nbsp;diagnóstico&nbsp;ilustrados&nbsp;nos&nbsp;itens&nbsp;9.7.1,</td><td class="diff_next"></td><td class="diff_header" id="to62_807">807</td><td nowrap="nowrap">recomenda&nbsp;a&nbsp;execução&nbsp;dos&nbsp;fluxogramas&nbsp;de&nbsp;diagnóstico&nbsp;ilustrados&nbsp;nos&nbsp;itens&nbsp;9.7.1,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_818">818</td><td nowrap="nowrap">9.7.2&nbsp;ou&nbsp;9.7.3&nbsp;deste&nbsp;Manual&nbsp;Técnico,&nbsp;a&nbsp;fim&nbsp;de&nbsp;tornar&nbsp;rápido&nbsp;o&nbsp;encaminhamento&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_808">808</td><td nowrap="nowrap">9.7.2&nbsp;ou&nbsp;9.7.3&nbsp;deste&nbsp;Manual&nbsp;Técnico,&nbsp;a&nbsp;fim&nbsp;de&nbsp;tornar&nbsp;rápido&nbsp;o&nbsp;encaminhamento&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_819">819</td><td nowrap="nowrap">paciente&nbsp;a&nbsp;um&nbsp;especialista,&nbsp;quando&nbsp;necessário.</td><td class="diff_next"></td><td class="diff_header" id="to62_809">809</td><td nowrap="nowrap">paciente&nbsp;a&nbsp;um&nbsp;especialista,&nbsp;quando&nbsp;necessário.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_820">820</td><td nowrap="nowrap">A&nbsp;solicitação&nbsp;de&nbsp;marcadores&nbsp;para&nbsp;o&nbsp;estadiamento&nbsp;da&nbsp;doença&nbsp;deve&nbsp;ser&nbsp;fei-</td><td class="diff_next"></td><td class="diff_header" id="to62_810">810</td><td nowrap="nowrap">A&nbsp;solicitação&nbsp;de&nbsp;marcadores&nbsp;para&nbsp;o&nbsp;estadiamento&nbsp;da&nbsp;doença&nbsp;deve&nbsp;ser&nbsp;fei-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_821">821</td><td nowrap="nowrap">ta&nbsp;conforme&nbsp;preconizado&nbsp;pelo&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_811">811</td><td nowrap="nowrap">ta&nbsp;conforme&nbsp;preconizado&nbsp;pelo&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_822">822</td><td nowrap="nowrap">Hepatite&nbsp;B&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,&nbsp;2017c).&nbsp;Marcadores&nbsp;como&nbsp;o&nbsp;HBeAg&nbsp;e&nbsp;anti-HBe</td><td class="diff_next"></td><td class="diff_header" id="to62_812">812</td><td nowrap="nowrap">Hepatite&nbsp;B&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,&nbsp;2017c).&nbsp;Marcadores&nbsp;como&nbsp;o&nbsp;HBeAg&nbsp;e&nbsp;anti-HBe</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_823">823</td><td nowrap="nowrap">tem&nbsp;relevância&nbsp;para&nbsp;avaliar&nbsp;o&nbsp;desfecho&nbsp;da&nbsp;infecção&nbsp;no&nbsp;indivíduo.&nbsp;Não&nbsp;é&nbsp;recomen-</td><td class="diff_next"></td><td class="diff_header" id="to62_813">813</td><td nowrap="nowrap">tem&nbsp;relevância&nbsp;para&nbsp;avaliar&nbsp;o&nbsp;desfecho&nbsp;da&nbsp;infecção&nbsp;no&nbsp;indivíduo.&nbsp;Não&nbsp;é&nbsp;recomen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_824">824</td><td nowrap="nowrap">pelo&nbsp;HBV&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;confirmado.</td><td class="diff_next"></td><td class="diff_header" id="to62_814">814</td><td nowrap="nowrap">pelo&nbsp;HBV&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;confirmado.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_825">825</td><td nowrap="nowrap">9.7&nbsp;Fluxogramas&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td><td class="diff_next"></td><td class="diff_header" id="to62_815">815</td><td nowrap="nowrap">9.7&nbsp;Fluxogramas&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_826">826</td><td nowrap="nowrap">Os&nbsp;fluxogramas&nbsp;propostos&nbsp;a&nbsp;seguir&nbsp;incorporam&nbsp;as&nbsp;considerações&nbsp;acima&nbsp;descritas,</td><td class="diff_next"></td><td class="diff_header" id="to62_816">816</td><td nowrap="nowrap">Os&nbsp;fluxogramas&nbsp;propostos&nbsp;a&nbsp;seguir&nbsp;incorporam&nbsp;as&nbsp;considerações&nbsp;acima&nbsp;descritas,</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__17"></td><td class="diff_header" id="from62_827">827</td><td nowrap="nowrap">com&nbsp;o&nbsp;intuito&nbsp;de&nbsp;propiciar,&nbsp;o&nbsp;mais&nbsp;precocemente&nbsp;possível,&nbsp;a&nbsp;detecção&nbsp;da&nbsp;infecção&nbsp;pelo</td><td class="diff_next"></td><td class="diff_header" id="to62_817">817</td><td nowrap="nowrap">com&nbsp;o&nbsp;intuito&nbsp;de&nbsp;propiciar,&nbsp;o&nbsp;mais&nbsp;precocemente&nbsp;possível,&nbsp;a&nbsp;detecção&nbsp;da&nbsp;infecção&nbsp;pelo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_828">828</td><td nowrap="nowrap">HBV&nbsp;em&nbsp;indivíduos&nbsp;com&nbsp;doença&nbsp;crônica&nbsp;e&nbsp;aguda&nbsp;e,&nbsp;consequentemente,&nbsp;o&nbsp;seu&nbsp;encami-</td><td class="diff_next"></td><td class="diff_header" id="to62_818">818</td><td nowrap="nowrap">HBV&nbsp;em&nbsp;indivíduos&nbsp;com&nbsp;doença&nbsp;crônica&nbsp;e&nbsp;aguda&nbsp;e,&nbsp;consequentemente,&nbsp;o&nbsp;seu&nbsp;encami-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_829">829</td><td nowrap="nowrap">nhamento&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;assistência&nbsp;médica.&nbsp;A&nbsp;proposta&nbsp;de&nbsp;vários&nbsp;fluxogramas&nbsp;tem&nbsp;o&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_819">819</td><td nowrap="nowrap">nhamento&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;assistência&nbsp;médica.&nbsp;A&nbsp;proposta&nbsp;de&nbsp;vários&nbsp;fluxogramas&nbsp;tem&nbsp;o&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_830">830</td><td nowrap="nowrap">tuito&nbsp;de&nbsp;oferecer&nbsp;opções&nbsp;que&nbsp;possam&nbsp;ser&nbsp;selecionadas&nbsp;de&nbsp;acordo&nbsp;com&nbsp;a&nbsp;realidade&nbsp;local,</td><td class="diff_next"></td><td class="diff_header" id="to62_820">820</td><td nowrap="nowrap">tuito&nbsp;de&nbsp;oferecer&nbsp;opções&nbsp;que&nbsp;possam&nbsp;ser&nbsp;selecionadas&nbsp;de&nbsp;acordo&nbsp;com&nbsp;a&nbsp;realidade&nbsp;local,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_831">831</td><td nowrap="nowrap">a&nbsp;capacidade&nbsp;do&nbsp;laboratório&nbsp;e&nbsp;o&nbsp;contexto&nbsp;clínico&nbsp;envolvido.</td><td class="diff_next"></td><td class="diff_header" id="to62_821">821</td><td nowrap="nowrap">a&nbsp;capacidade&nbsp;do&nbsp;laboratório&nbsp;e&nbsp;o&nbsp;contexto&nbsp;clínico&nbsp;envolvido.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__18">n</a></td><td class="diff_header" id="from62_832">832</td><td nowrap="nowrap">9.7.1&nbsp;Fluxograma&nbsp;1&nbsp;<span class="diff_chg">–</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;usando&nbsp;testes</td><td class="diff_next"><a href="#difflib_chg_to62__18">n</a></td><td class="diff_header" id="to62_822">822</td><td nowrap="nowrap">9.7.1&nbsp;Fluxograma&nbsp;1&nbsp;<span class="diff_chg">-</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;usando&nbsp;testes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_833">833</td><td nowrap="nowrap">Os&nbsp;TR&nbsp;são&nbsp;ferramentas&nbsp;importantes&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;das&nbsp;possibilidades&nbsp;de&nbsp;diag-</td><td class="diff_next"></td><td class="diff_header" id="to62_823">823</td><td nowrap="nowrap">Os&nbsp;TR&nbsp;são&nbsp;ferramentas&nbsp;importantes&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;das&nbsp;possibilidades&nbsp;de&nbsp;diag-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_834">834</td><td nowrap="nowrap">nóstico&nbsp;para&nbsp;diversos&nbsp;agravos.&nbsp;Quando&nbsp;houver&nbsp;a&nbsp;possibilidade&nbsp;de&nbsp;testagem&nbsp;presencial</td><td class="diff_next"></td><td class="diff_header" id="to62_824">824</td><td nowrap="nowrap">nóstico&nbsp;para&nbsp;diversos&nbsp;agravos.&nbsp;Quando&nbsp;houver&nbsp;a&nbsp;possibilidade&nbsp;de&nbsp;testagem&nbsp;presencial</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_835">835</td><td nowrap="nowrap">em&nbsp;unidades&nbsp;de&nbsp;saúde,&nbsp;esses&nbsp;testes&nbsp;permitem&nbsp;identificar&nbsp;oportunamente&nbsp;o&nbsp;indivíduo</td><td class="diff_next"></td><td class="diff_header" id="to62_825">825</td><td nowrap="nowrap">em&nbsp;unidades&nbsp;de&nbsp;saúde,&nbsp;esses&nbsp;testes&nbsp;permitem&nbsp;identificar&nbsp;oportunamente&nbsp;o&nbsp;indivíduo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_836">836</td><td nowrap="nowrap">diagnóstica&nbsp;e&nbsp;para&nbsp;a&nbsp;vinculação&nbsp;da&nbsp;pessoa&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.&nbsp;O&nbsp;Fluxograma&nbsp;1&nbsp;(Figura</td><td class="diff_next"></td><td class="diff_header" id="to62_826">826</td><td nowrap="nowrap">diagnóstica&nbsp;e&nbsp;para&nbsp;a&nbsp;vinculação&nbsp;da&nbsp;pessoa&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.&nbsp;O&nbsp;Fluxograma&nbsp;1&nbsp;(Figura</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_837">837</td><td nowrap="nowrap">10)&nbsp;emprega&nbsp;um&nbsp;teste&nbsp;rápido&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;HBsAg&nbsp;em&nbsp;amostras&nbsp;de&nbsp;sangue&nbsp;total</td><td class="diff_next"></td><td class="diff_header" id="to62_827">827</td><td nowrap="nowrap">10)&nbsp;emprega&nbsp;um&nbsp;teste&nbsp;rápido&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;HBsAg&nbsp;em&nbsp;amostras&nbsp;de&nbsp;sangue&nbsp;total</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_838">838</td><td nowrap="nowrap">obtidas&nbsp;preferencialmente&nbsp;por&nbsp;punção&nbsp;digital.&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;indicado&nbsp;para&nbsp;uso&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_828">828</td><td nowrap="nowrap">obtidas&nbsp;preferencialmente&nbsp;por&nbsp;punção&nbsp;digital.&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;indicado&nbsp;para&nbsp;uso&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_839">839</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:32)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_829">829</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:32)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:31)(cid:8)(cid:35)(cid:8)(cid:36)(cid:25)(cid:37)(cid:2)(cid:13)(cid:</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:31)(cid:8)(cid:35)(cid:8)(cid:36)(cid:25)(cid:37)(cid:2)(cid:13)(cid:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:5)(cid:25)(cid:5)(cid:41)(cid:5)(cid:3)(cid:4)(cid:8)(cid:2</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:5)(cid:25)(cid:5)(cid:41)(cid:5)(cid:3)(cid:4)(cid:8)(cid:2</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__18"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">8)(cid:11)(cid:12)(cid:17)(cid:8)(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">8)(cid:11)(cid:12)(cid:17)(cid:8)(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_840">840</td><td nowrap="nowrap">serviços&nbsp;de&nbsp;saúde&nbsp;e&nbsp;assistência,&nbsp;permitindo&nbsp;a&nbsp;investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV.</td><td class="diff_next"></td><td class="diff_header" id="to62_830">830</td><td nowrap="nowrap">serviços&nbsp;de&nbsp;saúde&nbsp;e&nbsp;assistência,&nbsp;permitindo&nbsp;a&nbsp;investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_841">841</td><td nowrap="nowrap">(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:13)(cid:8)(cid:7)(cid:18)(cid:29)(cid:5)(cid:20)(cid:21)(cid:13)(cid:8)(cid:1</td><td class="diff_next"></td><td class="diff_header" id="to62_831">831</td><td nowrap="nowrap">(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:13)(cid:8)(cid:7)(cid:18)(cid:29)(cid:5)(cid:20)(cid:21)(cid:13)(cid:8)(cid:1</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:9)(cid:1)(cid:8)(cid:43)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:16)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:9)(cid:1)(cid:8)(cid:43)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:16)(cid:33)</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__19">n</a></td><td class="diff_header" id="from62_842">842</td><td nowrap="nowrap">Figura&nbsp;10.&nbsp;Fluxograma&nbsp;1&nbsp;<span class="diff_chg">–</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;utilizando&nbsp;testes&nbsp;rápidos&nbsp;(TR&nbsp;<span class="diff_chg">–</span>&nbsp;HBsAg)</td><td class="diff_next"><a href="#difflib_chg_to62__19">n</a></td><td class="diff_header" id="to62_832">832</td><td nowrap="nowrap">Figura&nbsp;10.&nbsp;Fluxograma&nbsp;1&nbsp;<span class="diff_chg">-</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;utilizando&nbsp;testes&nbsp;rápidos&nbsp;(TR&nbsp;<span class="diff_chg">-</span>&nbsp;HBsAg)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_843">843</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_833">833</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_844">844</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:16)</td><td class="diff_next"></td><td class="diff_header" id="to62_834">834</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_845">845</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_835">835</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_846">846</td><td nowrap="nowrap">(cid:10)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:16)</td><td class="diff_next"></td><td class="diff_header" id="to62_836">836</td><td nowrap="nowrap">(cid:10)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_847">847</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)&nbsp;(cid:6)(cid:7)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_837">837</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)&nbsp;(cid:6)(cid:7)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_848">848</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td><td class="diff_next"></td><td class="diff_header" id="to62_838">838</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:21)(cid:26)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:21)(cid:26)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_849">849</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:2)(cid:25)(cid:41</td><td class="diff_next"></td><td class="diff_header" id="to62_839">839</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:2)(cid:25)(cid:41</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:23)(cid:5)(cid:25)(cid:46)(cid:3)(cid:7)(cid:8)(cid:29)(cid:3)(cid:41)(cid:5)(cid:2)(cid:25)(cid:24)(cid:2)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:23)(cid:5)(cid:25)(cid:46)(cid:3)(cid:7)(cid:8)(cid:29)(cid:3)(cid:41)(cid:5)(cid:2)(cid:25)(cid:24)(cid:2)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_850">850</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:41)(cid:21)(cid:23)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_840">840</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:41)(cid:21)(cid:23)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">9)(cid:4)(cid:2)(cid:23)(cid:2)(cid:25)(cid:24)(cid:3)(cid:7)(cid:8)(cid:21)(cid:8)(cid:20)(cid:5)(cid:3)(cid:15)(cid:25</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">9)(cid:4)(cid:2)(cid:23)(cid:2)(cid:25)(cid:24)(cid:3)(cid:7)(cid:8)(cid:21)(cid:8)(cid:20)(cid:5)(cid:3)(cid:15)(cid:25</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:47)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:47)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_851">851</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td><td class="diff_next"></td><td class="diff_header" id="to62_841">841</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_852">852</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:29)(cid:2)(cid:24)(cid:5)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)&nbsp;(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_842">842</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:29)(cid:2)(cid:24)(cid:5)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)&nbsp;(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_853">853</td><td nowrap="nowrap">(cid:10)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:16)&nbsp;(cid:6)(cid:7)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_843">843</td><td nowrap="nowrap">(cid:10)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:16)&nbsp;(cid:6)(cid:7)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_854">854</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td><td class="diff_next"></td><td class="diff_header" id="to62_844">844</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_855">855</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)</td><td class="diff_next"></td><td class="diff_header" id="to62_845">845</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_856">856</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)</td><td class="diff_next"></td><td class="diff_header" id="to62_846">846</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_857">857</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_847">847</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_858">858</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td><td class="diff_next"></td><td class="diff_header" id="to62_848">848</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_859">859</td><td nowrap="nowrap">(cid:5)(cid:25)(cid:37)(cid:2)(cid:13)(cid:24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:4)(cid:3)(cid:45</td><td class="diff_next"></td><td class="diff_header" id="to62_849">849</td><td nowrap="nowrap">(cid:5)(cid:25)(cid:37)(cid:2)(cid:13)(cid:24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:4)(cid:3)(cid:45</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:21)(cid:7)(cid:3)(cid:24)(cid:21)(cid:7)(cid:5)(cid:3)(cid:4)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:21)(cid:7)(cid:3)(cid:24)(cid:21)(cid:7)(cid:5)(cid:3)(cid:4)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_860">860</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_850">850</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_861">861</td><td nowrap="nowrap">(cid:30)(cid:21)(cid:25)(cid:24)(cid:2)(cid:48)(cid:8)(cid:49)(cid:36)(cid:14)(cid:11)(cid:17)(cid:50)(cid:51)(cid:17)(c</td><td class="diff_next"></td><td class="diff_header" id="to62_851">851</td><td nowrap="nowrap">(cid:30)(cid:21)(cid:25)(cid:24)(cid:2)(cid:48)(cid:8)(cid:49)(cid:36)(cid:14)(cid:11)(cid:17)(cid:50)(cid:51)(cid:17)(c</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:51)(cid:50)(cid:52)(cid:51)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:51)(cid:50)(cid:52)(cid:51)(cid:33)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_862">862</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;1&nbsp;é&nbsp;indicado&nbsp;para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;item&nbsp;5.1.3&nbsp;deste&nbsp;Manual,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_852">852</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;1&nbsp;é&nbsp;indicado&nbsp;para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;item&nbsp;5.1.3&nbsp;deste&nbsp;Manual,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_863">863</td><td nowrap="nowrap">permite&nbsp;iniciar&nbsp;a&nbsp;investigação&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;em&nbsp;unidades&nbsp;de&nbsp;saúde&nbsp;que&nbsp;usem&nbsp;TR.</td><td class="diff_next"></td><td class="diff_header" id="to62_853">853</td><td nowrap="nowrap">permite&nbsp;iniciar&nbsp;a&nbsp;investigação&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;em&nbsp;unidades&nbsp;de&nbsp;saúde&nbsp;que&nbsp;usem&nbsp;TR.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_864">864</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;pode&nbsp;ser&nbsp;utilizado&nbsp;em&nbsp;gestantes&nbsp;e&nbsp;em&nbsp;indivíduos&nbsp;menores</td><td class="diff_next"></td><td class="diff_header" id="to62_854">854</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;pode&nbsp;ser&nbsp;utilizado&nbsp;em&nbsp;gestantes&nbsp;e&nbsp;em&nbsp;indivíduos&nbsp;menores</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_865">865</td><td nowrap="nowrap">de&nbsp;18&nbsp;meses.</td><td class="diff_next"></td><td class="diff_header" id="to62_855">855</td><td nowrap="nowrap">de&nbsp;18&nbsp;meses.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_866">866</td><td nowrap="nowrap">›&nbsp;A&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;é&nbsp;sugestiva&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HBV.</td><td class="diff_next"></td><td class="diff_header" id="to62_856">856</td><td nowrap="nowrap">›&nbsp;A&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;é&nbsp;sugestiva&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HBV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_867">867</td><td nowrap="nowrap">›&nbsp;Após&nbsp;a&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;por&nbsp;meio&nbsp;de&nbsp;TR,&nbsp;a&nbsp;complementação&nbsp;do&nbsp;diagnósti-</td><td class="diff_next"></td><td class="diff_header" id="to62_857">857</td><td nowrap="nowrap">›&nbsp;Após&nbsp;a&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;por&nbsp;meio&nbsp;de&nbsp;TR,&nbsp;a&nbsp;complementação&nbsp;do&nbsp;diagnósti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_868">868</td><td nowrap="nowrap">co&nbsp;deve&nbsp;ser&nbsp;feita&nbsp;utilizando&nbsp;testes&nbsp;laboratoriais&nbsp;conforme&nbsp;os&nbsp;Fluxogramas&nbsp;2&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_858">858</td><td nowrap="nowrap">co&nbsp;deve&nbsp;ser&nbsp;feita&nbsp;utilizando&nbsp;testes&nbsp;laboratoriais&nbsp;conforme&nbsp;os&nbsp;Fluxogramas&nbsp;2&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_869">869</td><td nowrap="nowrap">3.&nbsp;Não&nbsp;há&nbsp;necessidade&nbsp;de&nbsp;repetir&nbsp;a&nbsp;pesquisa&nbsp;de&nbsp;HBsAg.</td><td class="diff_next"></td><td class="diff_header" id="to62_859">859</td><td nowrap="nowrap">3.&nbsp;Não&nbsp;há&nbsp;necessidade&nbsp;de&nbsp;repetir&nbsp;a&nbsp;pesquisa&nbsp;de&nbsp;HBsAg.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_870">870</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,</td><td class="diff_next"></td><td class="diff_header" id="to62_860">860</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_871">871</td><td nowrap="nowrap">deve-se&nbsp;coletar&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;repetir&nbsp;o&nbsp;fluxograma.</td><td class="diff_next"></td><td class="diff_header" id="to62_861">861</td><td nowrap="nowrap">deve-se&nbsp;coletar&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;repetir&nbsp;o&nbsp;fluxograma.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_872">872</td><td nowrap="nowrap">Na&nbsp;testagem&nbsp;rápida,&nbsp;a&nbsp;coleta&nbsp;da&nbsp;amostra&nbsp;pode&nbsp;ser&nbsp;realizada&nbsp;por&nbsp;punção&nbsp;da&nbsp;polpa</td><td class="diff_next"></td><td class="diff_header" id="to62_862">862</td><td nowrap="nowrap">Na&nbsp;testagem&nbsp;rápida,&nbsp;a&nbsp;coleta&nbsp;da&nbsp;amostra&nbsp;pode&nbsp;ser&nbsp;realizada&nbsp;por&nbsp;punção&nbsp;da&nbsp;polpa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_873">873</td><td nowrap="nowrap">digital&nbsp;ou&nbsp;punção&nbsp;venosa.&nbsp;A&nbsp;maioria&nbsp;dos&nbsp;TR&nbsp;também&nbsp;permite&nbsp;a&nbsp;utilização&nbsp;de&nbsp;soro&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_863">863</td><td nowrap="nowrap">digital&nbsp;ou&nbsp;punção&nbsp;venosa.&nbsp;A&nbsp;maioria&nbsp;dos&nbsp;TR&nbsp;também&nbsp;permite&nbsp;a&nbsp;utilização&nbsp;de&nbsp;soro&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_874">874</td><td nowrap="nowrap">plasma&nbsp;como&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;do&nbsp;teste.&nbsp;Contudo,&nbsp;esse&nbsp;fluxograma&nbsp;é&nbsp;proposto</td><td class="diff_next"></td><td class="diff_header" id="to62_864">864</td><td nowrap="nowrap">plasma&nbsp;como&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;do&nbsp;teste.&nbsp;Contudo,&nbsp;esse&nbsp;fluxograma&nbsp;é&nbsp;proposto</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_875">875</td><td nowrap="nowrap">para&nbsp;quando&nbsp;a&nbsp;testagem&nbsp;rápida&nbsp;ocorre,&nbsp;preferencialmente,&nbsp;na&nbsp;presença&nbsp;do&nbsp;paciente.&nbsp;A</td><td class="diff_next"></td><td class="diff_header" id="to62_865">865</td><td nowrap="nowrap">para&nbsp;quando&nbsp;a&nbsp;testagem&nbsp;rápida&nbsp;ocorre,&nbsp;preferencialmente,&nbsp;na&nbsp;presença&nbsp;do&nbsp;paciente.&nbsp;A</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_876">876</td><td nowrap="nowrap">testagem&nbsp;presencial&nbsp;reduz&nbsp;o&nbsp;risco&nbsp;de&nbsp;troca&nbsp;de&nbsp;amostras&nbsp;e&nbsp;garante&nbsp;segurança&nbsp;para&nbsp;o&nbsp;indi-</td><td class="diff_next"></td><td class="diff_header" id="to62_866">866</td><td nowrap="nowrap">testagem&nbsp;presencial&nbsp;reduz&nbsp;o&nbsp;risco&nbsp;de&nbsp;troca&nbsp;de&nbsp;amostras&nbsp;e&nbsp;garante&nbsp;segurança&nbsp;para&nbsp;o&nbsp;indi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_877">877</td><td nowrap="nowrap">víduo&nbsp;que&nbsp;está&nbsp;sendo&nbsp;testado&nbsp;e&nbsp;para&nbsp;o&nbsp;profissional&nbsp;que&nbsp;executa&nbsp;o&nbsp;teste.</td><td class="diff_next"></td><td class="diff_header" id="to62_867">867</td><td nowrap="nowrap">víduo&nbsp;que&nbsp;está&nbsp;sendo&nbsp;testado&nbsp;e&nbsp;para&nbsp;o&nbsp;profissional&nbsp;que&nbsp;executa&nbsp;o&nbsp;teste.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_878">878</td><td nowrap="nowrap">Leia&nbsp;atentamente&nbsp;as&nbsp;instruções&nbsp;de&nbsp;uso&nbsp;que&nbsp;acompanham&nbsp;o&nbsp;conjunto&nbsp;diag-</td><td class="diff_next"></td><td class="diff_header" id="to62_868">868</td><td nowrap="nowrap">Leia&nbsp;atentamente&nbsp;as&nbsp;instruções&nbsp;de&nbsp;uso&nbsp;que&nbsp;acompanham&nbsp;o&nbsp;conjunto&nbsp;diag-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_879">879</td><td nowrap="nowrap">nóstico&nbsp;antes&nbsp;da&nbsp;seleção&nbsp;da&nbsp;amostra&nbsp;a&nbsp;ser&nbsp;testada&nbsp;e&nbsp;da&nbsp;execução&nbsp;do&nbsp;teste.</td><td class="diff_next"></td><td class="diff_header" id="to62_869">869</td><td nowrap="nowrap">nóstico&nbsp;antes&nbsp;da&nbsp;seleção&nbsp;da&nbsp;amostra&nbsp;a&nbsp;ser&nbsp;testada&nbsp;e&nbsp;da&nbsp;execução&nbsp;do&nbsp;teste.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_880">880</td><td nowrap="nowrap">Um&nbsp;TR&nbsp;só&nbsp;pode&nbsp;ter&nbsp;seu&nbsp;resultado&nbsp;interpretado&nbsp;se&nbsp;for&nbsp;considerado&nbsp;um&nbsp;teste&nbsp;válido.</td><td class="diff_next"></td><td class="diff_header" id="to62_870">870</td><td nowrap="nowrap">Um&nbsp;TR&nbsp;só&nbsp;pode&nbsp;ter&nbsp;seu&nbsp;resultado&nbsp;interpretado&nbsp;se&nbsp;for&nbsp;considerado&nbsp;um&nbsp;teste&nbsp;válido.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_881">881</td><td nowrap="nowrap">Para&nbsp;o&nbsp;teste&nbsp;ser&nbsp;considerado&nbsp;válido,&nbsp;é&nbsp;necessária&nbsp;a&nbsp;presença&nbsp;de&nbsp;uma&nbsp;linha&nbsp;ou&nbsp;ponto&nbsp;na</td><td class="diff_next"></td><td class="diff_header" id="to62_871">871</td><td nowrap="nowrap">Para&nbsp;o&nbsp;teste&nbsp;ser&nbsp;considerado&nbsp;válido,&nbsp;é&nbsp;necessária&nbsp;a&nbsp;presença&nbsp;de&nbsp;uma&nbsp;linha&nbsp;ou&nbsp;ponto&nbsp;na</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_882">882</td><td nowrap="nowrap">região&nbsp;controle&nbsp;(C)&nbsp;do&nbsp;teste.&nbsp;Caso&nbsp;o&nbsp;resultado&nbsp;do&nbsp;TR&nbsp;seja&nbsp;inválido,&nbsp;deve-se&nbsp;repetir&nbsp;o&nbsp;teste,</td><td class="diff_next"></td><td class="diff_header" id="to62_872">872</td><td nowrap="nowrap">região&nbsp;controle&nbsp;(C)&nbsp;do&nbsp;teste.&nbsp;Caso&nbsp;o&nbsp;resultado&nbsp;do&nbsp;TR&nbsp;seja&nbsp;inválido,&nbsp;deve-se&nbsp;repetir&nbsp;o&nbsp;teste,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_883">883</td><td nowrap="nowrap">se&nbsp;possível,&nbsp;com&nbsp;um&nbsp;conjunto&nbsp;diagnóstico&nbsp;de&nbsp;lote&nbsp;distinto&nbsp;do&nbsp;que&nbsp;foi&nbsp;utilizado&nbsp;inicial-</td><td class="diff_next"></td><td class="diff_header" id="to62_873">873</td><td nowrap="nowrap">se&nbsp;possível,&nbsp;com&nbsp;um&nbsp;conjunto&nbsp;diagnóstico&nbsp;de&nbsp;lote&nbsp;distinto&nbsp;do&nbsp;que&nbsp;foi&nbsp;utilizado&nbsp;inicial-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_884">884</td><td nowrap="nowrap">mente.&nbsp;Persistindo&nbsp;o&nbsp;resultado&nbsp;inválido,&nbsp;uma&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;por&nbsp;punção</td><td class="diff_next"></td><td class="diff_header" id="to62_874">874</td><td nowrap="nowrap">mente.&nbsp;Persistindo&nbsp;o&nbsp;resultado&nbsp;inválido,&nbsp;uma&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;por&nbsp;punção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_885">885</td><td nowrap="nowrap">venosa&nbsp;e&nbsp;encaminhada&nbsp;para&nbsp;teste&nbsp;com&nbsp;um&nbsp;dos&nbsp;fluxogramas&nbsp;definidos&nbsp;para&nbsp;laboratório.</td><td class="diff_next"></td><td class="diff_header" id="to62_875">875</td><td nowrap="nowrap">venosa&nbsp;e&nbsp;encaminhada&nbsp;para&nbsp;teste&nbsp;com&nbsp;um&nbsp;dos&nbsp;fluxogramas&nbsp;definidos&nbsp;para&nbsp;laboratório.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_886">886</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_876">876</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_887">887</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_877">877</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_888">888</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não</td><td class="diff_next"></td><td class="diff_header" id="to62_878">878</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_889">889</td><td nowrap="nowrap">reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;Na&nbsp;amostra</td><td class="diff_next"></td><td class="diff_header" id="to62_879">879</td><td nowrap="nowrap">reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;Na&nbsp;amostra</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_890">890</td><td nowrap="nowrap">com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR,&nbsp;o&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;liberado&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:</td><td class="diff_next"></td><td class="diff_header" id="to62_880">880</td><td nowrap="nowrap">com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR,&nbsp;o&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;liberado&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_891">891</td><td nowrap="nowrap">“Em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada</td><td class="diff_next"></td><td class="diff_header" id="to62_881">881</td><td nowrap="nowrap">“Em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_892">892</td><td nowrap="nowrap">30&nbsp;dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra,&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_882">882</td><td nowrap="nowrap">30&nbsp;dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra,&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_893">893</td><td nowrap="nowrap">Essa&nbsp;é&nbsp;uma&nbsp;informação&nbsp;relevante,&nbsp;pois&nbsp;a&nbsp;presença&nbsp;dos&nbsp;antígenos&nbsp;virais&nbsp;varia&nbsp;em&nbsp;função</td><td class="diff_next"></td><td class="diff_header" id="to62_883">883</td><td nowrap="nowrap">Essa&nbsp;é&nbsp;uma&nbsp;informação&nbsp;relevante,&nbsp;pois&nbsp;a&nbsp;presença&nbsp;dos&nbsp;antígenos&nbsp;virais&nbsp;varia&nbsp;em&nbsp;função</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_894">894</td><td nowrap="nowrap">do&nbsp;tempo&nbsp;de&nbsp;infecção&nbsp;e&nbsp;do&nbsp;estágio&nbsp;da&nbsp;doença&nbsp;na&nbsp;qual&nbsp;o&nbsp;indivíduo&nbsp;se&nbsp;encontra.</td><td class="diff_next"></td><td class="diff_header" id="to62_884">884</td><td nowrap="nowrap">do&nbsp;tempo&nbsp;de&nbsp;infecção&nbsp;e&nbsp;do&nbsp;estágio&nbsp;da&nbsp;doença&nbsp;na&nbsp;qual&nbsp;o&nbsp;indivíduo&nbsp;se&nbsp;encontra.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_895">895</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_885">885</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_896">896</td><td nowrap="nowrap">para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_886">886</td><td nowrap="nowrap">para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_897">897</td><td nowrap="nowrap">emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Realizar&nbsp;confirmação&nbsp;do&nbsp;diagnóstico&nbsp;da&nbsp;infecção</td><td class="diff_next"></td><td class="diff_header" id="to62_887">887</td><td nowrap="nowrap">emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Realizar&nbsp;confirmação&nbsp;do&nbsp;diagnóstico&nbsp;da&nbsp;infecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_898">898</td><td nowrap="nowrap">pelo&nbsp;HBV&nbsp;utilizando&nbsp;teste&nbsp;molecular”.</td><td class="diff_next"></td><td class="diff_header" id="to62_888">888</td><td nowrap="nowrap">pelo&nbsp;HBV&nbsp;utilizando&nbsp;teste&nbsp;molecular”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_899">899</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td><td class="diff_next"></td><td class="diff_header" id="to62_889">889</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__19"></td><td class="diff_header" id="from62_900">900</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;o&nbsp;ponto&nbsp;de&nbsp;corte&nbsp;(CO,&nbsp;do&nbsp;inglês&nbsp;cut-off)&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_890">890</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;o&nbsp;ponto&nbsp;de&nbsp;corte&nbsp;(CO,&nbsp;do&nbsp;inglês&nbsp;cut-off)&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_901">901</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_891">891</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_902">902</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_892">892</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_903">903</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_893">893</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__20"></td><td class="diff_header" id="from62_904">904</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_894">894</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__20">n</a></td><td class="diff_header" id="from62_905">905</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__20">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_906">906</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_895">895</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_907">907</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_896">896</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_908">908</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_897">897</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__21">n</a></td><td class="diff_header" id="from62_909">909</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__21">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_910">910</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_898">898</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_911">911</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_899">899</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_912">912</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_900">900</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_913">913</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_901">901</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_914">914</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;1,&nbsp;com&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;TR,&nbsp;permite&nbsp;uma&nbsp;testagem&nbsp;rápida&nbsp;e&nbsp;a&nbsp;am-</td><td class="diff_next"></td><td class="diff_header" id="to62_902">902</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;1,&nbsp;com&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;TR,&nbsp;permite&nbsp;uma&nbsp;testagem&nbsp;rápida&nbsp;e&nbsp;a&nbsp;am-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_915">915</td><td nowrap="nowrap">pliação&nbsp;das&nbsp;oportunidades&nbsp;de&nbsp;diagnóstico,&nbsp;principalmente&nbsp;entre&nbsp;as&nbsp;populações-chave.</td><td class="diff_next"></td><td class="diff_header" id="to62_903">903</td><td nowrap="nowrap">pliação&nbsp;das&nbsp;oportunidades&nbsp;de&nbsp;diagnóstico,&nbsp;principalmente&nbsp;entre&nbsp;as&nbsp;populações-chave.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_916">916</td><td nowrap="nowrap">A&nbsp;pessoa&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;pode&nbsp;ser&nbsp;oportunamente&nbsp;encaminhada&nbsp;para&nbsp;a&nbsp;com-</td><td class="diff_next"></td><td class="diff_header" id="to62_904">904</td><td nowrap="nowrap">A&nbsp;pessoa&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;pode&nbsp;ser&nbsp;oportunamente&nbsp;encaminhada&nbsp;para&nbsp;a&nbsp;com-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_917">917</td><td nowrap="nowrap">plementação&nbsp;diagnóstica&nbsp;e&nbsp;vinculada&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.</td><td class="diff_next"></td><td class="diff_header" id="to62_905">905</td><td nowrap="nowrap">plementação&nbsp;diagnóstica&nbsp;e&nbsp;vinculada&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_918">918</td><td nowrap="nowrap">evidência&nbsp;direta&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV.&nbsp;Esse&nbsp;resultado&nbsp;deverá&nbsp;ser&nbsp;complementado&nbsp;com&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_906">906</td><td nowrap="nowrap">evidência&nbsp;direta&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV.&nbsp;Esse&nbsp;resultado&nbsp;deverá&nbsp;ser&nbsp;complementado&nbsp;com&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_919">919</td><td nowrap="nowrap">utilização&nbsp;de&nbsp;um&nbsp;teste&nbsp;molecular&nbsp;para&nbsp;detecção&nbsp;de&nbsp;material&nbsp;genético&nbsp;viral.</td><td class="diff_next"></td><td class="diff_header" id="to62_907">907</td><td nowrap="nowrap">utilização&nbsp;de&nbsp;um&nbsp;teste&nbsp;molecular&nbsp;para&nbsp;detecção&nbsp;de&nbsp;material&nbsp;genético&nbsp;viral.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_920">920</td><td nowrap="nowrap">O&nbsp;TR&nbsp;usado&nbsp;para&nbsp;detecção&nbsp;do&nbsp;HBsAg,&nbsp;por&nbsp;detectar&nbsp;antígenos&nbsp;virais,&nbsp;não&nbsp;possui&nbsp;res-</td><td class="diff_next"></td><td class="diff_header" id="to62_908">908</td><td nowrap="nowrap">O&nbsp;TR&nbsp;usado&nbsp;para&nbsp;detecção&nbsp;do&nbsp;HBsAg,&nbsp;por&nbsp;detectar&nbsp;antígenos&nbsp;virais,&nbsp;não&nbsp;possui&nbsp;res-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_921">921</td><td nowrap="nowrap">trições&nbsp;de&nbsp;uso&nbsp;com&nbsp;relação&nbsp;à&nbsp;idade&nbsp;do&nbsp;indivíduo&nbsp;e&nbsp;ao&nbsp;seu&nbsp;estado&nbsp;imunológico.</td><td class="diff_next"></td><td class="diff_header" id="to62_909">909</td><td nowrap="nowrap">trições&nbsp;de&nbsp;uso&nbsp;com&nbsp;relação&nbsp;à&nbsp;idade&nbsp;do&nbsp;indivíduo&nbsp;e&nbsp;ao&nbsp;seu&nbsp;estado&nbsp;imunológico.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_922">922</td><td nowrap="nowrap">No&nbsp;entanto,&nbsp;o&nbsp;TR&nbsp;poderá&nbsp;não&nbsp;ser&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;uma&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;nas&nbsp;si-</td><td class="diff_next"></td><td class="diff_header" id="to62_910">910</td><td nowrap="nowrap">No&nbsp;entanto,&nbsp;o&nbsp;TR&nbsp;poderá&nbsp;não&nbsp;ser&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;uma&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;nas&nbsp;si-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__21"></td><td class="diff_header" id="from62_923">923</td><td nowrap="nowrap">tuações&nbsp;descritas&nbsp;a&nbsp;seguir:</td><td class="diff_next"></td><td class="diff_header" id="to62_911">911</td><td nowrap="nowrap">tuações&nbsp;descritas&nbsp;a&nbsp;seguir:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_924">924</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;oculta,&nbsp;que&nbsp;ocorrem&nbsp;em&nbsp;aproximadamente&nbsp;2,7%&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_912">912</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;oculta,&nbsp;que&nbsp;ocorrem&nbsp;em&nbsp;aproximadamente&nbsp;2,7%&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_925">925</td><td nowrap="nowrap">população&nbsp;geral,&nbsp;em&nbsp;12%&nbsp;das&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;em&nbsp;33%</td><td class="diff_next"></td><td class="diff_header" id="to62_913">913</td><td nowrap="nowrap">população&nbsp;geral,&nbsp;em&nbsp;12%&nbsp;das&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;em&nbsp;33%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_926">926</td><td nowrap="nowrap">dos&nbsp;indivíduos&nbsp;com&nbsp;coinfecção&nbsp;HBV-HCV&nbsp;e&nbsp;em&nbsp;58%&nbsp;dos&nbsp;hemodialisados.</td><td class="diff_next"></td><td class="diff_header" id="to62_914">914</td><td nowrap="nowrap">dos&nbsp;indivíduos&nbsp;com&nbsp;coinfecção&nbsp;HBV-HCV&nbsp;e&nbsp;em&nbsp;58%&nbsp;dos&nbsp;hemodialisados.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_927">927</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;cepas&nbsp;virais&nbsp;com&nbsp;mutações&nbsp;no&nbsp;HBsAg.</td><td class="diff_next"></td><td class="diff_header" id="to62_915">915</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;cepas&nbsp;virais&nbsp;com&nbsp;mutações&nbsp;no&nbsp;HBsAg.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__22">n</a></td><td class="diff_header" id="from62_928">928</td><td nowrap="nowrap">9.7.2&nbsp;Fluxograma&nbsp;2&nbsp;<span class="diff_chg">–</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td><td class="diff_next"><a href="#difflib_chg_to62__22">n</a></td><td class="diff_header" id="to62_916">916</td><td nowrap="nowrap">9.7.2&nbsp;Fluxograma&nbsp;2&nbsp;<span class="diff_chg">-</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_929">929</td><td nowrap="nowrap">aguda&nbsp;ou&nbsp;crônica&nbsp;da&nbsp;doença,&nbsp;salvo&nbsp;nas&nbsp;situações&nbsp;definidas&nbsp;no&nbsp;item&nbsp;9.7.4.&nbsp;O&nbsp;Fluxograma</td><td class="diff_next"></td><td class="diff_header" id="to62_917">917</td><td nowrap="nowrap">aguda&nbsp;ou&nbsp;crônica&nbsp;da&nbsp;doença,&nbsp;salvo&nbsp;nas&nbsp;situações&nbsp;definidas&nbsp;no&nbsp;item&nbsp;9.7.4.&nbsp;O&nbsp;Fluxograma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_930">930</td><td nowrap="nowrap">2&nbsp;(Figura&nbsp;11)&nbsp;se&nbsp;inicia&nbsp;com&nbsp;um&nbsp;imunoensaio&nbsp;apto&nbsp;a&nbsp;detectar&nbsp;o&nbsp;HBsAg,&nbsp;como&nbsp;teste&nbsp;inicial,</td><td class="diff_next"></td><td class="diff_header" id="to62_918">918</td><td nowrap="nowrap">2&nbsp;(Figura&nbsp;11)&nbsp;se&nbsp;inicia&nbsp;com&nbsp;um&nbsp;imunoensaio&nbsp;apto&nbsp;a&nbsp;detectar&nbsp;o&nbsp;HBsAg,&nbsp;como&nbsp;teste&nbsp;inicial,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_931">931</td><td nowrap="nowrap">e&nbsp;um&nbsp;teste&nbsp;molecular&nbsp;como&nbsp;teste&nbsp;confirmatório,&nbsp;usados&nbsp;sequencialmente.&nbsp;O&nbsp;imunoen-</td><td class="diff_next"></td><td class="diff_header" id="to62_919">919</td><td nowrap="nowrap">e&nbsp;um&nbsp;teste&nbsp;molecular&nbsp;como&nbsp;teste&nbsp;confirmatório,&nbsp;usados&nbsp;sequencialmente.&nbsp;O&nbsp;imunoen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_932">932</td><td nowrap="nowrap">saio&nbsp;pode&nbsp;ser&nbsp;um&nbsp;TR&nbsp;ou&nbsp;um&nbsp;ensaio&nbsp;laboratorial&nbsp;convencional.&nbsp;Uma&nbsp;discordância&nbsp;entre</td><td class="diff_next"></td><td class="diff_header" id="to62_920">920</td><td nowrap="nowrap">saio&nbsp;pode&nbsp;ser&nbsp;um&nbsp;TR&nbsp;ou&nbsp;um&nbsp;ensaio&nbsp;laboratorial&nbsp;convencional.&nbsp;Uma&nbsp;discordância&nbsp;entre</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_933">933</td><td nowrap="nowrap">o&nbsp;primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes&nbsp;pode&nbsp;se&nbsp;dar&nbsp;em&nbsp;virtude&nbsp;de&nbsp;um&nbsp;resultado&nbsp;falso-reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_921">921</td><td nowrap="nowrap">o&nbsp;primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes&nbsp;pode&nbsp;se&nbsp;dar&nbsp;em&nbsp;virtude&nbsp;de&nbsp;um&nbsp;resultado&nbsp;falso-reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_934">934</td><td nowrap="nowrap">detecção&nbsp;da&nbsp;metodologia.</td><td class="diff_next"></td><td class="diff_header" id="to62_922">922</td><td nowrap="nowrap">detecção&nbsp;da&nbsp;metodologia.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_935">935</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:31)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_923">923</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:31)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:55)(cid:8)(cid:35)(cid:8)(cid:49)(cid:5)(cid:3)(cid:15)(cid:25)(cid:4</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:55)(cid:8)(cid:35)(cid:8)(cid:49)(cid:5)(cid:3)(cid:15)(cid:25)(cid:4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)(cid:20)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)(cid:20)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__22"></td><td class="diff_header">></td><td nowrap="nowrap">:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:8)(cid:11)(cid:12)(cid:17)(cid:8)(cid:26)(cid:24)(cid:5)(cid:4)(ci</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:8)(cid:11)(cid:12)(cid:17)(cid:8)(cid:26)(cid:24)(cid:5)(cid:4)(ci</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_936">936</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:8)(cid:2)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)(cid:23)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_924">924</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:8)(cid:2)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)(cid:23)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)(cid:8)(cid:10)(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)(cid:8)(cid:10)(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:14)(cid:16)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:14)(cid:16)(cid:33)</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__23">n</a></td><td class="diff_header" id="from62_937">937</td><td nowrap="nowrap">Figura&nbsp;11.&nbsp;Fluxograma&nbsp;2&nbsp;<span class="diff_chg">–</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;utilizando&nbsp;teste&nbsp;HBsAg&nbsp;e&nbsp;teste</td><td class="diff_next"><a href="#difflib_chg_to62__23">n</a></td><td class="diff_header" id="to62_925">925</td><td nowrap="nowrap">Figura&nbsp;11.&nbsp;Fluxograma&nbsp;2&nbsp;<span class="diff_chg">-</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;utilizando&nbsp;teste&nbsp;HBsAg&nbsp;e&nbsp;teste</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_938">938</td><td nowrap="nowrap">molecular&nbsp;(HBV-DNA)</td><td class="diff_next"></td><td class="diff_header" id="to62_926">926</td><td nowrap="nowrap">molecular&nbsp;(HBV-DNA)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_939">939</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_927">927</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_940">940</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:53)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_928">928</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:53)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_941">941</td><td nowrap="nowrap">(cid:13)(cid:21)(cid:7)(cid:21)(cid:8)(cid:21)(cid:26)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_929">929</td><td nowrap="nowrap">(cid:13)(cid:21)(cid:7)(cid:21)(cid:8)(cid:21)(cid:26)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_942">942</td><td nowrap="nowrap">(cid:29)(cid:4)(cid:3)(cid:13)(cid:23)(cid:3)(cid:16)</td><td class="diff_next"></td><td class="diff_header" id="to62_930">930</td><td nowrap="nowrap">(cid:29)(cid:4)(cid:3)(cid:13)(cid:23)(cid:3)(cid:16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_943">943</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_931">931</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_944">944</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)</td><td class="diff_next"></td><td class="diff_header" id="to62_932">932</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_945">945</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(</td><td class="diff_next"></td><td class="diff_header" id="to62_933">933</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)&nbsp;(cid:11)(cid:12)(cid:17)(cid:35)(</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)&nbsp;(cid:11)(cid:12)(cid:17)(cid:35)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:49)(cid:54)(cid:14)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:7)(cid:2</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:49)(cid:54)(cid:14)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:7)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_946">946</td><td nowrap="nowrap">(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4</td><td class="diff_next"></td><td class="diff_header" id="to62_934">934</td><td nowrap="nowrap">(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:7)&nbsp;(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:22)&nbsp;(cid:29)(cid:3)(cid</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:7)&nbsp;(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:22)&nbsp;(cid:29)(cid:3)(cid</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:17)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:17)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_947">947</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_935">935</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_948">948</td><td nowrap="nowrap">(cid:8)(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)</td><td class="diff_next"></td><td class="diff_header" id="to62_936">936</td><td nowrap="nowrap">(cid:8)(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)&nbsp;(cid:8)(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid:14)(cid:8)(cid</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)&nbsp;(cid:8)(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid:14)(cid:8)(cid</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:25)(cid:27)(cid:21)(cid:8)(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:25)(cid:27)(cid:21)(cid:8)(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_949">949</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)&nbsp;(cid:25)(cid:3)(cid:8)(cid:3)(cid:23)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_937">937</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)&nbsp;(cid:25)(cid:3)(cid:8)(cid:3)(cid:23)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:13)(cid:24)(cid:7)(cid:3)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:13)(cid:24)(cid:7)(cid:3)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_950">950</td><td nowrap="nowrap">Fon(cid:30)te(cid:21)(cid:25):&nbsp;(cid:24)D(cid:2)(cid:48)I(cid:8)A(cid:49)(cid:36)H(cid:14)(cid:11)V(cid:17)/S(cid:50)(cid</td><td class="diff_next"></td><td class="diff_header" id="to62_938">938</td><td nowrap="nowrap">Fon(cid:30)te(cid:21)(cid:25):&nbsp;(cid:24)D(cid:2)(cid:48)I(cid:8)A(cid:49)(cid:36)H(cid:14)(cid:11)V(cid:17)/S(cid:50)(cid</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:51)V(cid:17)S(cid:51)/(cid:50)M(cid:52)(cid:51)S(cid:33).</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:51)V(cid:17)S(cid:51)/(cid:50)M(cid:52)(cid:51)S(cid:33).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_951">951</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;2&nbsp;deve&nbsp;ser&nbsp;utilizado&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_939">939</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;2&nbsp;deve&nbsp;ser&nbsp;utilizado&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_952">952</td><td nowrap="nowrap">hepatite&nbsp;B”&nbsp;ou&nbsp;“diagnóstico&nbsp;de&nbsp;HBV”,&nbsp;ou&nbsp;mesmo&nbsp;“sorologia&nbsp;de&nbsp;hepatite”.&nbsp;O&nbsp;mesmo&nbsp;fluxo-</td><td class="diff_next"></td><td class="diff_header" id="to62_940">940</td><td nowrap="nowrap">hepatite&nbsp;B”&nbsp;ou&nbsp;“diagnóstico&nbsp;de&nbsp;HBV”,&nbsp;ou&nbsp;mesmo&nbsp;“sorologia&nbsp;de&nbsp;hepatite”.&nbsp;O&nbsp;mesmo&nbsp;fluxo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_953">953</td><td nowrap="nowrap">HAV&nbsp;e&nbsp;o&nbsp;Fluxograma&nbsp;5&nbsp;em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelos&nbsp;vírus&nbsp;causadores&nbsp;de&nbsp;hepatite.</td><td class="diff_next"></td><td class="diff_header" id="to62_941">941</td><td nowrap="nowrap">HAV&nbsp;e&nbsp;o&nbsp;Fluxograma&nbsp;5&nbsp;em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelos&nbsp;vírus&nbsp;causadores&nbsp;de&nbsp;hepatite.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_954">954</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;infecções&nbsp;ativas&nbsp;pelo&nbsp;HBV&nbsp;em&nbsp;adultos</td><td class="diff_next"></td><td class="diff_header" id="to62_942">942</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;infecções&nbsp;ativas&nbsp;pelo&nbsp;HBV&nbsp;em&nbsp;adultos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_955">955</td><td nowrap="nowrap">e&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses.</td><td class="diff_next"></td><td class="diff_header" id="to62_943">943</td><td nowrap="nowrap">e&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_956">956</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;primeiro&nbsp;teste,&nbsp;ou&nbsp;discordância&nbsp;entre&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_944">944</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;primeiro&nbsp;teste,&nbsp;ou&nbsp;discordância&nbsp;entre&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_957">957</td><td nowrap="nowrap">primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,&nbsp;deve-se</td><td class="diff_next"></td><td class="diff_header" id="to62_945">945</td><td nowrap="nowrap">primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,&nbsp;deve-se</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_958">958</td><td nowrap="nowrap">coletar&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;para&nbsp;repetir&nbsp;o&nbsp;fluxograma.</td><td class="diff_next"></td><td class="diff_header" id="to62_946">946</td><td nowrap="nowrap">coletar&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;para&nbsp;repetir&nbsp;o&nbsp;fluxograma.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_959">959</td><td nowrap="nowrap">Quando&nbsp;o&nbsp;teste&nbsp;inicial&nbsp;for&nbsp;um&nbsp;imunoensaio&nbsp;laboratorial,&nbsp;considere&nbsp;que&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_947">947</td><td nowrap="nowrap">Quando&nbsp;o&nbsp;teste&nbsp;inicial&nbsp;for&nbsp;um&nbsp;imunoensaio&nbsp;laboratorial,&nbsp;considere&nbsp;que&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_960">960</td><td nowrap="nowrap">pelo&nbsp;MS&nbsp;pode&nbsp;ser&nbsp;executado&nbsp;também&nbsp;com&nbsp;amostras&nbsp;de&nbsp;soro;&nbsp;portanto,</td><td class="diff_next"></td><td class="diff_header" id="to62_948">948</td><td nowrap="nowrap">pelo&nbsp;MS&nbsp;pode&nbsp;ser&nbsp;executado&nbsp;também&nbsp;com&nbsp;amostras&nbsp;de&nbsp;soro;&nbsp;portanto,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_961">961</td><td nowrap="nowrap">uma&nbsp;alíquota&nbsp;da&nbsp;amostra&nbsp;do&nbsp;paciente&nbsp;pode&nbsp;ser&nbsp;separada&nbsp;em&nbsp;caso&nbsp;de&nbsp;ne-</td><td class="diff_next"></td><td class="diff_header" id="to62_949">949</td><td nowrap="nowrap">uma&nbsp;alíquota&nbsp;da&nbsp;amostra&nbsp;do&nbsp;paciente&nbsp;pode&nbsp;ser&nbsp;separada&nbsp;em&nbsp;caso&nbsp;de&nbsp;ne-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_962">962</td><td nowrap="nowrap">cessidade&nbsp;da&nbsp;complementação&nbsp;do&nbsp;diagnóstico&nbsp;usando&nbsp;o&nbsp;teste&nbsp;molecular.</td><td class="diff_next"></td><td class="diff_header" id="to62_950">950</td><td nowrap="nowrap">cessidade&nbsp;da&nbsp;complementação&nbsp;do&nbsp;diagnóstico&nbsp;usando&nbsp;o&nbsp;teste&nbsp;molecular.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_963">963</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_951">951</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_964">964</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_952">952</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_965">965</td><td nowrap="nowrap">definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_953">953</td><td nowrap="nowrap">definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_966">966</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_954">954</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_967">967</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td><td class="diff_next"></td><td class="diff_header" id="to62_955">955</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_968">968</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_956">956</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_969">969</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;HBsAg&nbsp;será&nbsp;de-</td><td class="diff_next"></td><td class="diff_header" id="to62_957">957</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;HBsAg&nbsp;será&nbsp;de-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_970">970</td><td nowrap="nowrap">finida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite</td><td class="diff_next"></td><td class="diff_header" id="to62_958">958</td><td nowrap="nowrap">finida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_971">971</td><td nowrap="nowrap">B&nbsp;(HBsAg)”.&nbsp;A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“HBV-DNA&nbsp;não</td><td class="diff_next"></td><td class="diff_header" id="to62_959">959</td><td nowrap="nowrap">B&nbsp;(HBsAg)”.&nbsp;A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“HBV-DNA&nbsp;não</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_972">972</td><td nowrap="nowrap">detectado&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso</td><td class="diff_next"></td><td class="diff_header" id="to62_960">960</td><td nowrap="nowrap">detectado&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_973">973</td><td nowrap="nowrap">de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias</td><td class="diff_next"></td><td class="diff_header" id="to62_961">961</td><td nowrap="nowrap">de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_974">974</td><td nowrap="nowrap">após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_962">962</td><td nowrap="nowrap">após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_975">975</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HBV-DNA</td><td class="diff_next"></td><td class="diff_header" id="to62_963">963</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HBV-DNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_976">976</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável</td><td class="diff_next"></td><td class="diff_header" id="to62_964">964</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_977">977</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;presença&nbsp;do&nbsp;HBsAg&nbsp;e&nbsp;do&nbsp;HBV-DNA&nbsp;é</td><td class="diff_next"></td><td class="diff_header" id="to62_965">965</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;presença&nbsp;do&nbsp;HBsAg&nbsp;e&nbsp;do&nbsp;HBV-DNA&nbsp;é</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_978">978</td><td nowrap="nowrap">indicativa&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HBV”.</td><td class="diff_next"></td><td class="diff_header" id="to62_966">966</td><td nowrap="nowrap">indicativa&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HBV”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_979">979</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td><td class="diff_next"></td><td class="diff_header" id="to62_967">967</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__23"></td><td class="diff_header" id="from62_980">980</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_968">968</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_981">981</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_969">969</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_982">982</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_970">970</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_983">983</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_971">971</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__24"></td><td class="diff_header" id="from62_984">984</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_972">972</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__24">n</a></td><td class="diff_header" id="from62_985">985</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__24">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_986">986</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_973">973</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_987">987</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_974">974</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_988">988</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_975">975</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__25">n</a></td><td class="diff_header" id="from62_989">989</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__25">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_990">990</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_976">976</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_991">991</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_977">977</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_992">992</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_978">978</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_993">993</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_979">979</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_994">994</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;2&nbsp;é&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;seja&nbsp;ela&nbsp;aguda&nbsp;ou&nbsp;crônica.</td><td class="diff_next"></td><td class="diff_header" id="to62_980">980</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;2&nbsp;é&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;seja&nbsp;ela&nbsp;aguda&nbsp;ou&nbsp;crônica.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_995">995</td><td nowrap="nowrap">No&nbsp;caso&nbsp;da&nbsp;necessidade&nbsp;de&nbsp;complementação&nbsp;diagnóstica,&nbsp;caberá&nbsp;ao&nbsp;médico&nbsp;definir&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_981">981</td><td nowrap="nowrap">No&nbsp;caso&nbsp;da&nbsp;necessidade&nbsp;de&nbsp;complementação&nbsp;diagnóstica,&nbsp;caberá&nbsp;ao&nbsp;médico&nbsp;definir&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_996">996</td><td nowrap="nowrap">encaminhamento&nbsp;do&nbsp;paciente,&nbsp;conforme&nbsp;o&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas</td><td class="diff_next"></td><td class="diff_header" id="to62_982">982</td><td nowrap="nowrap">encaminhamento&nbsp;do&nbsp;paciente,&nbsp;conforme&nbsp;o&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_997">997</td><td nowrap="nowrap">para&nbsp;Hepatite&nbsp;B&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,&nbsp;2017c).</td><td class="diff_next"></td><td class="diff_header" id="to62_983">983</td><td nowrap="nowrap">para&nbsp;Hepatite&nbsp;B&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,&nbsp;2017c).</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__25"></td><td class="diff_header" id="from62_998">998</td><td nowrap="nowrap">descritas&nbsp;a&nbsp;seguir:</td><td class="diff_next"></td><td class="diff_header" id="to62_984">984</td><td nowrap="nowrap">descritas&nbsp;a&nbsp;seguir:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_999">999</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;oculta,&nbsp;que&nbsp;ocorrem&nbsp;em&nbsp;aproximadamente&nbsp;2,7%&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_985">985</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;oculta,&nbsp;que&nbsp;ocorrem&nbsp;em&nbsp;aproximadamente&nbsp;2,7%&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1000">1000</td><td nowrap="nowrap">população&nbsp;geral,&nbsp;em&nbsp;12%&nbsp;das&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;em&nbsp;33%</td><td class="diff_next"></td><td class="diff_header" id="to62_986">986</td><td nowrap="nowrap">população&nbsp;geral,&nbsp;em&nbsp;12%&nbsp;das&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;em&nbsp;33%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1001">1001</td><td nowrap="nowrap">dos&nbsp;indivíduos&nbsp;com&nbsp;coinfecção&nbsp;HBV-HCV&nbsp;e&nbsp;em&nbsp;58%&nbsp;dos&nbsp;hemodialisados.</td><td class="diff_next"></td><td class="diff_header" id="to62_987">987</td><td nowrap="nowrap">dos&nbsp;indivíduos&nbsp;com&nbsp;coinfecção&nbsp;HBV-HCV&nbsp;e&nbsp;em&nbsp;58%&nbsp;dos&nbsp;hemodialisados.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1002">1002</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;cepas&nbsp;virais&nbsp;com&nbsp;mutações&nbsp;no&nbsp;antígeno&nbsp;HBsAg.</td><td class="diff_next"></td><td class="diff_header" id="to62_988">988</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;cepas&nbsp;virais&nbsp;com&nbsp;mutações&nbsp;no&nbsp;antígeno&nbsp;HBsAg.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__26">n</a></td><td class="diff_header" id="from62_1003">1003</td><td nowrap="nowrap">9.7.3&nbsp;Fluxograma&nbsp;3&nbsp;<span class="diff_chg">–</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td><td class="diff_next"><a href="#difflib_chg_to62__26">n</a></td><td class="diff_header" id="to62_989">989</td><td nowrap="nowrap">9.7.3&nbsp;Fluxograma&nbsp;3&nbsp;<span class="diff_chg">-</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(HBV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1004">1004</td><td nowrap="nowrap">usando&nbsp;a&nbsp;detecção&nbsp;de&nbsp;HBsAg&nbsp;e&nbsp;anti-HBc&nbsp;total</td><td class="diff_next"></td><td class="diff_header" id="to62_990">990</td><td nowrap="nowrap">usando&nbsp;a&nbsp;detecção&nbsp;de&nbsp;HBsAg&nbsp;e&nbsp;anti-HBc&nbsp;total</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1005">1005</td><td nowrap="nowrap">aguda&nbsp;ou&nbsp;crônica&nbsp;da&nbsp;doença,&nbsp;salvo&nbsp;nas&nbsp;situações&nbsp;definidas&nbsp;mais&nbsp;à&nbsp;frente.&nbsp;O&nbsp;Fluxograma&nbsp;3</td><td class="diff_next"></td><td class="diff_header" id="to62_991">991</td><td nowrap="nowrap">aguda&nbsp;ou&nbsp;crônica&nbsp;da&nbsp;doença,&nbsp;salvo&nbsp;nas&nbsp;situações&nbsp;definidas&nbsp;mais&nbsp;à&nbsp;frente.&nbsp;O&nbsp;Fluxograma&nbsp;3</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1006">1006</td><td nowrap="nowrap">(Figura&nbsp;12)&nbsp;se&nbsp;inicia&nbsp;com&nbsp;um&nbsp;imunoensaio&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;HBsAg,&nbsp;como&nbsp;teste&nbsp;inicial,</td><td class="diff_next"></td><td class="diff_header" id="to62_992">992</td><td nowrap="nowrap">(Figura&nbsp;12)&nbsp;se&nbsp;inicia&nbsp;com&nbsp;um&nbsp;imunoensaio&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;HBsAg,&nbsp;como&nbsp;teste&nbsp;inicial,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1007">1007</td><td nowrap="nowrap">e&nbsp;um&nbsp;imunoensaio&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;anti-HBc&nbsp;total&nbsp;como&nbsp;teste&nbsp;complementar,&nbsp;usados</td><td class="diff_next"></td><td class="diff_header" id="to62_993">993</td><td nowrap="nowrap">e&nbsp;um&nbsp;imunoensaio&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;anti-HBc&nbsp;total&nbsp;como&nbsp;teste&nbsp;complementar,&nbsp;usados</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1008">1008</td><td nowrap="nowrap">sequencialmente.</td><td class="diff_next"></td><td class="diff_header" id="to62_994">994</td><td nowrap="nowrap">sequencialmente.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1009">1009</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:55)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_995">995</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:55)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:56)(cid:8)(cid:35)(cid:8)(cid:49)(cid:5)(cid:3)(cid:15)(cid:25)(cid:4</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:56)(cid:8)(cid:35)(cid:8)(cid:49)(cid:5)(cid:3)(cid:15)(cid:25)(cid:4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)(cid:20)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)(cid:20)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__26"></td><td class="diff_header">></td><td nowrap="nowrap">:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:8)(cid:37)(cid:57)(cid:7)(cid:26)(cid:13)(cid:8)(cid:20)(cid:3)(ci</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:8)(cid:37)(cid:57)(cid:7)(cid:26)(cid:13)(cid:8)(cid:20)(cid:3)(ci</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:8)(cid:46)(cid:2)(cid:29)(cid:3)(cid:24)(cid:5)(cid:24)(cid:2)(cid:8)(cid:12)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:8)(cid:46)(cid:2)(cid:29)(cid:3)(cid:24)(cid:5)(cid:24)(cid:2)(cid:8)(cid:12)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1010">1010</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td><td class="diff_next"></td><td class="diff_header" id="to62_996">996</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:8)(cid:2)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:1</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)(cid:8)(cid:2)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:1</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">2)(cid:41)(cid:8)(cid:24)(cid:21)(cid:24)(cid:3)(cid:4)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">2)(cid:41)(cid:8)(cid:24)(cid:21)(cid:24)(cid:3)(cid:4)(cid:33)</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__27">n</a></td><td class="diff_header" id="from62_1011">1011</td><td nowrap="nowrap">Figura&nbsp;12.&nbsp;Fluxograma&nbsp;3&nbsp;<span class="diff_chg">–</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;utilizando&nbsp;teste&nbsp;HBsAg&nbsp;e</td><td class="diff_next"><a href="#difflib_chg_to62__27">n</a></td><td class="diff_header" id="to62_997">997</td><td nowrap="nowrap">Figura&nbsp;12.&nbsp;Fluxograma&nbsp;3&nbsp;<span class="diff_chg">-</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;utilizando&nbsp;teste&nbsp;HBsAg&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1012">1012</td><td nowrap="nowrap">anti-HBc&nbsp;total</td><td class="diff_next"></td><td class="diff_header" id="to62_998">998</td><td nowrap="nowrap">anti-HBc&nbsp;total</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1013">1013</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_999">999</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1014">1014</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:53)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1000">1000</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:53)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1015">1015</td><td nowrap="nowrap">(cid:13)(cid:21)(cid:7)(cid:21)(cid:8)(cid:21)(cid:26)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1001">1001</td><td nowrap="nowrap">(cid:13)(cid:21)(cid:7)(cid:21)(cid:8)(cid:21)(cid:26)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1016">1016</td><td nowrap="nowrap">(cid:29)(cid:4)(cid:3)(cid:13)(cid:23)(cid:3)(cid:16)</td><td class="diff_next"></td><td class="diff_header" id="to62_1002">1002</td><td nowrap="nowrap">(cid:29)(cid:4)(cid:3)(cid:13)(cid:23)(cid:3)(cid:16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1017">1017</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1003">1003</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1018">1018</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)</td><td class="diff_next"></td><td class="diff_header" id="to62_1004">1004</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1019">1019</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(</td><td class="diff_next"></td><td class="diff_header" id="to62_1005">1005</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)&nbsp;(cid:1)(cid:2)(cid:13)(cid:26)(ci</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)&nbsp;(cid:1)(cid:2)(cid:13)(cid:26)(ci</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:8)(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:8)(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1020">1020</td><td nowrap="nowrap">(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:1</td><td class="diff_next"></td><td class="diff_header" id="to62_1006">1006</td><td nowrap="nowrap">(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:1</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">2)(cid:41)(cid:8)(cid:24)(cid:21)(cid:24)(cid:3)(cid:4)&nbsp;(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">2)(cid:41)(cid:8)(cid:24)(cid:21)(cid:24)(cid:3)(cid:4)&nbsp;(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">22)&nbsp;(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:17)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">22)&nbsp;(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:17)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1021">1021</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_1007">1007</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1022">1022</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td><td class="diff_next"></td><td class="diff_header" id="to62_1008">1008</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(ci</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(ci</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:13)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:13)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1023">1023</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)&nbsp;(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:</td><td class="diff_next"></td><td class="diff_header" id="to62_1009">1009</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:11)(cid:12)(cid:13)(cid:14)(cid:15)&nbsp;(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">26)(cid:4)(cid:3)(cid:7)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">26)(cid:4)(cid:3)(cid:7)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1024">1024</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid:14)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(c</td><td class="diff_next"></td><td class="diff_header" id="to62_1010">1010</td><td nowrap="nowrap">(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid:14)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(c</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:24)(cid:7)(cid:3)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:24)(cid:7)(cid:3)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1025">1025</td><td nowrap="nowrap">(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:22)&nbsp;(cid:29)(cid:3)(cid:7)(cid:3)(cid:8</td><td class="diff_next"></td><td class="diff_header" id="to62_1011">1011</td><td nowrap="nowrap">(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:22)&nbsp;(cid:29)(cid:3)(cid:7)(cid:3)(cid:8</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:11)(cid:12)(cid:17)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:11)(cid:12)(cid:17)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1026">1026</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_1012">1012</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1027">1027</td><td nowrap="nowrap">(cid:8)(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid:14)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:20)(cid:2)(cid</td><td class="diff_next"></td><td class="diff_header" id="to62_1013">1013</td><td nowrap="nowrap">(cid:8)(cid:11)(cid:12)(cid:17)(cid:35)(cid:49)(cid:54)(cid:14)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:20)(cid:2)(cid</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1028">1028</td><td nowrap="nowrap">(cid:25)(cid:3)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)</td><td class="diff_next"></td><td class="diff_header" id="to62_1014">1014</td><td nowrap="nowrap">(cid:25)(cid:3)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1029">1029</td><td nowrap="nowrap">(cid:30)(cid:21)(cid:25)(cid:24)(cid:2)(cid:48)(cid:8)(cid:49)(cid:36)(cid:14)(cid:11)(cid:17)(cid:50)(cid:51)(cid:17)(c</td><td class="diff_next"></td><td class="diff_header" id="to62_1015">1015</td><td nowrap="nowrap">(cid:30)(cid:21)(cid:25)(cid:24)(cid:2)(cid:48)(cid:8)(cid:49)(cid:36)(cid:14)(cid:11)(cid:17)(cid:50)(cid:51)(cid:17)(c</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:51)(cid:50)(cid:52)(cid:51)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:51)(cid:50)(cid:52)(cid:51)(cid:33)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1030">1030</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_1016">1016</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1031">1031</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;3&nbsp;deve&nbsp;ser&nbsp;utilizado&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1017">1017</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;3&nbsp;deve&nbsp;ser&nbsp;utilizado&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1032">1032</td><td nowrap="nowrap">hepatite&nbsp;B”&nbsp;ou&nbsp;“diagnóstico&nbsp;de&nbsp;HBV”,&nbsp;ou&nbsp;mesmo&nbsp;“sorologia&nbsp;de&nbsp;hepatite”.&nbsp;O&nbsp;mesmo&nbsp;fluxo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1018">1018</td><td nowrap="nowrap">hepatite&nbsp;B”&nbsp;ou&nbsp;“diagnóstico&nbsp;de&nbsp;HBV”,&nbsp;ou&nbsp;mesmo&nbsp;“sorologia&nbsp;de&nbsp;hepatite”.&nbsp;O&nbsp;mesmo&nbsp;fluxo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1033">1033</td><td nowrap="nowrap">HAV&nbsp;e&nbsp;o&nbsp;Fluxograma&nbsp;5&nbsp;em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelos&nbsp;vírus&nbsp;causadores&nbsp;de&nbsp;hepatite.</td><td class="diff_next"></td><td class="diff_header" id="to62_1019">1019</td><td nowrap="nowrap">HAV&nbsp;e&nbsp;o&nbsp;Fluxograma&nbsp;5&nbsp;em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelos&nbsp;vírus&nbsp;causadores&nbsp;de&nbsp;hepatite.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1034">1034</td><td nowrap="nowrap">›&nbsp;Por&nbsp;fazer&nbsp;uso&nbsp;de&nbsp;testes&nbsp;que&nbsp;detectam&nbsp;anticorpos&nbsp;totais,&nbsp;esse&nbsp;fluxograma&nbsp;não</td><td class="diff_next"></td><td class="diff_header" id="to62_1020">1020</td><td nowrap="nowrap">›&nbsp;Por&nbsp;fazer&nbsp;uso&nbsp;de&nbsp;testes&nbsp;que&nbsp;detectam&nbsp;anticorpos&nbsp;totais,&nbsp;esse&nbsp;fluxograma&nbsp;não</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1035">1035</td><td nowrap="nowrap">deve&nbsp;ser&nbsp;usado&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses&nbsp;de&nbsp;idade,&nbsp;e&nbsp;os&nbsp;resultados</td><td class="diff_next"></td><td class="diff_header" id="to62_1021">1021</td><td nowrap="nowrap">deve&nbsp;ser&nbsp;usado&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses&nbsp;de&nbsp;idade,&nbsp;e&nbsp;os&nbsp;resultados</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1036">1036</td><td nowrap="nowrap">devem&nbsp;ser&nbsp;avaliados&nbsp;com&nbsp;cuidado&nbsp;em&nbsp;indivíduos&nbsp;imunossuprimidos/imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_1022">1022</td><td nowrap="nowrap">devem&nbsp;ser&nbsp;avaliados&nbsp;com&nbsp;cuidado&nbsp;em&nbsp;indivíduos&nbsp;imunossuprimidos/imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1037">1037</td><td nowrap="nowrap">deprimidos.</td><td class="diff_next"></td><td class="diff_header" id="to62_1023">1023</td><td nowrap="nowrap">deprimidos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1038">1038</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;infecções&nbsp;ativas&nbsp;pelo&nbsp;HBV.</td><td class="diff_next"></td><td class="diff_header" id="to62_1024">1024</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;infecções&nbsp;ativas&nbsp;pelo&nbsp;HBV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1039">1039</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;primeiro&nbsp;teste,&nbsp;ou&nbsp;discordância&nbsp;entre</td><td class="diff_next"></td><td class="diff_header" id="to62_1025">1025</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;primeiro&nbsp;teste,&nbsp;ou&nbsp;discordância&nbsp;entre</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1040">1040</td><td nowrap="nowrap">o&nbsp;primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,&nbsp;coletar</td><td class="diff_next"></td><td class="diff_header" id="to62_1026">1026</td><td nowrap="nowrap">o&nbsp;primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,&nbsp;coletar</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1041">1041</td><td nowrap="nowrap">uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;repetir&nbsp;o&nbsp;fluxograma.</td><td class="diff_next"></td><td class="diff_header" id="to62_1027">1027</td><td nowrap="nowrap">uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;repetir&nbsp;o&nbsp;fluxograma.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1042">1042</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_1028">1028</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1043">1043</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_1029">1029</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1044">1044</td><td nowrap="nowrap">definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1030">1030</td><td nowrap="nowrap">definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1045">1045</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1031">1031</td><td nowrap="nowrap">hepatite&nbsp;B&nbsp;(HBsAg)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1046">1046</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td><td class="diff_next"></td><td class="diff_header" id="to62_1032">1032</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1047">1047</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1033">1033</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1048">1048</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;HBsAg&nbsp;será&nbsp;de-</td><td class="diff_next"></td><td class="diff_header" id="to62_1034">1034</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;HBsAg&nbsp;será&nbsp;de-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1049">1049</td><td nowrap="nowrap">finida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite</td><td class="diff_next"></td><td class="diff_header" id="to62_1035">1035</td><td nowrap="nowrap">finida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;antígeno&nbsp;de&nbsp;superfície&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1050">1050</td><td nowrap="nowrap">B&nbsp;(HBsAg)”.&nbsp;A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_1036">1036</td><td nowrap="nowrap">B&nbsp;(HBsAg)”.&nbsp;A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1051">1051</td><td nowrap="nowrap">anti-HBc&nbsp;total&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anti-HBc&nbsp;total”.&nbsp;O&nbsp;laudo</td><td class="diff_next"></td><td class="diff_header" id="to62_1037">1037</td><td nowrap="nowrap">anti-HBc&nbsp;total&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anti-HBc&nbsp;total”.&nbsp;O&nbsp;laudo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1052">1052</td><td nowrap="nowrap">com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;para&nbsp;o&nbsp;anti-HBc&nbsp;total&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_1038">1038</td><td nowrap="nowrap">com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;para&nbsp;o&nbsp;anti-HBc&nbsp;total&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1053">1053</td><td nowrap="nowrap">seguinte&nbsp;ressalva:&nbsp;“A&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;e&nbsp;do&nbsp;anti-HBc&nbsp;total&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção</td><td class="diff_next"></td><td class="diff_header" id="to62_1039">1039</td><td nowrap="nowrap">seguinte&nbsp;ressalva:&nbsp;“A&nbsp;detecção&nbsp;do&nbsp;HBsAg&nbsp;e&nbsp;do&nbsp;anti-HBc&nbsp;total&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1054">1054</td><td nowrap="nowrap">ativa&nbsp;pelo&nbsp;HBV”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1040">1040</td><td nowrap="nowrap">ativa&nbsp;pelo&nbsp;HBV”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1055">1055</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to62_1041">1041</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;anti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1056">1056</td><td nowrap="nowrap">-HBc&nbsp;total&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anti-HBc&nbsp;total”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1042">1042</td><td nowrap="nowrap">-HBc&nbsp;total&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anti-HBc&nbsp;total”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1057">1057</td><td nowrap="nowrap">Se&nbsp;o&nbsp;HBV-DNA&nbsp;não&nbsp;for&nbsp;detectado&nbsp;na&nbsp;amostra,&nbsp;o&nbsp;laudo&nbsp;será&nbsp;liberado&nbsp;como:&nbsp;“HBV-</td><td class="diff_next"></td><td class="diff_header" id="to62_1043">1043</td><td nowrap="nowrap">Se&nbsp;o&nbsp;HBV-DNA&nbsp;não&nbsp;for&nbsp;detectado&nbsp;na&nbsp;amostra,&nbsp;o&nbsp;laudo&nbsp;será&nbsp;liberado&nbsp;como:&nbsp;“HBV-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1058">1058</td><td nowrap="nowrap">DNA&nbsp;não&nbsp;detectável&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;também&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte</td><td class="diff_next"></td><td class="diff_header" id="to62_1044">1044</td><td nowrap="nowrap">DNA&nbsp;não&nbsp;detectável&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;também&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1059">1059</td><td nowrap="nowrap">ressalva:&nbsp;“Em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_1045">1045</td><td nowrap="nowrap">ressalva:&nbsp;“Em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1060">1060</td><td nowrap="nowrap">coletada&nbsp;30&nbsp;dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo</td><td class="diff_next"></td><td class="diff_header" id="to62_1046">1046</td><td nowrap="nowrap">coletada&nbsp;30&nbsp;dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1061">1061</td><td nowrap="nowrap">teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1047">1047</td><td nowrap="nowrap">teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1062">1062</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HBV-DNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1048">1048</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HBV-DNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1063">1063</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável</td><td class="diff_next"></td><td class="diff_header" id="to62_1049">1049</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1064">1064</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;presença&nbsp;do&nbsp;HBsAg&nbsp;e&nbsp;do&nbsp;HBV-DNA&nbsp;é</td><td class="diff_next"></td><td class="diff_header" id="to62_1050">1050</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;presença&nbsp;do&nbsp;HBsAg&nbsp;e&nbsp;do&nbsp;HBV-DNA&nbsp;é</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1065">1065</td><td nowrap="nowrap">indicativa&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HBV”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1051">1051</td><td nowrap="nowrap">indicativa&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HBV”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1066">1066</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td><td class="diff_next"></td><td class="diff_header" id="to62_1052">1052</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__27"></td><td class="diff_header" id="from62_1067">1067</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_1053">1053</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1068">1068</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_1054">1054</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1069">1069</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_1055">1055</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1070">1070</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_1056">1056</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__28"></td><td class="diff_header" id="from62_1071">1071</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_1057">1057</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__28">n</a></td><td class="diff_header" id="from62_1072">1072</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__28">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1073">1073</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_1058">1058</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1074">1074</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1059">1059</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1075">1075</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_1060">1060</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__29">n</a></td><td class="diff_header" id="from62_1076">1076</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__29">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1077">1077</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_1061">1061</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1078">1078</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1062">1062</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1079">1079</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_1063">1063</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1080">1080</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1064">1064</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1081">1081</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;3&nbsp;é&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;seja&nbsp;ela&nbsp;aguda&nbsp;ou&nbsp;crônica.</td><td class="diff_next"></td><td class="diff_header" id="to62_1065">1065</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;3&nbsp;é&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;seja&nbsp;ela&nbsp;aguda&nbsp;ou&nbsp;crônica.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1082">1082</td><td nowrap="nowrap">No&nbsp;caso&nbsp;de&nbsp;confirmação&nbsp;diagnóstica,&nbsp;caberá&nbsp;ao&nbsp;médico&nbsp;definir&nbsp;o&nbsp;encaminhamento&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_1066">1066</td><td nowrap="nowrap">No&nbsp;caso&nbsp;de&nbsp;confirmação&nbsp;diagnóstica,&nbsp;caberá&nbsp;ao&nbsp;médico&nbsp;definir&nbsp;o&nbsp;encaminhamento&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1083">1083</td><td nowrap="nowrap">paciente,&nbsp;conforme&nbsp;o&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;para&nbsp;Hepatite&nbsp;B&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1067">1067</td><td nowrap="nowrap">paciente,&nbsp;conforme&nbsp;o&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;para&nbsp;Hepatite&nbsp;B&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1084">1084</td><td nowrap="nowrap">Coinfecções”&nbsp;(BRASIL,&nbsp;2017c).</td><td class="diff_next"></td><td class="diff_header" id="to62_1068">1068</td><td nowrap="nowrap">Coinfecções”&nbsp;(BRASIL,&nbsp;2017c).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1085">1085</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;3&nbsp;não&nbsp;será&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;uma&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;nas&nbsp;situações</td><td class="diff_next"></td><td class="diff_header" id="to62_1069">1069</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;3&nbsp;não&nbsp;será&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;uma&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;nas&nbsp;situações</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1086">1086</td><td nowrap="nowrap">descritas&nbsp;a&nbsp;seguir:</td><td class="diff_next"></td><td class="diff_header" id="to62_1070">1070</td><td nowrap="nowrap">descritas&nbsp;a&nbsp;seguir:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1087">1087</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;oculta,&nbsp;que&nbsp;ocorrem&nbsp;em&nbsp;aproximadamente&nbsp;2,7%&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1071">1071</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;oculta,&nbsp;que&nbsp;ocorrem&nbsp;em&nbsp;aproximadamente&nbsp;2,7%&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1088">1088</td><td nowrap="nowrap">população&nbsp;geral,&nbsp;em&nbsp;12%&nbsp;das&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;em&nbsp;33%</td><td class="diff_next"></td><td class="diff_header" id="to62_1072">1072</td><td nowrap="nowrap">população&nbsp;geral,&nbsp;em&nbsp;12%&nbsp;das&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;em&nbsp;33%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1089">1089</td><td nowrap="nowrap">dos&nbsp;indivíduos&nbsp;com&nbsp;coinfecção&nbsp;HBV-HCV&nbsp;e&nbsp;em&nbsp;58%&nbsp;dos&nbsp;hemodialisados.</td><td class="diff_next"></td><td class="diff_header" id="to62_1073">1073</td><td nowrap="nowrap">dos&nbsp;indivíduos&nbsp;com&nbsp;coinfecção&nbsp;HBV-HCV&nbsp;e&nbsp;em&nbsp;58%&nbsp;dos&nbsp;hemodialisados.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1090">1090</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;cepas&nbsp;virais&nbsp;com&nbsp;mutações&nbsp;no&nbsp;antígeno&nbsp;HBsAg.</td><td class="diff_next"></td><td class="diff_header" id="to62_1074">1074</td><td nowrap="nowrap">›&nbsp;Nos&nbsp;casos&nbsp;de&nbsp;cepas&nbsp;virais&nbsp;com&nbsp;mutações&nbsp;no&nbsp;antígeno&nbsp;HBsAg.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1091">1091</td><td nowrap="nowrap">9.7.4&nbsp;Orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;laboratorial&nbsp;da&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;HBV&nbsp;(IOB)</td><td class="diff_next"></td><td class="diff_header" id="to62_1075">1075</td><td nowrap="nowrap">9.7.4&nbsp;Orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;laboratorial&nbsp;da&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;HBV&nbsp;(IOB)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1092">1092</td><td nowrap="nowrap">nos&nbsp;testes&nbsp;que&nbsp;detectam&nbsp;o&nbsp;HBsAg,&nbsp;é&nbsp;recomendada&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;teste&nbsp;molecular&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1076">1076</td><td nowrap="nowrap">nos&nbsp;testes&nbsp;que&nbsp;detectam&nbsp;o&nbsp;HBsAg,&nbsp;é&nbsp;recomendada&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;teste&nbsp;molecular&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1093">1093</td><td nowrap="nowrap">alta&nbsp;sensibilidade&nbsp;(capacidade&nbsp;de&nbsp;detecção&nbsp;de&nbsp;pelo&nbsp;menos&nbsp;100&nbsp;UI/mL)&nbsp;para&nbsp;a&nbsp;confirma-</td><td class="diff_next"></td><td class="diff_header" id="to62_1077">1077</td><td nowrap="nowrap">alta&nbsp;sensibilidade&nbsp;(capacidade&nbsp;de&nbsp;detecção&nbsp;de&nbsp;pelo&nbsp;menos&nbsp;100&nbsp;UI/mL)&nbsp;para&nbsp;a&nbsp;confirma-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1094">1094</td><td nowrap="nowrap">ção&nbsp;diagnóstica&nbsp;de&nbsp;um&nbsp;caso&nbsp;de&nbsp;IOB.&nbsp;Os&nbsp;indivíduos&nbsp;com&nbsp;maior&nbsp;probabilidade&nbsp;de&nbsp;apresen-</td><td class="diff_next"></td><td class="diff_header" id="to62_1078">1078</td><td nowrap="nowrap">ção&nbsp;diagnóstica&nbsp;de&nbsp;um&nbsp;caso&nbsp;de&nbsp;IOB.&nbsp;Os&nbsp;indivíduos&nbsp;com&nbsp;maior&nbsp;probabilidade&nbsp;de&nbsp;apresen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1095">1095</td><td nowrap="nowrap">tarem&nbsp;IOB&nbsp;são&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;portadores&nbsp;de&nbsp;HCV,&nbsp;hemodialisados</td><td class="diff_next"></td><td class="diff_header" id="to62_1079">1079</td><td nowrap="nowrap">tarem&nbsp;IOB&nbsp;são&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis,&nbsp;portadores&nbsp;de&nbsp;HCV,&nbsp;hemodialisados</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1096">1096</td><td nowrap="nowrap">o&nbsp;HBsAg&nbsp;não&nbsp;reagente.</td><td class="diff_next"></td><td class="diff_header" id="to62_1080">1080</td><td nowrap="nowrap">o&nbsp;HBsAg&nbsp;não&nbsp;reagente.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1097">1097</td><td nowrap="nowrap">Devem-se&nbsp;utilizar&nbsp;essas&nbsp;orientações&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia</td><td class="diff_next"></td><td class="diff_header" id="to62_1081">1081</td><td nowrap="nowrap">Devem-se&nbsp;utilizar&nbsp;essas&nbsp;orientações&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1098">1098</td><td nowrap="nowrap">da&nbsp;hepatite&nbsp;B&nbsp;oculta”,&nbsp;“diagnóstico&nbsp;de&nbsp;HBV&nbsp;oculto”,&nbsp;“pesquisa&nbsp;para&nbsp;hepatite&nbsp;B&nbsp;oculta”&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_1082">1082</td><td nowrap="nowrap">da&nbsp;hepatite&nbsp;B&nbsp;oculta”,&nbsp;“diagnóstico&nbsp;de&nbsp;HBV&nbsp;oculto”,&nbsp;“pesquisa&nbsp;para&nbsp;hepatite&nbsp;B&nbsp;oculta”&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1099">1099</td><td nowrap="nowrap">termos&nbsp;afins.</td><td class="diff_next"></td><td class="diff_header" id="to62_1083">1083</td><td nowrap="nowrap">termos&nbsp;afins.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1100">1100</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_1084">1084</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1101">1101</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_1085">1085</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1102">1102</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HBV-DNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1086">1086</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HBV-DNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1103">1103</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;também&nbsp;deverá&nbsp;conter&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;detecção&nbsp;do&nbsp;HBV-</td><td class="diff_next"></td><td class="diff_header" id="to62_1087">1087</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;também&nbsp;deverá&nbsp;conter&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;detecção&nbsp;do&nbsp;HBV-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1104">1104</td><td nowrap="nowrap">DNA&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1088">1088</td><td nowrap="nowrap">DNA&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;B”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1105">1105</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“HBV-DNA&nbsp;não&nbsp;detec-</td><td class="diff_next"></td><td class="diff_header" id="to62_1089">1089</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“HBV-DNA&nbsp;não&nbsp;detec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1106">1106</td><td nowrap="nowrap">tável&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1090">1090</td><td nowrap="nowrap">tável&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1107">1107</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td><td class="diff_next"></td><td class="diff_header" id="to62_1091">1091</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1108">1108</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1092">1092</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1109">1109</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td><td class="diff_next"></td><td class="diff_header" id="to62_1093">1093</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__29"></td><td class="diff_header" id="from62_1110">1110</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_1094">1094</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1111">1111</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_1095">1095</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1112">1112</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_1096">1096</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1113">1113</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_1097">1097</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__30"></td><td class="diff_header" id="from62_1114">1114</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_1098">1098</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__30">n</a></td><td class="diff_header" id="from62_1115">1115</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__30">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1116">1116</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_1099">1099</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1117">1117</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1100">1100</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1118">1118</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_1101">1101</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__31">n</a></td><td class="diff_header" id="from62_1119">1119</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__31">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1120">1120</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_1102">1102</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1121">1121</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1103">1103</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1122">1122</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_1104">1104</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1123">1123</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1105">1105</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1124">1124</td><td nowrap="nowrap">O&nbsp;uso&nbsp;do&nbsp;teste&nbsp;molecular&nbsp;permite&nbsp;identificar&nbsp;a&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;HBV&nbsp;e&nbsp;o&nbsp;encami-</td><td class="diff_next"></td><td class="diff_header" id="to62_1106">1106</td><td nowrap="nowrap">O&nbsp;uso&nbsp;do&nbsp;teste&nbsp;molecular&nbsp;permite&nbsp;identificar&nbsp;a&nbsp;infecção&nbsp;oculta&nbsp;pelo&nbsp;HBV&nbsp;e&nbsp;o&nbsp;encami-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1125">1125</td><td nowrap="nowrap">nhamento&nbsp;desses&nbsp;pacientes&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.&nbsp;As&nbsp;presentes&nbsp;orientações&nbsp;são&nbsp;indicadas</td><td class="diff_next"></td><td class="diff_header" id="to62_1107">1107</td><td nowrap="nowrap">nhamento&nbsp;desses&nbsp;pacientes&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.&nbsp;As&nbsp;presentes&nbsp;orientações&nbsp;são&nbsp;indicadas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1126">1126</td><td nowrap="nowrap">reagente&nbsp;para&nbsp;HBsAg.</td><td class="diff_next"></td><td class="diff_header" id="to62_1108">1108</td><td nowrap="nowrap">reagente&nbsp;para&nbsp;HBsAg.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1127">1127</td><td nowrap="nowrap">10.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;C&nbsp;(HCV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1109">1109</td><td nowrap="nowrap">10.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;C&nbsp;(HCV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1128">1128</td><td nowrap="nowrap">O&nbsp;HCV&nbsp;foi&nbsp;identificado&nbsp;por&nbsp;Choo&nbsp;e&nbsp;colaboradores,&nbsp;em&nbsp;1989,&nbsp;nos&nbsp;Estados&nbsp;Unidos,</td><td class="diff_next"></td><td class="diff_header" id="to62_1110">1110</td><td nowrap="nowrap">O&nbsp;HCV&nbsp;foi&nbsp;identificado&nbsp;por&nbsp;Choo&nbsp;e&nbsp;colaboradores,&nbsp;em&nbsp;1989,&nbsp;nos&nbsp;Estados&nbsp;Unidos,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1129">1129</td><td nowrap="nowrap">sendo&nbsp;o&nbsp;principal&nbsp;agente&nbsp;etiológico&nbsp;da&nbsp;hepatite&nbsp;crônica,&nbsp;anteriormente&nbsp;denominada</td><td class="diff_next"></td><td class="diff_header" id="to62_1111">1111</td><td nowrap="nowrap">sendo&nbsp;o&nbsp;principal&nbsp;agente&nbsp;etiológico&nbsp;da&nbsp;hepatite&nbsp;crônica,&nbsp;anteriormente&nbsp;denominada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1130">1130</td><td nowrap="nowrap">“hepatite&nbsp;Não&nbsp;A&nbsp;Não&nbsp;B”.&nbsp;Sua&nbsp;transmissão&nbsp;ocorre,&nbsp;principalmente,&nbsp;por&nbsp;via&nbsp;parenteral.&nbsp;É</td><td class="diff_next"></td><td class="diff_header" id="to62_1112">1112</td><td nowrap="nowrap">“hepatite&nbsp;Não&nbsp;A&nbsp;Não&nbsp;B”.&nbsp;Sua&nbsp;transmissão&nbsp;ocorre,&nbsp;principalmente,&nbsp;por&nbsp;via&nbsp;parenteral.&nbsp;É</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1131">1131</td><td nowrap="nowrap">importante&nbsp;ressaltar&nbsp;que,&nbsp;em&nbsp;um&nbsp;percentual&nbsp;significativo&nbsp;de&nbsp;casos,&nbsp;não&nbsp;é&nbsp;possível&nbsp;iden-</td><td class="diff_next"></td><td class="diff_header" id="to62_1113">1113</td><td nowrap="nowrap">importante&nbsp;ressaltar&nbsp;que,&nbsp;em&nbsp;um&nbsp;percentual&nbsp;significativo&nbsp;de&nbsp;casos,&nbsp;não&nbsp;é&nbsp;possível&nbsp;iden-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1132">1132</td><td nowrap="nowrap">tificar&nbsp;a&nbsp;via&nbsp;de&nbsp;infecção.&nbsp;São&nbsp;consideradas&nbsp;populações&nbsp;de&nbsp;risco&nbsp;acrescido&nbsp;para&nbsp;a&nbsp;infecção</td><td class="diff_next"></td><td class="diff_header" id="to62_1114">1114</td><td nowrap="nowrap">tificar&nbsp;a&nbsp;via&nbsp;de&nbsp;infecção.&nbsp;São&nbsp;consideradas&nbsp;populações&nbsp;de&nbsp;risco&nbsp;acrescido&nbsp;para&nbsp;a&nbsp;infecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1133">1133</td><td nowrap="nowrap">pelo&nbsp;HCV&nbsp;por&nbsp;via&nbsp;parenteral:&nbsp;indivíduos&nbsp;que&nbsp;receberam&nbsp;transfusão&nbsp;de&nbsp;sangue&nbsp;e/ou&nbsp;he-</td><td class="diff_next"></td><td class="diff_header" id="to62_1115">1115</td><td nowrap="nowrap">pelo&nbsp;HCV&nbsp;por&nbsp;via&nbsp;parenteral:&nbsp;indivíduos&nbsp;que&nbsp;receberam&nbsp;transfusão&nbsp;de&nbsp;sangue&nbsp;e/ou&nbsp;he-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__31"></td><td class="diff_header" id="from62_1134">1134</td><td nowrap="nowrap">moderivados&nbsp;antes&nbsp;de&nbsp;1993;&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis&nbsp;(cocaína,&nbsp;anabolizan-</td><td class="diff_next"></td><td class="diff_header" id="to62_1116">1116</td><td nowrap="nowrap">moderivados&nbsp;antes&nbsp;de&nbsp;1993;&nbsp;pessoas&nbsp;que&nbsp;usam&nbsp;drogas&nbsp;injetáveis&nbsp;(cocaína,&nbsp;anabolizan-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1135">1135</td><td nowrap="nowrap">tes&nbsp;e&nbsp;complexos&nbsp;vitamínicos),&nbsp;inaláveis&nbsp;(cocaína)&nbsp;ou&nbsp;pipadas&nbsp;(crack),&nbsp;e&nbsp;que&nbsp;compartilham</td><td class="diff_next"></td><td class="diff_header" id="to62_1117">1117</td><td nowrap="nowrap">tes&nbsp;e&nbsp;complexos&nbsp;vitamínicos),&nbsp;inaláveis&nbsp;(cocaína)&nbsp;ou&nbsp;pipadas&nbsp;(crack),&nbsp;e&nbsp;que&nbsp;compartilham</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1136">1136</td><td nowrap="nowrap">os&nbsp;respectivos&nbsp;equipamentos&nbsp;de&nbsp;uso;&nbsp;pessoas&nbsp;com&nbsp;tatuagem,&nbsp;piercings&nbsp;ou&nbsp;que&nbsp;apresen-</td><td class="diff_next"></td><td class="diff_header" id="to62_1118">1118</td><td nowrap="nowrap">os&nbsp;respectivos&nbsp;equipamentos&nbsp;de&nbsp;uso;&nbsp;pessoas&nbsp;com&nbsp;tatuagem,&nbsp;piercings&nbsp;ou&nbsp;que&nbsp;apresen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1137">1137</td><td nowrap="nowrap">tem&nbsp;outras&nbsp;formas&nbsp;de&nbsp;exposição&nbsp;percutânea&nbsp;(por&nbsp;exemplo,&nbsp;consultórios&nbsp;odontológicos,</td><td class="diff_next"></td><td class="diff_header" id="to62_1119">1119</td><td nowrap="nowrap">tem&nbsp;outras&nbsp;formas&nbsp;de&nbsp;exposição&nbsp;percutânea&nbsp;(por&nbsp;exemplo,&nbsp;consultórios&nbsp;odontológicos,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1138">1138</td><td nowrap="nowrap">clínicas&nbsp;de&nbsp;podologia,&nbsp;salões&nbsp;de&nbsp;beleza,&nbsp;etc.,&nbsp;que&nbsp;não&nbsp;obedecem&nbsp;às&nbsp;normas&nbsp;de&nbsp;biosse-</td><td class="diff_next"></td><td class="diff_header" id="to62_1120">1120</td><td nowrap="nowrap">clínicas&nbsp;de&nbsp;podologia,&nbsp;salões&nbsp;de&nbsp;beleza,&nbsp;etc.,&nbsp;que&nbsp;não&nbsp;obedecem&nbsp;às&nbsp;normas&nbsp;de&nbsp;biosse-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__32">n</a></td><td class="diff_header" id="from62_1139">1139</td><td nowrap="nowrap">gurança).&nbsp;A&nbsp;transmissão&nbsp;sexual&nbsp;é&nbsp;pouco&nbsp;frequente&nbsp;<span class="diff_chg">–</span>&nbsp;menos&nbsp;de&nbsp;1%&nbsp;em&nbsp;parceiros&nbsp;estáveis</td><td class="diff_next"><a href="#difflib_chg_to62__32">n</a></td><td class="diff_header" id="to62_1121">1121</td><td nowrap="nowrap">gurança).&nbsp;A&nbsp;transmissão&nbsp;sexual&nbsp;é&nbsp;pouco&nbsp;frequente&nbsp;<span class="diff_chg">-</span>&nbsp;menos&nbsp;de&nbsp;1%&nbsp;em&nbsp;parceiros&nbsp;estáveis</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1140">1140</td><td nowrap="nowrap"><span class="diff_chg">–</span>&nbsp;e&nbsp;ocorre,&nbsp;principalmente,&nbsp;em&nbsp;pessoas&nbsp;com&nbsp;múltiplos&nbsp;parceiros&nbsp;e&nbsp;com&nbsp;prática&nbsp;sexual</td><td class="diff_next"></td><td class="diff_header" id="to62_1122">1122</td><td nowrap="nowrap"><span class="diff_chg">-</span>&nbsp;e&nbsp;ocorre,&nbsp;principalmente,&nbsp;em&nbsp;pessoas&nbsp;com&nbsp;múltiplos&nbsp;parceiros&nbsp;e&nbsp;com&nbsp;prática&nbsp;sexual</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1141">1141</td><td nowrap="nowrap">de&nbsp;risco&nbsp;(sem&nbsp;uso&nbsp;de&nbsp;preservativo),&nbsp;sendo&nbsp;que&nbsp;a&nbsp;coexistência&nbsp;de&nbsp;alguma&nbsp;IST,&nbsp;inclusive&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_1123">1123</td><td nowrap="nowrap">de&nbsp;risco&nbsp;(sem&nbsp;uso&nbsp;de&nbsp;preservativo),&nbsp;sendo&nbsp;que&nbsp;a&nbsp;coexistência&nbsp;de&nbsp;alguma&nbsp;IST,&nbsp;inclusive&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1142">1142</td><td nowrap="nowrap">vírus&nbsp;da&nbsp;imunodeficiência&nbsp;humana&nbsp;(HIV,&nbsp;do&nbsp;inglês&nbsp;human&nbsp;immunodeficiency&nbsp;virus),&nbsp;cons-</td><td class="diff_next"></td><td class="diff_header" id="to62_1124">1124</td><td nowrap="nowrap">vírus&nbsp;da&nbsp;imunodeficiência&nbsp;humana&nbsp;(HIV,&nbsp;do&nbsp;inglês&nbsp;human&nbsp;immunodeficiency&nbsp;virus),&nbsp;cons-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1143">1143</td><td nowrap="nowrap">titui&nbsp;um&nbsp;importante&nbsp;facilitador&nbsp;dessa&nbsp;transmissão.&nbsp;A&nbsp;transmissão&nbsp;vertical&nbsp;da&nbsp;hepatite&nbsp;C</td><td class="diff_next"></td><td class="diff_header" id="to62_1125">1125</td><td nowrap="nowrap">titui&nbsp;um&nbsp;importante&nbsp;facilitador&nbsp;dessa&nbsp;transmissão.&nbsp;A&nbsp;transmissão&nbsp;vertical&nbsp;da&nbsp;hepatite&nbsp;C</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1144">1144</td><td nowrap="nowrap">é&nbsp;rara&nbsp;quando&nbsp;comparada&nbsp;à&nbsp;da&nbsp;hepatite&nbsp;B.&nbsp;Entretanto,&nbsp;já&nbsp;se&nbsp;demonstrou&nbsp;que&nbsp;gestan-</td><td class="diff_next"></td><td class="diff_header" id="to62_1126">1126</td><td nowrap="nowrap">é&nbsp;rara&nbsp;quando&nbsp;comparada&nbsp;à&nbsp;da&nbsp;hepatite&nbsp;B.&nbsp;Entretanto,&nbsp;já&nbsp;se&nbsp;demonstrou&nbsp;que&nbsp;gestan-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1145">1145</td><td nowrap="nowrap">de&nbsp;transmissão&nbsp;da&nbsp;doença&nbsp;para&nbsp;os&nbsp;recém-nascidos.&nbsp;A&nbsp;cronificação&nbsp;da&nbsp;doença&nbsp;ocorre&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1127">1127</td><td nowrap="nowrap">de&nbsp;transmissão&nbsp;da&nbsp;doença&nbsp;para&nbsp;os&nbsp;recém-nascidos.&nbsp;A&nbsp;cronificação&nbsp;da&nbsp;doença&nbsp;ocorre&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1146">1146</td><td nowrap="nowrap">70%&nbsp;a&nbsp;85%&nbsp;dos&nbsp;casos,&nbsp;sendo&nbsp;que,&nbsp;em&nbsp;média,&nbsp;entre&nbsp;um&nbsp;quarto&nbsp;e&nbsp;um&nbsp;terço&nbsp;destes&nbsp;podem</td><td class="diff_next"></td><td class="diff_header" id="to62_1128">1128</td><td nowrap="nowrap">70%&nbsp;a&nbsp;85%&nbsp;dos&nbsp;casos,&nbsp;sendo&nbsp;que,&nbsp;em&nbsp;média,&nbsp;entre&nbsp;um&nbsp;quarto&nbsp;e&nbsp;um&nbsp;terço&nbsp;destes&nbsp;podem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1147">1147</td><td nowrap="nowrap">evoluir&nbsp;para&nbsp;formas&nbsp;histológicas&nbsp;graves&nbsp;ou&nbsp;cirrose,&nbsp;no&nbsp;período&nbsp;de&nbsp;20&nbsp;anos,&nbsp;caso&nbsp;não&nbsp;haja</td><td class="diff_next"></td><td class="diff_header" id="to62_1129">1129</td><td nowrap="nowrap">evoluir&nbsp;para&nbsp;formas&nbsp;histológicas&nbsp;graves&nbsp;ou&nbsp;cirrose,&nbsp;no&nbsp;período&nbsp;de&nbsp;20&nbsp;anos,&nbsp;caso&nbsp;não&nbsp;haja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1148">1148</td><td nowrap="nowrap">intervenção&nbsp;terapêutica.&nbsp;O&nbsp;restante&nbsp;dos&nbsp;pacientes&nbsp;evoluem&nbsp;de&nbsp;forma&nbsp;mais&nbsp;lenta&nbsp;e&nbsp;talvez</td><td class="diff_next"></td><td class="diff_header" id="to62_1130">1130</td><td nowrap="nowrap">intervenção&nbsp;terapêutica.&nbsp;O&nbsp;restante&nbsp;dos&nbsp;pacientes&nbsp;evoluem&nbsp;de&nbsp;forma&nbsp;mais&nbsp;lenta&nbsp;e&nbsp;talvez</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1149">1149</td><td nowrap="nowrap">nunca&nbsp;desenvolvam&nbsp;hepatopatia&nbsp;grave.&nbsp;É&nbsp;importante&nbsp;destacar&nbsp;que&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1131">1131</td><td nowrap="nowrap">nunca&nbsp;desenvolvam&nbsp;hepatopatia&nbsp;grave.&nbsp;É&nbsp;importante&nbsp;destacar&nbsp;que&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1150">1150</td><td nowrap="nowrap">já&nbsp;é&nbsp;a&nbsp;maior&nbsp;responsável&nbsp;por&nbsp;cirrose&nbsp;e&nbsp;transplante&nbsp;hepático&nbsp;no&nbsp;mundo&nbsp;ocidental.</td><td class="diff_next"></td><td class="diff_header" id="to62_1132">1132</td><td nowrap="nowrap">já&nbsp;é&nbsp;a&nbsp;maior&nbsp;responsável&nbsp;por&nbsp;cirrose&nbsp;e&nbsp;transplante&nbsp;hepático&nbsp;no&nbsp;mundo&nbsp;ocidental.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1151">1151</td><td nowrap="nowrap">10.1&nbsp;Partícula&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_1133">1133</td><td nowrap="nowrap">10.1&nbsp;Partícula&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1152">1152</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;C&nbsp;é&nbsp;causada&nbsp;pelo&nbsp;HCV.&nbsp;Esse&nbsp;vírus&nbsp;foi&nbsp;o&nbsp;primeiro&nbsp;membro&nbsp;do&nbsp;gênero</td><td class="diff_next"></td><td class="diff_header" id="to62_1134">1134</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;C&nbsp;é&nbsp;causada&nbsp;pelo&nbsp;HCV.&nbsp;Esse&nbsp;vírus&nbsp;foi&nbsp;o&nbsp;primeiro&nbsp;membro&nbsp;do&nbsp;gênero</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1153">1153</td><td nowrap="nowrap">Hepacivirus,&nbsp;da&nbsp;família&nbsp;Flaviridae.&nbsp;A&nbsp;partícula&nbsp;viral&nbsp;(Figura&nbsp;13)&nbsp;possui,&nbsp;aproximadamente,</td><td class="diff_next"></td><td class="diff_header" id="to62_1135">1135</td><td nowrap="nowrap">Hepacivirus,&nbsp;da&nbsp;família&nbsp;Flaviridae.&nbsp;A&nbsp;partícula&nbsp;viral&nbsp;(Figura&nbsp;13)&nbsp;possui,&nbsp;aproximadamente,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1154">1154</td><td nowrap="nowrap">65nm&nbsp;e&nbsp;é&nbsp;dotada&nbsp;de&nbsp;um&nbsp;envelope&nbsp;lipoproteico,&nbsp;contendo&nbsp;as&nbsp;duas&nbsp;glicoproteínas&nbsp;de&nbsp;en-</td><td class="diff_next"></td><td class="diff_header" id="to62_1136">1136</td><td nowrap="nowrap">65nm&nbsp;e&nbsp;é&nbsp;dotada&nbsp;de&nbsp;um&nbsp;envelope&nbsp;lipoproteico,&nbsp;contendo&nbsp;as&nbsp;duas&nbsp;glicoproteínas&nbsp;de&nbsp;en-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1155">1155</td><td nowrap="nowrap">velope&nbsp;(E1&nbsp;e&nbsp;E2),&nbsp;e&nbsp;um&nbsp;capsídeo&nbsp;proteico,&nbsp;composto&nbsp;pela&nbsp;proteína&nbsp;de&nbsp;capsídeo&nbsp;(C),&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_1137">1137</td><td nowrap="nowrap">velope&nbsp;(E1&nbsp;e&nbsp;E2),&nbsp;e&nbsp;um&nbsp;capsídeo&nbsp;proteico,&nbsp;composto&nbsp;pela&nbsp;proteína&nbsp;de&nbsp;capsídeo&nbsp;(C),&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1156">1156</td><td nowrap="nowrap">envolve&nbsp;o&nbsp;genoma&nbsp;viral&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).</td><td class="diff_next"></td><td class="diff_header" id="to62_1138">1138</td><td nowrap="nowrap">envolve&nbsp;o&nbsp;genoma&nbsp;viral&nbsp;(FIELDS;&nbsp;KNIPE;&nbsp;HOWLEY,&nbsp;2007).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1157">1157</td><td nowrap="nowrap">Figura&nbsp;13.&nbsp;Estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1139">1139</td><td nowrap="nowrap">Figura&nbsp;13.&nbsp;Estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1158">1158</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_1140">1140</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1159">1159</td><td nowrap="nowrap">de&nbsp;polaridade&nbsp;positiva,&nbsp;que&nbsp;possui,&nbsp;aproximadamente,&nbsp;9.600&nbsp;bases&nbsp;(9,6kb).&nbsp;Esse&nbsp;RNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1141">1141</td><td nowrap="nowrap">de&nbsp;polaridade&nbsp;positiva,&nbsp;que&nbsp;possui,&nbsp;aproximadamente,&nbsp;9.600&nbsp;bases&nbsp;(9,6kb).&nbsp;Esse&nbsp;RNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1160">1160</td><td nowrap="nowrap">é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;região&nbsp;5’&nbsp;não&nbsp;traduzida&nbsp;(NTR,&nbsp;do&nbsp;inglês&nbsp;non&nbsp;translated&nbsp;region),&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_1142">1142</td><td nowrap="nowrap">é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;região&nbsp;5’&nbsp;não&nbsp;traduzida&nbsp;(NTR,&nbsp;do&nbsp;inglês&nbsp;non&nbsp;translated&nbsp;region),&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1161">1161</td><td nowrap="nowrap">qual&nbsp;inclui&nbsp;um&nbsp;sítio&nbsp;interno&nbsp;de&nbsp;entrada&nbsp;do&nbsp;ribossomo&nbsp;(IRES,&nbsp;do&nbsp;inglês&nbsp;internal&nbsp;ribosome</td><td class="diff_next"></td><td class="diff_header" id="to62_1143">1143</td><td nowrap="nowrap">qual&nbsp;inclui&nbsp;um&nbsp;sítio&nbsp;interno&nbsp;de&nbsp;entrada&nbsp;do&nbsp;ribossomo&nbsp;(IRES,&nbsp;do&nbsp;inglês&nbsp;internal&nbsp;ribosome</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1162">1162</td><td nowrap="nowrap">entry&nbsp;site),&nbsp;que&nbsp;é&nbsp;capaz&nbsp;de&nbsp;direcionar&nbsp;a&nbsp;tradução&nbsp;do&nbsp;genoma&nbsp;viral&nbsp;independentemente</td><td class="diff_next"></td><td class="diff_header" id="to62_1144">1144</td><td nowrap="nowrap">entry&nbsp;site),&nbsp;que&nbsp;é&nbsp;capaz&nbsp;de&nbsp;direcionar&nbsp;a&nbsp;tradução&nbsp;do&nbsp;genoma&nbsp;viral&nbsp;independentemente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1163">1163</td><td nowrap="nowrap">do&nbsp;capG,&nbsp;e&nbsp;codifica&nbsp;uma&nbsp;única&nbsp;ORF&nbsp;de&nbsp;3006-3037&nbsp;códons.&nbsp;Na&nbsp;porção&nbsp;final&nbsp;3’&nbsp;do&nbsp;genoma</td><td class="diff_next"></td><td class="diff_header" id="to62_1145">1145</td><td nowrap="nowrap">do&nbsp;capG,&nbsp;e&nbsp;codifica&nbsp;uma&nbsp;única&nbsp;ORF&nbsp;de&nbsp;3006-3037&nbsp;códons.&nbsp;Na&nbsp;porção&nbsp;final&nbsp;3’&nbsp;do&nbsp;genoma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1164">1164</td><td nowrap="nowrap">há&nbsp;uma&nbsp;NTR&nbsp;(Figura&nbsp;14).</td><td class="diff_next"></td><td class="diff_header" id="to62_1146">1146</td><td nowrap="nowrap">há&nbsp;uma&nbsp;NTR&nbsp;(Figura&nbsp;14).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1165">1165</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;traduzido&nbsp;via&nbsp;IRES&nbsp;para&nbsp;produzir&nbsp;uma&nbsp;poliproteína,&nbsp;que&nbsp;é&nbsp;clivada</td><td class="diff_next"></td><td class="diff_header" id="to62_1147">1147</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;traduzido&nbsp;via&nbsp;IRES&nbsp;para&nbsp;produzir&nbsp;uma&nbsp;poliproteína,&nbsp;que&nbsp;é&nbsp;clivada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1166">1166</td><td nowrap="nowrap">durante&nbsp;e&nbsp;após&nbsp;a&nbsp;tradução&nbsp;por&nbsp;proteases&nbsp;celulares&nbsp;e&nbsp;virais&nbsp;em&nbsp;dez&nbsp;produtos&nbsp;gênicos.&nbsp;A</td><td class="diff_next"></td><td class="diff_header" id="to62_1148">1148</td><td nowrap="nowrap">durante&nbsp;e&nbsp;após&nbsp;a&nbsp;tradução&nbsp;por&nbsp;proteases&nbsp;celulares&nbsp;e&nbsp;virais&nbsp;em&nbsp;dez&nbsp;produtos&nbsp;gênicos.&nbsp;A</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1167">1167</td><td nowrap="nowrap">região&nbsp;amino-terminal&nbsp;codifica&nbsp;as&nbsp;proteínas&nbsp;estruturais,&nbsp;que&nbsp;são&nbsp;aquelas&nbsp;incorporadas</td><td class="diff_next"></td><td class="diff_header" id="to62_1149">1149</td><td nowrap="nowrap">região&nbsp;amino-terminal&nbsp;codifica&nbsp;as&nbsp;proteínas&nbsp;estruturais,&nbsp;que&nbsp;são&nbsp;aquelas&nbsp;incorporadas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1168">1168</td><td nowrap="nowrap">na&nbsp;partícula&nbsp;viral:&nbsp;a&nbsp;proteína&nbsp;do&nbsp;capsídeo&nbsp;(C)&nbsp;e&nbsp;as&nbsp;glicoproteínas&nbsp;de&nbsp;envelope&nbsp;(E1&nbsp;e&nbsp;E2).</td><td class="diff_next"></td><td class="diff_header" id="to62_1150">1150</td><td nowrap="nowrap">na&nbsp;partícula&nbsp;viral:&nbsp;a&nbsp;proteína&nbsp;do&nbsp;capsídeo&nbsp;(C)&nbsp;e&nbsp;as&nbsp;glicoproteínas&nbsp;de&nbsp;envelope&nbsp;(E1&nbsp;e&nbsp;E2).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1169">1169</td><td nowrap="nowrap">Os&nbsp;dois&nbsp;terços&nbsp;carboxi-terminais&nbsp;da&nbsp;poliproteína&nbsp;codificam&nbsp;as&nbsp;proteínas&nbsp;não&nbsp;estruturais:</td><td class="diff_next"></td><td class="diff_header" id="to62_1151">1151</td><td nowrap="nowrap">Os&nbsp;dois&nbsp;terços&nbsp;carboxi-terminais&nbsp;da&nbsp;poliproteína&nbsp;codificam&nbsp;as&nbsp;proteínas&nbsp;não&nbsp;estruturais:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1170">1170</td><td nowrap="nowrap">p7,&nbsp;NS2,&nbsp;NS3,&nbsp;NS4A,&nbsp;NS4B,&nbsp;NS5A&nbsp;e&nbsp;NS5B.&nbsp;Por&nbsp;definição,&nbsp;as&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;são</td><td class="diff_next"></td><td class="diff_header" id="to62_1152">1152</td><td nowrap="nowrap">p7,&nbsp;NS2,&nbsp;NS3,&nbsp;NS4A,&nbsp;NS4B,&nbsp;NS5A&nbsp;e&nbsp;NS5B.&nbsp;Por&nbsp;definição,&nbsp;as&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;são</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1171">1171</td><td nowrap="nowrap">expressas&nbsp;nas&nbsp;células&nbsp;infectadas,&nbsp;mas&nbsp;não&nbsp;são&nbsp;incorporadas&nbsp;na&nbsp;partícula&nbsp;viral.&nbsp;Elas&nbsp;ser-</td><td class="diff_next"></td><td class="diff_header" id="to62_1153">1153</td><td nowrap="nowrap">expressas&nbsp;nas&nbsp;células&nbsp;infectadas,&nbsp;mas&nbsp;não&nbsp;são&nbsp;incorporadas&nbsp;na&nbsp;partícula&nbsp;viral.&nbsp;Elas&nbsp;ser-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1172">1172</td><td nowrap="nowrap">vem&nbsp;para&nbsp;coordenar&nbsp;os&nbsp;aspectos&nbsp;intracelulares&nbsp;da&nbsp;replicação&nbsp;do&nbsp;HCV,&nbsp;incluindo&nbsp;a&nbsp;sín-</td><td class="diff_next"></td><td class="diff_header" id="to62_1154">1154</td><td nowrap="nowrap">vem&nbsp;para&nbsp;coordenar&nbsp;os&nbsp;aspectos&nbsp;intracelulares&nbsp;da&nbsp;replicação&nbsp;do&nbsp;HCV,&nbsp;incluindo&nbsp;a&nbsp;sín-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1173">1173</td><td nowrap="nowrap">tese&nbsp;de&nbsp;RNA,&nbsp;modulação&nbsp;dos&nbsp;mecanismos&nbsp;de&nbsp;defesa&nbsp;do&nbsp;hospedeiro&nbsp;e&nbsp;montagem&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1155">1155</td><td nowrap="nowrap">tese&nbsp;de&nbsp;RNA,&nbsp;modulação&nbsp;dos&nbsp;mecanismos&nbsp;de&nbsp;defesa&nbsp;do&nbsp;hospedeiro&nbsp;e&nbsp;montagem&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1174">1174</td><td nowrap="nowrap">partícula&nbsp;viral.&nbsp;A&nbsp;porção&nbsp;N-terminal&nbsp;da&nbsp;NS3&nbsp;codifica&nbsp;a&nbsp;serino-protease,&nbsp;responsável&nbsp;pelo</td><td class="diff_next"></td><td class="diff_header" id="to62_1156">1156</td><td nowrap="nowrap">partícula&nbsp;viral.&nbsp;A&nbsp;porção&nbsp;N-terminal&nbsp;da&nbsp;NS3&nbsp;codifica&nbsp;a&nbsp;serino-protease,&nbsp;responsável&nbsp;pelo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1175">1175</td><td nowrap="nowrap">processamento&nbsp;da&nbsp;poliproteína&nbsp;do&nbsp;HCV.&nbsp;A&nbsp;replicação&nbsp;do&nbsp;RNA&nbsp;viral&nbsp;é&nbsp;catalisada&nbsp;pela&nbsp;NS5B</td><td class="diff_next"></td><td class="diff_header" id="to62_1157">1157</td><td nowrap="nowrap">processamento&nbsp;da&nbsp;poliproteína&nbsp;do&nbsp;HCV.&nbsp;A&nbsp;replicação&nbsp;do&nbsp;RNA&nbsp;viral&nbsp;é&nbsp;catalisada&nbsp;pela&nbsp;NS5B</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1176">1176</td><td nowrap="nowrap">(RNA&nbsp;polimerase&nbsp;dependente&nbsp;de&nbsp;RNA).&nbsp;Tanto&nbsp;a&nbsp;protease&nbsp;quanto&nbsp;a&nbsp;RNA&nbsp;polimerase&nbsp;são</td><td class="diff_next"></td><td class="diff_header" id="to62_1158">1158</td><td nowrap="nowrap">(RNA&nbsp;polimerase&nbsp;dependente&nbsp;de&nbsp;RNA).&nbsp;Tanto&nbsp;a&nbsp;protease&nbsp;quanto&nbsp;a&nbsp;RNA&nbsp;polimerase&nbsp;são</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1177">1177</td><td nowrap="nowrap">o&nbsp;desenvolvimento&nbsp;de&nbsp;medicamentos&nbsp;(LINDENBACH;&nbsp;RICE,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1159">1159</td><td nowrap="nowrap">o&nbsp;desenvolvimento&nbsp;de&nbsp;medicamentos&nbsp;(LINDENBACH;&nbsp;RICE,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1178">1178</td><td nowrap="nowrap">Figura&nbsp;14.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;organização&nbsp;genômica&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1160">1160</td><td nowrap="nowrap">Figura&nbsp;14.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;organização&nbsp;genômica&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1179">1179</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;RICE,&nbsp;2011.</td><td class="diff_next"></td><td class="diff_header" id="to62_1161">1161</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;RICE,&nbsp;2011.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1180">1180</td><td nowrap="nowrap">Nota:&nbsp;O&nbsp;esquema&nbsp;mostra&nbsp;as&nbsp;proteínas&nbsp;estruturais&nbsp;e&nbsp;não&nbsp;estruturais&nbsp;do&nbsp;vírus&nbsp;após&nbsp;o&nbsp;processamento.</td><td class="diff_next"></td><td class="diff_header" id="to62_1162">1162</td><td nowrap="nowrap">Nota:&nbsp;O&nbsp;esquema&nbsp;mostra&nbsp;as&nbsp;proteínas&nbsp;estruturais&nbsp;e&nbsp;não&nbsp;estruturais&nbsp;do&nbsp;vírus&nbsp;após&nbsp;o&nbsp;processamento.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1181">1181</td><td nowrap="nowrap">10.2&nbsp;Variabilidade&nbsp;genética</td><td class="diff_next"></td><td class="diff_header" id="to62_1163">1163</td><td nowrap="nowrap">10.2&nbsp;Variabilidade&nbsp;genética</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1182">1182</td><td nowrap="nowrap">A&nbsp;RNA&nbsp;polimerase&nbsp;dependente&nbsp;de&nbsp;RNA&nbsp;do&nbsp;HCV&nbsp;não&nbsp;possui&nbsp;atividade&nbsp;revisora;&nbsp;por</td><td class="diff_next"></td><td class="diff_header" id="to62_1164">1164</td><td nowrap="nowrap">A&nbsp;RNA&nbsp;polimerase&nbsp;dependente&nbsp;de&nbsp;RNA&nbsp;do&nbsp;HCV&nbsp;não&nbsp;possui&nbsp;atividade&nbsp;revisora;&nbsp;por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1183">1183</td><td nowrap="nowrap">isso,&nbsp;os&nbsp;isolados&nbsp;do&nbsp;HCV&nbsp;possuem&nbsp;grande&nbsp;variabilidade&nbsp;genética,&nbsp;podendo&nbsp;ser&nbsp;classifi-</td><td class="diff_next"></td><td class="diff_header" id="to62_1165">1165</td><td nowrap="nowrap">isso,&nbsp;os&nbsp;isolados&nbsp;do&nbsp;HCV&nbsp;possuem&nbsp;grande&nbsp;variabilidade&nbsp;genética,&nbsp;podendo&nbsp;ser&nbsp;classifi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1184">1184</td><td nowrap="nowrap">cados&nbsp;em&nbsp;genótipos&nbsp;e&nbsp;subtipos.&nbsp;Existem&nbsp;sete&nbsp;genótipos&nbsp;principais,&nbsp;que&nbsp;possuem&nbsp;uma</td><td class="diff_next"></td><td class="diff_header" id="to62_1166">1166</td><td nowrap="nowrap">cados&nbsp;em&nbsp;genótipos&nbsp;e&nbsp;subtipos.&nbsp;Existem&nbsp;sete&nbsp;genótipos&nbsp;principais,&nbsp;que&nbsp;possuem&nbsp;uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1185">1185</td><td nowrap="nowrap">variabilidade&nbsp;de&nbsp;30%&nbsp;a&nbsp;35%&nbsp;entre&nbsp;si&nbsp;e&nbsp;são&nbsp;nomeados&nbsp;por&nbsp;números&nbsp;de&nbsp;1&nbsp;a&nbsp;7&nbsp;(JACKA&nbsp;et&nbsp;al.,</td><td class="diff_next"></td><td class="diff_header" id="to62_1167">1167</td><td nowrap="nowrap">variabilidade&nbsp;de&nbsp;30%&nbsp;a&nbsp;35%&nbsp;entre&nbsp;si&nbsp;e&nbsp;são&nbsp;nomeados&nbsp;por&nbsp;números&nbsp;de&nbsp;1&nbsp;a&nbsp;7&nbsp;(JACKA&nbsp;et&nbsp;al.,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1186">1186</td><td nowrap="nowrap">2013).&nbsp;Cada&nbsp;genótipo&nbsp;pode&nbsp;ser&nbsp;dividido&nbsp;em&nbsp;subtipos,&nbsp;que&nbsp;são&nbsp;identificados&nbsp;por&nbsp;letras</td><td class="diff_next"></td><td class="diff_header" id="to62_1168">1168</td><td nowrap="nowrap">2013).&nbsp;Cada&nbsp;genótipo&nbsp;pode&nbsp;ser&nbsp;dividido&nbsp;em&nbsp;subtipos,&nbsp;que&nbsp;são&nbsp;identificados&nbsp;por&nbsp;letras</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1187">1187</td><td nowrap="nowrap">(a,&nbsp;b,&nbsp;c,&nbsp;e&nbsp;assim&nbsp;sucessivamente).&nbsp;Existem&nbsp;67&nbsp;subtipos&nbsp;confirmados&nbsp;e&nbsp;20&nbsp;subtipos&nbsp;prová-</td><td class="diff_next"></td><td class="diff_header" id="to62_1169">1169</td><td nowrap="nowrap">(a,&nbsp;b,&nbsp;c,&nbsp;e&nbsp;assim&nbsp;sucessivamente).&nbsp;Existem&nbsp;67&nbsp;subtipos&nbsp;confirmados&nbsp;e&nbsp;20&nbsp;subtipos&nbsp;prová-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1188">1188</td><td nowrap="nowrap">veis,&nbsp;que&nbsp;diferem&nbsp;entre&nbsp;si&nbsp;de&nbsp;15%&nbsp;a&nbsp;25%&nbsp;de&nbsp;suas&nbsp;sequências&nbsp;nucleotídicas&nbsp;(MESSINA&nbsp;et</td><td class="diff_next"></td><td class="diff_header" id="to62_1170">1170</td><td nowrap="nowrap">veis,&nbsp;que&nbsp;diferem&nbsp;entre&nbsp;si&nbsp;de&nbsp;15%&nbsp;a&nbsp;25%&nbsp;de&nbsp;suas&nbsp;sequências&nbsp;nucleotídicas&nbsp;(MESSINA&nbsp;et</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1189">1189</td><td nowrap="nowrap">al.,&nbsp;2015;&nbsp;SMITH&nbsp;et&nbsp;al.,&nbsp;2014).&nbsp;A&nbsp;eficácia&nbsp;da&nbsp;terapia&nbsp;antiviral&nbsp;contra&nbsp;o&nbsp;HCV&nbsp;é&nbsp;dependente</td><td class="diff_next"></td><td class="diff_header" id="to62_1171">1171</td><td nowrap="nowrap">al.,&nbsp;2015;&nbsp;SMITH&nbsp;et&nbsp;al.,&nbsp;2014).&nbsp;A&nbsp;eficácia&nbsp;da&nbsp;terapia&nbsp;antiviral&nbsp;contra&nbsp;o&nbsp;HCV&nbsp;é&nbsp;dependente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1190">1190</td><td nowrap="nowrap">do&nbsp;genótipo&nbsp;viral;&nbsp;por&nbsp;isso,&nbsp;no&nbsp;âmbito&nbsp;do&nbsp;SUS,&nbsp;esta&nbsp;é&nbsp;definida&nbsp;pelo&nbsp;“Protocolo&nbsp;Clínico&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1172">1172</td><td nowrap="nowrap">do&nbsp;genótipo&nbsp;viral;&nbsp;por&nbsp;isso,&nbsp;no&nbsp;âmbito&nbsp;do&nbsp;SUS,&nbsp;esta&nbsp;é&nbsp;definida&nbsp;pelo&nbsp;“Protocolo&nbsp;Clínico&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1191">1191</td><td nowrap="nowrap">Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;C&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,&nbsp;2017d).</td><td class="diff_next"></td><td class="diff_header" id="to62_1173">1173</td><td nowrap="nowrap">Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;C&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,&nbsp;2017d).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1192">1192</td><td nowrap="nowrap">10.3&nbsp;Ciclo&nbsp;replicativo</td><td class="diff_next"></td><td class="diff_header" id="to62_1174">1174</td><td nowrap="nowrap">10.3&nbsp;Ciclo&nbsp;replicativo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1193">1193</td><td nowrap="nowrap">O&nbsp;modo&nbsp;de&nbsp;entrada&nbsp;do&nbsp;HCV&nbsp;na&nbsp;célula&nbsp;não&nbsp;está&nbsp;completamente&nbsp;elucidado,&nbsp;mas&nbsp;é&nbsp;um</td><td class="diff_next"></td><td class="diff_header" id="to62_1175">1175</td><td nowrap="nowrap">O&nbsp;modo&nbsp;de&nbsp;entrada&nbsp;do&nbsp;HCV&nbsp;na&nbsp;célula&nbsp;não&nbsp;está&nbsp;completamente&nbsp;elucidado,&nbsp;mas&nbsp;é&nbsp;um</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1194">1194</td><td nowrap="nowrap">processo&nbsp;complexo&nbsp;que&nbsp;requer&nbsp;a&nbsp;ação&nbsp;coordenada&nbsp;de&nbsp;diversas&nbsp;proteínas&nbsp;do&nbsp;hospedeiro,</td><td class="diff_next"></td><td class="diff_header" id="to62_1176">1176</td><td nowrap="nowrap">processo&nbsp;complexo&nbsp;que&nbsp;requer&nbsp;a&nbsp;ação&nbsp;coordenada&nbsp;de&nbsp;diversas&nbsp;proteínas&nbsp;do&nbsp;hospedeiro,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1195">1195</td><td nowrap="nowrap">incluindo&nbsp;as&nbsp;glicosaminoglicanas&nbsp;(GAG),&nbsp;o&nbsp;receptor&nbsp;de&nbsp;lipoproteína&nbsp;de&nbsp;baixa&nbsp;densida-</td><td class="diff_next"></td><td class="diff_header" id="to62_1177">1177</td><td nowrap="nowrap">incluindo&nbsp;as&nbsp;glicosaminoglicanas&nbsp;(GAG),&nbsp;o&nbsp;receptor&nbsp;de&nbsp;lipoproteína&nbsp;de&nbsp;baixa&nbsp;densida-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1196">1196</td><td nowrap="nowrap">de&nbsp;(LDLR,&nbsp;do&nbsp;inglês&nbsp;low-density&nbsp;lipoprotein&nbsp;receptor),&nbsp;o&nbsp;receptor&nbsp;de&nbsp;lipoproteína&nbsp;de&nbsp;alta</td><td class="diff_next"></td><td class="diff_header" id="to62_1178">1178</td><td nowrap="nowrap">de&nbsp;(LDLR,&nbsp;do&nbsp;inglês&nbsp;low-density&nbsp;lipoprotein&nbsp;receptor),&nbsp;o&nbsp;receptor&nbsp;de&nbsp;lipoproteína&nbsp;de&nbsp;alta</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1197">1197</td><td nowrap="nowrap">densidade&nbsp;SR-BI,&nbsp;CD81,&nbsp;e&nbsp;duas&nbsp;proteínas&nbsp;de&nbsp;junção,&nbsp;a&nbsp;claudina-1&nbsp;(CLDN1)&nbsp;e&nbsp;a&nbsp;ocludina</td><td class="diff_next"></td><td class="diff_header" id="to62_1179">1179</td><td nowrap="nowrap">densidade&nbsp;SR-BI,&nbsp;CD81,&nbsp;e&nbsp;duas&nbsp;proteínas&nbsp;de&nbsp;junção,&nbsp;a&nbsp;claudina-1&nbsp;(CLDN1)&nbsp;e&nbsp;a&nbsp;ocludina</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1198">1198</td><td nowrap="nowrap">(OCLN).&nbsp;É&nbsp;provável&nbsp;que&nbsp;o&nbsp;vírion&nbsp;utilize&nbsp;esses&nbsp;fatores&nbsp;de&nbsp;forma&nbsp;sequencial&nbsp;(BARTOSCH&nbsp;et</td><td class="diff_next"></td><td class="diff_header" id="to62_1180">1180</td><td nowrap="nowrap">(OCLN).&nbsp;É&nbsp;provável&nbsp;que&nbsp;o&nbsp;vírion&nbsp;utilize&nbsp;esses&nbsp;fatores&nbsp;de&nbsp;forma&nbsp;sequencial&nbsp;(BARTOSCH&nbsp;et</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1199">1199</td><td nowrap="nowrap">al.,&nbsp;2003;&nbsp;EVANS;&nbsp;HAHN;&nbsp;TSCHERNE,&nbsp;2007;&nbsp;PILERI&nbsp;et&nbsp;al.,&nbsp;1998;&nbsp;PLOSS&nbsp;et&nbsp;al.,&nbsp;2009).&nbsp;Um&nbsp;gru-</td><td class="diff_next"></td><td class="diff_header" id="to62_1181">1181</td><td nowrap="nowrap">al.,&nbsp;2003;&nbsp;EVANS;&nbsp;HAHN;&nbsp;TSCHERNE,&nbsp;2007;&nbsp;PILERI&nbsp;et&nbsp;al.,&nbsp;1998;&nbsp;PLOSS&nbsp;et&nbsp;al.,&nbsp;2009).&nbsp;Um&nbsp;gru-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1200">1200</td><td nowrap="nowrap">po&nbsp;de&nbsp;receptores&nbsp;é,&nbsp;provavelmente,&nbsp;responsável&nbsp;por&nbsp;mediar&nbsp;interações&nbsp;iniciais&nbsp;de&nbsp;baixa</td><td class="diff_next"></td><td class="diff_header" id="to62_1182">1182</td><td nowrap="nowrap">po&nbsp;de&nbsp;receptores&nbsp;é,&nbsp;provavelmente,&nbsp;responsável&nbsp;por&nbsp;mediar&nbsp;interações&nbsp;iniciais&nbsp;de&nbsp;baixa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1201">1201</td><td nowrap="nowrap">afinidade,&nbsp;necessárias&nbsp;à&nbsp;entrada&nbsp;do&nbsp;HCV&nbsp;(KOUTSOUDAKIS&nbsp;et&nbsp;al.,&nbsp;2006;&nbsp;MONAZAHIAN&nbsp;et</td><td class="diff_next"></td><td class="diff_header" id="to62_1183">1183</td><td nowrap="nowrap">afinidade,&nbsp;necessárias&nbsp;à&nbsp;entrada&nbsp;do&nbsp;HCV&nbsp;(KOUTSOUDAKIS&nbsp;et&nbsp;al.,&nbsp;2006;&nbsp;MONAZAHIAN&nbsp;et</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1202">1202</td><td nowrap="nowrap">al.,&nbsp;1999;&nbsp;ZEISEL&nbsp;et&nbsp;al.,&nbsp;2007).&nbsp;A&nbsp;proteína&nbsp;de&nbsp;envelope&nbsp;(E2)&nbsp;se&nbsp;liga&nbsp;à&nbsp;CD81.&nbsp;Em&nbsp;seguida,</td><td class="diff_next"></td><td class="diff_header" id="to62_1184">1184</td><td nowrap="nowrap">al.,&nbsp;1999;&nbsp;ZEISEL&nbsp;et&nbsp;al.,&nbsp;2007).&nbsp;A&nbsp;proteína&nbsp;de&nbsp;envelope&nbsp;(E2)&nbsp;se&nbsp;liga&nbsp;à&nbsp;CD81.&nbsp;Em&nbsp;seguida,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1203">1203</td><td nowrap="nowrap">eventos&nbsp;de&nbsp;sinalização&nbsp;são&nbsp;necessários&nbsp;para&nbsp;o&nbsp;recrutamento&nbsp;da&nbsp;CLDN1.&nbsp;O&nbsp;receptor&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1185">1185</td><td nowrap="nowrap">eventos&nbsp;de&nbsp;sinalização&nbsp;são&nbsp;necessários&nbsp;para&nbsp;o&nbsp;recrutamento&nbsp;da&nbsp;CLDN1.&nbsp;O&nbsp;receptor&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1204">1204</td><td nowrap="nowrap">fator&nbsp;de&nbsp;crescimento&nbsp;epidérmico&nbsp;(EGFR,&nbsp;do&nbsp;inglês&nbsp;epidermal&nbsp;growth&nbsp;factor&nbsp;receptor)&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1186">1186</td><td nowrap="nowrap">fator&nbsp;de&nbsp;crescimento&nbsp;epidérmico&nbsp;(EGFR,&nbsp;do&nbsp;inglês&nbsp;epidermal&nbsp;growth&nbsp;factor&nbsp;receptor)&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1205">1205</td><td nowrap="nowrap">o&nbsp;receptor&nbsp;de&nbsp;efrina&nbsp;A2&nbsp;(EphA2,&nbsp;do&nbsp;inglês&nbsp;ephrin&nbsp;type-A&nbsp;receptor&nbsp;2)&nbsp;modulam&nbsp;a&nbsp;associa-</td><td class="diff_next"></td><td class="diff_header" id="to62_1187">1187</td><td nowrap="nowrap">o&nbsp;receptor&nbsp;de&nbsp;efrina&nbsp;A2&nbsp;(EphA2,&nbsp;do&nbsp;inglês&nbsp;ephrin&nbsp;type-A&nbsp;receptor&nbsp;2)&nbsp;modulam&nbsp;a&nbsp;associa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1206">1206</td><td nowrap="nowrap">ção&nbsp;CD81-CLDN1.&nbsp;Após&nbsp;a&nbsp;ligação&nbsp;CD81-CLDN1,&nbsp;o&nbsp;complexo&nbsp;HCV-receptor&nbsp;interage&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to62_1188">1188</td><td nowrap="nowrap">ção&nbsp;CD81-CLDN1.&nbsp;Após&nbsp;a&nbsp;ligação&nbsp;CD81-CLDN1,&nbsp;o&nbsp;complexo&nbsp;HCV-receptor&nbsp;interage&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1207">1207</td><td nowrap="nowrap">a&nbsp;OCLN&nbsp;e&nbsp;é&nbsp;internalizado&nbsp;nas&nbsp;junções&nbsp;celulares,&nbsp;via&nbsp;endocitose&nbsp;mediada&nbsp;por&nbsp;clatrina.</td><td class="diff_next"></td><td class="diff_header" id="to62_1189">1189</td><td nowrap="nowrap">a&nbsp;OCLN&nbsp;e&nbsp;é&nbsp;internalizado&nbsp;nas&nbsp;junções&nbsp;celulares,&nbsp;via&nbsp;endocitose&nbsp;mediada&nbsp;por&nbsp;clatrina.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1208">1208</td><td nowrap="nowrap">O&nbsp;desencapsidamento&nbsp;ocorre&nbsp;em&nbsp;endossomos&nbsp;acidificados&nbsp;(BLANCHARD&nbsp;et&nbsp;al.,&nbsp;2006;</td><td class="diff_next"></td><td class="diff_header" id="to62_1190">1190</td><td nowrap="nowrap">O&nbsp;desencapsidamento&nbsp;ocorre&nbsp;em&nbsp;endossomos&nbsp;acidificados&nbsp;(BLANCHARD&nbsp;et&nbsp;al.,&nbsp;2006;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1209">1209</td><td nowrap="nowrap">LUPBERGER&nbsp;et&nbsp;al.,&nbsp;2011).</td><td class="diff_next"></td><td class="diff_header" id="to62_1191">1191</td><td nowrap="nowrap">LUPBERGER&nbsp;et&nbsp;al.,&nbsp;2011).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1210">1210</td><td nowrap="nowrap">A&nbsp;poliproteína&nbsp;do&nbsp;HCV&nbsp;é&nbsp;traduzida&nbsp;na&nbsp;membrana&nbsp;do&nbsp;retículo&nbsp;endoplasmático&nbsp;rugo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1192">1192</td><td nowrap="nowrap">A&nbsp;poliproteína&nbsp;do&nbsp;HCV&nbsp;é&nbsp;traduzida&nbsp;na&nbsp;membrana&nbsp;do&nbsp;retículo&nbsp;endoplasmático&nbsp;rugo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1211">1211</td><td nowrap="nowrap">so,&nbsp;com&nbsp;a&nbsp;fita&nbsp;positiva&nbsp;de&nbsp;RNA&nbsp;servindo&nbsp;de&nbsp;molde.&nbsp;A&nbsp;tradução&nbsp;é&nbsp;iniciada&nbsp;de&nbsp;maneira&nbsp;inde-</td><td class="diff_next"></td><td class="diff_header" id="to62_1193">1193</td><td nowrap="nowrap">so,&nbsp;com&nbsp;a&nbsp;fita&nbsp;positiva&nbsp;de&nbsp;RNA&nbsp;servindo&nbsp;de&nbsp;molde.&nbsp;A&nbsp;tradução&nbsp;é&nbsp;iniciada&nbsp;de&nbsp;maneira&nbsp;inde-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1212">1212</td><td nowrap="nowrap">pendente&nbsp;do&nbsp;cap,&nbsp;por&nbsp;meio&nbsp;do&nbsp;IRES&nbsp;localizado&nbsp;na&nbsp;5’NTR.&nbsp;É&nbsp;produzida&nbsp;uma&nbsp;poliproteína</td><td class="diff_next"></td><td class="diff_header" id="to62_1194">1194</td><td nowrap="nowrap">pendente&nbsp;do&nbsp;cap,&nbsp;por&nbsp;meio&nbsp;do&nbsp;IRES&nbsp;localizado&nbsp;na&nbsp;5’NTR.&nbsp;É&nbsp;produzida&nbsp;uma&nbsp;poliproteína</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1213">1213</td><td nowrap="nowrap">precursora&nbsp;de,&nbsp;aproximadamente,&nbsp;3.000&nbsp;aminoácidos,&nbsp;que&nbsp;é&nbsp;posteriormente&nbsp;processada</td><td class="diff_next"></td><td class="diff_header" id="to62_1195">1195</td><td nowrap="nowrap">precursora&nbsp;de,&nbsp;aproximadamente,&nbsp;3.000&nbsp;aminoácidos,&nbsp;que&nbsp;é&nbsp;posteriormente&nbsp;processada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1214">1214</td><td nowrap="nowrap">por&nbsp;proteases&nbsp;celulares&nbsp;(ex.:&nbsp;peptidases&nbsp;de&nbsp;sinal)&nbsp;e&nbsp;virais&nbsp;(NS2&nbsp;e&nbsp;NS3)&nbsp;para&nbsp;gerar&nbsp;as&nbsp;dez&nbsp;pro-</td><td class="diff_next"></td><td class="diff_header" id="to62_1196">1196</td><td nowrap="nowrap">por&nbsp;proteases&nbsp;celulares&nbsp;(ex.:&nbsp;peptidases&nbsp;de&nbsp;sinal)&nbsp;e&nbsp;virais&nbsp;(NS2&nbsp;e&nbsp;NS3)&nbsp;para&nbsp;gerar&nbsp;as&nbsp;dez&nbsp;pro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1215">1215</td><td nowrap="nowrap">teínas&nbsp;virais:&nbsp;core,&nbsp;E1&nbsp;e&nbsp;E2,&nbsp;p7,&nbsp;NS2,&nbsp;NS3,&nbsp;NS4A,&nbsp;NS4B,&nbsp;NS5A&nbsp;e&nbsp;NS5B&nbsp;(KIM;&nbsp;CHANG,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1197">1197</td><td nowrap="nowrap">teínas&nbsp;virais:&nbsp;core,&nbsp;E1&nbsp;e&nbsp;E2,&nbsp;p7,&nbsp;NS2,&nbsp;NS3,&nbsp;NS4A,&nbsp;NS4B,&nbsp;NS5A&nbsp;e&nbsp;NS5B&nbsp;(KIM;&nbsp;CHANG,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1216">1216</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;replicado&nbsp;pela&nbsp;NS5B;&nbsp;a&nbsp;proteína&nbsp;NS5A&nbsp;tem&nbsp;papel&nbsp;regulatório&nbsp;na&nbsp;re-</td><td class="diff_next"></td><td class="diff_header" id="to62_1198">1198</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;replicado&nbsp;pela&nbsp;NS5B;&nbsp;a&nbsp;proteína&nbsp;NS5A&nbsp;tem&nbsp;papel&nbsp;regulatório&nbsp;na&nbsp;re-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1217">1217</td><td nowrap="nowrap">plicação&nbsp;do&nbsp;vírus&nbsp;e&nbsp;a&nbsp;proteína&nbsp;NS3&nbsp;possui&nbsp;uma&nbsp;porção&nbsp;com&nbsp;função&nbsp;helicase,&nbsp;que&nbsp;também</td><td class="diff_next"></td><td class="diff_header" id="to62_1199">1199</td><td nowrap="nowrap">plicação&nbsp;do&nbsp;vírus&nbsp;e&nbsp;a&nbsp;proteína&nbsp;NS3&nbsp;possui&nbsp;uma&nbsp;porção&nbsp;com&nbsp;função&nbsp;helicase,&nbsp;que&nbsp;também</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1218">1218</td><td nowrap="nowrap">é&nbsp;importante&nbsp;para&nbsp;a&nbsp;replicação&nbsp;do&nbsp;genoma&nbsp;viral.&nbsp;Finalmente,&nbsp;a&nbsp;NS4B&nbsp;é&nbsp;uma&nbsp;proteína&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to62_1200">1200</td><td nowrap="nowrap">é&nbsp;importante&nbsp;para&nbsp;a&nbsp;replicação&nbsp;do&nbsp;genoma&nbsp;viral.&nbsp;Finalmente,&nbsp;a&nbsp;NS4B&nbsp;é&nbsp;uma&nbsp;proteína&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1219">1219</td><td nowrap="nowrap">papel&nbsp;significativo&nbsp;no&nbsp;rearranjo&nbsp;de&nbsp;membranas&nbsp;da&nbsp;célula,&nbsp;levando&nbsp;à&nbsp;formação&nbsp;da&nbsp;chama-</td><td class="diff_next"></td><td class="diff_header" id="to62_1201">1201</td><td nowrap="nowrap">papel&nbsp;significativo&nbsp;no&nbsp;rearranjo&nbsp;de&nbsp;membranas&nbsp;da&nbsp;célula,&nbsp;levando&nbsp;à&nbsp;formação&nbsp;da&nbsp;chama-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1220">1220</td><td nowrap="nowrap">da&nbsp;“teia&nbsp;membranosa”&nbsp;(ou&nbsp;complexo&nbsp;de&nbsp;replicação)&nbsp;que&nbsp;suporta&nbsp;e&nbsp;compartimentaliza&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_1202">1202</td><td nowrap="nowrap">da&nbsp;“teia&nbsp;membranosa”&nbsp;(ou&nbsp;complexo&nbsp;de&nbsp;replicação)&nbsp;que&nbsp;suporta&nbsp;e&nbsp;compartimentaliza&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1221">1221</td><td nowrap="nowrap">replicação&nbsp;do&nbsp;HCV.&nbsp;Esse&nbsp;complexo&nbsp;se&nbsp;associa&nbsp;a&nbsp;proteínas&nbsp;virais,&nbsp;componentes&nbsp;celulares</td><td class="diff_next"></td><td class="diff_header" id="to62_1203">1203</td><td nowrap="nowrap">replicação&nbsp;do&nbsp;HCV.&nbsp;Esse&nbsp;complexo&nbsp;se&nbsp;associa&nbsp;a&nbsp;proteínas&nbsp;virais,&nbsp;componentes&nbsp;celulares</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1222">1222</td><td nowrap="nowrap">do&nbsp;hospedeiro&nbsp;e&nbsp;fitas&nbsp;nascentes&nbsp;de&nbsp;RNA&nbsp;(CHEVALIEZ;&nbsp;PAWLOTSKY,&nbsp;2012).</td><td class="diff_next"></td><td class="diff_header" id="to62_1204">1204</td><td nowrap="nowrap">do&nbsp;hospedeiro&nbsp;e&nbsp;fitas&nbsp;nascentes&nbsp;de&nbsp;RNA&nbsp;(CHEVALIEZ;&nbsp;PAWLOTSKY,&nbsp;2012).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1223">1223</td><td nowrap="nowrap">Os&nbsp;estágios&nbsp;tardios&nbsp;do&nbsp;ciclo&nbsp;do&nbsp;HCV&nbsp;não&nbsp;estão&nbsp;completamente&nbsp;elucidados.&nbsp;No&nbsp;en-</td><td class="diff_next"></td><td class="diff_header" id="to62_1205">1205</td><td nowrap="nowrap">Os&nbsp;estágios&nbsp;tardios&nbsp;do&nbsp;ciclo&nbsp;do&nbsp;HCV&nbsp;não&nbsp;estão&nbsp;completamente&nbsp;elucidados.&nbsp;No&nbsp;en-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1224">1224</td><td nowrap="nowrap">tanto,&nbsp;sabe-se&nbsp;que&nbsp;a&nbsp;montagem&nbsp;e&nbsp;a&nbsp;liberação&nbsp;da&nbsp;partícula&nbsp;são&nbsp;processos&nbsp;firmemente</td><td class="diff_next"></td><td class="diff_header" id="to62_1206">1206</td><td nowrap="nowrap">tanto,&nbsp;sabe-se&nbsp;que&nbsp;a&nbsp;montagem&nbsp;e&nbsp;a&nbsp;liberação&nbsp;da&nbsp;partícula&nbsp;são&nbsp;processos&nbsp;firmemente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1225">1225</td><td nowrap="nowrap">regulados&nbsp;com&nbsp;a&nbsp;síntese&nbsp;de&nbsp;lipídios&nbsp;da&nbsp;célula&nbsp;hospedeira.&nbsp;Após&nbsp;a&nbsp;clivagem&nbsp;pelas&nbsp;prote-</td><td class="diff_next"></td><td class="diff_header" id="to62_1207">1207</td><td nowrap="nowrap">regulados&nbsp;com&nbsp;a&nbsp;síntese&nbsp;de&nbsp;lipídios&nbsp;da&nbsp;célula&nbsp;hospedeira.&nbsp;Após&nbsp;a&nbsp;clivagem&nbsp;pelas&nbsp;prote-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1226">1226</td><td nowrap="nowrap">ases&nbsp;celulares,&nbsp;a&nbsp;proteína&nbsp;do&nbsp;core&nbsp;se&nbsp;realoca&nbsp;na&nbsp;membrana&nbsp;do&nbsp;retículo&nbsp;endoplasmático</td><td class="diff_next"></td><td class="diff_header" id="to62_1208">1208</td><td nowrap="nowrap">ases&nbsp;celulares,&nbsp;a&nbsp;proteína&nbsp;do&nbsp;core&nbsp;se&nbsp;realoca&nbsp;na&nbsp;membrana&nbsp;do&nbsp;retículo&nbsp;endoplasmático</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1227">1227</td><td nowrap="nowrap">em&nbsp;gotículas&nbsp;de&nbsp;lipídios&nbsp;(SCHEEL;&nbsp;RICE,&nbsp;2013).&nbsp;Acredita-se&nbsp;que&nbsp;o&nbsp;RNA&nbsp;viral&nbsp;é&nbsp;conduzido</td><td class="diff_next"></td><td class="diff_header" id="to62_1209">1209</td><td nowrap="nowrap">em&nbsp;gotículas&nbsp;de&nbsp;lipídios&nbsp;(SCHEEL;&nbsp;RICE,&nbsp;2013).&nbsp;Acredita-se&nbsp;que&nbsp;o&nbsp;RNA&nbsp;viral&nbsp;é&nbsp;conduzido</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1228">1228</td><td nowrap="nowrap">ao&nbsp;core&nbsp;pela&nbsp;NS5B,&nbsp;além&nbsp;de&nbsp;ocorrer&nbsp;uma&nbsp;interação&nbsp;com&nbsp;NS5A.&nbsp;A&nbsp;interação&nbsp;NS5A-core</td><td class="diff_next"></td><td class="diff_header" id="to62_1210">1210</td><td nowrap="nowrap">ao&nbsp;core&nbsp;pela&nbsp;NS5B,&nbsp;além&nbsp;de&nbsp;ocorrer&nbsp;uma&nbsp;interação&nbsp;com&nbsp;NS5A.&nbsp;A&nbsp;interação&nbsp;NS5A-core</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1229">1229</td><td nowrap="nowrap">aciona&nbsp;a&nbsp;formação&nbsp;do&nbsp;nucleocapsídeo.&nbsp;Os&nbsp;capsídeos&nbsp;recém-formados&nbsp;brotam&nbsp;do&nbsp;lúmen</td><td class="diff_next"></td><td class="diff_header" id="to62_1211">1211</td><td nowrap="nowrap">aciona&nbsp;a&nbsp;formação&nbsp;do&nbsp;nucleocapsídeo.&nbsp;Os&nbsp;capsídeos&nbsp;recém-formados&nbsp;brotam&nbsp;do&nbsp;lúmen</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1230">1230</td><td nowrap="nowrap">do&nbsp;retículo&nbsp;endoplasmático&nbsp;em&nbsp;um&nbsp;processo&nbsp;ligado&nbsp;à&nbsp;síntese&nbsp;de&nbsp;VLDL.&nbsp;Dessa&nbsp;forma,</td><td class="diff_next"></td><td class="diff_header" id="to62_1212">1212</td><td nowrap="nowrap">do&nbsp;retículo&nbsp;endoplasmático&nbsp;em&nbsp;um&nbsp;processo&nbsp;ligado&nbsp;à&nbsp;síntese&nbsp;de&nbsp;VLDL.&nbsp;Dessa&nbsp;forma,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1231">1231</td><td nowrap="nowrap">(BARTENSCHLAGER;&nbsp;COSSET;&nbsp;LOHMANN,&nbsp;2010).&nbsp;O&nbsp;ciclo&nbsp;replicativo&nbsp;do&nbsp;HCV&nbsp;encontra-se</td><td class="diff_next"></td><td class="diff_header" id="to62_1213">1213</td><td nowrap="nowrap">(BARTENSCHLAGER;&nbsp;COSSET;&nbsp;LOHMANN,&nbsp;2010).&nbsp;O&nbsp;ciclo&nbsp;replicativo&nbsp;do&nbsp;HCV&nbsp;encontra-se</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1232">1232</td><td nowrap="nowrap">representado&nbsp;esquematicamente&nbsp;na&nbsp;Figura&nbsp;15.</td><td class="diff_next"></td><td class="diff_header" id="to62_1214">1214</td><td nowrap="nowrap">representado&nbsp;esquematicamente&nbsp;na&nbsp;Figura&nbsp;15.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1233">1233</td><td nowrap="nowrap">Figura&nbsp;15.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1215">1215</td><td nowrap="nowrap">Figura&nbsp;15.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1234">1234</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;MORADPOUR;&nbsp;PENIN;&nbsp;RICE,&nbsp;2007.</td><td class="diff_next"></td><td class="diff_header" id="to62_1216">1216</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;MORADPOUR;&nbsp;PENIN;&nbsp;RICE,&nbsp;2007.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1235">1235</td><td nowrap="nowrap">Notas:&nbsp;(a)&nbsp;Contato&nbsp;de&nbsp;internalização&nbsp;do&nbsp;vírion&nbsp;na&nbsp;célula;&nbsp;(b)&nbsp;liberação&nbsp;do&nbsp;RNA&nbsp;viral&nbsp;no&nbsp;citoplasma;&nbsp;(c)</td><td class="diff_next"></td><td class="diff_header" id="to62_1217">1217</td><td nowrap="nowrap">Notas:&nbsp;(a)&nbsp;Contato&nbsp;de&nbsp;internalização&nbsp;do&nbsp;vírion&nbsp;na&nbsp;célula;&nbsp;(b)&nbsp;liberação&nbsp;do&nbsp;RNA&nbsp;viral&nbsp;no&nbsp;citoplasma;&nbsp;(c)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1236">1236</td><td nowrap="nowrap">tradução&nbsp;e&nbsp;processamento&nbsp;da&nbsp;poliproteína&nbsp;viral;&nbsp;(d)&nbsp;replicação&nbsp;do&nbsp;RNA&nbsp;viral;&nbsp;(e)&nbsp;empacotamento&nbsp;do&nbsp;RNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1218">1218</td><td nowrap="nowrap">tradução&nbsp;e&nbsp;processamento&nbsp;da&nbsp;poliproteína&nbsp;viral;&nbsp;(d)&nbsp;replicação&nbsp;do&nbsp;RNA&nbsp;viral;&nbsp;(e)&nbsp;empacotamento&nbsp;do&nbsp;RNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1237">1237</td><td nowrap="nowrap">viral&nbsp;e&nbsp;montagem&nbsp;da&nbsp;partícula;&nbsp;(f)&nbsp;maturação&nbsp;do&nbsp;vírion&nbsp;e&nbsp;liberação.</td><td class="diff_next"></td><td class="diff_header" id="to62_1219">1219</td><td nowrap="nowrap">viral&nbsp;e&nbsp;montagem&nbsp;da&nbsp;partícula;&nbsp;(f)&nbsp;maturação&nbsp;do&nbsp;vírion&nbsp;e&nbsp;liberação.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1238">1238</td><td nowrap="nowrap">10.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td><td class="diff_next"></td><td class="diff_header" id="to62_1220">1220</td><td nowrap="nowrap">10.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1239">1239</td><td nowrap="nowrap">A&nbsp;transmissão&nbsp;do&nbsp;HCV&nbsp;ocorre,&nbsp;primariamente,&nbsp;por&nbsp;via&nbsp;parenteral.&nbsp;Desde&nbsp;o&nbsp;advento</td><td class="diff_next"></td><td class="diff_header" id="to62_1221">1221</td><td nowrap="nowrap">A&nbsp;transmissão&nbsp;do&nbsp;HCV&nbsp;ocorre,&nbsp;primariamente,&nbsp;por&nbsp;via&nbsp;parenteral.&nbsp;Desde&nbsp;o&nbsp;advento</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1240">1240</td><td nowrap="nowrap">da&nbsp;testagem&nbsp;das&nbsp;bolsas&nbsp;de&nbsp;sangue,&nbsp;a&nbsp;transmissão&nbsp;por&nbsp;meio&nbsp;do&nbsp;sangue&nbsp;e&nbsp;seus&nbsp;derivados</td><td class="diff_next"></td><td class="diff_header" id="to62_1222">1222</td><td nowrap="nowrap">da&nbsp;testagem&nbsp;das&nbsp;bolsas&nbsp;de&nbsp;sangue,&nbsp;a&nbsp;transmissão&nbsp;por&nbsp;meio&nbsp;do&nbsp;sangue&nbsp;e&nbsp;seus&nbsp;derivados</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1241">1241</td><td nowrap="nowrap">foi&nbsp;praticamente&nbsp;eliminada&nbsp;em&nbsp;países&nbsp;desenvolvidos.&nbsp;Hoje,&nbsp;a&nbsp;epidemia&nbsp;continua&nbsp;se&nbsp;es-</td><td class="diff_next"></td><td class="diff_header" id="to62_1223">1223</td><td nowrap="nowrap">foi&nbsp;praticamente&nbsp;eliminada&nbsp;em&nbsp;países&nbsp;desenvolvidos.&nbsp;Hoje,&nbsp;a&nbsp;epidemia&nbsp;continua&nbsp;se&nbsp;es-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1242">1242</td><td nowrap="nowrap">palhando,&nbsp;principalmente,&nbsp;entre&nbsp;as&nbsp;pessoas&nbsp;que&nbsp;compartilham&nbsp;seringas,&nbsp;agulhas&nbsp;e&nbsp;ou-</td><td class="diff_next"></td><td class="diff_header" id="to62_1224">1224</td><td nowrap="nowrap">palhando,&nbsp;principalmente,&nbsp;entre&nbsp;as&nbsp;pessoas&nbsp;que&nbsp;compartilham&nbsp;seringas,&nbsp;agulhas&nbsp;e&nbsp;ou-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1243">1243</td><td nowrap="nowrap">tros&nbsp;instrumentos&nbsp;para&nbsp;uso&nbsp;de&nbsp;drogas.&nbsp;Sob&nbsp;algumas&nbsp;condições,&nbsp;as&nbsp;transmissões&nbsp;iatrogê-</td><td class="diff_next"></td><td class="diff_header" id="to62_1225">1225</td><td nowrap="nowrap">tros&nbsp;instrumentos&nbsp;para&nbsp;uso&nbsp;de&nbsp;drogas.&nbsp;Sob&nbsp;algumas&nbsp;condições,&nbsp;as&nbsp;transmissões&nbsp;iatrogê-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1244">1244</td><td nowrap="nowrap">nicaG,&nbsp;nosocomial,&nbsp;sexual&nbsp;e&nbsp;vertical&nbsp;podem&nbsp;ocorrer&nbsp;(DUSTIN;&nbsp;RICE,&nbsp;2007).</td><td class="diff_next"></td><td class="diff_header" id="to62_1226">1226</td><td nowrap="nowrap">nicaG,&nbsp;nosocomial,&nbsp;sexual&nbsp;e&nbsp;vertical&nbsp;podem&nbsp;ocorrer&nbsp;(DUSTIN;&nbsp;RICE,&nbsp;2007).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1245">1245</td><td nowrap="nowrap">De&nbsp;modo&nbsp;geral,&nbsp;a&nbsp;hepatite&nbsp;C&nbsp;aguda&nbsp;apresenta&nbsp;evolução&nbsp;subclínica,&nbsp;com&nbsp;cerca&nbsp;de&nbsp;80%</td><td class="diff_next"></td><td class="diff_header" id="to62_1227">1227</td><td nowrap="nowrap">De&nbsp;modo&nbsp;geral,&nbsp;a&nbsp;hepatite&nbsp;C&nbsp;aguda&nbsp;apresenta&nbsp;evolução&nbsp;subclínica,&nbsp;com&nbsp;cerca&nbsp;de&nbsp;80%</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1246">1246</td><td nowrap="nowrap">de&nbsp;casos&nbsp;assintomáticos&nbsp;e&nbsp;anictéricos,&nbsp;dificultando&nbsp;o&nbsp;diagnóstico.&nbsp;Aproximadamente,</td><td class="diff_next"></td><td class="diff_header" id="to62_1228">1228</td><td nowrap="nowrap">de&nbsp;casos&nbsp;assintomáticos&nbsp;e&nbsp;anictéricos,&nbsp;dificultando&nbsp;o&nbsp;diagnóstico.&nbsp;Aproximadamente,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1247">1247</td><td nowrap="nowrap">20%&nbsp;a&nbsp;30%&nbsp;dos&nbsp;casos&nbsp;podem&nbsp;apresentar&nbsp;icterícia&nbsp;e&nbsp;10%&nbsp;a&nbsp;20%&nbsp;apresentam&nbsp;sintomas&nbsp;ines-</td><td class="diff_next"></td><td class="diff_header" id="to62_1229">1229</td><td nowrap="nowrap">20%&nbsp;a&nbsp;30%&nbsp;dos&nbsp;casos&nbsp;podem&nbsp;apresentar&nbsp;icterícia&nbsp;e&nbsp;10%&nbsp;a&nbsp;20%&nbsp;apresentam&nbsp;sintomas&nbsp;ines-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1248">1248</td><td nowrap="nowrap">pecíficos,&nbsp;como&nbsp;anorexia,&nbsp;astenia,&nbsp;mal-estar&nbsp;e&nbsp;dor&nbsp;abdominal.&nbsp;Quando&nbsp;presente,&nbsp;o&nbsp;quadro</td><td class="diff_next"></td><td class="diff_header" id="to62_1230">1230</td><td nowrap="nowrap">pecíficos,&nbsp;como&nbsp;anorexia,&nbsp;astenia,&nbsp;mal-estar&nbsp;e&nbsp;dor&nbsp;abdominal.&nbsp;Quando&nbsp;presente,&nbsp;o&nbsp;quadro</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1249">1249</td><td nowrap="nowrap">clínico&nbsp;é&nbsp;semelhante&nbsp;àquele&nbsp;decorrente&nbsp;de&nbsp;outros&nbsp;agentes&nbsp;que&nbsp;causam&nbsp;hepatites&nbsp;virais,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1231">1231</td><td nowrap="nowrap">clínico&nbsp;é&nbsp;semelhante&nbsp;àquele&nbsp;decorrente&nbsp;de&nbsp;outros&nbsp;agentes&nbsp;que&nbsp;causam&nbsp;hepatites&nbsp;virais,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1250">1250</td><td nowrap="nowrap">anticorpos&nbsp;específicos,&nbsp;antígenos&nbsp;virais&nbsp;ou&nbsp;material&nbsp;genético&nbsp;viral&nbsp;(BRASIL,&nbsp;2017d).</td><td class="diff_next"></td><td class="diff_header" id="to62_1232">1232</td><td nowrap="nowrap">anticorpos&nbsp;específicos,&nbsp;antígenos&nbsp;virais&nbsp;ou&nbsp;material&nbsp;genético&nbsp;viral&nbsp;(BRASIL,&nbsp;2017d).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1251">1251</td><td nowrap="nowrap">genética&nbsp;do&nbsp;vírus,&nbsp;que&nbsp;permitiria&nbsp;ao&nbsp;vírus&nbsp;escapar&nbsp;à&nbsp;resposta&nbsp;imune&nbsp;do&nbsp;hospedeiro.&nbsp;A&nbsp;via</td><td class="diff_next"></td><td class="diff_header" id="to62_1233">1233</td><td nowrap="nowrap">genética&nbsp;do&nbsp;vírus,&nbsp;que&nbsp;permitiria&nbsp;ao&nbsp;vírus&nbsp;escapar&nbsp;à&nbsp;resposta&nbsp;imune&nbsp;do&nbsp;hospedeiro.&nbsp;A&nbsp;via</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1252">1252</td><td nowrap="nowrap">de&nbsp;contaminação&nbsp;também&nbsp;é&nbsp;um&nbsp;fator&nbsp;importante&nbsp;para&nbsp;definir&nbsp;a&nbsp;história&nbsp;natural&nbsp;da&nbsp;do-</td><td class="diff_next"></td><td class="diff_header" id="to62_1234">1234</td><td nowrap="nowrap">de&nbsp;contaminação&nbsp;também&nbsp;é&nbsp;um&nbsp;fator&nbsp;importante&nbsp;para&nbsp;definir&nbsp;a&nbsp;história&nbsp;natural&nbsp;da&nbsp;do-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1253">1253</td><td nowrap="nowrap">ença.&nbsp;Pacientes&nbsp;infectados&nbsp;por&nbsp;transfusão&nbsp;sanguínea&nbsp;evoluiriam&nbsp;mais&nbsp;frequentemente</td><td class="diff_next"></td><td class="diff_header" id="to62_1235">1235</td><td nowrap="nowrap">ença.&nbsp;Pacientes&nbsp;infectados&nbsp;por&nbsp;transfusão&nbsp;sanguínea&nbsp;evoluiriam&nbsp;mais&nbsp;frequentemente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1254">1254</td><td nowrap="nowrap">para&nbsp;as&nbsp;formas&nbsp;crônicas&nbsp;da&nbsp;doença&nbsp;do&nbsp;que&nbsp;aqueles&nbsp;infectados&nbsp;por&nbsp;outras&nbsp;vias.&nbsp;A&nbsp;infecção</td><td class="diff_next"></td><td class="diff_header" id="to62_1236">1236</td><td nowrap="nowrap">para&nbsp;as&nbsp;formas&nbsp;crônicas&nbsp;da&nbsp;doença&nbsp;do&nbsp;que&nbsp;aqueles&nbsp;infectados&nbsp;por&nbsp;outras&nbsp;vias.&nbsp;A&nbsp;infecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1255">1255</td><td nowrap="nowrap">crônica&nbsp;se&nbsp;desenvolve&nbsp;ao&nbsp;longo&nbsp;de&nbsp;anos&nbsp;ou&nbsp;décadas.&nbsp;Acredita-se&nbsp;que&nbsp;a&nbsp;evolução&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_1237">1237</td><td nowrap="nowrap">crônica&nbsp;se&nbsp;desenvolve&nbsp;ao&nbsp;longo&nbsp;de&nbsp;anos&nbsp;ou&nbsp;décadas.&nbsp;Acredita-se&nbsp;que&nbsp;a&nbsp;evolução&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1256">1256</td><td nowrap="nowrap">cirrose&nbsp;e&nbsp;carcinoma&nbsp;hepatocelular&nbsp;(HCC,&nbsp;do&nbsp;inglês&nbsp;hepatocellular&nbsp;carcinoma)&nbsp;dependa</td><td class="diff_next"></td><td class="diff_header" id="to62_1238">1238</td><td nowrap="nowrap">cirrose&nbsp;e&nbsp;carcinoma&nbsp;hepatocelular&nbsp;(HCC,&nbsp;do&nbsp;inglês&nbsp;hepatocellular&nbsp;carcinoma)&nbsp;dependa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1257">1257</td><td nowrap="nowrap">de&nbsp;fatores&nbsp;como&nbsp;carga&nbsp;viral&nbsp;e&nbsp;genótipo,&nbsp;mas&nbsp;ainda&nbsp;há&nbsp;discussão&nbsp;sobre&nbsp;o&nbsp;assunto.&nbsp;O&nbsp;dano</td><td class="diff_next"></td><td class="diff_header" id="to62_1239">1239</td><td nowrap="nowrap">de&nbsp;fatores&nbsp;como&nbsp;carga&nbsp;viral&nbsp;e&nbsp;genótipo,&nbsp;mas&nbsp;ainda&nbsp;há&nbsp;discussão&nbsp;sobre&nbsp;o&nbsp;assunto.&nbsp;O&nbsp;dano</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1258">1258</td><td nowrap="nowrap">celular&nbsp;causado&nbsp;pelo&nbsp;HCV&nbsp;é&nbsp;pequeno;&nbsp;por&nbsp;isso,&nbsp;supõe-se&nbsp;que&nbsp;o&nbsp;dano&nbsp;hepático&nbsp;ocorra,</td><td class="diff_next"></td><td class="diff_header" id="to62_1240">1240</td><td nowrap="nowrap">celular&nbsp;causado&nbsp;pelo&nbsp;HCV&nbsp;é&nbsp;pequeno;&nbsp;por&nbsp;isso,&nbsp;supõe-se&nbsp;que&nbsp;o&nbsp;dano&nbsp;hepático&nbsp;ocorra,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1259">1259</td><td nowrap="nowrap">primariamente,&nbsp;por&nbsp;ação&nbsp;de&nbsp;mecanismos&nbsp;imunológicos&nbsp;(STRAUSS,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1241">1241</td><td nowrap="nowrap">primariamente,&nbsp;por&nbsp;ação&nbsp;de&nbsp;mecanismos&nbsp;imunológicos&nbsp;(STRAUSS,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1260">1260</td><td nowrap="nowrap">10.5&nbsp;Resposta&nbsp;imune</td><td class="diff_next"></td><td class="diff_header" id="to62_1242">1242</td><td nowrap="nowrap">10.5&nbsp;Resposta&nbsp;imune</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1261">1261</td><td nowrap="nowrap">O&nbsp;HCV&nbsp;pode&nbsp;induzir&nbsp;uma&nbsp;forte&nbsp;resposta&nbsp;imune&nbsp;inata,&nbsp;uma&nbsp;vez&nbsp;que&nbsp;a&nbsp;infecção&nbsp;causa</td><td class="diff_next"></td><td class="diff_header" id="to62_1243">1243</td><td nowrap="nowrap">O&nbsp;HCV&nbsp;pode&nbsp;induzir&nbsp;uma&nbsp;forte&nbsp;resposta&nbsp;imune&nbsp;inata,&nbsp;uma&nbsp;vez&nbsp;que&nbsp;a&nbsp;infecção&nbsp;causa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1262">1262</td><td nowrap="nowrap">a&nbsp;ativação&nbsp;de&nbsp;genes&nbsp;de&nbsp;resposta&nbsp;ao&nbsp;interferon.&nbsp;No&nbsp;entanto,&nbsp;o&nbsp;vírus&nbsp;é&nbsp;capaz&nbsp;de&nbsp;resistir&nbsp;aos</td><td class="diff_next"></td><td class="diff_header" id="to62_1244">1244</td><td nowrap="nowrap">a&nbsp;ativação&nbsp;de&nbsp;genes&nbsp;de&nbsp;resposta&nbsp;ao&nbsp;interferon.&nbsp;No&nbsp;entanto,&nbsp;o&nbsp;vírus&nbsp;é&nbsp;capaz&nbsp;de&nbsp;resistir&nbsp;aos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1263">1263</td><td nowrap="nowrap">efeitos&nbsp;da&nbsp;terapia&nbsp;e&nbsp;estabelecer&nbsp;infecções&nbsp;crônicas&nbsp;(REHERMANN;&nbsp;NASCIMBENI,&nbsp;2005).</td><td class="diff_next"></td><td class="diff_header" id="to62_1245">1245</td><td nowrap="nowrap">efeitos&nbsp;da&nbsp;terapia&nbsp;e&nbsp;estabelecer&nbsp;infecções&nbsp;crônicas&nbsp;(REHERMANN;&nbsp;NASCIMBENI,&nbsp;2005).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1264">1264</td><td nowrap="nowrap">Os&nbsp;pacientes&nbsp;que&nbsp;se&nbsp;recuperam&nbsp;espontaneamente&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;são&nbsp;aque-</td><td class="diff_next"></td><td class="diff_header" id="to62_1246">1246</td><td nowrap="nowrap">Os&nbsp;pacientes&nbsp;que&nbsp;se&nbsp;recuperam&nbsp;espontaneamente&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;são&nbsp;aque-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1265">1265</td><td nowrap="nowrap">les&nbsp;que&nbsp;estabelecem&nbsp;respostas&nbsp;imunes&nbsp;fortes,&nbsp;as&nbsp;quais&nbsp;podem&nbsp;ser&nbsp;prontamente&nbsp;detec-</td><td class="diff_next"></td><td class="diff_header" id="to62_1247">1247</td><td nowrap="nowrap">les&nbsp;que&nbsp;estabelecem&nbsp;respostas&nbsp;imunes&nbsp;fortes,&nbsp;as&nbsp;quais&nbsp;podem&nbsp;ser&nbsp;prontamente&nbsp;detec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1266">1266</td><td nowrap="nowrap">tadas&nbsp;no&nbsp;sangue.&nbsp;Pacientes&nbsp;que&nbsp;desenvolvem&nbsp;doenças&nbsp;crônicas&nbsp;apresentam&nbsp;respostas</td><td class="diff_next"></td><td class="diff_header" id="to62_1248">1248</td><td nowrap="nowrap">tadas&nbsp;no&nbsp;sangue.&nbsp;Pacientes&nbsp;que&nbsp;desenvolvem&nbsp;doenças&nbsp;crônicas&nbsp;apresentam&nbsp;respostas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1267">1267</td><td nowrap="nowrap">imunes&nbsp;localizadas&nbsp;ou&nbsp;transientes,&nbsp;baseadas&nbsp;em&nbsp;células&nbsp;T.&nbsp;Os&nbsp;anticorpos&nbsp;contra&nbsp;as&nbsp;pro-</td><td class="diff_next"></td><td class="diff_header" id="to62_1249">1249</td><td nowrap="nowrap">imunes&nbsp;localizadas&nbsp;ou&nbsp;transientes,&nbsp;baseadas&nbsp;em&nbsp;células&nbsp;T.&nbsp;Os&nbsp;anticorpos&nbsp;contra&nbsp;as&nbsp;pro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1268">1268</td><td nowrap="nowrap">teínas&nbsp;de&nbsp;envelope&nbsp;podem&nbsp;estar&nbsp;associados&nbsp;à&nbsp;modulação&nbsp;dos&nbsp;níveis&nbsp;circulantes&nbsp;de&nbsp;vírus.</td><td class="diff_next"></td><td class="diff_header" id="to62_1250">1250</td><td nowrap="nowrap">teínas&nbsp;de&nbsp;envelope&nbsp;podem&nbsp;estar&nbsp;associados&nbsp;à&nbsp;modulação&nbsp;dos&nbsp;níveis&nbsp;circulantes&nbsp;de&nbsp;vírus.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1269">1269</td><td nowrap="nowrap">No&nbsp;entanto,&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;possível&nbsp;relacionar&nbsp;esses&nbsp;anticorpos&nbsp;a&nbsp;algum&nbsp;tipo&nbsp;de&nbsp;imunida-</td><td class="diff_next"></td><td class="diff_header" id="to62_1251">1251</td><td nowrap="nowrap">No&nbsp;entanto,&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;possível&nbsp;relacionar&nbsp;esses&nbsp;anticorpos&nbsp;a&nbsp;algum&nbsp;tipo&nbsp;de&nbsp;imunida-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1270">1270</td><td nowrap="nowrap">de&nbsp;protetora,&nbsp;embora&nbsp;existam&nbsp;estudos&nbsp;indicando&nbsp;que&nbsp;os&nbsp;pacientes&nbsp;que&nbsp;se&nbsp;recuperam&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1252">1252</td><td nowrap="nowrap">de&nbsp;protetora,&nbsp;embora&nbsp;existam&nbsp;estudos&nbsp;indicando&nbsp;que&nbsp;os&nbsp;pacientes&nbsp;que&nbsp;se&nbsp;recuperam&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1271">1271</td><td nowrap="nowrap">infecção&nbsp;podem&nbsp;ser&nbsp;resistentes&nbsp;a&nbsp;novas&nbsp;exposições&nbsp;ao&nbsp;vírus&nbsp;(ASHFAQ&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;MEHTA</td><td class="diff_next"></td><td class="diff_header" id="to62_1253">1253</td><td nowrap="nowrap">infecção&nbsp;podem&nbsp;ser&nbsp;resistentes&nbsp;a&nbsp;novas&nbsp;exposições&nbsp;ao&nbsp;vírus&nbsp;(ASHFAQ&nbsp;et&nbsp;al.,&nbsp;2011;&nbsp;MEHTA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1272">1272</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2002;&nbsp;REHERMANN;&nbsp;NASCIMBENI,&nbsp;2005).</td><td class="diff_next"></td><td class="diff_header" id="to62_1254">1254</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2002;&nbsp;REHERMANN;&nbsp;NASCIMBENI,&nbsp;2005).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1273">1273</td><td nowrap="nowrap">10.6&nbsp;Diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_1255">1255</td><td nowrap="nowrap">10.6&nbsp;Diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1274">1274</td><td nowrap="nowrap">A&nbsp;triagem&nbsp;de&nbsp;amostras&nbsp;de&nbsp;sangue&nbsp;total,&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;FO&nbsp;é&nbsp;feita&nbsp;com&nbsp;a&nbsp;utilização</td><td class="diff_next"></td><td class="diff_header" id="to62_1256">1256</td><td nowrap="nowrap">A&nbsp;triagem&nbsp;de&nbsp;amostras&nbsp;de&nbsp;sangue&nbsp;total,&nbsp;soro,&nbsp;plasma&nbsp;ou&nbsp;FO&nbsp;é&nbsp;feita&nbsp;com&nbsp;a&nbsp;utilização</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1275">1275</td><td nowrap="nowrap">de&nbsp;imunoensaios.&nbsp;Amostras&nbsp;com&nbsp;resultados&nbsp;reagentes&nbsp;nessa&nbsp;etapa&nbsp;têm&nbsp;seu&nbsp;resultado</td><td class="diff_next"></td><td class="diff_header" id="to62_1257">1257</td><td nowrap="nowrap">de&nbsp;imunoensaios.&nbsp;Amostras&nbsp;com&nbsp;resultados&nbsp;reagentes&nbsp;nessa&nbsp;etapa&nbsp;têm&nbsp;seu&nbsp;resultado</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1276">1276</td><td nowrap="nowrap">confirmado&nbsp;por&nbsp;meio&nbsp;de&nbsp;outros&nbsp;testes,&nbsp;que&nbsp;visam&nbsp;à&nbsp;detecção&nbsp;direta&nbsp;do&nbsp;vírus.</td><td class="diff_next"></td><td class="diff_header" id="to62_1258">1258</td><td nowrap="nowrap">confirmado&nbsp;por&nbsp;meio&nbsp;de&nbsp;outros&nbsp;testes,&nbsp;que&nbsp;visam&nbsp;à&nbsp;detecção&nbsp;direta&nbsp;do&nbsp;vírus.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1277">1277</td><td nowrap="nowrap">Os&nbsp;imunoensaios&nbsp;empregados&nbsp;estritamente&nbsp;em&nbsp;laboratório&nbsp;e&nbsp;os&nbsp;TR&nbsp;detectam&nbsp;o&nbsp;an-</td><td class="diff_next"></td><td class="diff_header" id="to62_1259">1259</td><td nowrap="nowrap">Os&nbsp;imunoensaios&nbsp;empregados&nbsp;estritamente&nbsp;em&nbsp;laboratório&nbsp;e&nbsp;os&nbsp;TR&nbsp;detectam&nbsp;o&nbsp;an-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1278">1278</td><td nowrap="nowrap">ticorpo&nbsp;anti-HCV,&nbsp;que&nbsp;indica&nbsp;contato&nbsp;com&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C.&nbsp;O&nbsp;antígeno&nbsp;core&nbsp;do&nbsp;HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1260">1260</td><td nowrap="nowrap">ticorpo&nbsp;anti-HCV,&nbsp;que&nbsp;indica&nbsp;contato&nbsp;com&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C.&nbsp;O&nbsp;antígeno&nbsp;core&nbsp;do&nbsp;HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1279">1279</td><td nowrap="nowrap">ativa,&nbsp;podendo&nbsp;ser&nbsp;utilizado&nbsp;para&nbsp;confirmar&nbsp;o&nbsp;resultado&nbsp;da&nbsp;pesquisa&nbsp;de&nbsp;anticorpos.</td><td class="diff_next"></td><td class="diff_header" id="to62_1261">1261</td><td nowrap="nowrap">ativa,&nbsp;podendo&nbsp;ser&nbsp;utilizado&nbsp;para&nbsp;confirmar&nbsp;o&nbsp;resultado&nbsp;da&nbsp;pesquisa&nbsp;de&nbsp;anticorpos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1280">1280</td><td nowrap="nowrap">Além&nbsp;dos&nbsp;imunoensaios&nbsp;laboratoriais&nbsp;e&nbsp;dos&nbsp;TR,&nbsp;o&nbsp;teste&nbsp;molecular&nbsp;oferece&nbsp;uma&nbsp;al-</td><td class="diff_next"></td><td class="diff_header" id="to62_1262">1262</td><td nowrap="nowrap">Além&nbsp;dos&nbsp;imunoensaios&nbsp;laboratoriais&nbsp;e&nbsp;dos&nbsp;TR,&nbsp;o&nbsp;teste&nbsp;molecular&nbsp;oferece&nbsp;uma&nbsp;al-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1281">1281</td><td nowrap="nowrap">a&nbsp;confirmação&nbsp;dos&nbsp;casos&nbsp;anti-HCV&nbsp;reagentes.&nbsp;Os&nbsp;fluxogramas&nbsp;propostos&nbsp;com&nbsp;testes&nbsp;uti-</td><td class="diff_next"></td><td class="diff_header" id="to62_1263">1263</td><td nowrap="nowrap">a&nbsp;confirmação&nbsp;dos&nbsp;casos&nbsp;anti-HCV&nbsp;reagentes.&nbsp;Os&nbsp;fluxogramas&nbsp;propostos&nbsp;com&nbsp;testes&nbsp;uti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1282">1282</td><td nowrap="nowrap">lizados&nbsp;em&nbsp;laboratório&nbsp;incorporaram&nbsp;essas&nbsp;considerações,&nbsp;e&nbsp;oferecem&nbsp;opções&nbsp;que&nbsp;po-</td><td class="diff_next"></td><td class="diff_header" id="to62_1264">1264</td><td nowrap="nowrap">lizados&nbsp;em&nbsp;laboratório&nbsp;incorporaram&nbsp;essas&nbsp;considerações,&nbsp;e&nbsp;oferecem&nbsp;opções&nbsp;que&nbsp;po-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1283">1283</td><td nowrap="nowrap">dem&nbsp;ser&nbsp;selecionadas&nbsp;dependendo&nbsp;da&nbsp;capacidade&nbsp;do&nbsp;laboratório&nbsp;e&nbsp;do&nbsp;contexto&nbsp;clínico.</td><td class="diff_next"></td><td class="diff_header" id="to62_1265">1265</td><td nowrap="nowrap">dem&nbsp;ser&nbsp;selecionadas&nbsp;dependendo&nbsp;da&nbsp;capacidade&nbsp;do&nbsp;laboratório&nbsp;e&nbsp;do&nbsp;contexto&nbsp;clínico.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1284">1284</td><td nowrap="nowrap">de&nbsp;genomas&nbsp;virais&nbsp;circulantes&nbsp;em&nbsp;um&nbsp;paciente.&nbsp;As&nbsp;metodologias&nbsp;disponíveis&nbsp;hoje&nbsp;são</td><td class="diff_next"></td><td class="diff_header" id="to62_1266">1266</td><td nowrap="nowrap">de&nbsp;genomas&nbsp;virais&nbsp;circulantes&nbsp;em&nbsp;um&nbsp;paciente.&nbsp;As&nbsp;metodologias&nbsp;disponíveis&nbsp;hoje&nbsp;são</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1285">1285</td><td nowrap="nowrap">similares&nbsp;no&nbsp;que&nbsp;se&nbsp;refere&nbsp;à&nbsp;sensibilidade&nbsp;(aproximadamente&nbsp;10&nbsp;UI/mL)&nbsp;e&nbsp;especificidade</td><td class="diff_next"></td><td class="diff_header" id="to62_1267">1267</td><td nowrap="nowrap">similares&nbsp;no&nbsp;que&nbsp;se&nbsp;refere&nbsp;à&nbsp;sensibilidade&nbsp;(aproximadamente&nbsp;10&nbsp;UI/mL)&nbsp;e&nbsp;especificidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1286">1286</td><td nowrap="nowrap">(&gt;99%)&nbsp;(BELD&nbsp;et&nbsp;al.,&nbsp;2002;&nbsp;DREXLER&nbsp;et&nbsp;al.,&nbsp;2012;&nbsp;FRANCISCUS;&nbsp;HIGHLEYMAN,&nbsp;2014).</td><td class="diff_next"></td><td class="diff_header" id="to62_1268">1268</td><td nowrap="nowrap">(&gt;99%)&nbsp;(BELD&nbsp;et&nbsp;al.,&nbsp;2002;&nbsp;DREXLER&nbsp;et&nbsp;al.,&nbsp;2012;&nbsp;FRANCISCUS;&nbsp;HIGHLEYMAN,&nbsp;2014).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1287">1287</td><td nowrap="nowrap">10.7&nbsp;Fluxogramas&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C</td><td class="diff_next"></td><td class="diff_header" id="to62_1269">1269</td><td nowrap="nowrap">10.7&nbsp;Fluxogramas&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__32"></td><td class="diff_header" id="from62_1288">1288</td><td nowrap="nowrap">(HCV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1270">1270</td><td nowrap="nowrap">(HCV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1289">1289</td><td nowrap="nowrap">Os&nbsp;fluxogramas&nbsp;propostos&nbsp;a&nbsp;seguir&nbsp;incorporaram&nbsp;as&nbsp;considerações&nbsp;acima&nbsp;descritas,</td><td class="diff_next"></td><td class="diff_header" id="to62_1271">1271</td><td nowrap="nowrap">Os&nbsp;fluxogramas&nbsp;propostos&nbsp;a&nbsp;seguir&nbsp;incorporaram&nbsp;as&nbsp;considerações&nbsp;acima&nbsp;descritas,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1290">1290</td><td nowrap="nowrap">com&nbsp;o&nbsp;intuito&nbsp;de&nbsp;propiciar,&nbsp;o&nbsp;mais&nbsp;precocemente&nbsp;possível,&nbsp;a&nbsp;detecção&nbsp;da&nbsp;infecção&nbsp;pelo</td><td class="diff_next"></td><td class="diff_header" id="to62_1272">1272</td><td nowrap="nowrap">com&nbsp;o&nbsp;intuito&nbsp;de&nbsp;propiciar,&nbsp;o&nbsp;mais&nbsp;precocemente&nbsp;possível,&nbsp;a&nbsp;detecção&nbsp;da&nbsp;infecção&nbsp;pelo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1291">1291</td><td nowrap="nowrap">HCV&nbsp;em&nbsp;indivíduos&nbsp;com&nbsp;doença&nbsp;crônica&nbsp;e&nbsp;aguda&nbsp;e,&nbsp;consequentemente,&nbsp;o&nbsp;seu&nbsp;encami-</td><td class="diff_next"></td><td class="diff_header" id="to62_1273">1273</td><td nowrap="nowrap">HCV&nbsp;em&nbsp;indivíduos&nbsp;com&nbsp;doença&nbsp;crônica&nbsp;e&nbsp;aguda&nbsp;e,&nbsp;consequentemente,&nbsp;o&nbsp;seu&nbsp;encami-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1292">1292</td><td nowrap="nowrap">nhamento&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;assistência&nbsp;médica.</td><td class="diff_next"></td><td class="diff_header" id="to62_1274">1274</td><td nowrap="nowrap">nhamento&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;assistência&nbsp;médica.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__33">n</a></td><td class="diff_header" id="from62_1293">1293</td><td nowrap="nowrap">10.8&nbsp;Fluxograma&nbsp;4&nbsp;<span class="diff_chg">–</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;usando&nbsp;testes</td><td class="diff_next"><a href="#difflib_chg_to62__33">n</a></td><td class="diff_header" id="to62_1275">1275</td><td nowrap="nowrap">10.8&nbsp;Fluxograma&nbsp;4&nbsp;<span class="diff_chg">-</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;usando&nbsp;testes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1294">1294</td><td nowrap="nowrap">rápidos&nbsp;para&nbsp;detecção&nbsp;do&nbsp;anti-HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1276">1276</td><td nowrap="nowrap">rápidos&nbsp;para&nbsp;detecção&nbsp;do&nbsp;anti-HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1295">1295</td><td nowrap="nowrap">Os&nbsp;TR&nbsp;são&nbsp;ferramentas&nbsp;importantes&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;das&nbsp;possibilidades&nbsp;de&nbsp;diag-</td><td class="diff_next"></td><td class="diff_header" id="to62_1277">1277</td><td nowrap="nowrap">Os&nbsp;TR&nbsp;são&nbsp;ferramentas&nbsp;importantes&nbsp;para&nbsp;a&nbsp;ampliação&nbsp;das&nbsp;possibilidades&nbsp;de&nbsp;diag-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1296">1296</td><td nowrap="nowrap">nóstico&nbsp;para&nbsp;diversos&nbsp;agravos.&nbsp;Quando&nbsp;houver&nbsp;a&nbsp;possibilidade&nbsp;de&nbsp;testagem&nbsp;presencial</td><td class="diff_next"></td><td class="diff_header" id="to62_1278">1278</td><td nowrap="nowrap">nóstico&nbsp;para&nbsp;diversos&nbsp;agravos.&nbsp;Quando&nbsp;houver&nbsp;a&nbsp;possibilidade&nbsp;de&nbsp;testagem&nbsp;presencial</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1297">1297</td><td nowrap="nowrap">em&nbsp;unidades&nbsp;de&nbsp;saúde,&nbsp;esses&nbsp;testes&nbsp;permitem&nbsp;identificar&nbsp;oportunamente&nbsp;o&nbsp;indivíduo</td><td class="diff_next"></td><td class="diff_header" id="to62_1279">1279</td><td nowrap="nowrap">em&nbsp;unidades&nbsp;de&nbsp;saúde,&nbsp;esses&nbsp;testes&nbsp;permitem&nbsp;identificar&nbsp;oportunamente&nbsp;o&nbsp;indivíduo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1298">1298</td><td nowrap="nowrap">portador&nbsp;de&nbsp;hepatite&nbsp;C&nbsp;e&nbsp;fazer&nbsp;os&nbsp;devidos&nbsp;encaminhamentos&nbsp;para&nbsp;a&nbsp;confirmação&nbsp;diag-</td><td class="diff_next"></td><td class="diff_header" id="to62_1280">1280</td><td nowrap="nowrap">portador&nbsp;de&nbsp;hepatite&nbsp;C&nbsp;e&nbsp;fazer&nbsp;os&nbsp;devidos&nbsp;encaminhamentos&nbsp;para&nbsp;a&nbsp;confirmação&nbsp;diag-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1299">1299</td><td nowrap="nowrap">nóstica&nbsp;e&nbsp;para&nbsp;a&nbsp;vinculação&nbsp;da&nbsp;pessoa&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.&nbsp;O&nbsp;Fluxograma&nbsp;4&nbsp;(Figura&nbsp;16)</td><td class="diff_next"></td><td class="diff_header" id="to62_1281">1281</td><td nowrap="nowrap">nóstica&nbsp;e&nbsp;para&nbsp;a&nbsp;vinculação&nbsp;da&nbsp;pessoa&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.&nbsp;O&nbsp;Fluxograma&nbsp;4&nbsp;(Figura&nbsp;16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1300">1300</td><td nowrap="nowrap">emprega&nbsp;um&nbsp;teste&nbsp;rápido&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;anti-HCV&nbsp;em&nbsp;amostras&nbsp;de&nbsp;sangue&nbsp;total</td><td class="diff_next"></td><td class="diff_header" id="to62_1282">1282</td><td nowrap="nowrap">emprega&nbsp;um&nbsp;teste&nbsp;rápido&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;anti-HCV&nbsp;em&nbsp;amostras&nbsp;de&nbsp;sangue&nbsp;total</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1301">1301</td><td nowrap="nowrap">obtidas&nbsp;preferencialmente&nbsp;por&nbsp;punção&nbsp;digital.&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;indicado&nbsp;para&nbsp;uso&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_1283">1283</td><td nowrap="nowrap">obtidas&nbsp;preferencialmente&nbsp;por&nbsp;punção&nbsp;digital.&nbsp;Esse&nbsp;fluxograma&nbsp;é&nbsp;indicado&nbsp;para&nbsp;uso&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1302">1302</td><td nowrap="nowrap">serviços&nbsp;de&nbsp;saúde&nbsp;e&nbsp;assistência,&nbsp;permitindo&nbsp;a&nbsp;investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV.</td><td class="diff_next"></td><td class="diff_header" id="to62_1284">1284</td><td nowrap="nowrap">serviços&nbsp;de&nbsp;saúde&nbsp;e&nbsp;assistência,&nbsp;permitindo&nbsp;a&nbsp;investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1303">1303</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:59)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_1285">1285</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:59)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:60)(cid:8)(cid:35)(cid:8)(cid:36)(cid:25)(cid:37)(cid:2)(cid:13)(cid:</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:60)(cid:8)(cid:35)(cid:8)(cid:36)(cid:25)(cid:37)(cid:2)(cid:13)(cid:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__33"></td><td class="diff_header">></td><td nowrap="nowrap">24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:5)(cid:25)(cid:5)(cid:41)(cid:5)(cid:3)(cid:4)(cid:8)(cid:2</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:5)(cid:25)(cid:5)(cid:41)(cid:5)(cid:3)(cid:4)(cid:8)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">8)(cid:11)(cid:44)(cid:17)(cid:8)(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">8)(cid:11)(cid:44)(cid:17)(cid:8)(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1304">1304</td><td nowrap="nowrap">(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:13)(cid:8)(cid:7)(cid:18)(cid:29)(cid:5)(cid:20)(cid:21)(cid:13)(cid:8)(cid:1</td><td class="diff_next"></td><td class="diff_header" id="to62_1286">1286</td><td nowrap="nowrap">(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:13)(cid:8)(cid:7)(cid:18)(cid:29)(cid:5)(cid:20)(cid:21)(cid:13)(cid:8)(cid:1</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:9)(cid:1)(cid:8)(cid:43)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:16)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">0)(cid:9)(cid:1)(cid:8)(cid:43)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:16)(cid:33)</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__34">n</a></td><td class="diff_header" id="from62_1305">1305</td><td nowrap="nowrap">Figura&nbsp;16.&nbsp;Fluxograma&nbsp;4&nbsp;<span class="diff_chg">–</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;utilizando&nbsp;testes&nbsp;rápidos&nbsp;(TR</td><td class="diff_next"><a href="#difflib_chg_to62__34">n</a></td><td class="diff_header" id="to62_1287">1287</td><td nowrap="nowrap">Figura&nbsp;16.&nbsp;Fluxograma&nbsp;4&nbsp;<span class="diff_chg">-</span>&nbsp;Investigação&nbsp;inicial&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;utilizando&nbsp;testes&nbsp;rápidos&nbsp;(TR</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1306">1306</td><td nowrap="nowrap">anti-HCV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1288">1288</td><td nowrap="nowrap">anti-HCV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1307">1307</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1289">1289</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1308">1308</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:16)</td><td class="diff_next"></td><td class="diff_header" id="to62_1290">1290</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1309">1309</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1291">1291</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1310">1310</td><td nowrap="nowrap">(cid:10)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:16)</td><td class="diff_next"></td><td class="diff_header" id="to62_1292">1292</td><td nowrap="nowrap">(cid:10)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1311">1311</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)&nbsp;(cid:6)(cid:7)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1293">1293</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)&nbsp;(cid:6)(cid:7)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1312">1312</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td><td class="diff_next"></td><td class="diff_header" id="to62_1294">1294</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:21)(cid:26)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:21)(cid:26)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1313">1313</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:2)(cid:25)(cid:41</td><td class="diff_next"></td><td class="diff_header" id="to62_1295">1295</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:2)(cid:25)(cid:41</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:23)(cid:5)(cid:25)(cid:46)(cid:3)(cid:7)(cid:8)(cid:29)(cid:3)(cid:41)(cid:5)(cid:2)(cid:25)(cid:24)(cid:2)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:23)(cid:5)(cid:25)(cid:46)(cid:3)(cid:7)(cid:8)(cid:29)(cid:3)(cid:41)(cid:5)(cid:2)(cid:25)(cid:24)(cid:2)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1314">1314</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:41)(cid:21)(cid:23)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_1296">1296</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:41)(cid:21)(cid:23)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">9)(cid:4)(cid:2)(cid:23)(cid:2)(cid:25)(cid:24)(cid:3)(cid:7)(cid:8)(cid:21)(cid:8)(cid:20)(cid:5)(cid:3)(cid:15)(cid:25</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">9)(cid:4)(cid:2)(cid:23)(cid:2)(cid:25)(cid:24)(cid:3)(cid:7)(cid:8)(cid:21)(cid:8)(cid:20)(cid:5)(cid:3)(cid:15)(cid:25</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:47)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:47)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1315">1315</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td><td class="diff_next"></td><td class="diff_header" id="to62_1297">1297</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1316">1316</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:29)(cid:2)(cid:24)(cid:5)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)&nbsp;(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_1298">1298</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:29)(cid:2)(cid:24)(cid:5)(cid:7)(cid:8)(cid:9)(cid:1)(cid:8)&nbsp;(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1317">1317</td><td nowrap="nowrap">(cid:10)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:16)&nbsp;(cid:6)(cid:7)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1299">1299</td><td nowrap="nowrap">(cid:10)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:16)&nbsp;(cid:6)(cid:7)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1318">1318</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td><td class="diff_next"></td><td class="diff_header" id="to62_1300">1300</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1319">1319</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)</td><td class="diff_next"></td><td class="diff_header" id="to62_1301">1301</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1320">1320</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)</td><td class="diff_next"></td><td class="diff_header" id="to62_1302">1302</td><td nowrap="nowrap">(cid:17)(cid:18)(cid:4)(cid:5)(cid:20)(cid:21)(cid:22)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1321">1321</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_1303">1303</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1322">1322</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td><td class="diff_next"></td><td class="diff_header" id="to62_1304">1304</td><td nowrap="nowrap">(cid:44)(cid:21)(cid:4)(cid:2)(cid:24)(cid:3)(cid:7)(cid:8)(cid:3)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1323">1323</td><td nowrap="nowrap">(cid:5)(cid:25)(cid:37)(cid:2)(cid:13)(cid:24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:4)(cid:3)(cid:45</td><td class="diff_next"></td><td class="diff_header" id="to62_1305">1305</td><td nowrap="nowrap">(cid:5)(cid:25)(cid:37)(cid:2)(cid:13)(cid:24)(cid:5)(cid:15)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:4)(cid:3)(cid:45</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:21)(cid:7)(cid:3)(cid:24)(cid:21)(cid:7)(cid:5)(cid:3)(cid:4)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:21)(cid:7)(cid:3)(cid:24)(cid:21)(cid:7)(cid:5)(cid:3)(cid:4)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1324">1324</td><td nowrap="nowrap">(cid:30)(cid:21)(cid:25)(cid:24)(cid:2)(cid:48)(cid:8)(cid:49)(cid:36)(cid:14)(cid:11)(cid:17)(cid:50)(cid:51)(cid:17)(c</td><td class="diff_next"></td><td class="diff_header" id="to62_1306">1306</td><td nowrap="nowrap">(cid:30)(cid:21)(cid:25)(cid:24)(cid:2)(cid:48)(cid:8)(cid:49)(cid:36)(cid:14)(cid:11)(cid:17)(cid:50)(cid:51)(cid:17)(c</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:51)(cid:50)(cid:52)(cid:51)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">id:51)(cid:50)(cid:52)(cid:51)(cid:33)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1325">1325</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_1307">1307</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1326">1326</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;4&nbsp;é&nbsp;indicado&nbsp;para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;item&nbsp;5.1.3&nbsp;deste&nbsp;Manual,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1308">1308</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;4&nbsp;é&nbsp;indicado&nbsp;para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;item&nbsp;5.1.3&nbsp;deste&nbsp;Manual,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1327">1327</td><td nowrap="nowrap">permite&nbsp;iniciar&nbsp;a&nbsp;investigação&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;unidades&nbsp;de&nbsp;saúde&nbsp;que&nbsp;usem&nbsp;TR.</td><td class="diff_next"></td><td class="diff_header" id="to62_1309">1309</td><td nowrap="nowrap">permite&nbsp;iniciar&nbsp;a&nbsp;investigação&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;unidades&nbsp;de&nbsp;saúde&nbsp;que&nbsp;usem&nbsp;TR.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1328">1328</td><td nowrap="nowrap">›&nbsp;Pode&nbsp;ser&nbsp;utilizado&nbsp;em&nbsp;gestantes.</td><td class="diff_next"></td><td class="diff_header" id="to62_1310">1310</td><td nowrap="nowrap">›&nbsp;Pode&nbsp;ser&nbsp;utilizado&nbsp;em&nbsp;gestantes.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1329">1329</td><td nowrap="nowrap">›&nbsp;O&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;teste&nbsp;de&nbsp;detecção&nbsp;do&nbsp;anti-HCV&nbsp;indica&nbsp;contato&nbsp;prévio</td><td class="diff_next"></td><td class="diff_header" id="to62_1311">1311</td><td nowrap="nowrap">›&nbsp;O&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;teste&nbsp;de&nbsp;detecção&nbsp;do&nbsp;anti-HCV&nbsp;indica&nbsp;contato&nbsp;prévio</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1330">1330</td><td nowrap="nowrap">com&nbsp;o&nbsp;HCV.&nbsp;É&nbsp;necessário&nbsp;complementar&nbsp;o&nbsp;diagnóstico&nbsp;por&nbsp;meio&nbsp;de&nbsp;testes&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1312">1312</td><td nowrap="nowrap">com&nbsp;o&nbsp;HCV.&nbsp;É&nbsp;necessário&nbsp;complementar&nbsp;o&nbsp;diagnóstico&nbsp;por&nbsp;meio&nbsp;de&nbsp;testes&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1331">1331</td><td nowrap="nowrap">detecção&nbsp;direta&nbsp;do&nbsp;vírus&nbsp;(teste&nbsp;molecular&nbsp;ou&nbsp;teste&nbsp;de&nbsp;antígeno).</td><td class="diff_next"></td><td class="diff_header" id="to62_1313">1313</td><td nowrap="nowrap">detecção&nbsp;direta&nbsp;do&nbsp;vírus&nbsp;(teste&nbsp;molecular&nbsp;ou&nbsp;teste&nbsp;de&nbsp;antígeno).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1332">1332</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,</td><td class="diff_next"></td><td class="diff_header" id="to62_1314">1314</td><td nowrap="nowrap">›&nbsp;Em&nbsp;caso&nbsp;de&nbsp;resultado&nbsp;não&nbsp;reagente,&nbsp;permanecendo&nbsp;a&nbsp;suspeita&nbsp;de&nbsp;infecção,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1333">1333</td><td nowrap="nowrap">coletar&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;repetir&nbsp;a&nbsp;testagem.</td><td class="diff_next"></td><td class="diff_header" id="to62_1315">1315</td><td nowrap="nowrap">coletar&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;após&nbsp;30&nbsp;dias&nbsp;e&nbsp;repetir&nbsp;a&nbsp;testagem.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1334">1334</td><td nowrap="nowrap">Na&nbsp;testagem&nbsp;rápida,&nbsp;a&nbsp;coleta&nbsp;da&nbsp;amostra&nbsp;pode&nbsp;ser&nbsp;realizada&nbsp;por&nbsp;punção&nbsp;da&nbsp;polpa</td><td class="diff_next"></td><td class="diff_header" id="to62_1316">1316</td><td nowrap="nowrap">Na&nbsp;testagem&nbsp;rápida,&nbsp;a&nbsp;coleta&nbsp;da&nbsp;amostra&nbsp;pode&nbsp;ser&nbsp;realizada&nbsp;por&nbsp;punção&nbsp;da&nbsp;polpa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1335">1335</td><td nowrap="nowrap">digital&nbsp;ou&nbsp;punção&nbsp;venosa.&nbsp;A&nbsp;maioria&nbsp;dos&nbsp;TR&nbsp;também&nbsp;permite&nbsp;a&nbsp;utilização&nbsp;de&nbsp;soro&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_1317">1317</td><td nowrap="nowrap">digital&nbsp;ou&nbsp;punção&nbsp;venosa.&nbsp;A&nbsp;maioria&nbsp;dos&nbsp;TR&nbsp;também&nbsp;permite&nbsp;a&nbsp;utilização&nbsp;de&nbsp;soro&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1336">1336</td><td nowrap="nowrap">plasma&nbsp;como&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;do&nbsp;teste.&nbsp;Contudo,&nbsp;esse&nbsp;fluxograma&nbsp;é&nbsp;proposto</td><td class="diff_next"></td><td class="diff_header" id="to62_1318">1318</td><td nowrap="nowrap">plasma&nbsp;como&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;do&nbsp;teste.&nbsp;Contudo,&nbsp;esse&nbsp;fluxograma&nbsp;é&nbsp;proposto</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1337">1337</td><td nowrap="nowrap">para&nbsp;quando&nbsp;a&nbsp;testagem&nbsp;rápida&nbsp;ocorre,&nbsp;preferencialmente,&nbsp;na&nbsp;presença&nbsp;do&nbsp;paciente.&nbsp;A</td><td class="diff_next"></td><td class="diff_header" id="to62_1319">1319</td><td nowrap="nowrap">para&nbsp;quando&nbsp;a&nbsp;testagem&nbsp;rápida&nbsp;ocorre,&nbsp;preferencialmente,&nbsp;na&nbsp;presença&nbsp;do&nbsp;paciente.&nbsp;A</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1338">1338</td><td nowrap="nowrap">testagem&nbsp;presencial&nbsp;reduz&nbsp;o&nbsp;risco&nbsp;de&nbsp;troca&nbsp;de&nbsp;amostras&nbsp;e&nbsp;garante&nbsp;segurança&nbsp;para&nbsp;o&nbsp;indi-</td><td class="diff_next"></td><td class="diff_header" id="to62_1320">1320</td><td nowrap="nowrap">testagem&nbsp;presencial&nbsp;reduz&nbsp;o&nbsp;risco&nbsp;de&nbsp;troca&nbsp;de&nbsp;amostras&nbsp;e&nbsp;garante&nbsp;segurança&nbsp;para&nbsp;o&nbsp;indi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1339">1339</td><td nowrap="nowrap">víduo&nbsp;que&nbsp;está&nbsp;sendo&nbsp;testado&nbsp;e&nbsp;para&nbsp;o&nbsp;profissional&nbsp;executa&nbsp;o&nbsp;teste.</td><td class="diff_next"></td><td class="diff_header" id="to62_1321">1321</td><td nowrap="nowrap">víduo&nbsp;que&nbsp;está&nbsp;sendo&nbsp;testado&nbsp;e&nbsp;para&nbsp;o&nbsp;profissional&nbsp;executa&nbsp;o&nbsp;teste.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1340">1340</td><td nowrap="nowrap">Leia&nbsp;atentamente&nbsp;as&nbsp;instruções&nbsp;de&nbsp;uso&nbsp;que&nbsp;acompanham&nbsp;o&nbsp;conjunto&nbsp;diag-</td><td class="diff_next"></td><td class="diff_header" id="to62_1322">1322</td><td nowrap="nowrap">Leia&nbsp;atentamente&nbsp;as&nbsp;instruções&nbsp;de&nbsp;uso&nbsp;que&nbsp;acompanham&nbsp;o&nbsp;conjunto&nbsp;diag-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1341">1341</td><td nowrap="nowrap">nóstico&nbsp;antes&nbsp;da&nbsp;seleção&nbsp;da&nbsp;amostra&nbsp;a&nbsp;ser&nbsp;testada&nbsp;e&nbsp;da&nbsp;execução&nbsp;do&nbsp;teste.</td><td class="diff_next"></td><td class="diff_header" id="to62_1323">1323</td><td nowrap="nowrap">nóstico&nbsp;antes&nbsp;da&nbsp;seleção&nbsp;da&nbsp;amostra&nbsp;a&nbsp;ser&nbsp;testada&nbsp;e&nbsp;da&nbsp;execução&nbsp;do&nbsp;teste.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1342">1342</td><td nowrap="nowrap">Um&nbsp;TR&nbsp;só&nbsp;pode&nbsp;ter&nbsp;seu&nbsp;resultado&nbsp;interpretado&nbsp;se&nbsp;for&nbsp;considerado&nbsp;um&nbsp;teste&nbsp;válido.</td><td class="diff_next"></td><td class="diff_header" id="to62_1324">1324</td><td nowrap="nowrap">Um&nbsp;TR&nbsp;só&nbsp;pode&nbsp;ter&nbsp;seu&nbsp;resultado&nbsp;interpretado&nbsp;se&nbsp;for&nbsp;considerado&nbsp;um&nbsp;teste&nbsp;válido.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1343">1343</td><td nowrap="nowrap">Para&nbsp;o&nbsp;teste&nbsp;ser&nbsp;considerado&nbsp;válido,&nbsp;é&nbsp;necessária&nbsp;a&nbsp;presença&nbsp;de&nbsp;uma&nbsp;linha&nbsp;ou&nbsp;ponto&nbsp;na</td><td class="diff_next"></td><td class="diff_header" id="to62_1325">1325</td><td nowrap="nowrap">Para&nbsp;o&nbsp;teste&nbsp;ser&nbsp;considerado&nbsp;válido,&nbsp;é&nbsp;necessária&nbsp;a&nbsp;presença&nbsp;de&nbsp;uma&nbsp;linha&nbsp;ou&nbsp;ponto&nbsp;na</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1344">1344</td><td nowrap="nowrap">região&nbsp;controle&nbsp;(C)&nbsp;do&nbsp;teste.&nbsp;Caso&nbsp;o&nbsp;resultado&nbsp;do&nbsp;TR&nbsp;seja&nbsp;inválido,&nbsp;deve-se&nbsp;repetir&nbsp;o&nbsp;teste,</td><td class="diff_next"></td><td class="diff_header" id="to62_1326">1326</td><td nowrap="nowrap">região&nbsp;controle&nbsp;(C)&nbsp;do&nbsp;teste.&nbsp;Caso&nbsp;o&nbsp;resultado&nbsp;do&nbsp;TR&nbsp;seja&nbsp;inválido,&nbsp;deve-se&nbsp;repetir&nbsp;o&nbsp;teste,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1345">1345</td><td nowrap="nowrap">se&nbsp;possível,&nbsp;com&nbsp;um&nbsp;conjunto&nbsp;diagnóstico&nbsp;de&nbsp;lote&nbsp;distinto&nbsp;do&nbsp;que&nbsp;foi&nbsp;utilizado&nbsp;inicial-</td><td class="diff_next"></td><td class="diff_header" id="to62_1327">1327</td><td nowrap="nowrap">se&nbsp;possível,&nbsp;com&nbsp;um&nbsp;conjunto&nbsp;diagnóstico&nbsp;de&nbsp;lote&nbsp;distinto&nbsp;do&nbsp;que&nbsp;foi&nbsp;utilizado&nbsp;inicial-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1346">1346</td><td nowrap="nowrap">mente.&nbsp;Persistindo&nbsp;o&nbsp;resultado&nbsp;inválido,&nbsp;uma&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;por&nbsp;punção</td><td class="diff_next"></td><td class="diff_header" id="to62_1328">1328</td><td nowrap="nowrap">mente.&nbsp;Persistindo&nbsp;o&nbsp;resultado&nbsp;inválido,&nbsp;uma&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;por&nbsp;punção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1347">1347</td><td nowrap="nowrap">venosa&nbsp;e&nbsp;encaminhada&nbsp;para&nbsp;teste&nbsp;com&nbsp;o&nbsp;fluxograma&nbsp;definido&nbsp;para&nbsp;laboratório.</td><td class="diff_next"></td><td class="diff_header" id="to62_1329">1329</td><td nowrap="nowrap">venosa&nbsp;e&nbsp;encaminhada&nbsp;para&nbsp;teste&nbsp;com&nbsp;o&nbsp;fluxograma&nbsp;definido&nbsp;para&nbsp;laboratório.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1348">1348</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_1330">1330</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1349">1349</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_1331">1331</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1350">1350</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não</td><td class="diff_next"></td><td class="diff_header" id="to62_1332">1332</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1351">1351</td><td nowrap="nowrap">reagente&nbsp;para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(anti-HCV)”.&nbsp;Na&nbsp;amostra&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to62_1333">1333</td><td nowrap="nowrap">reagente&nbsp;para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(anti-HCV)”.&nbsp;Na&nbsp;amostra&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1352">1352</td><td nowrap="nowrap">resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR,&nbsp;o&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em</td><td class="diff_next"></td><td class="diff_header" id="to62_1334">1334</td><td nowrap="nowrap">resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;TR,&nbsp;o&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1353">1353</td><td nowrap="nowrap">caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HCV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30</td><td class="diff_next"></td><td class="diff_header" id="to62_1335">1335</td><td nowrap="nowrap">caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HCV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1354">1354</td><td nowrap="nowrap">dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.&nbsp;Essa</td><td class="diff_next"></td><td class="diff_header" id="to62_1336">1336</td><td nowrap="nowrap">dias&nbsp;após&nbsp;a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.&nbsp;Essa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1355">1355</td><td nowrap="nowrap">é&nbsp;uma&nbsp;informação&nbsp;relevante,&nbsp;pois&nbsp;a&nbsp;presença&nbsp;dos&nbsp;anticorpos&nbsp;virais&nbsp;varia&nbsp;dependendo&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_1337">1337</td><td nowrap="nowrap">é&nbsp;uma&nbsp;informação&nbsp;relevante,&nbsp;pois&nbsp;a&nbsp;presença&nbsp;dos&nbsp;anticorpos&nbsp;virais&nbsp;varia&nbsp;dependendo&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1356">1356</td><td nowrap="nowrap">tempo&nbsp;de&nbsp;infecção&nbsp;do&nbsp;indivíduo.</td><td class="diff_next"></td><td class="diff_header" id="to62_1338">1338</td><td nowrap="nowrap">tempo&nbsp;de&nbsp;infecção&nbsp;do&nbsp;indivíduo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1357">1357</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente</td><td class="diff_next"></td><td class="diff_header" id="to62_1339">1339</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;TR&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1358">1358</td><td nowrap="nowrap">para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(anti-HCV)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido</td><td class="diff_next"></td><td class="diff_header" id="to62_1340">1340</td><td nowrap="nowrap">para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(anti-HCV)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1359">1359</td><td nowrap="nowrap">com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Realizar&nbsp;confirmação&nbsp;do&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1341">1341</td><td nowrap="nowrap">com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Realizar&nbsp;confirmação&nbsp;do&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1360">1360</td><td nowrap="nowrap">utilizando&nbsp;um&nbsp;teste&nbsp;de&nbsp;detecção&nbsp;direta&nbsp;do&nbsp;vírus&nbsp;(HCV-RNA&nbsp;ou&nbsp;HCV-Ag)”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1342">1342</td><td nowrap="nowrap">utilizando&nbsp;um&nbsp;teste&nbsp;de&nbsp;detecção&nbsp;direta&nbsp;do&nbsp;vírus&nbsp;(HCV-RNA&nbsp;ou&nbsp;HCV-Ag)”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1361">1361</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td><td class="diff_next"></td><td class="diff_header" id="to62_1343">1343</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__34"></td><td class="diff_header" id="from62_1362">1362</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;o&nbsp;ponto&nbsp;de&nbsp;corte&nbsp;(CO,&nbsp;do&nbsp;inglês&nbsp;cut-off)&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_1344">1344</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;o&nbsp;ponto&nbsp;de&nbsp;corte&nbsp;(CO,&nbsp;do&nbsp;inglês&nbsp;cut-off)&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1363">1363</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_1345">1345</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1364">1364</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_1346">1346</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1365">1365</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_1347">1347</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__35"></td><td class="diff_header" id="from62_1366">1366</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_1348">1348</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__35">n</a></td><td class="diff_header" id="from62_1367">1367</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__35">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1368">1368</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_1349">1349</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1369">1369</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1350">1350</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1370">1370</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_1351">1351</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__36">n</a></td><td class="diff_header" id="from62_1371">1371</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__36">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1372">1372</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_1352">1352</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1373">1373</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1353">1353</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1374">1374</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_1354">1354</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1375">1375</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1355">1355</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1376">1376</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;4,&nbsp;com&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;TR,&nbsp;permite&nbsp;uma&nbsp;testagem&nbsp;rápida&nbsp;e&nbsp;a&nbsp;am-</td><td class="diff_next"></td><td class="diff_header" id="to62_1356">1356</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;4,&nbsp;com&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;TR,&nbsp;permite&nbsp;uma&nbsp;testagem&nbsp;rápida&nbsp;e&nbsp;a&nbsp;am-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1377">1377</td><td nowrap="nowrap">pliação&nbsp;das&nbsp;oportunidades&nbsp;de&nbsp;diagnóstico,&nbsp;principalmente&nbsp;entre&nbsp;as&nbsp;populações-chave.</td><td class="diff_next"></td><td class="diff_header" id="to62_1357">1357</td><td nowrap="nowrap">pliação&nbsp;das&nbsp;oportunidades&nbsp;de&nbsp;diagnóstico,&nbsp;principalmente&nbsp;entre&nbsp;as&nbsp;populações-chave.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1378">1378</td><td nowrap="nowrap">da&nbsp;infecção&nbsp;e&nbsp;oportunamente&nbsp;vinculada&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.</td><td class="diff_next"></td><td class="diff_header" id="to62_1358">1358</td><td nowrap="nowrap">da&nbsp;infecção&nbsp;e&nbsp;oportunamente&nbsp;vinculada&nbsp;ao&nbsp;serviço&nbsp;de&nbsp;saúde.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1379">1379</td><td nowrap="nowrap">O&nbsp;resultado&nbsp;reagente&nbsp;na&nbsp;pesquisa&nbsp;pelo&nbsp;anti-HCV&nbsp;em&nbsp;uma&nbsp;amostra&nbsp;representa&nbsp;uma</td><td class="diff_next"></td><td class="diff_header" id="to62_1359">1359</td><td nowrap="nowrap">O&nbsp;resultado&nbsp;reagente&nbsp;na&nbsp;pesquisa&nbsp;pelo&nbsp;anti-HCV&nbsp;em&nbsp;uma&nbsp;amostra&nbsp;representa&nbsp;uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1380">1380</td><td nowrap="nowrap">evidência&nbsp;de&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;HCV.&nbsp;Sabe-se&nbsp;que&nbsp;cerca&nbsp;de&nbsp;80%&nbsp;dos&nbsp;infectados&nbsp;pelo</td><td class="diff_next"></td><td class="diff_header" id="to62_1360">1360</td><td nowrap="nowrap">evidência&nbsp;de&nbsp;contato&nbsp;prévio&nbsp;com&nbsp;o&nbsp;HCV.&nbsp;Sabe-se&nbsp;que&nbsp;cerca&nbsp;de&nbsp;80%&nbsp;dos&nbsp;infectados&nbsp;pelo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1381">1381</td><td nowrap="nowrap">HCV&nbsp;se&nbsp;tornarão&nbsp;portadores&nbsp;crônicos&nbsp;da&nbsp;infecção.&nbsp;Por&nbsp;esse&nbsp;motivo,&nbsp;o&nbsp;resultado&nbsp;da&nbsp;pes-</td><td class="diff_next"></td><td class="diff_header" id="to62_1361">1361</td><td nowrap="nowrap">HCV&nbsp;se&nbsp;tornarão&nbsp;portadores&nbsp;crônicos&nbsp;da&nbsp;infecção.&nbsp;Por&nbsp;esse&nbsp;motivo,&nbsp;o&nbsp;resultado&nbsp;da&nbsp;pes-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1382">1382</td><td nowrap="nowrap">quisa&nbsp;pelo&nbsp;anti-HCV&nbsp;deverá&nbsp;ser&nbsp;complementado&nbsp;com&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;teste&nbsp;para&nbsp;de-</td><td class="diff_next"></td><td class="diff_header" id="to62_1362">1362</td><td nowrap="nowrap">quisa&nbsp;pelo&nbsp;anti-HCV&nbsp;deverá&nbsp;ser&nbsp;complementado&nbsp;com&nbsp;a&nbsp;utilização&nbsp;de&nbsp;um&nbsp;teste&nbsp;para&nbsp;de-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__36"></td><td class="diff_header" id="from62_1383">1383</td><td nowrap="nowrap">tecção&nbsp;direta&nbsp;do&nbsp;agente&nbsp;viral&nbsp;(HCV-RNA&nbsp;ou&nbsp;HCV-Ag).</td><td class="diff_next"></td><td class="diff_header" id="to62_1363">1363</td><td nowrap="nowrap">tecção&nbsp;direta&nbsp;do&nbsp;agente&nbsp;viral&nbsp;(HCV-RNA&nbsp;ou&nbsp;HCV-Ag).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1384">1384</td><td nowrap="nowrap">O&nbsp;uso&nbsp;do&nbsp;TR&nbsp;para&nbsp;detecção&nbsp;do&nbsp;anti-HCV,&nbsp;por&nbsp;detectar&nbsp;anticorpos&nbsp;totais,&nbsp;não&nbsp;deve&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_1364">1364</td><td nowrap="nowrap">O&nbsp;uso&nbsp;do&nbsp;TR&nbsp;para&nbsp;detecção&nbsp;do&nbsp;anti-HCV,&nbsp;por&nbsp;detectar&nbsp;anticorpos&nbsp;totais,&nbsp;não&nbsp;deve&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1385">1385</td><td nowrap="nowrap">utilizado&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses,&nbsp;e&nbsp;seu&nbsp;uso&nbsp;em&nbsp;indivíduos&nbsp;imunossuprimi-</td><td class="diff_next"></td><td class="diff_header" id="to62_1365">1365</td><td nowrap="nowrap">utilizado&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses,&nbsp;e&nbsp;seu&nbsp;uso&nbsp;em&nbsp;indivíduos&nbsp;imunossuprimi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1386">1386</td><td nowrap="nowrap">dos/imunodeprimidos&nbsp;necessita&nbsp;ser&nbsp;avaliado&nbsp;com&nbsp;cuidado,&nbsp;em&nbsp;virtude&nbsp;da&nbsp;possibilidade</td><td class="diff_next"></td><td class="diff_header" id="to62_1366">1366</td><td nowrap="nowrap">dos/imunodeprimidos&nbsp;necessita&nbsp;ser&nbsp;avaliado&nbsp;com&nbsp;cuidado,&nbsp;em&nbsp;virtude&nbsp;da&nbsp;possibilidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1387">1387</td><td nowrap="nowrap">de&nbsp;resultados&nbsp;falsos&nbsp;não-reagentes.</td><td class="diff_next"></td><td class="diff_header" id="to62_1367">1367</td><td nowrap="nowrap">de&nbsp;resultados&nbsp;falsos&nbsp;não-reagentes.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__37">n</a></td><td class="diff_header" id="from62_1388">1388</td><td nowrap="nowrap">10.9&nbsp;Fluxograma&nbsp;5&nbsp;<span class="diff_chg">–</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td><td class="diff_next"><a href="#difflib_chg_to62__37">n</a></td><td class="diff_header" id="to62_1368">1368</td><td nowrap="nowrap">10.9&nbsp;Fluxograma&nbsp;5&nbsp;<span class="diff_chg">-</span>&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(HCV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1389">1389</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;5&nbsp;(Figura&nbsp;17)&nbsp;emprega&nbsp;um&nbsp;imunoensaio&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;anticor-</td><td class="diff_next"></td><td class="diff_header" id="to62_1369">1369</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;5&nbsp;(Figura&nbsp;17)&nbsp;emprega&nbsp;um&nbsp;imunoensaio&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;o&nbsp;anticor-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1390">1390</td><td nowrap="nowrap">po&nbsp;contra&nbsp;o&nbsp;HCV,&nbsp;como&nbsp;teste&nbsp;de&nbsp;triagem,&nbsp;e&nbsp;um&nbsp;teste&nbsp;de&nbsp;detecção&nbsp;direta&nbsp;do&nbsp;HCV&nbsp;(HCV-</td><td class="diff_next"></td><td class="diff_header" id="to62_1370">1370</td><td nowrap="nowrap">po&nbsp;contra&nbsp;o&nbsp;HCV,&nbsp;como&nbsp;teste&nbsp;de&nbsp;triagem,&nbsp;e&nbsp;um&nbsp;teste&nbsp;de&nbsp;detecção&nbsp;direta&nbsp;do&nbsp;HCV&nbsp;(HCV-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1391">1391</td><td nowrap="nowrap">RNA&nbsp;ou&nbsp;HCV-Ag),&nbsp;como&nbsp;teste&nbsp;complementar,&nbsp;usados&nbsp;sequencialmente.</td><td class="diff_next"></td><td class="diff_header" id="to62_1371">1371</td><td nowrap="nowrap">RNA&nbsp;ou&nbsp;HCV-Ag),&nbsp;como&nbsp;teste&nbsp;complementar,&nbsp;usados&nbsp;sequencialmente.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1392">1392</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:61)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td><td class="diff_next"></td><td class="diff_header" id="to62_1372">1372</td><td nowrap="nowrap">(cid:30)(cid:5)(cid:15)(cid:26)(cid:7)(cid:3)(cid:8)(cid:31)(cid:61)(cid:33)(cid:8)(cid:30)(cid:4)(cid:26)(cid:34)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:62)(cid:8)(cid:35)(cid:8)(cid:49)(cid:5)(cid:3)(cid:15)(cid:25)(cid:4</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">1)(cid:15)(cid:7)(cid:3)(cid:23)(cid:3)(cid:8)(cid:62)(cid:8)(cid:35)(cid:8)(cid:49)(cid:5)(cid:3)(cid:15)(cid:25)(cid:4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)(cid:20)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)(cid:8)(cid:20)(cid:3)(cid:8)(cid:5)(cid:25)(cid:42)(cid:2)(cid:41)(cid:38)(cid</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:8)(cid:37)(cid:57)(cid:7)(cid:26)(cid:13)(cid:8)(cid:20)(cid:3)(ci</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:27)(cid:21)(cid:8)(cid:29)(cid:2)(cid:4)(cid:21)(cid:8)(cid:37)(cid:57)(cid:7)(cid:26)(cid:13)(cid:8)(cid:20)(cid:3)(ci</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:8)(cid:46)(cid:2)(cid:29)(cid:3)(cid:24)(cid:5)(cid:24)(cid:2)(cid:8)(cid:44)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">d:8)(cid:46)(cid:2)(cid:29)(cid:3)(cid:24)(cid:5)(cid:24)(cid:2)(cid:8)(cid:44)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1393">1393</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td><td class="diff_next"></td><td class="diff_header" id="to62_1373">1373</td><td nowrap="nowrap">(cid:26)(cid:24)(cid:5)(cid:4)(cid:5)(cid:6)(cid:3)(cid:25)(cid:20)(cid:21)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:38)(cid:27)(cid:21)(cid:8)(cid:20)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:38)(cid:27)(cid:21)(cid:8)(cid:20)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:21)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:8)(cid:2)(cid:8)(cid:24)(cid:2)(cid:13</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:21)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)(cid:8)(cid:2)(cid:8)(cid:24)(cid:2)(cid:13</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:24)(cid:2)(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)(cid:8)(cid:10)(cid:11)(cid:44</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:24)(cid:2)(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)(cid:8)(cid:10)(cid:11)(cid:44</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:17)(cid:35)(cid:1)(cid:54)(cid:14)(cid:16)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:17)(cid:35)(cid:1)(cid:54)(cid:14)(cid:16)(cid:33)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1394">1394</td><td nowrap="nowrap">Figura&nbsp;17.&nbsp;Fluxograma&nbsp;5&nbsp;-&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;utilizando&nbsp;teste&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_1374">1374</td><td nowrap="nowrap">Figura&nbsp;17.&nbsp;Fluxograma&nbsp;5&nbsp;-&nbsp;Diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;utilizando&nbsp;teste&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1395">1395</td><td nowrap="nowrap">detecção&nbsp;do&nbsp;anti-HCV&nbsp;e&nbsp;teste&nbsp;molecular&nbsp;(HCV-RNA)</td><td class="diff_next"></td><td class="diff_header" id="to62_1375">1375</td><td nowrap="nowrap">detecção&nbsp;do&nbsp;anti-HCV&nbsp;e&nbsp;teste&nbsp;molecular&nbsp;(HCV-RNA)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1396">1396</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1376">1376</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1397">1397</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:53)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1377">1377</td><td nowrap="nowrap">(cid:10)(cid:13)(cid:3)(cid:25)(cid:15)(cid:26)(cid:2)(cid:53)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1398">1398</td><td nowrap="nowrap">(cid:13)(cid:21)(cid:7)(cid:21)(cid:8)(cid:21)(cid:26)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1378">1378</td><td nowrap="nowrap">(cid:13)(cid:21)(cid:7)(cid:21)(cid:8)(cid:21)(cid:26)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1399">1399</td><td nowrap="nowrap">(cid:29)(cid:4)(cid:3)(cid:13)(cid:23)(cid:3)(cid:16)</td><td class="diff_next"></td><td class="diff_header" id="to62_1379">1379</td><td nowrap="nowrap">(cid:29)(cid:4)(cid:3)(cid:13)(cid:23)(cid:3)(cid:16)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1400">1400</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header" id="to62_1380">1380</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1401">1401</td><td nowrap="nowrap">(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)</td><td class="diff_next"></td><td class="diff_header" id="to62_1381">1381</td><td nowrap="nowrap">(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1402">1402</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(</td><td class="diff_next"></td><td class="diff_header" id="to62_1382">1382</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:13)(cid:26)(cid:4)(cid:24)(cid:3)(cid:20)(cid:21)(cid:8)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:1)(cid:2)(cid:3)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)&nbsp;(cid:11)(cid:44)(cid:17)(cid:35)(</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:24)(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)&nbsp;(cid:11)(cid:44)(cid:17)(cid:35)(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:1)(cid:54)(cid:14)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:7)(cid:2)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:1)(cid:54)(cid:14)&nbsp;(cid:6)(cid:7)(cid:8)&nbsp;(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:7)(cid:2)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1403">1403</td><td nowrap="nowrap">(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4</td><td class="diff_next"></td><td class="diff_header" id="to62_1383">1383</td><td nowrap="nowrap">(cid:7)(cid:2)(cid:3)(cid:15)(cid:2)(cid:25)(cid:24)(cid:2)(cid:22)&nbsp;(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:7)&nbsp;(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:22)&nbsp;(cid:29)(cid:3)(cid</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:3)(cid:7)&nbsp;(cid:20)(cid:2)(cid:24)(cid:2)(cid:41)(cid:24)(cid:18)(cid:37)(cid:2)(cid:4)(cid:22)&nbsp;(cid:29)(cid:3)(cid</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:7)(cid:3)(cid:8)(cid:11)(cid:44)(cid:17)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">:7)(cid:3)(cid:8)(cid:11)(cid:44)(cid:17)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1404">1404</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:1)(cid:2)(cid:5)</td><td class="diff_next"></td><td class="diff_header" id="to62_1384">1384</td><td nowrap="nowrap">(cid:1)(cid:2)(cid:5)&nbsp;(cid:1)(cid:2)(cid:5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1405">1405</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td><td class="diff_next"></td><td class="diff_header" id="to62_1385">1385</td><td nowrap="nowrap">(cid:14)(cid:23)(cid:21)(cid:13)(cid:24)(cid:7)(cid:3)(cid:8)(cid:25)(cid:27)(cid:21)(cid:8)(cid:7)(cid:2)(cid:3)(cid:15</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)&nbsp;(cid:1)(cid:2)(cid:29)(cid:2)(cid:24)(cid:5)(cid:7)(cid:8)(cid:21)(cid:8)(cid:24)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:2)(cid:25)(cid:24)(cid:2)(cid:8)&nbsp;(cid:1)(cid:2)(cid:29)(cid:2)(cid:24)(cid:5)(cid:7)(cid:8)(cid:21)(cid:8)(cid:24)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">(cid:2)(cid:13)(cid:24)(cid:2)(cid:8)(cid:23)(cid:21)(cid:4)(cid:2)(cid:41)(cid:26)(cid:4)(cid:3)(cid:7)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1406">1406</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)&nbsp;(cid:3)(cid:29)(cid:4</td><td class="diff_next"></td><td class="diff_header" id="to62_1386">1386</td><td nowrap="nowrap">(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)(cid:3)(cid:25)(cid:24)(cid:5)(cid:35)(cid:11)(cid:44)(cid:17)&nbsp;(cid:3)(cid:29)(cid:4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:8)(cid:24)(cid:7)(cid:63)(cid:13)(cid:8)(cid:2)(cid:8)(cid:13)(cid:2)(cid:5)(cid:13)(cid:8)(cid:23)(cid:2</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">7)(cid:13)(cid:8)(cid:24)(cid:7)(cid:63)(cid:13)(cid:8)(cid:2)(cid:8)(cid:13)(cid:2)(cid:5)(cid:13)(cid:8)(cid:23)(cid:2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:13)(cid:2)(cid:13)(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">)(cid:13)(cid:2)(cid:13)(cid:8)(cid:29)(cid:3)(cid:7)(cid:3)(cid:8)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1407">1407</td><td nowrap="nowrap">(cid:41)(cid:21)(cid:25)(cid:42)(cid:5)(cid:7)(cid:23)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:20)(cid:21)(cid:8)(cid:</td><td class="diff_next"></td><td class="diff_header" id="to62_1387">1387</td><td nowrap="nowrap">(cid:41)(cid:21)(cid:25)(cid:42)(cid:5)(cid:7)(cid:23)(cid:3)(cid:38)(cid:27)(cid:21)(cid:8)(cid:20)(cid:21)(cid:8)(cid:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">20)(cid:5)(cid:3)(cid:15)(cid:25)(cid:47)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">20)(cid:5)(cid:3)(cid:15)(cid:25)(cid:47)(cid:13)(cid:24)(cid:5)(cid:41)(cid:21)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1408">1408</td><td nowrap="nowrap">Fonte:&nbsp;D(cid:30)I(cid:21)A(cid:25)H(cid:24)(cid:2)(cid:48)V(cid:8)(cid:49)/(cid:36)S(cid:14)V(cid:11)(cid:17)S(cid:50)/(</td><td class="diff_next"></td><td class="diff_header" id="to62_1388">1388</td><td nowrap="nowrap">Fonte:&nbsp;D(cid:30)I(cid:21)A(cid:25)H(cid:24)(cid:2)(cid:48)V(cid:8)(cid:49)/(cid:36)S(cid:14)V(cid:11)(cid:17)S(cid:50)/(</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:51)M(cid:17)(cid:51)S(cid:50).(cid:52)(cid:51)(cid:33)</td><td class="diff_next"></td><td class="diff_header">></td><td nowrap="nowrap">cid:51)M(cid:17)(cid:51)S(cid:50).(cid:52)(cid:51)(cid:33)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1409">1409</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;5&nbsp;deve&nbsp;ser&nbsp;utilizado&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia</td><td class="diff_next"></td><td class="diff_header" id="to62_1389">1389</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;5&nbsp;deve&nbsp;ser&nbsp;utilizado&nbsp;quando&nbsp;houver&nbsp;uma&nbsp;solicitação&nbsp;para&nbsp;“sorologia</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1410">1410</td><td nowrap="nowrap">da&nbsp;hepatite&nbsp;C”&nbsp;ou&nbsp;“diagnóstico&nbsp;de&nbsp;HCV”,&nbsp;ou&nbsp;mesmo&nbsp;“sorologia&nbsp;de&nbsp;hepatite”.&nbsp;Esse&nbsp;fluxogra-</td><td class="diff_next"></td><td class="diff_header" id="to62_1390">1390</td><td nowrap="nowrap">da&nbsp;hepatite&nbsp;C”&nbsp;ou&nbsp;“diagnóstico&nbsp;de&nbsp;HCV”,&nbsp;ou&nbsp;mesmo&nbsp;“sorologia&nbsp;de&nbsp;hepatite”.&nbsp;Esse&nbsp;fluxogra-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1411">1411</td><td nowrap="nowrap">Fluxogramas&nbsp;2&nbsp;ou&nbsp;3&nbsp;em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelos&nbsp;vírus&nbsp;causadores&nbsp;de&nbsp;hepatite.</td><td class="diff_next"></td><td class="diff_header" id="to62_1391">1391</td><td nowrap="nowrap">Fluxogramas&nbsp;2&nbsp;ou&nbsp;3&nbsp;em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelos&nbsp;vírus&nbsp;causadores&nbsp;de&nbsp;hepatite.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1412">1412</td><td nowrap="nowrap">Amostras&nbsp;reagentes&nbsp;no&nbsp;primeiro&nbsp;teste&nbsp;indicam&nbsp;contato&nbsp;com&nbsp;o&nbsp;HCV,&nbsp;salvo&nbsp;em&nbsp;casos</td><td class="diff_next"></td><td class="diff_header" id="to62_1392">1392</td><td nowrap="nowrap">Amostras&nbsp;reagentes&nbsp;no&nbsp;primeiro&nbsp;teste&nbsp;indicam&nbsp;contato&nbsp;com&nbsp;o&nbsp;HCV,&nbsp;salvo&nbsp;em&nbsp;casos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1413">1413</td><td nowrap="nowrap">de&nbsp;falso-positivos.&nbsp;Uma&nbsp;discordância&nbsp;entre&nbsp;o&nbsp;primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes&nbsp;pode&nbsp;se&nbsp;dar</td><td class="diff_next"></td><td class="diff_header" id="to62_1393">1393</td><td nowrap="nowrap">de&nbsp;falso-positivos.&nbsp;Uma&nbsp;discordância&nbsp;entre&nbsp;o&nbsp;primeiro&nbsp;e&nbsp;o&nbsp;segundo&nbsp;testes&nbsp;pode&nbsp;se&nbsp;dar</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1414">1414</td><td nowrap="nowrap">em&nbsp;virtude&nbsp;de&nbsp;uma&nbsp;resolução&nbsp;natural&nbsp;da&nbsp;doença.</td><td class="diff_next"></td><td class="diff_header" id="to62_1394">1394</td><td nowrap="nowrap">em&nbsp;virtude&nbsp;de&nbsp;uma&nbsp;resolução&nbsp;natural&nbsp;da&nbsp;doença.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1415">1415</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_1395">1395</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1416">1416</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_1396">1396</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1417">1417</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;anti-HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1397">1397</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;não&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;anti-HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1418">1418</td><td nowrap="nowrap">será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;he-</td><td class="diff_next"></td><td class="diff_header" id="to62_1398">1398</td><td nowrap="nowrap">será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;não&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;he-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1419">1419</td><td nowrap="nowrap">patite&nbsp;C&nbsp;(anti-HCV)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1399">1399</td><td nowrap="nowrap">patite&nbsp;C&nbsp;(anti-HCV)”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1420">1420</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HCV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td><td class="diff_next"></td><td class="diff_header" id="to62_1400">1400</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HCV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1421">1421</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1401">1401</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1422">1422</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;anti-HCV&nbsp;será</td><td class="diff_next"></td><td class="diff_header" id="to62_1402">1402</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;no&nbsp;imunoensaio&nbsp;para&nbsp;detectar&nbsp;o&nbsp;anti-HCV&nbsp;será</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1423">1423</td><td nowrap="nowrap">definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C</td><td class="diff_next"></td><td class="diff_header" id="to62_1403">1403</td><td nowrap="nowrap">definida&nbsp;como:&nbsp;“Amostra&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1424">1424</td><td nowrap="nowrap">(anti-HCV)”.&nbsp;A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como&nbsp;“HCV-RNA&nbsp;não</td><td class="diff_next"></td><td class="diff_header" id="to62_1404">1404</td><td nowrap="nowrap">(anti-HCV)”.&nbsp;A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como&nbsp;“HCV-RNA&nbsp;não</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1425">1425</td><td nowrap="nowrap">detectado&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Repetir</td><td class="diff_next"></td><td class="diff_header" id="to62_1405">1405</td><td nowrap="nowrap">detectado&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Repetir</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1426">1426</td><td nowrap="nowrap">o&nbsp;teste&nbsp;molecular&nbsp;após&nbsp;três&nbsp;e&nbsp;seis&nbsp;meses&nbsp;para&nbsp;confirmação&nbsp;do&nbsp;diagnóstico”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1406">1406</td><td nowrap="nowrap">o&nbsp;teste&nbsp;molecular&nbsp;após&nbsp;três&nbsp;e&nbsp;seis&nbsp;meses&nbsp;para&nbsp;confirmação&nbsp;do&nbsp;diagnóstico”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1427">1427</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HCV-RNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1407">1407</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HCV-RNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1428">1428</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anti-HCV&nbsp;e&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detec-</td><td class="diff_next"></td><td class="diff_header" id="to62_1408">1408</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;com&nbsp;resultado&nbsp;reagente&nbsp;para&nbsp;o&nbsp;anti-HCV&nbsp;e&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1429">1429</td><td nowrap="nowrap">tável&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;presença&nbsp;do&nbsp;anti-HCV&nbsp;e&nbsp;do&nbsp;HCV-</td><td class="diff_next"></td><td class="diff_header" id="to62_1409">1409</td><td nowrap="nowrap">tável&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;presença&nbsp;do&nbsp;anti-HCV&nbsp;e&nbsp;do&nbsp;HCV-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1430">1430</td><td nowrap="nowrap">RNA&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HCV”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1410">1410</td><td nowrap="nowrap">RNA&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção&nbsp;ativa&nbsp;pelo&nbsp;HCV”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1431">1431</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td><td class="diff_next"></td><td class="diff_header" id="to62_1411">1411</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resulta-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__37"></td><td class="diff_header" id="from62_1432">1432</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_1412">1412</td><td nowrap="nowrap">dos&nbsp;de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1433">1433</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_1413">1413</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1434">1434</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_1414">1414</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1435">1435</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_1415">1415</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__38"></td><td class="diff_header" id="from62_1436">1436</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_1416">1416</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__38">n</a></td><td class="diff_header" id="from62_1437">1437</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__38">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1438">1438</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_1417">1417</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1439">1439</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1418">1418</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1440">1440</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_1419">1419</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__39">n</a></td><td class="diff_header" id="from62_1441">1441</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__39">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1442">1442</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_1420">1420</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1443">1443</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1421">1421</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1444">1444</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_1422">1422</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1445">1445</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1423">1423</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1446">1446</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;5&nbsp;é&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;a&nbsp;infecção&nbsp;crônica&nbsp;pelo&nbsp;HCV.&nbsp;No&nbsp;caso&nbsp;de&nbsp;confir-</td><td class="diff_next"></td><td class="diff_header" id="to62_1424">1424</td><td nowrap="nowrap">O&nbsp;Fluxograma&nbsp;5&nbsp;é&nbsp;capaz&nbsp;de&nbsp;detectar&nbsp;a&nbsp;infecção&nbsp;crônica&nbsp;pelo&nbsp;HCV.&nbsp;No&nbsp;caso&nbsp;de&nbsp;confir-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1447">1447</td><td nowrap="nowrap">mação&nbsp;diagnóstica,&nbsp;caberá&nbsp;ao&nbsp;médico&nbsp;definir&nbsp;o&nbsp;encaminhamento&nbsp;do&nbsp;paciente&nbsp;conforme</td><td class="diff_next"></td><td class="diff_header" id="to62_1425">1425</td><td nowrap="nowrap">mação&nbsp;diagnóstica,&nbsp;caberá&nbsp;ao&nbsp;médico&nbsp;definir&nbsp;o&nbsp;encaminhamento&nbsp;do&nbsp;paciente&nbsp;conforme</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1448">1448</td><td nowrap="nowrap">o&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;C&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,</td><td class="diff_next"></td><td class="diff_header" id="to62_1426">1426</td><td nowrap="nowrap">o&nbsp;“Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;C&nbsp;e&nbsp;Coinfecções”&nbsp;(BRASIL,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1449">1449</td><td nowrap="nowrap">2017d).</td><td class="diff_next"></td><td class="diff_header" id="to62_1427">1427</td><td nowrap="nowrap">2017d).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1450">1450</td><td nowrap="nowrap">›&nbsp;O&nbsp;Fluxograma&nbsp;5,&nbsp;por&nbsp;detectar&nbsp;anticorpos&nbsp;totais&nbsp;contra&nbsp;o&nbsp;vírus,&nbsp;não&nbsp;é&nbsp;indicado</td><td class="diff_next"></td><td class="diff_header" id="to62_1428">1428</td><td nowrap="nowrap">›&nbsp;O&nbsp;Fluxograma&nbsp;5,&nbsp;por&nbsp;detectar&nbsp;anticorpos&nbsp;totais&nbsp;contra&nbsp;o&nbsp;vírus,&nbsp;não&nbsp;é&nbsp;indicado</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1451">1451</td><td nowrap="nowrap">para&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses.</td><td class="diff_next"></td><td class="diff_header" id="to62_1429">1429</td><td nowrap="nowrap">para&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1452">1452</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;pode&nbsp;ser&nbsp;utilizado&nbsp;no&nbsp;diagnóstico&nbsp;em&nbsp;gestantes.</td><td class="diff_next"></td><td class="diff_header" id="to62_1430">1430</td><td nowrap="nowrap">›&nbsp;Esse&nbsp;fluxograma&nbsp;pode&nbsp;ser&nbsp;utilizado&nbsp;no&nbsp;diagnóstico&nbsp;em&nbsp;gestantes.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1453">1453</td><td nowrap="nowrap">›&nbsp;O&nbsp;mesmo&nbsp;fluxograma&nbsp;não&nbsp;será&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;indivíduos&nbsp;infectados&nbsp;no</td><td class="diff_next"></td><td class="diff_header" id="to62_1431">1431</td><td nowrap="nowrap">›&nbsp;O&nbsp;mesmo&nbsp;fluxograma&nbsp;não&nbsp;será&nbsp;capaz&nbsp;de&nbsp;identificar&nbsp;indivíduos&nbsp;infectados&nbsp;no</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1454">1454</td><td nowrap="nowrap">período&nbsp;de&nbsp;janela&nbsp;imunológica&nbsp;ou&nbsp;imunossuprimidos.</td><td class="diff_next"></td><td class="diff_header" id="to62_1432">1432</td><td nowrap="nowrap">período&nbsp;de&nbsp;janela&nbsp;imunológica&nbsp;ou&nbsp;imunossuprimidos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1455">1455</td><td nowrap="nowrap">10.10&nbsp;Orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C</td><td class="diff_next"></td><td class="diff_header" id="to62_1433">1433</td><td nowrap="nowrap">10.10&nbsp;Orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1456">1456</td><td nowrap="nowrap">(HCV)&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses</td><td class="diff_next"></td><td class="diff_header" id="to62_1434">1434</td><td nowrap="nowrap">(HCV)&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1457">1457</td><td nowrap="nowrap">A&nbsp;transmissão&nbsp;vertical,&nbsp;apesar&nbsp;de&nbsp;ser&nbsp;um&nbsp;evento&nbsp;raro,&nbsp;é&nbsp;a&nbsp;forma&nbsp;mais&nbsp;comum&nbsp;de&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_1435">1435</td><td nowrap="nowrap">A&nbsp;transmissão&nbsp;vertical,&nbsp;apesar&nbsp;de&nbsp;ser&nbsp;um&nbsp;evento&nbsp;raro,&nbsp;é&nbsp;a&nbsp;forma&nbsp;mais&nbsp;comum&nbsp;de&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1458">1458</td><td nowrap="nowrap">fecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;recém-nascidos.&nbsp;Considera-se&nbsp;que&nbsp;a&nbsp;infecção&nbsp;durante&nbsp;o&nbsp;parto&nbsp;seja</td><td class="diff_next"></td><td class="diff_header" id="to62_1436">1436</td><td nowrap="nowrap">fecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;recém-nascidos.&nbsp;Considera-se&nbsp;que&nbsp;a&nbsp;infecção&nbsp;durante&nbsp;o&nbsp;parto&nbsp;seja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1459">1459</td><td nowrap="nowrap">a&nbsp;via&nbsp;mais&nbsp;frequente&nbsp;de&nbsp;transmissão;&nbsp;no&nbsp;entanto&nbsp;a&nbsp;transmissão&nbsp;intrauterina&nbsp;também&nbsp;é</td><td class="diff_next"></td><td class="diff_header" id="to62_1437">1437</td><td nowrap="nowrap">a&nbsp;via&nbsp;mais&nbsp;frequente&nbsp;de&nbsp;transmissão;&nbsp;no&nbsp;entanto&nbsp;a&nbsp;transmissão&nbsp;intrauterina&nbsp;também&nbsp;é</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1460">1460</td><td nowrap="nowrap">possível&nbsp;(GOLDBERG;&nbsp;CHOPRA;&nbsp;O’DONOVAN,&nbsp;2017;&nbsp;MACK&nbsp;et&nbsp;al.,&nbsp;2012;&nbsp;BRASIL,&nbsp;2017e).</td><td class="diff_next"></td><td class="diff_header" id="to62_1438">1438</td><td nowrap="nowrap">possível&nbsp;(GOLDBERG;&nbsp;CHOPRA;&nbsp;O’DONOVAN,&nbsp;2017;&nbsp;MACK&nbsp;et&nbsp;al.,&nbsp;2012;&nbsp;BRASIL,&nbsp;2017e).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1461">1461</td><td nowrap="nowrap">durante&nbsp;a&nbsp;gravidez&nbsp;ou&nbsp;no&nbsp;momento&nbsp;do&nbsp;parto,&nbsp;a&nbsp;coinfecção&nbsp;HCV/HIV&nbsp;e&nbsp;a&nbsp;infecção&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1439">1439</td><td nowrap="nowrap">durante&nbsp;a&nbsp;gravidez&nbsp;ou&nbsp;no&nbsp;momento&nbsp;do&nbsp;parto,&nbsp;a&nbsp;coinfecção&nbsp;HCV/HIV&nbsp;e&nbsp;a&nbsp;infecção&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1462">1462</td><td nowrap="nowrap">células&nbsp;mononucleadas&nbsp;periféricas&nbsp;do&nbsp;sangue&nbsp;(PBMC,&nbsp;do&nbsp;inglês&nbsp;peripheral&nbsp;blood&nbsp;mono-</td><td class="diff_next"></td><td class="diff_header" id="to62_1440">1440</td><td nowrap="nowrap">células&nbsp;mononucleadas&nbsp;periféricas&nbsp;do&nbsp;sangue&nbsp;(PBMC,&nbsp;do&nbsp;inglês&nbsp;peripheral&nbsp;blood&nbsp;mono-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1463">1463</td><td nowrap="nowrap">nuclear&nbsp;cell).&nbsp;Mães&nbsp;com&nbsp;carga&nbsp;viral&nbsp;suprimida&nbsp;tem&nbsp;chances&nbsp;mínimas&nbsp;de&nbsp;transmitir&nbsp;o&nbsp;vírus</td><td class="diff_next"></td><td class="diff_header" id="to62_1441">1441</td><td nowrap="nowrap">nuclear&nbsp;cell).&nbsp;Mães&nbsp;com&nbsp;carga&nbsp;viral&nbsp;suprimida&nbsp;tem&nbsp;chances&nbsp;mínimas&nbsp;de&nbsp;transmitir&nbsp;o&nbsp;vírus</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1464">1464</td><td nowrap="nowrap">(GOLDBERG;&nbsp;CHOPRA;&nbsp;O’DONOVAN,&nbsp;2017).</td><td class="diff_next"></td><td class="diff_header" id="to62_1442">1442</td><td nowrap="nowrap">(GOLDBERG;&nbsp;CHOPRA;&nbsp;O’DONOVAN,&nbsp;2017).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1465">1465</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;em&nbsp;recém-nascidos&nbsp;normalmente&nbsp;tem&nbsp;curso&nbsp;assintomático,&nbsp;e&nbsp;boa&nbsp;parte</td><td class="diff_next"></td><td class="diff_header" id="to62_1443">1443</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;em&nbsp;recém-nascidos&nbsp;normalmente&nbsp;tem&nbsp;curso&nbsp;assintomático,&nbsp;e&nbsp;boa&nbsp;parte</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1466">1466</td><td nowrap="nowrap">dos&nbsp;infectados&nbsp;apresentam&nbsp;níveis&nbsp;apenas&nbsp;levemente&nbsp;elevados&nbsp;de&nbsp;aminotransferases.&nbsp;Por</td><td class="diff_next"></td><td class="diff_header" id="to62_1444">1444</td><td nowrap="nowrap">dos&nbsp;infectados&nbsp;apresentam&nbsp;níveis&nbsp;apenas&nbsp;levemente&nbsp;elevados&nbsp;de&nbsp;aminotransferases.&nbsp;Por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1467">1467</td><td nowrap="nowrap">isso,&nbsp;indica-se&nbsp;que&nbsp;todos&nbsp;aqueles&nbsp;nascidos&nbsp;de&nbsp;mães&nbsp;sabidamente&nbsp;infectadas&nbsp;pelo&nbsp;HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1445">1445</td><td nowrap="nowrap">isso,&nbsp;indica-se&nbsp;que&nbsp;todos&nbsp;aqueles&nbsp;nascidos&nbsp;de&nbsp;mães&nbsp;sabidamente&nbsp;infectadas&nbsp;pelo&nbsp;HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1468">1468</td><td nowrap="nowrap">sejam&nbsp;testados.&nbsp;Normalmente,&nbsp;a&nbsp;triagem&nbsp;para&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;é&nbsp;feita&nbsp;pela&nbsp;detecção</td><td class="diff_next"></td><td class="diff_header" id="to62_1446">1446</td><td nowrap="nowrap">sejam&nbsp;testados.&nbsp;Normalmente,&nbsp;a&nbsp;triagem&nbsp;para&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;é&nbsp;feita&nbsp;pela&nbsp;detecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1469">1469</td><td nowrap="nowrap">do&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;(anti-HCV);&nbsp;no&nbsp;entanto,&nbsp;anticorpos&nbsp;da&nbsp;classe&nbsp;IgG&nbsp;atravessam</td><td class="diff_next"></td><td class="diff_header" id="to62_1447">1447</td><td nowrap="nowrap">do&nbsp;anticorpo&nbsp;contra&nbsp;o&nbsp;vírus&nbsp;(anti-HCV);&nbsp;no&nbsp;entanto,&nbsp;anticorpos&nbsp;da&nbsp;classe&nbsp;IgG&nbsp;atravessam</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1470">1470</td><td nowrap="nowrap">a&nbsp;barreira&nbsp;placentária,&nbsp;o&nbsp;que&nbsp;pode&nbsp;levar&nbsp;a&nbsp;resultados&nbsp;reagentes&nbsp;em&nbsp;crianças&nbsp;não&nbsp;neces-</td><td class="diff_next"></td><td class="diff_header" id="to62_1448">1448</td><td nowrap="nowrap">a&nbsp;barreira&nbsp;placentária,&nbsp;o&nbsp;que&nbsp;pode&nbsp;levar&nbsp;a&nbsp;resultados&nbsp;reagentes&nbsp;em&nbsp;crianças&nbsp;não&nbsp;neces-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1471">1471</td><td nowrap="nowrap">sariamente&nbsp;infectadas&nbsp;(GOLDBERG;&nbsp;CHOPRA;&nbsp;O’DONOVAN,&nbsp;2017;&nbsp;MACK&nbsp;et&nbsp;al.,&nbsp;2012).&nbsp;Por</td><td class="diff_next"></td><td class="diff_header" id="to62_1449">1449</td><td nowrap="nowrap">sariamente&nbsp;infectadas&nbsp;(GOLDBERG;&nbsp;CHOPRA;&nbsp;O’DONOVAN,&nbsp;2017;&nbsp;MACK&nbsp;et&nbsp;al.,&nbsp;2012).&nbsp;Por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1472">1472</td><td nowrap="nowrap">isso,&nbsp;a&nbsp;orientação&nbsp;é&nbsp;de&nbsp;que&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;indivíduos&nbsp;menores</td><td class="diff_next"></td><td class="diff_header" id="to62_1450">1450</td><td nowrap="nowrap">isso,&nbsp;a&nbsp;orientação&nbsp;é&nbsp;de&nbsp;que&nbsp;o&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;indivíduos&nbsp;menores</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1473">1473</td><td nowrap="nowrap">de&nbsp;18&nbsp;meses&nbsp;seja&nbsp;feito&nbsp;por&nbsp;meio&nbsp;de&nbsp;teste&nbsp;molecular.&nbsp;A&nbsp;detecção&nbsp;do&nbsp;HCV-RNA&nbsp;em&nbsp;duas</td><td class="diff_next"></td><td class="diff_header" id="to62_1451">1451</td><td nowrap="nowrap">de&nbsp;18&nbsp;meses&nbsp;seja&nbsp;feito&nbsp;por&nbsp;meio&nbsp;de&nbsp;teste&nbsp;molecular.&nbsp;A&nbsp;detecção&nbsp;do&nbsp;HCV-RNA&nbsp;em&nbsp;duas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1474">1474</td><td nowrap="nowrap">testagens&nbsp;diferentes&nbsp;confirma&nbsp;a&nbsp;infecção.&nbsp;É&nbsp;recomendado&nbsp;que&nbsp;o&nbsp;primeiro&nbsp;teste&nbsp;seja&nbsp;fei-</td><td class="diff_next"></td><td class="diff_header" id="to62_1452">1452</td><td nowrap="nowrap">testagens&nbsp;diferentes&nbsp;confirma&nbsp;a&nbsp;infecção.&nbsp;É&nbsp;recomendado&nbsp;que&nbsp;o&nbsp;primeiro&nbsp;teste&nbsp;seja&nbsp;fei-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1475">1475</td><td nowrap="nowrap">to&nbsp;a&nbsp;partir&nbsp;dos&nbsp;três&nbsp;meses&nbsp;de&nbsp;idade,&nbsp;com&nbsp;um&nbsp;intervalo&nbsp;de&nbsp;6&nbsp;a&nbsp;12&nbsp;meses&nbsp;para&nbsp;a&nbsp;segunda</td><td class="diff_next"></td><td class="diff_header" id="to62_1453">1453</td><td nowrap="nowrap">to&nbsp;a&nbsp;partir&nbsp;dos&nbsp;três&nbsp;meses&nbsp;de&nbsp;idade,&nbsp;com&nbsp;um&nbsp;intervalo&nbsp;de&nbsp;6&nbsp;a&nbsp;12&nbsp;meses&nbsp;para&nbsp;a&nbsp;segunda</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1476">1476</td><td nowrap="nowrap">testagem.&nbsp;Após&nbsp;os&nbsp;18&nbsp;meses,&nbsp;recomenda-se&nbsp;realizar&nbsp;o&nbsp;teste&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;anti-HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1454">1454</td><td nowrap="nowrap">testagem.&nbsp;Após&nbsp;os&nbsp;18&nbsp;meses,&nbsp;recomenda-se&nbsp;realizar&nbsp;o&nbsp;teste&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;anti-HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1477">1477</td><td nowrap="nowrap">(BRASIL,&nbsp;2017e).</td><td class="diff_next"></td><td class="diff_header" id="to62_1455">1455</td><td nowrap="nowrap">(BRASIL,&nbsp;2017e).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1478">1478</td><td nowrap="nowrap">Essas&nbsp;orientações&nbsp;devem&nbsp;ser&nbsp;utilizadas&nbsp;quando&nbsp;houver&nbsp;solicitação&nbsp;para&nbsp;“sorologia</td><td class="diff_next"></td><td class="diff_header" id="to62_1456">1456</td><td nowrap="nowrap">Essas&nbsp;orientações&nbsp;devem&nbsp;ser&nbsp;utilizadas&nbsp;quando&nbsp;houver&nbsp;solicitação&nbsp;para&nbsp;“sorologia</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1479">1479</td><td nowrap="nowrap">da&nbsp;hepatite&nbsp;C”,&nbsp;“diagnóstico&nbsp;de&nbsp;HCV”&nbsp;ou&nbsp;termos&nbsp;afins,&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;me-</td><td class="diff_next"></td><td class="diff_header" id="to62_1457">1457</td><td nowrap="nowrap">da&nbsp;hepatite&nbsp;C”,&nbsp;“diagnóstico&nbsp;de&nbsp;HCV”&nbsp;ou&nbsp;termos&nbsp;afins,&nbsp;em&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;me-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1480">1480</td><td nowrap="nowrap">ses&nbsp;nascidos&nbsp;de&nbsp;mães&nbsp;sabidamente&nbsp;infectadas&nbsp;pelo&nbsp;HCV.</td><td class="diff_next"></td><td class="diff_header" id="to62_1458">1458</td><td nowrap="nowrap">ses&nbsp;nascidos&nbsp;de&nbsp;mães&nbsp;sabidamente&nbsp;infectadas&nbsp;pelo&nbsp;HCV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1481">1481</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td><td class="diff_next"></td><td class="diff_header" id="to62_1459">1459</td><td nowrap="nowrap">nº&nbsp;302/Anvisa,&nbsp;de&nbsp;13&nbsp;de&nbsp;outubro&nbsp;de&nbsp;2005,&nbsp;suas&nbsp;alterações,&nbsp;ou&nbsp;outro&nbsp;instrumento&nbsp;legal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1482">1482</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td><td class="diff_next"></td><td class="diff_header" id="to62_1460">1460</td><td nowrap="nowrap">que&nbsp;venha&nbsp;a&nbsp;substituí-la.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1483">1483</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HCV-RNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1461">1461</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;detectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“Amostra&nbsp;com&nbsp;HCV-RNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1484">1484</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;também&nbsp;deverá&nbsp;conter&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;detecção&nbsp;do&nbsp;HCV-</td><td class="diff_next"></td><td class="diff_header" id="to62_1462">1462</td><td nowrap="nowrap">detectável”.&nbsp;O&nbsp;laudo&nbsp;também&nbsp;deverá&nbsp;conter&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“A&nbsp;detecção&nbsp;do&nbsp;HCV-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1485">1485</td><td nowrap="nowrap">RNA&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1463">1463</td><td nowrap="nowrap">RNA&nbsp;é&nbsp;indicativa&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;C”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1486">1486</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“HCV-RNA&nbsp;não&nbsp;detec-</td><td class="diff_next"></td><td class="diff_header" id="to62_1464">1464</td><td nowrap="nowrap">A&nbsp;amostra&nbsp;com&nbsp;carga&nbsp;viral&nbsp;indetectável&nbsp;será&nbsp;definida&nbsp;como:&nbsp;“HCV-RNA&nbsp;não&nbsp;detec-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1487">1487</td><td nowrap="nowrap">tado&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1465">1465</td><td nowrap="nowrap">tado&nbsp;na&nbsp;amostra”.&nbsp;O&nbsp;laudo&nbsp;deverá&nbsp;ser&nbsp;emitido&nbsp;com&nbsp;a&nbsp;seguinte&nbsp;ressalva:&nbsp;“Em&nbsp;caso&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1488">1488</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HCV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td><td class="diff_next"></td><td class="diff_header" id="to62_1466">1466</td><td nowrap="nowrap">suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HCV,&nbsp;uma&nbsp;nova&nbsp;amostra&nbsp;deverá&nbsp;ser&nbsp;coletada&nbsp;30&nbsp;dias&nbsp;após</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1489">1489</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1467">1467</td><td nowrap="nowrap">a&nbsp;data&nbsp;da&nbsp;coleta&nbsp;desta&nbsp;amostra&nbsp;para&nbsp;a&nbsp;realização&nbsp;de&nbsp;um&nbsp;novo&nbsp;teste”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1490">1490</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resultados</td><td class="diff_next"></td><td class="diff_header" id="to62_1468">1468</td><td nowrap="nowrap">Além&nbsp;das&nbsp;informações&nbsp;citadas&nbsp;anteriormente,&nbsp;os&nbsp;laudos&nbsp;devem&nbsp;conter&nbsp;os&nbsp;resultados</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__39"></td><td class="diff_header" id="from62_1491">1491</td><td nowrap="nowrap">de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;a&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td><td class="diff_next"></td><td class="diff_header" id="to62_1469">1469</td><td nowrap="nowrap">de&nbsp;todos&nbsp;os&nbsp;testes&nbsp;realizados,&nbsp;incluindo&nbsp;valores&nbsp;de&nbsp;cut-off&nbsp;e&nbsp;a&nbsp;carga&nbsp;viral,&nbsp;e&nbsp;a&nbsp;unidade</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1492">1492</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td><td class="diff_next"></td><td class="diff_header" id="to62_1470">1470</td><td nowrap="nowrap">de&nbsp;medição&nbsp;do&nbsp;método&nbsp;utilizado,&nbsp;excetuando-se&nbsp;os&nbsp;resultados&nbsp;obtidos&nbsp;por&nbsp;testes&nbsp;cuja</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1493">1493</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td><td class="diff_next"></td><td class="diff_header" id="to62_1471">1471</td><td nowrap="nowrap">leitura&nbsp;é&nbsp;visual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1494">1494</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td><td class="diff_next"></td><td class="diff_header" id="to62_1472">1472</td><td nowrap="nowrap">No&nbsp;campo&nbsp;de&nbsp;observações,&nbsp;deverão&nbsp;ser&nbsp;incluídos&nbsp;os&nbsp;seguintes&nbsp;avisos:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__40"></td><td class="diff_header" id="from62_1495">1495</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td><td class="diff_next"></td><td class="diff_header" id="to62_1473">1473</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;do&nbsp;SUS</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__40">n</a></td><td class="diff_header" id="from62_1496">1496</td><td nowrap="nowrap"><span class="diff_sub">para&nbsp;crianças&nbsp;de&nbsp;15&nbsp;meses&nbsp;até&nbsp;4&nbsp;anos&nbsp;de&nbsp;idade&nbsp;(http://portalarquivos.saude.</span></td><td class="diff_next"><a href="#difflib_chg_to62__40">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1497">1497</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_1474">1474</td><td nowrap="nowrap">gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está&nbsp;disponível&nbsp;nos&nbsp;Crie,&nbsp;sendo&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1498">1498</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1475">1475</td><td nowrap="nowrap">Imunobiológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1499">1499</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td><td class="diff_next"></td><td class="diff_header" id="to62_1476">1476</td><td nowrap="nowrap">›&nbsp;“A&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;B&nbsp;faz&nbsp;parte&nbsp;do&nbsp;calendário&nbsp;de&nbsp;vacinação&nbsp;da&nbsp;crian-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__41">n</a></td><td class="diff_header" id="from62_1500">1500</td><td nowrap="nowrap"><span class="diff_sub">ça&nbsp;(http://portalarquivos.saude.gov.br/campanhas/pni/).&nbsp;Além&nbsp;disso,&nbsp;ela&nbsp;está</span></td><td class="diff_next"><a href="#difflib_chg_to62__41">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1501">1501</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_1477">1477</td><td nowrap="nowrap">disponível&nbsp;nas&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;do&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;todas&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1502">1502</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1478">1478</td><td nowrap="nowrap">pessoas,&nbsp;independentemente&nbsp;de&nbsp;idade&nbsp;e/ou&nbsp;condições&nbsp;de&nbsp;vulnerabilidade,&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1503">1503</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td><td class="diff_next"></td><td class="diff_header" id="to62_1479">1479</td><td nowrap="nowrap">para&nbsp;as&nbsp;situações&nbsp;previstas&nbsp;no&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imuno-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1504">1504</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td><td class="diff_next"></td><td class="diff_header" id="to62_1480">1480</td><td nowrap="nowrap">biológicos&nbsp;Especiais”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1505">1505</td><td nowrap="nowrap">›&nbsp;Essas&nbsp;orientações&nbsp;são&nbsp;indicadas&nbsp;apenas&nbsp;para&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;me-</td><td class="diff_next"></td><td class="diff_header" id="to62_1481">1481</td><td nowrap="nowrap">›&nbsp;Essas&nbsp;orientações&nbsp;são&nbsp;indicadas&nbsp;apenas&nbsp;para&nbsp;indivíduos&nbsp;menores&nbsp;de&nbsp;18&nbsp;me-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1506">1506</td><td nowrap="nowrap">ses&nbsp;nascidos&nbsp;de&nbsp;mães&nbsp;sabidamente&nbsp;portadoras&nbsp;do&nbsp;HCV.&nbsp;O&nbsp;diagnóstico&nbsp;infantil</td><td class="diff_next"></td><td class="diff_header" id="to62_1482">1482</td><td nowrap="nowrap">ses&nbsp;nascidos&nbsp;de&nbsp;mães&nbsp;sabidamente&nbsp;portadoras&nbsp;do&nbsp;HCV.&nbsp;O&nbsp;diagnóstico&nbsp;infantil</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1507">1507</td><td nowrap="nowrap">também&nbsp;pode&nbsp;ser&nbsp;realizado&nbsp;utilizando&nbsp;um&nbsp;imunoensaio&nbsp;HCV-Ag,&nbsp;capaz&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1483">1483</td><td nowrap="nowrap">também&nbsp;pode&nbsp;ser&nbsp;realizado&nbsp;utilizando&nbsp;um&nbsp;imunoensaio&nbsp;HCV-Ag,&nbsp;capaz&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1508">1508</td><td nowrap="nowrap">detectar&nbsp;e&nbsp;quantificar&nbsp;antígenos&nbsp;virais&nbsp;do&nbsp;HCV.</td><td class="diff_next"></td><td class="diff_header" id="to62_1484">1484</td><td nowrap="nowrap">detectar&nbsp;e&nbsp;quantificar&nbsp;antígenos&nbsp;virais&nbsp;do&nbsp;HCV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1509">1509</td><td nowrap="nowrap">›&nbsp;Um&nbsp;resultado&nbsp;indetectável&nbsp;para&nbsp;HCV-RNA&nbsp;no&nbsp;primeiro&nbsp;teste&nbsp;deverá&nbsp;ser&nbsp;con-</td><td class="diff_next"></td><td class="diff_header" id="to62_1485">1485</td><td nowrap="nowrap">›&nbsp;Um&nbsp;resultado&nbsp;indetectável&nbsp;para&nbsp;HCV-RNA&nbsp;no&nbsp;primeiro&nbsp;teste&nbsp;deverá&nbsp;ser&nbsp;con-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1510">1510</td><td nowrap="nowrap">seis&nbsp;meses&nbsp;da&nbsp;coleta&nbsp;da&nbsp;primeira&nbsp;amostra.</td><td class="diff_next"></td><td class="diff_header" id="to62_1486">1486</td><td nowrap="nowrap">seis&nbsp;meses&nbsp;da&nbsp;coleta&nbsp;da&nbsp;primeira&nbsp;amostra.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1511">1511</td><td nowrap="nowrap">›&nbsp;A&nbsp;documentação&nbsp;da&nbsp;soroconversão&nbsp;da&nbsp;criança&nbsp;deve&nbsp;ser&nbsp;feita&nbsp;com&nbsp;a&nbsp;realização</td><td class="diff_next"></td><td class="diff_header" id="to62_1487">1487</td><td nowrap="nowrap">›&nbsp;A&nbsp;documentação&nbsp;da&nbsp;soroconversão&nbsp;da&nbsp;criança&nbsp;deve&nbsp;ser&nbsp;feita&nbsp;com&nbsp;a&nbsp;realização</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1512">1512</td><td nowrap="nowrap">de&nbsp;sorologia&nbsp;anti-HCV&nbsp;após&nbsp;os&nbsp;18&nbsp;meses&nbsp;de&nbsp;idade&nbsp;da&nbsp;criança.</td><td class="diff_next"></td><td class="diff_header" id="to62_1488">1488</td><td nowrap="nowrap">de&nbsp;sorologia&nbsp;anti-HCV&nbsp;após&nbsp;os&nbsp;18&nbsp;meses&nbsp;de&nbsp;idade&nbsp;da&nbsp;criança.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1513">1513</td><td nowrap="nowrap">11.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;D&nbsp;(HDV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1489">1489</td><td nowrap="nowrap">11.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;D&nbsp;(HDV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1514">1514</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;D&nbsp;é&nbsp;causada&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV,&nbsp;anteriormente&nbsp;conhecido</td><td class="diff_next"></td><td class="diff_header" id="to62_1490">1490</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;D&nbsp;é&nbsp;causada&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV,&nbsp;anteriormente&nbsp;conhecido</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1515">1515</td><td nowrap="nowrap">como&nbsp;agente&nbsp;Delta),&nbsp;podendo&nbsp;apresentar-se&nbsp;como&nbsp;infecção&nbsp;assintomática,&nbsp;sintomática</td><td class="diff_next"></td><td class="diff_header" id="to62_1491">1491</td><td nowrap="nowrap">como&nbsp;agente&nbsp;Delta),&nbsp;podendo&nbsp;apresentar-se&nbsp;como&nbsp;infecção&nbsp;assintomática,&nbsp;sintomática</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1516">1516</td><td nowrap="nowrap">ou&nbsp;de&nbsp;formas&nbsp;graves.&nbsp;O&nbsp;HDV&nbsp;é&nbsp;um&nbsp;vírus&nbsp;defectivo,&nbsp;satélite&nbsp;do&nbsp;HBV,&nbsp;que&nbsp;precisa&nbsp;do&nbsp;HBsAg</td><td class="diff_next"></td><td class="diff_header" id="to62_1492">1492</td><td nowrap="nowrap">ou&nbsp;de&nbsp;formas&nbsp;graves.&nbsp;O&nbsp;HDV&nbsp;é&nbsp;um&nbsp;vírus&nbsp;defectivo,&nbsp;satélite&nbsp;do&nbsp;HBV,&nbsp;que&nbsp;precisa&nbsp;do&nbsp;HBsAg</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1517">1517</td><td nowrap="nowrap">para&nbsp;realizar&nbsp;sua&nbsp;infecção.&nbsp;A&nbsp;infecção&nbsp;Delta&nbsp;crônica&nbsp;é&nbsp;a&nbsp;principal&nbsp;causa&nbsp;de&nbsp;cirrose&nbsp;hepáti-</td><td class="diff_next"></td><td class="diff_header" id="to62_1493">1493</td><td nowrap="nowrap">para&nbsp;realizar&nbsp;sua&nbsp;infecção.&nbsp;A&nbsp;infecção&nbsp;Delta&nbsp;crônica&nbsp;é&nbsp;a&nbsp;principal&nbsp;causa&nbsp;de&nbsp;cirrose&nbsp;hepáti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1518">1518</td><td nowrap="nowrap">ca&nbsp;em&nbsp;crianças&nbsp;e&nbsp;adultos&nbsp;jovens&nbsp;em&nbsp;áreas&nbsp;endêmicas&nbsp;na&nbsp;Itália,&nbsp;na&nbsp;Inglaterra&nbsp;e&nbsp;na&nbsp;região</td><td class="diff_next"></td><td class="diff_header" id="to62_1494">1494</td><td nowrap="nowrap">ca&nbsp;em&nbsp;crianças&nbsp;e&nbsp;adultos&nbsp;jovens&nbsp;em&nbsp;áreas&nbsp;endêmicas&nbsp;na&nbsp;Itália,&nbsp;na&nbsp;Inglaterra&nbsp;e&nbsp;na&nbsp;região</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1519">1519</td><td nowrap="nowrap">amazônica&nbsp;do&nbsp;Brasil.&nbsp;Devido&nbsp;à&nbsp;sua&nbsp;dependência&nbsp;funcional&nbsp;em&nbsp;relação&nbsp;ao&nbsp;HBV,&nbsp;o&nbsp;vírus</td><td class="diff_next"></td><td class="diff_header" id="to62_1495">1495</td><td nowrap="nowrap">amazônica&nbsp;do&nbsp;Brasil.&nbsp;Devido&nbsp;à&nbsp;sua&nbsp;dependência&nbsp;funcional&nbsp;em&nbsp;relação&nbsp;ao&nbsp;HBV,&nbsp;o&nbsp;vírus</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1520">1520</td><td nowrap="nowrap">Delta&nbsp;tem&nbsp;mecanismos&nbsp;de&nbsp;transmissão&nbsp;idênticos&nbsp;aos&nbsp;do&nbsp;HBV.&nbsp;Os&nbsp;portadores&nbsp;crônicos</td><td class="diff_next"></td><td class="diff_header" id="to62_1496">1496</td><td nowrap="nowrap">Delta&nbsp;tem&nbsp;mecanismos&nbsp;de&nbsp;transmissão&nbsp;idênticos&nbsp;aos&nbsp;do&nbsp;HBV.&nbsp;Os&nbsp;portadores&nbsp;crônicos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1521">1521</td><td nowrap="nowrap">inativos&nbsp;do&nbsp;vírus&nbsp;B&nbsp;são&nbsp;reservatórios&nbsp;importantes&nbsp;para&nbsp;a&nbsp;disseminação&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepa-</td><td class="diff_next"></td><td class="diff_header" id="to62_1497">1497</td><td nowrap="nowrap">inativos&nbsp;do&nbsp;vírus&nbsp;B&nbsp;são&nbsp;reservatórios&nbsp;importantes&nbsp;para&nbsp;a&nbsp;disseminação&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1522">1522</td><td nowrap="nowrap">tite&nbsp;Delta&nbsp;em&nbsp;áreas&nbsp;de&nbsp;alta&nbsp;endemicidade&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV.</td><td class="diff_next"></td><td class="diff_header" id="to62_1498">1498</td><td nowrap="nowrap">tite&nbsp;Delta&nbsp;em&nbsp;áreas&nbsp;de&nbsp;alta&nbsp;endemicidade&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HBV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1523">1523</td><td nowrap="nowrap">11.1&nbsp;Partícula&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_1499">1499</td><td nowrap="nowrap">11.1&nbsp;Partícula&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1524">1524</td><td nowrap="nowrap">O&nbsp;HDV&nbsp;é&nbsp;o&nbsp;único&nbsp;membro&nbsp;da&nbsp;família&nbsp;Deltaviridae,&nbsp;gênero&nbsp;Deltavirus,&nbsp;sendo&nbsp;um&nbsp;vírus</td><td class="diff_next"></td><td class="diff_header" id="to62_1500">1500</td><td nowrap="nowrap">O&nbsp;HDV&nbsp;é&nbsp;o&nbsp;único&nbsp;membro&nbsp;da&nbsp;família&nbsp;Deltaviridae,&nbsp;gênero&nbsp;Deltavirus,&nbsp;sendo&nbsp;um&nbsp;vírus</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1525">1525</td><td nowrap="nowrap">considerado&nbsp;similar&nbsp;aos&nbsp;viroides,&nbsp;vírus&nbsp;de&nbsp;RNA&nbsp;que&nbsp;infectam&nbsp;plantas.&nbsp;O&nbsp;vírion&nbsp;é&nbsp;compos-</td><td class="diff_next"></td><td class="diff_header" id="to62_1501">1501</td><td nowrap="nowrap">considerado&nbsp;similar&nbsp;aos&nbsp;viroides,&nbsp;vírus&nbsp;de&nbsp;RNA&nbsp;que&nbsp;infectam&nbsp;plantas.&nbsp;O&nbsp;vírion&nbsp;é&nbsp;compos-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1526">1526</td><td nowrap="nowrap">to&nbsp;por&nbsp;uma&nbsp;partícula&nbsp;esférica&nbsp;de,&nbsp;aproximadamente,&nbsp;36nm&nbsp;de&nbsp;diâmetro,&nbsp;que&nbsp;apresenta,</td><td class="diff_next"></td><td class="diff_header" id="to62_1502">1502</td><td nowrap="nowrap">to&nbsp;por&nbsp;uma&nbsp;partícula&nbsp;esférica&nbsp;de,&nbsp;aproximadamente,&nbsp;36nm&nbsp;de&nbsp;diâmetro,&nbsp;que&nbsp;apresenta,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1527">1527</td><td nowrap="nowrap">em&nbsp;sua&nbsp;porção&nbsp;mais&nbsp;externa,&nbsp;um&nbsp;envelope&nbsp;bilipídico&nbsp;contendo&nbsp;as&nbsp;três&nbsp;formas&nbsp;do&nbsp;HBsAg,</td><td class="diff_next"></td><td class="diff_header" id="to62_1503">1503</td><td nowrap="nowrap">em&nbsp;sua&nbsp;porção&nbsp;mais&nbsp;externa,&nbsp;um&nbsp;envelope&nbsp;bilipídico&nbsp;contendo&nbsp;as&nbsp;três&nbsp;formas&nbsp;do&nbsp;HBsAg,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1528">1528</td><td nowrap="nowrap">do&nbsp;qual&nbsp;o&nbsp;HDV&nbsp;depende&nbsp;para&nbsp;conseguir&nbsp;infectar&nbsp;novas&nbsp;células&nbsp;(Figura&nbsp;18).&nbsp;O&nbsp;nucleocap-</td><td class="diff_next"></td><td class="diff_header" id="to62_1504">1504</td><td nowrap="nowrap">do&nbsp;qual&nbsp;o&nbsp;HDV&nbsp;depende&nbsp;para&nbsp;conseguir&nbsp;infectar&nbsp;novas&nbsp;células&nbsp;(Figura&nbsp;18).&nbsp;O&nbsp;nucleocap-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1529">1529</td><td nowrap="nowrap">sídeo&nbsp;é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;RNA&nbsp;circular&nbsp;de&nbsp;fita&nbsp;simples&nbsp;(em&nbsp;formado&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1505">1505</td><td nowrap="nowrap">sídeo&nbsp;é&nbsp;composto&nbsp;por&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;RNA&nbsp;circular&nbsp;de&nbsp;fita&nbsp;simples&nbsp;(em&nbsp;formado&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1530">1530</td><td nowrap="nowrap">“rodo”&nbsp;ou&nbsp;“bastonete”)&nbsp;que&nbsp;contém&nbsp;1.679&nbsp;nucleotídeos&nbsp;e,&nbsp;aproximadamente,&nbsp;200&nbsp;cópias</td><td class="diff_next"></td><td class="diff_header" id="to62_1506">1506</td><td nowrap="nowrap">“rodo”&nbsp;ou&nbsp;“bastonete”)&nbsp;que&nbsp;contém&nbsp;1.679&nbsp;nucleotídeos&nbsp;e,&nbsp;aproximadamente,&nbsp;200&nbsp;cópias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1531">1531</td><td nowrap="nowrap">do&nbsp;antígeno&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV-Ag)&nbsp;por&nbsp;genoma.&nbsp;A&nbsp;única&nbsp;proteína&nbsp;codificada</td><td class="diff_next"></td><td class="diff_header" id="to62_1507">1507</td><td nowrap="nowrap">do&nbsp;antígeno&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV-Ag)&nbsp;por&nbsp;genoma.&nbsp;A&nbsp;única&nbsp;proteína&nbsp;codificada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1532">1532</td><td nowrap="nowrap">pelo&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;o&nbsp;HDV-Ag.&nbsp;A&nbsp;estrutura&nbsp;do&nbsp;genoma&nbsp;viral,&nbsp;bem&nbsp;como&nbsp;sua&nbsp;composição</td><td class="diff_next"></td><td class="diff_header" id="to62_1508">1508</td><td nowrap="nowrap">pelo&nbsp;genoma&nbsp;viral&nbsp;é&nbsp;o&nbsp;HDV-Ag.&nbsp;A&nbsp;estrutura&nbsp;do&nbsp;genoma&nbsp;viral,&nbsp;bem&nbsp;como&nbsp;sua&nbsp;composição</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1533">1533</td><td nowrap="nowrap">nucleotídica,&nbsp;permite&nbsp;relacionar&nbsp;o&nbsp;HDV&nbsp;com&nbsp;os&nbsp;viroides&nbsp;vegetais.&nbsp;O&nbsp;RNA&nbsp;viral&nbsp;é&nbsp;uma&nbsp;ribo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1509">1509</td><td nowrap="nowrap">nucleotídica,&nbsp;permite&nbsp;relacionar&nbsp;o&nbsp;HDV&nbsp;com&nbsp;os&nbsp;viroides&nbsp;vegetais.&nbsp;O&nbsp;RNA&nbsp;viral&nbsp;é&nbsp;uma&nbsp;ribo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1534">1534</td><td nowrap="nowrap">zima,&nbsp;ou&nbsp;seja,&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;ácido&nbsp;nucleico&nbsp;com&nbsp;capacidade&nbsp;catalítica&nbsp;(GHAMARI&nbsp;et</td><td class="diff_next"></td><td class="diff_header" id="to62_1510">1510</td><td nowrap="nowrap">zima,&nbsp;ou&nbsp;seja,&nbsp;uma&nbsp;molécula&nbsp;de&nbsp;ácido&nbsp;nucleico&nbsp;com&nbsp;capacidade&nbsp;catalítica&nbsp;(GHAMARI&nbsp;et</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1535">1535</td><td nowrap="nowrap">al.,&nbsp;2013;&nbsp;HUGHES;&nbsp;WEDEMEYER;&nbsp;HARRISON,&nbsp;2011).</td><td class="diff_next"></td><td class="diff_header" id="to62_1511">1511</td><td nowrap="nowrap">al.,&nbsp;2013;&nbsp;HUGHES;&nbsp;WEDEMEYER;&nbsp;HARRISON,&nbsp;2011).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1536">1536</td><td nowrap="nowrap">11.2&nbsp;Variabilidade&nbsp;genética</td><td class="diff_next"></td><td class="diff_header" id="to62_1512">1512</td><td nowrap="nowrap">11.2&nbsp;Variabilidade&nbsp;genética</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1537">1537</td><td nowrap="nowrap">Foram&nbsp;identificados,&nbsp;até&nbsp;o&nbsp;momento,&nbsp;oito&nbsp;genótipos&nbsp;do&nbsp;HDV,&nbsp;denominados&nbsp;por</td><td class="diff_next"></td><td class="diff_header" id="to62_1513">1513</td><td nowrap="nowrap">Foram&nbsp;identificados,&nbsp;até&nbsp;o&nbsp;momento,&nbsp;oito&nbsp;genótipos&nbsp;do&nbsp;HDV,&nbsp;denominados&nbsp;por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1538">1538</td><td nowrap="nowrap">números&nbsp;(de&nbsp;1&nbsp;a&nbsp;8),&nbsp;os&nbsp;quais&nbsp;possuem&nbsp;divergências&nbsp;de&nbsp;até&nbsp;16%&nbsp;entre&nbsp;as&nbsp;sequências&nbsp;nu-</td><td class="diff_next"></td><td class="diff_header" id="to62_1514">1514</td><td nowrap="nowrap">números&nbsp;(de&nbsp;1&nbsp;a&nbsp;8),&nbsp;os&nbsp;quais&nbsp;possuem&nbsp;divergências&nbsp;de&nbsp;até&nbsp;16%&nbsp;entre&nbsp;as&nbsp;sequências&nbsp;nu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1539">1539</td><td nowrap="nowrap">cleotídicas&nbsp;dentro&nbsp;do&nbsp;mesmo&nbsp;genótipo&nbsp;e&nbsp;de&nbsp;20%&nbsp;a&nbsp;40%&nbsp;entre&nbsp;os&nbsp;diferentes&nbsp;genótipos.</td><td class="diff_next"></td><td class="diff_header" id="to62_1515">1515</td><td nowrap="nowrap">cleotídicas&nbsp;dentro&nbsp;do&nbsp;mesmo&nbsp;genótipo&nbsp;e&nbsp;de&nbsp;20%&nbsp;a&nbsp;40%&nbsp;entre&nbsp;os&nbsp;diferentes&nbsp;genótipos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1540">1540</td><td nowrap="nowrap">O&nbsp;genótipo&nbsp;1&nbsp;é&nbsp;o&nbsp;mais&nbsp;presente&nbsp;no&nbsp;mundo,&nbsp;e&nbsp;existem&nbsp;evidências&nbsp;de&nbsp;que&nbsp;pode&nbsp;haver</td><td class="diff_next"></td><td class="diff_header" id="to62_1516">1516</td><td nowrap="nowrap">O&nbsp;genótipo&nbsp;1&nbsp;é&nbsp;o&nbsp;mais&nbsp;presente&nbsp;no&nbsp;mundo,&nbsp;e&nbsp;existem&nbsp;evidências&nbsp;de&nbsp;que&nbsp;pode&nbsp;haver</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1541">1541</td><td nowrap="nowrap">subtipos&nbsp;dentro&nbsp;desse&nbsp;genótipo.&nbsp;O&nbsp;genótipo&nbsp;2&nbsp;foi,&nbsp;originalmente,&nbsp;identificado&nbsp;no&nbsp;Japão,</td><td class="diff_next"></td><td class="diff_header" id="to62_1517">1517</td><td nowrap="nowrap">subtipos&nbsp;dentro&nbsp;desse&nbsp;genótipo.&nbsp;O&nbsp;genótipo&nbsp;2&nbsp;foi,&nbsp;originalmente,&nbsp;identificado&nbsp;no&nbsp;Japão,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1542">1542</td><td nowrap="nowrap">sendo&nbsp;encontrado,&nbsp;predominantemente,&nbsp;em&nbsp;Taiwan.&nbsp;Esse&nbsp;genótipo&nbsp;está&nbsp;associado&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_1518">1518</td><td nowrap="nowrap">sendo&nbsp;encontrado,&nbsp;predominantemente,&nbsp;em&nbsp;Taiwan.&nbsp;Esse&nbsp;genótipo&nbsp;está&nbsp;associado&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1543">1543</td><td nowrap="nowrap">uma&nbsp;doença&nbsp;menos&nbsp;agressiva&nbsp;do&nbsp;que&nbsp;a&nbsp;decorrente&nbsp;do&nbsp;genótipo&nbsp;1.&nbsp;Os&nbsp;outros&nbsp;genótipos,</td><td class="diff_next"></td><td class="diff_header" id="to62_1519">1519</td><td nowrap="nowrap">uma&nbsp;doença&nbsp;menos&nbsp;agressiva&nbsp;do&nbsp;que&nbsp;a&nbsp;decorrente&nbsp;do&nbsp;genótipo&nbsp;1.&nbsp;Os&nbsp;outros&nbsp;genótipos,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1544">1544</td><td nowrap="nowrap">em&nbsp;especial&nbsp;o&nbsp;genótipo&nbsp;3,&nbsp;foram&nbsp;identificados&nbsp;em&nbsp;surtos&nbsp;ocorridos&nbsp;em&nbsp;diferentes&nbsp;locais</td><td class="diff_next"></td><td class="diff_header" id="to62_1520">1520</td><td nowrap="nowrap">em&nbsp;especial&nbsp;o&nbsp;genótipo&nbsp;3,&nbsp;foram&nbsp;identificados&nbsp;em&nbsp;surtos&nbsp;ocorridos&nbsp;em&nbsp;diferentes&nbsp;locais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1545">1545</td><td nowrap="nowrap">do&nbsp;mundo,&nbsp;principalmente&nbsp;nos&nbsp;continentes&nbsp;americano&nbsp;e&nbsp;africano&nbsp;(ABBAS;&nbsp;AFZAL,&nbsp;2013;</td><td class="diff_next"></td><td class="diff_header" id="to62_1521">1521</td><td nowrap="nowrap">do&nbsp;mundo,&nbsp;principalmente&nbsp;nos&nbsp;continentes&nbsp;americano&nbsp;e&nbsp;africano&nbsp;(ABBAS;&nbsp;AFZAL,&nbsp;2013;</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1546">1546</td><td nowrap="nowrap">HADZIYANNIS,&nbsp;1997).</td><td class="diff_next"></td><td class="diff_header" id="to62_1522">1522</td><td nowrap="nowrap">HADZIYANNIS,&nbsp;1997).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1547">1547</td><td nowrap="nowrap">11.3&nbsp;Ciclo&nbsp;replicativo</td><td class="diff_next"></td><td class="diff_header" id="to62_1523">1523</td><td nowrap="nowrap">11.3&nbsp;Ciclo&nbsp;replicativo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1548">1548</td><td nowrap="nowrap">O&nbsp;vírion&nbsp;se&nbsp;liga&nbsp;ao&nbsp;hepatócito&nbsp;por&nbsp;interação&nbsp;entre&nbsp;o&nbsp;L-HBsAg&nbsp;e&nbsp;um&nbsp;receptor&nbsp;de&nbsp;mem-</td><td class="diff_next"></td><td class="diff_header" id="to62_1524">1524</td><td nowrap="nowrap">O&nbsp;vírion&nbsp;se&nbsp;liga&nbsp;ao&nbsp;hepatócito&nbsp;por&nbsp;interação&nbsp;entre&nbsp;o&nbsp;L-HBsAg&nbsp;e&nbsp;um&nbsp;receptor&nbsp;de&nbsp;mem-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1549">1549</td><td nowrap="nowrap">brana&nbsp;ainda&nbsp;não&nbsp;identificado;&nbsp;o&nbsp;material&nbsp;genético&nbsp;viral&nbsp;é&nbsp;então&nbsp;desnudado&nbsp;no&nbsp;citoplas-</td><td class="diff_next"></td><td class="diff_header" id="to62_1525">1525</td><td nowrap="nowrap">brana&nbsp;ainda&nbsp;não&nbsp;identificado;&nbsp;o&nbsp;material&nbsp;genético&nbsp;viral&nbsp;é&nbsp;então&nbsp;desnudado&nbsp;no&nbsp;citoplas-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1550">1550</td><td nowrap="nowrap">ma&nbsp;da&nbsp;célula.&nbsp;A&nbsp;ribonucleoproteínaG&nbsp;viral&nbsp;é&nbsp;direcionada&nbsp;ao&nbsp;núcleo,&nbsp;onde&nbsp;é&nbsp;transcrita&nbsp;na</td><td class="diff_next"></td><td class="diff_header" id="to62_1526">1526</td><td nowrap="nowrap">ma&nbsp;da&nbsp;célula.&nbsp;A&nbsp;ribonucleoproteínaG&nbsp;viral&nbsp;é&nbsp;direcionada&nbsp;ao&nbsp;núcleo,&nbsp;onde&nbsp;é&nbsp;transcrita&nbsp;na</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1551">1551</td><td nowrap="nowrap">forma&nbsp;de&nbsp;RNA&nbsp;antigenômico,&nbsp;que&nbsp;é&nbsp;o&nbsp;molde&nbsp;para&nbsp;a&nbsp;replicação&nbsp;de&nbsp;novas&nbsp;transcrições&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to62_1527">1527</td><td nowrap="nowrap">forma&nbsp;de&nbsp;RNA&nbsp;antigenômico,&nbsp;que&nbsp;é&nbsp;o&nbsp;molde&nbsp;para&nbsp;a&nbsp;replicação&nbsp;de&nbsp;novas&nbsp;transcrições&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1552">1552</td><td nowrap="nowrap">RNA&nbsp;circular&nbsp;viral.&nbsp;Os&nbsp;RNA&nbsp;mensageiros&nbsp;produzidos&nbsp;são&nbsp;transportados&nbsp;ao&nbsp;retículo&nbsp;endo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1528">1528</td><td nowrap="nowrap">RNA&nbsp;circular&nbsp;viral.&nbsp;Os&nbsp;RNA&nbsp;mensageiros&nbsp;produzidos&nbsp;são&nbsp;transportados&nbsp;ao&nbsp;retículo&nbsp;endo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1553">1553</td><td nowrap="nowrap">plasmático,&nbsp;onde&nbsp;são&nbsp;traduzidos&nbsp;sob&nbsp;a&nbsp;forma&nbsp;de&nbsp;novas&nbsp;moléculas&nbsp;do&nbsp;HDV-Ag,&nbsp;as&nbsp;quais</td><td class="diff_next"></td><td class="diff_header" id="to62_1529">1529</td><td nowrap="nowrap">plasmático,&nbsp;onde&nbsp;são&nbsp;traduzidos&nbsp;sob&nbsp;a&nbsp;forma&nbsp;de&nbsp;novas&nbsp;moléculas&nbsp;do&nbsp;HDV-Ag,&nbsp;as&nbsp;quais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1554">1554</td><td nowrap="nowrap">complexos&nbsp;ribonucleoproteicos.&nbsp;Os&nbsp;complexos&nbsp;são&nbsp;exportados&nbsp;para&nbsp;o&nbsp;citoplasma&nbsp;e&nbsp;se</td><td class="diff_next"></td><td class="diff_header" id="to62_1530">1530</td><td nowrap="nowrap">complexos&nbsp;ribonucleoproteicos.&nbsp;Os&nbsp;complexos&nbsp;são&nbsp;exportados&nbsp;para&nbsp;o&nbsp;citoplasma&nbsp;e&nbsp;se</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1555">1555</td><td nowrap="nowrap">associam&nbsp;às&nbsp;proteínas&nbsp;de&nbsp;envelope&nbsp;do&nbsp;HBV&nbsp;presentes&nbsp;no&nbsp;complexo&nbsp;golgiense,&nbsp;forman-</td><td class="diff_next"></td><td class="diff_header" id="to62_1531">1531</td><td nowrap="nowrap">associam&nbsp;às&nbsp;proteínas&nbsp;de&nbsp;envelope&nbsp;do&nbsp;HBV&nbsp;presentes&nbsp;no&nbsp;complexo&nbsp;golgiense,&nbsp;forman-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1556">1556</td><td nowrap="nowrap">do&nbsp;novas&nbsp;partículas&nbsp;virais,&nbsp;que&nbsp;são&nbsp;exocitadas&nbsp;pela&nbsp;via&nbsp;trans-Golgi.&nbsp;A&nbsp;Figura&nbsp;18&nbsp;mostra&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_1532">1532</td><td nowrap="nowrap">do&nbsp;novas&nbsp;partículas&nbsp;virais,&nbsp;que&nbsp;são&nbsp;exocitadas&nbsp;pela&nbsp;via&nbsp;trans-Golgi.&nbsp;A&nbsp;Figura&nbsp;18&nbsp;mostra&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1557">1557</td><td nowrap="nowrap">(HUGHES;&nbsp;WEDEMEYER;&nbsp;HARRISON,&nbsp;2011).</td><td class="diff_next"></td><td class="diff_header" id="to62_1533">1533</td><td nowrap="nowrap">(HUGHES;&nbsp;WEDEMEYER;&nbsp;HARRISON,&nbsp;2011).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1558">1558</td><td nowrap="nowrap">Figura&nbsp;18.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1534">1534</td><td nowrap="nowrap">Figura&nbsp;18.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;(HDV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1559">1559</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;HUGHES;&nbsp;WEDEMEYER;&nbsp;HARRISON,&nbsp;2011.</td><td class="diff_next"></td><td class="diff_header" id="to62_1535">1535</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;HUGHES;&nbsp;WEDEMEYER;&nbsp;HARRISON,&nbsp;2011.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1560">1560</td><td nowrap="nowrap">11.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td><td class="diff_next"></td><td class="diff_header" id="to62_1536">1536</td><td nowrap="nowrap">11.4&nbsp;História&nbsp;natural&nbsp;da&nbsp;doença</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1561">1561</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelo&nbsp;HDV&nbsp;é&nbsp;dependente&nbsp;de&nbsp;uma&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;associada.&nbsp;A&nbsp;evolu-</td><td class="diff_next"></td><td class="diff_header" id="to62_1537">1537</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelo&nbsp;HDV&nbsp;é&nbsp;dependente&nbsp;de&nbsp;uma&nbsp;infecção&nbsp;pelo&nbsp;HBV&nbsp;associada.&nbsp;A&nbsp;evolu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1562">1562</td><td nowrap="nowrap">ção&nbsp;da&nbsp;doença&nbsp;está&nbsp;relacionada&nbsp;ao&nbsp;contato&nbsp;inicial&nbsp;com&nbsp;os&nbsp;vírus.&nbsp;Caso&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HBV</td><td class="diff_next"></td><td class="diff_header" id="to62_1538">1538</td><td nowrap="nowrap">ção&nbsp;da&nbsp;doença&nbsp;está&nbsp;relacionada&nbsp;ao&nbsp;contato&nbsp;inicial&nbsp;com&nbsp;os&nbsp;vírus.&nbsp;Caso&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;HBV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1563">1563</td><td nowrap="nowrap">e&nbsp;pelo&nbsp;HDV&nbsp;seja&nbsp;simultânea,&nbsp;é&nbsp;denominada&nbsp;coinfecção.&nbsp;Caso&nbsp;uma&nbsp;pessoa,&nbsp;cronicamente</td><td class="diff_next"></td><td class="diff_header" id="to62_1539">1539</td><td nowrap="nowrap">e&nbsp;pelo&nbsp;HDV&nbsp;seja&nbsp;simultânea,&nbsp;é&nbsp;denominada&nbsp;coinfecção.&nbsp;Caso&nbsp;uma&nbsp;pessoa,&nbsp;cronicamente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1564">1564</td><td nowrap="nowrap">infectada&nbsp;com&nbsp;o&nbsp;HBV,&nbsp;seja,&nbsp;posteriormente,&nbsp;infectada&nbsp;com&nbsp;o&nbsp;HDV,&nbsp;ocorre&nbsp;o&nbsp;fenômeno&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1540">1540</td><td nowrap="nowrap">infectada&nbsp;com&nbsp;o&nbsp;HBV,&nbsp;seja,&nbsp;posteriormente,&nbsp;infectada&nbsp;com&nbsp;o&nbsp;HDV,&nbsp;ocorre&nbsp;o&nbsp;fenômeno&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1565">1565</td><td nowrap="nowrap">superinfecção&nbsp;(ALVARADO-MORA&nbsp;et&nbsp;al.,&nbsp;2013;&nbsp;WHO,&nbsp;2017b).</td><td class="diff_next"></td><td class="diff_header" id="to62_1541">1541</td><td nowrap="nowrap">superinfecção&nbsp;(ALVARADO-MORA&nbsp;et&nbsp;al.,&nbsp;2013;&nbsp;WHO,&nbsp;2017b).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1566">1566</td><td nowrap="nowrap">O&nbsp;resultado&nbsp;da&nbsp;coinfecção&nbsp;é&nbsp;um&nbsp;estado&nbsp;agudo&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;D.&nbsp;O&nbsp;tempo&nbsp;de&nbsp;incu-</td><td class="diff_next"></td><td class="diff_header" id="to62_1542">1542</td><td nowrap="nowrap">O&nbsp;resultado&nbsp;da&nbsp;coinfecção&nbsp;é&nbsp;um&nbsp;estado&nbsp;agudo&nbsp;das&nbsp;hepatites&nbsp;B&nbsp;e&nbsp;D.&nbsp;O&nbsp;tempo&nbsp;de&nbsp;incu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1567">1567</td><td nowrap="nowrap">bação&nbsp;é&nbsp;dependente&nbsp;do&nbsp;título&nbsp;do&nbsp;inóculo&nbsp;inicial&nbsp;e,&nbsp;normalmente,&nbsp;a&nbsp;coinfecção&nbsp;é&nbsp;um&nbsp;esta-</td><td class="diff_next"></td><td class="diff_header" id="to62_1543">1543</td><td nowrap="nowrap">bação&nbsp;é&nbsp;dependente&nbsp;do&nbsp;título&nbsp;do&nbsp;inóculo&nbsp;inicial&nbsp;e,&nbsp;normalmente,&nbsp;a&nbsp;coinfecção&nbsp;é&nbsp;um&nbsp;esta-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1568">1568</td><td nowrap="nowrap">do&nbsp;autolimitado.&nbsp;Menos&nbsp;de&nbsp;5%&nbsp;das&nbsp;pessoas&nbsp;coinfectadas&nbsp;desenvolvem&nbsp;a&nbsp;forma&nbsp;crônica</td><td class="diff_next"></td><td class="diff_header" id="to62_1544">1544</td><td nowrap="nowrap">do&nbsp;autolimitado.&nbsp;Menos&nbsp;de&nbsp;5%&nbsp;das&nbsp;pessoas&nbsp;coinfectadas&nbsp;desenvolvem&nbsp;a&nbsp;forma&nbsp;crônica</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1569">1569</td><td nowrap="nowrap">da&nbsp;doença.&nbsp;Os&nbsp;sintomas&nbsp;surgem&nbsp;entre&nbsp;três&nbsp;a&nbsp;sete&nbsp;dias&nbsp;após&nbsp;a&nbsp;infecção&nbsp;e&nbsp;incluem&nbsp;fadiga,</td><td class="diff_next"></td><td class="diff_header" id="to62_1545">1545</td><td nowrap="nowrap">da&nbsp;doença.&nbsp;Os&nbsp;sintomas&nbsp;surgem&nbsp;entre&nbsp;três&nbsp;a&nbsp;sete&nbsp;dias&nbsp;após&nbsp;a&nbsp;infecção&nbsp;e&nbsp;incluem&nbsp;fadiga,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1570">1570</td><td nowrap="nowrap">anorexia,&nbsp;náuseas&nbsp;e&nbsp;icterícia.&nbsp;Os&nbsp;níveis&nbsp;de&nbsp;transaminases&nbsp;sofrem&nbsp;alteração&nbsp;durante&nbsp;esse</td><td class="diff_next"></td><td class="diff_header" id="to62_1546">1546</td><td nowrap="nowrap">anorexia,&nbsp;náuseas&nbsp;e&nbsp;icterícia.&nbsp;Os&nbsp;níveis&nbsp;de&nbsp;transaminases&nbsp;sofrem&nbsp;alteração&nbsp;durante&nbsp;esse</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1571">1571</td><td nowrap="nowrap">período.&nbsp;Nos&nbsp;pacientes&nbsp;que&nbsp;não&nbsp;desenvolvem&nbsp;a&nbsp;forma&nbsp;crônica&nbsp;da&nbsp;doença,&nbsp;os&nbsp;sintomas</td><td class="diff_next"></td><td class="diff_header" id="to62_1547">1547</td><td nowrap="nowrap">período.&nbsp;Nos&nbsp;pacientes&nbsp;que&nbsp;não&nbsp;desenvolvem&nbsp;a&nbsp;forma&nbsp;crônica&nbsp;da&nbsp;doença,&nbsp;os&nbsp;sintomas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1572">1572</td><td nowrap="nowrap">clínicos&nbsp;desaparecem&nbsp;após&nbsp;esse&nbsp;intervalo&nbsp;de&nbsp;tempo.</td><td class="diff_next"></td><td class="diff_header" id="to62_1548">1548</td><td nowrap="nowrap">clínicos&nbsp;desaparecem&nbsp;após&nbsp;esse&nbsp;intervalo&nbsp;de&nbsp;tempo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1573">1573</td><td nowrap="nowrap">A&nbsp;superinfecção&nbsp;causa&nbsp;um&nbsp;quadro&nbsp;de&nbsp;hepatite&nbsp;aguda&nbsp;grave,&nbsp;com&nbsp;um&nbsp;período&nbsp;de&nbsp;in-</td><td class="diff_next"></td><td class="diff_header" id="to62_1549">1549</td><td nowrap="nowrap">A&nbsp;superinfecção&nbsp;causa&nbsp;um&nbsp;quadro&nbsp;de&nbsp;hepatite&nbsp;aguda&nbsp;grave,&nbsp;com&nbsp;um&nbsp;período&nbsp;de&nbsp;in-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1574">1574</td><td nowrap="nowrap">cubação&nbsp;curto,&nbsp;que&nbsp;leva&nbsp;à&nbsp;cronificação&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;em&nbsp;80%&nbsp;dos&nbsp;casos.&nbsp;A&nbsp;superinfecção</td><td class="diff_next"></td><td class="diff_header" id="to62_1550">1550</td><td nowrap="nowrap">cubação&nbsp;curto,&nbsp;que&nbsp;leva&nbsp;à&nbsp;cronificação&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;em&nbsp;80%&nbsp;dos&nbsp;casos.&nbsp;A&nbsp;superinfecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1575">1575</td><td nowrap="nowrap">é&nbsp;associada&nbsp;a&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;fulminante&nbsp;e&nbsp;a&nbsp;hepatite&nbsp;crônica&nbsp;severa,&nbsp;frequentemente</td><td class="diff_next"></td><td class="diff_header" id="to62_1551">1551</td><td nowrap="nowrap">é&nbsp;associada&nbsp;a&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;fulminante&nbsp;e&nbsp;a&nbsp;hepatite&nbsp;crônica&nbsp;severa,&nbsp;frequentemente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1576">1576</td><td nowrap="nowrap">evoluindo&nbsp;para&nbsp;cirrose&nbsp;hepática.&nbsp;A&nbsp;hepatite&nbsp;D&nbsp;crônica,&nbsp;normalmente,&nbsp;inicia-se&nbsp;com&nbsp;um</td><td class="diff_next"></td><td class="diff_header" id="to62_1552">1552</td><td nowrap="nowrap">evoluindo&nbsp;para&nbsp;cirrose&nbsp;hepática.&nbsp;A&nbsp;hepatite&nbsp;D&nbsp;crônica,&nbsp;normalmente,&nbsp;inicia-se&nbsp;com&nbsp;um</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1577">1577</td><td nowrap="nowrap">quadro&nbsp;clínico&nbsp;semelhante&nbsp;ao&nbsp;da&nbsp;infecção&nbsp;aguda.&nbsp;Os&nbsp;sintomas&nbsp;clínicos&nbsp;são&nbsp;mais&nbsp;leves</td><td class="diff_next"></td><td class="diff_header" id="to62_1553">1553</td><td nowrap="nowrap">quadro&nbsp;clínico&nbsp;semelhante&nbsp;ao&nbsp;da&nbsp;infecção&nbsp;aguda.&nbsp;Os&nbsp;sintomas&nbsp;clínicos&nbsp;são&nbsp;mais&nbsp;leves</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1578">1578</td><td nowrap="nowrap">que&nbsp;na&nbsp;doença&nbsp;aguda,&nbsp;enquanto&nbsp;os&nbsp;níveis&nbsp;de&nbsp;transaminases&nbsp;sofrem&nbsp;elevação.&nbsp;Na&nbsp;hepa-</td><td class="diff_next"></td><td class="diff_header" id="to62_1554">1554</td><td nowrap="nowrap">que&nbsp;na&nbsp;doença&nbsp;aguda,&nbsp;enquanto&nbsp;os&nbsp;níveis&nbsp;de&nbsp;transaminases&nbsp;sofrem&nbsp;elevação.&nbsp;Na&nbsp;hepa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1579">1579</td><td nowrap="nowrap">tite&nbsp;D&nbsp;crônica,&nbsp;os&nbsp;marcadores&nbsp;do&nbsp;HBV&nbsp;podem&nbsp;ser&nbsp;inibidos.&nbsp;A&nbsp;evolução&nbsp;para&nbsp;cirrose&nbsp;costu-</td><td class="diff_next"></td><td class="diff_header" id="to62_1555">1555</td><td nowrap="nowrap">tite&nbsp;D&nbsp;crônica,&nbsp;os&nbsp;marcadores&nbsp;do&nbsp;HBV&nbsp;podem&nbsp;ser&nbsp;inibidos.&nbsp;A&nbsp;evolução&nbsp;para&nbsp;cirrose&nbsp;costu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1580">1580</td><td nowrap="nowrap">ma&nbsp;ocorrer&nbsp;em&nbsp;um&nbsp;período&nbsp;de&nbsp;dois&nbsp;anos&nbsp;após&nbsp;a&nbsp;infecção&nbsp;e,&nbsp;aproximadamente,&nbsp;70%&nbsp;dos</td><td class="diff_next"></td><td class="diff_header" id="to62_1556">1556</td><td nowrap="nowrap">ma&nbsp;ocorrer&nbsp;em&nbsp;um&nbsp;período&nbsp;de&nbsp;dois&nbsp;anos&nbsp;após&nbsp;a&nbsp;infecção&nbsp;e,&nbsp;aproximadamente,&nbsp;70%&nbsp;dos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1581">1581</td><td nowrap="nowrap">pacientes&nbsp;crônicos&nbsp;desenvolvem&nbsp;essa&nbsp;condição.&nbsp;A&nbsp;mortalidade&nbsp;nas&nbsp;infecções&nbsp;pelo&nbsp;HDV</td><td class="diff_next"></td><td class="diff_header" id="to62_1557">1557</td><td nowrap="nowrap">pacientes&nbsp;crônicos&nbsp;desenvolvem&nbsp;essa&nbsp;condição.&nbsp;A&nbsp;mortalidade&nbsp;nas&nbsp;infecções&nbsp;pelo&nbsp;HDV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1582">1582</td><td nowrap="nowrap">varia&nbsp;entre&nbsp;2%&nbsp;e&nbsp;20%,&nbsp;sendo&nbsp;cerca&nbsp;de&nbsp;dez&nbsp;vezes&nbsp;maior&nbsp;que&nbsp;na&nbsp;hepatite&nbsp;B&nbsp;isoladamente</td><td class="diff_next"></td><td class="diff_header" id="to62_1558">1558</td><td nowrap="nowrap">varia&nbsp;entre&nbsp;2%&nbsp;e&nbsp;20%,&nbsp;sendo&nbsp;cerca&nbsp;de&nbsp;dez&nbsp;vezes&nbsp;maior&nbsp;que&nbsp;na&nbsp;hepatite&nbsp;B&nbsp;isoladamente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1583">1583</td><td nowrap="nowrap">(WHO,&nbsp;2017b).</td><td class="diff_next"></td><td class="diff_header" id="to62_1559">1559</td><td nowrap="nowrap">(WHO,&nbsp;2017b).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1584">1584</td><td nowrap="nowrap">11.5&nbsp;Resposta&nbsp;imune</td><td class="diff_next"></td><td class="diff_header" id="to62_1560">1560</td><td nowrap="nowrap">11.5&nbsp;Resposta&nbsp;imune</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1585">1585</td><td nowrap="nowrap">A&nbsp;resposta&nbsp;imune&nbsp;durante&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;total-</td><td class="diff_next"></td><td class="diff_header" id="to62_1561">1561</td><td nowrap="nowrap">A&nbsp;resposta&nbsp;imune&nbsp;durante&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;D&nbsp;ainda&nbsp;não&nbsp;foi&nbsp;total-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1586">1586</td><td nowrap="nowrap">mente&nbsp;compreendida.&nbsp;A&nbsp;patogenia&nbsp;é&nbsp;mediada&nbsp;pelo&nbsp;sistema&nbsp;imune,&nbsp;o&nbsp;qual&nbsp;é&nbsp;responsável</td><td class="diff_next"></td><td class="diff_header" id="to62_1562">1562</td><td nowrap="nowrap">mente&nbsp;compreendida.&nbsp;A&nbsp;patogenia&nbsp;é&nbsp;mediada&nbsp;pelo&nbsp;sistema&nbsp;imune,&nbsp;o&nbsp;qual&nbsp;é&nbsp;responsável</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1587">1587</td><td nowrap="nowrap">pelos&nbsp;efeitos&nbsp;citotóxicos&nbsp;no&nbsp;fígado&nbsp;do&nbsp;infectado.&nbsp;O&nbsp;HDV-Ag&nbsp;é&nbsp;capaz&nbsp;de&nbsp;estimular&nbsp;uma</td><td class="diff_next"></td><td class="diff_header" id="to62_1563">1563</td><td nowrap="nowrap">pelos&nbsp;efeitos&nbsp;citotóxicos&nbsp;no&nbsp;fígado&nbsp;do&nbsp;infectado.&nbsp;O&nbsp;HDV-Ag&nbsp;é&nbsp;capaz&nbsp;de&nbsp;estimular&nbsp;uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1588">1588</td><td nowrap="nowrap">resposta&nbsp;humoral&nbsp;IgM&nbsp;e&nbsp;IgG.&nbsp;Estudos&nbsp;em&nbsp;chimpanzés&nbsp;demonstram&nbsp;que&nbsp;a&nbsp;infecção&nbsp;resol-</td><td class="diff_next"></td><td class="diff_header" id="to62_1564">1564</td><td nowrap="nowrap">resposta&nbsp;humoral&nbsp;IgM&nbsp;e&nbsp;IgG.&nbsp;Estudos&nbsp;em&nbsp;chimpanzés&nbsp;demonstram&nbsp;que&nbsp;a&nbsp;infecção&nbsp;resol-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1589">1589</td><td nowrap="nowrap">vida&nbsp;pelo&nbsp;HDV&nbsp;é&nbsp;capaz&nbsp;de&nbsp;conferir&nbsp;proteção&nbsp;contra&nbsp;uma&nbsp;reinfecção&nbsp;precoce.&nbsp;O&nbsp;escape</td><td class="diff_next"></td><td class="diff_header" id="to62_1565">1565</td><td nowrap="nowrap">vida&nbsp;pelo&nbsp;HDV&nbsp;é&nbsp;capaz&nbsp;de&nbsp;conferir&nbsp;proteção&nbsp;contra&nbsp;uma&nbsp;reinfecção&nbsp;precoce.&nbsp;O&nbsp;escape</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1590">1590</td><td nowrap="nowrap">imunológico&nbsp;do&nbsp;vírus&nbsp;se&nbsp;dá&nbsp;em&nbsp;virtude&nbsp;de&nbsp;sua&nbsp;grande&nbsp;variabilidade&nbsp;genética&nbsp;(SMEDILE</td><td class="diff_next"></td><td class="diff_header" id="to62_1566">1566</td><td nowrap="nowrap">imunológico&nbsp;do&nbsp;vírus&nbsp;se&nbsp;dá&nbsp;em&nbsp;virtude&nbsp;de&nbsp;sua&nbsp;grande&nbsp;variabilidade&nbsp;genética&nbsp;(SMEDILE</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1591">1591</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1567">1567</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1592">1592</td><td nowrap="nowrap">11.6&nbsp;Diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_1568">1568</td><td nowrap="nowrap">11.6&nbsp;Diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1593">1593</td><td nowrap="nowrap">anti-HDV&nbsp;quanto&nbsp;pela&nbsp;pesquisa&nbsp;de&nbsp;marcadores&nbsp;diretos,&nbsp;como&nbsp;o&nbsp;antígeno&nbsp;do&nbsp;HDV,&nbsp;e&nbsp;pela</td><td class="diff_next"></td><td class="diff_header" id="to62_1569">1569</td><td nowrap="nowrap">anti-HDV&nbsp;quanto&nbsp;pela&nbsp;pesquisa&nbsp;de&nbsp;marcadores&nbsp;diretos,&nbsp;como&nbsp;o&nbsp;antígeno&nbsp;do&nbsp;HDV,&nbsp;e&nbsp;pela</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1594">1594</td><td nowrap="nowrap">detecção&nbsp;do&nbsp;genoma&nbsp;viral&nbsp;circulante&nbsp;(CIANCIO;&nbsp;RIZZETTO,&nbsp;2014;&nbsp;SMEDILE&nbsp;et&nbsp;al.,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1570">1570</td><td nowrap="nowrap">detecção&nbsp;do&nbsp;genoma&nbsp;viral&nbsp;circulante&nbsp;(CIANCIO;&nbsp;RIZZETTO,&nbsp;2014;&nbsp;SMEDILE&nbsp;et&nbsp;al.,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1595">1595</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;D&nbsp;deve&nbsp;ser&nbsp;investigada&nbsp;em&nbsp;indivíduos&nbsp;que&nbsp;apresentem&nbsp;resultados&nbsp;rea-</td><td class="diff_next"></td><td class="diff_header" id="to62_1571">1571</td><td nowrap="nowrap">A&nbsp;hepatite&nbsp;D&nbsp;deve&nbsp;ser&nbsp;investigada&nbsp;em&nbsp;indivíduos&nbsp;que&nbsp;apresentem&nbsp;resultados&nbsp;rea-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1596">1596</td><td nowrap="nowrap">gentes&nbsp;em&nbsp;imunoensaios&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;que&nbsp;residam&nbsp;ou&nbsp;tenham&nbsp;estado&nbsp;em&nbsp;áreas&nbsp;en-</td><td class="diff_next"></td><td class="diff_header" id="to62_1572">1572</td><td nowrap="nowrap">gentes&nbsp;em&nbsp;imunoensaios&nbsp;para&nbsp;o&nbsp;HBsAg&nbsp;e&nbsp;que&nbsp;residam&nbsp;ou&nbsp;tenham&nbsp;estado&nbsp;em&nbsp;áreas&nbsp;en-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1597">1597</td><td nowrap="nowrap">dêmicas&nbsp;para&nbsp;esse&nbsp;agravo.</td><td class="diff_next"></td><td class="diff_header" id="to62_1573">1573</td><td nowrap="nowrap">dêmicas&nbsp;para&nbsp;esse&nbsp;agravo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1598">1598</td><td nowrap="nowrap">12.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;E&nbsp;(HEV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1574">1574</td><td nowrap="nowrap">12.&nbsp;VÍRUS&nbsp;DA&nbsp;HEPATITE&nbsp;E&nbsp;(HEV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1599">1599</td><td nowrap="nowrap">O&nbsp;HEV&nbsp;é&nbsp;um&nbsp;vírus&nbsp;de&nbsp;transmissão&nbsp;fecal-oral.&nbsp;Essa&nbsp;via&nbsp;de&nbsp;transmissão&nbsp;favorece&nbsp;a&nbsp;dis-</td><td class="diff_next"></td><td class="diff_header" id="to62_1575">1575</td><td nowrap="nowrap">O&nbsp;HEV&nbsp;é&nbsp;um&nbsp;vírus&nbsp;de&nbsp;transmissão&nbsp;fecal-oral.&nbsp;Essa&nbsp;via&nbsp;de&nbsp;transmissão&nbsp;favorece&nbsp;a&nbsp;dis-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1600">1600</td><td nowrap="nowrap">seminação&nbsp;da&nbsp;infecção&nbsp;nos&nbsp;países&nbsp;em&nbsp;desenvolvimento,&nbsp;nos&nbsp;quais&nbsp;a&nbsp;contaminação&nbsp;dos</td><td class="diff_next"></td><td class="diff_header" id="to62_1576">1576</td><td nowrap="nowrap">seminação&nbsp;da&nbsp;infecção&nbsp;nos&nbsp;países&nbsp;em&nbsp;desenvolvimento,&nbsp;nos&nbsp;quais&nbsp;a&nbsp;contaminação&nbsp;dos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1601">1601</td><td nowrap="nowrap">reservatórios&nbsp;de&nbsp;água&nbsp;mantém&nbsp;a&nbsp;cadeia&nbsp;de&nbsp;transmissão&nbsp;da&nbsp;doença.&nbsp;A&nbsp;transmissão&nbsp;inter-</td><td class="diff_next"></td><td class="diff_header" id="to62_1577">1577</td><td nowrap="nowrap">reservatórios&nbsp;de&nbsp;água&nbsp;mantém&nbsp;a&nbsp;cadeia&nbsp;de&nbsp;transmissão&nbsp;da&nbsp;doença.&nbsp;A&nbsp;transmissão&nbsp;inter-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1602">1602</td><td nowrap="nowrap">pessoal&nbsp;não&nbsp;é&nbsp;comum.&nbsp;Em&nbsp;alguns&nbsp;casos,&nbsp;os&nbsp;fatores&nbsp;de&nbsp;risco&nbsp;não&nbsp;puderam&nbsp;ser&nbsp;identifica-</td><td class="diff_next"></td><td class="diff_header" id="to62_1578">1578</td><td nowrap="nowrap">pessoal&nbsp;não&nbsp;é&nbsp;comum.&nbsp;Em&nbsp;alguns&nbsp;casos,&nbsp;os&nbsp;fatores&nbsp;de&nbsp;risco&nbsp;não&nbsp;puderam&nbsp;ser&nbsp;identifica-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1603">1603</td><td nowrap="nowrap">dos.&nbsp;A&nbsp;doença&nbsp;é&nbsp;autolimitada&nbsp;e&nbsp;pode&nbsp;apresentar&nbsp;formas&nbsp;clínicas&nbsp;graves,&nbsp;principalmente</td><td class="diff_next"></td><td class="diff_header" id="to62_1579">1579</td><td nowrap="nowrap">dos.&nbsp;A&nbsp;doença&nbsp;é&nbsp;autolimitada&nbsp;e&nbsp;pode&nbsp;apresentar&nbsp;formas&nbsp;clínicas&nbsp;graves,&nbsp;principalmente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1604">1604</td><td nowrap="nowrap">em&nbsp;gestantes.&nbsp;Essa&nbsp;forma&nbsp;de&nbsp;hepatite&nbsp;viral&nbsp;é&nbsp;mais&nbsp;comum&nbsp;em&nbsp;países&nbsp;na&nbsp;Ásia&nbsp;e&nbsp;África,</td><td class="diff_next"></td><td class="diff_header" id="to62_1580">1580</td><td nowrap="nowrap">em&nbsp;gestantes.&nbsp;Essa&nbsp;forma&nbsp;de&nbsp;hepatite&nbsp;viral&nbsp;é&nbsp;mais&nbsp;comum&nbsp;em&nbsp;países&nbsp;na&nbsp;Ásia&nbsp;e&nbsp;África,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1605">1605</td><td nowrap="nowrap">principalmente&nbsp;na&nbsp;Índia&nbsp;(BRASIL,&nbsp;2009).</td><td class="diff_next"></td><td class="diff_header" id="to62_1581">1581</td><td nowrap="nowrap">principalmente&nbsp;na&nbsp;Índia&nbsp;(BRASIL,&nbsp;2009).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1606">1606</td><td nowrap="nowrap">12.1&nbsp;Partícula&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_1582">1582</td><td nowrap="nowrap">12.1&nbsp;Partícula&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1607">1607</td><td nowrap="nowrap">O&nbsp;HEV&nbsp;pertence&nbsp;ao&nbsp;gênero&nbsp;Hepevirus,&nbsp;família&nbsp;Hepeviridae&nbsp;(ICTV,&nbsp;2014).&nbsp;O&nbsp;HEV&nbsp;é&nbsp;um</td><td class="diff_next"></td><td class="diff_header" id="to62_1583">1583</td><td nowrap="nowrap">O&nbsp;HEV&nbsp;pertence&nbsp;ao&nbsp;gênero&nbsp;Hepevirus,&nbsp;família&nbsp;Hepeviridae&nbsp;(ICTV,&nbsp;2014).&nbsp;O&nbsp;HEV&nbsp;é&nbsp;um</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1608">1608</td><td nowrap="nowrap">vírus&nbsp;pequeno,&nbsp;não&nbsp;envelopado,&nbsp;com&nbsp;capsídeo&nbsp;icosaédrico&nbsp;de,&nbsp;aproximadamente,&nbsp;27-</td><td class="diff_next"></td><td class="diff_header" id="to62_1584">1584</td><td nowrap="nowrap">vírus&nbsp;pequeno,&nbsp;não&nbsp;envelopado,&nbsp;com&nbsp;capsídeo&nbsp;icosaédrico&nbsp;de,&nbsp;aproximadamente,&nbsp;27-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1609">1609</td><td nowrap="nowrap">34nm&nbsp;de&nbsp;diâmetro&nbsp;(Figura&nbsp;19)&nbsp;(MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014;&nbsp;FOCCACIA,&nbsp;2007).</td><td class="diff_next"></td><td class="diff_header" id="to62_1585">1585</td><td nowrap="nowrap">34nm&nbsp;de&nbsp;diâmetro&nbsp;(Figura&nbsp;19)&nbsp;(MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014;&nbsp;FOCCACIA,&nbsp;2007).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1610">1610</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;é&nbsp;formado&nbsp;por&nbsp;uma&nbsp;fita&nbsp;simples&nbsp;de&nbsp;RNA&nbsp;positiva,&nbsp;com&nbsp;cerca&nbsp;de&nbsp;7.200&nbsp;nu-</td><td class="diff_next"></td><td class="diff_header" id="to62_1586">1586</td><td nowrap="nowrap">O&nbsp;genoma&nbsp;é&nbsp;formado&nbsp;por&nbsp;uma&nbsp;fita&nbsp;simples&nbsp;de&nbsp;RNA&nbsp;positiva,&nbsp;com&nbsp;cerca&nbsp;de&nbsp;7.200&nbsp;nu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1611">1611</td><td nowrap="nowrap">cleotídeos,&nbsp;que&nbsp;apresenta&nbsp;três&nbsp;fases&nbsp;de&nbsp;leitura&nbsp;aberta&nbsp;(ORF)&nbsp;descontínuas&nbsp;e&nbsp;parcialmente</td><td class="diff_next"></td><td class="diff_header" id="to62_1587">1587</td><td nowrap="nowrap">cleotídeos,&nbsp;que&nbsp;apresenta&nbsp;três&nbsp;fases&nbsp;de&nbsp;leitura&nbsp;aberta&nbsp;(ORF)&nbsp;descontínuas&nbsp;e&nbsp;parcialmente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1612">1612</td><td nowrap="nowrap">sobrepostas.&nbsp;A&nbsp;ORF1&nbsp;codifica&nbsp;as&nbsp;sete&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;e&nbsp;está&nbsp;envolvida&nbsp;na&nbsp;repli-</td><td class="diff_next"></td><td class="diff_header" id="to62_1588">1588</td><td nowrap="nowrap">sobrepostas.&nbsp;A&nbsp;ORF1&nbsp;codifica&nbsp;as&nbsp;sete&nbsp;proteínas&nbsp;não&nbsp;estruturais&nbsp;e&nbsp;está&nbsp;envolvida&nbsp;na&nbsp;repli-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1613">1613</td><td nowrap="nowrap">cação&nbsp;viral&nbsp;e&nbsp;no&nbsp;processamento&nbsp;de&nbsp;proteínas&nbsp;virais,&nbsp;incluindo&nbsp;a&nbsp;codificação&nbsp;de&nbsp;uma&nbsp;RNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1589">1589</td><td nowrap="nowrap">cação&nbsp;viral&nbsp;e&nbsp;no&nbsp;processamento&nbsp;de&nbsp;proteínas&nbsp;virais,&nbsp;incluindo&nbsp;a&nbsp;codificação&nbsp;de&nbsp;uma&nbsp;RNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1614">1614</td><td nowrap="nowrap">helicase,&nbsp;uma&nbsp;RNA&nbsp;polimerase&nbsp;dependente&nbsp;do&nbsp;RNA&nbsp;(RpRd),&nbsp;uma&nbsp;metiltransferase,&nbsp;uma</td><td class="diff_next"></td><td class="diff_header" id="to62_1590">1590</td><td nowrap="nowrap">helicase,&nbsp;uma&nbsp;RNA&nbsp;polimerase&nbsp;dependente&nbsp;do&nbsp;RNA&nbsp;(RpRd),&nbsp;uma&nbsp;metiltransferase,&nbsp;uma</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1615">1615</td><td nowrap="nowrap">cisteína&nbsp;protease&nbsp;e&nbsp;uma&nbsp;guanilil&nbsp;protease.&nbsp;A&nbsp;ORF2&nbsp;codifica&nbsp;as&nbsp;proteínas&nbsp;do&nbsp;capsídeo&nbsp;viral</td><td class="diff_next"></td><td class="diff_header" id="to62_1591">1591</td><td nowrap="nowrap">cisteína&nbsp;protease&nbsp;e&nbsp;uma&nbsp;guanilil&nbsp;protease.&nbsp;A&nbsp;ORF2&nbsp;codifica&nbsp;as&nbsp;proteínas&nbsp;do&nbsp;capsídeo&nbsp;viral</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1616">1616</td><td nowrap="nowrap">(pORF2)&nbsp;e&nbsp;contém&nbsp;epitoposG&nbsp;importantes,&nbsp;que&nbsp;podem&nbsp;induzir&nbsp;a&nbsp;produção&nbsp;de&nbsp;anticor-</td><td class="diff_next"></td><td class="diff_header" id="to62_1592">1592</td><td nowrap="nowrap">(pORF2)&nbsp;e&nbsp;contém&nbsp;epitoposG&nbsp;importantes,&nbsp;que&nbsp;podem&nbsp;induzir&nbsp;a&nbsp;produção&nbsp;de&nbsp;anticor-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1617">1617</td><td nowrap="nowrap">pos&nbsp;neutralizantes.&nbsp;A&nbsp;ORF3&nbsp;se&nbsp;sobrepõe&nbsp;às&nbsp;duas&nbsp;outras&nbsp;ORF&nbsp;e&nbsp;codifica&nbsp;uma&nbsp;fosfoproteína</td><td class="diff_next"></td><td class="diff_header" id="to62_1593">1593</td><td nowrap="nowrap">pos&nbsp;neutralizantes.&nbsp;A&nbsp;ORF3&nbsp;se&nbsp;sobrepõe&nbsp;às&nbsp;duas&nbsp;outras&nbsp;ORF&nbsp;e&nbsp;codifica&nbsp;uma&nbsp;fosfoproteína</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1618">1618</td><td nowrap="nowrap">(pORF3),&nbsp;que&nbsp;é&nbsp;expressa&nbsp;intracelularmente&nbsp;e&nbsp;é&nbsp;capaz&nbsp;de&nbsp;se&nbsp;ligar&nbsp;ao&nbsp;citoesqueleto&nbsp;das</td><td class="diff_next"></td><td class="diff_header" id="to62_1594">1594</td><td nowrap="nowrap">(pORF3),&nbsp;que&nbsp;é&nbsp;expressa&nbsp;intracelularmente&nbsp;e&nbsp;é&nbsp;capaz&nbsp;de&nbsp;se&nbsp;ligar&nbsp;ao&nbsp;citoesqueleto&nbsp;das</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1619">1619</td><td nowrap="nowrap">células&nbsp;hepáticas,&nbsp;servindo&nbsp;como&nbsp;um&nbsp;âncora&nbsp;à&nbsp;qual&nbsp;a&nbsp;pORF2&nbsp;e&nbsp;o&nbsp;RNA&nbsp;podem&nbsp;se&nbsp;ligar&nbsp;para</td><td class="diff_next"></td><td class="diff_header" id="to62_1595">1595</td><td nowrap="nowrap">células&nbsp;hepáticas,&nbsp;servindo&nbsp;como&nbsp;um&nbsp;âncora&nbsp;à&nbsp;qual&nbsp;a&nbsp;pORF2&nbsp;e&nbsp;o&nbsp;RNA&nbsp;podem&nbsp;se&nbsp;ligar&nbsp;para</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1620">1620</td><td nowrap="nowrap">iniciar&nbsp;o&nbsp;processo&nbsp;de&nbsp;estruturação&nbsp;do&nbsp;nucleocapsídeo&nbsp;viral&nbsp;(PARVEZ,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1596">1596</td><td nowrap="nowrap">iniciar&nbsp;o&nbsp;processo&nbsp;de&nbsp;estruturação&nbsp;do&nbsp;nucleocapsídeo&nbsp;viral&nbsp;(PARVEZ,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1621">1621</td><td nowrap="nowrap">Figura&nbsp;19.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1597">1597</td><td nowrap="nowrap">Figura&nbsp;19.&nbsp;Representação&nbsp;esquemática&nbsp;da&nbsp;estrutura&nbsp;da&nbsp;partícula&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1622">1622</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_1598">1598</td><td nowrap="nowrap">Fonte:&nbsp;BRASIL,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1623">1623</td><td nowrap="nowrap">12.2&nbsp;Variabilidade&nbsp;genética</td><td class="diff_next"></td><td class="diff_header" id="to62_1599">1599</td><td nowrap="nowrap">12.2&nbsp;Variabilidade&nbsp;genética</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1624">1624</td><td nowrap="nowrap">englobando&nbsp;as&nbsp;regiões&nbsp;ORF1&nbsp;e&nbsp;ORF2,&nbsp;o&nbsp;HEV&nbsp;pode&nbsp;ser&nbsp;classificado&nbsp;em&nbsp;um&nbsp;único&nbsp;sorotipo,</td><td class="diff_next"></td><td class="diff_header" id="to62_1600">1600</td><td nowrap="nowrap">englobando&nbsp;as&nbsp;regiões&nbsp;ORF1&nbsp;e&nbsp;ORF2,&nbsp;o&nbsp;HEV&nbsp;pode&nbsp;ser&nbsp;classificado&nbsp;em&nbsp;um&nbsp;único&nbsp;sorotipo,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1625">1625</td><td nowrap="nowrap">o&nbsp;qual,&nbsp;por&nbsp;sua&nbsp;vez,&nbsp;pode&nbsp;ser&nbsp;dividido&nbsp;em&nbsp;quatro&nbsp;genótipos&nbsp;principais.&nbsp;Os&nbsp;genótipos&nbsp;1&nbsp;e&nbsp;2</td><td class="diff_next"></td><td class="diff_header" id="to62_1601">1601</td><td nowrap="nowrap">o&nbsp;qual,&nbsp;por&nbsp;sua&nbsp;vez,&nbsp;pode&nbsp;ser&nbsp;dividido&nbsp;em&nbsp;quatro&nbsp;genótipos&nbsp;principais.&nbsp;Os&nbsp;genótipos&nbsp;1&nbsp;e&nbsp;2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1626">1626</td><td nowrap="nowrap">podem&nbsp;ainda&nbsp;ser&nbsp;subclassificados&nbsp;em&nbsp;subtipos,&nbsp;de&nbsp;acordo&nbsp;com&nbsp;cinco&nbsp;reconstruções&nbsp;filo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1602">1602</td><td nowrap="nowrap">podem&nbsp;ainda&nbsp;ser&nbsp;subclassificados&nbsp;em&nbsp;subtipos,&nbsp;de&nbsp;acordo&nbsp;com&nbsp;cinco&nbsp;reconstruções&nbsp;filo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1627">1627</td><td nowrap="nowrap">genéticas:&nbsp;5’&nbsp;ORF1,&nbsp;3’&nbsp;ORF1,&nbsp;5’&nbsp;ORF2,&nbsp;3’&nbsp;ORF2&nbsp;e&nbsp;genoma&nbsp;completo.&nbsp;O&nbsp;genótipo&nbsp;1&nbsp;pode&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_1603">1603</td><td nowrap="nowrap">genéticas:&nbsp;5’&nbsp;ORF1,&nbsp;3’&nbsp;ORF1,&nbsp;5’&nbsp;ORF2,&nbsp;3’&nbsp;ORF2&nbsp;e&nbsp;genoma&nbsp;completo.&nbsp;O&nbsp;genótipo&nbsp;1&nbsp;pode&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1628">1628</td><td nowrap="nowrap">dividido&nbsp;em&nbsp;cinco&nbsp;subtipos&nbsp;(1a-e);&nbsp;o&nbsp;genótipo&nbsp;2,&nbsp;em&nbsp;dois&nbsp;subtipos&nbsp;(2a-b);&nbsp;o&nbsp;genótipo&nbsp;3,</td><td class="diff_next"></td><td class="diff_header" id="to62_1604">1604</td><td nowrap="nowrap">dividido&nbsp;em&nbsp;cinco&nbsp;subtipos&nbsp;(1a-e);&nbsp;o&nbsp;genótipo&nbsp;2,&nbsp;em&nbsp;dois&nbsp;subtipos&nbsp;(2a-b);&nbsp;o&nbsp;genótipo&nbsp;3,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1629">1629</td><td nowrap="nowrap">em&nbsp;10&nbsp;subtipos&nbsp;(3a-j)&nbsp;e&nbsp;o&nbsp;genótipo&nbsp;4,&nbsp;em&nbsp;sete&nbsp;subtipos&nbsp;(4a-g)&nbsp;(GONÇALES,&nbsp;2013;&nbsp;MIRAZO</td><td class="diff_next"></td><td class="diff_header" id="to62_1605">1605</td><td nowrap="nowrap">em&nbsp;10&nbsp;subtipos&nbsp;(3a-j)&nbsp;e&nbsp;o&nbsp;genótipo&nbsp;4,&nbsp;em&nbsp;sete&nbsp;subtipos&nbsp;(4a-g)&nbsp;(GONÇALES,&nbsp;2013;&nbsp;MIRAZO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1630">1630</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2014;&nbsp;PARVEZ,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1606">1606</td><td nowrap="nowrap">et&nbsp;al.,&nbsp;2014;&nbsp;PARVEZ,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1631">1631</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelos&nbsp;genótipos&nbsp;1&nbsp;e&nbsp;2&nbsp;do&nbsp;HEV&nbsp;é&nbsp;considerada&nbsp;uma&nbsp;antroponose,&nbsp;classe</td><td class="diff_next"></td><td class="diff_header" id="to62_1607">1607</td><td nowrap="nowrap">A&nbsp;infecção&nbsp;pelos&nbsp;genótipos&nbsp;1&nbsp;e&nbsp;2&nbsp;do&nbsp;HEV&nbsp;é&nbsp;considerada&nbsp;uma&nbsp;antroponose,&nbsp;classe</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1632">1632</td><td nowrap="nowrap">de&nbsp;doenças&nbsp;em&nbsp;que&nbsp;o&nbsp;ser&nbsp;humano&nbsp;é&nbsp;o&nbsp;único&nbsp;reservatório,&nbsp;suscetível&nbsp;e&nbsp;hospedeiro.&nbsp;Já&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_1608">1608</td><td nowrap="nowrap">de&nbsp;doenças&nbsp;em&nbsp;que&nbsp;o&nbsp;ser&nbsp;humano&nbsp;é&nbsp;o&nbsp;único&nbsp;reservatório,&nbsp;suscetível&nbsp;e&nbsp;hospedeiro.&nbsp;Já&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1633">1633</td><td nowrap="nowrap">infecção&nbsp;pelo&nbsp;genótipo&nbsp;3&nbsp;é&nbsp;uma&nbsp;enzoonose,&nbsp;doença&nbsp;infecciosa&nbsp;de&nbsp;animais&nbsp;de&nbsp;uma&nbsp;área</td><td class="diff_next"></td><td class="diff_header" id="to62_1609">1609</td><td nowrap="nowrap">infecção&nbsp;pelo&nbsp;genótipo&nbsp;3&nbsp;é&nbsp;uma&nbsp;enzoonose,&nbsp;doença&nbsp;infecciosa&nbsp;de&nbsp;animais&nbsp;de&nbsp;uma&nbsp;área</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1634">1634</td><td nowrap="nowrap">específica&nbsp;ou&nbsp;constantemente&nbsp;presente&nbsp;nesta;&nbsp;e&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;genótipo&nbsp;4&nbsp;é&nbsp;uma&nbsp;zoo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1610">1610</td><td nowrap="nowrap">específica&nbsp;ou&nbsp;constantemente&nbsp;presente&nbsp;nesta;&nbsp;e&nbsp;a&nbsp;infecção&nbsp;pelo&nbsp;genótipo&nbsp;4&nbsp;é&nbsp;uma&nbsp;zoo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1635">1635</td><td nowrap="nowrap">nose,&nbsp;doença&nbsp;que&nbsp;pode&nbsp;ser&nbsp;transmitida&nbsp;aos&nbsp;seres&nbsp;humanos&nbsp;pelos&nbsp;animais&nbsp;(GONÇALES,</td><td class="diff_next"></td><td class="diff_header" id="to62_1611">1611</td><td nowrap="nowrap">nose,&nbsp;doença&nbsp;que&nbsp;pode&nbsp;ser&nbsp;transmitida&nbsp;aos&nbsp;seres&nbsp;humanos&nbsp;pelos&nbsp;animais&nbsp;(GONÇALES,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1636">1636</td><td nowrap="nowrap">2013;&nbsp;PARVEZ,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1612">1612</td><td nowrap="nowrap">2013;&nbsp;PARVEZ,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1637">1637</td><td nowrap="nowrap">O&nbsp;genótipo&nbsp;1&nbsp;é&nbsp;encontrado&nbsp;na&nbsp;Ásia&nbsp;e&nbsp;no&nbsp;norte&nbsp;da&nbsp;África&nbsp;e&nbsp;está&nbsp;associado,&nbsp;nessas&nbsp;re-</td><td class="diff_next"></td><td class="diff_header" id="to62_1613">1613</td><td nowrap="nowrap">O&nbsp;genótipo&nbsp;1&nbsp;é&nbsp;encontrado&nbsp;na&nbsp;Ásia&nbsp;e&nbsp;no&nbsp;norte&nbsp;da&nbsp;África&nbsp;e&nbsp;está&nbsp;associado,&nbsp;nessas&nbsp;re-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1638">1638</td><td nowrap="nowrap">giões,&nbsp;a&nbsp;surtos&nbsp;com&nbsp;grande&nbsp;contaminação&nbsp;do&nbsp;suprimento&nbsp;de&nbsp;água.&nbsp;Também&nbsp;se&nbsp;relataram</td><td class="diff_next"></td><td class="diff_header" id="to62_1614">1614</td><td nowrap="nowrap">giões,&nbsp;a&nbsp;surtos&nbsp;com&nbsp;grande&nbsp;contaminação&nbsp;do&nbsp;suprimento&nbsp;de&nbsp;água.&nbsp;Também&nbsp;se&nbsp;relataram</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1639">1639</td><td nowrap="nowrap">pequenos&nbsp;surtos&nbsp;de&nbsp;HEV&nbsp;em&nbsp;Cuba&nbsp;e&nbsp;casos&nbsp;esporádicos&nbsp;na&nbsp;Venezuela&nbsp;e&nbsp;no&nbsp;Uruguai.&nbsp;O</td><td class="diff_next"></td><td class="diff_header" id="to62_1615">1615</td><td nowrap="nowrap">pequenos&nbsp;surtos&nbsp;de&nbsp;HEV&nbsp;em&nbsp;Cuba&nbsp;e&nbsp;casos&nbsp;esporádicos&nbsp;na&nbsp;Venezuela&nbsp;e&nbsp;no&nbsp;Uruguai.&nbsp;O</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1640">1640</td><td nowrap="nowrap">genótipo&nbsp;2&nbsp;foi&nbsp;caracterizado&nbsp;em&nbsp;uma&nbsp;única&nbsp;cepa&nbsp;isolada&nbsp;de&nbsp;fezes&nbsp;coletadas&nbsp;durante&nbsp;um</td><td class="diff_next"></td><td class="diff_header" id="to62_1616">1616</td><td nowrap="nowrap">genótipo&nbsp;2&nbsp;foi&nbsp;caracterizado&nbsp;em&nbsp;uma&nbsp;única&nbsp;cepa&nbsp;isolada&nbsp;de&nbsp;fezes&nbsp;coletadas&nbsp;durante&nbsp;um</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1641">1641</td><td nowrap="nowrap">surto&nbsp;de&nbsp;hepatite&nbsp;“Não&nbsp;A&nbsp;Não&nbsp;B”&nbsp;no&nbsp;México,&nbsp;em&nbsp;1986,&nbsp;e&nbsp;na&nbsp;África.&nbsp;O&nbsp;genótipo&nbsp;3&nbsp;apresenta</td><td class="diff_next"></td><td class="diff_header" id="to62_1617">1617</td><td nowrap="nowrap">surto&nbsp;de&nbsp;hepatite&nbsp;“Não&nbsp;A&nbsp;Não&nbsp;B”&nbsp;no&nbsp;México,&nbsp;em&nbsp;1986,&nbsp;e&nbsp;na&nbsp;África.&nbsp;O&nbsp;genótipo&nbsp;3&nbsp;apresenta</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1642">1642</td><td nowrap="nowrap">alta&nbsp;prevalência&nbsp;em&nbsp;rebanhos&nbsp;suínos&nbsp;dos&nbsp;Estados&nbsp;Unidos,&nbsp;Canadá,&nbsp;México,&nbsp;Europa,&nbsp;Nova</td><td class="diff_next"></td><td class="diff_header" id="to62_1618">1618</td><td nowrap="nowrap">alta&nbsp;prevalência&nbsp;em&nbsp;rebanhos&nbsp;suínos&nbsp;dos&nbsp;Estados&nbsp;Unidos,&nbsp;Canadá,&nbsp;México,&nbsp;Europa,&nbsp;Nova</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1643">1643</td><td nowrap="nowrap">Zelândia,&nbsp;Coreia&nbsp;do&nbsp;Sul,&nbsp;Japão&nbsp;e&nbsp;Tailândia.&nbsp;O&nbsp;HEV&nbsp;pode&nbsp;ser&nbsp;a&nbsp;causa&nbsp;de&nbsp;casos&nbsp;raros&nbsp;e&nbsp;espo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1619">1619</td><td nowrap="nowrap">Zelândia,&nbsp;Coreia&nbsp;do&nbsp;Sul,&nbsp;Japão&nbsp;e&nbsp;Tailândia.&nbsp;O&nbsp;HEV&nbsp;pode&nbsp;ser&nbsp;a&nbsp;causa&nbsp;de&nbsp;casos&nbsp;raros&nbsp;e&nbsp;espo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1644">1644</td><td nowrap="nowrap">rádicos&nbsp;de&nbsp;hepatite&nbsp;aguda&nbsp;por&nbsp;ingestão&nbsp;de&nbsp;alimentos&nbsp;de&nbsp;origem&nbsp;animal.&nbsp;Acredita-se&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_1620">1620</td><td nowrap="nowrap">rádicos&nbsp;de&nbsp;hepatite&nbsp;aguda&nbsp;por&nbsp;ingestão&nbsp;de&nbsp;alimentos&nbsp;de&nbsp;origem&nbsp;animal.&nbsp;Acredita-se&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1645">1645</td><td nowrap="nowrap">os&nbsp;suínos&nbsp;sejam&nbsp;o&nbsp;reservatório&nbsp;natural&nbsp;do&nbsp;vírus,&nbsp;ou&nbsp;que&nbsp;humanos&nbsp;e&nbsp;suínos&nbsp;compartilhem</td><td class="diff_next"></td><td class="diff_header" id="to62_1621">1621</td><td nowrap="nowrap">os&nbsp;suínos&nbsp;sejam&nbsp;o&nbsp;reservatório&nbsp;natural&nbsp;do&nbsp;vírus,&nbsp;ou&nbsp;que&nbsp;humanos&nbsp;e&nbsp;suínos&nbsp;compartilhem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1646">1646</td><td nowrap="nowrap">outro&nbsp;reservatório&nbsp;comum.&nbsp;O&nbsp;genótipo&nbsp;4&nbsp;é&nbsp;encontrado&nbsp;na&nbsp;China,&nbsp;Japão,&nbsp;Índia,&nbsp;Indonésia</td><td class="diff_next"></td><td class="diff_header" id="to62_1622">1622</td><td nowrap="nowrap">outro&nbsp;reservatório&nbsp;comum.&nbsp;O&nbsp;genótipo&nbsp;4&nbsp;é&nbsp;encontrado&nbsp;na&nbsp;China,&nbsp;Japão,&nbsp;Índia,&nbsp;Indonésia</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1647">1647</td><td nowrap="nowrap">e&nbsp;Vietnã,&nbsp;sendo&nbsp;identificados&nbsp;em&nbsp;humanos,&nbsp;suínos&nbsp;e&nbsp;outros&nbsp;animais.&nbsp;Nessas&nbsp;regiões,&nbsp;ca-</td><td class="diff_next"></td><td class="diff_header" id="to62_1623">1623</td><td nowrap="nowrap">e&nbsp;Vietnã,&nbsp;sendo&nbsp;identificados&nbsp;em&nbsp;humanos,&nbsp;suínos&nbsp;e&nbsp;outros&nbsp;animais.&nbsp;Nessas&nbsp;regiões,&nbsp;ca-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1648">1648</td><td nowrap="nowrap">origem&nbsp;animal,&nbsp;mas&nbsp;sua&nbsp;presença&nbsp;em&nbsp;surtos&nbsp;por&nbsp;contaminação&nbsp;de&nbsp;suprimento&nbsp;água&nbsp;ain-</td><td class="diff_next"></td><td class="diff_header" id="to62_1624">1624</td><td nowrap="nowrap">origem&nbsp;animal,&nbsp;mas&nbsp;sua&nbsp;presença&nbsp;em&nbsp;surtos&nbsp;por&nbsp;contaminação&nbsp;de&nbsp;suprimento&nbsp;água&nbsp;ain-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1649">1649</td><td nowrap="nowrap">da&nbsp;permanece&nbsp;desconhecida.&nbsp;Esse&nbsp;genótipo&nbsp;também&nbsp;já&nbsp;foi&nbsp;identificado&nbsp;em&nbsp;alguns&nbsp;paí-</td><td class="diff_next"></td><td class="diff_header" id="to62_1625">1625</td><td nowrap="nowrap">da&nbsp;permanece&nbsp;desconhecida.&nbsp;Esse&nbsp;genótipo&nbsp;também&nbsp;já&nbsp;foi&nbsp;identificado&nbsp;em&nbsp;alguns&nbsp;paí-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1650">1650</td><td nowrap="nowrap">ses&nbsp;da&nbsp;Europa&nbsp;Central&nbsp;(Figura&nbsp;20)&nbsp;(GONÇALES,&nbsp;2013;&nbsp;MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014;&nbsp;PARVEZ,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1626">1626</td><td nowrap="nowrap">ses&nbsp;da&nbsp;Europa&nbsp;Central&nbsp;(Figura&nbsp;20)&nbsp;(GONÇALES,&nbsp;2013;&nbsp;MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014;&nbsp;PARVEZ,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1651">1651</td><td nowrap="nowrap">Figura&nbsp;20.&nbsp;Distribuição&nbsp;geográfica&nbsp;dos&nbsp;principais&nbsp;genótipos&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1627">1627</td><td nowrap="nowrap">Figura&nbsp;20.&nbsp;Distribuição&nbsp;geográfica&nbsp;dos&nbsp;principais&nbsp;genótipos&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1652">1652</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_1628">1628</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1653">1653</td><td nowrap="nowrap">12.3&nbsp;Ciclo&nbsp;replicativo</td><td class="diff_next"></td><td class="diff_header" id="to62_1629">1629</td><td nowrap="nowrap">12.3&nbsp;Ciclo&nbsp;replicativo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1654">1654</td><td nowrap="nowrap">No&nbsp;citoplasma&nbsp;celular,&nbsp;o&nbsp;RNA&nbsp;genômico&nbsp;de&nbsp;fita&nbsp;positiva&nbsp;é&nbsp;traduzido&nbsp;para&nbsp;produzir&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_1630">1630</td><td nowrap="nowrap">No&nbsp;citoplasma&nbsp;celular,&nbsp;o&nbsp;RNA&nbsp;genômico&nbsp;de&nbsp;fita&nbsp;positiva&nbsp;é&nbsp;traduzido&nbsp;para&nbsp;produzir&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1655">1655</td><td nowrap="nowrap">proteínas&nbsp;não&nbsp;estruturais&nbsp;codificadas&nbsp;pela&nbsp;ORF1.&nbsp;O&nbsp;RNA&nbsp;complementar&nbsp;ao&nbsp;RNA&nbsp;genômi-</td><td class="diff_next"></td><td class="diff_header" id="to62_1631">1631</td><td nowrap="nowrap">proteínas&nbsp;não&nbsp;estruturais&nbsp;codificadas&nbsp;pela&nbsp;ORF1.&nbsp;O&nbsp;RNA&nbsp;complementar&nbsp;ao&nbsp;RNA&nbsp;genômi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1656">1656</td><td nowrap="nowrap">co&nbsp;é,&nbsp;então,&nbsp;transcrito&nbsp;em&nbsp;RNA&nbsp;genômico&nbsp;e&nbsp;RNA&nbsp;subgenômico.&nbsp;Acredita-se&nbsp;que&nbsp;o&nbsp;RNA</td><td class="diff_next"></td><td class="diff_header" id="to62_1632">1632</td><td nowrap="nowrap">co&nbsp;é,&nbsp;então,&nbsp;transcrito&nbsp;em&nbsp;RNA&nbsp;genômico&nbsp;e&nbsp;RNA&nbsp;subgenômico.&nbsp;Acredita-se&nbsp;que&nbsp;o&nbsp;RNA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1657">1657</td><td nowrap="nowrap">pelas&nbsp;ORF2&nbsp;e&nbsp;ORF3.&nbsp;Essas&nbsp;proteínas&nbsp;podem&nbsp;encapsular&nbsp;o&nbsp;RNA&nbsp;genômico,&nbsp;resultando&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_1633">1633</td><td nowrap="nowrap">pelas&nbsp;ORF2&nbsp;e&nbsp;ORF3.&nbsp;Essas&nbsp;proteínas&nbsp;podem&nbsp;encapsular&nbsp;o&nbsp;RNA&nbsp;genômico,&nbsp;resultando&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1658">1658</td><td nowrap="nowrap">uma&nbsp;partícula&nbsp;viral&nbsp;progenitora.&nbsp;Ainda&nbsp;não&nbsp;está&nbsp;ainda&nbsp;bem&nbsp;definido&nbsp;o&nbsp;modo&nbsp;como&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to62_1634">1634</td><td nowrap="nowrap">uma&nbsp;partícula&nbsp;viral&nbsp;progenitora.&nbsp;Ainda&nbsp;não&nbsp;está&nbsp;ainda&nbsp;bem&nbsp;definido&nbsp;o&nbsp;modo&nbsp;como&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1659">1659</td><td nowrap="nowrap">partícula&nbsp;viral&nbsp;deixa&nbsp;a&nbsp;célula&nbsp;infectada&nbsp;(Figura&nbsp;21)&nbsp;(CAO;&nbsp;MENG,&nbsp;2012;&nbsp;GONÇALES,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1635">1635</td><td nowrap="nowrap">partícula&nbsp;viral&nbsp;deixa&nbsp;a&nbsp;célula&nbsp;infectada&nbsp;(Figura&nbsp;21)&nbsp;(CAO;&nbsp;MENG,&nbsp;2012;&nbsp;GONÇALES,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1660">1660</td><td nowrap="nowrap">Figura&nbsp;21.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1636">1636</td><td nowrap="nowrap">Figura&nbsp;21.&nbsp;Ciclo&nbsp;replicativo&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;E&nbsp;(HEV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1661">1661</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;CAO;&nbsp;MENG,&nbsp;2012.</td><td class="diff_next"></td><td class="diff_header" id="to62_1637">1637</td><td nowrap="nowrap">Fonte:&nbsp;Adaptado&nbsp;de&nbsp;CAO;&nbsp;MENG,&nbsp;2012.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1662">1662</td><td nowrap="nowrap">O&nbsp;HEV&nbsp;é&nbsp;um&nbsp;importante&nbsp;agente&nbsp;causador&nbsp;de&nbsp;surtos&nbsp;epidêmicos,&nbsp;ocorrendo,&nbsp;princi-</td><td class="diff_next"></td><td class="diff_header" id="to62_1638">1638</td><td nowrap="nowrap">O&nbsp;HEV&nbsp;é&nbsp;um&nbsp;importante&nbsp;agente&nbsp;causador&nbsp;de&nbsp;surtos&nbsp;epidêmicos,&nbsp;ocorrendo,&nbsp;princi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1663">1663</td><td nowrap="nowrap">palmente,&nbsp;em&nbsp;áreas&nbsp;tropicais&nbsp;e&nbsp;subtropicais.&nbsp;As&nbsp;principais&nbsp;vias&nbsp;de&nbsp;transmissão&nbsp;são:&nbsp;reser-</td><td class="diff_next"></td><td class="diff_header" id="to62_1639">1639</td><td nowrap="nowrap">palmente,&nbsp;em&nbsp;áreas&nbsp;tropicais&nbsp;e&nbsp;subtropicais.&nbsp;As&nbsp;principais&nbsp;vias&nbsp;de&nbsp;transmissão&nbsp;são:&nbsp;reser-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1664">1664</td><td nowrap="nowrap">vatórios&nbsp;de&nbsp;água&nbsp;potável&nbsp;contaminada&nbsp;(transmissão&nbsp;fecal-oral);&nbsp;ingestão&nbsp;de&nbsp;carne&nbsp;crua</td><td class="diff_next"></td><td class="diff_header" id="to62_1640">1640</td><td nowrap="nowrap">vatórios&nbsp;de&nbsp;água&nbsp;potável&nbsp;contaminada&nbsp;(transmissão&nbsp;fecal-oral);&nbsp;ingestão&nbsp;de&nbsp;carne&nbsp;crua</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1665">1665</td><td nowrap="nowrap">ou&nbsp;mal&nbsp;cozida&nbsp;de&nbsp;animais&nbsp;selvagens,&nbsp;como&nbsp;javalis&nbsp;e&nbsp;cervos,&nbsp;e&nbsp;animais&nbsp;domésticos,&nbsp;como</td><td class="diff_next"></td><td class="diff_header" id="to62_1641">1641</td><td nowrap="nowrap">ou&nbsp;mal&nbsp;cozida&nbsp;de&nbsp;animais&nbsp;selvagens,&nbsp;como&nbsp;javalis&nbsp;e&nbsp;cervos,&nbsp;e&nbsp;animais&nbsp;domésticos,&nbsp;como</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1666">1666</td><td nowrap="nowrap">porcos&nbsp;e&nbsp;galinhas&nbsp;(transmissão&nbsp;alimentar-zoonótica);&nbsp;pelo&nbsp;sangue&nbsp;(transmissão&nbsp;parente-</td><td class="diff_next"></td><td class="diff_header" id="to62_1642">1642</td><td nowrap="nowrap">porcos&nbsp;e&nbsp;galinhas&nbsp;(transmissão&nbsp;alimentar-zoonótica);&nbsp;pelo&nbsp;sangue&nbsp;(transmissão&nbsp;parente-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1667">1667</td><td nowrap="nowrap">ral)&nbsp;e&nbsp;da&nbsp;mãe&nbsp;para&nbsp;o&nbsp;filho&nbsp;(transmissão&nbsp;vertical&nbsp;perinatal).</td><td class="diff_next"></td><td class="diff_header" id="to62_1643">1643</td><td nowrap="nowrap">ral)&nbsp;e&nbsp;da&nbsp;mãe&nbsp;para&nbsp;o&nbsp;filho&nbsp;(transmissão&nbsp;vertical&nbsp;perinatal).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1668">1668</td><td nowrap="nowrap">A&nbsp;maioria&nbsp;dos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;E&nbsp;aguda&nbsp;é&nbsp;silenciosa&nbsp;e&nbsp;se&nbsp;resolve&nbsp;rapidamente.&nbsp;O</td><td class="diff_next"></td><td class="diff_header" id="to62_1644">1644</td><td nowrap="nowrap">A&nbsp;maioria&nbsp;dos&nbsp;casos&nbsp;de&nbsp;hepatite&nbsp;E&nbsp;aguda&nbsp;é&nbsp;silenciosa&nbsp;e&nbsp;se&nbsp;resolve&nbsp;rapidamente.&nbsp;O</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1669">1669</td><td nowrap="nowrap">quadro&nbsp;sintomático&nbsp;aparece&nbsp;em,&nbsp;aproximadamente,&nbsp;20%&nbsp;dos&nbsp;indivíduos&nbsp;infectados&nbsp;e&nbsp;é</td><td class="diff_next"></td><td class="diff_header" id="to62_1645">1645</td><td nowrap="nowrap">quadro&nbsp;sintomático&nbsp;aparece&nbsp;em,&nbsp;aproximadamente,&nbsp;20%&nbsp;dos&nbsp;indivíduos&nbsp;infectados&nbsp;e&nbsp;é</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1670">1670</td><td nowrap="nowrap">observado,&nbsp;principalmente,&nbsp;em&nbsp;jovens&nbsp;e&nbsp;adultos&nbsp;de&nbsp;14&nbsp;a&nbsp;40&nbsp;anos.&nbsp;Além&nbsp;do&nbsp;quadro&nbsp;ictéri-</td><td class="diff_next"></td><td class="diff_header" id="to62_1646">1646</td><td nowrap="nowrap">observado,&nbsp;principalmente,&nbsp;em&nbsp;jovens&nbsp;e&nbsp;adultos&nbsp;de&nbsp;14&nbsp;a&nbsp;40&nbsp;anos.&nbsp;Além&nbsp;do&nbsp;quadro&nbsp;ictéri-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1671">1671</td><td nowrap="nowrap">co&nbsp;característico&nbsp;de&nbsp;doença,&nbsp;são&nbsp;relatados,&nbsp;frequentemente,&nbsp;colúria,&nbsp;prurido&nbsp;e&nbsp;sintomas</td><td class="diff_next"></td><td class="diff_header" id="to62_1647">1647</td><td nowrap="nowrap">co&nbsp;característico&nbsp;de&nbsp;doença,&nbsp;são&nbsp;relatados,&nbsp;frequentemente,&nbsp;colúria,&nbsp;prurido&nbsp;e&nbsp;sintomas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1672">1672</td><td nowrap="nowrap">gastrointestinais,&nbsp;como&nbsp;dor&nbsp;epigástrica,&nbsp;náuseas,&nbsp;vômitos&nbsp;e&nbsp;hipocolia&nbsp;fecal.&nbsp;Metade&nbsp;dos</td><td class="diff_next"></td><td class="diff_header" id="to62_1648">1648</td><td nowrap="nowrap">gastrointestinais,&nbsp;como&nbsp;dor&nbsp;epigástrica,&nbsp;náuseas,&nbsp;vômitos&nbsp;e&nbsp;hipocolia&nbsp;fecal.&nbsp;Metade&nbsp;dos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1673">1673</td><td nowrap="nowrap">pacientes&nbsp;infectados&nbsp;relatam&nbsp;manifestação&nbsp;de&nbsp;febre&nbsp;e&nbsp;dois&nbsp;terços&nbsp;apresentam&nbsp;artralgias.</td><td class="diff_next"></td><td class="diff_header" id="to62_1649">1649</td><td nowrap="nowrap">pacientes&nbsp;infectados&nbsp;relatam&nbsp;manifestação&nbsp;de&nbsp;febre&nbsp;e&nbsp;dois&nbsp;terços&nbsp;apresentam&nbsp;artralgias.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1674">1674</td><td nowrap="nowrap">Além&nbsp;disso,&nbsp;85%&nbsp;dos&nbsp;indivíduos&nbsp;que&nbsp;desenvolvem&nbsp;quadro&nbsp;ictérico&nbsp;apresentam&nbsp;hepato-</td><td class="diff_next"></td><td class="diff_header" id="to62_1650">1650</td><td nowrap="nowrap">Além&nbsp;disso,&nbsp;85%&nbsp;dos&nbsp;indivíduos&nbsp;que&nbsp;desenvolvem&nbsp;quadro&nbsp;ictérico&nbsp;apresentam&nbsp;hepato-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1675">1675</td><td nowrap="nowrap">megalia.&nbsp;A&nbsp;forma&nbsp;crônica&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HEV&nbsp;é&nbsp;rara,&nbsp;apenas&nbsp;tendo&nbsp;sido&nbsp;reportada&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_1651">1651</td><td nowrap="nowrap">megalia.&nbsp;A&nbsp;forma&nbsp;crônica&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;HEV&nbsp;é&nbsp;rara,&nbsp;apenas&nbsp;tendo&nbsp;sido&nbsp;reportada&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1676">1676</td><td nowrap="nowrap">indivíduos&nbsp;imunossuprimidos.&nbsp;Após&nbsp;a&nbsp;entrada&nbsp;do&nbsp;HEV&nbsp;no&nbsp;hospedeiro,&nbsp;habitualmente</td><td class="diff_next"></td><td class="diff_header" id="to62_1652">1652</td><td nowrap="nowrap">indivíduos&nbsp;imunossuprimidos.&nbsp;Após&nbsp;a&nbsp;entrada&nbsp;do&nbsp;HEV&nbsp;no&nbsp;hospedeiro,&nbsp;habitualmente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1677">1677</td><td nowrap="nowrap">por&nbsp;via&nbsp;oral&nbsp;(pela&nbsp;ingestão&nbsp;de&nbsp;água&nbsp;e&nbsp;alimentos&nbsp;contaminados),&nbsp;o&nbsp;vírus&nbsp;atinge&nbsp;o&nbsp;fígado&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1653">1653</td><td nowrap="nowrap">por&nbsp;via&nbsp;oral&nbsp;(pela&nbsp;ingestão&nbsp;de&nbsp;água&nbsp;e&nbsp;alimentos&nbsp;contaminados),&nbsp;o&nbsp;vírus&nbsp;atinge&nbsp;o&nbsp;fígado&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1678">1678</td><td nowrap="nowrap">se&nbsp;replica&nbsp;no&nbsp;citoplasma&nbsp;dos&nbsp;hepatócitos&nbsp;(GONÇALES,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1654">1654</td><td nowrap="nowrap">se&nbsp;replica&nbsp;no&nbsp;citoplasma&nbsp;dos&nbsp;hepatócitos&nbsp;(GONÇALES,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1679">1679</td><td nowrap="nowrap">A&nbsp;detecção&nbsp;da&nbsp;imunoglobulina&nbsp;da&nbsp;classe&nbsp;IgM&nbsp;anti-HEV&nbsp;ocorre&nbsp;no&nbsp;período&nbsp;inicial&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1655">1655</td><td nowrap="nowrap">A&nbsp;detecção&nbsp;da&nbsp;imunoglobulina&nbsp;da&nbsp;classe&nbsp;IgM&nbsp;anti-HEV&nbsp;ocorre&nbsp;no&nbsp;período&nbsp;inicial&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1680">1680</td><td nowrap="nowrap">fase&nbsp;aguda&nbsp;de&nbsp;infecção,&nbsp;nas&nbsp;primeiras&nbsp;duas&nbsp;semanas&nbsp;após&nbsp;o&nbsp;início&nbsp;dos&nbsp;sintomas,&nbsp;poden-</td><td class="diff_next"></td><td class="diff_header" id="to62_1656">1656</td><td nowrap="nowrap">fase&nbsp;aguda&nbsp;de&nbsp;infecção,&nbsp;nas&nbsp;primeiras&nbsp;duas&nbsp;semanas&nbsp;após&nbsp;o&nbsp;início&nbsp;dos&nbsp;sintomas,&nbsp;poden-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1681">1681</td><td nowrap="nowrap">do&nbsp;persistir&nbsp;até&nbsp;cinco&nbsp;meses&nbsp;(KHUDYAKOV;&nbsp;KAMILI,&nbsp;2011).&nbsp;A&nbsp;imunoglobulina&nbsp;da&nbsp;classe</td><td class="diff_next"></td><td class="diff_header" id="to62_1657">1657</td><td nowrap="nowrap">do&nbsp;persistir&nbsp;até&nbsp;cinco&nbsp;meses&nbsp;(KHUDYAKOV;&nbsp;KAMILI,&nbsp;2011).&nbsp;A&nbsp;imunoglobulina&nbsp;da&nbsp;classe</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1682">1682</td><td nowrap="nowrap">IgG&nbsp;anti-HEV&nbsp;surge&nbsp;imediatamente&nbsp;após&nbsp;o&nbsp;aparecimento&nbsp;da&nbsp;IgM&nbsp;e&nbsp;persiste&nbsp;por&nbsp;períodos</td><td class="diff_next"></td><td class="diff_header" id="to62_1658">1658</td><td nowrap="nowrap">IgG&nbsp;anti-HEV&nbsp;surge&nbsp;imediatamente&nbsp;após&nbsp;o&nbsp;aparecimento&nbsp;da&nbsp;IgM&nbsp;e&nbsp;persiste&nbsp;por&nbsp;períodos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1683">1683</td><td nowrap="nowrap">mais&nbsp;longos.&nbsp;A&nbsp;literatura&nbsp;demonstra&nbsp;que&nbsp;menos&nbsp;de&nbsp;50%&nbsp;dos&nbsp;indivíduos&nbsp;infectados&nbsp;con-</td><td class="diff_next"></td><td class="diff_header" id="to62_1659">1659</td><td nowrap="nowrap">mais&nbsp;longos.&nbsp;A&nbsp;literatura&nbsp;demonstra&nbsp;que&nbsp;menos&nbsp;de&nbsp;50%&nbsp;dos&nbsp;indivíduos&nbsp;infectados&nbsp;con-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1684">1684</td><td nowrap="nowrap">seguem&nbsp;manter&nbsp;níveis&nbsp;detectáveis&nbsp;de&nbsp;IgG&nbsp;por&nbsp;longos&nbsp;períodos,&nbsp;ao&nbsp;contrário&nbsp;do&nbsp;IgG&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to62_1660">1660</td><td nowrap="nowrap">seguem&nbsp;manter&nbsp;níveis&nbsp;detectáveis&nbsp;de&nbsp;IgG&nbsp;por&nbsp;longos&nbsp;períodos,&nbsp;ao&nbsp;contrário&nbsp;do&nbsp;IgG&nbsp;anti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1685">1685</td><td nowrap="nowrap">-HAV,&nbsp;que&nbsp;pode&nbsp;persistir&nbsp;indefinidamente.&nbsp;O&nbsp;IgG&nbsp;anti-HEV&nbsp;detectável&nbsp;após&nbsp;30&nbsp;anos&nbsp;é&nbsp;raro</td><td class="diff_next"></td><td class="diff_header" id="to62_1661">1661</td><td nowrap="nowrap">-HAV,&nbsp;que&nbsp;pode&nbsp;persistir&nbsp;indefinidamente.&nbsp;O&nbsp;IgG&nbsp;anti-HEV&nbsp;detectável&nbsp;após&nbsp;30&nbsp;anos&nbsp;é&nbsp;raro</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1686">1686</td><td nowrap="nowrap">(KHUDYAKOV;&nbsp;KAMILI,&nbsp;2011;&nbsp;KHUROO,&nbsp;2011).</td><td class="diff_next"></td><td class="diff_header" id="to62_1662">1662</td><td nowrap="nowrap">(KHUDYAKOV;&nbsp;KAMILI,&nbsp;2011;&nbsp;KHUROO,&nbsp;2011).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1687">1687</td><td nowrap="nowrap">Os&nbsp;anticorpos&nbsp;neutralizantes&nbsp;representam&nbsp;o&nbsp;principal&nbsp;mecanismo&nbsp;de&nbsp;proteção&nbsp;con-</td><td class="diff_next"></td><td class="diff_header" id="to62_1663">1663</td><td nowrap="nowrap">Os&nbsp;anticorpos&nbsp;neutralizantes&nbsp;representam&nbsp;o&nbsp;principal&nbsp;mecanismo&nbsp;de&nbsp;proteção&nbsp;con-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1688">1688</td><td nowrap="nowrap">tra&nbsp;o&nbsp;vírus&nbsp;e&nbsp;são,&nbsp;normalmente,&nbsp;direcionados&nbsp;contra&nbsp;proteínas&nbsp;do&nbsp;capsídeo&nbsp;viral,&nbsp;em&nbsp;espe-</td><td class="diff_next"></td><td class="diff_header" id="to62_1664">1664</td><td nowrap="nowrap">tra&nbsp;o&nbsp;vírus&nbsp;e&nbsp;são,&nbsp;normalmente,&nbsp;direcionados&nbsp;contra&nbsp;proteínas&nbsp;do&nbsp;capsídeo&nbsp;viral,&nbsp;em&nbsp;espe-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1689">1689</td><td nowrap="nowrap">cial&nbsp;da&nbsp;região&nbsp;codificada&nbsp;pelo&nbsp;ORF2.&nbsp;A&nbsp;proteína&nbsp;ORF2&nbsp;tem&nbsp;elevada&nbsp;imunogenicidade.&nbsp;Os</td><td class="diff_next"></td><td class="diff_header" id="to62_1665">1665</td><td nowrap="nowrap">cial&nbsp;da&nbsp;região&nbsp;codificada&nbsp;pelo&nbsp;ORF2.&nbsp;A&nbsp;proteína&nbsp;ORF2&nbsp;tem&nbsp;elevada&nbsp;imunogenicidade.&nbsp;Os</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1690">1690</td><td nowrap="nowrap">na&nbsp;produção&nbsp;de&nbsp;vacinas.&nbsp;A&nbsp;vacinação&nbsp;está&nbsp;indicada&nbsp;para&nbsp;indivíduos&nbsp;suscetíveis,&nbsp;inclusive</td><td class="diff_next"></td><td class="diff_header" id="to62_1666">1666</td><td nowrap="nowrap">na&nbsp;produção&nbsp;de&nbsp;vacinas.&nbsp;A&nbsp;vacinação&nbsp;está&nbsp;indicada&nbsp;para&nbsp;indivíduos&nbsp;suscetíveis,&nbsp;inclusive</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1691">1691</td><td nowrap="nowrap">IgG,&nbsp;pois&nbsp;a&nbsp;reinfecção&nbsp;pode&nbsp;ocorrer.&nbsp;Cabe&nbsp;ressaltar&nbsp;que&nbsp;a&nbsp;vacina&nbsp;nesse&nbsp;momento&nbsp;ainda</td><td class="diff_next"></td><td class="diff_header" id="to62_1667">1667</td><td nowrap="nowrap">IgG,&nbsp;pois&nbsp;a&nbsp;reinfecção&nbsp;pode&nbsp;ocorrer.&nbsp;Cabe&nbsp;ressaltar&nbsp;que&nbsp;a&nbsp;vacina&nbsp;nesse&nbsp;momento&nbsp;ainda</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1692">1692</td><td nowrap="nowrap">não&nbsp;é&nbsp;recomendada&nbsp;pela&nbsp;OMS,&nbsp;e&nbsp;tem&nbsp;seu&nbsp;uso&nbsp;restrito&nbsp;à&nbsp;China&nbsp;(KHUDYAKOV;&nbsp;KAMILI,</td><td class="diff_next"></td><td class="diff_header" id="to62_1668">1668</td><td nowrap="nowrap">não&nbsp;é&nbsp;recomendada&nbsp;pela&nbsp;OMS,&nbsp;e&nbsp;tem&nbsp;seu&nbsp;uso&nbsp;restrito&nbsp;à&nbsp;China&nbsp;(KHUDYAKOV;&nbsp;KAMILI,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1693">1693</td><td nowrap="nowrap">2011;&nbsp;ZHANG&nbsp;et&nbsp;al.,&nbsp;2012).</td><td class="diff_next"></td><td class="diff_header" id="to62_1669">1669</td><td nowrap="nowrap">2011;&nbsp;ZHANG&nbsp;et&nbsp;al.,&nbsp;2012).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1694">1694</td><td nowrap="nowrap">12.4&nbsp;Diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_1670">1670</td><td nowrap="nowrap">12.4&nbsp;Diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1695">1695</td><td nowrap="nowrap">O&nbsp;imunoensaio&nbsp;é&nbsp;o&nbsp;método&nbsp;laboratorial&nbsp;mais&nbsp;utilizado&nbsp;no&nbsp;diagnóstico&nbsp;de&nbsp;HEV.&nbsp;Os</td><td class="diff_next"></td><td class="diff_header" id="to62_1671">1671</td><td nowrap="nowrap">O&nbsp;imunoensaio&nbsp;é&nbsp;o&nbsp;método&nbsp;laboratorial&nbsp;mais&nbsp;utilizado&nbsp;no&nbsp;diagnóstico&nbsp;de&nbsp;HEV.&nbsp;Os</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1696">1696</td><td nowrap="nowrap">antígenos-alvo&nbsp;para&nbsp;o&nbsp;imunoensaio&nbsp;são&nbsp;as&nbsp;proteínas&nbsp;recombinantes,&nbsp;peptídeos&nbsp;sintéti-</td><td class="diff_next"></td><td class="diff_header" id="to62_1672">1672</td><td nowrap="nowrap">antígenos-alvo&nbsp;para&nbsp;o&nbsp;imunoensaio&nbsp;são&nbsp;as&nbsp;proteínas&nbsp;recombinantes,&nbsp;peptídeos&nbsp;sintéti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1697">1697</td><td nowrap="nowrap">cos&nbsp;que&nbsp;correspondem&nbsp;aos&nbsp;epitopos&nbsp;imunodominantes&nbsp;das&nbsp;proteínas&nbsp;estruturais&nbsp;(ORF2</td><td class="diff_next"></td><td class="diff_header" id="to62_1673">1673</td><td nowrap="nowrap">cos&nbsp;que&nbsp;correspondem&nbsp;aos&nbsp;epitopos&nbsp;imunodominantes&nbsp;das&nbsp;proteínas&nbsp;estruturais&nbsp;(ORF2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1698">1698</td><td nowrap="nowrap">e&nbsp;ORF3).&nbsp;Entretanto,&nbsp;é&nbsp;importante&nbsp;considerar&nbsp;o&nbsp;fato&nbsp;de&nbsp;que&nbsp;a&nbsp;heterogeneidade&nbsp;genética</td><td class="diff_next"></td><td class="diff_header" id="to62_1674">1674</td><td nowrap="nowrap">e&nbsp;ORF3).&nbsp;Entretanto,&nbsp;é&nbsp;importante&nbsp;considerar&nbsp;o&nbsp;fato&nbsp;de&nbsp;que&nbsp;a&nbsp;heterogeneidade&nbsp;genética</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1699">1699</td><td nowrap="nowrap">expressa&nbsp;em&nbsp;relação&nbsp;aos&nbsp;aminoácidos&nbsp;das&nbsp;proteínas&nbsp;da&nbsp;ORF3&nbsp;é&nbsp;maior&nbsp;que&nbsp;a&nbsp;da&nbsp;ORF2;&nbsp;os</td><td class="diff_next"></td><td class="diff_header" id="to62_1675">1675</td><td nowrap="nowrap">expressa&nbsp;em&nbsp;relação&nbsp;aos&nbsp;aminoácidos&nbsp;das&nbsp;proteínas&nbsp;da&nbsp;ORF3&nbsp;é&nbsp;maior&nbsp;que&nbsp;a&nbsp;da&nbsp;ORF2;&nbsp;os</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1700">1700</td><td nowrap="nowrap">anticorpos&nbsp;derivados&nbsp;das&nbsp;proteínas&nbsp;da&nbsp;ORF3&nbsp;têm&nbsp;uma&nbsp;vida&nbsp;média&nbsp;menor&nbsp;do&nbsp;que&nbsp;aque-</td><td class="diff_next"></td><td class="diff_header" id="to62_1676">1676</td><td nowrap="nowrap">anticorpos&nbsp;derivados&nbsp;das&nbsp;proteínas&nbsp;da&nbsp;ORF3&nbsp;têm&nbsp;uma&nbsp;vida&nbsp;média&nbsp;menor&nbsp;do&nbsp;que&nbsp;aque-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1701">1701</td><td nowrap="nowrap">les&nbsp;derivados&nbsp;da&nbsp;ORF2;&nbsp;e&nbsp;as&nbsp;proteínas&nbsp;derivadas&nbsp;da&nbsp;ORF2&nbsp;estimulam&nbsp;anticorpos&nbsp;neu-</td><td class="diff_next"></td><td class="diff_header" id="to62_1677">1677</td><td nowrap="nowrap">les&nbsp;derivados&nbsp;da&nbsp;ORF2;&nbsp;e&nbsp;as&nbsp;proteínas&nbsp;derivadas&nbsp;da&nbsp;ORF2&nbsp;estimulam&nbsp;anticorpos&nbsp;neu-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1702">1702</td><td nowrap="nowrap">tralizantes,&nbsp;enquanto&nbsp;as&nbsp;proteínas&nbsp;derivadas&nbsp;da&nbsp;ORF3&nbsp;não&nbsp;os&nbsp;estimulam.&nbsp;Dessa&nbsp;forma,</td><td class="diff_next"></td><td class="diff_header" id="to62_1678">1678</td><td nowrap="nowrap">tralizantes,&nbsp;enquanto&nbsp;as&nbsp;proteínas&nbsp;derivadas&nbsp;da&nbsp;ORF3&nbsp;não&nbsp;os&nbsp;estimulam.&nbsp;Dessa&nbsp;forma,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1703">1703</td><td nowrap="nowrap">as&nbsp;proteínas&nbsp;derivadas&nbsp;da&nbsp;ORF2&nbsp;são&nbsp;suficientes&nbsp;para&nbsp;a&nbsp;produção&nbsp;de&nbsp;ensaios&nbsp;sensíveis&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1679">1679</td><td nowrap="nowrap">as&nbsp;proteínas&nbsp;derivadas&nbsp;da&nbsp;ORF2&nbsp;são&nbsp;suficientes&nbsp;para&nbsp;a&nbsp;produção&nbsp;de&nbsp;ensaios&nbsp;sensíveis&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1704">1704</td><td nowrap="nowrap">específicos&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;HEV&nbsp;(ECHEVARRÍA,&nbsp;2014;&nbsp;GONÇALES,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1680">1680</td><td nowrap="nowrap">específicos&nbsp;para&nbsp;a&nbsp;detecção&nbsp;do&nbsp;HEV&nbsp;(ECHEVARRÍA,&nbsp;2014;&nbsp;GONÇALES,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1705">1705</td><td nowrap="nowrap">O&nbsp;teste&nbsp;para&nbsp;a&nbsp;pesquisa&nbsp;de&nbsp;anticorpos&nbsp;IgM&nbsp;anti-HEV&nbsp;pode&nbsp;ser&nbsp;usado&nbsp;para&nbsp;o&nbsp;diag-</td><td class="diff_next"></td><td class="diff_header" id="to62_1681">1681</td><td nowrap="nowrap">O&nbsp;teste&nbsp;para&nbsp;a&nbsp;pesquisa&nbsp;de&nbsp;anticorpos&nbsp;IgM&nbsp;anti-HEV&nbsp;pode&nbsp;ser&nbsp;usado&nbsp;para&nbsp;o&nbsp;diag-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1706">1706</td><td nowrap="nowrap">nóstico&nbsp;da&nbsp;infecção&nbsp;recente&nbsp;pelo&nbsp;HEV.&nbsp;Anticorpos&nbsp;IgG&nbsp;anti-HEV&nbsp;são&nbsp;encontrados&nbsp;desde</td><td class="diff_next"></td><td class="diff_header" id="to62_1682">1682</td><td nowrap="nowrap">nóstico&nbsp;da&nbsp;infecção&nbsp;recente&nbsp;pelo&nbsp;HEV.&nbsp;Anticorpos&nbsp;IgG&nbsp;anti-HEV&nbsp;são&nbsp;encontrados&nbsp;desde</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1707">1707</td><td nowrap="nowrap">o&nbsp;início&nbsp;da&nbsp;infecção,&nbsp;com&nbsp;pico&nbsp;entre&nbsp;30&nbsp;e&nbsp;40&nbsp;dias&nbsp;após&nbsp;a&nbsp;fase&nbsp;aguda&nbsp;da&nbsp;doença,&nbsp;e&nbsp;podem</td><td class="diff_next"></td><td class="diff_header" id="to62_1683">1683</td><td nowrap="nowrap">o&nbsp;início&nbsp;da&nbsp;infecção,&nbsp;com&nbsp;pico&nbsp;entre&nbsp;30&nbsp;e&nbsp;40&nbsp;dias&nbsp;após&nbsp;a&nbsp;fase&nbsp;aguda&nbsp;da&nbsp;doença,&nbsp;e&nbsp;podem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1708">1708</td><td nowrap="nowrap">persistir&nbsp;por&nbsp;até&nbsp;14&nbsp;anos&nbsp;(GONÇALES,&nbsp;2013;&nbsp;MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014).</td><td class="diff_next"></td><td class="diff_header" id="to62_1684">1684</td><td nowrap="nowrap">persistir&nbsp;por&nbsp;até&nbsp;14&nbsp;anos&nbsp;(GONÇALES,&nbsp;2013;&nbsp;MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1709">1709</td><td nowrap="nowrap">A&nbsp;detecção&nbsp;da&nbsp;viremia&nbsp;em&nbsp;amostras&nbsp;de&nbsp;fezes&nbsp;por&nbsp;transcrição&nbsp;reversa&nbsp;seguida&nbsp;de&nbsp;rea-</td><td class="diff_next"></td><td class="diff_header" id="to62_1685">1685</td><td nowrap="nowrap">A&nbsp;detecção&nbsp;da&nbsp;viremia&nbsp;em&nbsp;amostras&nbsp;de&nbsp;fezes&nbsp;por&nbsp;transcrição&nbsp;reversa&nbsp;seguida&nbsp;de&nbsp;rea-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1710">1710</td><td nowrap="nowrap">ção&nbsp;em&nbsp;cadeia&nbsp;da&nbsp;polimerase&nbsp;(RT-PCR)&nbsp;tem&nbsp;auxiliado&nbsp;no&nbsp;diagnóstico&nbsp;dos&nbsp;casos&nbsp;agudos</td><td class="diff_next"></td><td class="diff_header" id="to62_1686">1686</td><td nowrap="nowrap">ção&nbsp;em&nbsp;cadeia&nbsp;da&nbsp;polimerase&nbsp;(RT-PCR)&nbsp;tem&nbsp;auxiliado&nbsp;no&nbsp;diagnóstico&nbsp;dos&nbsp;casos&nbsp;agudos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1711">1711</td><td nowrap="nowrap">de&nbsp;hepatite&nbsp;E&nbsp;(MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014).&nbsp;O&nbsp;HEV&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;nas&nbsp;fezes,&nbsp;aproximada-</td><td class="diff_next"></td><td class="diff_header" id="to62_1687">1687</td><td nowrap="nowrap">de&nbsp;hepatite&nbsp;E&nbsp;(MIRAZO&nbsp;et&nbsp;al.,&nbsp;2014).&nbsp;O&nbsp;HEV&nbsp;pode&nbsp;ser&nbsp;detectado&nbsp;nas&nbsp;fezes,&nbsp;aproximada-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1712">1712</td><td nowrap="nowrap">mente,&nbsp;uma&nbsp;semana&nbsp;antes&nbsp;do&nbsp;início&nbsp;dos&nbsp;sintomas&nbsp;da&nbsp;doença&nbsp;e&nbsp;costuma&nbsp;persistir&nbsp;por</td><td class="diff_next"></td><td class="diff_header" id="to62_1688">1688</td><td nowrap="nowrap">mente,&nbsp;uma&nbsp;semana&nbsp;antes&nbsp;do&nbsp;início&nbsp;dos&nbsp;sintomas&nbsp;da&nbsp;doença&nbsp;e&nbsp;costuma&nbsp;persistir&nbsp;por</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1713">1713</td><td nowrap="nowrap">mais&nbsp;duas&nbsp;semanas,&nbsp;podendo,&nbsp;em&nbsp;alguns&nbsp;casos,&nbsp;ser&nbsp;detectado&nbsp;em&nbsp;até&nbsp;52&nbsp;dias&nbsp;após&nbsp;o&nbsp;iní-</td><td class="diff_next"></td><td class="diff_header" id="to62_1689">1689</td><td nowrap="nowrap">mais&nbsp;duas&nbsp;semanas,&nbsp;podendo,&nbsp;em&nbsp;alguns&nbsp;casos,&nbsp;ser&nbsp;detectado&nbsp;em&nbsp;até&nbsp;52&nbsp;dias&nbsp;após&nbsp;o&nbsp;iní-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1714">1714</td><td nowrap="nowrap">cio&nbsp;da&nbsp;infecção.&nbsp;No&nbsp;soro,&nbsp;o&nbsp;RNA&nbsp;viral&nbsp;pode&nbsp;ser&nbsp;detectado,&nbsp;na&nbsp;maioria&nbsp;dos&nbsp;pacientes,&nbsp;duas</td><td class="diff_next"></td><td class="diff_header" id="to62_1690">1690</td><td nowrap="nowrap">cio&nbsp;da&nbsp;infecção.&nbsp;No&nbsp;soro,&nbsp;o&nbsp;RNA&nbsp;viral&nbsp;pode&nbsp;ser&nbsp;detectado,&nbsp;na&nbsp;maioria&nbsp;dos&nbsp;pacientes,&nbsp;duas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1715">1715</td><td nowrap="nowrap">semanas&nbsp;após&nbsp;o&nbsp;início&nbsp;da&nbsp;doença;&nbsp;em&nbsp;alguns&nbsp;casos,&nbsp;a&nbsp;reatividade&nbsp;chega&nbsp;a&nbsp;se&nbsp;prolongar</td><td class="diff_next"></td><td class="diff_header" id="to62_1691">1691</td><td nowrap="nowrap">semanas&nbsp;após&nbsp;o&nbsp;início&nbsp;da&nbsp;doença;&nbsp;em&nbsp;alguns&nbsp;casos,&nbsp;a&nbsp;reatividade&nbsp;chega&nbsp;a&nbsp;se&nbsp;prolongar</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1716">1716</td><td nowrap="nowrap">por&nbsp;4&nbsp;a&nbsp;16&nbsp;semanas.</td><td class="diff_next"></td><td class="diff_header" id="to62_1692">1692</td><td nowrap="nowrap">por&nbsp;4&nbsp;a&nbsp;16&nbsp;semanas.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1717">1717</td><td nowrap="nowrap">A&nbsp;suspeita&nbsp;diagnóstica&nbsp;de&nbsp;HEV&nbsp;em&nbsp;áreas&nbsp;não&nbsp;endêmicas&nbsp;deve&nbsp;basear-se&nbsp;na&nbsp;exclusão</td><td class="diff_next"></td><td class="diff_header" id="to62_1693">1693</td><td nowrap="nowrap">A&nbsp;suspeita&nbsp;diagnóstica&nbsp;de&nbsp;HEV&nbsp;em&nbsp;áreas&nbsp;não&nbsp;endêmicas&nbsp;deve&nbsp;basear-se&nbsp;na&nbsp;exclusão</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1718">1718</td><td nowrap="nowrap">dos&nbsp;agentes&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B&nbsp;e&nbsp;C,&nbsp;além&nbsp;dos&nbsp;vírus&nbsp;Epstein-Barr&nbsp;e&nbsp;citomegalovírus.&nbsp;O&nbsp;his-</td><td class="diff_next"></td><td class="diff_header" id="to62_1694">1694</td><td nowrap="nowrap">dos&nbsp;agentes&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B&nbsp;e&nbsp;C,&nbsp;além&nbsp;dos&nbsp;vírus&nbsp;Epstein-Barr&nbsp;e&nbsp;citomegalovírus.&nbsp;O&nbsp;his-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1719">1719</td><td nowrap="nowrap">tórico&nbsp;de&nbsp;viagens,&nbsp;a&nbsp;procedência&nbsp;de&nbsp;regiões&nbsp;endêmicas&nbsp;para&nbsp;o&nbsp;HEV&nbsp;e&nbsp;a&nbsp;ocorrência&nbsp;de&nbsp;epi-</td><td class="diff_next"></td><td class="diff_header" id="to62_1695">1695</td><td nowrap="nowrap">tórico&nbsp;de&nbsp;viagens,&nbsp;a&nbsp;procedência&nbsp;de&nbsp;regiões&nbsp;endêmicas&nbsp;para&nbsp;o&nbsp;HEV&nbsp;e&nbsp;a&nbsp;ocorrência&nbsp;de&nbsp;epi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1720">1720</td><td nowrap="nowrap">demias&nbsp;que&nbsp;têm&nbsp;como&nbsp;fonte&nbsp;de&nbsp;contágio&nbsp;os&nbsp;reservatórios&nbsp;de&nbsp;água&nbsp;devem&nbsp;ser&nbsp;interpre-</td><td class="diff_next"></td><td class="diff_header" id="to62_1696">1696</td><td nowrap="nowrap">demias&nbsp;que&nbsp;têm&nbsp;como&nbsp;fonte&nbsp;de&nbsp;contágio&nbsp;os&nbsp;reservatórios&nbsp;de&nbsp;água&nbsp;devem&nbsp;ser&nbsp;interpre-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1721">1721</td><td nowrap="nowrap">tados&nbsp;como&nbsp;indícios&nbsp;importantes&nbsp;de&nbsp;aquisição&nbsp;de&nbsp;infecção&nbsp;por&nbsp;HEV&nbsp;(GONÇALES,&nbsp;2013).</td><td class="diff_next"></td><td class="diff_header" id="to62_1697">1697</td><td nowrap="nowrap">tados&nbsp;como&nbsp;indícios&nbsp;importantes&nbsp;de&nbsp;aquisição&nbsp;de&nbsp;infecção&nbsp;por&nbsp;HEV&nbsp;(GONÇALES,&nbsp;2013).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1722">1722</td><td nowrap="nowrap">A&nbsp;Figura&nbsp;22&nbsp;mostra&nbsp;a&nbsp;dinâmica&nbsp;dos&nbsp;principais&nbsp;marcadores&nbsp;utilizados&nbsp;no&nbsp;diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_1698">1698</td><td nowrap="nowrap">A&nbsp;Figura&nbsp;22&nbsp;mostra&nbsp;a&nbsp;dinâmica&nbsp;dos&nbsp;principais&nbsp;marcadores&nbsp;utilizados&nbsp;no&nbsp;diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1723">1723</td><td nowrap="nowrap">da&nbsp;infecção&nbsp;pelo&nbsp;HEV.</td><td class="diff_next"></td><td class="diff_header" id="to62_1699">1699</td><td nowrap="nowrap">da&nbsp;infecção&nbsp;pelo&nbsp;HEV.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1724">1724</td><td nowrap="nowrap">Figura&nbsp;22.&nbsp;Dinâmica&nbsp;dos&nbsp;principais&nbsp;marcadores&nbsp;utilizados&nbsp;no&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1700">1700</td><td nowrap="nowrap">Figura&nbsp;22.&nbsp;Dinâmica&nbsp;dos&nbsp;principais&nbsp;marcadores&nbsp;utilizados&nbsp;no&nbsp;diagnóstico&nbsp;da&nbsp;infecção&nbsp;pelo&nbsp;vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1725">1725</td><td nowrap="nowrap">hepatite&nbsp;E&nbsp;(HEV)</td><td class="diff_next"></td><td class="diff_header" id="to62_1701">1701</td><td nowrap="nowrap">hepatite&nbsp;E&nbsp;(HEV)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1726">1726</td><td nowrap="nowrap">Fonte:&nbsp;GONÇALVES,&nbsp;2013.</td><td class="diff_next"></td><td class="diff_header" id="to62_1702">1702</td><td nowrap="nowrap">Fonte:&nbsp;GONÇALVES,&nbsp;2013.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1727">1727</td><td nowrap="nowrap">13.&nbsp;SISTEMATIZAÇÃO&nbsp;DO&nbsp;DIAGNÓSTICO&nbsp;DAS&nbsp;HEPATITES&nbsp;VIRAIS</td><td class="diff_next"></td><td class="diff_header" id="to62_1703">1703</td><td nowrap="nowrap">13.&nbsp;SISTEMATIZAÇÃO&nbsp;DO&nbsp;DIAGNÓSTICO&nbsp;DAS&nbsp;HEPATITES&nbsp;VIRAIS</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1728">1728</td><td nowrap="nowrap">“Sorologia&nbsp;de&nbsp;hepatite”&nbsp;(sem&nbsp;explicitar&nbsp;quais&nbsp;os</td><td class="diff_next"></td><td class="diff_header" id="to62_1704">1704</td><td nowrap="nowrap">“Sorologia&nbsp;de&nbsp;hepatite”&nbsp;(sem&nbsp;explicitar&nbsp;quais&nbsp;os</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1729">1729</td><td nowrap="nowrap">Realizar&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B&nbsp;e&nbsp;C</td><td class="diff_next"></td><td class="diff_header" id="to62_1705">1705</td><td nowrap="nowrap">Realizar&nbsp;diagnóstico&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B&nbsp;e&nbsp;C</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1730">1730</td><td nowrap="nowrap">marcadores&nbsp;a&nbsp;serem&nbsp;pesquisados)</td><td class="diff_next"></td><td class="diff_header" id="to62_1706">1706</td><td nowrap="nowrap">marcadores&nbsp;a&nbsp;serem&nbsp;pesquisados)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1731">1731</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;HAV”&nbsp;Realizar&nbsp;diagnóstico&nbsp;da&nbsp;hepatite&nbsp;A</td><td class="diff_next"></td><td class="diff_header" id="to62_1707">1707</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;HAV”&nbsp;Realizar&nbsp;diagnóstico&nbsp;da&nbsp;hepatite&nbsp;A</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1732">1732</td><td nowrap="nowrap">Realizar&nbsp;diagnóstico&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(Fluxogramas&nbsp;2</td><td class="diff_next"></td><td class="diff_header" id="to62_1708">1708</td><td nowrap="nowrap">Realizar&nbsp;diagnóstico&nbsp;da&nbsp;hepatite&nbsp;B&nbsp;(Fluxogramas&nbsp;2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1733">1733</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;HBV”</td><td class="diff_next"></td><td class="diff_header" id="to62_1709">1709</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;HBV”</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1734">1734</td><td nowrap="nowrap">ou&nbsp;3)</td><td class="diff_next"></td><td class="diff_header" id="to62_1710">1710</td><td nowrap="nowrap">ou&nbsp;3)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1735">1735</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;oculta”&nbsp;Seguir&nbsp;as&nbsp;orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;de&nbsp;IOB</td><td class="diff_next"></td><td class="diff_header" id="to62_1711">1711</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;oculta”&nbsp;Seguir&nbsp;as&nbsp;orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;de&nbsp;IOB</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1736">1736</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;em</td><td class="diff_next"></td><td class="diff_header" id="to62_1712">1712</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;hepatite&nbsp;B&nbsp;em</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1737">1737</td><td nowrap="nowrap">Realizar&nbsp;Fluxograma&nbsp;2</td><td class="diff_next"></td><td class="diff_header" id="to62_1713">1713</td><td nowrap="nowrap">Realizar&nbsp;Fluxograma&nbsp;2</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1738">1738</td><td nowrap="nowrap">menores&nbsp;de&nbsp;18&nbsp;meses”</td><td class="diff_next"></td><td class="diff_header" id="to62_1714">1714</td><td nowrap="nowrap">menores&nbsp;de&nbsp;18&nbsp;meses”</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1739">1739</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;HCV”&nbsp;Realizar&nbsp;diagnóstico&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(Fluxograma&nbsp;5)</td><td class="diff_next"></td><td class="diff_header" id="to62_1715">1715</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;HCV”&nbsp;Realizar&nbsp;diagnóstico&nbsp;da&nbsp;hepatite&nbsp;C&nbsp;(Fluxograma&nbsp;5)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1740">1740</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;hepatite&nbsp;C&nbsp;em&nbsp;Seguir&nbsp;as&nbsp;orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1716">1716</td><td nowrap="nowrap">“Sorologia&nbsp;(ou&nbsp;diagnóstico)&nbsp;de&nbsp;hepatite&nbsp;C&nbsp;em&nbsp;Seguir&nbsp;as&nbsp;orientações&nbsp;para&nbsp;o&nbsp;diagnóstico&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1741">1741</td><td nowrap="nowrap">menores&nbsp;de&nbsp;18&nbsp;meses”&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses</td><td class="diff_next"></td><td class="diff_header" id="to62_1717">1717</td><td nowrap="nowrap">menores&nbsp;de&nbsp;18&nbsp;meses”&nbsp;infecção&nbsp;pelo&nbsp;HCV&nbsp;em&nbsp;menores&nbsp;de&nbsp;18&nbsp;meses</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1742">1742</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_1718">1718</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1743">1743</td><td nowrap="nowrap">14.&nbsp;SITUAÇÕES&nbsp;ESPECIAIS&nbsp;NO&nbsp;DIAGNÓSTICO&nbsp;DAS&nbsp;HEPATITES</td><td class="diff_next"></td><td class="diff_header" id="to62_1719">1719</td><td nowrap="nowrap">14.&nbsp;SITUAÇÕES&nbsp;ESPECIAIS&nbsp;NO&nbsp;DIAGNÓSTICO&nbsp;DAS&nbsp;HEPATITES</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1744">1744</td><td nowrap="nowrap">Hepatite&nbsp;C&nbsp;Suspeita&nbsp;de&nbsp;hepatite&nbsp;C&nbsp;aguda&nbsp;Realizar&nbsp;teste&nbsp;molecular1</td><td class="diff_next"></td><td class="diff_header" id="to62_1720">1720</td><td nowrap="nowrap">Hepatite&nbsp;C&nbsp;Suspeita&nbsp;de&nbsp;hepatite&nbsp;C&nbsp;aguda&nbsp;Realizar&nbsp;teste&nbsp;molecular1</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1745">1745</td><td nowrap="nowrap">Realizar&nbsp;pesquisa&nbsp;de&nbsp;anticorpos&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to62_1721">1721</td><td nowrap="nowrap">Realizar&nbsp;pesquisa&nbsp;de&nbsp;anticorpos&nbsp;anti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1746">1746</td><td nowrap="nowrap">Hepatite&nbsp;D&nbsp;Suspeita&nbsp;de&nbsp;hepatite&nbsp;D&nbsp;(ou&nbsp;Delta)</td><td class="diff_next"></td><td class="diff_header" id="to62_1722">1722</td><td nowrap="nowrap">Hepatite&nbsp;D&nbsp;Suspeita&nbsp;de&nbsp;hepatite&nbsp;D&nbsp;(ou&nbsp;Delta)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1747">1747</td><td nowrap="nowrap">Realizar&nbsp;pesquisa&nbsp;de&nbsp;anticorpos&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to62_1723">1723</td><td nowrap="nowrap">Realizar&nbsp;pesquisa&nbsp;de&nbsp;anticorpos&nbsp;anti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1748">1748</td><td nowrap="nowrap">referência&nbsp;em&nbsp;hepatites&nbsp;virais1</td><td class="diff_next"></td><td class="diff_header" id="to62_1724">1724</td><td nowrap="nowrap">referência&nbsp;em&nbsp;hepatites&nbsp;virais1</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1749">1749</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td><td class="diff_next"></td><td class="diff_header" id="to62_1725">1725</td><td nowrap="nowrap">Fonte:&nbsp;DIAHV/SVS/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1750">1750</td><td nowrap="nowrap">1O&nbsp;diagnóstico&nbsp;somente&nbsp;será&nbsp;confirmado&nbsp;após&nbsp;soroconversão&nbsp;para&nbsp;anti-HCV,&nbsp;a&nbsp;qual&nbsp;irá&nbsp;depender&nbsp;da&nbsp;janela</td><td class="diff_next"></td><td class="diff_header" id="to62_1726">1726</td><td nowrap="nowrap">1O&nbsp;diagnóstico&nbsp;somente&nbsp;será&nbsp;confirmado&nbsp;após&nbsp;soroconversão&nbsp;para&nbsp;anti-HCV,&nbsp;a&nbsp;qual&nbsp;irá&nbsp;depender&nbsp;da&nbsp;janela</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1751">1751</td><td nowrap="nowrap">imunológica&nbsp;(período&nbsp;de&nbsp;até&nbsp;90&nbsp;dias).</td><td class="diff_next"></td><td class="diff_header" id="to62_1727">1727</td><td nowrap="nowrap">imunológica&nbsp;(período&nbsp;de&nbsp;até&nbsp;90&nbsp;dias).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1752">1752</td><td nowrap="nowrap">Em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HEV,&nbsp;a&nbsp;unidade&nbsp;solicitante&nbsp;deverá&nbsp;en-</td><td class="diff_next"></td><td class="diff_header" id="to62_1728">1728</td><td nowrap="nowrap">Em&nbsp;caso&nbsp;de&nbsp;suspeita&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HEV,&nbsp;a&nbsp;unidade&nbsp;solicitante&nbsp;deverá&nbsp;en-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1753">1753</td><td nowrap="nowrap">trar&nbsp;em&nbsp;contato&nbsp;com&nbsp;o&nbsp;DIAHV&nbsp;pelo&nbsp;e-mail&nbsp;clab@aids.gov.br&nbsp;para&nbsp;a&nbsp;definição</td><td class="diff_next"></td><td class="diff_header" id="to62_1729">1729</td><td nowrap="nowrap">trar&nbsp;em&nbsp;contato&nbsp;com&nbsp;o&nbsp;DIAHV&nbsp;pelo&nbsp;e-mail&nbsp;clab@aids.gov.br&nbsp;para&nbsp;a&nbsp;definição</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1754">1754</td><td nowrap="nowrap">de&nbsp;solicitação,&nbsp;na&nbsp;qual&nbsp;deverá&nbsp;ser&nbsp;confirmada&nbsp;a&nbsp;exclusão&nbsp;de&nbsp;outros&nbsp;agentes</td><td class="diff_next"></td><td class="diff_header" id="to62_1730">1730</td><td nowrap="nowrap">de&nbsp;solicitação,&nbsp;na&nbsp;qual&nbsp;deverá&nbsp;ser&nbsp;confirmada&nbsp;a&nbsp;exclusão&nbsp;de&nbsp;outros&nbsp;agentes</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1755">1755</td><td nowrap="nowrap">infecciosos&nbsp;(citados&nbsp;no&nbsp;item&nbsp;12.4).</td><td class="diff_next"></td><td class="diff_header" id="to62_1731">1731</td><td nowrap="nowrap">infecciosos&nbsp;(citados&nbsp;no&nbsp;item&nbsp;12.4).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1756">1756</td><td nowrap="nowrap">15.&nbsp;TECNOVIGILÂNCIA</td><td class="diff_next"></td><td class="diff_header" id="to62_1732">1732</td><td nowrap="nowrap">15.&nbsp;TECNOVIGILÂNCIA</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1757">1757</td><td nowrap="nowrap">A&nbsp;Tecnovigilância,&nbsp;da&nbsp;Agência&nbsp;Nacional&nbsp;de&nbsp;Vigilância&nbsp;Sanitária&nbsp;(Anvisa),&nbsp;do&nbsp;Ministério</td><td class="diff_next"></td><td class="diff_header" id="to62_1733">1733</td><td nowrap="nowrap">A&nbsp;Tecnovigilância,&nbsp;da&nbsp;Agência&nbsp;Nacional&nbsp;de&nbsp;Vigilância&nbsp;Sanitária&nbsp;(Anvisa),&nbsp;do&nbsp;Ministério</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1758">1758</td><td nowrap="nowrap">da&nbsp;Saúde,&nbsp;tem&nbsp;por&nbsp;objetivo&nbsp;monitorar&nbsp;e,&nbsp;quando&nbsp;apropriado,&nbsp;verificar&nbsp;a&nbsp;segurança&nbsp;sani-</td><td class="diff_next"></td><td class="diff_header" id="to62_1734">1734</td><td nowrap="nowrap">da&nbsp;Saúde,&nbsp;tem&nbsp;por&nbsp;objetivo&nbsp;monitorar&nbsp;e,&nbsp;quando&nbsp;apropriado,&nbsp;verificar&nbsp;a&nbsp;segurança&nbsp;sani-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1759">1759</td><td nowrap="nowrap">tária&nbsp;e&nbsp;o&nbsp;desempenho&nbsp;de&nbsp;produtos&nbsp;para&nbsp;saúde&nbsp;na&nbsp;etapa&nbsp;pós-comercialização&nbsp;(equipa-</td><td class="diff_next"></td><td class="diff_header" id="to62_1735">1735</td><td nowrap="nowrap">tária&nbsp;e&nbsp;o&nbsp;desempenho&nbsp;de&nbsp;produtos&nbsp;para&nbsp;saúde&nbsp;na&nbsp;etapa&nbsp;pós-comercialização&nbsp;(equipa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1760">1760</td><td nowrap="nowrap">mentos,&nbsp;materiais,&nbsp;artigos&nbsp;médico-hospitalares,&nbsp;implantes&nbsp;e&nbsp;produtos&nbsp;para&nbsp;diagnóstico</td><td class="diff_next"></td><td class="diff_header" id="to62_1736">1736</td><td nowrap="nowrap">mentos,&nbsp;materiais,&nbsp;artigos&nbsp;médico-hospitalares,&nbsp;implantes&nbsp;e&nbsp;produtos&nbsp;para&nbsp;diagnóstico</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1761">1761</td><td nowrap="nowrap">de&nbsp;uso&nbsp;in-vitro),&nbsp;com&nbsp;vistas&nbsp;a&nbsp;identificar&nbsp;eventos&nbsp;e&nbsp;desvios&nbsp;da&nbsp;qualidade&nbsp;que&nbsp;produzam</td><td class="diff_next"></td><td class="diff_header" id="to62_1737">1737</td><td nowrap="nowrap">de&nbsp;uso&nbsp;in-vitro),&nbsp;com&nbsp;vistas&nbsp;a&nbsp;identificar&nbsp;eventos&nbsp;e&nbsp;desvios&nbsp;da&nbsp;qualidade&nbsp;que&nbsp;produzam</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1762">1762</td><td nowrap="nowrap">ou,&nbsp;potencialmente,&nbsp;possam&nbsp;produzir&nbsp;resultados&nbsp;inesperados&nbsp;ou&nbsp;indesejáveis,&nbsp;afetando</td><td class="diff_next"></td><td class="diff_header" id="to62_1738">1738</td><td nowrap="nowrap">ou,&nbsp;potencialmente,&nbsp;possam&nbsp;produzir&nbsp;resultados&nbsp;inesperados&nbsp;ou&nbsp;indesejáveis,&nbsp;afetando</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1763">1763</td><td nowrap="nowrap">a&nbsp;segurança&nbsp;do&nbsp;paciente.&nbsp;Consiste&nbsp;em&nbsp;um&nbsp;sistema&nbsp;de&nbsp;vigilância&nbsp;de&nbsp;eventos&nbsp;adversos&nbsp;(EA)</td><td class="diff_next"></td><td class="diff_header" id="to62_1739">1739</td><td nowrap="nowrap">a&nbsp;segurança&nbsp;do&nbsp;paciente.&nbsp;Consiste&nbsp;em&nbsp;um&nbsp;sistema&nbsp;de&nbsp;vigilância&nbsp;de&nbsp;eventos&nbsp;adversos&nbsp;(EA)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1764">1764</td><td nowrap="nowrap">e&nbsp;queixas&nbsp;técnicas&nbsp;(QT)&nbsp;em&nbsp;relação&nbsp;a&nbsp;esses&nbsp;produtos&nbsp;e&nbsp;recomenda&nbsp;a&nbsp;adoção&nbsp;de&nbsp;medi-</td><td class="diff_next"></td><td class="diff_header" id="to62_1740">1740</td><td nowrap="nowrap">e&nbsp;queixas&nbsp;técnicas&nbsp;(QT)&nbsp;em&nbsp;relação&nbsp;a&nbsp;esses&nbsp;produtos&nbsp;e&nbsp;recomenda&nbsp;a&nbsp;adoção&nbsp;de&nbsp;medi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1765">1765</td><td nowrap="nowrap">das&nbsp;que&nbsp;garantam&nbsp;a&nbsp;proteção&nbsp;e&nbsp;a&nbsp;promoção&nbsp;da&nbsp;saúde&nbsp;da&nbsp;população.&nbsp;Considera-se&nbsp;EA&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_1741">1741</td><td nowrap="nowrap">das&nbsp;que&nbsp;garantam&nbsp;a&nbsp;proteção&nbsp;e&nbsp;a&nbsp;promoção&nbsp;da&nbsp;saúde&nbsp;da&nbsp;população.&nbsp;Considera-se&nbsp;EA&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1766">1766</td><td nowrap="nowrap">evento&nbsp;que&nbsp;causou&nbsp;dano&nbsp;à&nbsp;saúde&nbsp;de&nbsp;um&nbsp;indivíduo.&nbsp;Se,&nbsp;até&nbsp;o&nbsp;momento&nbsp;da&nbsp;notificação,&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to62_1742">1742</td><td nowrap="nowrap">evento&nbsp;que&nbsp;causou&nbsp;dano&nbsp;à&nbsp;saúde&nbsp;de&nbsp;um&nbsp;indivíduo.&nbsp;Se,&nbsp;até&nbsp;o&nbsp;momento&nbsp;da&nbsp;notificação,&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1767">1767</td><td nowrap="nowrap">problema&nbsp;observado&nbsp;no&nbsp;produto&nbsp;ainda&nbsp;não&nbsp;tiver&nbsp;acarretado&nbsp;nenhum&nbsp;dano&nbsp;à&nbsp;saúde,&nbsp;este</td><td class="diff_next"></td><td class="diff_header" id="to62_1743">1743</td><td nowrap="nowrap">problema&nbsp;observado&nbsp;no&nbsp;produto&nbsp;ainda&nbsp;não&nbsp;tiver&nbsp;acarretado&nbsp;nenhum&nbsp;dano&nbsp;à&nbsp;saúde,&nbsp;este</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1768">1768</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;notificado&nbsp;como&nbsp;QT.</td><td class="diff_next"></td><td class="diff_header" id="to62_1744">1744</td><td nowrap="nowrap">deverá&nbsp;ser&nbsp;notificado&nbsp;como&nbsp;QT.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1769">1769</td><td nowrap="nowrap">Outro&nbsp;objetivo&nbsp;importante&nbsp;da&nbsp;Tecnovigilância&nbsp;é&nbsp;a&nbsp;coordenação&nbsp;nacional&nbsp;dessas&nbsp;ati-</td><td class="diff_next"></td><td class="diff_header" id="to62_1745">1745</td><td nowrap="nowrap">Outro&nbsp;objetivo&nbsp;importante&nbsp;da&nbsp;Tecnovigilância&nbsp;é&nbsp;a&nbsp;coordenação&nbsp;nacional&nbsp;dessas&nbsp;ati-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1770">1770</td><td nowrap="nowrap">vidades&nbsp;de&nbsp;monitoramento.&nbsp;As&nbsp;diversas&nbsp;competências&nbsp;dessa&nbsp;área&nbsp;da&nbsp;Anvisa&nbsp;estão&nbsp;des-</td><td class="diff_next"></td><td class="diff_header" id="to62_1746">1746</td><td nowrap="nowrap">vidades&nbsp;de&nbsp;monitoramento.&nbsp;As&nbsp;diversas&nbsp;competências&nbsp;dessa&nbsp;área&nbsp;da&nbsp;Anvisa&nbsp;estão&nbsp;des-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1771">1771</td><td nowrap="nowrap">critas&nbsp;na&nbsp;Portaria&nbsp;nº&nbsp;593,&nbsp;de&nbsp;25&nbsp;de&nbsp;agosto&nbsp;de&nbsp;2000,&nbsp;atualizada&nbsp;pela&nbsp;Portaria&nbsp;nº&nbsp;406,&nbsp;de&nbsp;14</td><td class="diff_next"></td><td class="diff_header" id="to62_1747">1747</td><td nowrap="nowrap">critas&nbsp;na&nbsp;Portaria&nbsp;nº&nbsp;593,&nbsp;de&nbsp;25&nbsp;de&nbsp;agosto&nbsp;de&nbsp;2000,&nbsp;atualizada&nbsp;pela&nbsp;Portaria&nbsp;nº&nbsp;406,&nbsp;de&nbsp;14</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1772">1772</td><td nowrap="nowrap">de&nbsp;outubro&nbsp;de&nbsp;2005.</td><td class="diff_next"></td><td class="diff_header" id="to62_1748">1748</td><td nowrap="nowrap">de&nbsp;outubro&nbsp;de&nbsp;2005.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1773">1773</td><td nowrap="nowrap">Os&nbsp;EA&nbsp;e&nbsp;as&nbsp;QT&nbsp;de&nbsp;produtos&nbsp;para&nbsp;a&nbsp;saúde,&nbsp;na&nbsp;fase&nbsp;de&nbsp;pós-comercialização,&nbsp;podem</td><td class="diff_next"></td><td class="diff_header" id="to62_1749">1749</td><td nowrap="nowrap">Os&nbsp;EA&nbsp;e&nbsp;as&nbsp;QT&nbsp;de&nbsp;produtos&nbsp;para&nbsp;a&nbsp;saúde,&nbsp;na&nbsp;fase&nbsp;de&nbsp;pós-comercialização,&nbsp;podem</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1774">1774</td><td nowrap="nowrap">ser&nbsp;notificados&nbsp;à&nbsp;Tecnovigilância/Anvisa/Ministério&nbsp;da&nbsp;Saúde&nbsp;pelo&nbsp;Notivisa.&nbsp;Trata-se&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1750">1750</td><td nowrap="nowrap">ser&nbsp;notificados&nbsp;à&nbsp;Tecnovigilância/Anvisa/Ministério&nbsp;da&nbsp;Saúde&nbsp;pelo&nbsp;Notivisa.&nbsp;Trata-se&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1775">1775</td><td nowrap="nowrap">um&nbsp;sistema&nbsp;informatizado&nbsp;em&nbsp;plataforma&nbsp;web,&nbsp;previsto&nbsp;pela&nbsp;Portaria&nbsp;n°&nbsp;1.660,&nbsp;de&nbsp;22&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1751">1751</td><td nowrap="nowrap">um&nbsp;sistema&nbsp;informatizado&nbsp;em&nbsp;plataforma&nbsp;web,&nbsp;previsto&nbsp;pela&nbsp;Portaria&nbsp;n°&nbsp;1.660,&nbsp;de&nbsp;22&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1776">1776</td><td nowrap="nowrap">julho&nbsp;de&nbsp;2009,&nbsp;do&nbsp;Ministério&nbsp;da&nbsp;Saúde.</td><td class="diff_next"></td><td class="diff_header" id="to62_1752">1752</td><td nowrap="nowrap">julho&nbsp;de&nbsp;2009,&nbsp;do&nbsp;Ministério&nbsp;da&nbsp;Saúde.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1777">1777</td><td nowrap="nowrap">Podem&nbsp;utilizar&nbsp;o&nbsp;Notivisa&nbsp;os&nbsp;profissionais&nbsp;de&nbsp;serviços&nbsp;de&nbsp;saúde;&nbsp;a&nbsp;Anvisa;&nbsp;as</td><td class="diff_next"></td><td class="diff_header" id="to62_1753">1753</td><td nowrap="nowrap">Podem&nbsp;utilizar&nbsp;o&nbsp;Notivisa&nbsp;os&nbsp;profissionais&nbsp;de&nbsp;serviços&nbsp;de&nbsp;saúde;&nbsp;a&nbsp;Anvisa;&nbsp;as</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1778">1778</td><td nowrap="nowrap">Vigilâncias&nbsp;Sanitárias&nbsp;Estaduais&nbsp;e&nbsp;Municipais;&nbsp;as&nbsp;Secretarias&nbsp;Estaduais&nbsp;e&nbsp;Municipais&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1754">1754</td><td nowrap="nowrap">Vigilâncias&nbsp;Sanitárias&nbsp;Estaduais&nbsp;e&nbsp;Municipais;&nbsp;as&nbsp;Secretarias&nbsp;Estaduais&nbsp;e&nbsp;Municipais&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1779">1779</td><td nowrap="nowrap">Saúde;&nbsp;Laboratórios&nbsp;de&nbsp;Saúde&nbsp;Pública;&nbsp;Universidades/Centros&nbsp;de&nbsp;Pesquisa;&nbsp;profissionais</td><td class="diff_next"></td><td class="diff_header" id="to62_1755">1755</td><td nowrap="nowrap">Saúde;&nbsp;Laboratórios&nbsp;de&nbsp;Saúde&nbsp;Pública;&nbsp;Universidades/Centros&nbsp;de&nbsp;Pesquisa;&nbsp;profissionais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1780">1780</td><td nowrap="nowrap">que&nbsp;atuam&nbsp;em&nbsp;drogarias,&nbsp;farmácias&nbsp;e&nbsp;em&nbsp;empresas&nbsp;detentoras&nbsp;de&nbsp;registro&nbsp;de&nbsp;produtos</td><td class="diff_next"></td><td class="diff_header" id="to62_1756">1756</td><td nowrap="nowrap">que&nbsp;atuam&nbsp;em&nbsp;drogarias,&nbsp;farmácias&nbsp;e&nbsp;em&nbsp;empresas&nbsp;detentoras&nbsp;de&nbsp;registro&nbsp;de&nbsp;produtos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1781">1781</td><td nowrap="nowrap">sob&nbsp;vigilância&nbsp;sanitária&nbsp;(fabricantes,&nbsp;importadores&nbsp;e&nbsp;distribuidores)&nbsp;e&nbsp;os&nbsp;profissionais&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1757">1757</td><td nowrap="nowrap">sob&nbsp;vigilância&nbsp;sanitária&nbsp;(fabricantes,&nbsp;importadores&nbsp;e&nbsp;distribuidores)&nbsp;e&nbsp;os&nbsp;profissionais&nbsp;de</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__41"></td><td class="diff_header" id="from62_1782">1782</td><td nowrap="nowrap">saúde&nbsp;liberais.&nbsp;Para&nbsp;acessar&nbsp;o&nbsp;sistema,&nbsp;é&nbsp;preciso&nbsp;se&nbsp;cadastrar&nbsp;de&nbsp;acordo&nbsp;com&nbsp;a&nbsp;categoria</td><td class="diff_next"></td><td class="diff_header" id="to62_1758">1758</td><td nowrap="nowrap">saúde&nbsp;liberais.&nbsp;Para&nbsp;acessar&nbsp;o&nbsp;sistema,&nbsp;é&nbsp;preciso&nbsp;se&nbsp;cadastrar&nbsp;de&nbsp;acordo&nbsp;com&nbsp;a&nbsp;categoria</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1783">1783</td><td nowrap="nowrap">do&nbsp;notificante.&nbsp;Por&nbsp;exemplo,&nbsp;o&nbsp;profissional&nbsp;liberal&nbsp;deve&nbsp;se&nbsp;cadastrar&nbsp;como&nbsp;profissional</td><td class="diff_next"></td><td class="diff_header" id="to62_1759">1759</td><td nowrap="nowrap">do&nbsp;notificante.&nbsp;Por&nbsp;exemplo,&nbsp;o&nbsp;profissional&nbsp;liberal&nbsp;deve&nbsp;se&nbsp;cadastrar&nbsp;como&nbsp;profissional</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1784">1784</td><td nowrap="nowrap">de&nbsp;saúde,&nbsp;mas&nbsp;se&nbsp;for&nbsp;um&nbsp;profissional&nbsp;vinculado&nbsp;a&nbsp;alguma&nbsp;instituição/empresa,&nbsp;deve&nbsp;pro-</td><td class="diff_next"></td><td class="diff_header" id="to62_1760">1760</td><td nowrap="nowrap">de&nbsp;saúde,&nbsp;mas&nbsp;se&nbsp;for&nbsp;um&nbsp;profissional&nbsp;vinculado&nbsp;a&nbsp;alguma&nbsp;instituição/empresa,&nbsp;deve&nbsp;pro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1785">1785</td><td nowrap="nowrap">videnciar&nbsp;o&nbsp;cadastro&nbsp;institucional.&nbsp;Os&nbsp;cidadãos&nbsp;poderão&nbsp;notificar&nbsp;EA&nbsp;e&nbsp;QT&nbsp;por&nbsp;meio&nbsp;dos</td><td class="diff_next"></td><td class="diff_header" id="to62_1761">1761</td><td nowrap="nowrap">videnciar&nbsp;o&nbsp;cadastro&nbsp;institucional.&nbsp;Os&nbsp;cidadãos&nbsp;poderão&nbsp;notificar&nbsp;EA&nbsp;e&nbsp;QT&nbsp;por&nbsp;meio&nbsp;dos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1786">1786</td><td nowrap="nowrap">formulários&nbsp;próprios&nbsp;de&nbsp;notificação.</td><td class="diff_next"></td><td class="diff_header" id="to62_1762">1762</td><td nowrap="nowrap">formulários&nbsp;próprios&nbsp;de&nbsp;notificação.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__42">n</a></td><td class="diff_header" id="from62_1787">1787</td><td nowrap="nowrap"><span class="diff_sub">O&nbsp;sistema&nbsp;Tecnovigilância&nbsp;da&nbsp;Anvisa&nbsp;está&nbsp;disponível&nbsp;em&nbsp;http://portal.anvisa.gov.br/</span></td><td class="diff_next"><a href="#difflib_chg_to62__42">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1788">1788</td><td nowrap="nowrap"><span class="diff_sub">notivisa,&nbsp;e&nbsp;a&nbsp;notificação&nbsp;avulsa,&nbsp;em&nbsp;http://www.anvisa.gov.br/sistec/notificacaoavulsa/</span></td><td class="diff_next"></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1789">1789</td><td nowrap="nowrap">notificacaoavulsa1.asp.</td><td class="diff_next"></td><td class="diff_header" id="to62_1763">1763</td><td nowrap="nowrap">notificacaoavulsa1.asp.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__42"></td><td class="diff_header" id="from62_1790">1790</td><td nowrap="nowrap">16.&nbsp;REFERÊNCIAS</td><td class="diff_next"></td><td class="diff_header" id="to62_1764">1764</td><td nowrap="nowrap">16.&nbsp;REFERÊNCIAS</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1791">1791</td><td nowrap="nowrap">ABBAS,&nbsp;Z.;&nbsp;AFZAL,&nbsp;R.&nbsp;Life&nbsp;cycle&nbsp;and&nbsp;pathogenesis&nbsp;of&nbsp;hepatitis&nbsp;D&nbsp;virus:&nbsp;A&nbsp;review.&nbsp;World</td><td class="diff_next"></td><td class="diff_header" id="to62_1765">1765</td><td nowrap="nowrap">ABBAS,&nbsp;Z.;&nbsp;AFZAL,&nbsp;R.&nbsp;Life&nbsp;cycle&nbsp;and&nbsp;pathogenesis&nbsp;of&nbsp;hepatitis&nbsp;D&nbsp;virus:&nbsp;A&nbsp;review.&nbsp;World</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1792">1792</td><td nowrap="nowrap">journal&nbsp;of&nbsp;hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;5,&nbsp;n.&nbsp;12,&nbsp;p.&nbsp;666-75,&nbsp;27&nbsp;dez.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1766">1766</td><td nowrap="nowrap">journal&nbsp;of&nbsp;hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;5,&nbsp;n.&nbsp;12,&nbsp;p.&nbsp;666-75,&nbsp;27&nbsp;dez.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1793">1793</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pmc/articles/PMC3879688/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1767">1767</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pmc/articles/PMC3879688/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1794">1794</td><td nowrap="nowrap">ALVARADO-MORA,&nbsp;M.&nbsp;V.&nbsp;et&nbsp;al.&nbsp;An&nbsp;update&nbsp;on&nbsp;HDV:&nbsp;Virology,&nbsp;pathogenesis&nbsp;and&nbsp;treatment.</td><td class="diff_next"></td><td class="diff_header" id="to62_1768">1768</td><td nowrap="nowrap">ALVARADO-MORA,&nbsp;M.&nbsp;V.&nbsp;et&nbsp;al.&nbsp;An&nbsp;update&nbsp;on&nbsp;HDV:&nbsp;Virology,&nbsp;pathogenesis&nbsp;and&nbsp;treatment.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__43"><a href="#difflib_chg_to62__43">n</a></td><td class="diff_header" id="from62_1795">1795</td><td nowrap="nowrap"><span class="diff_sub">Antiviral&nbsp;Therapy,&nbsp;[S.l.],&nbsp;v.&nbsp;18,&nbsp;n.&nbsp;3&nbsp;Pt&nbsp;B,&nbsp;p.&nbsp;541-8,&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.int-</span></td><td class="diff_next"><a href="#difflib_chg_to62__43">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1796">1796</td><td nowrap="nowrap">medpress.com/serveFile.cfm?sUID=68afc346-72f4-482e-b40b-2b14cbf5c37d&gt;.&nbsp;Acesso</td><td class="diff_next"></td><td class="diff_header" id="to62_1769">1769</td><td nowrap="nowrap">medpress.com/serveFile.cfm?sUID=68afc346-72f4-482e-b40b-2b14cbf5c37d&gt;.&nbsp;Acesso</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1797">1797</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1770">1770</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__44"></td><td class="diff_header" id="from62_1798">1798</td><td nowrap="nowrap">ARAÚJO,&nbsp;N.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;High&nbsp;proportion&nbsp;of&nbsp;subgroup&nbsp;A’&nbsp;(genotype&nbsp;A)&nbsp;among&nbsp;Brazilian&nbsp;iso-</td><td class="diff_next"></td><td class="diff_header" id="to62_1771">1771</td><td nowrap="nowrap">ARAÚJO,&nbsp;N.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;High&nbsp;proportion&nbsp;of&nbsp;subgroup&nbsp;A’&nbsp;(genotype&nbsp;A)&nbsp;among&nbsp;Brazilian&nbsp;iso-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1799">1799</td><td nowrap="nowrap">lates&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;virus.&nbsp;Archives&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;149,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;1383-95,&nbsp;jul.&nbsp;2004.</td><td class="diff_next"></td><td class="diff_header" id="to62_1772">1772</td><td nowrap="nowrap">lates&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;virus.&nbsp;Archives&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;149,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;1383-95,&nbsp;jul.&nbsp;2004.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__44">n</a></td><td class="diff_header" id="from62_1800">1800</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://link.springer.com/article/10.1007/s00705-003-0269-4&gt;.&nbsp;Acesso</span></td><td class="diff_next"><a href="#difflib_chg_to62__44">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1801">1801</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1773">1773</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1802">1802</td><td nowrap="nowrap">ASHFAQ,&nbsp;U.&nbsp;A&nbsp;et&nbsp;al.&nbsp;An&nbsp;overview&nbsp;of&nbsp;HCV&nbsp;molecular&nbsp;biology,&nbsp;replication&nbsp;and&nbsp;immune&nbsp;res-</td><td class="diff_next"></td><td class="diff_header" id="to62_1774">1774</td><td nowrap="nowrap">ASHFAQ,&nbsp;U.&nbsp;A&nbsp;et&nbsp;al.&nbsp;An&nbsp;overview&nbsp;of&nbsp;HCV&nbsp;molecular&nbsp;biology,&nbsp;replication&nbsp;and&nbsp;immune&nbsp;res-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__45">n</a></td><td class="diff_header" id="from62_1803">1803</td><td nowrap="nowrap"><span class="diff_sub">ponses.&nbsp;Virology&nbsp;journal,&nbsp;[S.l.],&nbsp;v.&nbsp;8,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;161,&nbsp;jan.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.</span></td><td class="diff_next"><a href="#difflib_chg_to62__45">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1804">1804</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/21477382&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1775">1775</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/21477382&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__45"></td><td class="diff_header" id="from62_1805">1805</td><td nowrap="nowrap">ASPINALL,&nbsp;E.&nbsp;J.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;prevention,&nbsp;diagnosis,&nbsp;treatment&nbsp;and&nbsp;care:&nbsp;a&nbsp;review.</td><td class="diff_next"></td><td class="diff_header" id="to62_1776">1776</td><td nowrap="nowrap">ASPINALL,&nbsp;E.&nbsp;J.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;prevention,&nbsp;diagnosis,&nbsp;treatment&nbsp;and&nbsp;care:&nbsp;a&nbsp;review.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1806">1806</td><td nowrap="nowrap">Occupational&nbsp;medicine,&nbsp;[S.l.],&nbsp;v.&nbsp;61,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;531-40,&nbsp;dez.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1777">1777</td><td nowrap="nowrap">Occupational&nbsp;medicine,&nbsp;[S.l.],&nbsp;v.&nbsp;61,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;531-40,&nbsp;dez.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1807">1807</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/22114089&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1778">1778</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/22114089&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1808">1808</td><td nowrap="nowrap">BARON,&nbsp;J.&nbsp;L.&nbsp;et&nbsp;al.&nbsp;Activation&nbsp;of&nbsp;a&nbsp;Nonclassical&nbsp;NKT&nbsp;Cell&nbsp;Subset&nbsp;in&nbsp;a&nbsp;Transgenic&nbsp;Mouse</td><td class="diff_next"></td><td class="diff_header" id="to62_1779">1779</td><td nowrap="nowrap">BARON,&nbsp;J.&nbsp;L.&nbsp;et&nbsp;al.&nbsp;Activation&nbsp;of&nbsp;a&nbsp;Nonclassical&nbsp;NKT&nbsp;Cell&nbsp;Subset&nbsp;in&nbsp;a&nbsp;Transgenic&nbsp;Mouse</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1809">1809</td><td nowrap="nowrap">Model&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Infection.&nbsp;Immunity,&nbsp;[S.l.],&nbsp;v.&nbsp;16,&nbsp;n.&nbsp;4,&nbsp;p.&nbsp;583-594,&nbsp;4&nbsp;abr.&nbsp;2002.</td><td class="diff_next"></td><td class="diff_header" id="to62_1780">1780</td><td nowrap="nowrap">Model&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Infection.&nbsp;Immunity,&nbsp;[S.l.],&nbsp;v.&nbsp;16,&nbsp;n.&nbsp;4,&nbsp;p.&nbsp;583-594,&nbsp;4&nbsp;abr.&nbsp;2002.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__46">n</a></td><td class="diff_header" id="from62_1810">1810</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879688/&gt;.&nbsp;Acesso</span></td><td class="diff_next"><a href="#difflib_chg_to62__46">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1811">1811</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1781">1781</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1812">1812</td><td nowrap="nowrap">BARTENSCHLAGER,&nbsp;R.;&nbsp;COSSET,&nbsp;F.-L.;&nbsp;LOHMANN,&nbsp;V.&nbsp;Hepatitis&nbsp;C&nbsp;virus&nbsp;replication&nbsp;cycle.</td><td class="diff_next"></td><td class="diff_header" id="to62_1782">1782</td><td nowrap="nowrap">BARTENSCHLAGER,&nbsp;R.;&nbsp;COSSET,&nbsp;F.-L.;&nbsp;LOHMANN,&nbsp;V.&nbsp;Hepatitis&nbsp;C&nbsp;virus&nbsp;replication&nbsp;cycle.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__46"></td><td class="diff_header" id="from62_1813">1813</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;53,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;583-585,&nbsp;set.&nbsp;2010.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1783">1783</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;53,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;583-585,&nbsp;set.&nbsp;2010.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1814">1814</td><td nowrap="nowrap">www.journal-of-hepatology.eu/article/S0168-8278(10)00474-5/abstract&gt;.&nbsp;Acesso&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_1784">1784</td><td nowrap="nowrap">www.journal-of-hepatology.eu/article/S0168-8278(10)00474-5/abstract&gt;.&nbsp;Acesso&nbsp;em:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1815">1815</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1785">1785</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1816">1816</td><td nowrap="nowrap">BARTOSCH,&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Cell&nbsp;Entry&nbsp;of&nbsp;Hepatitis&nbsp;C&nbsp;Virus&nbsp;Requires&nbsp;a&nbsp;Set&nbsp;of&nbsp;Co-receptors&nbsp;that</td><td class="diff_next"></td><td class="diff_header" id="to62_1786">1786</td><td nowrap="nowrap">BARTOSCH,&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Cell&nbsp;Entry&nbsp;of&nbsp;Hepatitis&nbsp;C&nbsp;Virus&nbsp;Requires&nbsp;a&nbsp;Set&nbsp;of&nbsp;Co-receptors&nbsp;that</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1817">1817</td><td nowrap="nowrap">Include&nbsp;the&nbsp;CD81&nbsp;Tetraspanin&nbsp;and&nbsp;the&nbsp;SR-B1&nbsp;Scavenger&nbsp;Receptor.&nbsp;Journal&nbsp;of&nbsp;Biological</td><td class="diff_next"></td><td class="diff_header" id="to62_1787">1787</td><td nowrap="nowrap">Include&nbsp;the&nbsp;CD81&nbsp;Tetraspanin&nbsp;and&nbsp;the&nbsp;SR-B1&nbsp;Scavenger&nbsp;Receptor.&nbsp;Journal&nbsp;of&nbsp;Biological</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__47">n</a></td><td class="diff_header" id="from62_1818">1818</td><td nowrap="nowrap"><span class="diff_sub">Chemistry,&nbsp;[S.l.],&nbsp;v.&nbsp;278,&nbsp;n.&nbsp;43,&nbsp;p.&nbsp;41624-30,&nbsp;out.&nbsp;2003.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"><a href="#difflib_chg_to62__47">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__47"></td><td class="diff_header" id="from62_1819">1819</td><td nowrap="nowrap">nlm.nih.gov/pubmed/12913001&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1788">1788</td><td nowrap="nowrap">nlm.nih.gov/pubmed/12913001&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1820">1820</td><td nowrap="nowrap">BELD,&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;of&nbsp;the&nbsp;New&nbsp;Bayer&nbsp;VERSANT&nbsp;HCV&nbsp;RNA&nbsp;3.0&nbsp;Assay&nbsp;for</td><td class="diff_next"></td><td class="diff_header" id="to62_1789">1789</td><td nowrap="nowrap">BELD,&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;of&nbsp;the&nbsp;New&nbsp;Bayer&nbsp;VERSANT&nbsp;HCV&nbsp;RNA&nbsp;3.0&nbsp;Assay&nbsp;for</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1821">1821</td><td nowrap="nowrap">Quantitation&nbsp;of&nbsp;Hepatitis&nbsp;C&nbsp;Virus&nbsp;RNA&nbsp;in&nbsp;Plasma&nbsp;and&nbsp;Serum:&nbsp;Conversion&nbsp;to&nbsp;International</td><td class="diff_next"></td><td class="diff_header" id="to62_1790">1790</td><td nowrap="nowrap">Quantitation&nbsp;of&nbsp;Hepatitis&nbsp;C&nbsp;Virus&nbsp;RNA&nbsp;in&nbsp;Plasma&nbsp;and&nbsp;Serum:&nbsp;Conversion&nbsp;to&nbsp;International</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1822">1822</td><td nowrap="nowrap">Units&nbsp;and&nbsp;Comparison&nbsp;with&nbsp;the&nbsp;Roche&nbsp;COBAS&nbsp;Amplicor&nbsp;HCV&nbsp;Monitor,&nbsp;Version&nbsp;2.0,&nbsp;Assay.</td><td class="diff_next"></td><td class="diff_header" id="to62_1791">1791</td><td nowrap="nowrap">Units&nbsp;and&nbsp;Comparison&nbsp;with&nbsp;the&nbsp;Roche&nbsp;COBAS&nbsp;Amplicor&nbsp;HCV&nbsp;Monitor,&nbsp;Version&nbsp;2.0,&nbsp;Assay.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1823">1823</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;Clinical&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;40,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;788-793,&nbsp;1&nbsp;mar.&nbsp;2002.&nbsp;Disponível</td><td class="diff_next"></td><td class="diff_header" id="to62_1792">1792</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;Clinical&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;40,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;788-793,&nbsp;1&nbsp;mar.&nbsp;2002.&nbsp;Disponível</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__48">n</a></td><td class="diff_header" id="from62_1824">1824</td><td nowrap="nowrap"><span class="diff_sub">em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/11880394&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__48">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1825">1825</td><td nowrap="nowrap">BLANCHARD,&nbsp;E.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;depends&nbsp;on&nbsp;clathrin-mediated&nbsp;endocytosis.</td><td class="diff_next"></td><td class="diff_header" id="to62_1793">1793</td><td nowrap="nowrap">BLANCHARD,&nbsp;E.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;depends&nbsp;on&nbsp;clathrin-mediated&nbsp;endocytosis.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__48"></td><td class="diff_header" id="from62_1826">1826</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;80,&nbsp;n.&nbsp;14,&nbsp;p.&nbsp;6964-72,&nbsp;jul.&nbsp;2006.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1794">1794</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;80,&nbsp;n.&nbsp;14,&nbsp;p.&nbsp;6964-72,&nbsp;jul.&nbsp;2006.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1827">1827</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pmc/articles/PMC1489042/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1795">1795</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pmc/articles/PMC1489042/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__49"></td><td class="diff_header" id="from62_1828">1828</td><td nowrap="nowrap">BRASIL.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Coordenação-Geral&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_1796">1796</td><td nowrap="nowrap">BRASIL.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Coordenação-Geral&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1829">1829</td><td nowrap="nowrap">Desenvolvimento&nbsp;da&nbsp;Epidemiologia&nbsp;em&nbsp;Serviços.&nbsp;Guia&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;2.&nbsp;ed.</td><td class="diff_next"></td><td class="diff_header" id="to62_1797">1797</td><td nowrap="nowrap">Desenvolvimento&nbsp;da&nbsp;Epidemiologia&nbsp;em&nbsp;Serviços.&nbsp;Guia&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;2.&nbsp;ed.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1830">1830</td><td nowrap="nowrap">Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2017a.</td><td class="diff_next"></td><td class="diff_header" id="to62_1798">1798</td><td nowrap="nowrap">Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2017a.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__49">n</a></td><td class="diff_header" id="from62_1831">1831</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td><td class="diff_next"><a href="#difflib_chg_to62__49">n</a></td><td class="diff_header" id="to62_1799">1799</td><td nowrap="nowrap">_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__50"></td><td class="diff_header" id="from62_1832">1832</td><td nowrap="nowrap">Vigilância&nbsp;Epidemiológica.&nbsp;Hepatites&nbsp;virais:&nbsp;o&nbsp;Brasil&nbsp;está&nbsp;atento.&nbsp;3.&nbsp;ed.&nbsp;Brasília:</td><td class="diff_next"></td><td class="diff_header" id="to62_1800">1800</td><td nowrap="nowrap">Vigilância&nbsp;Epidemiológica.&nbsp;Hepatites&nbsp;virais:&nbsp;o&nbsp;Brasil&nbsp;está&nbsp;atento.&nbsp;3.&nbsp;ed.&nbsp;Brasília:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__50">n</a></td><td class="diff_header" id="from62_1833">1833</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td><td class="diff_next"><a href="#difflib_chg_to62__50">n</a></td><td class="diff_header" id="to62_1801">1801</td><td nowrap="nowrap">_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1834">1834</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td><td class="diff_next"></td><td class="diff_header" id="to62_1802">1802</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1835">1835</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Boletim&nbsp;Epidemiológico&nbsp;de&nbsp;Hepatites&nbsp;Virais.&nbsp;Brasília:&nbsp;Ministério</td><td class="diff_next"></td><td class="diff_header" id="to62_1803">1803</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Boletim&nbsp;Epidemiológico&nbsp;de&nbsp;Hepatites&nbsp;Virais.&nbsp;Brasília:&nbsp;Ministério</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__51"></td><td class="diff_header" id="from62_1836">1836</td><td nowrap="nowrap">da&nbsp;Saúde,&nbsp;2017b.</td><td class="diff_next"></td><td class="diff_header" id="to62_1804">1804</td><td nowrap="nowrap">da&nbsp;Saúde,&nbsp;2017b.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__51">n</a></td><td class="diff_header" id="from62_1837">1837</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td><td class="diff_next"><a href="#difflib_chg_to62__51">n</a></td><td class="diff_header" id="to62_1805">1805</td><td nowrap="nowrap">_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1838">1838</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td><td class="diff_next"></td><td class="diff_header" id="to62_1806">1806</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1839">1839</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;B&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1807">1807</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;B&nbsp;e</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__52"></td><td class="diff_header" id="from62_1840">1840</td><td nowrap="nowrap">Coinfecções.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2017c.</td><td class="diff_next"></td><td class="diff_header" id="to62_1808">1808</td><td nowrap="nowrap">Coinfecções.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2017c.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__52">n</a></td><td class="diff_header" id="from62_1841">1841</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td><td class="diff_next"><a href="#difflib_chg_to62__52">n</a></td><td class="diff_header" id="to62_1809">1809</td><td nowrap="nowrap">_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1842">1842</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td><td class="diff_next"></td><td class="diff_header" id="to62_1810">1810</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1843">1843</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;C&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to62_1811">1811</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Hepatite&nbsp;C&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1844">1844</td><td nowrap="nowrap">Coinfecções.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2017d.</td><td class="diff_next"></td><td class="diff_header" id="to62_1812">1812</td><td nowrap="nowrap">Coinfecções.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2017d.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__53"><a href="#difflib_chg_to62__53">n</a></td><td class="diff_header" id="from62_1845">1845</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td><td class="diff_next"><a href="#difflib_chg_to62__53">n</a></td><td class="diff_header" id="to62_1813">1813</td><td nowrap="nowrap">_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1846">1846</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td><td class="diff_next"></td><td class="diff_header" id="to62_1814">1814</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;do&nbsp;HIV/Aids</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1847">1847</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Prevenção&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1815">1815</td><td nowrap="nowrap">e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Prevenção&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1848">1848</td><td nowrap="nowrap">Transmissão&nbsp;Vertical&nbsp;de&nbsp;HIV,&nbsp;Sífilis&nbsp;e&nbsp;Hepatites&nbsp;Virais.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,</td><td class="diff_next"></td><td class="diff_header" id="to62_1816">1816</td><td nowrap="nowrap">Transmissão&nbsp;Vertical&nbsp;de&nbsp;HIV,&nbsp;Sífilis&nbsp;e&nbsp;Hepatites&nbsp;Virais.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1849">1849</td><td nowrap="nowrap">2017e.</td><td class="diff_next"></td><td class="diff_header" id="to62_1817">1817</td><td nowrap="nowrap">2017e.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__54"><a href="#difflib_chg_to62__54">n</a></td><td class="diff_header" id="from62_1850">1850</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td><td class="diff_next"><a href="#difflib_chg_to62__54">n</a></td><td class="diff_header" id="to62_1818">1818</td><td nowrap="nowrap">_.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde.&nbsp;Departamento&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1851">1851</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;IST,&nbsp;do&nbsp;HIV/Aids&nbsp;e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Telelab&nbsp;-</td><td class="diff_next"></td><td class="diff_header" id="to62_1819">1819</td><td nowrap="nowrap">Vigilância,&nbsp;Prevenção&nbsp;e&nbsp;Controle&nbsp;das&nbsp;IST,&nbsp;do&nbsp;HIV/Aids&nbsp;e&nbsp;das&nbsp;Hepatites&nbsp;Virais.&nbsp;Telelab&nbsp;-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1852">1852</td><td nowrap="nowrap">Diagnóstico&nbsp;de&nbsp;Hepatites&nbsp;Virais.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2014.</td><td class="diff_next"></td><td class="diff_header" id="to62_1820">1820</td><td nowrap="nowrap">Diagnóstico&nbsp;de&nbsp;Hepatites&nbsp;Virais.&nbsp;Brasília:&nbsp;Ministério&nbsp;da&nbsp;Saúde,&nbsp;2014.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1853">1853</td><td nowrap="nowrap">CALIENDO,&nbsp;A.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Multilaboratory&nbsp;evaluation&nbsp;of&nbsp;real-time&nbsp;PCR&nbsp;tests&nbsp;for&nbsp;hepatitis&nbsp;B</td><td class="diff_next"></td><td class="diff_header" id="to62_1821">1821</td><td nowrap="nowrap">CALIENDO,&nbsp;A.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Multilaboratory&nbsp;evaluation&nbsp;of&nbsp;real-time&nbsp;PCR&nbsp;tests&nbsp;for&nbsp;hepatitis&nbsp;B</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1854">1854</td><td nowrap="nowrap">virus&nbsp;DNA&nbsp;quantification.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;49,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;2854-8,</td><td class="diff_next"></td><td class="diff_header" id="to62_1822">1822</td><td nowrap="nowrap">virus&nbsp;DNA&nbsp;quantification.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;49,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;2854-8,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__55">n</a></td><td class="diff_header" id="from62_1855">1855</td><td nowrap="nowrap"><span class="diff_sub">ago.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147738/&gt;</span></td><td class="diff_next"><a href="#difflib_chg_to62__55">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__55"></td><td class="diff_header" id="from62_1856">1856</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1823">1823</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1857">1857</td><td nowrap="nowrap">CAO,&nbsp;D.;&nbsp;MENG,&nbsp;X.-J.&nbsp;Molecular&nbsp;biology&nbsp;and&nbsp;replication&nbsp;of&nbsp;hepatitis&nbsp;E&nbsp;virus.&nbsp;Emerging</td><td class="diff_next"></td><td class="diff_header" id="to62_1824">1824</td><td nowrap="nowrap">CAO,&nbsp;D.;&nbsp;MENG,&nbsp;X.-J.&nbsp;Molecular&nbsp;biology&nbsp;and&nbsp;replication&nbsp;of&nbsp;hepatitis&nbsp;E&nbsp;virus.&nbsp;Emerging</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1858">1858</td><td nowrap="nowrap">Microbes&nbsp;&amp;&nbsp;Infections,&nbsp;[S.l.],&nbsp;v.&nbsp;1,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;e17,&nbsp;22&nbsp;ago.&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1825">1825</td><td nowrap="nowrap">Microbes&nbsp;&amp;&nbsp;Infections,&nbsp;[S.l.],&nbsp;v.&nbsp;1,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;e17,&nbsp;22&nbsp;ago.&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1859">1859</td><td nowrap="nowrap">www.nature.com/articles/emi20127&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1826">1826</td><td nowrap="nowrap">www.nature.com/articles/emi20127&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__56"></td><td class="diff_header" id="from62_1860">1860</td><td nowrap="nowrap">CHEVALIEZ,&nbsp;S.;&nbsp;PAWLOTSKY,&nbsp;J.-M.&nbsp;Virology&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;infection.&nbsp;Best&nbsp;Pract&nbsp;Res</td><td class="diff_next"></td><td class="diff_header" id="to62_1827">1827</td><td nowrap="nowrap">CHEVALIEZ,&nbsp;S.;&nbsp;PAWLOTSKY,&nbsp;J.-M.&nbsp;Virology&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;infection.&nbsp;Best&nbsp;Pract&nbsp;Res</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__56">n</a></td><td class="diff_header" id="from62_1861">1861</td><td nowrap="nowrap"><span class="diff_sub">Clin&nbsp;Gastroenterol,&nbsp;[S.l.],&nbsp;v.&nbsp;26,&nbsp;n.&nbsp;4,&nbsp;p.&nbsp;381-389,&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"><a href="#difflib_chg_to62__56">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1862">1862</td><td nowrap="nowrap">nlm.nih.gov/pubmed/23199498&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1828">1828</td><td nowrap="nowrap">nlm.nih.gov/pubmed/23199498&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1863">1863</td><td nowrap="nowrap">CHEVALIEZ,&nbsp;S.;&nbsp;RODRIGUEZ,&nbsp;C.;&nbsp;PAWLOTSKY,&nbsp;J.-M.&nbsp;New&nbsp;Virologic&nbsp;Tools&nbsp;for&nbsp;Management</td><td class="diff_next"></td><td class="diff_header" id="to62_1829">1829</td><td nowrap="nowrap">CHEVALIEZ,&nbsp;S.;&nbsp;RODRIGUEZ,&nbsp;C.;&nbsp;PAWLOTSKY,&nbsp;J.-M.&nbsp;New&nbsp;Virologic&nbsp;Tools&nbsp;for&nbsp;Management</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__57"></td><td class="diff_header" id="from62_1864">1864</td><td nowrap="nowrap">of&nbsp;Chronic&nbsp;Hepatitis&nbsp;B&nbsp;and&nbsp;C.&nbsp;Gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;142,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;1303-13.e1,&nbsp;maio</td><td class="diff_next"></td><td class="diff_header" id="to62_1830">1830</td><td nowrap="nowrap">of&nbsp;Chronic&nbsp;Hepatitis&nbsp;B&nbsp;and&nbsp;C.&nbsp;Gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;142,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;1303-13.e1,&nbsp;maio</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__57">n</a></td><td class="diff_header" id="from62_1865">1865</td><td nowrap="nowrap"><span class="diff_sub">2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/22537437&gt;.&nbsp;Acesso&nbsp;em:</span></td><td class="diff_next"><a href="#difflib_chg_to62__57">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__58"></td><td class="diff_header" id="from62_1866">1866</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1831">1831</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1867">1867</td><td nowrap="nowrap">CIANCIO,&nbsp;A.;&nbsp;RIZZETTO,&nbsp;M.&nbsp;Chronic&nbsp;hepatitis&nbsp;D&nbsp;at&nbsp;a&nbsp;standstill:&nbsp;where&nbsp;do&nbsp;we&nbsp;go&nbsp;from&nbsp;here?</td><td class="diff_next"></td><td class="diff_header" id="to62_1832">1832</td><td nowrap="nowrap">CIANCIO,&nbsp;A.;&nbsp;RIZZETTO,&nbsp;M.&nbsp;Chronic&nbsp;hepatitis&nbsp;D&nbsp;at&nbsp;a&nbsp;standstill:&nbsp;where&nbsp;do&nbsp;we&nbsp;go&nbsp;from&nbsp;here?</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1868">1868</td><td nowrap="nowrap">Nat&nbsp;Rev&nbsp;Gastroenterol&nbsp;Hepatol,&nbsp;[S.l.],&nbsp;v.&nbsp;11,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;68-71,&nbsp;10&nbsp;jan.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_1833">1833</td><td nowrap="nowrap">Nat&nbsp;Rev&nbsp;Gastroenterol&nbsp;Hepatol,&nbsp;[S.l.],&nbsp;v.&nbsp;11,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;68-71,&nbsp;10&nbsp;jan.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__58">n</a></td><td class="diff_header" id="from62_1869">1869</td><td nowrap="nowrap"><span class="diff_sub">&lt;https://www.ncbi.nlm.nih.gov/pubmed/24019153&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__58">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1870">1870</td><td nowrap="nowrap">CUTHBERT,&nbsp;J.&nbsp;A.&nbsp;Hepatitis&nbsp;A:&nbsp;old&nbsp;and&nbsp;new.&nbsp;Clinical&nbsp;Microbiology&nbsp;Reviews,&nbsp;[S.l.],&nbsp;v.&nbsp;14,&nbsp;n.&nbsp;1,</td><td class="diff_next"></td><td class="diff_header" id="to62_1834">1834</td><td nowrap="nowrap">CUTHBERT,&nbsp;J.&nbsp;A.&nbsp;Hepatitis&nbsp;A:&nbsp;old&nbsp;and&nbsp;new.&nbsp;Clinical&nbsp;Microbiology&nbsp;Reviews,&nbsp;[S.l.],&nbsp;v.&nbsp;14,&nbsp;n.&nbsp;1,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__59">n</a></td><td class="diff_header" id="from62_1871">1871</td><td nowrap="nowrap"><span class="diff_sub">p.&nbsp;38-58,&nbsp;jan.&nbsp;2001.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/11148002&gt;.</span></td><td class="diff_next"><a href="#difflib_chg_to62__59">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1872">1872</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1835">1835</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1873">1873</td><td nowrap="nowrap">DA&nbsp;CONCEIÇÃO,&nbsp;O.&nbsp;J.&nbsp;G.;&nbsp;SICILIANO,&nbsp;R.&nbsp;F.;&nbsp;FOCACCIA,&nbsp;R.&nbsp;Hepatite&nbsp;A:&nbsp;Patogenia.&nbsp;In:</td><td class="diff_next"></td><td class="diff_header" id="to62_1836">1836</td><td nowrap="nowrap">DA&nbsp;CONCEIÇÃO,&nbsp;O.&nbsp;J.&nbsp;G.;&nbsp;SICILIANO,&nbsp;R.&nbsp;F.;&nbsp;FOCACCIA,&nbsp;R.&nbsp;Hepatite&nbsp;A:&nbsp;Patogenia.&nbsp;In:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1874">1874</td><td nowrap="nowrap">FOCACCIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.&nbsp;3.&nbsp;ed.&nbsp;São</td><td class="diff_next"></td><td class="diff_header" id="to62_1837">1837</td><td nowrap="nowrap">FOCACCIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.&nbsp;3.&nbsp;ed.&nbsp;São</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1875">1875</td><td nowrap="nowrap">Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;245-247.</td><td class="diff_next"></td><td class="diff_header" id="to62_1838">1838</td><td nowrap="nowrap">Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;245-247.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1876">1876</td><td nowrap="nowrap">DA&nbsp;ROSA,&nbsp;L.&nbsp;et&nbsp;al.&nbsp;Diagnostic&nbsp;Performance&nbsp;of&nbsp;Two&nbsp;Point-of-Care&nbsp;Tests&nbsp;for&nbsp;Anti-HCV</td><td class="diff_next"></td><td class="diff_header" id="to62_1839">1839</td><td nowrap="nowrap">DA&nbsp;ROSA,&nbsp;L.&nbsp;et&nbsp;al.&nbsp;Diagnostic&nbsp;Performance&nbsp;of&nbsp;Two&nbsp;Point-of-Care&nbsp;Tests&nbsp;for&nbsp;Anti-HCV</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1877">1877</td><td nowrap="nowrap">Detection.&nbsp;Hepatitis&nbsp;monthly,&nbsp;[S.l.],&nbsp;v.&nbsp;13,&nbsp;n.&nbsp;9,&nbsp;p.&nbsp;e12274,&nbsp;jan.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;htt-</td><td class="diff_next"></td><td class="diff_header" id="to62_1840">1840</td><td nowrap="nowrap">Detection.&nbsp;Hepatitis&nbsp;monthly,&nbsp;[S.l.],&nbsp;v.&nbsp;13,&nbsp;n.&nbsp;9,&nbsp;p.&nbsp;e12274,&nbsp;jan.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;htt-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1878">1878</td><td nowrap="nowrap">ps://www.ncbi.nlm.nih.gov/pubmed/24282422&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1841">1841</td><td nowrap="nowrap">ps://www.ncbi.nlm.nih.gov/pubmed/24282422&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__59"></td><td class="diff_header" id="from62_1879">1879</td><td nowrap="nowrap">DOMINGO,&nbsp;E.;&nbsp;PARRISH,&nbsp;C.&nbsp;R.;&nbsp;HOLLAND,&nbsp;J.&nbsp;J.&nbsp;Origin&nbsp;and&nbsp;Evolution&nbsp;of&nbsp;Viruses.&nbsp;[S.l.]:</td><td class="diff_next"></td><td class="diff_header" id="to62_1842">1842</td><td nowrap="nowrap">DOMINGO,&nbsp;E.;&nbsp;PARRISH,&nbsp;C.&nbsp;R.;&nbsp;HOLLAND,&nbsp;J.&nbsp;J.&nbsp;Origin&nbsp;and&nbsp;Evolution&nbsp;of&nbsp;Viruses.&nbsp;[S.l.]:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1880">1880</td><td nowrap="nowrap">Elsevier&nbsp;Science,&nbsp;2008.</td><td class="diff_next"></td><td class="diff_header" id="to62_1843">1843</td><td nowrap="nowrap">Elsevier&nbsp;Science,&nbsp;2008.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1881">1881</td><td nowrap="nowrap">DREXLER,&nbsp;J.&nbsp;F.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;of&nbsp;the&nbsp;novel&nbsp;Qiagen&nbsp;artus&nbsp;QS-RGQ&nbsp;viral&nbsp;load&nbsp;assays&nbsp;com-</td><td class="diff_next"></td><td class="diff_header" id="to62_1844">1844</td><td nowrap="nowrap">DREXLER,&nbsp;J.&nbsp;F.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;of&nbsp;the&nbsp;novel&nbsp;Qiagen&nbsp;artus&nbsp;QS-RGQ&nbsp;viral&nbsp;load&nbsp;assays&nbsp;com-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1882">1882</td><td nowrap="nowrap">pared&nbsp;to&nbsp;that&nbsp;of&nbsp;the&nbsp;Abbott&nbsp;RealTime&nbsp;system&nbsp;with&nbsp;genetically&nbsp;diversified&nbsp;HIV&nbsp;and&nbsp;hepati-</td><td class="diff_next"></td><td class="diff_header" id="to62_1845">1845</td><td nowrap="nowrap">pared&nbsp;to&nbsp;that&nbsp;of&nbsp;the&nbsp;Abbott&nbsp;RealTime&nbsp;system&nbsp;with&nbsp;genetically&nbsp;diversified&nbsp;HIV&nbsp;and&nbsp;hepati-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1883">1883</td><td nowrap="nowrap">tis&nbsp;C&nbsp;Virus&nbsp;plasma&nbsp;specimens.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;50,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;2114-</td><td class="diff_next"></td><td class="diff_header" id="to62_1846">1846</td><td nowrap="nowrap">tis&nbsp;C&nbsp;Virus&nbsp;plasma&nbsp;specimens.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;50,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;2114-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__60">n</a></td><td class="diff_header" id="from62_1884">1884</td><td nowrap="nowrap"><span class="diff_sub">17,&nbsp;jun.&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/22403428&gt;.</span></td><td class="diff_next"><a href="#difflib_chg_to62__60">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1885">1885</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1847">1847</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__60"></td><td class="diff_header" id="from62_1886">1886</td><td nowrap="nowrap">DUSTIN,&nbsp;L.&nbsp;B.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;Flying&nbsp;under&nbsp;the&nbsp;radar:&nbsp;the&nbsp;immunobiology&nbsp;of&nbsp;hepatitis&nbsp;C.</td><td class="diff_next"></td><td class="diff_header" id="to62_1848">1848</td><td nowrap="nowrap">DUSTIN,&nbsp;L.&nbsp;B.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;Flying&nbsp;under&nbsp;the&nbsp;radar:&nbsp;the&nbsp;immunobiology&nbsp;of&nbsp;hepatitis&nbsp;C.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1887">1887</td><td nowrap="nowrap">Annual&nbsp;review&nbsp;of&nbsp;immunology,&nbsp;[S.l.],&nbsp;v.&nbsp;25,&nbsp;p.&nbsp;71-99,&nbsp;jan.&nbsp;2007.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1849">1849</td><td nowrap="nowrap">Annual&nbsp;review&nbsp;of&nbsp;immunology,&nbsp;[S.l.],&nbsp;v.&nbsp;25,&nbsp;p.&nbsp;71-99,&nbsp;jan.&nbsp;2007.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1888">1888</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/17067278&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1850">1850</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/17067278&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1889">1889</td><td nowrap="nowrap">ECDC&nbsp;(European&nbsp;Centre&nbsp;for&nbsp;Disease&nbsp;Prevention&nbsp;and&nbsp;Control).&nbsp;Hepatitis&nbsp;A&nbsp;outbreaks&nbsp;in</td><td class="diff_next"></td><td class="diff_header" id="to62_1851">1851</td><td nowrap="nowrap">ECDC&nbsp;(European&nbsp;Centre&nbsp;for&nbsp;Disease&nbsp;Prevention&nbsp;and&nbsp;Control).&nbsp;Hepatitis&nbsp;A&nbsp;outbreaks&nbsp;in</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1890">1890</td><td nowrap="nowrap">the&nbsp;EU/EEA&nbsp;mostly&nbsp;affecting&nbsp;men&nbsp;who&nbsp;have&nbsp;sex&nbsp;with&nbsp;men&nbsp;[on-line].&nbsp;19&nbsp;maio&nbsp;2017.</td><td class="diff_next"></td><td class="diff_header" id="to62_1852">1852</td><td nowrap="nowrap">the&nbsp;EU/EEA&nbsp;mostly&nbsp;affecting&nbsp;men&nbsp;who&nbsp;have&nbsp;sex&nbsp;with&nbsp;men&nbsp;[on-line].&nbsp;19&nbsp;maio&nbsp;2017.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__61"><a href="#difflib_chg_to62__61">n</a></td><td class="diff_header" id="from62_1891">1891</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://ecdc.europa.eu/en/publications-data/rapid-risk-assessment-</span></td><td class="diff_next"><a href="#difflib_chg_to62__61">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1892">1892</td><td nowrap="nowrap">-hepatitis-outbreaks-eueea-mostly-affecting-men-who-have-0&gt;.&nbsp;Acesso&nbsp;em:&nbsp;17&nbsp;abr.</td><td class="diff_next"></td><td class="diff_header" id="to62_1853">1853</td><td nowrap="nowrap">-hepatitis-outbreaks-eueea-mostly-affecting-men-who-have-0&gt;.&nbsp;Acesso&nbsp;em:&nbsp;17&nbsp;abr.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1893">1893</td><td nowrap="nowrap">2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1854">1854</td><td nowrap="nowrap">2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__62"></td><td class="diff_header" id="from62_1894">1894</td><td nowrap="nowrap">ECHEVARRÍA,&nbsp;J.-M.&nbsp;Light&nbsp;and&nbsp;Darkness:&nbsp;Prevalence&nbsp;of&nbsp;Hepatitis&nbsp;E&nbsp;Virus&nbsp;Infection&nbsp;among</td><td class="diff_next"></td><td class="diff_header" id="to62_1855">1855</td><td nowrap="nowrap">ECHEVARRÍA,&nbsp;J.-M.&nbsp;Light&nbsp;and&nbsp;Darkness:&nbsp;Prevalence&nbsp;of&nbsp;Hepatitis&nbsp;E&nbsp;Virus&nbsp;Infection&nbsp;among</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1895">1895</td><td nowrap="nowrap">the&nbsp;General&nbsp;Population.&nbsp;Scientifica,&nbsp;[S.l.],&nbsp;v.&nbsp;2014,&nbsp;p.&nbsp;481016,&nbsp;jan.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_1856">1856</td><td nowrap="nowrap">the&nbsp;General&nbsp;Population.&nbsp;Scientifica,&nbsp;[S.l.],&nbsp;v.&nbsp;2014,&nbsp;p.&nbsp;481016,&nbsp;jan.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__62">n</a></td><td class="diff_header" id="from62_1896">1896</td><td nowrap="nowrap"><span class="diff_sub">&lt;https://www.ncbi.nlm.nih.gov/pubmed/24672733&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__62">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__63"></td><td class="diff_header" id="from62_1897">1897</td><td nowrap="nowrap">EVANS,&nbsp;M.;&nbsp;HAHN,&nbsp;T.&nbsp;VON;&nbsp;TSCHERNE,&nbsp;D.&nbsp;Claudin-1&nbsp;is&nbsp;a&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;co-receptor&nbsp;re-</td><td class="diff_next"></td><td class="diff_header" id="to62_1857">1857</td><td nowrap="nowrap">EVANS,&nbsp;M.;&nbsp;HAHN,&nbsp;T.&nbsp;VON;&nbsp;TSCHERNE,&nbsp;D.&nbsp;Claudin-1&nbsp;is&nbsp;a&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;co-receptor&nbsp;re-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1898">1898</td><td nowrap="nowrap">quired&nbsp;for&nbsp;a&nbsp;late&nbsp;step&nbsp;in&nbsp;entry.&nbsp;Nature,&nbsp;[S.l.],&nbsp;v.&nbsp;446,&nbsp;n.&nbsp;7137,&nbsp;p.&nbsp;801-5,&nbsp;abr.&nbsp;2007.&nbsp;Disponível</td><td class="diff_next"></td><td class="diff_header" id="to62_1858">1858</td><td nowrap="nowrap">quired&nbsp;for&nbsp;a&nbsp;late&nbsp;step&nbsp;in&nbsp;entry.&nbsp;Nature,&nbsp;[S.l.],&nbsp;v.&nbsp;446,&nbsp;n.&nbsp;7137,&nbsp;p.&nbsp;801-5,&nbsp;abr.&nbsp;2007.&nbsp;Disponível</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__63">n</a></td><td class="diff_header" id="from62_1899">1899</td><td nowrap="nowrap"><span class="diff_sub">em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/17325668&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__63">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1900">1900</td><td nowrap="nowrap">FERREIRA,&nbsp;R.&nbsp;C.&nbsp;et&nbsp;al.&nbsp;Prevalence&nbsp;of&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;and&nbsp;risk&nbsp;factors&nbsp;in&nbsp;Brazilian&nbsp;non-</td><td class="diff_next"></td><td class="diff_header" id="to62_1859">1859</td><td nowrap="nowrap">FERREIRA,&nbsp;R.&nbsp;C.&nbsp;et&nbsp;al.&nbsp;Prevalence&nbsp;of&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;and&nbsp;risk&nbsp;factors&nbsp;in&nbsp;Brazilian&nbsp;non-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1901">1901</td><td nowrap="nowrap">-injecting&nbsp;drug&nbsp;users.&nbsp;Journal&nbsp;of&nbsp;medical&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;81,&nbsp;n.&nbsp;4,&nbsp;p.&nbsp;602-9,&nbsp;abr.&nbsp;2009.</td><td class="diff_next"></td><td class="diff_header" id="to62_1860">1860</td><td nowrap="nowrap">-injecting&nbsp;drug&nbsp;users.&nbsp;Journal&nbsp;of&nbsp;medical&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;81,&nbsp;n.&nbsp;4,&nbsp;p.&nbsp;602-9,&nbsp;abr.&nbsp;2009.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__64"><a href="#difflib_chg_to62__64">n</a></td><td class="diff_header" id="from62_1902">1902</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/19235862&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29</span></td><td class="diff_next"><a href="#difflib_chg_to62__64">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1903">1903</td><td nowrap="nowrap">maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1861">1861</td><td nowrap="nowrap">maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1904">1904</td><td nowrap="nowrap">FIELDS,&nbsp;B.&nbsp;N.;&nbsp;KNIPE,&nbsp;D.&nbsp;M.;&nbsp;HOWLEY,&nbsp;P.&nbsp;M.&nbsp;Fields’&nbsp;Virology.&nbsp;5.&nbsp;ed.&nbsp;[S.l.]:&nbsp;Wolters&nbsp;Kluwer</td><td class="diff_next"></td><td class="diff_header" id="to62_1862">1862</td><td nowrap="nowrap">FIELDS,&nbsp;B.&nbsp;N.;&nbsp;KNIPE,&nbsp;D.&nbsp;M.;&nbsp;HOWLEY,&nbsp;P.&nbsp;M.&nbsp;Fields’&nbsp;Virology.&nbsp;5.&nbsp;ed.&nbsp;[S.l.]:&nbsp;Wolters&nbsp;Kluwer</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1905">1905</td><td nowrap="nowrap">Health/Lippincott&nbsp;Williams&nbsp;&amp;&nbsp;Wilkins,&nbsp;2007.</td><td class="diff_next"></td><td class="diff_header" id="to62_1863">1863</td><td nowrap="nowrap">Health/Lippincott&nbsp;Williams&nbsp;&amp;&nbsp;Wilkins,&nbsp;2007.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1906">1906</td><td nowrap="nowrap">FRANCISCUS,&nbsp;A.;&nbsp;HIGHLEYMAN,&nbsp;L.&nbsp;HCV&nbsp;diagnostic&nbsp;tools:&nbsp;HCV&nbsp;Viral&nbsp;Load&nbsp;Tests.&nbsp;HCSP&nbsp;Fact</td><td class="diff_next"></td><td class="diff_header" id="to62_1864">1864</td><td nowrap="nowrap">FRANCISCUS,&nbsp;A.;&nbsp;HIGHLEYMAN,&nbsp;L.&nbsp;HCV&nbsp;diagnostic&nbsp;tools:&nbsp;HCV&nbsp;Viral&nbsp;Load&nbsp;Tests.&nbsp;HCSP&nbsp;Fact</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__65"><a href="#difflib_chg_to62__65">n</a></td><td class="diff_header" id="from62_1907">1907</td><td nowrap="nowrap"><span class="diff_sub">Sheet,&nbsp;[S.l.],&nbsp;p.&nbsp;1-3,&nbsp;2014.&nbsp;Disponível&nbsp;em:&nbsp;&lt;http://hcvadvocate.org/hepatitis/factsheets_</span></td><td class="diff_next"><a href="#difflib_chg_to62__65">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1908">1908</td><td nowrap="nowrap">pdf/viralload.pdf&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1865">1865</td><td nowrap="nowrap">pdf/viralload.pdf&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1909">1909</td><td nowrap="nowrap">FUNG,&nbsp;J.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;Surface&nbsp;Antigen&nbsp;Seroclearance:&nbsp;Relationship&nbsp;to&nbsp;Hepatitis&nbsp;B&nbsp;e-</td><td class="diff_next"></td><td class="diff_header" id="to62_1866">1866</td><td nowrap="nowrap">FUNG,&nbsp;J.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;Surface&nbsp;Antigen&nbsp;Seroclearance:&nbsp;Relationship&nbsp;to&nbsp;Hepatitis&nbsp;B&nbsp;e-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1910">1910</td><td nowrap="nowrap">-Antigen&nbsp;Seroclearance&nbsp;and&nbsp;Hepatitis&nbsp;B&nbsp;e-Antigen-Negative&nbsp;Hepatitis.&nbsp;The&nbsp;American</td><td class="diff_next"></td><td class="diff_header" id="to62_1867">1867</td><td nowrap="nowrap">-Antigen&nbsp;Seroclearance&nbsp;and&nbsp;Hepatitis&nbsp;B&nbsp;e-Antigen-Negative&nbsp;Hepatitis.&nbsp;The&nbsp;American</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1911">1911</td><td nowrap="nowrap">journal&nbsp;of&nbsp;gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;109,&nbsp;n.&nbsp;11,&nbsp;p.&nbsp;1764-70,&nbsp;nov.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_1868">1868</td><td nowrap="nowrap">journal&nbsp;of&nbsp;gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;109,&nbsp;n.&nbsp;11,&nbsp;p.&nbsp;1764-70,&nbsp;nov.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__66"><a href="#difflib_chg_to62__66">n</a></td><td class="diff_header" id="from62_1912">1912</td><td nowrap="nowrap"><span class="diff_sub">&lt;https://www.ncbi.nlm.nih.gov/pubmed/25244963&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__66">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1913">1913</td><td nowrap="nowrap">GASPAR,&nbsp;A.&nbsp;M.&nbsp;C.;&nbsp;VITRAL,&nbsp;C.&nbsp;LA.;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;J.&nbsp;M.&nbsp;Biologia&nbsp;Molecular&nbsp;do&nbsp;Vírus&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to62_1869">1869</td><td nowrap="nowrap">GASPAR,&nbsp;A.&nbsp;M.&nbsp;C.;&nbsp;VITRAL,&nbsp;C.&nbsp;LA.;&nbsp;DE&nbsp;OLIVEIRA,&nbsp;J.&nbsp;M.&nbsp;Biologia&nbsp;Molecular&nbsp;do&nbsp;Vírus&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1914">1914</td><td nowrap="nowrap">Hepatite&nbsp;A.&nbsp;In:&nbsp;FOCCACIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.</td><td class="diff_next"></td><td class="diff_header" id="to62_1870">1870</td><td nowrap="nowrap">Hepatite&nbsp;A.&nbsp;In:&nbsp;FOCCACIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1915">1915</td><td nowrap="nowrap">3.&nbsp;ed.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;249-55.</td><td class="diff_next"></td><td class="diff_header" id="to62_1871">1871</td><td nowrap="nowrap">3.&nbsp;ed.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;249-55.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__67"></td><td class="diff_header" id="from62_1916">1916</td><td nowrap="nowrap">GERLICH,&nbsp;W.&nbsp;H.&nbsp;Medical&nbsp;virology&nbsp;of&nbsp;hepatitis&nbsp;B:&nbsp;how&nbsp;it&nbsp;began&nbsp;and&nbsp;where&nbsp;we&nbsp;are&nbsp;now.</td><td class="diff_next"></td><td class="diff_header" id="to62_1872">1872</td><td nowrap="nowrap">GERLICH,&nbsp;W.&nbsp;H.&nbsp;Medical&nbsp;virology&nbsp;of&nbsp;hepatitis&nbsp;B:&nbsp;how&nbsp;it&nbsp;began&nbsp;and&nbsp;where&nbsp;we&nbsp;are&nbsp;now.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__67">n</a></td><td class="diff_header" id="from62_1917">1917</td><td nowrap="nowrap"><span class="diff_sub">Virology&nbsp;journal,&nbsp;[S.l.],&nbsp;v.&nbsp;10,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;239,&nbsp;jan.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"><a href="#difflib_chg_to62__67">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1918">1918</td><td nowrap="nowrap">nlm.nih.gov/pubmed/23870415&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1873">1873</td><td nowrap="nowrap">nlm.nih.gov/pubmed/23870415&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1919">1919</td><td nowrap="nowrap">GHAMARI,&nbsp;S.&nbsp;et&nbsp;al.&nbsp;Prevalence&nbsp;of&nbsp;hepatitis&nbsp;delta&nbsp;virus&nbsp;(HDV)&nbsp;infection&nbsp;in&nbsp;chronic&nbsp;hepatitis</td><td class="diff_next"></td><td class="diff_header" id="to62_1874">1874</td><td nowrap="nowrap">GHAMARI,&nbsp;S.&nbsp;et&nbsp;al.&nbsp;Prevalence&nbsp;of&nbsp;hepatitis&nbsp;delta&nbsp;virus&nbsp;(HDV)&nbsp;infection&nbsp;in&nbsp;chronic&nbsp;hepatitis</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1920">1920</td><td nowrap="nowrap">B&nbsp;patients&nbsp;with&nbsp;unusual&nbsp;clinical&nbsp;pictures.&nbsp;Hepatitis&nbsp;monthly,&nbsp;[S.l.],&nbsp;v.&nbsp;13,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;e6731,</td><td class="diff_next"></td><td class="diff_header" id="to62_1875">1875</td><td nowrap="nowrap">B&nbsp;patients&nbsp;with&nbsp;unusual&nbsp;clinical&nbsp;pictures.&nbsp;Hepatitis&nbsp;monthly,&nbsp;[S.l.],&nbsp;v.&nbsp;13,&nbsp;n.&nbsp;8,&nbsp;p.&nbsp;e6731,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__68">n</a></td><td class="diff_header" id="from62_1921">1921</td><td nowrap="nowrap"><span class="diff_sub">2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/24098308&gt;.&nbsp;Acesso&nbsp;em:</span></td><td class="diff_next"><a href="#difflib_chg_to62__68">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1922">1922</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1876">1876</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1923">1923</td><td nowrap="nowrap">GOLDBERG,&nbsp;E.;&nbsp;CHOPRA,&nbsp;S.;&nbsp;O’DONOVAN,&nbsp;D.&nbsp;J.&nbsp;Vertical&nbsp;transmission&nbsp;of&nbsp;hepatitis&nbsp;C</td><td class="diff_next"></td><td class="diff_header" id="to62_1877">1877</td><td nowrap="nowrap">GOLDBERG,&nbsp;E.;&nbsp;CHOPRA,&nbsp;S.;&nbsp;O’DONOVAN,&nbsp;D.&nbsp;J.&nbsp;Vertical&nbsp;transmission&nbsp;of&nbsp;hepatitis&nbsp;C</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1924">1924</td><td nowrap="nowrap">virus.&nbsp;Up&nbsp;To&nbsp;Date&nbsp;[on-line].&nbsp;Última&nbsp;atualização:&nbsp;29&nbsp;nov.&nbsp;2017.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1878">1878</td><td nowrap="nowrap">virus.&nbsp;Up&nbsp;To&nbsp;Date&nbsp;[on-line].&nbsp;Última&nbsp;atualização:&nbsp;29&nbsp;nov.&nbsp;2017.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1925">1925</td><td nowrap="nowrap">www.uptodate.com/contents/vertical-transmission-of-hepatitis-c-virus&gt;.&nbsp;Acesso&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_1879">1879</td><td nowrap="nowrap">www.uptodate.com/contents/vertical-transmission-of-hepatitis-c-virus&gt;.&nbsp;Acesso&nbsp;em:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1926">1926</td><td nowrap="nowrap">17&nbsp;abr.&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1880">1880</td><td nowrap="nowrap">17&nbsp;abr.&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1927">1927</td><td nowrap="nowrap">GONÇALES,&nbsp;N.&nbsp;S.&nbsp;L.&nbsp;Vírus&nbsp;da&nbsp;Hepatite&nbsp;E:&nbsp;Virologia&nbsp;Molecular,&nbsp;Quadro&nbsp;Clínico,&nbsp;Diagnóstico,</td><td class="diff_next"></td><td class="diff_header" id="to62_1881">1881</td><td nowrap="nowrap">GONÇALES,&nbsp;N.&nbsp;S.&nbsp;L.&nbsp;Vírus&nbsp;da&nbsp;Hepatite&nbsp;E:&nbsp;Virologia&nbsp;Molecular,&nbsp;Quadro&nbsp;Clínico,&nbsp;Diagnóstico,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1928">1928</td><td nowrap="nowrap">Transmissão&nbsp;e&nbsp;Prevenção.&nbsp;In:&nbsp;FOCACCIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças</td><td class="diff_next"></td><td class="diff_header" id="to62_1882">1882</td><td nowrap="nowrap">Transmissão&nbsp;e&nbsp;Prevenção.&nbsp;In:&nbsp;FOCACCIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1929">1929</td><td nowrap="nowrap">Associadas.&nbsp;3.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;973-85.</td><td class="diff_next"></td><td class="diff_header" id="to62_1883">1883</td><td nowrap="nowrap">Associadas.&nbsp;3.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;973-85.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1930">1930</td><td nowrap="nowrap">GONÇALVES&nbsp;JUNIOR,&nbsp;F.&nbsp;L.&nbsp;Hepatite&nbsp;por&nbsp;Vírus&nbsp;B:&nbsp;História&nbsp;Natural&nbsp;da&nbsp;Infecção.&nbsp;In:&nbsp;FOCACCIA,</td><td class="diff_next"></td><td class="diff_header" id="to62_1884">1884</td><td nowrap="nowrap">GONÇALVES&nbsp;JUNIOR,&nbsp;F.&nbsp;L.&nbsp;Hepatite&nbsp;por&nbsp;Vírus&nbsp;B:&nbsp;História&nbsp;Natural&nbsp;da&nbsp;Infecção.&nbsp;In:&nbsp;FOCACCIA,</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__68"></td><td class="diff_header" id="from62_1931">1931</td><td nowrap="nowrap">R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.&nbsp;3.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora</td><td class="diff_next"></td><td class="diff_header" id="to62_1885">1885</td><td nowrap="nowrap">R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.&nbsp;3.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1932">1932</td><td nowrap="nowrap">Atheneu,&nbsp;2013.&nbsp;p.&nbsp;327-39.</td><td class="diff_next"></td><td class="diff_header" id="to62_1886">1886</td><td nowrap="nowrap">Atheneu,&nbsp;2013.&nbsp;p.&nbsp;327-39.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1933">1933</td><td nowrap="nowrap">GUIDOTTI,&nbsp;L.&nbsp;G.&nbsp;et&nbsp;al.&nbsp;Intracellular&nbsp;Inactivation&nbsp;of&nbsp;the&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;by&nbsp;Cytotoxic&nbsp;T</td><td class="diff_next"></td><td class="diff_header" id="to62_1887">1887</td><td nowrap="nowrap">GUIDOTTI,&nbsp;L.&nbsp;G.&nbsp;et&nbsp;al.&nbsp;Intracellular&nbsp;Inactivation&nbsp;of&nbsp;the&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;by&nbsp;Cytotoxic&nbsp;T</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1934">1934</td><td nowrap="nowrap">Lymphocytes.&nbsp;Immunity,&nbsp;[S.l.],&nbsp;v.&nbsp;4,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;25-36,&nbsp;1&nbsp;jan.&nbsp;1996.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1888">1888</td><td nowrap="nowrap">Lymphocytes.&nbsp;Immunity,&nbsp;[S.l.],&nbsp;v.&nbsp;4,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;25-36,&nbsp;1&nbsp;jan.&nbsp;1996.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__69"></td><td class="diff_header" id="from62_1935">1935</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/8574849&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1889">1889</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/8574849&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__69">n</a></td><td class="diff_header" id="from62_1936">1936</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Viral&nbsp;clearance&nbsp;without&nbsp;destruction&nbsp;of&nbsp;infected&nbsp;cells&nbsp;during&nbsp;acute&nbsp;HBV&nbsp;infection.</td><td class="diff_next"><a href="#difflib_chg_to62__69">n</a></td><td class="diff_header" id="to62_1890">1890</td><td nowrap="nowrap">_.&nbsp;Viral&nbsp;clearance&nbsp;without&nbsp;destruction&nbsp;of&nbsp;infected&nbsp;cells&nbsp;during&nbsp;acute&nbsp;HBV&nbsp;infection.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1937">1937</td><td nowrap="nowrap"><span class="diff_sub">Science,&nbsp;[S.l.],&nbsp;v.&nbsp;284,&nbsp;n.&nbsp;5415,&nbsp;p.&nbsp;825-9,&nbsp;30&nbsp;abr.&nbsp;1999.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__70"></td><td class="diff_header" id="from62_1938">1938</td><td nowrap="nowrap">nlm.nih.gov/pubmed/10221919&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1891">1891</td><td nowrap="nowrap">nlm.nih.gov/pubmed/10221919&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1939">1939</td><td nowrap="nowrap">GÜNTHER,&nbsp;S.&nbsp;Genetic&nbsp;variation&nbsp;in&nbsp;HBV&nbsp;infection:&nbsp;genotypes&nbsp;and&nbsp;mutants.&nbsp;Journal&nbsp;of</td><td class="diff_next"></td><td class="diff_header" id="to62_1892">1892</td><td nowrap="nowrap">GÜNTHER,&nbsp;S.&nbsp;Genetic&nbsp;variation&nbsp;in&nbsp;HBV&nbsp;infection:&nbsp;genotypes&nbsp;and&nbsp;mutants.&nbsp;Journal&nbsp;of</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__70">n</a></td><td class="diff_header" id="from62_1940">1940</td><td nowrap="nowrap"><span class="diff_sub">Clinical&nbsp;Virology,&nbsp;[S.l.],&nbsp;v.&nbsp;36,&nbsp;p.&nbsp;S3-S11,&nbsp;5&nbsp;maio&nbsp;2006.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"><a href="#difflib_chg_to62__70">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__71"></td><td class="diff_header" id="from62_1941">1941</td><td nowrap="nowrap">nlm.nih.gov/pubmed/16831690&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1893">1893</td><td nowrap="nowrap">nlm.nih.gov/pubmed/16831690&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1942">1942</td><td nowrap="nowrap">HADZIYANNIS,&nbsp;S.&nbsp;J.&nbsp;Review:&nbsp;hepatitis&nbsp;delta.&nbsp;J&nbsp;Gastroenterol&nbsp;Hepatol,&nbsp;[S.l.],&nbsp;v.&nbsp;12,&nbsp;n.&nbsp;4,&nbsp;p.</td><td class="diff_next"></td><td class="diff_header" id="to62_1894">1894</td><td nowrap="nowrap">HADZIYANNIS,&nbsp;S.&nbsp;J.&nbsp;Review:&nbsp;hepatitis&nbsp;delta.&nbsp;J&nbsp;Gastroenterol&nbsp;Hepatol,&nbsp;[S.l.],&nbsp;v.&nbsp;12,&nbsp;n.&nbsp;4,&nbsp;p.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__71">n</a></td><td class="diff_header" id="from62_1943">1943</td><td nowrap="nowrap"><span class="diff_sub">289-98,&nbsp;abr.&nbsp;1997.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/9195369&gt;.</span></td><td class="diff_next"><a href="#difflib_chg_to62__71">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1944">1944</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1895">1895</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__72"></td><td class="diff_header" id="from62_1945">1945</td><td nowrap="nowrap">HUGHES,&nbsp;S.&nbsp;A.;&nbsp;WEDEMEYER,&nbsp;H.;&nbsp;HARRISON,&nbsp;P.&nbsp;M.&nbsp;Hepatitis&nbsp;delta&nbsp;virus.&nbsp;The&nbsp;Lancet,&nbsp;[S.l.],</td><td class="diff_next"></td><td class="diff_header" id="to62_1896">1896</td><td nowrap="nowrap">HUGHES,&nbsp;S.&nbsp;A.;&nbsp;WEDEMEYER,&nbsp;H.;&nbsp;HARRISON,&nbsp;P.&nbsp;M.&nbsp;Hepatitis&nbsp;delta&nbsp;virus.&nbsp;The&nbsp;Lancet,&nbsp;[S.l.],</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__72">n</a></td><td class="diff_header" id="from62_1946">1946</td><td nowrap="nowrap"><span class="diff_sub">v.&nbsp;378,&nbsp;n.&nbsp;9785,&nbsp;p.&nbsp;73-85,&nbsp;2&nbsp;jul.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pub-</span></td><td class="diff_next"><a href="#difflib_chg_to62__72">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1947">1947</td><td nowrap="nowrap">med/21511329&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1897">1897</td><td nowrap="nowrap">med/21511329&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__73"></td><td class="diff_header" id="from62_1948">1948</td><td nowrap="nowrap">ISMAIL,&nbsp;A.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;characteristics&nbsp;and&nbsp;comparison&nbsp;of&nbsp;Abbott&nbsp;and&nbsp;artus&nbsp;real-</td><td class="diff_next"></td><td class="diff_header" id="to62_1898">1898</td><td nowrap="nowrap">ISMAIL,&nbsp;A.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;characteristics&nbsp;and&nbsp;comparison&nbsp;of&nbsp;Abbott&nbsp;and&nbsp;artus&nbsp;real-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1949">1949</td><td nowrap="nowrap">-time&nbsp;systems&nbsp;for&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;DNA&nbsp;quantification.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;microbio-</td><td class="diff_next"></td><td class="diff_header" id="to62_1899">1899</td><td nowrap="nowrap">-time&nbsp;systems&nbsp;for&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;DNA&nbsp;quantification.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;microbio-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__73">n</a></td><td class="diff_header" id="from62_1950">1950</td><td nowrap="nowrap"><span class="diff_sub">logy,&nbsp;[S.l.],&nbsp;v.&nbsp;49,&nbsp;n.&nbsp;9,&nbsp;p.&nbsp;3215-21,&nbsp;set.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.</span></td><td class="diff_next"><a href="#difflib_chg_to62__73">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__74"></td><td class="diff_header" id="from62_1951">1951</td><td nowrap="nowrap">gov/pubmed/21795507&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1900">1900</td><td nowrap="nowrap">gov/pubmed/21795507&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1952">1952</td><td nowrap="nowrap">JACKA,&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Sequencing&nbsp;of&nbsp;the&nbsp;Hepatitis&nbsp;C&nbsp;Virus:&nbsp;A&nbsp;Systematic&nbsp;Review.&nbsp;PloS&nbsp;one,&nbsp;[S.l.],</td><td class="diff_next"></td><td class="diff_header" id="to62_1901">1901</td><td nowrap="nowrap">JACKA,&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Sequencing&nbsp;of&nbsp;the&nbsp;Hepatitis&nbsp;C&nbsp;Virus:&nbsp;A&nbsp;Systematic&nbsp;Review.&nbsp;PloS&nbsp;one,&nbsp;[S.l.],</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__74">n</a></td><td class="diff_header" id="from62_1953">1953</td><td nowrap="nowrap"><span class="diff_sub">v.&nbsp;8,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;e67073,&nbsp;27&nbsp;jan.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pmc/</span></td><td class="diff_next"><a href="#difflib_chg_to62__74">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1954">1954</td><td nowrap="nowrap">articles/PMC3694929/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1902">1902</td><td nowrap="nowrap">articles/PMC3694929/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__75"></td><td class="diff_header" id="from62_1955">1955</td><td nowrap="nowrap">JONAS,&nbsp;M.&nbsp;M.&nbsp;Hepatitis&nbsp;B&nbsp;and&nbsp;pregnancy:&nbsp;an&nbsp;underestimated&nbsp;issue.&nbsp;Liver&nbsp;international,</td><td class="diff_next"></td><td class="diff_header" id="to62_1903">1903</td><td nowrap="nowrap">JONAS,&nbsp;M.&nbsp;M.&nbsp;Hepatitis&nbsp;B&nbsp;and&nbsp;pregnancy:&nbsp;an&nbsp;underestimated&nbsp;issue.&nbsp;Liver&nbsp;international,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__75">n</a></td><td class="diff_header" id="from62_1956">1956</td><td nowrap="nowrap"><span class="diff_sub">[S.l.],&nbsp;v.&nbsp;29,&nbsp;Suppl.&nbsp;1,&nbsp;p.&nbsp;133-9,&nbsp;jan.&nbsp;2009.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/</span></td><td class="diff_next"><a href="#difflib_chg_to62__75">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1957">1957</td><td nowrap="nowrap">pubmed/19207977&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1904">1904</td><td nowrap="nowrap">pubmed/19207977&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1958">1958</td><td nowrap="nowrap">KAKIMI,&nbsp;K.&nbsp;et&nbsp;al.&nbsp;Cutting&nbsp;Edge:&nbsp;Inhibition&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Replication&nbsp;by&nbsp;Activated</td><td class="diff_next"></td><td class="diff_header" id="to62_1905">1905</td><td nowrap="nowrap">KAKIMI,&nbsp;K.&nbsp;et&nbsp;al.&nbsp;Cutting&nbsp;Edge:&nbsp;Inhibition&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Replication&nbsp;by&nbsp;Activated</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__76"></td><td class="diff_header" id="from62_1959">1959</td><td nowrap="nowrap">NK&nbsp;T&nbsp;Cells&nbsp;Does&nbsp;Not&nbsp;Require&nbsp;Inflammatory&nbsp;Cell&nbsp;Recruitment&nbsp;to&nbsp;the&nbsp;Liver.&nbsp;The&nbsp;Journal&nbsp;of</td><td class="diff_next"></td><td class="diff_header" id="to62_1906">1906</td><td nowrap="nowrap">NK&nbsp;T&nbsp;Cells&nbsp;Does&nbsp;Not&nbsp;Require&nbsp;Inflammatory&nbsp;Cell&nbsp;Recruitment&nbsp;to&nbsp;the&nbsp;Liver.&nbsp;The&nbsp;Journal&nbsp;of</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__76">n</a></td><td class="diff_header" id="from62_1960">1960</td><td nowrap="nowrap"><span class="diff_sub">Immunology,&nbsp;[S.l.],&nbsp;v.&nbsp;167,&nbsp;n.&nbsp;12,&nbsp;p.&nbsp;6701-5,&nbsp;15&nbsp;dez.&nbsp;2001.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.</span></td><td class="diff_next"><a href="#difflib_chg_to62__76">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1961">1961</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/11739482&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1907">1907</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/11739482&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__77"></td><td class="diff_header" id="from62_1962">1962</td><td nowrap="nowrap">KAWATANI,&nbsp;T.&nbsp;et&nbsp;al.&nbsp;Incidence&nbsp;of&nbsp;hepatitis&nbsp;virus&nbsp;infection&nbsp;and&nbsp;severe&nbsp;liver&nbsp;dysfunction&nbsp;in</td><td class="diff_next"></td><td class="diff_header" id="to62_1908">1908</td><td nowrap="nowrap">KAWATANI,&nbsp;T.&nbsp;et&nbsp;al.&nbsp;Incidence&nbsp;of&nbsp;hepatitis&nbsp;virus&nbsp;infection&nbsp;and&nbsp;severe&nbsp;liver&nbsp;dysfunction&nbsp;in</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1963">1963</td><td nowrap="nowrap">patients&nbsp;receiving&nbsp;chemotherapy&nbsp;for&nbsp;hematologic&nbsp;malignancies.&nbsp;European&nbsp;Journal&nbsp;of</td><td class="diff_next"></td><td class="diff_header" id="to62_1909">1909</td><td nowrap="nowrap">patients&nbsp;receiving&nbsp;chemotherapy&nbsp;for&nbsp;hematologic&nbsp;malignancies.&nbsp;European&nbsp;Journal&nbsp;of</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__77">n</a></td><td class="diff_header" id="from62_1964">1964</td><td nowrap="nowrap"><span class="diff_sub">Haematology,&nbsp;[S.l.],&nbsp;v.&nbsp;67,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;45-50,&nbsp;jul.&nbsp;2001.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"><a href="#difflib_chg_to62__77">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1965">1965</td><td nowrap="nowrap">nlm.nih.gov/pubmed/11553266&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1910">1910</td><td nowrap="nowrap">nlm.nih.gov/pubmed/11553266&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__78"></td><td class="diff_header" id="from62_1966">1966</td><td nowrap="nowrap">KHUDYAKOV,&nbsp;Y.;&nbsp;KAMILI,&nbsp;S.&nbsp;Serological&nbsp;diagnostics&nbsp;of&nbsp;hepatitis&nbsp;E&nbsp;virus&nbsp;infection.&nbsp;Virus</td><td class="diff_next"></td><td class="diff_header" id="to62_1911">1911</td><td nowrap="nowrap">KHUDYAKOV,&nbsp;Y.;&nbsp;KAMILI,&nbsp;S.&nbsp;Serological&nbsp;diagnostics&nbsp;of&nbsp;hepatitis&nbsp;E&nbsp;virus&nbsp;infection.&nbsp;Virus</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__78">n</a></td><td class="diff_header" id="from62_1967">1967</td><td nowrap="nowrap"><span class="diff_sub">Research,&nbsp;[S.l.],&nbsp;v.&nbsp;161,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;84-92,&nbsp;out.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.</span></td><td class="diff_next"><a href="#difflib_chg_to62__78">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__79"></td><td class="diff_header" id="from62_1968">1968</td><td nowrap="nowrap">nih.gov/pubmed/21704091&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1912">1912</td><td nowrap="nowrap">nih.gov/pubmed/21704091&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1969">1969</td><td nowrap="nowrap">KHUROO,&nbsp;M.&nbsp;S.&nbsp;Discovery&nbsp;of&nbsp;hepatitis&nbsp;E:&nbsp;The&nbsp;epidemic&nbsp;non-A,&nbsp;non-B&nbsp;hepatitis&nbsp;30&nbsp;years</td><td class="diff_next"></td><td class="diff_header" id="to62_1913">1913</td><td nowrap="nowrap">KHUROO,&nbsp;M.&nbsp;S.&nbsp;Discovery&nbsp;of&nbsp;hepatitis&nbsp;E:&nbsp;The&nbsp;epidemic&nbsp;non-A,&nbsp;non-B&nbsp;hepatitis&nbsp;30&nbsp;years</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1970">1970</td><td nowrap="nowrap">down&nbsp;the&nbsp;memory&nbsp;lane.&nbsp;Virus&nbsp;Research,&nbsp;[S.l.],&nbsp;v.&nbsp;161,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;3-14,&nbsp;out.&nbsp;2011.&nbsp;Disponível</td><td class="diff_next"></td><td class="diff_header" id="to62_1914">1914</td><td nowrap="nowrap">down&nbsp;the&nbsp;memory&nbsp;lane.&nbsp;Virus&nbsp;Research,&nbsp;[S.l.],&nbsp;v.&nbsp;161,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;3-14,&nbsp;out.&nbsp;2011.&nbsp;Disponível</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__79">n</a></td><td class="diff_header" id="from62_1971">1971</td><td nowrap="nowrap"><span class="diff_sub">em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/21320558&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__79">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__80"></td><td class="diff_header" id="from62_1972">1972</td><td nowrap="nowrap">KIM,&nbsp;C.&nbsp;W.;&nbsp;CHANG,&nbsp;K.-M.&nbsp;Hepatitis&nbsp;C&nbsp;virus:&nbsp;virology&nbsp;and&nbsp;life&nbsp;cycle.&nbsp;Clinical&nbsp;and&nbsp;molecular</td><td class="diff_next"></td><td class="diff_header" id="to62_1915">1915</td><td nowrap="nowrap">KIM,&nbsp;C.&nbsp;W.;&nbsp;CHANG,&nbsp;K.-M.&nbsp;Hepatitis&nbsp;C&nbsp;virus:&nbsp;virology&nbsp;and&nbsp;life&nbsp;cycle.&nbsp;Clinical&nbsp;and&nbsp;molecular</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__80">n</a></td><td class="diff_header" id="from62_1973">1973</td><td nowrap="nowrap"><span class="diff_sub">hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;19,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;17-25,&nbsp;mar.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.</span></td><td class="diff_next"><a href="#difflib_chg_to62__80">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1974">1974</td><td nowrap="nowrap">nih.gov/pubmed/23593605&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1916">1916</td><td nowrap="nowrap">nih.gov/pubmed/23593605&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1975">1975</td><td nowrap="nowrap">KOUTSOUDAKIS,&nbsp;G.&nbsp;et&nbsp;al.&nbsp;Characterization&nbsp;of&nbsp;the&nbsp;early&nbsp;steps&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;infection</td><td class="diff_next"></td><td class="diff_header" id="to62_1917">1917</td><td nowrap="nowrap">KOUTSOUDAKIS,&nbsp;G.&nbsp;et&nbsp;al.&nbsp;Characterization&nbsp;of&nbsp;the&nbsp;early&nbsp;steps&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;infection</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1976">1976</td><td nowrap="nowrap">by&nbsp;using&nbsp;luciferase&nbsp;reporter&nbsp;viruses.&nbsp;Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;80,&nbsp;n.&nbsp;11,&nbsp;p.&nbsp;5308-20,</td><td class="diff_next"></td><td class="diff_header" id="to62_1918">1918</td><td nowrap="nowrap">by&nbsp;using&nbsp;luciferase&nbsp;reporter&nbsp;viruses.&nbsp;Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;80,&nbsp;n.&nbsp;11,&nbsp;p.&nbsp;5308-20,</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__81"><a href="#difflib_chg_to62__81">n</a></td><td class="diff_header" id="from62_1977">1977</td><td nowrap="nowrap"><span class="diff_sub">jun.&nbsp;2006.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/16699011&gt;.&nbsp;Acesso</span></td><td class="diff_next"><a href="#difflib_chg_to62__81">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1978">1978</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1919">1919</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1979">1979</td><td nowrap="nowrap">LAU,&nbsp;G.&nbsp;K.&nbsp;K.&nbsp;High&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;(HBV)&nbsp;DNA&nbsp;viral&nbsp;load&nbsp;as&nbsp;the&nbsp;most&nbsp;important&nbsp;risk&nbsp;factor</td><td class="diff_next"></td><td class="diff_header" id="to62_1920">1920</td><td nowrap="nowrap">LAU,&nbsp;G.&nbsp;K.&nbsp;K.&nbsp;High&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;(HBV)&nbsp;DNA&nbsp;viral&nbsp;load&nbsp;as&nbsp;the&nbsp;most&nbsp;important&nbsp;risk&nbsp;factor</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1980">1980</td><td nowrap="nowrap">for&nbsp;HBV&nbsp;reactivation&nbsp;in&nbsp;patients&nbsp;positive&nbsp;for&nbsp;HBV&nbsp;surface&nbsp;antigen&nbsp;undergoing&nbsp;autolo-</td><td class="diff_next"></td><td class="diff_header" id="to62_1921">1921</td><td nowrap="nowrap">for&nbsp;HBV&nbsp;reactivation&nbsp;in&nbsp;patients&nbsp;positive&nbsp;for&nbsp;HBV&nbsp;surface&nbsp;antigen&nbsp;undergoing&nbsp;autolo-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1981">1981</td><td nowrap="nowrap">gous&nbsp;hematopoietic&nbsp;cell&nbsp;transplantation.&nbsp;Blood,&nbsp;[S.l.],&nbsp;v.&nbsp;99,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;2324-30,&nbsp;1&nbsp;abr.&nbsp;2002.</td><td class="diff_next"></td><td class="diff_header" id="to62_1922">1922</td><td nowrap="nowrap">gous&nbsp;hematopoietic&nbsp;cell&nbsp;transplantation.&nbsp;Blood,&nbsp;[S.l.],&nbsp;v.&nbsp;99,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;2324-30,&nbsp;1&nbsp;abr.&nbsp;2002.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__82">n</a></td><td class="diff_header" id="from62_1982">1982</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/11895763&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29</span></td><td class="diff_next"><a href="#difflib_chg_to62__82">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__82"></td><td class="diff_header" id="from62_1983">1983</td><td nowrap="nowrap">maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1923">1923</td><td nowrap="nowrap">maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1984">1984</td><td nowrap="nowrap">LEE,&nbsp;J.&nbsp;M.;&nbsp;AHN,&nbsp;S.&nbsp;H.&nbsp;Quantification&nbsp;of&nbsp;HBsAg:&nbsp;basic&nbsp;virology&nbsp;for&nbsp;clinical&nbsp;practice.&nbsp;World</td><td class="diff_next"></td><td class="diff_header" id="to62_1924">1924</td><td nowrap="nowrap">LEE,&nbsp;J.&nbsp;M.;&nbsp;AHN,&nbsp;S.&nbsp;H.&nbsp;Quantification&nbsp;of&nbsp;HBsAg:&nbsp;basic&nbsp;virology&nbsp;for&nbsp;clinical&nbsp;practice.&nbsp;World</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1985">1985</td><td nowrap="nowrap">journal&nbsp;of&nbsp;gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;17,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;283-9,&nbsp;21&nbsp;jan.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;ht-</td><td class="diff_next"></td><td class="diff_header" id="to62_1925">1925</td><td nowrap="nowrap">journal&nbsp;of&nbsp;gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;17,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;283-9,&nbsp;21&nbsp;jan.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;ht-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__83"></td><td class="diff_header" id="from62_1986">1986</td><td nowrap="nowrap">tps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022287/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1926">1926</td><td nowrap="nowrap">tps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022287/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1987">1987</td><td nowrap="nowrap">LEMON,&nbsp;S.&nbsp;M.&nbsp;Type&nbsp;A&nbsp;viral&nbsp;hepatitis:&nbsp;epidemiology,&nbsp;diagnosis,&nbsp;and&nbsp;prevention.&nbsp;Clinical</td><td class="diff_next"></td><td class="diff_header" id="to62_1927">1927</td><td nowrap="nowrap">LEMON,&nbsp;S.&nbsp;M.&nbsp;Type&nbsp;A&nbsp;viral&nbsp;hepatitis:&nbsp;epidemiology,&nbsp;diagnosis,&nbsp;and&nbsp;prevention.&nbsp;Clinical</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__83">n</a></td><td class="diff_header" id="from62_1988">1988</td><td nowrap="nowrap"><span class="diff_sub">chemistry,&nbsp;[S.l.],&nbsp;v.&nbsp;43,&nbsp;n.&nbsp;8,&nbsp;Pt&nbsp;2,&nbsp;p.&nbsp;1494-9,&nbsp;ago.&nbsp;1997.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"><a href="#difflib_chg_to62__83">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1989">1989</td><td nowrap="nowrap">nlm.nih.gov/pubmed/9265900&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1928">1928</td><td nowrap="nowrap">nlm.nih.gov/pubmed/9265900&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__84"></td><td class="diff_header" id="from62_1990">1990</td><td nowrap="nowrap">LIANG,&nbsp;T.&nbsp;J.&nbsp;Hepatitis&nbsp;B:&nbsp;the&nbsp;virus&nbsp;and&nbsp;disease.&nbsp;Hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;49,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;S13-21,&nbsp;maio</td><td class="diff_next"></td><td class="diff_header" id="to62_1929">1929</td><td nowrap="nowrap">LIANG,&nbsp;T.&nbsp;J.&nbsp;Hepatitis&nbsp;B:&nbsp;the&nbsp;virus&nbsp;and&nbsp;disease.&nbsp;Hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;49,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;S13-21,&nbsp;maio</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__84">n</a></td><td class="diff_header" id="from62_1991">1991</td><td nowrap="nowrap"><span class="diff_sub">2009.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/19399811&gt;.&nbsp;Acesso&nbsp;em:</span></td><td class="diff_next"><a href="#difflib_chg_to62__84">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1992">1992</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1930">1930</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__85"></td><td class="diff_header" id="from62_1993">1993</td><td nowrap="nowrap">LINDENBACH,&nbsp;B.&nbsp;D.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;The&nbsp;ins&nbsp;and&nbsp;outs&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;and&nbsp;assembly.</td><td class="diff_next"></td><td class="diff_header" id="to62_1931">1931</td><td nowrap="nowrap">LINDENBACH,&nbsp;B.&nbsp;D.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;The&nbsp;ins&nbsp;and&nbsp;outs&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;and&nbsp;assembly.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1994">1994</td><td nowrap="nowrap">Nature&nbsp;reviews&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;11,&nbsp;n.&nbsp;10,&nbsp;p.&nbsp;688-700,&nbsp;10&nbsp;set.&nbsp;2013.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_1932">1932</td><td nowrap="nowrap">Nature&nbsp;reviews&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;11,&nbsp;n.&nbsp;10,&nbsp;p.&nbsp;688-700,&nbsp;10&nbsp;set.&nbsp;2013.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__85">n</a></td><td class="diff_header" id="from62_1995">1995</td><td nowrap="nowrap"><span class="diff_sub">&lt;https://www.ncbi.nlm.nih.gov/pubmed/24018384&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__85">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1996">1996</td><td nowrap="nowrap">LUPBERGER,&nbsp;J.&nbsp;et&nbsp;al.&nbsp;EGFR&nbsp;and&nbsp;EphA2&nbsp;are&nbsp;host&nbsp;factors&nbsp;for&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;and</td><td class="diff_next"></td><td class="diff_header" id="to62_1933">1933</td><td nowrap="nowrap">LUPBERGER,&nbsp;J.&nbsp;et&nbsp;al.&nbsp;EGFR&nbsp;and&nbsp;EphA2&nbsp;are&nbsp;host&nbsp;factors&nbsp;for&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;and</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__86"></td><td class="diff_header" id="from62_1997">1997</td><td nowrap="nowrap">possible&nbsp;targets&nbsp;for&nbsp;antiviral&nbsp;therapy.&nbsp;Nature&nbsp;medicine,&nbsp;[S.l.],&nbsp;v.&nbsp;17,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;589-95,&nbsp;maio</td><td class="diff_next"></td><td class="diff_header" id="to62_1934">1934</td><td nowrap="nowrap">possible&nbsp;targets&nbsp;for&nbsp;antiviral&nbsp;therapy.&nbsp;Nature&nbsp;medicine,&nbsp;[S.l.],&nbsp;v.&nbsp;17,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;589-95,&nbsp;maio</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__86">n</a></td><td class="diff_header" id="from62_1998">1998</td><td nowrap="nowrap"><span class="diff_sub">2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/21516087&gt;.&nbsp;Acesso&nbsp;em:</span></td><td class="diff_next"><a href="#difflib_chg_to62__86">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_1999">1999</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1935">1935</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2000">2000</td><td nowrap="nowrap">MACK,&nbsp;C.&nbsp;L.&nbsp;et&nbsp;al.&nbsp;NASPGHAN&nbsp;practice&nbsp;guidelines:&nbsp;Diagnosis&nbsp;and&nbsp;management&nbsp;of&nbsp;hepati-</td><td class="diff_next"></td><td class="diff_header" id="to62_1936">1936</td><td nowrap="nowrap">MACK,&nbsp;C.&nbsp;L.&nbsp;et&nbsp;al.&nbsp;NASPGHAN&nbsp;practice&nbsp;guidelines:&nbsp;Diagnosis&nbsp;and&nbsp;management&nbsp;of&nbsp;hepati-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2001">2001</td><td nowrap="nowrap">tis&nbsp;C&nbsp;infection&nbsp;in&nbsp;infants,&nbsp;children,&nbsp;and&nbsp;adolescents.&nbsp;Journal&nbsp;of&nbsp;pediatric&nbsp;gastroentero-</td><td class="diff_next"></td><td class="diff_header" id="to62_1937">1937</td><td nowrap="nowrap">tis&nbsp;C&nbsp;infection&nbsp;in&nbsp;infants,&nbsp;children,&nbsp;and&nbsp;adolescents.&nbsp;Journal&nbsp;of&nbsp;pediatric&nbsp;gastroentero-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__87">n</a></td><td class="diff_header" id="from62_2002">2002</td><td nowrap="nowrap"><span class="diff_sub">logy&nbsp;and&nbsp;nutrition,&nbsp;[S.l.],&nbsp;v.&nbsp;54,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;838-55,&nbsp;jun.&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.</span></td><td class="diff_next"><a href="#difflib_chg_to62__87">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__87"></td><td class="diff_header" id="from62_2003">2003</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/22487950&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1938">1938</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/22487950&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2004">2004</td><td nowrap="nowrap">MARUYAMA,&nbsp;T.&nbsp;et&nbsp;al.&nbsp;The&nbsp;serology&nbsp;of&nbsp;chronic&nbsp;hepatitis&nbsp;B&nbsp;infection&nbsp;revisited.&nbsp;The&nbsp;Journal</td><td class="diff_next"></td><td class="diff_header" id="to62_1939">1939</td><td nowrap="nowrap">MARUYAMA,&nbsp;T.&nbsp;et&nbsp;al.&nbsp;The&nbsp;serology&nbsp;of&nbsp;chronic&nbsp;hepatitis&nbsp;B&nbsp;infection&nbsp;revisited.&nbsp;The&nbsp;Journal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2005">2005</td><td nowrap="nowrap">of&nbsp;clinical&nbsp;investigation,&nbsp;[S.l.],&nbsp;v.&nbsp;91,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;2586-95,&nbsp;jun.&nbsp;1993.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1940">1940</td><td nowrap="nowrap">of&nbsp;clinical&nbsp;investigation,&nbsp;[S.l.],&nbsp;v.&nbsp;91,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;2586-95,&nbsp;jun.&nbsp;1993.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2006">2006</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/8514870&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1941">1941</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/8514870&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__88"></td><td class="diff_header" id="from62_2007">2007</td><td nowrap="nowrap">MATHENY,&nbsp;S.&nbsp;C.;&nbsp;KINGERY,&nbsp;J.&nbsp;E.&nbsp;Hepatitis&nbsp;A.&nbsp;American&nbsp;family&nbsp;physician,&nbsp;[S.l.],&nbsp;v.&nbsp;86,</td><td class="diff_next"></td><td class="diff_header" id="to62_1942">1942</td><td nowrap="nowrap">MATHENY,&nbsp;S.&nbsp;C.;&nbsp;KINGERY,&nbsp;J.&nbsp;E.&nbsp;Hepatitis&nbsp;A.&nbsp;American&nbsp;family&nbsp;physician,&nbsp;[S.l.],&nbsp;v.&nbsp;86,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__88">n</a></td><td class="diff_header" id="from62_2008">2008</td><td nowrap="nowrap"><span class="diff_sub">n.&nbsp;11,&nbsp;p.&nbsp;1022-27,&nbsp;dez.&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pub-</span></td><td class="diff_next"><a href="#difflib_chg_to62__88">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2009">2009</td><td nowrap="nowrap">med/23198670&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1943">1943</td><td nowrap="nowrap">med/23198670&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2010">2010</td><td nowrap="nowrap">MATHEW,&nbsp;B.&nbsp;C.;&nbsp;BIJU,&nbsp;R.&nbsp;S.;&nbsp;THAPALIA,&nbsp;N.&nbsp;An&nbsp;overview&nbsp;of&nbsp;electrochemiluminescent</td><td class="diff_next"></td><td class="diff_header" id="to62_1944">1944</td><td nowrap="nowrap">MATHEW,&nbsp;B.&nbsp;C.;&nbsp;BIJU,&nbsp;R.&nbsp;S.;&nbsp;THAPALIA,&nbsp;N.&nbsp;An&nbsp;overview&nbsp;of&nbsp;electrochemiluminescent</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__89"></td><td class="diff_header" id="from62_2011">2011</td><td nowrap="nowrap">(ECL)&nbsp;technology&nbsp;in&nbsp;laboratory&nbsp;investigations.&nbsp;Kathmandu&nbsp;University&nbsp;medical&nbsp;jour-</td><td class="diff_next"></td><td class="diff_header" id="to62_1945">1945</td><td nowrap="nowrap">(ECL)&nbsp;technology&nbsp;in&nbsp;laboratory&nbsp;investigations.&nbsp;Kathmandu&nbsp;University&nbsp;medical&nbsp;jour-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__89">n</a></td><td class="diff_header" id="from62_2012">2012</td><td nowrap="nowrap"><span class="diff_sub">nal,&nbsp;[S.l.],&nbsp;v.&nbsp;3,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;91-3,&nbsp;2005.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pub-</span></td><td class="diff_next"><a href="#difflib_chg_to62__89">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2013">2013</td><td nowrap="nowrap">med/16401954&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1946">1946</td><td nowrap="nowrap">med/16401954&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2014">2014</td><td nowrap="nowrap">MATOS,&nbsp;M.&nbsp;A.&nbsp;D.&nbsp;DE&nbsp;et&nbsp;al.&nbsp;Occult&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;infection&nbsp;among&nbsp;injecting&nbsp;drug&nbsp;users&nbsp;in</td><td class="diff_next"></td><td class="diff_header" id="to62_1947">1947</td><td nowrap="nowrap">MATOS,&nbsp;M.&nbsp;A.&nbsp;D.&nbsp;DE&nbsp;et&nbsp;al.&nbsp;Occult&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;infection&nbsp;among&nbsp;injecting&nbsp;drug&nbsp;users&nbsp;in</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__90"></td><td class="diff_header" id="from62_2015">2015</td><td nowrap="nowrap">the&nbsp;Central-West&nbsp;Region&nbsp;of&nbsp;Brazil.&nbsp;Memórias&nbsp;do&nbsp;Instituto&nbsp;Oswaldo&nbsp;Cruz,&nbsp;[S.l.],&nbsp;v.&nbsp;108,&nbsp;n.</td><td class="diff_next"></td><td class="diff_header" id="to62_1948">1948</td><td nowrap="nowrap">the&nbsp;Central-West&nbsp;Region&nbsp;of&nbsp;Brazil.&nbsp;Memórias&nbsp;do&nbsp;Instituto&nbsp;Oswaldo&nbsp;Cruz,&nbsp;[S.l.],&nbsp;v.&nbsp;108,&nbsp;n.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__90">n</a></td><td class="diff_header" id="from62_2016">2016</td><td nowrap="nowrap"><span class="diff_sub">3,&nbsp;p.&nbsp;386-89,&nbsp;maio&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;http://www.scielo.br/scielo.php?script=sci_art</span></td><td class="diff_next"><a href="#difflib_chg_to62__90">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2017">2017</td><td nowrap="nowrap">text&amp;pid=S0074-02762013000300386&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1949">1949</td><td nowrap="nowrap">text&amp;pid=S0074-02762013000300386&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__91"></td><td class="diff_header" id="from62_2018">2018</td><td nowrap="nowrap">MCCLARY,&nbsp;H.&nbsp;et&nbsp;al.&nbsp;Relative&nbsp;Sensitivity&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;and&nbsp;Other&nbsp;Hepatotropic&nbsp;Viruses</td><td class="diff_next"></td><td class="diff_header" id="to62_1950">1950</td><td nowrap="nowrap">MCCLARY,&nbsp;H.&nbsp;et&nbsp;al.&nbsp;Relative&nbsp;Sensitivity&nbsp;of&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;and&nbsp;Other&nbsp;Hepatotropic&nbsp;Viruses</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2019">2019</td><td nowrap="nowrap">to&nbsp;the&nbsp;Antiviral&nbsp;Effects&nbsp;of&nbsp;Cytokines.&nbsp;Journal&nbsp;of&nbsp;Virology,&nbsp;[S.l.],&nbsp;v.&nbsp;74,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;2255-64,&nbsp;1</td><td class="diff_next"></td><td class="diff_header" id="to62_1951">1951</td><td nowrap="nowrap">to&nbsp;the&nbsp;Antiviral&nbsp;Effects&nbsp;of&nbsp;Cytokines.&nbsp;Journal&nbsp;of&nbsp;Virology,&nbsp;[S.l.],&nbsp;v.&nbsp;74,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;2255-64,&nbsp;1</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__91">n</a></td><td class="diff_header" id="from62_2020">2020</td><td nowrap="nowrap"><span class="diff_sub">mar.&nbsp;2000.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/10666256&gt;&nbsp;Acesso</span></td><td class="diff_next"><a href="#difflib_chg_to62__91">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2021">2021</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1952">1952</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__92"></td><td class="diff_header" id="from62_2022">2022</td><td nowrap="nowrap">MEHTA,&nbsp;S.&nbsp;H.&nbsp;et&nbsp;al.&nbsp;Protection&nbsp;against&nbsp;persistence&nbsp;of&nbsp;hepatitis&nbsp;C.&nbsp;Lancet,&nbsp;[S.l.],&nbsp;v.&nbsp;359,</td><td class="diff_next"></td><td class="diff_header" id="to62_1953">1953</td><td nowrap="nowrap">MEHTA,&nbsp;S.&nbsp;H.&nbsp;et&nbsp;al.&nbsp;Protection&nbsp;against&nbsp;persistence&nbsp;of&nbsp;hepatitis&nbsp;C.&nbsp;Lancet,&nbsp;[S.l.],&nbsp;v.&nbsp;359,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__92">n</a></td><td class="diff_header" id="from62_2023">2023</td><td nowrap="nowrap"><span class="diff_sub">n.&nbsp;9316,&nbsp;p.&nbsp;1478-83,&nbsp;27&nbsp;abr.&nbsp;2002.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pub-</span></td><td class="diff_next"><a href="#difflib_chg_to62__92">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__93"></td><td class="diff_header" id="from62_2024">2024</td><td nowrap="nowrap">med/11988247&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1954">1954</td><td nowrap="nowrap">med/11988247&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2025">2025</td><td nowrap="nowrap">MELLO,&nbsp;F.&nbsp;C.&nbsp;A.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;virus&nbsp;genotypes&nbsp;circulating&nbsp;in&nbsp;Brazil:&nbsp;molecular&nbsp;charac-</td><td class="diff_next"></td><td class="diff_header" id="to62_1955">1955</td><td nowrap="nowrap">MELLO,&nbsp;F.&nbsp;C.&nbsp;A.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;virus&nbsp;genotypes&nbsp;circulating&nbsp;in&nbsp;Brazil:&nbsp;molecular&nbsp;charac-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2026">2026</td><td nowrap="nowrap">terization&nbsp;of&nbsp;genotype&nbsp;F&nbsp;isolates.&nbsp;BMC&nbsp;microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;7,&nbsp;p.&nbsp;103,&nbsp;2007.&nbsp;Disponível</td><td class="diff_next"></td><td class="diff_header" id="to62_1956">1956</td><td nowrap="nowrap">terization&nbsp;of&nbsp;genotype&nbsp;F&nbsp;isolates.&nbsp;BMC&nbsp;microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;7,&nbsp;p.&nbsp;103,&nbsp;2007.&nbsp;Disponível</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__93">n</a></td><td class="diff_header" id="from62_2027">2027</td><td nowrap="nowrap"><span class="diff_sub">em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/18036224&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__93">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__94"></td><td class="diff_header" id="from62_2028">2028</td><td nowrap="nowrap">MESSINA,&nbsp;J.&nbsp;P.&nbsp;et&nbsp;al.&nbsp;Global&nbsp;distribution&nbsp;and&nbsp;prevalence&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;genotypes.</td><td class="diff_next"></td><td class="diff_header" id="to62_1957">1957</td><td nowrap="nowrap">MESSINA,&nbsp;J.&nbsp;P.&nbsp;et&nbsp;al.&nbsp;Global&nbsp;distribution&nbsp;and&nbsp;prevalence&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;genotypes.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__94">n</a></td><td class="diff_header" id="from62_2029">2029</td><td nowrap="nowrap"><span class="diff_sub">Hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;61,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;77-87,&nbsp;jan.&nbsp;2015.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.</span></td><td class="diff_next"><a href="#difflib_chg_to62__94">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2030">2030</td><td nowrap="nowrap">nih.gov/pubmed/25069599&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1958">1958</td><td nowrap="nowrap">nih.gov/pubmed/25069599&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__95"></td><td class="diff_header" id="from62_2031">2031</td><td nowrap="nowrap">MIRAZO,&nbsp;S.&nbsp;et&nbsp;al.&nbsp;Transmission,&nbsp;diagnosis,&nbsp;and&nbsp;management&nbsp;of&nbsp;hepatitis&nbsp;E:&nbsp;an&nbsp;update.</td><td class="diff_next"></td><td class="diff_header" id="to62_1959">1959</td><td nowrap="nowrap">MIRAZO,&nbsp;S.&nbsp;et&nbsp;al.&nbsp;Transmission,&nbsp;diagnosis,&nbsp;and&nbsp;management&nbsp;of&nbsp;hepatitis&nbsp;E:&nbsp;an&nbsp;update.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2032">2032</td><td nowrap="nowrap">Hepatic&nbsp;Medicine&nbsp;Evidence&nbsp;and&nbsp;Research,&nbsp;[S.l.],&nbsp;v.&nbsp;6,&nbsp;p.&nbsp;45-59,&nbsp;jan.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_1960">1960</td><td nowrap="nowrap">Hepatic&nbsp;Medicine&nbsp;Evidence&nbsp;and&nbsp;Research,&nbsp;[S.l.],&nbsp;v.&nbsp;6,&nbsp;p.&nbsp;45-59,&nbsp;jan.&nbsp;2014.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__95">n</a></td><td class="diff_header" id="from62_2033">2033</td><td nowrap="nowrap"><span class="diff_sub">&lt;https://www.ncbi.nlm.nih.gov/pubmed/24966702&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__95">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__96"></td><td class="diff_header" id="from62_2034">2034</td><td nowrap="nowrap">MONAZAHIAN,&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Low&nbsp;density&nbsp;lipoprotein&nbsp;receptor&nbsp;as&nbsp;a&nbsp;candidate&nbsp;receptor&nbsp;for</td><td class="diff_next"></td><td class="diff_header" id="to62_1961">1961</td><td nowrap="nowrap">MONAZAHIAN,&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Low&nbsp;density&nbsp;lipoprotein&nbsp;receptor&nbsp;as&nbsp;a&nbsp;candidate&nbsp;receptor&nbsp;for</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2035">2035</td><td nowrap="nowrap">hepatitis&nbsp;C&nbsp;virus.&nbsp;Journal&nbsp;of&nbsp;medical&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;57,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;223-9,&nbsp;mar.&nbsp;1999.</td><td class="diff_next"></td><td class="diff_header" id="to62_1962">1962</td><td nowrap="nowrap">hepatitis&nbsp;C&nbsp;virus.&nbsp;Journal&nbsp;of&nbsp;medical&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;57,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;223-9,&nbsp;mar.&nbsp;1999.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__96">n</a></td><td class="diff_header" id="from62_2036">2036</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/10022791&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29</span></td><td class="diff_next"><a href="#difflib_chg_to62__96">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2037">2037</td><td nowrap="nowrap">maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1963">1963</td><td nowrap="nowrap">maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2038">2038</td><td nowrap="nowrap">MORADPOUR,&nbsp;D.;&nbsp;PENIN,&nbsp;F.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;Replication&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus.&nbsp;Nature&nbsp;reviews</td><td class="diff_next"></td><td class="diff_header" id="to62_1964">1964</td><td nowrap="nowrap">MORADPOUR,&nbsp;D.;&nbsp;PENIN,&nbsp;F.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;Replication&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus.&nbsp;Nature&nbsp;reviews</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__97">n</a></td><td class="diff_header" id="from62_2039">2039</td><td nowrap="nowrap"><span class="diff_sub">Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;5,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;453-63,&nbsp;jun.&nbsp;2007.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.</span></td><td class="diff_next"><a href="#difflib_chg_to62__97">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2040">2040</td><td nowrap="nowrap">nlm.nih.gov/pubmed/17487147&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1965">1965</td><td nowrap="nowrap">nlm.nih.gov/pubmed/17487147&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__97"></td><td class="diff_header" id="from62_2041">2041</td><td nowrap="nowrap">NAINAN,&nbsp;O.&nbsp;V&nbsp;et&nbsp;al.&nbsp;Diagnosis&nbsp;of&nbsp;hepatitis&nbsp;A&nbsp;virus&nbsp;infection:&nbsp;A&nbsp;molecular&nbsp;approach.</td><td class="diff_next"></td><td class="diff_header" id="to62_1966">1966</td><td nowrap="nowrap">NAINAN,&nbsp;O.&nbsp;V&nbsp;et&nbsp;al.&nbsp;Diagnosis&nbsp;of&nbsp;hepatitis&nbsp;A&nbsp;virus&nbsp;infection:&nbsp;A&nbsp;molecular&nbsp;approach.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2042">2042</td><td nowrap="nowrap">Clinical&nbsp;Microbiology&nbsp;Reviews,&nbsp;[S.l.],&nbsp;v.&nbsp;19,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;63-79.&nbsp;jan.&nbsp;2006.&nbsp;Disponível&nbsp;em:&nbsp;&lt;htt-</td><td class="diff_next"></td><td class="diff_header" id="to62_1967">1967</td><td nowrap="nowrap">Clinical&nbsp;Microbiology&nbsp;Reviews,&nbsp;[S.l.],&nbsp;v.&nbsp;19,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;63-79.&nbsp;jan.&nbsp;2006.&nbsp;Disponível&nbsp;em:&nbsp;&lt;htt-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2043">2043</td><td nowrap="nowrap">ps://www.ncbi.nlm.nih.gov/pubmed/16418523&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1968">1968</td><td nowrap="nowrap">ps://www.ncbi.nlm.nih.gov/pubmed/16418523&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2044">2044</td><td nowrap="nowrap">NETTO,&nbsp;G.&nbsp;J.;&nbsp;SAAD,&nbsp;R.&nbsp;D.;&nbsp;DYSERT,&nbsp;P.&nbsp;A.&nbsp;Diagnostic&nbsp;molecular&nbsp;pathology:&nbsp;current&nbsp;techni-</td><td class="diff_next"></td><td class="diff_header" id="to62_1969">1969</td><td nowrap="nowrap">NETTO,&nbsp;G.&nbsp;J.;&nbsp;SAAD,&nbsp;R.&nbsp;D.;&nbsp;DYSERT,&nbsp;P.&nbsp;A.&nbsp;Diagnostic&nbsp;molecular&nbsp;pathology:&nbsp;current&nbsp;techni-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__98"></td><td class="diff_header" id="from62_2045">2045</td><td nowrap="nowrap">ques&nbsp;and&nbsp;clinical&nbsp;applications,&nbsp;part&nbsp;I.&nbsp;Proceedings&nbsp;(Baylor&nbsp;University&nbsp;Medical&nbsp;Center),</td><td class="diff_next"></td><td class="diff_header" id="to62_1970">1970</td><td nowrap="nowrap">ques&nbsp;and&nbsp;clinical&nbsp;applications,&nbsp;part&nbsp;I.&nbsp;Proceedings&nbsp;(Baylor&nbsp;University&nbsp;Medical&nbsp;Center),</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__98">n</a></td><td class="diff_header" id="from62_2046">2046</td><td nowrap="nowrap"><span class="diff_sub">[S.l.],&nbsp;v.&nbsp;16,&nbsp;n.&nbsp;4,&nbsp;p.&nbsp;379-83,&nbsp;2003.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pmc/</span></td><td class="diff_next"><a href="#difflib_chg_to62__98">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2047">2047</td><td nowrap="nowrap">articles/PMC1214554/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1971">1971</td><td nowrap="nowrap">articles/PMC1214554/&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2048">2048</td><td nowrap="nowrap">NGUYEN,&nbsp;M.&nbsp;H.;&nbsp;KEEFFE,&nbsp;E.&nbsp;B.&nbsp;Are&nbsp;hepatitis&nbsp;B&nbsp;e&nbsp;antigen&nbsp;(HBeAg)-positive&nbsp;chronic&nbsp;hepatitis</td><td class="diff_next"></td><td class="diff_header" id="to62_1972">1972</td><td nowrap="nowrap">NGUYEN,&nbsp;M.&nbsp;H.;&nbsp;KEEFFE,&nbsp;E.&nbsp;B.&nbsp;Are&nbsp;hepatitis&nbsp;B&nbsp;e&nbsp;antigen&nbsp;(HBeAg)-positive&nbsp;chronic&nbsp;hepatitis</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__99"></td><td class="diff_header" id="from62_2049">2049</td><td nowrap="nowrap">B&nbsp;and&nbsp;HBeAg-negative&nbsp;chronic&nbsp;hepatitis&nbsp;B&nbsp;distinct&nbsp;diseases?&nbsp;Clinical&nbsp;infectious&nbsp;disea-</td><td class="diff_next"></td><td class="diff_header" id="to62_1973">1973</td><td nowrap="nowrap">B&nbsp;and&nbsp;HBeAg-negative&nbsp;chronic&nbsp;hepatitis&nbsp;B&nbsp;distinct&nbsp;diseases?&nbsp;Clinical&nbsp;infectious&nbsp;disea-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__99">n</a></td><td class="diff_header" id="from62_2050">2050</td><td nowrap="nowrap"><span class="diff_sub">ses,&nbsp;[S.l.],&nbsp;v.&nbsp;47,&nbsp;n.&nbsp;10,&nbsp;p.&nbsp;1312-4,&nbsp;15&nbsp;nov.&nbsp;2008.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.</span></td><td class="diff_next"><a href="#difflib_chg_to62__99">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2051">2051</td><td nowrap="nowrap">gov/pubmed/18840075&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1974">1974</td><td nowrap="nowrap">gov/pubmed/18840075&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2052">2052</td><td nowrap="nowrap">NGUYEN,&nbsp;T.;&nbsp;LOCARNINI,&nbsp;S.&nbsp;Hepatitis:&nbsp;Monitoring&nbsp;drug&nbsp;therapy&nbsp;for&nbsp;hepatitis&nbsp;B—a&nbsp;global</td><td class="diff_next"></td><td class="diff_header" id="to62_1975">1975</td><td nowrap="nowrap">NGUYEN,&nbsp;T.;&nbsp;LOCARNINI,&nbsp;S.&nbsp;Hepatitis:&nbsp;Monitoring&nbsp;drug&nbsp;therapy&nbsp;for&nbsp;hepatitis&nbsp;B—a&nbsp;global</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2053">2053</td><td nowrap="nowrap">challenge?&nbsp;Nature&nbsp;Reviews&nbsp;Gastroenterology&nbsp;&amp;&nbsp;Hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;6,&nbsp;n.&nbsp;10,&nbsp;p.&nbsp;565-</td><td class="diff_next"></td><td class="diff_header" id="to62_1976">1976</td><td nowrap="nowrap">challenge?&nbsp;Nature&nbsp;Reviews&nbsp;Gastroenterology&nbsp;&amp;&nbsp;Hepatology,&nbsp;[S.l.],&nbsp;v.&nbsp;6,&nbsp;n.&nbsp;10,&nbsp;p.&nbsp;565-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__100">n</a></td><td class="diff_header" id="from62_2054">2054</td><td nowrap="nowrap"><span class="diff_sub">7,&nbsp;2009.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.nature.com/articles/nrgastro.2009.160&gt;.&nbsp;Acesso</span></td><td class="diff_next"><a href="#difflib_chg_to62__100">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__100"></td><td class="diff_header" id="from62_2055">2055</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1977">1977</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2056">2056</td><td nowrap="nowrap">OCANA,&nbsp;S.&nbsp;et&nbsp;al.&nbsp;Diagnostic&nbsp;strategy&nbsp;for&nbsp;occult&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;infection.&nbsp;World&nbsp;journal</td><td class="diff_next"></td><td class="diff_header" id="to62_1978">1978</td><td nowrap="nowrap">OCANA,&nbsp;S.&nbsp;et&nbsp;al.&nbsp;Diagnostic&nbsp;strategy&nbsp;for&nbsp;occult&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;infection.&nbsp;World&nbsp;journal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2057">2057</td><td nowrap="nowrap">of&nbsp;gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;17,&nbsp;n.&nbsp;12,&nbsp;p.&nbsp;1553-7,&nbsp;28&nbsp;mar.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1979">1979</td><td nowrap="nowrap">of&nbsp;gastroenterology,&nbsp;[S.l.],&nbsp;v.&nbsp;17,&nbsp;n.&nbsp;12,&nbsp;p.&nbsp;1553-7,&nbsp;28&nbsp;mar.&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2058">2058</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/21472120&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1980">1980</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/21472120&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2059">2059</td><td nowrap="nowrap">PARVEZ,&nbsp;M.&nbsp;K.&nbsp;Chronic&nbsp;hepatitis&nbsp;E&nbsp;infection:&nbsp;risks&nbsp;and&nbsp;controls.&nbsp;Intervirology,&nbsp;[S.l.],</td><td class="diff_next"></td><td class="diff_header" id="to62_1981">1981</td><td nowrap="nowrap">PARVEZ,&nbsp;M.&nbsp;K.&nbsp;Chronic&nbsp;hepatitis&nbsp;E&nbsp;infection:&nbsp;risks&nbsp;and&nbsp;controls.&nbsp;Intervirology,&nbsp;[S.l.],</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__101">n</a></td><td class="diff_header" id="from62_2060">2060</td><td nowrap="nowrap"><span class="diff_sub">v.&nbsp;56,&nbsp;n.&nbsp;4,&nbsp;p.&nbsp;213-6,&nbsp;jan.&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.karger.com/Article/</span></td><td class="diff_next"><a href="#difflib_chg_to62__101">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__101"></td><td class="diff_header" id="from62_2061">2061</td><td nowrap="nowrap">FullText/349888&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1982">1982</td><td nowrap="nowrap">FullText/349888&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2062">2062</td><td nowrap="nowrap">PEREIRA,&nbsp;L.&nbsp;M.&nbsp;B.;&nbsp;XIMENES,&nbsp;R.&nbsp;A.&nbsp;DE&nbsp;A.;&nbsp;MOREIRA,&nbsp;R.&nbsp;C.&nbsp;Estudo&nbsp;de&nbsp;prevalência&nbsp;de&nbsp;base</td><td class="diff_next"></td><td class="diff_header" id="to62_1983">1983</td><td nowrap="nowrap">PEREIRA,&nbsp;L.&nbsp;M.&nbsp;B.;&nbsp;XIMENES,&nbsp;R.&nbsp;A.&nbsp;DE&nbsp;A.;&nbsp;MOREIRA,&nbsp;R.&nbsp;C.&nbsp;Estudo&nbsp;de&nbsp;prevalência&nbsp;de&nbsp;base</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2063">2063</td><td nowrap="nowrap">populacional&nbsp;das&nbsp;infecções&nbsp;pelos&nbsp;vírus&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B&nbsp;e&nbsp;C&nbsp;nas&nbsp;capitais&nbsp;do&nbsp;Brasil.</td><td class="diff_next"></td><td class="diff_header" id="to62_1984">1984</td><td nowrap="nowrap">populacional&nbsp;das&nbsp;infecções&nbsp;pelos&nbsp;vírus&nbsp;das&nbsp;hepatites&nbsp;A,&nbsp;B&nbsp;e&nbsp;C&nbsp;nas&nbsp;capitais&nbsp;do&nbsp;Brasil.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2064">2064</td><td nowrap="nowrap">Recife:&nbsp;Universidade&nbsp;de&nbsp;Pernambuco,&nbsp;2010.</td><td class="diff_next"></td><td class="diff_header" id="to62_1985">1985</td><td nowrap="nowrap">Recife:&nbsp;Universidade&nbsp;de&nbsp;Pernambuco,&nbsp;2010.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2065">2065</td><td nowrap="nowrap">PILERI,&nbsp;P.&nbsp;et&nbsp;al.&nbsp;Binding&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;to&nbsp;CD81.&nbsp;Science,&nbsp;New&nbsp;York,&nbsp;v.&nbsp;282,&nbsp;n.&nbsp;5390,&nbsp;p.</td><td class="diff_next"></td><td class="diff_header" id="to62_1986">1986</td><td nowrap="nowrap">PILERI,&nbsp;P.&nbsp;et&nbsp;al.&nbsp;Binding&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;to&nbsp;CD81.&nbsp;Science,&nbsp;New&nbsp;York,&nbsp;v.&nbsp;282,&nbsp;n.&nbsp;5390,&nbsp;p.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__102">n</a></td><td class="diff_header" id="from62_2066">2066</td><td nowrap="nowrap"><span class="diff_sub">938-41,&nbsp;out.&nbsp;1998.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/9794763&gt;.</span></td><td class="diff_next"><a href="#difflib_chg_to62__102">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2067">2067</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1987">1987</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2068">2068</td><td nowrap="nowrap">PLOSS,&nbsp;A.&nbsp;et&nbsp;al.&nbsp;Human&nbsp;occludin&nbsp;is&nbsp;a&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;factor&nbsp;required&nbsp;for&nbsp;infection</td><td class="diff_next"></td><td class="diff_header" id="to62_1988">1988</td><td nowrap="nowrap">PLOSS,&nbsp;A.&nbsp;et&nbsp;al.&nbsp;Human&nbsp;occludin&nbsp;is&nbsp;a&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;entry&nbsp;factor&nbsp;required&nbsp;for&nbsp;infection</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2069">2069</td><td nowrap="nowrap">of&nbsp;mouse&nbsp;cells.&nbsp;Nature,&nbsp;[S.l.],&nbsp;v.&nbsp;457,&nbsp;n.&nbsp;7231,&nbsp;p.&nbsp;882-6,&nbsp;fev.&nbsp;2009.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1989">1989</td><td nowrap="nowrap">of&nbsp;mouse&nbsp;cells.&nbsp;Nature,&nbsp;[S.l.],&nbsp;v.&nbsp;457,&nbsp;n.&nbsp;7231,&nbsp;p.&nbsp;882-6,&nbsp;fev.&nbsp;2009.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__102"></td><td class="diff_header" id="from62_2070">2070</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/19182773&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1990">1990</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/19182773&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2071">2071</td><td nowrap="nowrap">REHERMANN,&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;virus&nbsp;(HBV)&nbsp;sequence&nbsp;variation&nbsp;of&nbsp;cytotoxic&nbsp;T&nbsp;lym-</td><td class="diff_next"></td><td class="diff_header" id="to62_1991">1991</td><td nowrap="nowrap">REHERMANN,&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;B&nbsp;virus&nbsp;(HBV)&nbsp;sequence&nbsp;variation&nbsp;of&nbsp;cytotoxic&nbsp;T&nbsp;lym-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__103"></td><td class="diff_header" id="from62_2072">2072</td><td nowrap="nowrap">phocyte&nbsp;epitopes&nbsp;is&nbsp;not&nbsp;common&nbsp;in&nbsp;patients&nbsp;with&nbsp;chronic&nbsp;HBV&nbsp;infection.&nbsp;The&nbsp;Journal</td><td class="diff_next"></td><td class="diff_header" id="to62_1992">1992</td><td nowrap="nowrap">phocyte&nbsp;epitopes&nbsp;is&nbsp;not&nbsp;common&nbsp;in&nbsp;patients&nbsp;with&nbsp;chronic&nbsp;HBV&nbsp;infection.&nbsp;The&nbsp;Journal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2073">2073</td><td nowrap="nowrap">of&nbsp;clinical&nbsp;investigation,&nbsp;[S.l.],&nbsp;v.&nbsp;96,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;1527-34,&nbsp;set.&nbsp;1995.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td><td class="diff_next"></td><td class="diff_header" id="to62_1993">1993</td><td nowrap="nowrap">of&nbsp;clinical&nbsp;investigation,&nbsp;[S.l.],&nbsp;v.&nbsp;96,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;1527-34,&nbsp;set.&nbsp;1995.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2074">2074</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/7544809&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1994">1994</td><td nowrap="nowrap">www.ncbi.nlm.nih.gov/pubmed/7544809&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__103">n</a></td><td class="diff_header" id="from62_2075">2075</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;The&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;persists&nbsp;for&nbsp;decades&nbsp;after&nbsp;patients’&nbsp;recovery&nbsp;from&nbsp;acute&nbsp;viral</td><td class="diff_next"><a href="#difflib_chg_to62__103">n</a></td><td class="diff_header" id="to62_1995">1995</td><td nowrap="nowrap">_.&nbsp;The&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;persists&nbsp;for&nbsp;decades&nbsp;after&nbsp;patients’&nbsp;recovery&nbsp;from&nbsp;acute&nbsp;viral</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__104"></td><td class="diff_header" id="from62_2076">2076</td><td nowrap="nowrap">hepatitis&nbsp;despite&nbsp;active&nbsp;maintenance&nbsp;of&nbsp;a&nbsp;cytotoxic&nbsp;T-lymphocyte&nbsp;response.&nbsp;Nature&nbsp;me-</td><td class="diff_next"></td><td class="diff_header" id="to62_1996">1996</td><td nowrap="nowrap">hepatitis&nbsp;despite&nbsp;active&nbsp;maintenance&nbsp;of&nbsp;a&nbsp;cytotoxic&nbsp;T-lymphocyte&nbsp;response.&nbsp;Nature&nbsp;me-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__104">n</a></td><td class="diff_header" id="from62_2077">2077</td><td nowrap="nowrap"><span class="diff_sub">dicine,&nbsp;[S.l.],&nbsp;v.&nbsp;2,&nbsp;n.&nbsp;10,&nbsp;p.&nbsp;1104-8,&nbsp;out.&nbsp;1996.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.</span></td><td class="diff_next"><a href="#difflib_chg_to62__104">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__105"></td><td class="diff_header" id="from62_2078">2078</td><td nowrap="nowrap">gov/pubmed/8837608&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_1997">1997</td><td nowrap="nowrap">gov/pubmed/8837608&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2079">2079</td><td nowrap="nowrap">REHERMANN,&nbsp;B.;&nbsp;NASCIMBENI,&nbsp;M.&nbsp;Immunology&nbsp;of&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;and&nbsp;hepatitis&nbsp;C&nbsp;virus</td><td class="diff_next"></td><td class="diff_header" id="to62_1998">1998</td><td nowrap="nowrap">REHERMANN,&nbsp;B.;&nbsp;NASCIMBENI,&nbsp;M.&nbsp;Immunology&nbsp;of&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;and&nbsp;hepatitis&nbsp;C&nbsp;virus</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2080">2080</td><td nowrap="nowrap">infection.&nbsp;Nature&nbsp;reviews&nbsp;Immunology,&nbsp;[S.l.],&nbsp;v.&nbsp;5,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;215-29,&nbsp;mar.&nbsp;2005.&nbsp;Disponível</td><td class="diff_next"></td><td class="diff_header" id="to62_1999">1999</td><td nowrap="nowrap">infection.&nbsp;Nature&nbsp;reviews&nbsp;Immunology,&nbsp;[S.l.],&nbsp;v.&nbsp;5,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;215-29,&nbsp;mar.&nbsp;2005.&nbsp;Disponível</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__105">n</a></td><td class="diff_header" id="from62_2081">2081</td><td nowrap="nowrap"><span class="diff_sub">em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/15738952&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__105">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__106"></td><td class="diff_header" id="from62_2082">2082</td><td nowrap="nowrap">RICE,&nbsp;C.&nbsp;M.&nbsp;New&nbsp;insights&nbsp;into&nbsp;HCV&nbsp;replication:&nbsp;potential&nbsp;antiviral&nbsp;targets.&nbsp;Topics&nbsp;in&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to62_2000">2000</td><td nowrap="nowrap">RICE,&nbsp;C.&nbsp;M.&nbsp;New&nbsp;insights&nbsp;into&nbsp;HCV&nbsp;replication:&nbsp;potential&nbsp;antiviral&nbsp;targets.&nbsp;Topics&nbsp;in&nbsp;anti-</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__106">n</a></td><td class="diff_header" id="from62_2083">2083</td><td nowrap="nowrap"><span class="diff_sub">viral&nbsp;medicine,&nbsp;[S.l.],&nbsp;v.&nbsp;19,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;117-20,&nbsp;2011.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.</span></td><td class="diff_next"><a href="#difflib_chg_to62__106">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2084">2084</td><td nowrap="nowrap">nih.gov/pubmed/21946389&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2001">2001</td><td nowrap="nowrap">nih.gov/pubmed/21946389&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2085">2085</td><td nowrap="nowrap">SABLON,&nbsp;E.;&nbsp;SHAPIRO,&nbsp;F.&nbsp;Advances&nbsp;in&nbsp;molecular&nbsp;diagnosis&nbsp;of&nbsp;HBV&nbsp;infection&nbsp;and&nbsp;drug</td><td class="diff_next"></td><td class="diff_header" id="to62_2002">2002</td><td nowrap="nowrap">SABLON,&nbsp;E.;&nbsp;SHAPIRO,&nbsp;F.&nbsp;Advances&nbsp;in&nbsp;molecular&nbsp;diagnosis&nbsp;of&nbsp;HBV&nbsp;infection&nbsp;and&nbsp;drug</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__107"></td><td class="diff_header" id="from62_2086">2086</td><td nowrap="nowrap">resistance.&nbsp;International&nbsp;journal&nbsp;of&nbsp;medical&nbsp;sciences,&nbsp;[S.l.],&nbsp;v.&nbsp;2,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;8-16,&nbsp;2005.</td><td class="diff_next"></td><td class="diff_header" id="to62_2003">2003</td><td nowrap="nowrap">resistance.&nbsp;International&nbsp;journal&nbsp;of&nbsp;medical&nbsp;sciences,&nbsp;[S.l.],&nbsp;v.&nbsp;2,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;8-16,&nbsp;2005.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__107">n</a></td><td class="diff_header" id="from62_2087">2087</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142219/&gt;.&nbsp;Acesso</span></td><td class="diff_next"><a href="#difflib_chg_to62__107">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2088">2088</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2004">2004</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2089">2089</td><td nowrap="nowrap">SCALIONI,&nbsp;L.&nbsp;DE&nbsp;P.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;of&nbsp;rapid&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;antibody&nbsp;assays&nbsp;among</td><td class="diff_next"></td><td class="diff_header" id="to62_2005">2005</td><td nowrap="nowrap">SCALIONI,&nbsp;L.&nbsp;DE&nbsp;P.&nbsp;et&nbsp;al.&nbsp;Performance&nbsp;of&nbsp;rapid&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;antibody&nbsp;assays&nbsp;among</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__108"></td><td class="diff_header" id="from62_2090">2090</td><td nowrap="nowrap">high-&nbsp;and&nbsp;low-risk&nbsp;populations.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;60,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;200-5,&nbsp;1</td><td class="diff_next"></td><td class="diff_header" id="to62_2006">2006</td><td nowrap="nowrap">high-&nbsp;and&nbsp;low-risk&nbsp;populations.&nbsp;Journal&nbsp;of&nbsp;clinical&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;60,&nbsp;n.&nbsp;3,&nbsp;p.&nbsp;200-5,&nbsp;1</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__108">n</a></td><td class="diff_header" id="from62_2091">2091</td><td nowrap="nowrap"><span class="diff_sub">jul.&nbsp;2014.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/24794796&gt;.&nbsp;Acesso</span></td><td class="diff_next"><a href="#difflib_chg_to62__108">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2092">2092</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2007">2007</td><td nowrap="nowrap">em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__109"></td><td class="diff_header" id="from62_2093">2093</td><td nowrap="nowrap">SCHEEL,&nbsp;T.&nbsp;K.&nbsp;H.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;Understanding&nbsp;the&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;life&nbsp;cycle&nbsp;paves&nbsp;the&nbsp;way</td><td class="diff_next"></td><td class="diff_header" id="to62_2008">2008</td><td nowrap="nowrap">SCHEEL,&nbsp;T.&nbsp;K.&nbsp;H.;&nbsp;RICE,&nbsp;C.&nbsp;M.&nbsp;Understanding&nbsp;the&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;life&nbsp;cycle&nbsp;paves&nbsp;the&nbsp;way</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2094">2094</td><td nowrap="nowrap">for&nbsp;highly&nbsp;effective&nbsp;therapies.&nbsp;Nature&nbsp;medicine,&nbsp;[S.l.],&nbsp;v.&nbsp;19,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;837-49,&nbsp;jul.&nbsp;2013.</td><td class="diff_next"></td><td class="diff_header" id="to62_2009">2009</td><td nowrap="nowrap">for&nbsp;highly&nbsp;effective&nbsp;therapies.&nbsp;Nature&nbsp;medicine,&nbsp;[S.l.],&nbsp;v.&nbsp;19,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;837-49,&nbsp;jul.&nbsp;2013.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__109">n</a></td><td class="diff_header" id="from62_2095">2095</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/23836234&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29</span></td><td class="diff_next"><a href="#difflib_chg_to62__109">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2096">2096</td><td nowrap="nowrap">maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2010">2010</td><td nowrap="nowrap">maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2097">2097</td><td nowrap="nowrap">SEEGER,&nbsp;C.;&nbsp;MASON,&nbsp;W.&nbsp;S.&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Biology.&nbsp;Microbiology&nbsp;and&nbsp;Molecular</td><td class="diff_next"></td><td class="diff_header" id="to62_2011">2011</td><td nowrap="nowrap">SEEGER,&nbsp;C.;&nbsp;MASON,&nbsp;W.&nbsp;S.&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Biology.&nbsp;Microbiology&nbsp;and&nbsp;Molecular</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__110">n</a></td><td class="diff_header" id="from62_2098">2098</td><td nowrap="nowrap"><span class="diff_sub">Biology&nbsp;Reviews,&nbsp;[S.l.],&nbsp;v.&nbsp;64,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;51-68,&nbsp;1&nbsp;mar.&nbsp;2000.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.</span></td><td class="diff_next"><a href="#difflib_chg_to62__110">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2099">2099</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/10704474&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2012">2012</td><td nowrap="nowrap">ncbi.nlm.nih.gov/pubmed/10704474&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2100">2100</td><td nowrap="nowrap">SILVA,&nbsp;C.&nbsp;et&nbsp;al.&nbsp;The&nbsp;influence&nbsp;of&nbsp;occult&nbsp;infection&nbsp;with&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;on&nbsp;liver&nbsp;histology</td><td class="diff_next"></td><td class="diff_header" id="to62_2013">2013</td><td nowrap="nowrap">SILVA,&nbsp;C.&nbsp;et&nbsp;al.&nbsp;The&nbsp;influence&nbsp;of&nbsp;occult&nbsp;infection&nbsp;with&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;on&nbsp;liver&nbsp;histology</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2101">2101</td><td nowrap="nowrap">and&nbsp;response&nbsp;to&nbsp;interferon&nbsp;treatment&nbsp;in&nbsp;chronic&nbsp;hepatitis&nbsp;C&nbsp;patients.&nbsp;The&nbsp;Brazilian</td><td class="diff_next"></td><td class="diff_header" id="to62_2014">2014</td><td nowrap="nowrap">and&nbsp;response&nbsp;to&nbsp;interferon&nbsp;treatment&nbsp;in&nbsp;chronic&nbsp;hepatitis&nbsp;C&nbsp;patients.&nbsp;The&nbsp;Brazilian</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__110"></td><td class="diff_header" id="from62_2102">2102</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;Infectious&nbsp;Diseases,&nbsp;[S.l.],&nbsp;v.&nbsp;8,&nbsp;p.&nbsp;431-439,&nbsp;2004.&nbsp;Disponível&nbsp;em:&nbsp;&lt;http://</td><td class="diff_next"></td><td class="diff_header" id="to62_2015">2015</td><td nowrap="nowrap">Journal&nbsp;of&nbsp;Infectious&nbsp;Diseases,&nbsp;[S.l.],&nbsp;v.&nbsp;8,&nbsp;p.&nbsp;431-439,&nbsp;2004.&nbsp;Disponível&nbsp;em:&nbsp;&lt;http://</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2103">2103</td><td nowrap="nowrap">www.scielo.br/scielo.php?script=sci_abstract&amp;pid=S1413-86702004000600007&amp;lng=e</td><td class="diff_next"></td><td class="diff_header" id="to62_2016">2016</td><td nowrap="nowrap">www.scielo.br/scielo.php?script=sci_abstract&amp;pid=S1413-86702004000600007&amp;lng=e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2104">2104</td><td nowrap="nowrap">n&amp;nrm=iso&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2017">2017</td><td nowrap="nowrap">n&amp;nrm=iso&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2105">2105</td><td nowrap="nowrap">SITNIK,&nbsp;R.;&nbsp;PINHO,&nbsp;J.&nbsp;R.&nbsp;R.&nbsp;Hepatitis&nbsp;B&nbsp;virus&nbsp;genotypes&nbsp;and&nbsp;precore&nbsp;and&nbsp;core&nbsp;mutants&nbsp;in</td><td class="diff_next"></td><td class="diff_header" id="to62_2018">2018</td><td nowrap="nowrap">SITNIK,&nbsp;R.;&nbsp;PINHO,&nbsp;J.&nbsp;R.&nbsp;R.&nbsp;Hepatitis&nbsp;B&nbsp;virus&nbsp;genotypes&nbsp;and&nbsp;precore&nbsp;and&nbsp;core&nbsp;mutants&nbsp;in</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2106">2106</td><td nowrap="nowrap">Brazilian&nbsp;patients.&nbsp;Journal&nbsp;of&nbsp;Clinical&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;42,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;2455-60,&nbsp;2004.</td><td class="diff_next"></td><td class="diff_header" id="to62_2019">2019</td><td nowrap="nowrap">Brazilian&nbsp;patients.&nbsp;Journal&nbsp;of&nbsp;Clinical&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;42,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;2455-60,&nbsp;2004.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__111">n</a></td><td class="diff_header" id="from62_2107">2107</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/15184419&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29</span></td><td class="diff_next"><a href="#difflib_chg_to62__111">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2108">2108</td><td nowrap="nowrap">maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2020">2020</td><td nowrap="nowrap">maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__111"></td><td class="diff_header" id="from62_2109">2109</td><td nowrap="nowrap">SMEDILE,&nbsp;A.&nbsp;et&nbsp;al.&nbsp;Hepatite&nbsp;Delta:&nbsp;Historia&nbsp;Natural&nbsp;-&nbsp;Transmissão&nbsp;-&nbsp;Imunodiagnóstico.</td><td class="diff_next"></td><td class="diff_header" id="to62_2021">2021</td><td nowrap="nowrap">SMEDILE,&nbsp;A.&nbsp;et&nbsp;al.&nbsp;Hepatite&nbsp;Delta:&nbsp;Historia&nbsp;Natural&nbsp;-&nbsp;Transmissão&nbsp;-&nbsp;Imunodiagnóstico.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2110">2110</td><td nowrap="nowrap">In:&nbsp;FOCACCIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.&nbsp;3.&nbsp;ed.&nbsp;São</td><td class="diff_next"></td><td class="diff_header" id="to62_2022">2022</td><td nowrap="nowrap">In:&nbsp;FOCACCIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças&nbsp;Associadas.&nbsp;3.&nbsp;ed.&nbsp;São</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2111">2111</td><td nowrap="nowrap">Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;939-955.</td><td class="diff_next"></td><td class="diff_header" id="to62_2023">2023</td><td nowrap="nowrap">Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;939-955.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2112">2112</td><td nowrap="nowrap">SMITH,&nbsp;D.&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Expanded&nbsp;classification&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;into&nbsp;7&nbsp;genotypes&nbsp;and&nbsp;67</td><td class="diff_next"></td><td class="diff_header" id="to62_2024">2024</td><td nowrap="nowrap">SMITH,&nbsp;D.&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Expanded&nbsp;classification&nbsp;of&nbsp;hepatitis&nbsp;C&nbsp;virus&nbsp;into&nbsp;7&nbsp;genotypes&nbsp;and&nbsp;67</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2113">2113</td><td nowrap="nowrap">subtypes:&nbsp;updated&nbsp;criteria&nbsp;and&nbsp;genotype&nbsp;assignment&nbsp;web&nbsp;resource.&nbsp;Hepatology,&nbsp;[S.l.],</td><td class="diff_next"></td><td class="diff_header" id="to62_2025">2025</td><td nowrap="nowrap">subtypes:&nbsp;updated&nbsp;criteria&nbsp;and&nbsp;genotype&nbsp;assignment&nbsp;web&nbsp;resource.&nbsp;Hepatology,&nbsp;[S.l.],</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__112">n</a></td><td class="diff_header" id="from62_2114">2114</td><td nowrap="nowrap"><span class="diff_sub">v.&nbsp;59,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;318-27,&nbsp;jan.&nbsp;2014.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pub-</span></td><td class="diff_next"><a href="#difflib_chg_to62__112">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2115">2115</td><td nowrap="nowrap">med/24115039&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2026">2026</td><td nowrap="nowrap">med/24115039&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__112"></td><td class="diff_header" id="from62_2116">2116</td><td nowrap="nowrap">STRAUSS,&nbsp;E.&nbsp;História&nbsp;Natural&nbsp;da&nbsp;Hepatite&nbsp;C&nbsp;-&nbsp;Fatores&nbsp;de&nbsp;Progressão.&nbsp;Avaliação&nbsp;Prognóstica</td><td class="diff_next"></td><td class="diff_header" id="to62_2027">2027</td><td nowrap="nowrap">STRAUSS,&nbsp;E.&nbsp;História&nbsp;Natural&nbsp;da&nbsp;Hepatite&nbsp;C&nbsp;-&nbsp;Fatores&nbsp;de&nbsp;Progressão.&nbsp;Avaliação&nbsp;Prognóstica</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2117">2117</td><td nowrap="nowrap">da&nbsp;Hepatite&nbsp;C&nbsp;Crônica.&nbsp;In:&nbsp;FOCCACIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças</td><td class="diff_next"></td><td class="diff_header" id="to62_2028">2028</td><td nowrap="nowrap">da&nbsp;Hepatite&nbsp;C&nbsp;Crônica.&nbsp;In:&nbsp;FOCCACIA,&nbsp;R.&nbsp;(Ed.).&nbsp;Tratado&nbsp;de&nbsp;Hepatites&nbsp;Virais&nbsp;e&nbsp;Doenças</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2118">2118</td><td nowrap="nowrap">Associadas.&nbsp;3.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;453-470.</td><td class="diff_next"></td><td class="diff_header" id="to62_2029">2029</td><td nowrap="nowrap">Associadas.&nbsp;3.&nbsp;ed.&nbsp;São&nbsp;Paulo:&nbsp;Editora&nbsp;Atheneu,&nbsp;2013.&nbsp;p.&nbsp;453-470.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__113"></td><td class="diff_header" id="from62_2119">2119</td><td nowrap="nowrap">TATEMATSU,&nbsp;K.&nbsp;et&nbsp;al.&nbsp;A&nbsp;genetic&nbsp;variant&nbsp;of&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;divergent&nbsp;from&nbsp;known&nbsp;human</td><td class="diff_next"></td><td class="diff_header" id="to62_2030">2030</td><td nowrap="nowrap">TATEMATSU,&nbsp;K.&nbsp;et&nbsp;al.&nbsp;A&nbsp;genetic&nbsp;variant&nbsp;of&nbsp;hepatitis&nbsp;B&nbsp;virus&nbsp;divergent&nbsp;from&nbsp;known&nbsp;human</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2120">2120</td><td nowrap="nowrap">genotype&nbsp;J.&nbsp;Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;83,&nbsp;n.&nbsp;20,&nbsp;p.&nbsp;10538-47,&nbsp;out.&nbsp;2009.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to62_2031">2031</td><td nowrap="nowrap">genotype&nbsp;J.&nbsp;Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;83,&nbsp;n.&nbsp;20,&nbsp;p.&nbsp;10538-47,&nbsp;out.&nbsp;2009.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__113">n</a></td><td class="diff_header" id="from62_2121">2121</td><td nowrap="nowrap"><span class="diff_sub">&lt;https://www.ncbi.nlm.nih.gov/pubmed/19640977&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</span></td><td class="diff_next"><a href="#difflib_chg_to62__113">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2122">2122</td><td nowrap="nowrap">THIMME,&nbsp;R.&nbsp;et&nbsp;al.&nbsp;CD8+&nbsp;T&nbsp;Cells&nbsp;Mediate&nbsp;Viral&nbsp;Clearance&nbsp;and&nbsp;Disease&nbsp;Pathogenesis&nbsp;during</td><td class="diff_next"></td><td class="diff_header" id="to62_2032">2032</td><td nowrap="nowrap">THIMME,&nbsp;R.&nbsp;et&nbsp;al.&nbsp;CD8+&nbsp;T&nbsp;Cells&nbsp;Mediate&nbsp;Viral&nbsp;Clearance&nbsp;and&nbsp;Disease&nbsp;Pathogenesis&nbsp;during</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__114"></td><td class="diff_header" id="from62_2123">2123</td><td nowrap="nowrap">Acute&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Infection.&nbsp;Journal&nbsp;of&nbsp;Virology,&nbsp;[S.l.],&nbsp;v.&nbsp;77,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;68-76,&nbsp;1&nbsp;jan.</td><td class="diff_next"></td><td class="diff_header" id="to62_2033">2033</td><td nowrap="nowrap">Acute&nbsp;Hepatitis&nbsp;B&nbsp;Virus&nbsp;Infection.&nbsp;Journal&nbsp;of&nbsp;Virology,&nbsp;[S.l.],&nbsp;v.&nbsp;77,&nbsp;n.&nbsp;1,&nbsp;p.&nbsp;68-76,&nbsp;1&nbsp;jan.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__114">n</a></td><td class="diff_header" id="from62_2124">2124</td><td nowrap="nowrap"><span class="diff_sub">2003.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/12477811&gt;.&nbsp;Acesso&nbsp;em:</span></td><td class="diff_next"><a href="#difflib_chg_to62__114">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2125">2125</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2034">2034</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2126">2126</td><td nowrap="nowrap">TRAN,&nbsp;T.&nbsp;T.&nbsp;H.;&nbsp;TRINH,&nbsp;T.&nbsp;N.;&nbsp;ABE,&nbsp;K.&nbsp;New&nbsp;complex&nbsp;recombinant&nbsp;genotype&nbsp;of&nbsp;hepatitis&nbsp;B</td><td class="diff_next"></td><td class="diff_header" id="to62_2035">2035</td><td nowrap="nowrap">TRAN,&nbsp;T.&nbsp;T.&nbsp;H.;&nbsp;TRINH,&nbsp;T.&nbsp;N.;&nbsp;ABE,&nbsp;K.&nbsp;New&nbsp;complex&nbsp;recombinant&nbsp;genotype&nbsp;of&nbsp;hepatitis&nbsp;B</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__115"></td><td class="diff_header" id="from62_2127">2127</td><td nowrap="nowrap">virus&nbsp;identified&nbsp;in&nbsp;Vietnam.&nbsp;Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;82,&nbsp;n.&nbsp;11,&nbsp;p.&nbsp;5657-63,&nbsp;jun.&nbsp;2008.</td><td class="diff_next"></td><td class="diff_header" id="to62_2036">2036</td><td nowrap="nowrap">virus&nbsp;identified&nbsp;in&nbsp;Vietnam.&nbsp;Journal&nbsp;of&nbsp;virology,&nbsp;[S.l.],&nbsp;v.&nbsp;82,&nbsp;n.&nbsp;11,&nbsp;p.&nbsp;5657-63,&nbsp;jun.&nbsp;2008.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__115">n</a></td><td class="diff_header" id="from62_2128">2128</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/18353958&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29</span></td><td class="diff_next"><a href="#difflib_chg_to62__115">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2129">2129</td><td nowrap="nowrap">maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2037">2037</td><td nowrap="nowrap">maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2130">2130</td><td nowrap="nowrap">VILLAR,&nbsp;L.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Co-circulation&nbsp;of&nbsp;genotypes&nbsp;IA&nbsp;and&nbsp;IB&nbsp;of&nbsp;hepatitis&nbsp;A&nbsp;virus&nbsp;in&nbsp;Northeast</td><td class="diff_next"></td><td class="diff_header" id="to62_2038">2038</td><td nowrap="nowrap">VILLAR,&nbsp;L.&nbsp;M.&nbsp;et&nbsp;al.&nbsp;Co-circulation&nbsp;of&nbsp;genotypes&nbsp;IA&nbsp;and&nbsp;IB&nbsp;of&nbsp;hepatitis&nbsp;A&nbsp;virus&nbsp;in&nbsp;Northeast</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__116"></td><td class="diff_header" id="from62_2131">2131</td><td nowrap="nowrap">Brazil.&nbsp;Brazilian&nbsp;Journal&nbsp;of&nbsp;Medical&nbsp;and&nbsp;Biological&nbsp;Research,&nbsp;[S.l.],&nbsp;v.&nbsp;39,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;873-81,</td><td class="diff_next"></td><td class="diff_header" id="to62_2039">2039</td><td nowrap="nowrap">Brazil.&nbsp;Brazilian&nbsp;Journal&nbsp;of&nbsp;Medical&nbsp;and&nbsp;Biological&nbsp;Research,&nbsp;[S.l.],&nbsp;v.&nbsp;39,&nbsp;n.&nbsp;7,&nbsp;p.&nbsp;873-81,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__116">n</a></td><td class="diff_header" id="from62_2132">2132</td><td nowrap="nowrap"><span class="diff_sub">2006.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/16862277&gt;&nbsp;Acesso&nbsp;em:</span></td><td class="diff_next"><a href="#difflib_chg_to62__116">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__117"></td><td class="diff_header" id="from62_2133">2133</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2040">2040</td><td nowrap="nowrap">29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2134">2134</td><td nowrap="nowrap">WHO&nbsp;(WORLD&nbsp;HEALTH&nbsp;ORGANIZATION).&nbsp;Hepatitis&nbsp;A&nbsp;outbreaks&nbsp;mostly&nbsp;affecting&nbsp;men</td><td class="diff_next"></td><td class="diff_header" id="to62_2041">2041</td><td nowrap="nowrap">WHO&nbsp;(WORLD&nbsp;HEALTH&nbsp;ORGANIZATION).&nbsp;Hepatitis&nbsp;A&nbsp;outbreaks&nbsp;mostly&nbsp;affecting&nbsp;men</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2135">2135</td><td nowrap="nowrap">who&nbsp;have&nbsp;sex&nbsp;with&nbsp;men:&nbsp;European&nbsp;Region&nbsp;and&nbsp;the&nbsp;Americas.&nbsp;7&nbsp;jun.&nbsp;2017.&nbsp;[On-line].</td><td class="diff_next"></td><td class="diff_header" id="to62_2042">2042</td><td nowrap="nowrap">who&nbsp;have&nbsp;sex&nbsp;with&nbsp;men:&nbsp;European&nbsp;Region&nbsp;and&nbsp;the&nbsp;Americas.&nbsp;7&nbsp;jun.&nbsp;2017.&nbsp;[On-line].</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__118"><a href="#difflib_chg_to62__117">n</a></td><td class="diff_header" id="from62_2136">2136</td><td nowrap="nowrap"><span class="diff_sub">2017a.&nbsp;Disponível&nbsp;em:&nbsp;&lt;http://www.who.int/csr/don/07-june-2017-hepatitis-a/en/&gt;.</span></td><td class="diff_next"><a href="#difflib_chg_to62__117">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2137">2137</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;18&nbsp;abr.&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2043">2043</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;18&nbsp;abr.&nbsp;2018.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__118">n</a></td><td class="diff_header" id="from62_2138">2138</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;Hepatitis&nbsp;Delta&nbsp;Fact&nbsp;sheet.&nbsp;Reviewed&nbsp;July&nbsp;2017&nbsp;[On-line].&nbsp;2017b.&nbsp;Disponível</td><td class="diff_next"><a href="#difflib_chg_to62__118">n</a></td><td class="diff_header" id="to62_2044">2044</td><td nowrap="nowrap">_.&nbsp;Hepatitis&nbsp;Delta&nbsp;Fact&nbsp;sheet.&nbsp;Reviewed&nbsp;July&nbsp;2017&nbsp;[On-line].&nbsp;2017b.&nbsp;Disponível</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2139">2139</td><td nowrap="nowrap"><span class="diff_sub">em:&nbsp;&lt;http://www.who.int/csr/disease/hepatitis/whocdscsrncs20011/en/&gt;.&nbsp;Acesso&nbsp;em:</span></td><td class="diff_next"></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2140">2140</td><td nowrap="nowrap">18&nbsp;abr.&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2045">2045</td><td nowrap="nowrap">18&nbsp;abr.&nbsp;2018.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__119">n</a></td><td class="diff_header" id="from62_2141">2141</td><td nowrap="nowrap"><span class="diff_sub">_____</span>_.&nbsp;List&nbsp;of&nbsp;diagnostics&nbsp;eligible&nbsp;to&nbsp;tender&nbsp;for&nbsp;procurement&nbsp;by&nbsp;WHO&nbsp;in&nbsp;2013&nbsp;(in-</td><td class="diff_next"><a href="#difflib_chg_to62__119">n</a></td><td class="diff_header" id="to62_2046">2046</td><td nowrap="nowrap">_.&nbsp;List&nbsp;of&nbsp;diagnostics&nbsp;eligible&nbsp;to&nbsp;tender&nbsp;for&nbsp;procurement&nbsp;by&nbsp;WHO&nbsp;in&nbsp;2013&nbsp;(in-</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__119"></td><td class="diff_header" id="from62_2142">2142</td><td nowrap="nowrap"><span class="diff_sub">cluding&nbsp;WHO&nbsp;prequalified&nbsp;diagnostics).&nbsp;2013.&nbsp;Disponível&nbsp;em:&nbsp;&lt;http://www.who.int/</span></td><td class="diff_next"></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2143">2143</td><td nowrap="nowrap">diagnostics_laboratory/procurement/130723_eligible_hiv_products_for_procure-</td><td class="diff_next"></td><td class="diff_header" id="to62_2047">2047</td><td nowrap="nowrap">diagnostics_laboratory/procurement/130723_eligible_hiv_products_for_procure-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2144">2144</td><td nowrap="nowrap">ment_2013.pdf&gt;.&nbsp;Acesso&nbsp;em:&nbsp;27&nbsp;abr.&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2048">2048</td><td nowrap="nowrap">ment_2013.pdf&gt;.&nbsp;Acesso&nbsp;em:&nbsp;27&nbsp;abr.&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2145">2145</td><td nowrap="nowrap">YOLKEN,&nbsp;R.&nbsp;H.;&nbsp;STOPA,&nbsp;P.&nbsp;J.&nbsp;Enzyme-linked&nbsp;fluorescence&nbsp;assay:&nbsp;ultrasensitive&nbsp;solid-phase</td><td class="diff_next"></td><td class="diff_header" id="to62_2049">2049</td><td nowrap="nowrap">YOLKEN,&nbsp;R.&nbsp;H.;&nbsp;STOPA,&nbsp;P.&nbsp;J.&nbsp;Enzyme-linked&nbsp;fluorescence&nbsp;assay:&nbsp;ultrasensitive&nbsp;solid-phase</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to62__120"></td><td class="diff_header" id="from62_2146">2146</td><td nowrap="nowrap">assay&nbsp;for&nbsp;detection&nbsp;of&nbsp;human&nbsp;rotavirus.&nbsp;Journal&nbsp;of&nbsp;Clinical&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;10,</td><td class="diff_next"></td><td class="diff_header" id="to62_2050">2050</td><td nowrap="nowrap">assay&nbsp;for&nbsp;detection&nbsp;of&nbsp;human&nbsp;rotavirus.&nbsp;Journal&nbsp;of&nbsp;Clinical&nbsp;Microbiology,&nbsp;[S.l.],&nbsp;v.&nbsp;10,</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__120">n</a></td><td class="diff_header" id="from62_2147">2147</td><td nowrap="nowrap"><span class="diff_sub">n.&nbsp;3,&nbsp;p.&nbsp;317-21,&nbsp;1979.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pubmed/226564&gt;.</span></td><td class="diff_next"><a href="#difflib_chg_to62__120">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2148">2148</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2051">2051</td><td nowrap="nowrap">Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2149">2149</td><td nowrap="nowrap">ZEISEL,&nbsp;M.&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Scavenger&nbsp;receptor&nbsp;class&nbsp;B&nbsp;type&nbsp;I&nbsp;is&nbsp;a&nbsp;key&nbsp;host&nbsp;factor&nbsp;for&nbsp;hepatitis</td><td class="diff_next"></td><td class="diff_header" id="to62_2052">2052</td><td nowrap="nowrap">ZEISEL,&nbsp;M.&nbsp;B.&nbsp;et&nbsp;al.&nbsp;Scavenger&nbsp;receptor&nbsp;class&nbsp;B&nbsp;type&nbsp;I&nbsp;is&nbsp;a&nbsp;key&nbsp;host&nbsp;factor&nbsp;for&nbsp;hepatitis</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2150">2150</td><td nowrap="nowrap">C&nbsp;virus&nbsp;infection&nbsp;required&nbsp;for&nbsp;an&nbsp;entry&nbsp;step&nbsp;closely&nbsp;linked&nbsp;to&nbsp;CD81.&nbsp;Hepatology,&nbsp;[S.l.],</td><td class="diff_next"></td><td class="diff_header" id="to62_2053">2053</td><td nowrap="nowrap">C&nbsp;virus&nbsp;infection&nbsp;required&nbsp;for&nbsp;an&nbsp;entry&nbsp;step&nbsp;closely&nbsp;linked&nbsp;to&nbsp;CD81.&nbsp;Hepatology,&nbsp;[S.l.],</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to62__top">t</a></td><td class="diff_header" id="from62_2151">2151</td><td nowrap="nowrap"><span class="diff_sub">v.&nbsp;46,&nbsp;n.&nbsp;6,&nbsp;p.&nbsp;1722-31,&nbsp;dez.&nbsp;2007.&nbsp;Disponível&nbsp;em:&nbsp;&lt;https://www.ncbi.nlm.nih.gov/pub-</span></td><td class="diff_next"><a href="#difflib_chg_to62__top">t</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2152">2152</td><td nowrap="nowrap">med/18000990&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2054">2054</td><td nowrap="nowrap">med/18000990&gt;.&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2153">2153</td><td nowrap="nowrap">ZHANG,&nbsp;J.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;E&nbsp;virus:&nbsp;Neutralizing&nbsp;sites,&nbsp;diagnosis,&nbsp;and&nbsp;protective&nbsp;immunity.</td><td class="diff_next"></td><td class="diff_header" id="to62_2055">2055</td><td nowrap="nowrap">ZHANG,&nbsp;J.&nbsp;et&nbsp;al.&nbsp;Hepatitis&nbsp;E&nbsp;virus:&nbsp;Neutralizing&nbsp;sites,&nbsp;diagnosis,&nbsp;and&nbsp;protective&nbsp;immunity.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2154">2154</td><td nowrap="nowrap">Reviews&nbsp;in&nbsp;Medical&nbsp;Virology,&nbsp;[S.l.],&nbsp;v.&nbsp;22,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;339-49,&nbsp;set.&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;ht-</td><td class="diff_next"></td><td class="diff_header" id="to62_2056">2056</td><td nowrap="nowrap">Reviews&nbsp;in&nbsp;Medical&nbsp;Virology,&nbsp;[S.l.],&nbsp;v.&nbsp;22,&nbsp;n.&nbsp;5,&nbsp;p.&nbsp;339-49,&nbsp;set.&nbsp;2012.&nbsp;Disponível&nbsp;em:&nbsp;&lt;ht-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2155">2155</td><td nowrap="nowrap">tps://www.ncbi.nlm.nih.gov/pubmed/22645002&gt;&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td><td class="diff_next"></td><td class="diff_header" id="to62_2057">2057</td><td nowrap="nowrap">tps://www.ncbi.nlm.nih.gov/pubmed/22645002&gt;&nbsp;Acesso&nbsp;em:&nbsp;29&nbsp;maio&nbsp;2018.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2156">2156</td><td nowrap="nowrap">17.&nbsp;GLOSSÁRIO</td><td class="diff_next"></td><td class="diff_header" id="to62_2058">2058</td><td nowrap="nowrap">17.&nbsp;GLOSSÁRIO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2157">2157</td><td nowrap="nowrap">em&nbsp;negrito,&nbsp;com&nbsp;a&nbsp;letra&nbsp;G&nbsp;sobrescrita.</td><td class="diff_next"></td><td class="diff_header" id="to62_2059">2059</td><td nowrap="nowrap">em&nbsp;negrito,&nbsp;com&nbsp;a&nbsp;letra&nbsp;G&nbsp;sobrescrita.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2158">2158</td><td nowrap="nowrap">Ácido&nbsp;nucleico.&nbsp;Macromoléculas&nbsp;formadas&nbsp;por&nbsp;unidades&nbsp;monoméricas&nbsp;denominadas</td><td class="diff_next"></td><td class="diff_header" id="to62_2060">2060</td><td nowrap="nowrap">Ácido&nbsp;nucleico.&nbsp;Macromoléculas&nbsp;formadas&nbsp;por&nbsp;unidades&nbsp;monoméricas&nbsp;denominadas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2159">2159</td><td nowrap="nowrap">nucleotídeos.&nbsp;São&nbsp;as&nbsp;moléculas&nbsp;em&nbsp;que&nbsp;estão&nbsp;armazenadas&nbsp;as&nbsp;informações&nbsp;genéticas.</td><td class="diff_next"></td><td class="diff_header" id="to62_2061">2061</td><td nowrap="nowrap">nucleotídeos.&nbsp;São&nbsp;as&nbsp;moléculas&nbsp;em&nbsp;que&nbsp;estão&nbsp;armazenadas&nbsp;as&nbsp;informações&nbsp;genéticas.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2160">2160</td><td nowrap="nowrap">Algoritmo.&nbsp;Sequência&nbsp;de&nbsp;procedimentos&nbsp;utilizados&nbsp;para&nbsp;a&nbsp;resolução&nbsp;de&nbsp;problemas.</td><td class="diff_next"></td><td class="diff_header" id="to62_2062">2062</td><td nowrap="nowrap">Algoritmo.&nbsp;Sequência&nbsp;de&nbsp;procedimentos&nbsp;utilizados&nbsp;para&nbsp;a&nbsp;resolução&nbsp;de&nbsp;problemas.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2161">2161</td><td nowrap="nowrap">Aminotransferases.&nbsp;Enzimas&nbsp;essenciais&nbsp;envolvidas&nbsp;no&nbsp;metabolismo.&nbsp;São&nbsp;liberadas&nbsp;na</td><td class="diff_next"></td><td class="diff_header" id="to62_2063">2063</td><td nowrap="nowrap">Aminotransferases.&nbsp;Enzimas&nbsp;essenciais&nbsp;envolvidas&nbsp;no&nbsp;metabolismo.&nbsp;São&nbsp;liberadas&nbsp;na</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2162">2162</td><td nowrap="nowrap">corrente&nbsp;sanguínea&nbsp;quando&nbsp;ocorre&nbsp;dano&nbsp;na&nbsp;membrana&nbsp;dos&nbsp;hepatócitos.</td><td class="diff_next"></td><td class="diff_header" id="to62_2064">2064</td><td nowrap="nowrap">corrente&nbsp;sanguínea&nbsp;quando&nbsp;ocorre&nbsp;dano&nbsp;na&nbsp;membrana&nbsp;dos&nbsp;hepatócitos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2163">2163</td><td nowrap="nowrap">Anictérico.&nbsp;Indivíduo&nbsp;com&nbsp;pele&nbsp;de&nbsp;aspecto&nbsp;normal,&nbsp;sem&nbsp;presença&nbsp;de&nbsp;Icterícia&nbsp;ou&nbsp;sinal</td><td class="diff_next"></td><td class="diff_header" id="to62_2065">2065</td><td nowrap="nowrap">Anictérico.&nbsp;Indivíduo&nbsp;com&nbsp;pele&nbsp;de&nbsp;aspecto&nbsp;normal,&nbsp;sem&nbsp;presença&nbsp;de&nbsp;Icterícia&nbsp;ou&nbsp;sinal</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2164">2164</td><td nowrap="nowrap">de&nbsp;bilirrubina&nbsp;na&nbsp;pele.</td><td class="diff_next"></td><td class="diff_header" id="to62_2066">2066</td><td nowrap="nowrap">de&nbsp;bilirrubina&nbsp;na&nbsp;pele.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2165">2165</td><td nowrap="nowrap">Anorexia.&nbsp;Distúrbio&nbsp;alimentar&nbsp;que&nbsp;provoca&nbsp;perda&nbsp;de&nbsp;peso&nbsp;acima&nbsp;do&nbsp;que&nbsp;é&nbsp;considerado</td><td class="diff_next"></td><td class="diff_header" id="to62_2067">2067</td><td nowrap="nowrap">Anorexia.&nbsp;Distúrbio&nbsp;alimentar&nbsp;que&nbsp;provoca&nbsp;perda&nbsp;de&nbsp;peso&nbsp;acima&nbsp;do&nbsp;que&nbsp;é&nbsp;considerado</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2166">2166</td><td nowrap="nowrap">saudável,&nbsp;considerando&nbsp;parâmetros&nbsp;como&nbsp;idade&nbsp;e&nbsp;peso.</td><td class="diff_next"></td><td class="diff_header" id="to62_2068">2068</td><td nowrap="nowrap">saudável,&nbsp;considerando&nbsp;parâmetros&nbsp;como&nbsp;idade&nbsp;e&nbsp;peso.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2167">2167</td><td nowrap="nowrap">Anticorpo.&nbsp;Proteína&nbsp;(imunoglobulina)&nbsp;produzida&nbsp;por&nbsp;linfócitos&nbsp;B,&nbsp;que&nbsp;se&nbsp;liga&nbsp;especifica-</td><td class="diff_next"></td><td class="diff_header" id="to62_2069">2069</td><td nowrap="nowrap">Anticorpo.&nbsp;Proteína&nbsp;(imunoglobulina)&nbsp;produzida&nbsp;por&nbsp;linfócitos&nbsp;B,&nbsp;que&nbsp;se&nbsp;liga&nbsp;especifica-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2168">2168</td><td nowrap="nowrap">mente&nbsp;a&nbsp;uma&nbsp;substância&nbsp;reconhecida&nbsp;como&nbsp;estranha&nbsp;pelo&nbsp;organismo.</td><td class="diff_next"></td><td class="diff_header" id="to62_2070">2070</td><td nowrap="nowrap">mente&nbsp;a&nbsp;uma&nbsp;substância&nbsp;reconhecida&nbsp;como&nbsp;estranha&nbsp;pelo&nbsp;organismo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2169">2169</td><td nowrap="nowrap">Antígeno.&nbsp;Qualquer&nbsp;substância&nbsp;ou&nbsp;material&nbsp;que&nbsp;possa&nbsp;estimular&nbsp;a&nbsp;produção&nbsp;de&nbsp;anticor-</td><td class="diff_next"></td><td class="diff_header" id="to62_2071">2071</td><td nowrap="nowrap">Antígeno.&nbsp;Qualquer&nbsp;substância&nbsp;ou&nbsp;material&nbsp;que&nbsp;possa&nbsp;estimular&nbsp;a&nbsp;produção&nbsp;de&nbsp;anticor-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2170">2170</td><td nowrap="nowrap">pos&nbsp;em&nbsp;um&nbsp;organismo.</td><td class="diff_next"></td><td class="diff_header" id="to62_2072">2072</td><td nowrap="nowrap">pos&nbsp;em&nbsp;um&nbsp;organismo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2171">2171</td><td nowrap="nowrap">Área&nbsp;endêmica.&nbsp;Espaço&nbsp;ou&nbsp;região&nbsp;onde&nbsp;existe&nbsp;a&nbsp;ocorrência&nbsp;de&nbsp;um&nbsp;grande&nbsp;número&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_2073">2073</td><td nowrap="nowrap">Área&nbsp;endêmica.&nbsp;Espaço&nbsp;ou&nbsp;região&nbsp;onde&nbsp;existe&nbsp;a&nbsp;ocorrência&nbsp;de&nbsp;um&nbsp;grande&nbsp;número&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2172">2172</td><td nowrap="nowrap">casos&nbsp;de&nbsp;uma&nbsp;doença,&nbsp;de&nbsp;forma&nbsp;contínua.</td><td class="diff_next"></td><td class="diff_header" id="to62_2074">2074</td><td nowrap="nowrap">casos&nbsp;de&nbsp;uma&nbsp;doença,&nbsp;de&nbsp;forma&nbsp;contínua.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2173">2173</td><td nowrap="nowrap">Bilirrubinas.&nbsp;Pigmentos&nbsp;resultantes&nbsp;da&nbsp;quebra&nbsp;de&nbsp;grupamentos&nbsp;químicos,&nbsp;principal-</td><td class="diff_next"></td><td class="diff_header" id="to62_2075">2075</td><td nowrap="nowrap">Bilirrubinas.&nbsp;Pigmentos&nbsp;resultantes&nbsp;da&nbsp;quebra&nbsp;de&nbsp;grupamentos&nbsp;químicos,&nbsp;principal-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2174">2174</td><td nowrap="nowrap">mente&nbsp;provenientes&nbsp;do&nbsp;grupamento&nbsp;heme.&nbsp;Normalmente&nbsp;circulam&nbsp;no&nbsp;plasma&nbsp;sanguí-</td><td class="diff_next"></td><td class="diff_header" id="to62_2076">2076</td><td nowrap="nowrap">mente&nbsp;provenientes&nbsp;do&nbsp;grupamento&nbsp;heme.&nbsp;Normalmente&nbsp;circulam&nbsp;no&nbsp;plasma&nbsp;sanguí-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2175">2175</td><td nowrap="nowrap">neo,&nbsp;sendo&nbsp;absorvidas&nbsp;pelas&nbsp;células&nbsp;do&nbsp;fígado&nbsp;e&nbsp;secretadas&nbsp;na&nbsp;bílis.</td><td class="diff_next"></td><td class="diff_header" id="to62_2077">2077</td><td nowrap="nowrap">neo,&nbsp;sendo&nbsp;absorvidas&nbsp;pelas&nbsp;células&nbsp;do&nbsp;fígado&nbsp;e&nbsp;secretadas&nbsp;na&nbsp;bílis.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2176">2176</td><td nowrap="nowrap">Cap.&nbsp;Estrutura&nbsp;típica&nbsp;do&nbsp;mRNA&nbsp;eucariótico.&nbsp;Sua&nbsp;função&nbsp;é&nbsp;de&nbsp;proteção&nbsp;contra&nbsp;a&nbsp;de-</td><td class="diff_next"></td><td class="diff_header" id="to62_2078">2078</td><td nowrap="nowrap">Cap.&nbsp;Estrutura&nbsp;típica&nbsp;do&nbsp;mRNA&nbsp;eucariótico.&nbsp;Sua&nbsp;função&nbsp;é&nbsp;de&nbsp;proteção&nbsp;contra&nbsp;a&nbsp;de-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2177">2177</td><td nowrap="nowrap">ribossomos.</td><td class="diff_next"></td><td class="diff_header" id="to62_2079">2079</td><td nowrap="nowrap">ribossomos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2178">2178</td><td nowrap="nowrap">Carga&nbsp;viral.&nbsp;Quantificação&nbsp;das&nbsp;partículas&nbsp;virais&nbsp;no&nbsp;plasma&nbsp;(HBV-DNA&nbsp;ou&nbsp;HCV-RNA).&nbsp;É</td><td class="diff_next"></td><td class="diff_header" id="to62_2080">2080</td><td nowrap="nowrap">Carga&nbsp;viral.&nbsp;Quantificação&nbsp;das&nbsp;partículas&nbsp;virais&nbsp;no&nbsp;plasma&nbsp;(HBV-DNA&nbsp;ou&nbsp;HCV-RNA).&nbsp;É</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2179">2179</td><td nowrap="nowrap">conhecida&nbsp;também&nbsp;como&nbsp;teste&nbsp;molecular&nbsp;quantitativo.</td><td class="diff_next"></td><td class="diff_header" id="to62_2081">2081</td><td nowrap="nowrap">conhecida&nbsp;também&nbsp;como&nbsp;teste&nbsp;molecular&nbsp;quantitativo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2180">2180</td><td nowrap="nowrap">Cirrose.&nbsp;Doença&nbsp;crônica&nbsp;do&nbsp;fígado&nbsp;que&nbsp;se&nbsp;caracteriza&nbsp;pela&nbsp;presença&nbsp;de&nbsp;fibrose&nbsp;e&nbsp;a&nbsp;forma-</td><td class="diff_next"></td><td class="diff_header" id="to62_2082">2082</td><td nowrap="nowrap">Cirrose.&nbsp;Doença&nbsp;crônica&nbsp;do&nbsp;fígado&nbsp;que&nbsp;se&nbsp;caracteriza&nbsp;pela&nbsp;presença&nbsp;de&nbsp;fibrose&nbsp;e&nbsp;a&nbsp;forma-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2181">2181</td><td nowrap="nowrap">ção&nbsp;de&nbsp;nódulos&nbsp;que&nbsp;impedem&nbsp;a&nbsp;circulação&nbsp;sanguínea.</td><td class="diff_next"></td><td class="diff_header" id="to62_2083">2083</td><td nowrap="nowrap">ção&nbsp;de&nbsp;nódulos&nbsp;que&nbsp;impedem&nbsp;a&nbsp;circulação&nbsp;sanguínea.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2182">2182</td><td nowrap="nowrap">Comunicantes.&nbsp;Contatos&nbsp;intradomiciliares&nbsp;ou&nbsp;sexuais&nbsp;ou&nbsp;qualquer&nbsp;outro&nbsp;indivíduo&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to62_2084">2084</td><td nowrap="nowrap">Comunicantes.&nbsp;Contatos&nbsp;intradomiciliares&nbsp;ou&nbsp;sexuais&nbsp;ou&nbsp;qualquer&nbsp;outro&nbsp;indivíduo&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2183">2183</td><td nowrap="nowrap">compartilhe&nbsp;objetos&nbsp;de&nbsp;uso&nbsp;pessoal&nbsp;do&nbsp;portador&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;(escova&nbsp;de&nbsp;den-</td><td class="diff_next"></td><td class="diff_header" id="to62_2085">2085</td><td nowrap="nowrap">compartilhe&nbsp;objetos&nbsp;de&nbsp;uso&nbsp;pessoal&nbsp;do&nbsp;portador&nbsp;das&nbsp;hepatites&nbsp;virais&nbsp;(escova&nbsp;de&nbsp;den-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2184">2184</td><td nowrap="nowrap">te,&nbsp;lâmina&nbsp;de&nbsp;barbear&nbsp;e&nbsp;outros&nbsp;objetos&nbsp;de&nbsp;uso&nbsp;pessoal).&nbsp;No&nbsp;caso&nbsp;de&nbsp;pessoas&nbsp;que&nbsp;usam</td><td class="diff_next"></td><td class="diff_header" id="to62_2086">2086</td><td nowrap="nowrap">te,&nbsp;lâmina&nbsp;de&nbsp;barbear&nbsp;e&nbsp;outros&nbsp;objetos&nbsp;de&nbsp;uso&nbsp;pessoal).&nbsp;No&nbsp;caso&nbsp;de&nbsp;pessoas&nbsp;que&nbsp;usam</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2185">2185</td><td nowrap="nowrap">drogas,&nbsp;estão&nbsp;incluídos&nbsp;aqueles&nbsp;que&nbsp;compartilham&nbsp;quaisquer&nbsp;materiais&nbsp;para&nbsp;o&nbsp;uso&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_2087">2087</td><td nowrap="nowrap">drogas,&nbsp;estão&nbsp;incluídos&nbsp;aqueles&nbsp;que&nbsp;compartilham&nbsp;quaisquer&nbsp;materiais&nbsp;para&nbsp;o&nbsp;uso&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2186">2186</td><td nowrap="nowrap">substâncias&nbsp;(seringas,&nbsp;agulhas,&nbsp;canudos,&nbsp;cachimbos&nbsp;etc).</td><td class="diff_next"></td><td class="diff_header" id="to62_2088">2088</td><td nowrap="nowrap">substâncias&nbsp;(seringas,&nbsp;agulhas,&nbsp;canudos,&nbsp;cachimbos&nbsp;etc).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2187">2187</td><td nowrap="nowrap">Custo-efetividade.&nbsp;Melhor&nbsp;resultado&nbsp;em&nbsp;uma&nbsp;avaliação&nbsp;econômica&nbsp;que&nbsp;considera&nbsp;dis-</td><td class="diff_next"></td><td class="diff_header" id="to62_2089">2089</td><td nowrap="nowrap">Custo-efetividade.&nbsp;Melhor&nbsp;resultado&nbsp;em&nbsp;uma&nbsp;avaliação&nbsp;econômica&nbsp;que&nbsp;considera&nbsp;dis-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2188">2188</td><td nowrap="nowrap">tintas&nbsp;intervenções&nbsp;de&nbsp;saúde,&nbsp;tendo&nbsp;seus&nbsp;resultados&nbsp;expressos&nbsp;em&nbsp;unidades&nbsp;monetárias</td><td class="diff_next"></td><td class="diff_header" id="to62_2090">2090</td><td nowrap="nowrap">tintas&nbsp;intervenções&nbsp;de&nbsp;saúde,&nbsp;tendo&nbsp;seus&nbsp;resultados&nbsp;expressos&nbsp;em&nbsp;unidades&nbsp;monetárias</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2189">2189</td><td nowrap="nowrap">e&nbsp;seus&nbsp;efeitos&nbsp;em&nbsp;unidades&nbsp;clínico-epidemiológicas.</td><td class="diff_next"></td><td class="diff_header" id="to62_2091">2091</td><td nowrap="nowrap">e&nbsp;seus&nbsp;efeitos&nbsp;em&nbsp;unidades&nbsp;clínico-epidemiológicas.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2190">2190</td><td nowrap="nowrap">Diagnóstico&nbsp;etiológico.&nbsp;Diagnóstico&nbsp;realizado&nbsp;por&nbsp;médico&nbsp;em&nbsp;relação&nbsp;a&nbsp;uma&nbsp;determi-</td><td class="diff_next"></td><td class="diff_header" id="to62_2092">2092</td><td nowrap="nowrap">Diagnóstico&nbsp;etiológico.&nbsp;Diagnóstico&nbsp;realizado&nbsp;por&nbsp;médico&nbsp;em&nbsp;relação&nbsp;a&nbsp;uma&nbsp;determi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2191">2191</td><td nowrap="nowrap">nada&nbsp;doença,&nbsp;a&nbsp;partir&nbsp;da&nbsp;comprovação&nbsp;de&nbsp;sua&nbsp;causa,&nbsp;seja&nbsp;por&nbsp;meio&nbsp;de&nbsp;método&nbsp;clínico&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_2093">2093</td><td nowrap="nowrap">nada&nbsp;doença,&nbsp;a&nbsp;partir&nbsp;da&nbsp;comprovação&nbsp;de&nbsp;sua&nbsp;causa,&nbsp;seja&nbsp;por&nbsp;meio&nbsp;de&nbsp;método&nbsp;clínico&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2192">2192</td><td nowrap="nowrap">por&nbsp;exames&nbsp;laboratoriais.</td><td class="diff_next"></td><td class="diff_header" id="to62_2094">2094</td><td nowrap="nowrap">por&nbsp;exames&nbsp;laboratoriais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2193">2193</td><td nowrap="nowrap">Epitopo.&nbsp;Também&nbsp;conhecido&nbsp;como&nbsp;determinante&nbsp;antigênico,&nbsp;é&nbsp;a&nbsp;parte&nbsp;de&nbsp;um&nbsp;antígeno</td><td class="diff_next"></td><td class="diff_header" id="to62_2095">2095</td><td nowrap="nowrap">Epitopo.&nbsp;Também&nbsp;conhecido&nbsp;como&nbsp;determinante&nbsp;antigênico,&nbsp;é&nbsp;a&nbsp;parte&nbsp;de&nbsp;um&nbsp;antígeno</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2194">2194</td><td nowrap="nowrap">reconhecida&nbsp;pelo&nbsp;sistema&nbsp;imune.</td><td class="diff_next"></td><td class="diff_header" id="to62_2096">2096</td><td nowrap="nowrap">reconhecida&nbsp;pelo&nbsp;sistema&nbsp;imune.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2195">2195</td><td nowrap="nowrap">Espécie&nbsp;química.&nbsp;Termo&nbsp;que&nbsp;se&nbsp;refere&nbsp;às&nbsp;diversas&nbsp;formas&nbsp;pelas&nbsp;quais&nbsp;elementos&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to62_2097">2097</td><td nowrap="nowrap">Espécie&nbsp;química.&nbsp;Termo&nbsp;que&nbsp;se&nbsp;refere&nbsp;às&nbsp;diversas&nbsp;formas&nbsp;pelas&nbsp;quais&nbsp;elementos&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2196">2196</td><td nowrap="nowrap">substâncias&nbsp;químicas&nbsp;existem&nbsp;na&nbsp;natureza&nbsp;ou&nbsp;em&nbsp;uma&nbsp;reação.&nbsp;Podem&nbsp;ser&nbsp;átomos,&nbsp;íons,</td><td class="diff_next"></td><td class="diff_header" id="to62_2098">2098</td><td nowrap="nowrap">substâncias&nbsp;químicas&nbsp;existem&nbsp;na&nbsp;natureza&nbsp;ou&nbsp;em&nbsp;uma&nbsp;reação.&nbsp;Podem&nbsp;ser&nbsp;átomos,&nbsp;íons,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2197">2197</td><td nowrap="nowrap">moléculas&nbsp;ou&nbsp;radicais.</td><td class="diff_next"></td><td class="diff_header" id="to62_2099">2099</td><td nowrap="nowrap">moléculas&nbsp;ou&nbsp;radicais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2198">2198</td><td nowrap="nowrap">Especificidade&nbsp;clínica&nbsp;ou&nbsp;especificidade&nbsp;diagnóstica.&nbsp;Capacidade&nbsp;de&nbsp;um&nbsp;ensaio&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_2100">2100</td><td nowrap="nowrap">Especificidade&nbsp;clínica&nbsp;ou&nbsp;especificidade&nbsp;diagnóstica.&nbsp;Capacidade&nbsp;de&nbsp;um&nbsp;ensaio&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2199">2199</td><td nowrap="nowrap">uma&nbsp;desordem&nbsp;clínica&nbsp;ou&nbsp;doença.</td><td class="diff_next"></td><td class="diff_header" id="to62_2101">2101</td><td nowrap="nowrap">uma&nbsp;desordem&nbsp;clínica&nbsp;ou&nbsp;doença.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2200">2200</td><td nowrap="nowrap">Fase&nbsp;de&nbsp;leitura&nbsp;aberta.&nbsp;Sequência&nbsp;de&nbsp;DNA&nbsp;que&nbsp;pode&nbsp;ser&nbsp;traduzida&nbsp;em&nbsp;proteína&nbsp;após&nbsp;ser</td><td class="diff_next"></td><td class="diff_header" id="to62_2102">2102</td><td nowrap="nowrap">Fase&nbsp;de&nbsp;leitura&nbsp;aberta.&nbsp;Sequência&nbsp;de&nbsp;DNA&nbsp;que&nbsp;pode&nbsp;ser&nbsp;traduzida&nbsp;em&nbsp;proteína&nbsp;após&nbsp;ser</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2201">2201</td><td nowrap="nowrap">reconhecida&nbsp;por&nbsp;ribossomos.</td><td class="diff_next"></td><td class="diff_header" id="to62_2103">2103</td><td nowrap="nowrap">reconhecida&nbsp;por&nbsp;ribossomos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2202">2202</td><td nowrap="nowrap">Fluido&nbsp;crevicular&nbsp;gengival.&nbsp;Líquido&nbsp;encontrado&nbsp;no&nbsp;sulco&nbsp;gengival,&nbsp;contendo&nbsp;proteínas</td><td class="diff_next"></td><td class="diff_header" id="to62_2104">2104</td><td nowrap="nowrap">Fluido&nbsp;crevicular&nbsp;gengival.&nbsp;Líquido&nbsp;encontrado&nbsp;no&nbsp;sulco&nbsp;gengival,&nbsp;contendo&nbsp;proteínas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2203">2203</td><td nowrap="nowrap">plasmáticas&nbsp;e&nbsp;anticorpos.&nbsp;É&nbsp;obtido&nbsp;pressionando&nbsp;a&nbsp;gengiva&nbsp;acima&nbsp;dos&nbsp;dentes.</td><td class="diff_next"></td><td class="diff_header" id="to62_2105">2105</td><td nowrap="nowrap">plasmáticas&nbsp;e&nbsp;anticorpos.&nbsp;É&nbsp;obtido&nbsp;pressionando&nbsp;a&nbsp;gengiva&nbsp;acima&nbsp;dos&nbsp;dentes.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2204">2204</td><td nowrap="nowrap">Fluido&nbsp;oral.&nbsp;Denominação&nbsp;popular&nbsp;para&nbsp;o&nbsp;fluido&nbsp;crevicular&nbsp;gengival.</td><td class="diff_next"></td><td class="diff_header" id="to62_2106">2106</td><td nowrap="nowrap">Fluido&nbsp;oral.&nbsp;Denominação&nbsp;popular&nbsp;para&nbsp;o&nbsp;fluido&nbsp;crevicular&nbsp;gengival.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2205">2205</td><td nowrap="nowrap">Fluxograma.&nbsp;Diagrama&nbsp;que&nbsp;pode&nbsp;ser&nbsp;entendido&nbsp;como&nbsp;uma&nbsp;representação&nbsp;esquemática</td><td class="diff_next"></td><td class="diff_header" id="to62_2107">2107</td><td nowrap="nowrap">Fluxograma.&nbsp;Diagrama&nbsp;que&nbsp;pode&nbsp;ser&nbsp;entendido&nbsp;como&nbsp;uma&nbsp;representação&nbsp;esquemática</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2206">2206</td><td nowrap="nowrap">de&nbsp;um&nbsp;processo.</td><td class="diff_next"></td><td class="diff_header" id="to62_2108">2108</td><td nowrap="nowrap">de&nbsp;um&nbsp;processo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2207">2207</td><td nowrap="nowrap">Fosfatase&nbsp;alcalina.&nbsp;Enzima&nbsp;hepática&nbsp;cujos&nbsp;níveis&nbsp;circulantes&nbsp;podem&nbsp;se&nbsp;elevar,&nbsp;entre&nbsp;ou-</td><td class="diff_next"></td><td class="diff_header" id="to62_2109">2109</td><td nowrap="nowrap">Fosfatase&nbsp;alcalina.&nbsp;Enzima&nbsp;hepática&nbsp;cujos&nbsp;níveis&nbsp;circulantes&nbsp;podem&nbsp;se&nbsp;elevar,&nbsp;entre&nbsp;ou-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2208">2208</td><td nowrap="nowrap">tros,&nbsp;nos&nbsp;casos&nbsp;de&nbsp;doença&nbsp;hepática.</td><td class="diff_next"></td><td class="diff_header" id="to62_2110">2110</td><td nowrap="nowrap">tros,&nbsp;nos&nbsp;casos&nbsp;de&nbsp;doença&nbsp;hepática.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2209">2209</td><td nowrap="nowrap">Iatrogênica.&nbsp;Reação&nbsp;adversa&nbsp;por&nbsp;uso&nbsp;de&nbsp;medicamento.</td><td class="diff_next"></td><td class="diff_header" id="to62_2111">2111</td><td nowrap="nowrap">Iatrogênica.&nbsp;Reação&nbsp;adversa&nbsp;por&nbsp;uso&nbsp;de&nbsp;medicamento.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2210">2210</td><td nowrap="nowrap">Ictérica.&nbsp;Pessoa&nbsp;com&nbsp;coloração&nbsp;amarelada&nbsp;na&nbsp;pele&nbsp;e&nbsp;mucosas&nbsp;devido&nbsp;ao&nbsp;aumento&nbsp;dos</td><td class="diff_next"></td><td class="diff_header" id="to62_2112">2112</td><td nowrap="nowrap">Ictérica.&nbsp;Pessoa&nbsp;com&nbsp;coloração&nbsp;amarelada&nbsp;na&nbsp;pele&nbsp;e&nbsp;mucosas&nbsp;devido&nbsp;ao&nbsp;aumento&nbsp;dos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2211">2211</td><td nowrap="nowrap">níveis&nbsp;de&nbsp;bilirrubina&nbsp;no&nbsp;sangue.</td><td class="diff_next"></td><td class="diff_header" id="to62_2113">2113</td><td nowrap="nowrap">níveis&nbsp;de&nbsp;bilirrubina&nbsp;no&nbsp;sangue.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2212">2212</td><td nowrap="nowrap">Imunoensaio.&nbsp;Método&nbsp;que&nbsp;detecta&nbsp;a&nbsp;presença&nbsp;de&nbsp;um&nbsp;complexo&nbsp;antígeno-anticorpo</td><td class="diff_next"></td><td class="diff_header" id="to62_2114">2114</td><td nowrap="nowrap">Imunoensaio.&nbsp;Método&nbsp;que&nbsp;detecta&nbsp;a&nbsp;presença&nbsp;de&nbsp;um&nbsp;complexo&nbsp;antígeno-anticorpo</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2213">2213</td><td nowrap="nowrap">em&nbsp;uma&nbsp;amostra&nbsp;biológica.</td><td class="diff_next"></td><td class="diff_header" id="to62_2115">2115</td><td nowrap="nowrap">em&nbsp;uma&nbsp;amostra&nbsp;biológica.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2214">2214</td><td nowrap="nowrap">Imunossuprimidos/imunodeprimidos.&nbsp;Indivíduos&nbsp;nos&nbsp;quais&nbsp;ocorre&nbsp;a&nbsp;redução&nbsp;das&nbsp;rea-</td><td class="diff_next"></td><td class="diff_header" id="to62_2116">2116</td><td nowrap="nowrap">Imunossuprimidos/imunodeprimidos.&nbsp;Indivíduos&nbsp;nos&nbsp;quais&nbsp;ocorre&nbsp;a&nbsp;redução&nbsp;das&nbsp;rea-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2215">2215</td><td nowrap="nowrap">ções&nbsp;imunitárias&nbsp;no&nbsp;organismo.&nbsp;A&nbsp;origem&nbsp;pode&nbsp;ser&nbsp;o&nbsp;tratamento&nbsp;terapêutico&nbsp;com&nbsp;medi-</td><td class="diff_next"></td><td class="diff_header" id="to62_2117">2117</td><td nowrap="nowrap">ções&nbsp;imunitárias&nbsp;no&nbsp;organismo.&nbsp;A&nbsp;origem&nbsp;pode&nbsp;ser&nbsp;o&nbsp;tratamento&nbsp;terapêutico&nbsp;com&nbsp;medi-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2216">2216</td><td nowrap="nowrap">camentos&nbsp;imunossupressores,&nbsp;a&nbsp;infecção&nbsp;por&nbsp;agentes&nbsp;etiológicos&nbsp;(como&nbsp;o&nbsp;vírus&nbsp;causa-</td><td class="diff_next"></td><td class="diff_header" id="to62_2118">2118</td><td nowrap="nowrap">camentos&nbsp;imunossupressores,&nbsp;a&nbsp;infecção&nbsp;por&nbsp;agentes&nbsp;etiológicos&nbsp;(como&nbsp;o&nbsp;vírus&nbsp;causa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2217">2217</td><td nowrap="nowrap">dor&nbsp;da&nbsp;aids,&nbsp;o&nbsp;HIV)&nbsp;ou&nbsp;ainda&nbsp;o&nbsp;tratamento&nbsp;quimioterápico&nbsp;para&nbsp;o&nbsp;câncer.</td><td class="diff_next"></td><td class="diff_header" id="to62_2119">2119</td><td nowrap="nowrap">dor&nbsp;da&nbsp;aids,&nbsp;o&nbsp;HIV)&nbsp;ou&nbsp;ainda&nbsp;o&nbsp;tratamento&nbsp;quimioterápico&nbsp;para&nbsp;o&nbsp;câncer.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2218">2218</td><td nowrap="nowrap">IOB&nbsp;(Infecção&nbsp;Oculta&nbsp;pelo&nbsp;Vírus&nbsp;da&nbsp;Hepatite&nbsp;B).&nbsp;Detecção&nbsp;do&nbsp;DNA&nbsp;do&nbsp;HBV&nbsp;no&nbsp;soro&nbsp;ou&nbsp;no</td><td class="diff_next"></td><td class="diff_header" id="to62_2120">2120</td><td nowrap="nowrap">IOB&nbsp;(Infecção&nbsp;Oculta&nbsp;pelo&nbsp;Vírus&nbsp;da&nbsp;Hepatite&nbsp;B).&nbsp;Detecção&nbsp;do&nbsp;DNA&nbsp;do&nbsp;HBV&nbsp;no&nbsp;soro&nbsp;ou&nbsp;no</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2219">2219</td><td nowrap="nowrap">tecido&nbsp;hepático&nbsp;de&nbsp;pacientes&nbsp;negativos&nbsp;para&nbsp;o&nbsp;HBsAg.</td><td class="diff_next"></td><td class="diff_header" id="to62_2121">2121</td><td nowrap="nowrap">tecido&nbsp;hepático&nbsp;de&nbsp;pacientes&nbsp;negativos&nbsp;para&nbsp;o&nbsp;HBsAg.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2220">2220</td><td nowrap="nowrap">Interferons.&nbsp;Proteínas&nbsp;da&nbsp;família&nbsp;das&nbsp;citocinas.&nbsp;Estimulam&nbsp;a&nbsp;resposta&nbsp;imune&nbsp;contra&nbsp;pa-</td><td class="diff_next"></td><td class="diff_header" id="to62_2122">2122</td><td nowrap="nowrap">Interferons.&nbsp;Proteínas&nbsp;da&nbsp;família&nbsp;das&nbsp;citocinas.&nbsp;Estimulam&nbsp;a&nbsp;resposta&nbsp;imune&nbsp;contra&nbsp;pa-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2221">2221</td><td nowrap="nowrap">tógenos&nbsp;como&nbsp;vírus,&nbsp;bactérias,&nbsp;parasitas&nbsp;e&nbsp;células&nbsp;tumorais.</td><td class="diff_next"></td><td class="diff_header" id="to62_2123">2123</td><td nowrap="nowrap">tógenos&nbsp;como&nbsp;vírus,&nbsp;bactérias,&nbsp;parasitas&nbsp;e&nbsp;células&nbsp;tumorais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2222">2222</td><td nowrap="nowrap">Janela&nbsp;diagnóstica.&nbsp;Conceito&nbsp;mais&nbsp;amplo&nbsp;que&nbsp;o&nbsp;de&nbsp;janela&nbsp;imunológica.&nbsp;O&nbsp;período&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to62_2124">2124</td><td nowrap="nowrap">Janela&nbsp;diagnóstica.&nbsp;Conceito&nbsp;mais&nbsp;amplo&nbsp;que&nbsp;o&nbsp;de&nbsp;janela&nbsp;imunológica.&nbsp;O&nbsp;período&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2223">2223</td><td nowrap="nowrap">de&nbsp;um&nbsp;marcador&nbsp;da&nbsp;infecção,&nbsp;seja&nbsp;ele&nbsp;DNA&nbsp;viral,&nbsp;RNA&nbsp;viral,&nbsp;antígeno&nbsp;ou&nbsp;anticorpo.&nbsp;A&nbsp;du-</td><td class="diff_next"></td><td class="diff_header" id="to62_2125">2125</td><td nowrap="nowrap">de&nbsp;um&nbsp;marcador&nbsp;da&nbsp;infecção,&nbsp;seja&nbsp;ele&nbsp;DNA&nbsp;viral,&nbsp;RNA&nbsp;viral,&nbsp;antígeno&nbsp;ou&nbsp;anticorpo.&nbsp;A&nbsp;du-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2224">2224</td><td nowrap="nowrap">ração&nbsp;desse&nbsp;período&nbsp;depende&nbsp;do&nbsp;tipo&nbsp;do&nbsp;teste,&nbsp;da&nbsp;sensibilidade&nbsp;do&nbsp;teste&nbsp;e&nbsp;do&nbsp;método</td><td class="diff_next"></td><td class="diff_header" id="to62_2126">2126</td><td nowrap="nowrap">ração&nbsp;desse&nbsp;período&nbsp;depende&nbsp;do&nbsp;tipo&nbsp;do&nbsp;teste,&nbsp;da&nbsp;sensibilidade&nbsp;do&nbsp;teste&nbsp;e&nbsp;do&nbsp;método</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2225">2225</td><td nowrap="nowrap">utilizado&nbsp;para&nbsp;detectar&nbsp;o&nbsp;marcador.</td><td class="diff_next"></td><td class="diff_header" id="to62_2127">2127</td><td nowrap="nowrap">utilizado&nbsp;para&nbsp;detectar&nbsp;o&nbsp;marcador.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2226">2226</td><td nowrap="nowrap">Janela&nbsp;imunológica.&nbsp;Duração&nbsp;do&nbsp;período&nbsp;entre&nbsp;uma&nbsp;infecção&nbsp;até&nbsp;a&nbsp;primeira&nbsp;detecção</td><td class="diff_next"></td><td class="diff_header" id="to62_2128">2128</td><td nowrap="nowrap">Janela&nbsp;imunológica.&nbsp;Duração&nbsp;do&nbsp;período&nbsp;entre&nbsp;uma&nbsp;infecção&nbsp;até&nbsp;a&nbsp;primeira&nbsp;detecção</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2227">2227</td><td nowrap="nowrap">de&nbsp;anticorpos&nbsp;contra&nbsp;o&nbsp;agente&nbsp;infeccioso.</td><td class="diff_next"></td><td class="diff_header" id="to62_2129">2129</td><td nowrap="nowrap">de&nbsp;anticorpos&nbsp;contra&nbsp;o&nbsp;agente&nbsp;infeccioso.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2228">2228</td><td nowrap="nowrap">Linfocitose.&nbsp;Aumento&nbsp;do&nbsp;número&nbsp;de&nbsp;linfócitos&nbsp;no&nbsp;sangue.</td><td class="diff_next"></td><td class="diff_header" id="to62_2130">2130</td><td nowrap="nowrap">Linfocitose.&nbsp;Aumento&nbsp;do&nbsp;número&nbsp;de&nbsp;linfócitos&nbsp;no&nbsp;sangue.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2229">2229</td><td nowrap="nowrap">ORF.&nbsp;Do&nbsp;inglês&nbsp;Open&nbsp;Reading&nbsp;Frame,&nbsp;o&nbsp;mesmo&nbsp;que&nbsp;Fase&nbsp;Aberta&nbsp;de&nbsp;Leitura.</td><td class="diff_next"></td><td class="diff_header" id="to62_2131">2131</td><td nowrap="nowrap">ORF.&nbsp;Do&nbsp;inglês&nbsp;Open&nbsp;Reading&nbsp;Frame,&nbsp;o&nbsp;mesmo&nbsp;que&nbsp;Fase&nbsp;Aberta&nbsp;de&nbsp;Leitura.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2230">2230</td><td nowrap="nowrap">Parênquima.&nbsp;Tecido&nbsp;que&nbsp;desempenha&nbsp;a&nbsp;função&nbsp;principal&nbsp;de&nbsp;um&nbsp;determinado&nbsp;órgão.</td><td class="diff_next"></td><td class="diff_header" id="to62_2132">2132</td><td nowrap="nowrap">Parênquima.&nbsp;Tecido&nbsp;que&nbsp;desempenha&nbsp;a&nbsp;função&nbsp;principal&nbsp;de&nbsp;um&nbsp;determinado&nbsp;órgão.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2231">2231</td><td nowrap="nowrap">Populações&nbsp;vulneráveis.&nbsp;Pessoas&nbsp;e&nbsp;grupos&nbsp;mais&nbsp;susceptíveis&nbsp;às&nbsp;infecções&nbsp;e&nbsp;adoecimen-</td><td class="diff_next"></td><td class="diff_header" id="to62_2133">2133</td><td nowrap="nowrap">Populações&nbsp;vulneráveis.&nbsp;Pessoas&nbsp;e&nbsp;grupos&nbsp;mais&nbsp;susceptíveis&nbsp;às&nbsp;infecções&nbsp;e&nbsp;adoecimen-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2232">2232</td><td nowrap="nowrap">tos&nbsp;do&nbsp;que&nbsp;outras,&nbsp;uma&nbsp;vez&nbsp;que&nbsp;dispõem&nbsp;de&nbsp;menos&nbsp;possibilidades&nbsp;de&nbsp;se&nbsp;proteger&nbsp;e&nbsp;se</td><td class="diff_next"></td><td class="diff_header" id="to62_2134">2134</td><td nowrap="nowrap">tos&nbsp;do&nbsp;que&nbsp;outras,&nbsp;uma&nbsp;vez&nbsp;que&nbsp;dispõem&nbsp;de&nbsp;menos&nbsp;possibilidades&nbsp;de&nbsp;se&nbsp;proteger&nbsp;e&nbsp;se</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2233">2233</td><td nowrap="nowrap">prevenir,&nbsp;ou&nbsp;cujo&nbsp;comportamento&nbsp;as&nbsp;expõe&nbsp;a&nbsp;fontes&nbsp;de&nbsp;infecção.</td><td class="diff_next"></td><td class="diff_header" id="to62_2135">2135</td><td nowrap="nowrap">prevenir,&nbsp;ou&nbsp;cujo&nbsp;comportamento&nbsp;as&nbsp;expõe&nbsp;a&nbsp;fontes&nbsp;de&nbsp;infecção.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2234">2234</td><td nowrap="nowrap">Ribonucleoproteína.&nbsp;Complexo&nbsp;contendo&nbsp;proteínas&nbsp;e&nbsp;ácido&nbsp;ribonucleico&nbsp;(RNA).</td><td class="diff_next"></td><td class="diff_header" id="to62_2136">2136</td><td nowrap="nowrap">Ribonucleoproteína.&nbsp;Complexo&nbsp;contendo&nbsp;proteínas&nbsp;e&nbsp;ácido&nbsp;ribonucleico&nbsp;(RNA).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2235">2235</td><td nowrap="nowrap">Sensibilidade&nbsp;clínica&nbsp;ou&nbsp;sensibilidade&nbsp;diagnóstica.&nbsp;Refere-se&nbsp;à&nbsp;capacidade&nbsp;de&nbsp;um&nbsp;en-</td><td class="diff_next"></td><td class="diff_header" id="to62_2137">2137</td><td nowrap="nowrap">Sensibilidade&nbsp;clínica&nbsp;ou&nbsp;sensibilidade&nbsp;diagnóstica.&nbsp;Refere-se&nbsp;à&nbsp;capacidade&nbsp;de&nbsp;um&nbsp;en-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2236">2236</td><td nowrap="nowrap">desordem&nbsp;clínica&nbsp;ou&nbsp;doença.</td><td class="diff_next"></td><td class="diff_header" id="to62_2138">2138</td><td nowrap="nowrap">desordem&nbsp;clínica&nbsp;ou&nbsp;doença.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2237">2237</td><td nowrap="nowrap">Serviço&nbsp;de&nbsp;saúde.&nbsp;Conjunto&nbsp;de&nbsp;instituições&nbsp;prestadoras&nbsp;de&nbsp;serviços&nbsp;de&nbsp;saúde&nbsp;no&nbsp;nível</td><td class="diff_next"></td><td class="diff_header" id="to62_2139">2139</td><td nowrap="nowrap">Serviço&nbsp;de&nbsp;saúde.&nbsp;Conjunto&nbsp;de&nbsp;instituições&nbsp;prestadoras&nbsp;de&nbsp;serviços&nbsp;de&nbsp;saúde&nbsp;no&nbsp;nível</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2238">2238</td><td nowrap="nowrap">municipal,&nbsp;estadual&nbsp;e&nbsp;federal.&nbsp;Deve-se&nbsp;observar&nbsp;a&nbsp;estrutura&nbsp;do&nbsp;sistema&nbsp;de&nbsp;saúde&nbsp;local</td><td class="diff_next"></td><td class="diff_header" id="to62_2140">2140</td><td nowrap="nowrap">municipal,&nbsp;estadual&nbsp;e&nbsp;federal.&nbsp;Deve-se&nbsp;observar&nbsp;a&nbsp;estrutura&nbsp;do&nbsp;sistema&nbsp;de&nbsp;saúde&nbsp;local</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2239">2239</td><td nowrap="nowrap">para&nbsp;um&nbsp;laboratório&nbsp;com&nbsp;infraestrutura&nbsp;suficiente&nbsp;para&nbsp;confirmar&nbsp;o&nbsp;diagnóstico.</td><td class="diff_next"></td><td class="diff_header" id="to62_2141">2141</td><td nowrap="nowrap">para&nbsp;um&nbsp;laboratório&nbsp;com&nbsp;infraestrutura&nbsp;suficiente&nbsp;para&nbsp;confirmar&nbsp;o&nbsp;diagnóstico.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2240">2240</td><td nowrap="nowrap">Tropismo.&nbsp;Propensão&nbsp;de&nbsp;um&nbsp;vírus&nbsp;possui&nbsp;a&nbsp;infectar&nbsp;determinado&nbsp;tipo&nbsp;de&nbsp;célula.&nbsp;Está</td><td class="diff_next"></td><td class="diff_header" id="to62_2142">2142</td><td nowrap="nowrap">Tropismo.&nbsp;Propensão&nbsp;de&nbsp;um&nbsp;vírus&nbsp;possui&nbsp;a&nbsp;infectar&nbsp;determinado&nbsp;tipo&nbsp;de&nbsp;célula.&nbsp;Está</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2241">2241</td><td nowrap="nowrap">virais.</td><td class="diff_next"></td><td class="diff_header" id="to62_2143">2143</td><td nowrap="nowrap">virais.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2242">2242</td><td nowrap="nowrap">Valor&nbsp;preditivo&nbsp;positivo.&nbsp;Proporção&nbsp;de&nbsp;indivíduos&nbsp;com&nbsp;um&nbsp;resultado&nbsp;positivo&nbsp;em&nbsp;um</td><td class="diff_next"></td><td class="diff_header" id="to62_2144">2144</td><td nowrap="nowrap">Valor&nbsp;preditivo&nbsp;positivo.&nbsp;Proporção&nbsp;de&nbsp;indivíduos&nbsp;com&nbsp;um&nbsp;resultado&nbsp;positivo&nbsp;em&nbsp;um</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2243">2243</td><td nowrap="nowrap">teste&nbsp;e&nbsp;que&nbsp;apresentam&nbsp;a&nbsp;doença&nbsp;ou&nbsp;condição&nbsp;de&nbsp;interesse.&nbsp;Esse&nbsp;valor,&nbsp;normalmente,&nbsp;é</td><td class="diff_next"></td><td class="diff_header" id="to62_2145">2145</td><td nowrap="nowrap">teste&nbsp;e&nbsp;que&nbsp;apresentam&nbsp;a&nbsp;doença&nbsp;ou&nbsp;condição&nbsp;de&nbsp;interesse.&nbsp;Esse&nbsp;valor,&nbsp;normalmente,&nbsp;é</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2244">2244</td><td nowrap="nowrap">informado&nbsp;em&nbsp;porcentagem.</td><td class="diff_next"></td><td class="diff_header" id="to62_2146">2146</td><td nowrap="nowrap">informado&nbsp;em&nbsp;porcentagem.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2245">2245</td><td nowrap="nowrap">Via&nbsp;parenteral.&nbsp;Administração&nbsp;de&nbsp;fármacos&nbsp;ou&nbsp;nutrição&nbsp;por&nbsp;meios&nbsp;injetáveis,&nbsp;sejam&nbsp;eles</td><td class="diff_next"></td><td class="diff_header" id="to62_2147">2147</td><td nowrap="nowrap">Via&nbsp;parenteral.&nbsp;Administração&nbsp;de&nbsp;fármacos&nbsp;ou&nbsp;nutrição&nbsp;por&nbsp;meios&nbsp;injetáveis,&nbsp;sejam&nbsp;eles</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2246">2246</td><td nowrap="nowrap">intradérmicos,&nbsp;subcutâneos,&nbsp;intramusculares&nbsp;ou&nbsp;endovenosos.</td><td class="diff_next"></td><td class="diff_header" id="to62_2148">2148</td><td nowrap="nowrap">intradérmicos,&nbsp;subcutâneos,&nbsp;intramusculares&nbsp;ou&nbsp;endovenosos.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2247">2247</td><td nowrap="nowrap">Vírion.&nbsp;Partícula&nbsp;viral&nbsp;completa,&nbsp;estruturalmente&nbsp;intacta&nbsp;e&nbsp;infecciosa.</td><td class="diff_next"></td><td class="diff_header" id="to62_2149">2149</td><td nowrap="nowrap">Vírion.&nbsp;Partícula&nbsp;viral&nbsp;completa,&nbsp;estruturalmente&nbsp;intacta&nbsp;e&nbsp;infecciosa.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2248">2248</td><td nowrap="nowrap">Capa:</td><td class="diff_next"></td><td class="diff_header" id="to62_2150">2150</td><td nowrap="nowrap">Capa:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2249">2249</td><td nowrap="nowrap">Formato:&nbsp;A4&nbsp;-&nbsp;4&nbsp;pg</td><td class="diff_next"></td><td class="diff_header" id="to62_2151">2151</td><td nowrap="nowrap">Formato:&nbsp;A4&nbsp;-&nbsp;4&nbsp;pg</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2250">2250</td><td nowrap="nowrap">Cor:&nbsp;4/4</td><td class="diff_next"></td><td class="diff_header" id="to62_2152">2152</td><td nowrap="nowrap">Cor:&nbsp;4/4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2251">2251</td><td nowrap="nowrap">Papel:&nbsp;Supremo&nbsp;Couchê&nbsp;Fosco&nbsp;320&nbsp;g</td><td class="diff_next"></td><td class="diff_header" id="to62_2153">2153</td><td nowrap="nowrap">Papel:&nbsp;Supremo&nbsp;Couchê&nbsp;Fosco&nbsp;320&nbsp;g</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2252">2252</td><td nowrap="nowrap">Encadernação:&nbsp;Lombada&nbsp;quadrada</td><td class="diff_next"></td><td class="diff_header" id="to62_2154">2154</td><td nowrap="nowrap">Encadernação:&nbsp;Lombada&nbsp;quadrada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2253">2253</td><td nowrap="nowrap">Acabamento:&nbsp;BOPP</td><td class="diff_next"></td><td class="diff_header" id="to62_2155">2155</td><td nowrap="nowrap">Acabamento:&nbsp;BOPP</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2254">2254</td><td nowrap="nowrap">Miolo:</td><td class="diff_next"></td><td class="diff_header" id="to62_2156">2156</td><td nowrap="nowrap">Miolo:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2255">2255</td><td nowrap="nowrap">Formato:&nbsp;A4&nbsp;-&nbsp;216&nbsp;pg</td><td class="diff_next"></td><td class="diff_header" id="to62_2157">2157</td><td nowrap="nowrap">Formato:&nbsp;A4&nbsp;-&nbsp;216&nbsp;pg</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2256">2256</td><td nowrap="nowrap">Cor:&nbsp;4/4</td><td class="diff_next"></td><td class="diff_header" id="to62_2158">2158</td><td nowrap="nowrap">Cor:&nbsp;4/4</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2257">2257</td><td nowrap="nowrap">Papel:&nbsp;Off&nbsp;set&nbsp;90&nbsp;g/m²</td><td class="diff_next"></td><td class="diff_header" id="to62_2159">2159</td><td nowrap="nowrap">Papel:&nbsp;Off&nbsp;set&nbsp;90&nbsp;g/m²</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2258">2258</td><td nowrap="nowrap">Gráfica:</td><td class="diff_next"></td><td class="diff_header" id="to62_2160">2160</td><td nowrap="nowrap">Gráfica:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2259">2259</td><td nowrap="nowrap">Tiragem:&nbsp;2.000</td><td class="diff_next"></td><td class="diff_header" id="to62_2161">2161</td><td nowrap="nowrap">Tiragem:&nbsp;2.000</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from62_2260">2260</td><td nowrap="nowrap">www.saude.gov.br/bvs</td><td class="diff_next"></td><td class="diff_header" id="to62_2162">2162</td><td nowrap="nowrap">www.saude.gov.br/bvs</td></tr>
        </tbody>
    </table>
    <table class="diff" summary="Legends">
        <tr> <th colspan="2"> Legends </th> </tr>
        <tr> <td> <table border="" summary="Colors">
                      <tr><th> Colors </th> </tr>
                      <tr><td class="diff_add">&nbsp;Added&nbsp;</td></tr>
                      <tr><td class="diff_chg">Changed</td> </tr>
                      <tr><td class="diff_sub">Deleted</td> </tr>
                  </table></td>
             <td> <table border="" summary="Links">
                      <tr><th colspan="2"> Links </th> </tr>
                      <tr><td>(f)irst change</td> </tr>
                      <tr><td>(n)ext change</td> </tr>
                      <tr><td>(t)op</td> </tr>
                  </table></td> </tr>
    </table>
</body>

</html>